1	Annu	NNP	PERSON	Annu	_	0	SENT_1	[p1l352t1775r375b1855],
2	.	.	O	.	_	0	SENT_1	[p1l352t1775r375b1855],

1	Rev.	NNP	O	Rev.	nn	2	SENT_2	[p1l352t1704r375b1764],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_2	[p1l352t1544r375b1693],
3	.	.	O	.	_	0	SENT_2	[p1l352t1544r375b1693],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_3	[p1l352t1424r375b1534],
2	.	.	O	.	_	0	SENT_3	[p1l352t1424r375b1534],

1	1996.36:161	CD	NUMBER	1996.36:161	num	2	SENT_4	[p1l352t1104r376b1336],
2	-183	CD	NUMBER	-183	_	0	SENT_4	[p1l352t1104r376b1336],
3	.	.	O	.	_	0	SENT_4	[p1l352t1104r376b1336],

1	Downloaded	VBN	O	download	_	0	SENT_5	[p1l352t924r375b1093],
2	from	IN	O	from	_	0	SENT_5	[p1l352t850r375b915],
3	wwwxannualr	NN	O	wwwxannualr	nn	5	SENT_5	[p1l352t660r375b841],
4	eviews.org	NN	O	eviews.org	nn	5	SENT_5	[p1l352t502r382b647],
5	onsin	NN	O	onsin	prep_from	1	SENT_5	[p1l385t1278r409b1349],
6	-	:	O	-	_	0	SENT_5	[p1l399t1259r402b1268],
7	Madison	NNP	O	Madison	dep	5	SENT_5	[p1l385t1133r409b1249],
8	on	IN	O	on	_	0	SENT_5	[p1l393t1091r409b1124],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_5	[p1l385t958r409b1082],
10	.	.	O	.	_	0	SENT_5	[p1l385t958r409b1082],

1	For	IN	O	for	_	0	SENT_6	[p1l386t901r409b947],
2	personal	JJ	O	personal	amod	3	SENT_6	[p1l385t781r416b893],
3	use	NN	O	use	pobj	1	SENT_6	[p1l393t727r409b771],
4	only	RB	O	only	advmod	3	SENT_6	[p1l385t660r416b718],
5	.	.	O	.	_	0	SENT_6	[p1l405t639r409b643],

1	1ualreviews	NNS	O	1ualreview	_	0	SENT_7	[p1l360t3030r390b3235],
2	.	.	O	.	_	0	SENT_7	[p1l360t3030r390b3235],

1	org	RB	O	org	_	0	SENT_8	[p1l360t3030r390b3235],
2	only	RB	O	only	dep	1	SENT_8	[p1l393t3167r424b3232],
3	.	.	O	.	_	0	SENT_8	[p1l393t3167r424b3232],

1	by	IN	O	by	_	0	SENT_9	[p1l385t1687r416b1719],
2	University	NNP	ORGANIZATION	University	pobj	1	SENT_9	[p1l385t1538r416b1677],
3	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l385t1499r409b1528],
4	Wise	NNP	ORGANIZATION	Wise	prep_of	2	SENT_9	[p1l385t1425r409b1492],

1	Annual	JJ	SET	annual	amod	2	SENT_10	[p1l442t21r563b50],
2	Reviews	NNS	O	review	nsubj	3	SENT_10	[p1l575t21r717b59],
3	_	VBP	O	_	_	0	SENT_10	[p1l949t54r954b59],
4	www.annualrev1ews.org	NN	O	www.annualrev1ews.org	dobj	3	SENT_10	[p1l442t54r861b92],
5	/	:	O	/	punct	6	SENT_10	[p1l442t54r861b92],
6	aronline	NN	O	aronline	dep	4	SENT_10	[p1l862t54r996b83],

1	Annu	NNP	PERSON	Annu	_	0	SENT_11	[p1l498t98r566b119],
2	.	.	O	.	_	0	SENT_11	[p1l498t98r566b119],

1	Rev.	NNP	O	Rev.	nn	3	SENT_12	[p1l577t98r625b120],
2	PharmaooL	NNP	PERSON	PharmaooL	nn	3	SENT_12	[p1l636t98r771b120],
3	Toxicol	NNP	PERSON	Toxicol	_	0	SENT_12	[p1l784t98r874b119],
4	.	.	O	.	_	0	SENT_12	[p1l784t98r874b119],

1	1996	CD	DATE	1996	_	0	SENT_13	[p1l887t98r948b120],
2	.	.	O	.	_	0	SENT_13	[p1l887t98r948b120],

1	36361-83	CD	NUMBER	36361-83	num	3	SENT_14	[p1l959t97r1086b120],
2	Copyright	NN	O	copyright	nn	3	SENT_14	[p1l501t131r618b159],
3	o	NN	O	o	_	0	SENT_14	[p1l626t132r649b154],
4	1996	CD	DATE	1996	dep	3	SENT_14	[p1l658t131r718b154],
5	by	IN	O	by	_	0	SENT_14	[p1l724t132r753b159],
6	Annual	JJ	SET	annual	amod	7	SENT_14	[p1l760t132r846b153],
7	Review	NN	O	review	prep_by	4	SENT_14	[p1l853t132r950b153],
8	:	:	O	:	_	0	SENT_14	[p1l853t132r950b153],
9	Inc.	NNP	O	Inc.	dep	3	SENT_14	[p1l957t133r999b153],
10	.	.	O	.	_	0	SENT_14	[p1l957t133r999b153],

1	All	DT	O	all	det	2	SENT_15	[p1l1010t132r1046b153],
2	right	NN	O	right	_	0	SENT_15	[p1l1054t132r1121b159],
3	:	:	O	:	_	0	SENT_15	[p1l1054t132r1121b159],
4	reserved	VBN	O	reserve	dep	2	SENT_15	[p1l1132t132r1232b154],

1	P-GLYCOPROTEINS	NNPS	O	P-GLYCOPROTEINS	_	0	SENT_16	[p1l500t234r1179b289],
2	AND	CC	O	and	_	0	SENT_16	[p1l1208t235r1367b288],
3	MULTIDRUG	NNPS	O	MULTIDRUG	conj_and	1	SENT_16	[p1l500t324r951b377],
4	RESISTANCE	NN	O	resistance	dep	1	SENT_16	[p1l975t323r1428b377],

1	William	NNP	PERSON	William	nn	4	SENT_17	[p1l503t452r658b489],
2	T.	NNP	PERSON	T.	nn	4	SENT_17	[p1l675t454r710b489],
3	Bellamy	NNP	PERSON	Bellamy	nn	4	SENT_17	[p1l729t452r893b498],
4	Department	NNP	ORGANIZATION	Department	_	0	SENT_17	[p1l500t510r678b546],
5	of	IN	ORGANIZATION	of	_	0	SENT_17	[p1l689t510r722b539],
6	Pathology	NNP	ORGANIZATION	Pathology	nn	8	SENT_17	[p1l731t510r893b546],
7	,	,	O	,	_	0	SENT_17	[p1l731t510r893b546],
8	University	NNP	ORGANIZATION	University	prep_of	4	SENT_17	[p1l905t510r1061b546],
9	of	IN	ORGANIZATION	of	_	0	SENT_17	[p1l1075t509r1107b538],
10	Arizona	NNP	ORGANIZATION	Arizona	nn	12	SENT_17	[p1l1117t510r1246b543],
11	,	,	O	,	_	0	SENT_17	[p1l1117t510r1246b543],
12	Tucson	NNP	LOCATION	Tucson	prep_of	8	SENT_17	[p1l1258t510r1375b543],
13	,	,	O	,	_	0	SENT_17	[p1l1258t510r1375b543],
14	Arizona	NNP	LOCATION	Arizona	dep	4	SENT_17	[p1l1390t510r1510b539],
15	85724	CD	NUMBER	85724	num	14	SENT_17	[p1l1523t510r1615b539],

1	KEY	JJ	O	key	amod	2	SENT_18	[p1l501t602r569b627],
2	WORDS	NNS	O	word	_	0	SENT_18	[p1l580t602r707b628],
3	:	:	O	:	_	0	SENT_18	[p1l580t602r707b628],
4	cancer	NN	O	cancer	nn	12	SENT_18	[p1l751t609r845b631],
5	,	,	O	,	_	0	SENT_18	[p1l751t609r845b631],
6	MDR1	NN	O	mdr1	dep	12	SENT_18	[p1l856t602r955b631],
7	,	,	O	,	_	0	SENT_18	[p1l856t602r955b631],
8	P-glycoprotein	NN	O	p-glycoprotein	dep	12	SENT_18	[p1l968t602r1171b634],
9	,	,	O	,	_	0	SENT_18	[p1l968t602r1171b634],
10	MRP	NN	ORGANIZATION	mrp	dep	12	SENT_18	[p1l1183t603r1260b631],
11	,	,	O	,	_	0	SENT_18	[p1l1183t603r1260b631],
12	chemosensitization	NN	O	chemosensitization	dep	2	SENT_18	[p1l1272t602r1525b628],

1	ABSTRACT	NN	O	abstract	_	0	SENT_19	[p1l1062t730r1242b761],

1	Multidrug	JJ	O	multidrug	amod	2	SENT_20	[p1l551t806r703b843],
2	resistance	NN	O	resistance	nsubj	3	SENT_20	[p1l719t806r866b835],
3	represents	VBZ	O	represent	_	0	SENT_20	[p1l881t811r1033b843],
4	a	DT	O	a	det	6	SENT_20	[p1l1050t815r1065b835],
5	major	JJ	O	major	amod	6	SENT_20	[p1l1081t806r1168b842],
6	obstacle	NN	O	obstacle	dobj	3	SENT_20	[p1l1183t807r1304b835],
7	in	IN	O	in	_	0	SENT_20	[p1l1320t806r1348b835],
8	the	DT	O	the	det	10	SENT_20	[p1l1364t806r1409b835],
9	successful	JJ	O	successful	amod	10	SENT_20	[p1l1426t806r1579b836],
10	therapy	NN	O	therapy	prep_in	6	SENT_20	[p1l1595t807r1707b843],
11	of	IN	O	of	_	0	SENT_20	[p1l1724t807r1757b836],
12	neoplastic	JJ	O	neoplastic	amod	13	SENT_20	[p1l552t849r703b885],
13	diseases	NNS	O	disease	prep_of	10	SENT_20	[p1l713t849r845b877],
14	.	.	O	.	_	0	SENT_20	[p1l713t849r845b877],

1	Studies	NNS	O	study	nsubj	3	SENT_21	[p1l857t848r966b877],
2	have	VBP	O	have	aux	3	SENT_21	[p1l976t849r1048b877],
3	demonstrated	VBN	O	demonstrate	_	0	SENT_21	[p1l1059t848r1260b877],
4	that	IN	O	that	complm	10	SENT_21	[p1l1271t849r1327b877],
5	this	DT	O	this	det	6	SENT_21	[p1l1337t849r1390b877],
6	form	NN	O	form	nsubj	10	SENT_21	[p1l1402t848r1475b877],
7	of	IN	O	of	_	0	SENT_21	[p1l1485t849r1519b877],
8	drug	NN	O	drug	nn	9	SENT_21	[p1l1527t849r1596b885],
9	resistance	NN	O	resistance	prep_of	6	SENT_21	[p1l1607t848r1755b878],
10	occurs	VBZ	O	occur	ccomp	3	SENT_21	[p1l550t899r648b920],
11	both	CC	O	both	advmod	10	SENT_21	[p1l660t891r728b920],
12	in	IN	O	in	_	0	SENT_21	[p1l742t891r770b919],
13	cultured	VBN	O	culture	prepc_in	10	SENT_21	[p1l782t891r906b920],
14	tumor	NN	O	tumor	nn	16	SENT_21	[p1l918t896r1009b920],
15	cell	NN	O	cell	nn	16	SENT_21	[p1l1021t891r1074b920],
16	lines	NNS	O	line	dobj	13	SENT_21	[p1l1088t890r1156b919],
17	as	RB	O	as	_	0	SENT_21	[p1l1171t900r1200b920],
18	well	RB	O	well	_	0	SENT_21	[p1l1214t891r1278b920],
19	as	IN	O	as	_	0	SENT_21	[p1l1291t899r1320b919],
20	in	IN	O	in	_	0	SENT_21	[p1l1334t891r1361b919],
21	human	JJ	O	human	amod	22	SENT_21	[p1l1376t891r1477b920],
22	cancers	NNS	O	cancer	conj_and	13	SENT_21	[p1l1490t899r1610b920],
23	.	.	O	.	_	0	SENT_21	[p1l1490t899r1610b920],

1	Pglycoprotein	NN	PERSON	pglycoprotein	nsubj	2	SENT_22	[p1l1624t891r1753b927, p1l551t933r656b969],
2	appears	VBZ	O	appear	_	0	SENT_22	[p1l669t941r784b970],
3	to	TO	O	to	aux	4	SENT_22	[p1l797t937r825b961],
4	play	VB	O	play	xcomp	2	SENT_22	[p1l838t932r902b970],
5	an	DT	O	a	det	7	SENT_22	[p1l915t942r951b962],
6	important	JJ	O	important	amod	7	SENT_22	[p1l963t933r1109b969],
7	role	NN	O	role	dobj	4	SENT_22	[p1l1121t933r1179b962],
8	in	IN	O	in	_	0	SENT_22	[p1l1192t933r1220b962],
9	such	JJ	O	such	amod	10	SENT_22	[p1l1234t933r1301b962],
10	cells	NNS	O	cell	prep_in	7	SENT_22	[p1l1314t932r1380b961],
11	by	IN	O	by	_	0	SENT_22	[p1l1394t932r1431b969],
12	acting	VBG	O	act	prepc_by	4	SENT_22	[p1l1445t933r1534b969],
13	as	IN	O	as	_	0	SENT_22	[p1l1548t941r1578b961],
14	an	DT	O	a	det	17	SENT_22	[p1l1592t941r1626b961],
15	energydependent	JJ	O	energydependent	amod	17	SENT_22	[p1l1639t941r1754b970, p1l551t975r706b1012],
16	efflux	NN	O	efflux	nn	17	SENT_22	[p1l718t975r809b1004],
17	pump	NN	O	pump	prep_as	12	SENT_22	[p1l822t983r907b1012],
18	to	TO	O	to	aux	19	SENT_22	[p1l921t980r950b1004],
19	remove	VB	O	remove	xcomp	12	SENT_22	[p1l963t984r1076b1004],
20	various	JJ	O	various	amod	23	SENT_22	[p1l1090t975r1199b1005],
21	natural	JJ	O	natural	amod	23	SENT_22	[p1l1214t975r1315b1004],
22	product	NN	O	product	nn	23	SENT_22	[p1l1330t975r1445b1012],
23	drugs	NNS	O	drug	dobj	19	SENT_22	[p1l1458t976r1541b1013],
24	from	IN	O	from	_	0	SENT_22	[p1l1556t975r1629b1004],
25	the	DT	O	the	det	26	SENT_22	[p1l1642t975r1687b1004],
26	cell	NN	O	cell	prep_from	19	SENT_22	[p1l1701t976r1754b1005],
27	before	IN	O	before	mark	29	SENT_22	[p1l551t1017r647b1047],
28	they	PRP	O	they	nsubj	29	SENT_22	[p1l662t1018r727b1055],
29	have	VBP	O	have	advcl	19	SENT_22	[p1l743t1018r814b1047],
30	a	DT	O	a	det	31	SENT_22	[p1l830t1026r847b1046],
31	chance	NN	O	chance	dobj	29	SENT_22	[p1l862t1018r967b1047],
32	to	TO	O	to	aux	33	SENT_22	[p1l982t1023r1010b1047],
33	exert	VB	O	exert	infmod	31	SENT_22	[p1l1025t1022r1101b1047],
34	their	PRP$	O	they	poss	36	SENT_22	[p1l1116t1018r1185b1047],
35	cytotoxic	JJ	O	cytotoxic	amod	36	SENT_22	[p1l1200t1018r1337b1055],
36	effects	NNS	O	effect	dobj	33	SENT_22	[p1l1354t1017r1462b1047],
37	.	.	O	.	_	0	SENT_22	[p1l1354t1017r1462b1047],

1	Expression	NN	O	expression	nsubjpass	9	SENT_23	[p1l1479t1018r1645b1055],
2	of	IN	O	of	_	0	SENT_23	[p1l1662t1017r1696b1047],
3	the	DT	O	the	det	6	SENT_23	[p1l1710t1019r1755b1047],
4	MDR1	NN	O	mdr1	nn	6	SENT_23	[p1l551t1059r653b1088],
5	gene	NN	O	gene	nn	6	SENT_23	[p1l664t1068r735b1096],
6	product	NN	O	product	prep_of	1	SENT_23	[p1l742t1059r857b1096],
7	has	VBZ	O	have	aux	9	SENT_23	[p1l863t1059r914b1088],
8	been	VBN	O	be	auxpass	9	SENT_23	[p1l921t1060r991b1088],
9	associated	VBN	O	associate	_	0	SENT_23	[p1l1000t1059r1153b1088],
10	with	IN	O	with	_	0	SENT_23	[p1l1161t1060r1227b1088],
11	a	DT	O	a	det	13	SENT_23	[p1l1235t1068r1251b1088],
12	poor	JJ	O	poor	amod	13	SENT_23	[p1l1259t1068r1327b1096],
13	prognosis	NN	O	prognosis	prep_with	9	SENT_23	[p1l1334t1060r1479b1096],
14	in	IN	O	in	_	0	SENT_23	[p1l1489t1060r1516b1088],
15	clinical	JJ	O	clinical	amod	16	SENT_23	[p1l1524t1060r1634b1088],
16	studies	NNS	O	study	prep_in	13	SENT_23	[p1l1642t1060r1753b1089],
17	.	.	O	.	_	0	SENT_23	[p1l1642t1060r1753b1089],

1	It	PRP	O	it	nsubjpass	4	SENT_24	[p1l551t1103r576b1129],
2	has	VBZ	O	have	aux	4	SENT_24	[p1l593t1102r643b1130],
3	been	VBN	O	be	auxpass	4	SENT_24	[p1l661t1103r733b1130],
4	demonstrated	VBN	O	demonstrate	_	0	SENT_24	[p1l751t1103r954b1130],
5	in	IN	O	in	_	0	SENT_24	[p1l972t1103r1000b1130],
6	the	DT	O	the	det	7	SENT_24	[p1l1020t1103r1065b1130],
7	laboratory	NN	O	laboratory	prep_in	4	SENT_24	[p1l1084t1102r1237b1138],
8	that	WDT	O	that	dobj	16	SENT_24	[p1l1257t1103r1313b1130],
9	resistance	NN	O	resistance	nsubjpass	16	SENT_24	[p1l1330t1102r1478b1130],
10	mediated	VBN	O	mediate	partmod	9	SENT_24	[p1l1498t1103r1633b1130],
11	by	IN	O	by	_	0	SENT_24	[p1l1653t1103r1689b1137],
12	the	DT	O	the	det	13	SENT_24	[p1l1710t1103r1755b1130],
13	P-glycoprotein	NN	O	p-glycoprotein	agent	10	SENT_24	[p1l552t1144r774b1180],
14	may	MD	O	may	aux	16	SENT_24	[p1l785t1152r849b1179],
15	be	VB	O	be	auxpass	16	SENT_24	[p1l859t1144r896b1172],
16	modulated	VBN	O	modulate	rcmod	7	SENT_24	[p1l905t1144r1063b1171],
17	by	IN	O	by	_	0	SENT_24	[p1l1072t1144r1110b1179],
18	a	DT	O	a	det	20	SENT_24	[p1l1122t1152r1138b1170],
19	wide	JJ	O	wide	amod	20	SENT_24	[p1l1148t1145r1220b1172],
20	variety	NN	O	variety	agent	16	SENT_24	[p1l1232t1144r1333b1179],
21	of	IN	O	of	_	0	SENT_24	[p1l1344t1144r1378b1171],
22	compounds	NNS	O	compound	prep_of	20	SENT_24	[p1l1386t1145r1566b1180],
23	.	.	O	.	_	0	SENT_24	[p1l1386t1145r1566b1180],

1	These	DT	O	these	det	2	SENT_25	[p1l1577t1145r1668b1171],
2	compounds	NNS	O	compound	nsubj	11	SENT_25	[p1l1678t1152r1754b1172, p1l551t1185r667b1219],
3	,	,	O	,	_	0	SENT_25	[p1l1678t1152r1754b1172, p1l551t1185r667b1219],
4	which	WDT	O	which	nsubj	5	SENT_25	[p1l685t1184r776b1211],
5	include	VBP	O	include	rcmod	2	SENT_25	[p1l791t1184r901b1211],
6	verapamil	NN	O	verapamil	dobj	5	SENT_25	[p1l916t1184r1064b1219],
7	and	CC	O	and	_	0	SENT_25	[p1l1080t1184r1134b1211],
8	cyclosporin	NN	O	cyclosporin	dobj	5	SENT_25	[p1l1149t1184r1330b1219],
9	,	,	O	,	_	0	SENT_25	[p1l1149t1184r1330b1219],
10	generally	RB	O	generally	advmod	11	SENT_25	[p1l1347t1185r1485b1219],
11	have	VBP	O	have	_	0	SENT_25	[p1l1502t1185r1572b1211],
12	little	JJ	O	little	dobj	11	SENT_25	[p1l1588t1184r1655b1211],
13	or	CC	O	or	_	0	SENT_25	[p1l1671t1192r1702b1211],
14	no	DT	O	no	det	15	SENT_25	[p1l1718t1193r1753b1212],
15	effect	NN	O	effect	conj_or	12	SENT_25	[p1l551t1225r638b1253],
16	by	IN	O	by	_	0	SENT_25	[p1l652t1227r690b1261],
17	themselves	PRP	O	themselves	prep_by	15	SENT_25	[p1l707t1226r873b1253],
18	on	IN	O	on	dep	15	SENT_25	[p1l889t1235r926b1253],
19	the	DT	O	the	det	21	SENT_25	[p1l942t1227r989b1253],
20	tumor	NN	O	tumor	nn	21	SENT_25	[p1l1005t1230r1095b1253],
21	cells	NNS	O	cell	pobj	18	SENT_25	[p1l1110t1226r1186b1258],
22	,	,	O	,	_	0	SENT_25	[p1l1110t1226r1186b1258],
23	but	CC	O	but	_	0	SENT_25	[p1l1203t1227r1252b1253],
24	when	WRB	O	when	advmod	25	SENT_25	[p1l1268t1226r1347b1253],
25	used	VBN	O	use	dep	15	SENT_25	[p1l1364t1227r1433b1253],
26	in	IN	O	in	_	0	SENT_25	[p1l1450t1227r1478b1253],
27	conjunction	NN	O	conjunction	prep_in	25	SENT_25	[p1l1495t1226r1671b1261],
28	with	IN	O	with	_	0	SENT_25	[p1l1689t1226r1754b1253],
29	antineoplastic	JJ	O	antineoplastic	amod	30	SENT_25	[p1l552t1267r759b1304],
30	agents	NNS	O	agent	prep_with	25	SENT_25	[p1l773t1272r876b1304],
31	,	,	O	,	_	0	SENT_25	[p1l773t1272r876b1304],
32	they	PRP	O	they	nsubj	33	SENT_25	[p1l890t1268r954b1304],
33	decrease	VBP	O	decrease	dep	25	SENT_25	[p1l968t1268r1104b1300],
34	,	,	O	,	_	0	SENT_25	[p1l968t1268r1104b1300],
35	and	CC	O	and	_	0	SENT_25	[p1l1119t1268r1172b1296],
36	in	IN	O	in	mark	39	SENT_25	[p1l1186t1268r1213b1296],
37	some	DT	O	some	det	38	SENT_25	[p1l1229t1276r1306b1296],
38	instances	NNS	O	instance	nsubj	39	SENT_25	[p1l1320t1268r1456b1296],
39	eliminate	VBP	O	eliminate	dep	25	SENT_25	[p1l1469t1268r1617b1300],
40	,	,	O	,	_	0	SENT_25	[p1l1469t1268r1617b1300],
41	drug	NN	O	drug	nn	42	SENT_25	[p1l1631t1268r1700b1303],
42	resistance	NN	O	resistance	dobj	11	SENT_25	[p1l1714t1277r1754b1296, p1l553t1308r679b1338],
43	.	.	O	.	_	0	SENT_25	[p1l1714t1277r1754b1296, p1l553t1308r679b1338],

1	Clinical	JJ	O	clinical	amod	2	SENT_26	[p1l692t1309r809b1338],
2	trials	NNS	O	trial	nsubj	8	SENT_26	[p1l821t1308r895b1338],
3	to	TO	O	to	aux	4	SENT_26	[p1l907t1314r936b1338],
4	modulate	VB	O	modulate	infmod	2	SENT_26	[p1l948t1309r1086b1338],
5	P-glycoprotein	NN	MISC	p-glycoprotein	nn	6	SENT_26	[p1l1097t1308r1318b1346],
6	activity	NN	O	activity	dobj	4	SENT_26	[p1l1331t1308r1442b1346],
7	are	VBP	O	be	cop	8	SENT_26	[p1l1455t1318r1500b1338],
8	underway	NN	O	underway	_	0	SENT_26	[p1l1512t1309r1659b1345],
9	at	IN	O	at	_	0	SENT_26	[p1l1672t1313r1698b1337],
10	the	DT	O	the	det	12	SENT_26	[p1l1710t1310r1755b1338],
11	present	JJ	DATE	present	amod	12	SENT_26	[p1l552t1429r662b1462],
12	time	NN	O	time	prep_at	8	SENT_26	[p1l671t1425r737b1454],
13	to	TO	O	to	aux	14	SENT_26	[p1l747t1429r776b1454],
14	determine	VB	O	determine	infmod	12	SENT_26	[p1l785t1425r935b1454],
15	if	IN	O	if	mark	20	SENT_26	[p1l945t1425r970b1454],
16	such	JJ	O	such	amod	17	SENT_26	[p1l978t1425r1045b1454],
17	strategies	NNS	O	strategy	nsubj	20	SENT_26	[p1l1057t1425r1196b1461],
18	will	MD	O	will	aux	20	SENT_26	[p1l1206t1425r1264b1454],
19	be	VB	O	be	cop	20	SENT_26	[p1l1274t1425r1308b1454],
20	feasible	JJ	O	feasible	advcl	14	SENT_26	[p1l1320t1425r1442b1454],
21	.	.	O	.	_	0	SENT_26	[p1l1320t1425r1442b1454],

1	Although	IN	O	although	mark	5	SENT_27	[p1l1454t1425r1596b1462],
2	the	DT	O	the	det	3	SENT_27	[p1l1605t1425r1651b1454],
3	Pglycoprotein	NN	O	pglycoprotein	nsubjpass	5	SENT_27	[p1l1662t1425r1755b1463, p1l552t1468r694b1504],
4	is	VBZ	O	be	auxpass	5	SENT_27	[p1l714t1468r737b1497],
5	expressed	VBN	O	express	advcl	22	SENT_27	[p1l756t1468r903b1504],
6	in	IN	O	in	_	0	SENT_27	[p1l923t1468r951b1497],
7	many	JJ	O	many	amod	9	SENT_27	[p1l970t1476r1051b1504],
8	cell	NN	O	cell	nn	9	SENT_27	[p1l1072t1467r1125b1496],
9	lines	NNS	O	line	prep_in	5	SENT_27	[p1l1145t1467r1213b1497],
10	and	CC	O	and	_	0	SENT_27	[p1l1233t1468r1285b1497],
11	occurs	VBZ	O	occur	advcl	22	SENT_27	[p1l1304t1476r1401b1496],
12	in	IN	O	in	_	0	SENT_27	[p1l1421t1467r1448b1497],
13	patient	NN	O	patient	nn	14	SENT_27	[p1l1468t1468r1569b1505],
14	tumors	NNS	O	tumor	prep_in	11	SENT_27	[p1l1589t1472r1702b1502],
15	,	,	O	,	_	0	SENT_27	[p1l1589t1472r1702b1502],
16	its	PRP$	O	its	poss	17	SENT_27	[p1l1721t1468r1755b1497],
17	expression	NN	O	expression	nsubj	22	SENT_27	[p1l551t1510r712b1546],
18	is	VBZ	O	be	cop	22	SENT_27	[p1l720t1509r745b1539],
19	not	RB	O	not	neg	22	SENT_27	[p1l753t1514r802b1539],
20	a	DT	O	a	det	22	SENT_27	[p1l809t1518r825b1538],
21	universal	JJ	O	universal	amod	22	SENT_27	[p1l832t1509r969b1539],
22	feature	NN	O	feature	_	0	SENT_27	[p1l977t1510r1081b1539],
23	of	IN	O	of	_	0	SENT_27	[p1l1089t1509r1122b1538],
24	multidru	FW	O	multidru	prep_of	22	SENT_27	[p1l1128t1510r1254b1539],
25	g	NN	O	g	nn	26	SENT_27	[p1l1256t1518r1274b1547],
26	resistance	NN	O	resistance	dep	24	SENT_27	[p1l1281t1509r1437b1544],
27	,	,	O	,	_	0	SENT_27	[p1l1281t1509r1437b1544],
28	suggesting	VBG	O	suggest	partmod	24	SENT_27	[p1l1447t1510r1606b1547],
29	that	IN	O	that	complm	33	SENT_27	[p1l1614t1510r1671b1539],
30	other	JJ	O	other	amod	31	SENT_27	[p1l1678t1511r1756b1540],
31	mechanisms	NNS	O	mechanism	nsubj	33	SENT_27	[p1l552t1553r737b1581],
32	are	VBP	O	be	aux	33	SENT_27	[p1l749t1561r795b1581],
33	operating	VBG	O	operate	ccomp	28	SENT_27	[p1l806t1553r955b1589],
34	.	.	O	.	_	0	SENT_27	[p1l806t1553r955b1589],

1	INTRODUCTION	NN	O	introduction	_	0	SENT_28	[p1l503t1681r880b1718],

1	Failure	NN	O	failure	nsubj	17	SENT_29	[p1l502t1788r620b1819],
2	of	IN	O	of	_	0	SENT_29	[p1l635t1788r673b1819],
3	a	DT	O	a	det	5	SENT_29	[p1l687t1797r705b1819],
4	chemotherapeutic	JJ	O	chemotherapeutic	amod	5	SENT_29	[p1l720t1788r1017b1828],
5	regimen	NN	O	regimen	prep_of	1	SENT_29	[p1l1032t1788r1168b1827],
6	to	TO	O	to	aux	7	SENT_29	[p1l1185t1793r1216b1819],
7	induce	VB	O	induce	infmod	5	SENT_29	[p1l1234t1788r1342b1819],
8	a	DT	O	a	det	9	SENT_29	[p1l1360t1797r1377b1819],
9	response	NN	O	response	dobj	7	SENT_29	[p1l1393t1797r1539b1828],
10	may	MD	O	may	aux	17	SENT_29	[p1l1556t1797r1625b1828],
11	be	VB	O	be	cop	17	SENT_29	[p1l1642t1788r1680b1819],
12	due	JJ	O	due	_	0	SENT_29	[p1l1697t1789r1757b1820],
13	to	TO	O	to	_	0	SENT_29	[p1l1774t1793r1805b1820],
14	many	JJ	O	many	amod	16	SENT_29	[p1l502t1847r595b1876],
15	different	JJ	O	different	amod	16	SENT_29	[p1l606t1838r751b1868],
16	factors	NNS	O	factor	prep_due_to	17	SENT_29	[p1l762t1838r875b1868],
17	(	VBP	O	(	_	0	SENT_29	[p1l888t1838r996b1875],
18	Table	NNP	O	Table	dobj	17	SENT_29	[p1l888t1838r996b1875],
19	1	CD	NUMBER	1	num	18	SENT_29	[p1l1012t1838r1049b1874],
20	)	CD	NUMBER	)	nsubj	17	SENT_29	[p1l1012t1838r1049b1874],
21	.	.	O	.	_	0	SENT_29	[p1l1012t1838r1049b1874],

1	Foremost	JJ	O	foremost	nsubj	6	SENT_30	[p1l1062t1838r1221b1869],
2	among	IN	O	among	_	0	SENT_30	[p1l1234t1847r1345b1877],
3	these	DT	O	these	prep_among	1	SENT_30	[p1l1358t1838r1443b1869],
4	is	VBZ	O	be	cop	6	SENT_30	[p1l1455t1839r1481b1869],
5	the	DT	O	the	det	6	SENT_30	[p1l1495t1839r1545b1869],
6	inability	NN	O	inability	_	0	SENT_30	[p1l1557t1838r1696b1876],
7	of	IN	O	of	_	0	SENT_30	[p1l1709t1838r1746b1869],
8	the	DT	O	the	det	9	SENT_30	[p1l1755t1839r1806b1869],
9	drugs	NNS	O	drug	prep_of	6	SENT_30	[p1l502t1886r594b1925],
10	to	TO	O	to	aux	11	SENT_30	[p1l608t1892r641b1917],
11	reach	VB	O	reach	infmod	6	SENT_30	[p1l652t1887r744b1917],
12	the	DT	O	the	det	15	SENT_30	[p1l756t1887r808b1916],
13	critical	JJ	O	critical	amod	15	SENT_30	[p1l820t1886r936b1917],
14	cellular	JJ	O	cellular	amod	15	SENT_30	[p1l949t1887r1074b1917],
15	target	NN	O	target	dobj	11	SENT_30	[p1l1087t1891r1189b1925],
16	.	.	O	.	_	0	SENT_30	[p1l1087t1891r1189b1925],

1	In	IN	O	in	_	0	SENT_31	[p1l1205t1888r1239b1917],
2	this	DT	O	this	det	3	SENT_31	[p1l1253t1887r1311b1917],
3	regard	NN	O	regard	prep_in	8	SENT_31	[p1l1325t1887r1441b1925],
4	,	,	O	,	_	0	SENT_31	[p1l1325t1887r1441b1925],
5	physiological	JJ	O	physiological	amod	6	SENT_31	[p1l1455t1887r1679b1926],
6	factors	NNS	O	factor	nsubj	8	SENT_31	[p1l1693t1887r1804b1918],
7	may	MD	O	may	aux	8	SENT_31	[p1l503t1944r575b1975],
8	play	VB	O	play	_	0	SENT_31	[p1l594t1937r666b1976],
9	a	DT	O	a	det	11	SENT_31	[p1l688t1945r707b1967],
10	large	JJ	O	large	amod	11	SENT_31	[p1l727t1936r810b1975],
11	role	NN	O	role	dobj	8	SENT_31	[p1l831t1936r896b1967],
12	in	IN	O	in	_	0	SENT_31	[p1l917t1936r948b1967],
13	the	DT	O	the	det	15	SENT_31	[p1l970t1937r1021b1967],
14	successful	JJ	O	successful	amod	15	SENT_31	[p1l1042t1937r1212b1967],
15	outcome	NN	O	outcome	prep_in	8	SENT_31	[p1l1233t1941r1375b1967],
16	of	IN	O	of	_	0	SENT_31	[p1l1397t1937r1435b1967],
17	therapy	NN	O	therapy	prep_of	15	SENT_31	[p1l1452t1937r1586b1976],
18	.	.	O	.	_	0	SENT_31	[p1l1452t1937r1586b1976],

1	Absorption	NN	O	absorption	nsubj	11	SENT_32	[p1l1609t1936r1805b1977],
2	,	,	O	,	_	0	SENT_32	[p1l1609t1936r1805b1977],
3	distribution	NN	O	distribution	conj_and	1	SENT_32	[p1l503t1985r704b2022],
4	,	,	O	,	_	0	SENT_32	[p1l503t1985r704b2022],
5	metabolism	NN	O	metabolism	conj_and	1	SENT_32	[p1l716t1986r920b2022],
6	,	,	O	,	_	0	SENT_32	[p1l716t1986r920b2022],
7	and	CC	O	and	_	0	SENT_32	[p1l932t1987r992b2017],
8	elimination	NN	O	elimination	conj_and	1	SENT_32	[p1l1001t1986r1191b2018],
9	are	VBP	O	be	cop	11	SENT_32	[p1l1202t1996r1252b2017],
10	key	JJ	O	key	amod	11	SENT_32	[p1l1264t1987r1323b2025],
11	principles	NNS	O	principle	_	0	SENT_32	[p1l1334t1986r1497b2026],
12	in	IN	O	in	_	0	SENT_32	[p1l1511t1987r1541b2017],
13	successful	JJ	O	successful	amod	15	SENT_32	[p1l1554t1986r1722b2017],
14	cancer	NN	O	cancer	nn	15	SENT_32	[p1l1736t1996r1805b2017, p1l503t2043r555b2065],
15	chemotherapy	NN	O	chemotherapy	prep_in	11	SENT_32	[p1l571t2034r816b2075],
16	,	,	O	,	_	0	SENT_32	[p1l571t2034r816b2075],
17	and	CC	O	and	_	0	SENT_32	[p1l835t2036r895b2066],
18	while	IN	O	while	mark	23	SENT_32	[p1l913t2035r1005b2066],
19	they	PRP	O	they	nsubjpass	23	SENT_32	[p1l1022t2035r1093b2075],
20	should	MD	O	should	aux	23	SENT_32	[p1l1111t2035r1222b2066],
21	not	RB	O	not	neg	23	SENT_32	[p1l1239t2040r1292b2066],
22	be	VB	O	be	auxpass	23	SENT_32	[p1l1307t2036r1347b2066],
23	deemphasized	VBN	O	deemphasize	advcl	42	SENT_32	[p1l1366t2035r1601b2076],
24	as	IN	O	as	_	0	SENT_32	[p1l1619t2044r1652b2066],
25	possible	JJ	O	possible	amod	26	SENT_32	[p1l1670t2036r1807b2075],
26	reasons	NNS	O	reason	prep_as	23	SENT_32	[p1l502t2091r626b2117],
27	for	IN	O	for	_	0	SENT_32	[p1l639t2086r689b2117],
28	a	DT	O	a	det	29	SENT_32	[p1l700t2095r719b2117],
29	cell	NN	O	cell	poss	31	SENT_32	[p1l730t2086r819b2116],
30	’s	POS	O	’s	_	0	SENT_32	[p1l730t2086r819b2116],
31	lack	NN	O	lack	prep_for	26	SENT_32	[p1l831t2085r902b2117],
32	of	IN	O	of	_	0	SENT_32	[p1l913t2086r951b2117],
33	response	NN	O	response	prep_of	31	SENT_32	[p1l958t2095r1104b2126],
34	to	TO	O	to	_	0	SENT_32	[p1l1117t2090r1149b2116],
35	therapy	NN	O	therapy	prep_to	23	SENT_32	[p1l1161t2086r1294b2126],
36	,	,	O	,	_	0	SENT_32	[p1l1161t2086r1294b2126],
37	the	DT	O	the	det	38	SENT_32	[p1l1308t2086r1357b2117],
38	focus	NN	O	focus	nsubj	42	SENT_32	[p1l1370t2086r1459b2117],
39	of	IN	O	of	_	0	SENT_32	[p1l1473t2087r1509b2117],
40	this	DT	O	this	det	41	SENT_32	[p1l1519t2086r1577b2117],
41	chapter	NN	O	chapter	prep_of	38	SENT_32	[p1l1590t2086r1714b2126],
42	is	VBZ	O	be	conj_and	11	SENT_32	[p1l1725t2086r1751b2117],
43	on	IN	O	on	_	0	SENT_32	[p1l1765t2096r1805b2118],
44	the	DT	O	the	det	45	SENT_32	[p1l503t2135r553b2166],
45	alterations	NNS	O	alteration	prep_on	42	SENT_32	[p1l570t2135r743b2167],
46	that	WDT	O	that	nsubj	47	SENT_32	[p1l760t2136r823b2166],
47	occur	VBP	O	occur	rcmod	45	SENT_32	[p1l838t2145r932b2167],
48	at	IN	O	at	_	0	SENT_32	[p1l946t2141r977b2167],
49	the	DT	O	the	det	52	SENT_32	[p1l992t2136r1044b2167],
50	cellular	JJ	O	cellular	amod	52	SENT_32	[p1l1059t2136r1185b2167],
51	level	NN	O	level	nn	52	SENT_32	[p1l1200t2136r1513b2176],
52	—	NN	O	—	prep_at	47	SENT_32	[p1l1200t2136r1513b2176],
53	speciﬁca1ly	RB	O	speciﬁca1ly	advmod	52	SENT_32	[p1l1200t2136r1513b2176],
54	those	DT	O	those	dobj	47	SENT_32	[p1l1531t2137r1618b2167],
55	associated	VBN	O	associate	partmod	54	SENT_32	[p1l1636t2137r1806b2167],
56	with	IN	O	with	_	0	SENT_32	[p1l503t2184r577b2214],
57	the	DT	O	the	det	58	SENT_32	[p1l590t2184r641b2215],
58	development	NN	O	development	prep_with	55	SENT_32	[p1l653t2185r870b2223],
59	of	IN	O	of	_	0	SENT_32	[p1l881t2185r919b2215],
60	multidrug	JJ	O	multidrug	amod	61	SENT_32	[p1l929t2185r1092b2223],
61	resistance	NN	O	resistance	prep_of	58	SENT_32	[p1l1105t2186r1277b2215],
62	.	.	O	.	_	0	SENT_32	[p1l1105t2186r1277b2215],

1	Annual	JJ	SET	annual	amod	2	SENT_33	[p1l450t2451r571b2480],
2	Reviews	NNS	O	review	_	0	SENT_33	[p1l583t2451r725b2489],
3	.	.	O	.	_	0	SENT_33	[p1l957t2484r962b2489],

1	www.annualrev1ews.org	NN	O	www.annualrev1ews.org	_	0	SENT_34	[p1l450t2485r869b2522],
2	/	:	O	/	punct	3	SENT_34	[p1l450t2485r869b2522],
3	aronlrne	NN	O	aronlrne	dep	1	SENT_34	[p1l870t2485r1004b2514],

1	162	CD	NUMBER	162	num	2	SENT_35	[p1l501t2584r552b2614],
2	BELLAMY	NN	O	bellamy	_	0	SENT_35	[p1l622t2584r803b2614],

1	Table	NNP	O	Table	nn	5	SENT_36	[p1l838t2681r920b2706],
2	1	CD	NUMBER	1	num	1	SENT_36	[p1l932t2682r945b2706],
3	Potential	JJ	O	potential	amod	5	SENT_36	[p1l978t2682r1093b2706],
4	cellular	JJ	O	cellular	amod	5	SENT_36	[p1l1105t2682r1205b2706],
5	alterations	NNS	O	alteration	nsubj	10	SENT_36	[p1l1216t2682r1352b2707],
6	resulting	VBG	O	result	partmod	5	SENT_36	[p1l1364t2682r1448b2707, p1l839t2722r880b2753],
7	in	IN	O	in	_	0	SENT_36	[p1l892t2722r916b2746],
8	drug	NN	O	drug	nn	9	SENT_36	[p1l927t2722r988b2753],
9	resistance	NN	O	resistance	prep_in	6	SENT_36	[p1l999t2722r1127b2746],
10	lncreased	VBD	O	lncrease	_	0	SENT_36	[p1l839t2795r966b2819],
11	detoxiﬁcation	NN	O	detoxiﬁcation	nn	13	SENT_36	[p1l975t2795r1159b2819],
12	GSH/GST	NN	O	gsh/gst	nn	13	SENT_36	[p1l869t2834r1007b2859],
13	Metallothiorrine	NN	O	metallothiorrine	dobj	10	SENT_36	[p1l869t2874r1080b2899],
14	.	.	O	.	_	0	SENT_36	[p1l1307t2897r1312b2902],

1	_	NN	O	_	nsubj	12	SENT_37	[p1l1307t2897r1312b2902],
2	Enhanced	VBN	O	enhance	partmod	1	SENT_37	[p1l837t2915r968b2939],
3	ability	NN	O	ability	dobj	2	SENT_37	[p1l979t2915r1062b2946],
4	to	TO	O	to	aux	5	SENT_37	[p1l1074t2919r1099b2939],
5	repair	VB	O	repair	xcomp	2	SENT_37	[p1l1110t2915r1187b2946],
6	DNA	NN	O	dna	nn	8	SENT_37	[p1l1199t2915r1268b2939],
7	damage	NN	O	damage	nn	8	SENT_37	[p1l1279t2915r1383b2946],
8	Alterations	NNS	O	alteration	dobj	5	SENT_37	[p1l838t2954r985b2979],
9	in	IN	O	in	_	0	SENT_37	[p1l997t2954r1020b2979],
10	the	DT	O	the	det	11	SENT_37	[p1l1032t2955r1072b2979],
11	drug	NN	O	drug	prep_in	5	SENT_37	[p1l1082t2955r1143b2986],
12	targets	VBZ	O	target	_	0	SENT_37	[p1l1153t2959r1241b2986],
13	Topoisomerase	NNP	MISC	Topoisomerase	nn	16	SENT_37	[p1l868t2995r1069b3026],
14	ll	NN	MISC	ll	nn	16	SENT_37	[p1l1081t2996r1102b3019],
15	DHFR	NN	MISC	dhfr	nn	16	SENT_37	[p1l869t3036r956b3060],
16	Alterations	NNS	MISC	alteration	dobj	12	SENT_37	[p1l838t3077r985b3101],
17	in	IN	O	in	_	0	SENT_37	[p1l996t3077r1020b3100],
18	cellular	JJ	O	cellular	amod	19	SENT_37	[p1l1031t3077r1131b3100],
19	metabolism	NN	O	metabolism	prep_in	12	SENT_37	[p1l1142t3077r1295b3101],
20	Decreased	VBN	MISC	decrease	partmod	19	SENT_37	[p1l869t3118r1006b3141],
21	levels	NNS	O	level	dobj	20	SENT_37	[p1l1017t3118r1093b3141],
22	of	IN	O	of	_	0	SENT_37	[p1l1104t3117r1133b3141],
23	deoxycytidine	NN	O	deoxycytidine	nn	24	SENT_37	[p1l1141t3118r1329b3148],
24	kinase	NN	O	kinase	prep_of	21	SENT_37	[p1l1340t3118r1424b3142],
25	Reduced	VBN	O	reduce	partmod	24	SENT_37	[p1l869t3158r984b3181],
26	levels	NNS	O	level	dobj	25	SENT_37	[p1l995t3158r1070b3181],
27	of	IN	O	of	_	0	SENT_37	[p1l1081t3158r1111b3181],
28	P450	NN	O	p450	nn	29	SENT_37	[p1l1120t3158r1188b3182],
29	isoenzymes	NNS	O	isoenzyme	prep_of	26	SENT_37	[p1l1198t3158r1352b3188],
30	Reduced	VBN	O	reduce	partmod	29	SENT_37	[p1l837t3197r954b3221],
31	intracellular	JJ	O	intracellular	amod	32	SENT_37	[p1l964t3197r1124b3221],
32	concentrations	NNS	O	concentration	dobj	30	SENT_37	[p1l1134t3197r1326b3221],

1	Annu	NNP	PERSON	Annu	_	0	SENT_38	[p2l360t951r383b1093],
2	.	.	O	.	_	0	SENT_38	[p2l360t951r383b1093],

1	Rev.	NNP	O	Rev.	nn	2	SENT_39	[p2l360t951r383b1093],
2	Pharrnacol	NNP	PERSON	Pharrnacol	_	0	SENT_39	[p2l360t792r383b940],
3	.	.	O	.	_	0	SENT_39	[p2l360t792r383b940],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_40	[p2l360t671r383b781],
2	.	.	O	.	_	0	SENT_40	[p2l360t671r383b781],

1	1996.36	CD	NUMBER	1996.36	_	0	SENT_41	[p2l360t546r384b657],
2	:	:	O	:	_	0	SENT_41	[p2l360t546r384b657],
3	161-183	CD	NUMBER	161-183	dep	1	SENT_41	[p2l360t426r383b539],
4	.	.	O	.	_	0	SENT_41	[p2l360t426r383b539],

1	Downloaded	VBN	O	download	_	0	SENT_42	[p2l360t246r383b415],
2	from	IN	O	from	_	0	SENT_42	[p2l360t173r383b237],
3	www	NN	O	www	prep_from	1	SENT_42	[p2l367t44r383b164],
4	.	.	O	.	_	0	SENT_42	[p2l367t44r383b164],

1	an1	NN	O	an1	_	0	SENT_43	[p2l367t44r383b164],

1	Annu	NNP	PERSON	Annu	_	0	SENT_44	[p2l353t3364r376b3509],
2	.	.	O	.	_	0	SENT_44	[p2l353t3364r376b3509],

1	Rev.	NNP	O	Rev.	nn	2	SENT_45	[p2l353t3364r376b3509],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_45	[p2l353t3205r376b3354],
3	.	.	O	.	_	0	SENT_45	[p2l353t3205r376b3354],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_46	[p2l353t3085r376b3195],
2	.	.	O	.	_	0	SENT_46	[p2l353t3085r376b3195],

1	1996.36	CD	NUMBER	1996.36	_	0	SENT_47	[p2l353t2959r377b3071],
2	:	:	O	:	_	0	SENT_47	[p2l353t2959r377b3071],
3	161-183	CD	NUMBER	161-183	dep	1	SENT_47	[p2l353t2839r376b2952],
4	.	.	O	.	_	0	SENT_47	[p2l353t2839r376b2952],

1	Downloaded	VBN	O	download	_	0	SENT_48	[p2l353t2658r376b2828],
2	from	IN	O	from	_	0	SENT_48	[p2l353t2584r376b2649],
3	www	NN	O	www	prep_from	1	SENT_48	[p2l360t2455r376b2575],
4	.	.	O	.	_	0	SENT_48	[p2l360t2455r376b2575],

1	an1	NN	O	an1	nn	2	SENT_49	[p2l360t2455r376b2575],
2	1ualreviews	NNS	O	1ualreview	_	0	SENT_49	[p2l353t2239r383b2443],
3	.	.	O	.	_	0	SENT_49	[p2l353t2239r383b2443],

1	org	NN	O	org	_	0	SENT_50	[p2l353t2239r383b2443],
2	by	IN	O	by	_	0	SENT_50	[p2l393t934r424b966],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_50	[p2l393t785r424b925],
4	of	IN	ORGANIZATION	of	_	0	SENT_50	[p2l393t746r417b775],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	3	SENT_50	[p2l393t599r417b740],
6	-	:	O	-	_	0	SENT_50	[p2l407t581r410b589],
7	Madison	NNP	O	Madison	dep	1	SENT_50	[p2l393t455r417b571],
8	on	IN	O	on	_	0	SENT_50	[p2l401t413r417b446],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_50	[p2l393t280r417b404],
10	.	.	O	.	_	0	SENT_50	[p2l393t280r417b404],

1	For	IN	O	for	dep	9	SENT_51	[p2l394t223r417b269],
2	personal	JJ	O	personal	amod	3	SENT_51	[p2l393t103r424b215],
3	use	NN	O	use	pobj	1	SENT_51	[p2l401t50r417b94],
4	by	IN	O	by	_	0	SENT_51	[p2l386t3348r417b3380],
5	University	NNP	ORGANIZATION	University	prep_by	3	SENT_51	[p2l386t3199r417b3338],
6	of	IN	ORGANIZATION	of	_	0	SENT_51	[p2l386t3160r410b3189],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_51	[p2l386t3012r410b3154],
8	-	:	O	-	_	0	SENT_51	[p2l400t2994r403b3003],
9	Madison	NNP	O	Madison	_	0	SENT_51	[p2l386t2868r410b2984],
10	on	IN	O	on	_	0	SENT_51	[p2l394t2826r410b2858],
11	01/05/14	CD	DATE	01/05/14	prep_on	9	SENT_51	[p2l386t2692r410b2816],
12	.	.	O	.	_	0	SENT_51	[p2l386t2692r410b2816],

1	For	IN	O	for	_	0	SENT_52	[p2l387t2635r410b2682],
2	personal	JJ	O	personal	amod	3	SENT_52	[p2l386t2515r417b2627],
3	use	NN	O	use	pobj	1	SENT_52	[p2l394t2461r410b2505],
4	only	RB	O	only	advmod	3	SENT_52	[p2l386t2375r417b2440],
5	.	.	O	.	_	0	SENT_52	[p2l386t2375r417b2440],

1	Decreased	VBN	O	decrease	_	0	SENT_53	[p2l868t47r1005b70],
2	uptake	NN	O	uptake	nn	4	SENT_53	[p2l1017t47r1104b77],
3	Increased	VBN	O	increase	amod	4	SENT_53	[p2l868t86r994b109],
4	efﬂux	NN	O	efﬂux	dobj	1	SENT_53	[p2l1005t86r1082b109],
5	(	CD	NUMBER	(	amod	4	SENT_53	[p2l1094t87r1163b114],
6	Mdr	NN	O	mdr	dep	5	SENT_53	[p2l1094t87r1163b114],
7	l	NN	O	l	tmod	6	SENT_53	[p2l1176t87r1196b113],
8	,	,	O	,	_	0	SENT_53	[p2l1176t87r1196b113],
9	MRP	NN	ORGANIZATION	mrp	nn	11	SENT_53	[p2l1208t87r1287b115],
10	)	CD	NUMBER	)	num	11	SENT_53	[p2l1208t87r1287b115],
11	Failure	NN	O	failure	appos	6	SENT_53	[p2l837t125r931b149],
12	to	TO	O	to	aux	13	SENT_53	[p2l942t130r968b149],
13	undergo	VB	O	undergo	infmod	11	SENT_53	[p2l978t126r1085b156],
14	apoptosis	NN	O	apoptosis	nn	15	SENT_53	[p2l1096t126r1220b156],
15	Alterations	NNS	O	alteration	dobj	13	SENT_53	[p2l868t166r1014b189],
16	in	IN	O	in	_	0	SENT_53	[p2l1026t166r1050b189],
17	bcl	NN	O	bcl	nn	18	SENT_53	[p2l1061t166r1129b189],
18	—	NN	O	—	prep_in	13	SENT_53	[p2l1061t166r1129b189],
19	2	CD	NUMBER	2	num	18	SENT_53	[p2l1061t166r1129b189],
20	or	CC	O	or	_	0	SENT_53	[p2l1140t173r1167b189],
21	bax	NN	O	bax	conj_or	11	SENT_53	[p2l1177t166r1225b189],

1	MULTIDRUG-RESISTANCE	JJ	O	multidrug-resistance	amod	2	SENT_54	[p2l495t323r1115b359],
2	PHENOTYPE	NN	O	phenotype	_	0	SENT_54	[p2l1131t324r1422b359],

1	Multidrug	JJ	O	multidrug	amod	5	SENT_55	[p2l495t416r664b455],
2	resistance	NN	O	resistance	nn	5	SENT_55	[p2l680t416r844b447],
3	(	CD	NUMBER	(	num	5	SENT_55	[p2l859t417r981b453],
4	MDR	NN	ORGANIZATION	mdr	nn	5	SENT_55	[p2l859t417r981b453],
5	)	NN	O	)	nsubj	6	SENT_55	[p2l859t417r981b453],
6	represents	VBZ	O	represent	_	0	SENT_55	[p2l997t422r1164b455],
7	a	DT	O	a	det	9	SENT_55	[p2l1180t426r1198b447],
8	major	JJ	O	major	amod	9	SENT_55	[p2l1214t417r1312b456],
9	challenge	NN	O	challenge	dobj	6	SENT_55	[p2l1326t417r1486b456],
10	in	IN	O	in	_	0	SENT_55	[p2l1501t417r1533b447],
11	cancer	NN	O	cancer	nn	12	SENT_55	[p2l1549t426r1659b448],
12	chemotherapy	NN	O	chemotherapy	prep_in	6	SENT_55	[p2l1674t418r1797b448, p2l496t467r620b506],
13	because	IN	O	because	mark	15	SENT_55	[p2l632t467r765b497],
14	it	PRP	O	it	nsubj	15	SENT_55	[p2l778t467r801b497],
15	limits	VBZ	O	limit	advcl	6	SENT_55	[p2l814t466r907b497],
16	the	DT	O	the	det	17	SENT_55	[p2l920t467r972b497],
17	effectiveness	NN	O	effectiveness	nsubj	23	SENT_55	[p2l984t467r1199b497],
18	of	IN	O	of	_	0	SENT_55	[p2l1213t467r1249b497],
19	many	JJ	O	many	amod	22	SENT_55	[p2l1259t476r1351b506],
20	clinically	RB	O	clinically	advmod	21	SENT_55	[p2l1364t468r1519b506],
21	important	JJ	O	important	amod	22	SENT_55	[p2l1532t468r1694b507],
22	drugs	NNS	O	drug	prep_of	17	SENT_55	[p2l1706t468r1797b507],
23	(	VBP	O	(	ccomp	15	SENT_55	[p2l496t516r604b553],
24	Table	NNP	O	Table	nsubj	26	SENT_55	[p2l496t516r604b553],
25	2	CD	NUMBER	2	num	26	SENT_55	[p2l617t516r661b552],
26	)	CD	NUMBER	)	xcomp	23	SENT_55	[p2l617t516r661b552],
27	.	.	O	.	_	0	SENT_55	[p2l617t516r661b552],

1	Since	IN	O	since	mark	14	SENT_56	[p2l538t566r630b596],
2	the	DT	O	the	det	4	SENT_56	[p2l645t566r695b596],
3	initial	JJ	O	initial	amod	4	SENT_56	[p2l711t566r807b596],
4	reports	NNS	O	report	nsubj	14	SENT_56	[p2l822t571r937b605],
5	of	IN	O	of	_	0	SENT_56	[p2l952t566r990b596],
6	MDR	NN	ORGANIZATION	mdr	prep_of	4	SENT_56	[p2l1002t566r1096b596],
7	in	IN	O	in	_	0	SENT_56	[p2l1111t566r1142b596],
8	the	DT	O	the	det	10	SENT_56	[p2l1158t566r1208b596],
9	late	JJ	O	late	amod	10	SENT_56	[p2l1224t566r1282b596],
10	1960s	NNS	DATE	1960	prep_in	6	SENT_56	[p2l1301t566r1395b597],
11	and	CC	O	and	_	0	SENT_56	[p2l1412t567r1471b596],
12	early	JJ	O	early	amod	13	SENT_56	[p2l1486t567r1568b606],
13	1970s	NNS	DATE	1970	conj_and	10	SENT_56	[p2l1589t567r1684b597],
14	(	VBP	O	(	advcl	21	SENT_56	[p2l1699t567r1798b604],
15	1-7	CD	NUMBER	1-7	num	16	SENT_56	[p2l1699t567r1798b604],
16	)	CD	NUMBER	)	dobj	14	SENT_56	[p2l1699t567r1798b604],
17	,	,	O	,	_	0	SENT_56	[p2l1699t567r1798b604],
18	numerous	JJ	O	numerous	amod	19	SENT_56	[p2l496t625r659b646],
19	investigators	NNS	O	investigator	nsubj	21	SENT_56	[p2l678t616r889b654],
20	have	VBP	O	have	aux	21	SENT_56	[p2l907t616r985b646],
21	described	VBN	O	describe	_	0	SENT_56	[p2l1003t616r1161b646],
22	tumor	NN	O	tumor	nn	24	SENT_56	[p2l1180t621r1278b646],
23	cell	NN	O	cell	nn	24	SENT_56	[p2l1295t616r1354b646],
24	lines	NNS	O	line	dobj	21	SENT_56	[p2l1373t616r1451b646],
25	that	WDT	O	that	nsubj	26	SENT_56	[p2l1469t617r1532b646],
26	display	VBP	O	display	rcmod	24	SENT_56	[p2l1548t616r1668b655],
27	such	JJ	O	such	prep	26	SENT_56	[p2l1687t617r1762b647],
28	a	DT	O	a	det	29	SENT_56	[p2l1782t626r1799b647],
29	phenotype	NN	O	phenotype	dep	27	SENT_56	[p2l496t665r669b704],
30	(	CD	NUMBER	(	num	32	SENT_56	[p2l682t664r801b702],
31	8-10	CD	NUMBER	8-10	num	32	SENT_56	[p2l682t664r801b702],
32	)	NN	O	)	dep	29	SENT_56	[p2l682t664r801b702],
33	.	.	O	.	_	0	SENT_56	[p2l682t664r801b702],

1	A	DT	O	a	det	3	SENT_57	[p2l815t665r844b695],
2	common	JJ	O	common	amod	3	SENT_57	[p2l858t674r1002b695],
3	feature	NN	O	feature	nsubj	14	SENT_57	[p2l1015t664r1130b695],
4	of	IN	O	of	_	0	SENT_57	[p2l1143t664r1180b695],
5	many	JJ	O	many	prep_of	3	SENT_57	[p2l1190t674r1281b704],
6	of	IN	O	of	_	0	SENT_57	[p2l1294t665r1332b696],
7	these	DT	O	these	det	9	SENT_57	[p2l1342t665r1426b696],
8	drug	NN	O	drug	nn	9	SENT_57	[p2l1439t665r1667b705],
9	—	NN	O	—	npadvmod	10	SENT_57	[p2l1439t665r1667b705],
10	resistant	JJ	O	resistant	amod	11	SENT_57	[p2l1439t665r1667b705],
11	lines	NNS	O	line	prep_of	5	SENT_57	[p2l1681t666r1757b696],
12	is	VBZ	O	be	cop	14	SENT_57	[p2l1773t666r1798b697],
13	the	DT	O	the	det	14	SENT_57	[p2l496t715r545b747],
14	expression	NN	O	expression	_	0	SENT_57	[p2l556t715r733b755],
15	of	IN	O	of	_	0	SENT_57	[p2l744t715r782b746],
16	the	DT	O	the	det	19	SENT_57	[p2l790t715r839b746],
17	P	NN	O	p	nn	19	SENT_57	[p2l850t715r1095b755],
18	—	CD	NUMBER	—	num	19	SENT_57	[p2l850t715r1095b755],
19	glycoprotein	NN	O	glycoprotein	prep_of	14	SENT_57	[p2l850t715r1095b755],
20	(	CD	NUMBER	(	number	21	SENT_57	[p2l1108t716r1184b753],
21	11	CD	NUMBER	11	num	22	SENT_57	[p2l1108t716r1184b753],
22	)	NN	O	)	dep	19	SENT_57	[p2l1108t716r1184b753],
23	.	.	O	.	_	0	SENT_57	[p2l1108t716r1184b753],

1	In	IN	O	in	_	0	SENT_58	[p2l1198t716r1229b746],
2	general	JJ	O	general	prep_in	12	SENT_58	[p2l1241t716r1373b756],
3	,	,	O	,	_	0	SENT_58	[p2l1241t716r1373b756],
4	cell	NN	O	cell	nn	5	SENT_58	[p2l1384t716r1445b747],
5	lines	NNS	O	line	nsubj	17	SENT_58	[p2l1456t716r1533b747],
6	that	WDT	O	that	nsubj	7	SENT_58	[p2l1545t716r1607b747],
7	display	VBP	O	display	rcmod	5	SENT_58	[p2l1616t716r1736b756],
8	the	DT	O	the	det	10	SENT_58	[p2l1749t717r1799b748],
9	MDR	NN	ORGANIZATION	mdr	nn	10	SENT_58	[p2l496t767r590b797],
10	phenotype	NN	O	phenotype	dobj	7	SENT_58	[p2l602t767r775b806],
11	are	VBP	O	be	cop	12	SENT_58	[p2l788t776r837b797],
12	resistant	JJ	O	resistant	_	0	SENT_58	[p2l850t767r988b797],
13	to	TO	O	to	_	0	SENT_58	[p2l1000t772r1031b797],
14	natural	JJ	O	natural	amod	15	SENT_58	[p2l1043t767r1156b797],
15	products	NNS	O	product	prep_to	12	SENT_58	[p2l1170t767r1312b806],
16	but	CC	O	but	_	0	SENT_58	[p2l1324t767r1378b798],
17	retain	VBP	O	retain	conj_but	12	SENT_58	[p2l1390t767r1483b798],
18	their	PRP$	O	they	poss	19	SENT_58	[p2l1496t767r1572b798],
19	sensitivity	NN	O	sensitivity	dobj	17	SENT_58	[p2l1584t767r1754b807],
20	to	TO	O	to	_	0	SENT_58	[p2l1767t773r1798b798],
21	alkylating	JJ	O	alkylating	amod	22	SENT_58	[p2l495t817r660b857],
22	agents	NNS	O	agent	prep_to	17	SENT_58	[p2l677t821r782b857],
23	and	CC	O	and	_	0	SENT_58	[p2l799t817r859b848],
24	antimetabolites	NNS	O	antimetabolite	conj_and	22	SENT_58	[p2l875t817r1136b848],
25	.	.	O	.	_	0	SENT_58	[p2l875t817r1136b848],

1	Resistance	NN	O	resistance	nsubj	6	SENT_59	[p2l1155t817r1331b848],
2	in	IN	O	in	_	0	SENT_59	[p2l1348t817r1378b848],
3	these	DT	O	these	det	4	SENT_59	[p2l1395t817r1480b848],
4	cells	NNS	O	cell	prep_in	1	SENT_59	[p2l1494t817r1570b848],
5	is	VBZ	O	be	cop	6	SENT_59	[p2l1587t817r1613b848],
6	secondary	JJ	O	secondary	_	0	SENT_59	[p2l1630t818r1798b857],
7	to	TO	O	to	_	0	SENT_59	[p2l495t873r527b899],
8	an	DT	O	a	det	12	SENT_59	[p2l540t877r578b899],
9	increased	VBN	O	increase	amod	12	SENT_59	[p2l592t867r748b900],
10	energy-dependent	JJ	O	energy-dependent	amod	12	SENT_59	[p2l761t868r1059b908],
11	drug	NN	O	drug	nn	12	SENT_59	[p2l1071t868r1147b908],
12	efﬂux	NN	O	efﬂux	prep_to	6	SENT_59	[p2l1160t868r1268b905],
13	,	,	O	,	_	0	SENT_59	[p2l1160t868r1268b905],
14	resulting	VBG	O	result	partmod	12	SENT_59	[p2l1281t868r1426b908],
15	in	IN	O	in	_	0	SENT_59	[p2l1439t868r1470b900],
16	decreased	VBN	O	decrease	amod	19	SENT_59	[p2l1482t868r1647b900],
17	intracellular	JJ	O	intracellular	amod	19	SENT_59	[p2l1661t868r1797b900, p2l495t919r571b950],
18	drug	NN	O	drug	nn	19	SENT_59	[p2l587t919r663b958],
19	accumulation	NN	O	accumulation	prep_in	14	SENT_59	[p2l680t919r903b950],
20	(	CD	NUMBER	(	num	22	SENT_59	[p2l920t919r997b956],
21	12	CD	NUMBER	12	num	22	SENT_59	[p2l920t919r997b956],
22	)	NN	O	)	dep	19	SENT_59	[p2l920t919r997b956],
23	.	.	O	.	_	0	SENT_59	[p2l920t919r997b956],

1	In	IN	O	in	_	0	SENT_60	[p2l1015t920r1048b950],
2	humans	NNS	O	human	pobj	1	SENT_60	[p2l1065t919r1203b954],
3	,	,	O	,	_	0	SENT_60	[p2l1065t919r1203b954],
4	two	CD	NUMBER	two	num	7	SENT_60	[p2l1220t924r1281b950],
5	closely	RB	O	closely	advmod	6	SENT_60	[p2l1298t919r1414b958],
6	related	JJ	O	related	amod	7	SENT_60	[p2l1432t919r1544b950],
7	genes	NNS	O	gene	appos	2	SENT_60	[p2l1560t928r1665b959],
8	,	,	O	,	_	0	SENT_60	[p2l1560t928r1665b959],
9	MDR	NN	O	mdr	appos	7	SENT_60	[p2l1681t919r1772b949],
10	1	CD	NUMBER	1	num	9	SENT_60	[p2l1789t920r1798b950],

1	Table	NNP	O	Table	_	0	SENT_61	[p2l848t1049r929b1073],
2	2	CD	NUMBER	2	num	4	SENT_61	[p2l940t1049r956b1073],
3	Chemotherapeutic	JJ	O	chemotherapeutic	amod	4	SENT_61	[p2l987t1049r1229b1080],
4	drugs	NNS	O	drug	dep	1	SENT_61	[p2l1240t1050r1312b1080],
5	involved	VBN	O	involve	partmod	1	SENT_61	[p2l1323t1049r1359b1073, p2l848t1089r938b1113],
6	in	IN	O	in	_	0	SENT_61	[p2l950t1089r974b1113],
7	multidrug	JJ	O	multidrug	amod	8	SENT_61	[p2l986t1089r1115b1120],
8	resistance	NN	O	resistance	prep_in	5	SENT_61	[p2l1125t1089r1255b1113],

1	Actinomycin	NN	O	actinomycin	nn	5	SENT_62	[p2l848t1167r1020b1199],
2	D	NN	O	d	nn	5	SENT_62	[p2l1032t1168r1055b1192],
3	Daunorubicin	NN	O	daunorubicin	nn	5	SENT_62	[p2l848t1207r1029b1232],
4	Doxombicin	NN	O	doxombicin	nn	5	SENT_62	[p2l848t1249r1014b1273],
5	Etoposide	NN	O	etoposide	_	0	SENT_62	[p2l847t1289r979b1320],
6	(	CD	NUMBER	(	num	7	SENT_62	[p2l991t1289r1097b1318],
7	VP-16	NN	O	vp-16	dep	5	SENT_62	[p2l991t1289r1097b1318],
8	)	CD	NUMBER	)	num	13	SENT_62	[p2l991t1289r1097b1318],
9	Mitoxantrone	NNP	O	Mitoxantrone	nn	13	SENT_62	[p2l848t1329r1027b1354],
10	Taxol	NNP	O	Taxol	nn	13	SENT_62	[p2l847t1370r923b1394],
11	Teniposide	NNP	O	Teniposide	nn	13	SENT_62	[p2l847t1409r995b1441],
12	(	NN	O	(	nn	13	SENT_62	[p2l1006t1410r1123b1439],
13	VM-26	NN	O	vm-26	dep	7	SENT_62	[p2l1006t1410r1123b1439],
14	)	CD	NUMBER	)	num	16	SENT_62	[p2l1006t1410r1123b1439],
15	Vinblastine	NNP	O	Vinblastine	nn	16	SENT_62	[p2l848t1449r1000b1474],
16	Vincristine	NNP	O	Vincristine	dep	5	SENT_62	[p2l848t1489r995b1514],

1	Annual	JJ	SET	annual	amod	2	SENT_63	[p2l443t1637r564b1666],
2	Reviews	NNS	O	review	nsubj	3	SENT_63	[p2l576t1637r718b1674],
3	_	VBP	O	_	_	0	SENT_63	[p2l950t1670r955b1674],
4	www.annualreviews.org/aronline	NN	O	www.annualreviews.org/aronline	dobj	3	SENT_63	[p2l444t1670r997b1708],

1	P-GLYCOPRUFEIN	JJ	O	p-glycoprufein	amod	2	SENT_64	[p2l897t1791r1216b1820],
2	S	NN	O	s	_	0	SENT_64	[p2l1217t1791r1237b1820],
3	AND	CC	O	and	_	0	SENT_64	[p2l1247t1792r1328b1820],
4	DRUG	NN	O	drug	nn	5	SENT_64	[p2l1337t1792r1444b1820],
5	RESISTANCE	NN	O	resistance	conj_and	2	SENT_64	[p2l1452t1791r1681b1820],
6	163	CD	NUMBER	163	dep	2	SENT_64	[p2l1753t1791r1805b1821],

1	and	CC	O	and	cc	12	SENT_65	[p2l503t1888r563b1919],
2	MDR2	NN	O	mdr2	nsubj	12	SENT_65	[p2l571t1889r683b1919],
3	or	CC	O	or	_	0	SENT_65	[p2l693t1897r728b1919],
4	MDR3	NN	O	mdr3	conj_or	2	SENT_65	[p2l736t1888r845b1919],
5	(	VBP	O	(	rcmod	2	SENT_65	[p2l858t1888r922b1926],
6	the	DT	O	the	det	9	SENT_65	[p2l858t1888r922b1926],
7	so-called	JJ	O	so-called	amod	9	SENT_65	[p2l932t1888r1081b1919],
8	multidrug-resistance	JJ	O	multidrug-resistance	amod	9	SENT_65	[p2l1091t1888r1432b1928],
9	genes	NNS	O	gene	nsubj	10	SENT_65	[p2l1441t1890r1560b1928],
10	)	VBP	O	)	ccomp	5	SENT_65	[p2l1441t1890r1560b1928],
11	,	,	O	,	_	0	SENT_65	[p2l1441t1890r1560b1928],
12	encode	VBP	O	encode	_	0	SENT_65	[p2l1570t1889r1689b1920],
13	highly	RB	O	highly	advmod	14	SENT_65	[p2l1698t1889r1804b1929],
14	homologous	JJ	O	homologous	amod	15	SENT_65	[p2l501t1937r707b1976],
15	P-glycoproteins	NNS	O	p-glycoprotein	dobj	12	SENT_65	[p2l725t1937r998b1977],
16	.	.	O	.	_	0	SENT_65	[p2l725t1937r998b1977],

1	Only	RB	O	only	advmod	4	SENT_66	[p2l1017t1938r1099b1977],
2	the	DT	O	the	det	4	SENT_66	[p2l1118t1938r1168b1968],
3	MDR1	NN	O	mdr1	nn	4	SENT_66	[p2l1184t1938r1293b1968],
4	gene	NN	O	gene	nsubjpass	7	SENT_66	[p2l1313t1947r1392b1977],
5	has	VBZ	O	have	aux	7	SENT_66	[p2l1410t1939r1466b1968],
6	been	VBN	O	be	auxpass	7	SENT_66	[p2l1483t1939r1563b1969],
7	linked	VBN	O	link	_	0	SENT_66	[p2l1582t1939r1685b1969],
8	to	TO	O	to	_	0	SENT_66	[p2l1703t1943r1736b1969],
9	the	DT	O	the	det	11	SENT_66	[p2l1753t1938r1805b1969],
10	multidrug-resistance	JJ	O	multidrug-resistance	amod	11	SENT_66	[p2l503t1987r843b2027],
11	phenomenon	NN	O	phenomenon	prep_to	7	SENT_66	[p2l857t1987r1071b2027],
12	however	RB	O	however	advmod	7	SENT_66	[p2l1083t1987r1237b2018],
13	.	.	O	.	_	0	SENT_66	[p2l1083t1987r1237b2018],

1	MDR1	NN	O	mdr1	_	0	SENT_67	[p2l502t2100r637b2138],
2	GENE	NN	O	gene	nn	3	SENT_67	[p2l657t2100r792b2138],
3	FAMILY	NN	O	family	dep	1	SENT_67	[p2l806t2100r997b2137],

1	DNA	NN	O	dna	nn	3	SENT_68	[p2l502t2199r593b2230],
2	transfection	NN	O	transfection	nn	3	SENT_68	[p2l602t2198r799b2230],
3	studies	NNS	O	study	nsubj	5	SENT_68	[p2l810t2198r923b2230],
4	have	VBP	O	have	aux	5	SENT_68	[p2l934t2198r1013b2230],
5	established	VBN	O	establish	_	0	SENT_68	[p2l1023t2198r1207b2230],
6	a	DT	O	a	det	8	SENT_68	[p2l1218t2207r1237b2229],
7	causative	JJ	O	causative	amod	8	SENT_68	[p2l1245t2198r1400b2230],
8	role	NN	O	role	dobj	5	SENT_68	[p2l1410t2199r1475b2230],
9	for	IN	O	for	_	0	SENT_68	[p2l1485t2199r1535b2230],
10	the	DT	O	the	det	12	SENT_68	[p2l1543t2198r1595b2230],
11	MDR1	NN	O	mdr1	nn	12	SENT_68	[p2l1604t2199r1712b2230],
12	gene	NN	O	gene	prep_for	8	SENT_68	[p2l1727t2208r1805b2239],
13	in	IN	O	in	_	0	SENT_68	[p2l502t2249r535b2279],
14	drug	NN	O	drug	nn	15	SENT_68	[p2l553t2250r629b2288],
15	resistance	NN	O	resistance	prep_in	5	SENT_68	[p2l647t2249r819b2279],
16	.	.	O	.	_	0	SENT_68	[p2l647t2249r819b2279],

1	Gros	NNP	O	Gros	nsubj	4	SENT_69	[p2l840t2249r919b2280],
2	et	FW	O	et	nn	3	SENT_69	[p2l938t2254r969b2279],
3	al	FW	O	al	dep	1	SENT_69	[p2l986t2249r1017b2279],
4	demonstrated	VBD	O	demonstrate	_	0	SENT_69	[p2l1034t2249r1258b2280],
5	that	IN	O	that	complm	17	SENT_69	[p2l1276t2250r1339b2280],
6	a	DT	O	a	det	9	SENT_69	[p2l1356t2258r1375b2280],
7	full-length	JJ	O	full-length	amod	9	SENT_69	[p2l1393t2249r1569b2288],
8	cDNA	NN	O	cdna	nn	9	SENT_69	[p2l1587t2250r1697b2280],
9	clone	NN	O	clone	nsubj	17	SENT_69	[p2l1714t2250r1805b2280],
10	coding	VBG	O	code	partmod	9	SENT_69	[p2l502t2299r615b2338],
11	for	IN	O	for	_	0	SENT_69	[p2l635t2299r685b2329],
12	the	DT	O	the	det	15	SENT_69	[p2l703t2300r754b2329],
13	MDR	NN	ORGANIZATION	mdr	nn	15	SENT_69	[p2l772t2299r880b2329],
14	]	NN	O	]	nn	15	SENT_69	[p2l772t2299r880b2329],
15	gene	NN	O	gene	prep_for	10	SENT_69	[p2l904t2308r982b2338],
16	was	VBD	O	be	cop	17	SENT_69	[p2l1001t2308r1065b2329],
17	sufﬁcient	JJ	O	sufﬁcient	ccomp	4	SENT_69	[p2l1085t2299r1242b2330],
18	to	TO	O	to	aux	19	SENT_69	[p2l1259t2305r1293b2330],
19	confer	VB	O	confer	xcomp	17	SENT_69	[p2l1310t2300r1418b2330],
20	the	DT	O	the	det	22	SENT_69	[p2l1435t2299r1488b2330],
21	MDR	NN	ORGANIZATION	mdr	nn	22	SENT_69	[p2l1506t2300r1602b2330],
22	phenotype	NN	O	phenotype	dobj	19	SENT_69	[p2l1620t2300r1804b2338],
23	,	,	O	,	_	0	SENT_69	[p2l1620t2300r1804b2338],
24	including	VBG	O	include	_	0	SENT_69	[p2l502t2347r659b2387],
25	the	DT	O	the	det	26	SENT_69	[p2l675t2348r726b2378],
26	expression	NN	O	expression	prep_including	4	SENT_69	[p2l743t2348r921b2387],
27	of	IN	O	of	_	0	SENT_69	[p2l937t2348r974b2378],
28	the	DT	O	the	det	29	SENT_69	[p2l987t2348r1039b2378],
29	P-glycoprotein	NN	O	p-glycoprotein	prep_of	26	SENT_69	[p2l1054t2348r1310b2387],
30	,	,	O	,	_	0	SENT_69	[p2l1054t2348r1310b2387],
31	when	WRB	O	when	advmod	37	SENT_69	[p2l1327t2348r1418b2379],
32	transfected	VBN	O	transfect	csubj	37	SENT_69	[p2l1434t2348r1617b2379],
33	into	IN	O	into	_	0	SENT_69	[p2l1633t2348r1699b2379],
34	drugsensitive	JJ	O	drugsensitive	amod	36	SENT_69	[p2l1714t2349r1804b2388, p2l503t2398r648b2428],
35	cell	NN	O	cell	nn	36	SENT_69	[p2l661t2398r720b2428],
36	lines	NNS	O	line	prep_into	32	SENT_69	[p2l734t2398r812b2428],
37	(	VBP	O	(	advcl	4	SENT_69	[p2l826t2398r903b2435],
38	13	CD	NUMBER	13	num	39	SENT_69	[p2l826t2398r903b2435],
39	)	CD	NUMBER	)	dobj	37	SENT_69	[p2l826t2398r903b2435],
40	.	.	O	.	_	0	SENT_69	[p2l826t2398r903b2435],

1	The	DT	O	the	det	5	SENT_70	[p2l544t2460r608b2490],
2	human	JJ	O	human	amod	5	SENT_70	[p2l623t2459r736b2490],
3	MDR	NN	O	mdr	nn	5	SENT_70	[p2l749t2459r857b2490],
4	]	NN	O	]	nn	5	SENT_70	[p2l749t2459r857b2490],
5	gene	NN	O	gene	nsubj	7	SENT_70	[p2l876t2468r954b2499],
6	was	VBD	O	be	cop	7	SENT_70	[p2l969t2468r1034b2490],
7	localized	JJ	O	localized	_	0	SENT_70	[p2l1048t2459r1199b2491],
8	to	TO	O	to	_	0	SENT_70	[p2l1213t2464r1245b2490],
9	chromosome	NN	O	chromosome	prep_to	7	SENT_70	[p2l1260t2460r1474b2491],
10	7	CD	NUMBER	7	num	9	SENT_70	[p2l1488t2461r1519b2496],
11	,	,	O	,	_	0	SENT_70	[p2l1488t2461r1519b2496],
12	band	NN	O	band	nn	13	SENT_70	[p2l1534t2460r1616b2491],
13	q21	NN	O	q21	appos	9	SENT_70	[p2l1630t2460r1720b2499],
14	.1	CD	NUMBER	.1	number	15	SENT_70	[p2l1630t2460r1720b2499],
15	(	CD	NUMBER	(	num	16	SENT_70	[p2l1740t2460r1804b2497],
16	14	CD	NUMBER	14	dep	13	SENT_70	[p2l1740t2460r1804b2497],
17	,	,	O	,	_	0	SENT_70	[p2l1740t2460r1804b2497],
18	15	CD	NUMBER	15	num	19	SENT_70	[p2l506t2509r566b2547],
19	)	NN	O	)	appos	9	SENT_70	[p2l506t2509r566b2547],
20	.	.	O	.	_	0	SENT_70	[p2l506t2509r566b2547],

1	The	DT	O	the	det	3	SENT_71	[p2l580t2510r645b2539],
2	protein-coding	JJ	O	protein-coding	amod	3	SENT_71	[p2l656t2509r902b2549],
3	portion	NN	O	portion	nsubj	7	SENT_71	[p2l913t2510r1033b2548],
4	of	IN	O	of	_	0	SENT_71	[p2l1046t2510r1082b2540],
5	this	DT	O	this	det	6	SENT_71	[p2l1091t2509r1151b2540],
6	gene	NN	O	gene	prep_of	3	SENT_71	[p2l1162t2519r1241b2549],
7	contains	VBZ	O	contain	_	0	SENT_71	[p2l1254t2509r1391b2541],
8	27	CD	NUMBER	27	num	9	SENT_71	[p2l1404t2510r1443b2540],
9	exons	NNS	O	exon	dobj	7	SENT_71	[p2l1456t2519r1563b2540],
10	:	:	O	:	_	0	SENT_71	[p2l1456t2519r1563b2540],
11	14	CD	NUMBER	14	dep	9	SENT_71	[p2l1581t2510r1619b2541],
12	coding	VBG	O	code	partmod	11	SENT_71	[p2l1630t2510r1744b2549],
13	for	IN	O	for	_	0	SENT_71	[p2l1757t2509r1805b2541],
14	the	DT	O	the	det	15	SENT_71	[p2l502t2560r552b2591],
15	left	NN	O	left	prep_for	12	SENT_71	[p2l568t2560r624b2590],
16	and	CC	O	and	_	0	SENT_71	[p2l639t2561r700b2591],
17	13	CD	NUMBER	13	prep_for	12	SENT_71	[p2l718t2560r755b2590],
18	coding	VBG	O	code	xcomp	12	SENT_71	[p2l771t2560r885b2599],
19	for	IN	O	for	_	0	SENT_71	[p2l900t2560r950b2590],
20	the	DT	O	the	det	22	SENT_71	[p2l964t2561r1014b2591],
21	right	JJ	O	right	amod	22	SENT_71	[p2l1029t2560r1108b2599],
22	half	NN	O	half	prep_for	18	SENT_71	[p2l1122t2560r1191b2591],
23	of	IN	O	of	_	0	SENT_71	[p2l1203t2560r1241b2591],
24	the	DT	O	the	det	28	SENT_71	[p2l1253t2561r1303b2591],
25	protein	NN	O	protein	nn	28	SENT_71	[p2l1318t2560r1435b2599],
26	(	NN	O	(	nn	28	SENT_71	[p2l1452t2560r1529b2597],
27	16	CD	NUMBER	16	num	28	SENT_71	[p2l1452t2560r1529b2597],
28	)	NN	O	)	prep_of	22	SENT_71	[p2l1452t2560r1529b2597],
29	.	.	O	.	_	0	SENT_71	[p2l1452t2560r1529b2597],

1	There	EX	O	there	expl	4	SENT_72	[p2l1546t2561r1644b2591],
2	does	VBZ	O	do	aux	4	SENT_72	[p2l1659t2561r1735b2591],
3	not	RB	O	not	neg	4	SENT_72	[p2l1752t2566r1806b2592],
4	appear	VB	O	appear	_	0	SENT_72	[p2l503t2620r614b2651],
5	to	TO	O	to	aux	8	SENT_72	[p2l626t2616r658b2642],
6	be	VB	O	be	cop	8	SENT_72	[p2l671t2612r711b2642],
7	any	DT	O	any	det	8	SENT_72	[p2l724t2620r783b2651],
8	correlation	NN	O	correlation	xcomp	4	SENT_72	[p2l797t2611r977b2642],
9	between	IN	O	between	_	0	SENT_72	[p2l989t2611r1128b2642],
10	individual	JJ	O	individual	amod	11	SENT_72	[p2l1141t2611r1308b2642],
11	exons	NNS	O	exon	prep_between	8	SENT_72	[p2l1322t2621r1418b2642],
12	and	CC	O	and	_	0	SENT_72	[p2l1432t2612r1492b2642],
13	speciﬁc	JJ	O	speciﬁc	amod	15	SENT_72	[p2l1506t2611r1634b2651],
14	structural	JJ	O	structural	amod	15	SENT_72	[p2l1649t2612r1805b2643],
15	elements	NNS	O	element	xcomp	4	SENT_72	[p2l502t2662r650b2693],
16	of	IN	O	of	_	0	SENT_72	[p2l665t2662r703b2693],
17	the	DT	O	the	det	18	SENT_72	[p2l716t2662r767b2693],
18	protein	NN	O	protein	prep_of	15	SENT_72	[p2l782t2662r909b2702],
19	.	.	O	.	_	0	SENT_72	[p2l782t2662r909b2702],

1	Genetic	JJ	O	genetic	amod	2	SENT_73	[p2l927t2661r1055b2693],
2	analysis	NN	O	analysis	nsubj	5	SENT_73	[p2l1072t2662r1204b2701],
3	has	VBZ	O	have	aux	5	SENT_73	[p2l1220t2662r1275b2693],
4	also	RB	O	also	advmod	5	SENT_73	[p2l1292t2662r1358b2692],
5	revealed	VBD	O	reveal	_	0	SENT_73	[p2l1373t2663r1515b2693],
6	the	DT	O	the	det	7	SENT_73	[p2l1531t2662r1582b2693],
7	existence	NN	O	existence	dobj	5	SENT_73	[p2l1598t2662r1754b2693],
8	of	IN	O	of	_	0	SENT_73	[p2l1771t2662r1807b2693],
9	more	JJR	O	more	mwe	10	SENT_73	[p2l502t2722r588b2744],
10	than	IN	O	than	quantmod	11	SENT_73	[p2l599t2714r671b2744],
11	one	CD	NUMBER	one	num	13	SENT_73	[p2l683t2722r742b2744],
12	mdr	NN	O	mdr	nn	13	SENT_73	[p2l754t2713r822b2743],
13	gene	NN	O	gene	prep_of	7	SENT_73	[p2l833t2722r911b2752],
14	in	IN	O	in	_	0	SENT_73	[p2l923t2713r955b2743],
15	mouse	NN	O	mouse	prep_in	5	SENT_73	[p2l966t2722r1085b2749],
16	,	,	O	,	_	0	SENT_73	[p2l966t2722r1085b2749],
17	hamster	NN	O	hamster	prep_in	5	SENT_73	[p2l1095t2714r1238b2748],
18	,	,	O	,	_	0	SENT_73	[p2l1095t2714r1238b2748],
19	and	CC	O	and	_	0	SENT_73	[p2l1249t2713r1310b2744],
20	human	JJ	O	human	amod	21	SENT_73	[p2l1320t2713r1434b2743],
21	(	NN	O	(	prep_in	5	SENT_73	[p2l1446t2714r1511b2750],
22	17	CD	NUMBER	17	num	21	SENT_73	[p2l1446t2714r1511b2750],
23	,	,	O	,	_	0	SENT_73	[p2l1446t2714r1511b2750],
24	18	CD	NUMBER	18	num	25	SENT_73	[p2l1527t2713r1588b2750],
25	)	NN	O	)	appos	21	SENT_73	[p2l1527t2713r1588b2750],
26	.	.	O	.	_	0	SENT_73	[p2l1527t2713r1588b2750],

1	Members	NNS	O	member	nsubjpass	12	SENT_74	[p2l1600t2714r1758b2744],
2	of	IN	O	of	_	0	SENT_74	[p2l1771t2714r1807b2744],
3	the	DT	O	the	det	6	SENT_74	[p2l501t2763r552b2794],
4	mdr	NN	O	mdr	nn	6	SENT_74	[p2l570t2763r638b2793],
5	gene	NN	O	gene	nn	6	SENT_74	[p2l653t2772r732b2803],
6	family	NN	O	family	prep_of	1	SENT_74	[p2l749t2763r857b2802],
7	from	IN	O	from	_	0	SENT_74	[p2l873t2763r956b2793],
8	different	JJ	O	different	amod	9	SENT_74	[p2l972t2763r1115b2794],
9	species	NNS	O	species	prep_from	6	SENT_74	[p2l1131t2763r1250b2802],
10	can	MD	O	can	aux	12	SENT_74	[p2l1268t2772r1325b2794],
11	be	VB	O	be	auxpass	12	SENT_74	[p2l1340t2763r1381b2794],
12	categorized	VBN	O	categorize	_	0	SENT_74	[p2l1397t2763r1591b2803],
13	into	IN	O	into	_	0	SENT_74	[p2l1607t2764r1672b2794],
14	classes	NNS	O	class	prep_into	12	SENT_74	[p2l1688t2764r1804b2794],
15	based	VBN	O	base	_	0	SENT_74	[p2l501t2813r597b2843],
16	on	IN	O	on	prepc_based_on	14	SENT_74	[p2l607t2821r649b2843],
17	sequence	NN	O	sequence	nn	18	SENT_74	[p2l660t2822r813b2851],
18	similarity	NN	O	similarity	pobj	14	SENT_74	[p2l824t2812r982b2851],
19	of	IN	O	of	_	0	SENT_74	[p2l992t2812r1030b2843],
20	the	DT	O	the	det	21	SENT_74	[p2l1037t2813r1087b2843],
21	3	CD	NUMBER	3	prep_of	18	SENT_74	[p2l1099t2810r1129b2843],
22	'	''	O	'	_	0	SENT_74	[p2l1099t2810r1129b2843],
23	untranslated	JJ	O	untranslated	amod	24	SENT_74	[p2l1139t2813r1343b2843],
24	regions	NNS	O	region	nsubj	25	SENT_74	[p2l1353t2813r1475b2852],
25	(	VBP	O	(	rcmod	14	SENT_74	[p2l1487t2813r1564b2850],
26	19	CD	NUMBER	19	num	27	SENT_74	[p2l1487t2813r1564b2850],
27	)	CD	NUMBER	)	dobj	25	SENT_74	[p2l1487t2813r1564b2850],
28	.	.	O	.	_	0	SENT_74	[p2l1487t2813r1564b2850],

1	Relationships	NNPS	O	Relationships	nsubjpass	14	SENT_75	[p2l1577t2813r1804b2852],
2	and	CC	O	and	_	0	SENT_75	[p2l502t2863r562b2892],
3	the	DT	O	the	det	5	SENT_75	[p2l574t2863r624b2892],
4	current	JJ	DATE	current	amod	5	SENT_75	[p2l637t2868r756b2892],
5	nomenclature	NN	O	nomenclature	conj_and	1	SENT_75	[p2l766t2863r993b2893],
6	of	IN	O	of	_	0	SENT_75	[p2l1005t2862r1043b2892],
7	the	DT	O	the	det	9	SENT_75	[p2l1052t2863r1102b2893],
8	mdr	NN	O	mdr	nn	9	SENT_75	[p2l1114t2863r1183b2893],
9	genes	NNS	O	gene	prep_of	5	SENT_75	[p2l1194t2871r1287b2901],
10	in	IN	O	in	_	0	SENT_75	[p2l1299t2862r1332b2892],
11	several	JJ	O	several	amod	12	SENT_75	[p2l1345t2863r1462b2893],
12	species	NNS	O	species	prep_in	9	SENT_75	[p2l1475t2862r1594b2901],
13	are	VBP	O	be	auxpass	14	SENT_75	[p2l1607t2872r1658b2893],
14	summarized	VBN	O	summarize	_	0	SENT_75	[p2l1671t2872r1803b2893, p2l502t2911r585b2941],
15	in	IN	O	in	_	0	SENT_75	[p2l599t2912r631b2941],
16	Table	NNP	O	Table	prep_in	14	SENT_75	[p2l644t2912r739b2941],
17	3	CD	NUMBER	3	num	16	SENT_75	[p2l754t2912r783b2942],
18	.	.	O	.	_	0	SENT_75	[p2l754t2912r783b2942],

1	Studies	NNS	O	study	nsubj	9	SENT_76	[p2l799t2912r919b2941],
2	by	IN	O	by	_	0	SENT_76	[p2l932t2912r975b2950],
3	Ling	NNP	PERSON	Ling	poss	5	SENT_76	[p2l988t2912r1095b2951],
4	’s	POS	O	’s	_	0	SENT_76	[p2l988t2912r1095b2951],
5	group	NN	O	group	prep_by	1	SENT_76	[p2l1109t2921r1206b2950],
6	in	IN	O	in	_	0	SENT_76	[p2l1219t2912r1252b2941],
7	Toronto	NNP	LOCATION	Toronto	prep_in	5	SENT_76	[p2l1265t2913r1398b2942],
8	have	VBP	O	have	aux	9	SENT_76	[p2l1411t2912r1490b2942],
9	demonstrated	VBN	O	demonstrate	_	0	SENT_76	[p2l1504t2913r1729b2942],
10	that	IN	O	that	complm	17	SENT_76	[p2l1742t2912r1806b2942],
11	the	DT	O	the	det	15	SENT_76	[p2l501t2961r552b2992],
12	hamster	NN	O	hamster	nn	15	SENT_76	[p2l563t2961r697b2992],
13	P-glycoprotein	NN	MISC	p-glycoprotein	nn	15	SENT_76	[p2l706t2960r954b3001],
14	gene	NN	O	gene	nn	15	SENT_76	[p2l966t2970r1045b3000],
15	family	NN	O	family	nsubjpass	17	SENT_76	[p2l1056t2960r1163b3000],
16	is	VBZ	O	be	auxpass	17	SENT_76	[p2l1176t2961r1202b2992],
17	composed	VBN	O	compose	ccomp	9	SENT_76	[p2l1214t2961r1383b3001],
18	of	IN	O	of	_	0	SENT_76	[p2l1394t2961r1432b2992],
19	three	CD	NUMBER	three	num	20	SENT_76	[p2l1440t2961r1523b2992],
20	members	NNS	O	member	prep_of	17	SENT_76	[p2l1535t2961r1697b2993],
21	:	:	O	:	_	0	SENT_76	[p2l1535t2961r1697b2993],
22	pgpl	NN	O	pgpl	dep	20	SENT_76	[p2l1708t2962r1801b3001],
23	,	,	O	,	_	0	SENT_76	[p2l1708t2962r1801b3001],
24	pgp2	NN	O	pgp2	dep	20	SENT_76	[p2l498t3011r592b3050],
25	,	,	O	,	_	0	SENT_76	[p2l498t3011r592b3050],
26	and	CC	O	and	_	0	SENT_76	[p2l612t3011r672b3041],
27	pgp3	NN	O	pgp3	dep	20	SENT_76	[p2l684t3011r771b3050],
28	(	CD	NUMBER	(	number	29	SENT_76	[p2l788t3010r864b3048],
29	18	CD	NUMBER	18	num	30	SENT_76	[p2l788t3010r864b3048],
30	)	NN	O	)	dep	22	SENT_76	[p2l788t3010r864b3048],
31	.	.	O	.	_	0	SENT_76	[p2l788t3010r864b3048],

1	The	DT	O	the	det	5	SENT_77	[p2l881t3011r946b3041],
2	mouse	NN	O	mouse	nn	5	SENT_77	[p2l963t3020r1071b3042],
3	MDR	NN	O	mdr	nn	5	SENT_77	[p2l1087t3011r1182b3041],
4	gene	NN	O	gene	nn	5	SENT_77	[p2l1197t3020r1276b3050],
5	family	NN	O	family	nsubjpass	11	SENT_77	[p2l1291t3010r1399b3051],
6	has	VBZ	O	have	aux	8	SENT_77	[p2l1415t3011r1471b3042],
7	been	VBN	O	be	auxpass	8	SENT_77	[p2l1486t3012r1566b3042],
8	characterized	VBN	O	characterize	_	0	SENT_77	[p2l1582t3011r1805b3043],
9	and	CC	O	and	_	0	SENT_77	[p2l502t3062r562b3092],
10	also	RB	O	also	advmod	11	SENT_77	[p2l577t3062r644b3092],
11	found	VBN	O	find	conj_and	8	SENT_77	[p2l658t3062r755b3092],
12	to	TO	O	to	aux	13	SENT_77	[p2l769t3067r802b3092],
13	have	VB	O	have	xcomp	11	SENT_77	[p2l816t3061r895b3092],
14	three	CD	NUMBER	three	num	15	SENT_77	[p2l908t3061r992b3092],
15	members	NNS	O	member	dobj	13	SENT_77	[p2l1007t3062r1168b3097],
16	,	,	O	,	_	0	SENT_77	[p2l1007t3062r1168b3097],
17	designated	VBN	O	designate	conj_and	8	SENT_77	[p2l1183t3061r1361b3101],
18	mdrla	NN	O	mdrlum	dobj	17	SENT_77	[p2l1374t3061r1490b3096],
19	,	,	O	,	_	0	SENT_77	[p2l1374t3061r1490b3096],
20	mdrlb	NN	O	mdrlb	dobj	17	SENT_77	[p2l1508t3061r1624b3096],
21	,	,	O	,	_	0	SENT_77	[p2l1508t3061r1624b3096],
22	and	CC	O	and	_	0	SENT_77	[p2l1642t3062r1703b3092],
23	mdr2	NN	O	mdr2	conj_and	18	SENT_77	[p2l1717t3061r1803b3092],
24	(	CD	NUMBER	(	num	26	SENT_77	[p2l503t3112r580b3151],
25	17	CD	NUMBER	17	num	26	SENT_77	[p2l503t3112r580b3151],
26	)	NN	O	)	dobj	8	SENT_77	[p2l503t3112r580b3151],
27	.	.	O	.	_	0	SENT_77	[p2l503t3112r580b3151],

1	The	DT	O	the	det	3	SENT_78	[p2l596t3112r662b3144],
2	mouse	NN	O	mouse	nn	3	SENT_78	[p2l678t3121r787b3144],
3	genes	NNS	O	gene	nsubj	11	SENT_78	[p2l802t3121r896b3152],
4	corresponding	VBG	O	correspond	partmod	3	SENT_78	[p2l912t3111r1150b3152],
5	to	TO	O	to	_	0	SENT_78	[p2l1165t3117r1198b3144],
6	the	DT	O	the	det	9	SENT_78	[p2l1213t3111r1264b3144],
7	human	JJ	O	human	amod	9	SENT_78	[p2l1279t3112r1392b3144],
8	MDRI	NN	O	mdrus	nn	9	SENT_78	[p2l1407t3112r1515b3144],
9	gene	NN	O	gene	prep_to	4	SENT_78	[p2l1535t3121r1614b3153],
10	are	VBP	O	be	cop	11	SENT_78	[p2l1630t3121r1681b3144],
11	mdrla	JJ	O	mdrla	_	0	SENT_78	[p2l1696t3112r1804b3145],
12	(	NN	O	(	nsubj	14	SENT_78	[p2l503t3164r583b3202],
13	also	RB	O	also	advmod	14	SENT_78	[p2l503t3164r583b3202],
14	referred	VBD	O	refer	ccomp	11	SENT_78	[p2l594t3163r726b3195],
15	to	TO	O	to	prep	14	SENT_78	[p2l738t3169r771b3195],
16	as	IN	O	as	_	0	SENT_78	[p2l784t3173r817b3195],
17	mdrl	NN	O	mdrl	nn	18	SENT_78	[p2l830t3163r930b3201],
18	)	NN	O	)	prep_as	14	SENT_78	[p2l830t3163r930b3201],
19	and	CC	O	and	_	0	SENT_78	[p2l944t3164r1004b3195],
20	mdr2a	NN	O	mdr2a	nn	21	SENT_78	[p2l1016t3164r1124b3195],
21	(	NN	O	(	conj_and	18	SENT_78	[p2l1137t3164r1217b3202],
22	also	RB	O	also	advmod	23	SENT_78	[p2l1137t3164r1217b3202],
23	known	VBN	O	know	partmod	18	SENT_78	[p2l1229t3164r1343b3195],
24	as	IN	O	as	_	0	SENT_78	[p2l1355t3174r1388b3195],
25	mdr3	NN	O	mdr3	nn	26	SENT_78	[p2l1401t3164r1513b3203],
26	)	NN	O	)	prep_as	23	SENT_78	[p2l1401t3164r1513b3203],
27	,	,	O	,	_	0	SENT_78	[p2l1401t3164r1513b3203],
28	and	CC	O	and	_	0	SENT_78	[p2l1527t3165r1587b3195],
29	both	DT	O	both	nsubj	30	SENT_78	[p2l1598t3164r1673b3195],
30	encode	VBP	O	encode	conj_and	11	SENT_78	[p2l1685t3165r1805b3197],
31	functional	JJ	O	functional	amod	32	SENT_78	[p2l502t3215r671b3246],
32	transporters	NNS	O	transporter	dobj	30	SENT_78	[p2l681t3220r887b3255],
33	.	.	O	.	_	0	SENT_78	[p2l681t3220r887b3255],

1	The	DT	O	the	det	4	SENT_79	[p2l899t3215r964b3246],
2	murine	JJ	O	murine	amod	4	SENT_79	[p2l974t3215r1092b3246],
3	mdr2	NN	O	mdr2	nn	4	SENT_79	[p2l1103t3214r1189b3245],
4	gene	NN	O	gene	nsubj	7	SENT_79	[p2l1201t3224r1280b3255],
5	does	VBZ	O	do	aux	7	SENT_79	[p2l1291t3216r1366b3246],
6	not	RB	O	not	neg	7	SENT_79	[p2l1378t3220r1432b3246],
7	appear	VB	O	appear	_	0	SENT_79	[p2l1443t3225r1555b3255],
8	to	TO	O	to	aux	10	SENT_79	[p2l1564t3221r1597b3246],
9	be	VB	O	be	auxpass	10	SENT_79	[p2l1608t3216r1647b3246],
10	involved	VBN	O	involve	xcomp	7	SENT_79	[p2l1659t3215r1805b3247],
11	in	IN	O	in	_	0	SENT_79	[p2l502t3265r534b3295],
12	drug	NN	O	drug	nn	13	SENT_79	[p2l551t3265r626b3304],
13	resistance	NN	O	resistance	prep_in	10	SENT_79	[p2l643t3265r815b3296],
14	.	.	O	.	_	0	SENT_79	[p2l643t3265r815b3296],

1	Using	VBG	O	use	partmod	22	SENT_80	[p2l833t3265r932b3304],
2	photoaffrnity	NN	O	photoaffrnity	nn	3	SENT_80	[p2l948t3265r1165b3305],
3	analogues	NNS	O	analogue	dobj	1	SENT_80	[p2l1182t3265r1347b3305],
4	of	IN	O	of	_	0	SENT_80	[p2l1364t3266r1401b3296],
5	adenosine	NN	O	adenosine	nn	6	SENT_80	[p2l1415t3265r1581b3297],
6	triphosphate	NN	O	triphosphate	prep_of	3	SENT_80	[p2l1597t3266r1805b3305],
7	(	CD	NUMBER	(	num	9	SENT_80	[p2l503t3316r608b3352],
8	ATP	NN	ORGANIZATION	atp	nn	9	SENT_80	[p2l503t3316r608b3352],
9	)	NN	O	)	dep	6	SENT_80	[p2l503t3316r608b3352],
10	and	CC	O	and	_	0	SENT_80	[p2l624t3316r684b3346],
11	prazosin	NN	O	prazosin	prep_of	3	SENT_80	[p2l701t3316r851b3355],
12	,	,	O	,	_	0	SENT_80	[p2l701t3316r851b3355],
13	a	DT	O	a	det	14	SENT_80	[p2l868t3325r887b3345],
14	substrate	NN	O	substrate	appos	11	SENT_80	[p2l904t3316r1051b3346],
15	for	IN	O	for	_	0	SENT_80	[p2l1067t3316r1116b3346],
16	mdr	NN	O	mdr	nn	17	SENT_80	[p2l1131t3317r1226b3350],
17	]	NN	O	]	prep_for	14	SENT_80	[p2l1131t3317r1226b3350],
18	,	,	O	,	_	0	SENT_80	[p2l1131t3317r1226b3350],
19	Buschman	NNP	ORGANIZATION	Buschman	nsubj	22	SENT_80	[p2l1245t3316r1420b3346],
20	&	CC	ORGANIZATION	&	_	0	SENT_80	[p2l1437t3317r1469b3347],
21	Gros	NNP	ORGANIZATION	Gros	conj_and	19	SENT_80	[p2l1485t3317r1566b3346],
22	have	VBP	O	have	_	0	SENT_80	[p2l1582t3317r1661b3347],
23	demonTable	JJ	O	demontable	acomp	22	SENT_80	[p2l1677t3317r1804b3347, p2l779t3465r861b3489],

1	3	CD	NUMBER	3	num	2	SENT_81	[p2l871t3465r887b3489],
2	Nomenclature	NN	O	nomenclature	_	0	SENT_81	[p2l918t3465r1106b3490],
3	for	IN	O	for	_	0	SENT_81	[p2l1116t3465r1155b3489],
4	multidrug-resistance	JJ	O	multidrug-resistance	amod	5	SENT_81	[p2l1164t3465r1438b3496],
5	genes	NNS	O	gene	prep_for	2	SENT_81	[p2l780t3501r867b3536],
6	'	POS	O	'	_	0	SENT_81	[p2l780t3501r867b3536],

1	Designation	NN	O	designation	_	0	SENT_82	[p2l1223t3584r1383b3617],

1	Class	NNP	O	Class	_	0	SENT_83	[p2l999t3659r1071b3685],
2	1	CD	NUMBER	1	num	1	SENT_83	[p2l1081t3660r1092b3684],
3	Class	NNP	O	Class	dep	1	SENT_83	[p2l1195t3660r1266b3685],
4	11	CD	NUMBER	11	num	3	SENT_83	[p2l1277t3660r1299b3685],
5	Class	NNP	O	Class	nn	6	SENT_83	[p2l1394t3660r1466b3685],
6	HI	NNP	O	HI	dep	1	SENT_83	[p2l1477t3661r1510b3685],

1	Human	JJ	O	human	amod	2	SENT_84	[p2l780t3746r877b3771],
2	MDR	NN	O	mdr	_	0	SENT_84	[p2l998t3746r1084b3771],
3	!	.	O	!	_	0	SENT_84	[p2l998t3746r1084b3771],

1	MDR3	NN	O	mdr3	_	0	SENT_85	[p2l1393t3736r1496b3772],
2	”	SYM	O	”	dep	1	SENT_85	[p2l1393t3736r1496b3772],

1	mwww	NN	O	mwww	_	0	SENT_86	[p3l359t3529r375b3634],
2	.	.	O	.	_	0	SENT_86	[p3l352t3237r382b3488],

1	annualreviews.org	NN	O	annualreviews.org	nn	3	SENT_87	[p3l352t3237r382b3488],
2	ersonal	JJ	O	ersonal	amod	3	SENT_87	[p3l385t3539r409b3634],
3	use	NN	O	use	nsubj	4	SENT_87	[p3l393t3448r409b3490],
4	only	RB	O	only	_	0	SENT_87	[p3l385t3373r416b3438],
5	.	.	O	.	_	0	SENT_87	[p3l385t3373r416b3438],

1	Annu	NNP	PERSON	Annu	_	0	SENT_88	[p3l354t2025r377b2105],
2	.	.	O	.	_	0	SENT_88	[p3l354t2025r377b2105],

1	Rev.	NNP	O	Rev.	nn	2	SENT_89	[p3l354t1955r377b2014],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_89	[p3l354t1795r377b1944],
3	.	.	O	.	_	0	SENT_89	[p3l354t1795r377b1944],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_90	[p3l354t1675r377b1785],
2	.	.	O	.	_	0	SENT_90	[p3l354t1675r377b1785],

1	1996.36	CD	NUMBER	1996.36	_	0	SENT_91	[p3l354t1550r378b1661],
2	:	:	O	:	_	0	SENT_91	[p3l354t1550r378b1661],
3	161-183	CD	NUMBER	161-183	dep	1	SENT_91	[p3l354t1430r377b1544],
4	.	.	O	.	_	0	SENT_91	[p3l354t1430r377b1544],

1	Downloaded	VBN	O	download	_	0	SENT_92	[p3l354t1249r377b1419],
2	from	IN	O	from	_	0	SENT_92	[p3l354t1176r377b1240],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_92	[p3l354t843r384b1167],
4	by	IN	O	by	_	0	SENT_92	[p3l387t1938r418b1970],
5	University	NNP	ORGANIZATION	University	prep_by	1	SENT_92	[p3l388t1789r418b1928],
6	of	IN	ORGANIZATION	of	_	0	SENT_92	[p3l387t1750r411b1779],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	8	SENT_92	[p3l388t1603r411b1743],
8	Madison	NNP	ORGANIZATION	Madison	prep_of	5	SENT_92	[p3l387t1459r411b1575],
9	on	IN	O	on	_	0	SENT_92	[p3l395t1417r411b1449],
10	01/05/14	NN	DATE	01/05/14	prep_on	8	SENT_92	[p3l387t1291r411b1408],
11	For	IN	O	for	_	0	SENT_92	[p3l388t1227r411b1273],
12	personal	JJ	O	personal	amod	13	SENT_92	[p3l387t1106r418b1219],
13	use	NN	O	use	prep_for	1	SENT_92	[p3l395t1054r411b1097],
14	only	RB	O	only	advmod	1	SENT_92	[p3l387t986r418b1044],

1	Mouse	NN	O	mouse	nn	2	SENT_93	[p3l779t34r870b59],
2	mdr3	NN	O	mdr3	_	0	SENT_93	[p3l998t33r1067b60],
3	mdrl	NN	O	mdrl	nn	4	SENT_93	[p3l1194t34r1261b59],
4	mdr2	NN	O	mdr2	dep	2	SENT_93	[p3l1394t34r1468b60],
5	<	JJR	O	<	dep	2	SENT_93	[p3l1394t34r1468b60],

1	Hamster	NN	O	hamster	_	0	SENT_94	[p3l779t115r893b140],
2	pspl	NN	O	pspl	nn	3	SENT_94	[p3l996t116r1060b146],
3	pxpl	NN	O	pxpl	dep	1	SENT_94	[p3l1191t116r1261b147],

1	Annual	JJ	SET	annual	amod	2	SENT_95	[p3l444t251r565b280],
2	Reviews	NNS	O	review	nsubj	3	SENT_95	[p3l577t251r718b288],
3	_	VBP	O	_	_	0	SENT_95	[p3l951t284r955b288],
4	www.annualrev1ews.org/aronline	NN	O	www.annualrev1ews.org/aronline	dobj	3	SENT_95	[p3l445t284r998b322],

1	164	CD	NUMBER	164	num	2	SENT_96	[p3l499t386r552b414],
2	BELLAMY	NN	O	bellamy	_	0	SENT_96	[p3l621t386r802b414],

1	strated	VBD	O	strate	_	0	SENT_97	[p3l497t482r607b513],
2	that	IN	O	that	complm	6	SENT_97	[p3l624t482r687b512],
3	mdr2	NN	O	mdr2	nn	4	SENT_97	[p3l702t481r788b512],
4	transfectants	NNS	O	transfectant	nsubj	6	SENT_97	[p3l806t481r1015b512],
5	are	VBP	O	be	cop	6	SENT_97	[p3l1033t490r1082b512],
6	capable	JJ	O	capable	ccomp	1	SENT_97	[p3l1099t481r1225b521],
7	of	IN	O	of	_	0	SENT_97	[p3l1243t482r1279b512],
8	binding	VBG	O	bind	amod	9	SENT_97	[p3l1292t481r1419b521],
9	ATP	NN	O	atp	prep_of	6	SENT_97	[p3l1436t482r1515b512],
10	with	IN	O	with	_	0	SENT_97	[p3l1531t481r1604b512],
11	an	DT	O	a	det	12	SENT_97	[p3l1621t491r1659b512],
12	afﬁnity	NN	O	afﬁnity	prep_with	9	SENT_97	[p3l1677t481r1798b521],
13	similar	JJ	O	similar	amod	12	SENT_97	[p3l497t530r611b561],
14	to	TO	O	to	_	0	SENT_97	[p3l629t535r662b561],
15	that	DT	O	that	prep_to	13	SENT_97	[p3l680t530r742b560],
16	observed	VBN	O	observe	partmod	15	SENT_97	[p3l761t529r911b560],
17	for	IN	O	for	_	0	SENT_97	[p3l929t529r978b560],
18	mdrl	NN	O	mdrl	prep_for	16	SENT_97	[p3l995t530r1088b565],
19	,	,	O	,	_	0	SENT_97	[p3l995t530r1088b565],
20	but	CC	O	but	_	0	SENT_97	[p3l1110t530r1164b561],
21	they	PRP	O	they	nsubj	23	SENT_97	[p3l1182t530r1252b569],
22	were	VBD	O	be	cop	23	SENT_97	[p3l1272t539r1351b560],
23	unable	JJ	O	unable	ccomp	1	SENT_97	[p3l1371t530r1480b561],
24	to	TO	O	to	aux	25	SENT_97	[p3l1499t535r1531b561],
25	bind	VB	O	bind	xcomp	23	SENT_97	[p3l1550t530r1624b560],
26	the	DT	O	the	det	28	SENT_97	[p3l1642t531r1691b561],
27	mdrl	NN	O	mdrl	nn	28	SENT_97	[p3l1711t530r1795b561],
28	substrate	NN	O	substrate	nsubj	31	SENT_97	[p3l497t579r644b610],
29	(	CD	NUMBER	(	number	30	SENT_97	[p3l659t579r736b616],
30	20	CD	NUMBER	20	num	31	SENT_97	[p3l659t579r736b616],
31	)	NN	O	)	xcomp	25	SENT_97	[p3l659t579r736b616],
32	.	.	O	.	_	0	SENT_97	[p3l659t579r736b616],

1	Thus	RB	O	thus	advmod	11	SENT_98	[p3l750t579r842b615],
2	,	,	O	,	_	0	SENT_98	[p3l750t579r842b615],
3	the	DT	O	the	det	4	SENT_98	[p3l857t580r908b610],
4	failure	NN	O	failure	nsubj	11	SENT_98	[p3l922t578r1029b610],
5	of	IN	O	of	_	0	SENT_98	[p3l1043t579r1079b609],
6	Mdr2	NN	O	mdr2	prep_of	4	SENT_98	[p3l1090t579r1182b610],
7	to	TO	O	to	aux	8	SENT_98	[p3l1195t584r1227b609],
8	confer	VB	O	confer	infmod	6	SENT_98	[p3l1241t579r1347b610],
9	drug	NN	O	drug	nn	10	SENT_98	[p3l1360t579r1436b618],
10	resistance	NN	O	resistance	dobj	8	SENT_98	[p3l1449t579r1613b610],
11	appears	VBZ	O	appear	_	0	SENT_98	[p3l1627t588r1753b619],
12	to	TO	O	to	aux	14	SENT_98	[p3l1767t584r1799b610],
13	be	VB	O	be	auxpass	14	SENT_98	[p3l496t627r535b659],
14	related	VBN	O	relate	xcomp	11	SENT_98	[p3l547t626r660b659],
15	to	TO	O	to	_	0	SENT_98	[p3l673t631r704b658],
16	its	PRP$	O	its	poss	18	SENT_98	[p3l717t626r755b658],
17	reduced	VBN	O	reduce	amod	18	SENT_98	[p3l768t626r899b658],
18	ability	NN	O	ability	prep_to	14	SENT_98	[p3l912t626r1016b667],
19	to	TO	O	to	aux	20	SENT_98	[p3l1030t631r1061b658],
20	bind	VB	O	bind	infmod	18	SENT_98	[p3l1073t626r1147b658],
21	drugs	NNS	O	drug	dobj	20	SENT_98	[p3l1159t626r1259b667],
22	.	.	O	.	_	0	SENT_98	[p3l1159t626r1259b667],

1	In	IN	O	in	_	0	SENT_99	[p3l1273t627r1307b658],
2	the	DT	O	the	det	3	SENT_99	[p3l1319t627r1369b658],
3	human	JJ	O	human	prep_in	6	SENT_99	[p3l1381t627r1503b664],
4	,	,	O	,	_	0	SENT_99	[p3l1381t627r1503b664],
5	there	EX	O	there	expl	6	SENT_99	[p3l1517t627r1598b659],
6	is	VBZ	O	be	_	0	SENT_99	[p3l1611t627r1637b659],
7	evidence	NN	O	evidence	nsubj	6	SENT_99	[p3l1650t627r1799b659],
8	for	IN	O	for	_	0	SENT_99	[p3l496t677r545b708],
9	a	DT	DURATION	a	det	13	SENT_99	[p3l560t686r578b708],
10	second	JJ	DURATION	second	amod	13	SENT_99	[p3l593t676r709b708],
11	human	JJ	O	human	amod	13	SENT_99	[p3l723t677r836b708],
12	MDR	NN	O	mdr	nn	13	SENT_99	[p3l852t676r947b708],
13	gene	NN	O	gene	prep_for	7	SENT_99	[p3l962t685r1048b716],
14	,	,	O	,	_	0	SENT_99	[p3l962t685r1048b716],
15	designated	VBN	O	designate	partmod	13	SENT_99	[p3l1065t676r1242b717],
16	the	DT	O	the	det	19	SENT_99	[p3l1257t677r1306b708],
17	MDR3	NN	O	mdr3	nn	19	SENT_99	[p3l1320t676r1430b708],
18	gene	NN	O	gene	nn	19	SENT_99	[p3l1447t686r1525b717],
19	(	NN	O	(	nsubj	21	SENT_99	[p3l1542t677r1621b715],
20	also	RB	O	also	advmod	21	SENT_99	[p3l1542t677r1621b715],
21	known	VBN	O	know	ccomp	15	SENT_99	[p3l1636t677r1749b708],
22	as	IN	O	as	_	0	SENT_99	[p3l1765t687r1797b709],
23	MDR2	NN	O	mdr2	prep_as	21	SENT_99	[p3l495t726r621b764],
24	)	CD	NUMBER	)	num	23	SENT_99	[p3l495t726r621b764],
25	(	CD	NUMBER	(	number	26	SENT_99	[p3l631t726r695b763],
26	18	CD	NUMBER	18	dobj	21	SENT_99	[p3l631t726r695b763],
27	,	,	O	,	_	0	SENT_99	[p3l631t726r695b763],
28	21	CD	NUMBER	21	appos	26	SENT_99	[p3l706t726r755b762],
29	,	,	O	,	_	0	SENT_99	[p3l706t726r755b762],
30	22	CD	NUMBER	22	num	31	SENT_99	[p3l767t725r830b763],
31	)	NN	O	)	appos	28	SENT_99	[p3l767t725r830b763],
32	.	.	O	.	_	0	SENT_99	[p3l767t725r830b763],

1	The	DT	O	the	det	3	SENT_100	[p3l841t726r905b756],
2	two	CD	NUMBER	two	num	3	SENT_100	[p3l916t730r977b756],
3	members	NNS	O	member	nsubj	10	SENT_100	[p3l986t726r1137b756],
4	of	IN	O	of	_	0	SENT_100	[p3l1147t725r1184b756],
5	the	DT	O	the	det	9	SENT_100	[p3l1191t726r1241b756],
6	human	JJ	O	human	amod	9	SENT_100	[p3l1250t726r1362b757],
7	MDR	NN	ORGANIZATION	mdr	nn	9	SENT_100	[p3l1372t726r1467b756],
8	gene	NN	O	gene	nn	9	SENT_100	[p3l1476t735r1555b765],
9	family	NN	O	family	prep_of	3	SENT_100	[p3l1564t726r1672b766],
10	encode	VBP	O	encode	_	0	SENT_100	[p3l1681t727r1800b757],
11	4.1	CD	NUMBER	4.1	dobj	10	SENT_100	[p3l496t776r561b806],
12	-	:	O	-	_	0	SENT_100	[p3l496t776r561b806],
13	to	TO	O	to	_	0	SENT_100	[p3l574t780r605b806],
14	4.5-kilobase	NN	O	4.5-kilobase	nn	15	SENT_100	[p3l617t776r822b806],
15	species	NNS	O	species	prep_to	10	SENT_100	[p3l833t775r952b814],
16	of	IN	O	of	_	0	SENT_100	[p3l964t776r1001b805],
17	RNA	NN	O	rna	prep_of	15	SENT_100	[p3l1009t776r1097b805],
18	that	WDT	O	that	nsubj	19	SENT_100	[p3l1109t776r1171b805],
19	have	VBP	O	have	rcmod	15	SENT_100	[p3l1181t775r1258b806],
20	a	DT	O	a	det	22	SENT_100	[p3l1271t784r1289b806],
21	high	JJ	O	high	amod	22	SENT_100	[p3l1299t775r1373b814],
22	degree	NN	O	degree	dobj	19	SENT_100	[p3l1385t776r1495b814],
23	of	IN	O	of	_	0	SENT_100	[p3l1508t775r1545b806],
24	homology	NN	O	homology	prep_of	22	SENT_100	[p3l1553t776r1722b814],
25	(	CD	NUMBER	(	number	26	SENT_100	[p3l1735t776r1798b813],
26	18	CD	NUMBER	18	dep	24	SENT_100	[p3l1735t776r1798b813],
27	,	,	O	,	_	0	SENT_100	[p3l1735t776r1798b813],
28	21	CD	NUMBER	21	appos	24	SENT_100	[p3l497t824r547b859],
29	,	,	O	,	_	0	SENT_100	[p3l497t824r547b859],
30	22	CD	NUMBER	22	num	31	SENT_100	[p3l562t824r625b861],
31	)	NN	O	)	appos	28	SENT_100	[p3l562t824r625b861],
32	.	.	O	.	_	0	SENT_100	[p3l562t824r625b861],

1	Smit	NNP	PERSON	Smit	nsubj	4	SENT_101	[p3l540t874r618b905],
2	et	FW	O	et	nn	3	SENT_101	[p3l628t878r659b906],
3	al	FW	O	al	dep	1	SENT_101	[p3l668t874r698b905],
4	observed	VBN	O	observe	_	0	SENT_101	[p3l708t874r858b905],
5	that	IN	O	that	complm	23	SENT_101	[p3l868t874r931b905],
6	mice	NNS	O	mouse	nsubj	23	SENT_101	[p3l941t874r1021b905],
7	homozygous	JJ	O	homozygous	amod	6	SENT_101	[p3l1031t874r1242b913],
8	for	IN	O	for	_	0	SENT_101	[p3l1253t874r1303b905],
9	a	DT	O	a	det	10	SENT_101	[p3l1312t883r1330b904],
10	disruption	NN	O	disruption	prep_for	7	SENT_101	[p3l1341t874r1508b913],
11	in	IN	O	in	_	0	SENT_101	[p3l1519t875r1550b905],
12	the	DT	O	the	det	15	SENT_101	[p3l1562t874r1611b905],
13	mdr2	NN	O	mdr2	nn	15	SENT_101	[p3l1623t873r1710b904],
14	gene	NN	O	gene	nn	15	SENT_101	[p3l1722t883r1800b913],
15	(	NN	O	(	prep_in	10	SENT_101	[p3l498t923r678b962],
16	analogous	JJ	O	analogous	amod	6	SENT_101	[p3l498t923r678b962],
17	to	TO	O	to	_	0	SENT_101	[p3l699t928r731b953],
18	the	DT	O	the	det	22	SENT_101	[p3l750t924r799b953],
19	human	JJ	O	human	amod	22	SENT_101	[p3l820t923r932b953],
20	MDR3	NN	O	mdr3	nn	22	SENT_101	[p3l950t923r1059b953],
21	gene	NN	O	gene	nn	22	SENT_101	[p3l1081t923r1171b962],
22	)	NN	O	)	prep_to	16	SENT_101	[p3l1081t923r1171b962],
23	developed	VBD	O	develop	ccomp	4	SENT_101	[p3l1193t923r1363b962],
24	a	DT	O	a	det	26	SENT_101	[p3l1382t933r1400b953],
25	liver	NN	O	liver	nn	26	SENT_101	[p3l1419t923r1496b953],
26	disease	NN	O	disease	dobj	23	SENT_101	[p3l1514t923r1634b953],
27	that	WDT	O	that	nsubj	31	SENT_101	[p3l1654t923r1715b953],
28	was	VBD	O	be	cop	31	SENT_101	[p3l1736t933r1798b954],
29	apparently	RB	O	apparently	advmod	31	SENT_101	[p3l498t973r673b1013],
30	the	DT	O	the	det	31	SENT_101	[p3l688t974r738b1004],
31	result	NN	O	result	rcmod	26	SENT_101	[p3l752t974r845b1004],
32	of	IN	O	of	_	0	SENT_101	[p3l859t973r896b1004],
33	the	DT	O	the	det	34	SENT_101	[p3l908t973r958b1003],
34	inability	NN	O	inability	prep_of	31	SENT_101	[p3l972t973r1109b1012],
35	of	IN	O	of	_	0	SENT_101	[p3l1125t973r1161b1004],
36	the	DT	O	the	det	37	SENT_101	[p3l1173t973r1222b1003],
37	liver	NN	O	liver	prep_of	34	SENT_101	[p3l1238t974r1314b1004],
38	to	TO	O	to	aux	39	SENT_101	[p3l1328t978r1359b1004],
39	secrete	VB	O	secrete	infmod	37	SENT_101	[p3l1375t978r1489b1004],
40	phospholipid	NN	O	phospholipid	dobj	39	SENT_101	[p3l1504t973r1721b1013],
41	into	IN	O	into	_	0	SENT_101	[p3l1736t974r1800b1004],
42	the	DT	O	the	det	46	SENT_101	[p3l497t1023r546b1054],
43	bile	NN	O	bile	nn	46	SENT_101	[p3l567t1024r630b1054],
44	(	NN	O	(	nn	46	SENT_101	[p3l652t1024r728b1061],
45	23	CD	NUMBER	23	num	46	SENT_101	[p3l652t1024r728b1061],
46	)	NN	O	)	prep_into	39	SENT_101	[p3l652t1024r728b1061],
47	.	.	O	.	_	0	SENT_101	[p3l652t1024r728b1061],

1	By	IN	O	by	_	0	SENT_102	[p3l751t1025r798b1062],
2	6-12	CD	NUMBER	6-12	num	3	SENT_102	[p3l820t1023r902b1054],
3	weeks	NNS	NUMBER	week	prep_by	11	SENT_102	[p3l923t1024r1025b1054],
4	of	IN	O	of	_	0	SENT_102	[p3l1047t1023r1083b1053],
5	age	NN	O	age	prep_of	3	SENT_102	[p3l1101t1033r1167b1063],
6	,	,	O	,	_	0	SENT_102	[p3l1101t1033r1167b1063],
7	mdr2	NN	O	mdr2	nn	9	SENT_102	[p3l1188t1023r1275b1053],
8	knockout	NN	O	knockout	nn	9	SENT_102	[p3l1295t1023r1451b1055],
9	mice	NNS	O	mouse	nsubj	11	SENT_102	[p3l1470t1024r1552b1055],
10	had	VBD	O	have	aux	11	SENT_102	[p3l1572t1024r1631b1054],
11	scattered	VBN	O	scatter	_	0	SENT_102	[p3l1653t1024r1800b1055],
12	hepatocyte	NN	O	hepatocyte	nn	13	SENT_102	[p3l497t1074r678b1113],
13	necrosis	NN	O	necrosis	dobj	11	SENT_102	[p3l690t1073r835b1109],
14	,	,	O	,	_	0	SENT_102	[p3l690t1073r835b1109],
15	proliferation	NN	O	proliferation	conj_and	13	SENT_102	[p3l848t1073r1054b1113],
16	of	IN	O	of	_	0	SENT_102	[p3l1067t1073r1104b1103],
17	bile	NN	O	bile	nn	18	SENT_102	[p3l1113t1073r1175b1104],
18	ducts	NNS	O	duct	prep_of	15	SENT_102	[p3l1187t1073r1283b1109],
19	,	,	O	,	_	0	SENT_102	[p3l1187t1073r1283b1109],
20	and	CC	O	and	_	0	SENT_102	[p3l1297t1074r1356b1104],
21	mild	JJ	O	mild	amod	23	SENT_102	[p3l1369t1073r1444b1104],
22	portal	JJ	O	portal	amod	23	SENT_102	[p3l1456t1073r1552b1113],
23	inﬂammation	NN	O	inﬂammation	conj_and	13	SENT_102	[p3l1565t1073r1798b1104],
24	.	.	O	.	_	0	SENT_102	[p3l1565t1073r1798b1104],

1	Bile	NN	O	bile	nn	2	SENT_103	[p3l498t1124r567b1155],
2	analysis	NN	O	analysis	nsubj	3	SENT_103	[p3l576t1124r709b1163],
3	showed	VBD	O	show	_	0	SENT_103	[p3l720t1124r846b1155],
4	an	DT	O	a	det	5	SENT_103	[p3l856t1134r894b1155],
5	absence	NN	O	absence	dobj	3	SENT_103	[p3l903t1124r1033b1155],
6	of	IN	O	of	_	0	SENT_103	[p3l1043t1124r1080b1154],
7	phospholipid	NN	O	phospholipid	prep_of	5	SENT_103	[p3l1087t1124r1311b1164],
8	.	.	O	.	_	0	SENT_103	[p3l1087t1124r1311b1164],

1	Mice	NNS	O	mouse	nsubj	9	SENT_104	[p3l1322t1124r1407b1155],
2	that	WDT	O	that	nsubj	4	SENT_104	[p3l1417t1124r1479b1155],
3	were	VBD	O	be	cop	4	SENT_104	[p3l1488t1134r1569b1155],
4	heterozygous	JJ	O	heterozygous	rcmod	1	SENT_104	[p3l1578t1125r1799b1164],
5	for	IN	O	for	_	0	SENT_104	[p3l497t1175r546b1207],
6	the	DT	O	the	det	8	SENT_104	[p3l561t1176r611b1207],
7	gene	NN	O	gene	nn	8	SENT_104	[p3l629t1184r707b1216],
8	disruption	NN	O	disruption	prep_for	4	SENT_104	[p3l724t1175r891b1215],
9	had	VBD	O	have	_	0	SENT_104	[p3l908t1175r967b1206],
10	no	DT	O	no	det	13	SENT_104	[p3l983t1185r1024b1207],
11	detectable	JJ	O	detectable	amod	13	SENT_104	[p3l1040t1175r1208b1206],
12	liver	NN	O	liver	nn	13	SENT_104	[p3l1224t1176r1301b1207],
13	pathology	NN	O	pathology	dobj	9	SENT_104	[p3l1316t1175r1481b1215],
14	but	CC	O	but	_	0	SENT_104	[p3l1497t1176r1552b1207],
15	had	VBD	O	have	aux	17	SENT_104	[p3l1567t1176r1626b1206],
16	markedly	RB	O	markedly	advmod	17	SENT_104	[p3l1643t1176r1799b1216],
17	reduced	VBN	O	reduce	conj_but	9	SENT_104	[p3l498t1226r630b1257],
18	biliary	JJ	O	biliary	amod	20	SENT_104	[p3l640t1225r747b1265],
19	phospholipid	JJ	O	phospholipid	amod	20	SENT_104	[p3l757t1225r974b1265],
20	levels	NNS	O	level	dobj	17	SENT_104	[p3l984t1226r1088b1256],
21	.	.	O	.	_	0	SENT_104	[p3l984t1226r1088b1256],

1	Smit	NNP	PERSON	Smit	nn	3	SENT_105	[p3l1101t1225r1178b1257],
2	et	NNP	O	et	nn	3	SENT_105	[p3l1188t1231r1217b1256],
3	al	NNP	O	al	nsubj	4	SENT_105	[p3l1227t1226r1256b1256],
4	hypothesized	VBD	O	hypothesize	_	0	SENT_105	[p3l1265t1225r1485b1265],
5	that	IN	O	that	complm	51	SENT_105	[p3l1495t1226r1557b1257],
6	in	IN	O	in	_	0	SENT_105	[p3l1567t1226r1599b1256],
7	the	DT	O	the	det	8	SENT_105	[p3l1610t1226r1659b1257],
8	absence	NN	O	absence	nsubj	38	SENT_105	[p3l1670t1226r1801b1257],
9	of	IN	O	of	_	0	SENT_105	[p3l498t1276r535b1308],
10	phospholipid	JJ	O	phospholipid	amod	11	SENT_105	[p3l546t1276r763b1316],
11	solubilization	NN	O	solubilization	prep_of	8	SENT_105	[p3l779t1276r1013b1312],
12	,	,	O	,	_	0	SENT_105	[p3l779t1276r1013b1312],
13	bile	NN	O	bile	nn	14	SENT_105	[p3l1028t1276r1090b1307],
14	acids	NNS	O	acid	appos	11	SENT_105	[p3l1105t1276r1199b1312],
15	,	,	O	,	_	0	SENT_105	[p3l1105t1276r1199b1312],
16	by	IN	O	by	_	0	SENT_105	[p3l1214t1276r1255b1316],
17	virtue	NN	O	virtue	prep_by	38	SENT_105	[p3l1270t1276r1366b1307],
18	of	IN	O	of	_	0	SENT_105	[p3l1381t1276r1418b1307],
19	their	PRP$	O	they	poss	21	SENT_105	[p3l1429t1276r1506b1307],
20	detergent	NN	O	detergent	nn	21	SENT_105	[p3l1519t1277r1675b1316],
21	action	NN	O	action	prep_of	17	SENT_105	[p3l1689t1277r1800b1313],
22	,	,	O	,	_	0	SENT_105	[p3l1689t1277r1800b1313],
23	damage	NN	O	damage	prep_by	38	SENT_105	[p3l498t1328r627b1366],
24	the	DT	O	the	det	27	SENT_105	[p3l649t1327r698b1356],
25	biliary	JJ	O	biliary	amod	27	SENT_105	[p3l719t1327r828b1365],
26	canaliculi	JJ	O	canaliculi	amod	27	SENT_105	[p3l849t1326r1009b1356],
27	membrane	NN	O	membrane	dep	23	SENT_105	[p3l1031t1327r1206b1356],
28	and	CC	O	and	_	0	SENT_105	[p3l1226t1327r1286b1356],
29	the	DT	O	the	det	31	SENT_105	[p3l1307t1327r1357b1356],
30	apical	JJ	O	apical	amod	31	SENT_105	[p3l1379t1326r1476b1365],
31	membrane	NN	O	membrane	prep_by	38	SENT_105	[p3l1498t1327r1674b1357],
32	of	IN	O	of	_	0	SENT_105	[p3l1695t1327r1731b1356],
33	the	DT	O	the	det	35	SENT_105	[p3l1750t1327r1801b1357],
34	capillary	JJ	O	capillary	amod	35	SENT_105	[p3l498t1376r643b1415],
35	ductules	NNS	O	ductule	prep_of	31	SENT_105	[p3l665t1376r812b1411],
36	,	,	O	,	_	0	SENT_105	[p3l665t1376r812b1411],
37	thereby	RB	O	thereby	advmod	38	SENT_105	[p3l834t1375r958b1413],
38	giving	VBG	O	give	prepc_in	51	SENT_105	[p3l979t1375r1084b1414],
39	rise	NN	O	rise	dobj	38	SENT_105	[p3l1104t1376r1165b1405],
40	to	TO	O	to	_	0	SENT_105	[p3l1185t1380r1217b1405],
41	the	DT	O	the	det	42	SENT_105	[p3l1238t1376r1288b1405],
42	pathology	NN	O	pathology	prep_to	38	SENT_105	[p3l1308t1376r1474b1413],
43	seen	VBN	O	see	partmod	42	SENT_105	[p3l1496t1384r1569b1406],
44	in	IN	O	in	_	0	SENT_105	[p3l1591t1376r1621b1405],
45	the	DT	O	the	det	46	SENT_105	[p3l1643t1376r1693b1405],
46	ma	NN	O	ma	poss	48	SENT_105	[p3l1714t1376r1800b1406],
47	'	POS	O	'	_	0	SENT_105	[p3l1714t1376r1800b1406],
48	r2	NN	O	r2	prep_in	43	SENT_105	[p3l1714t1376r1800b1406],
49	knockout	NN	O	knockout	nn	50	SENT_105	[p3l497t1426r654b1456],
50	mice	NNS	O	mouse	nsubj	51	SENT_105	[p3l669t1425r749b1456],
51	(	VBP	O	(	ccomp	4	SENT_105	[p3l765t1425r841b1462],
52	23	CD	NUMBER	23	num	53	SENT_105	[p3l765t1425r841b1462],
53	)	CD	NUMBER	)	dobj	51	SENT_105	[p3l765t1425r841b1462],
54	.	.	O	.	_	0	SENT_105	[p3l765t1425r841b1462],

1	Thus	RB	O	thus	advmod	4	SENT_106	[p3l859t1426r951b1460],
2	,	,	O	,	_	0	SENT_106	[p3l859t1426r951b1460],
3	mdr2	NN	O	mdr2	nsubj	4	SENT_106	[p3l967t1425r1053b1455],
4	appears	VBZ	O	appear	_	0	SENT_106	[p3l1070t1433r1195b1464],
5	to	TO	O	to	aux	7	SENT_106	[p3l1212t1429r1242b1455],
6	be	VB	O	be	cop	7	SENT_106	[p3l1258t1425r1297b1455],
7	essential	JJ	O	essential	xcomp	4	SENT_106	[p3l1313t1424r1456b1455],
8	for	IN	O	for	_	0	SENT_106	[p3l1472t1425r1521b1455],
9	the	DT	O	the	det	10	SENT_106	[p3l1535t1425r1585b1456],
10	secretion	NN	O	secretion	prep_for	7	SENT_106	[p3l1602t1425r1751b1455],
11	of	IN	O	of	_	0	SENT_106	[p3l1767t1424r1804b1456],
12	phosphatidylcholine	NN	O	phosphatidylcholine	prep_of	10	SENT_106	[p3l498t1475r836b1515],
13	into	IN	O	into	_	0	SENT_106	[p3l849t1476r914b1506],
14	bile	NN	O	bile	prep_into	7	SENT_106	[p3l927t1475r997b1506],
15	.	.	O	.	_	0	SENT_106	[p3l927t1475r997b1506],

1	Schinkel	NNP	PERSON	Schinkel	nsubj	5	SENT_107	[p3l541t1525r686b1555],
2	et	FW	O	et	nn	3	SENT_107	[p3l705t1530r735b1555],
3	al	FW	O	al	dep	1	SENT_107	[p3l754t1524r781b1555],
4	have	VBP	O	have	aux	5	SENT_107	[p3l801t1525r880b1555],
5	generated	VBN	O	generate	_	0	SENT_107	[p3l899t1524r1059b1563],
6	mice	NNS	O	mouse	nsubj	7	SENT_107	[p3l1078t1524r1159b1555],
7	homozygous	JJ	O	homozygous	xcomp	5	SENT_107	[p3l1177t1524r1388b1563],
8	for	IN	O	for	_	0	SENT_107	[p3l1408t1524r1457b1555],
9	a	DT	O	a	det	10	SENT_107	[p3l1474t1534r1492b1555],
10	disruption	NN	O	disruption	prep_for	7	SENT_107	[p3l1511t1525r1679b1564],
11	of	IN	O	of	_	0	SENT_107	[p3l1698t1524r1735b1554],
12	the	DT	O	the	det	17	SENT_107	[p3l1751t1525r1802b1555],
13	murine	JJ	O	murine	amod	17	SENT_107	[p3l498t1575r616b1606],
14	mdr3	NN	O	mdr3	nn	17	SENT_107	[p3l625t1575r713b1606],
15	gene	NN	O	gene	nn	17	SENT_107	[p3l725t1584r802b1615],
16	(	CD	NUMBER	(	num	17	SENT_107	[p3l813t1575r910b1612],
17	mdrl	NN	O	mdrl	prep_of	10	SENT_107	[p3l813t1575r910b1612],
18	a	DT	O	a	det	19	SENT_107	[p3l914t1575r947b1612],
19	)	NN	O	)	dep	17	SENT_107	[p3l914t1575r947b1612],
20	(	CD	NUMBER	(	number	21	SENT_107	[p3l959t1575r1034b1612],
21	24	CD	NUMBER	24	num	22	SENT_107	[p3l959t1575r1034b1612],
22	)	NN	O	)	dep	19	SENT_107	[p3l959t1575r1034b1612],
23	.	.	O	.	_	0	SENT_107	[p3l959t1575r1034b1612],

1	These	DT	O	these	det	2	SENT_108	[p3l1047t1575r1146b1605],
2	mice	NNS	O	mouse	nsubj	6	SENT_108	[p3l1157t1574r1237b1605],
3	were	VBD	O	be	cop	6	SENT_108	[p3l1247t1583r1328b1605],
4	viable	JJ	O	viable	amod	6	SENT_108	[p3l1339t1575r1449b1610],
5	,	,	O	,	_	0	SENT_108	[p3l1339t1575r1449b1610],
6	fertile	JJ	O	fertile	_	0	SENT_108	[p3l1461t1575r1569b1611],
7	,	,	O	,	_	0	SENT_108	[p3l1461t1575r1569b1611],
8	and	CC	O	and	_	0	SENT_108	[p3l1581t1575r1640b1605],
9	appeared	VBD	O	appear	cop	11	SENT_108	[p3l1651t1576r1801b1615],
10	phenotypically	RB	O	phenotypically	advmod	11	SENT_108	[p3l499t1626r746b1666],
11	normal	JJ	O	normal	conj_and	6	SENT_108	[p3l759t1626r875b1657],
12	but	CC	O	but	_	0	SENT_108	[p3l886t1626r939b1657],
13	displayed	VBD	O	display	conj_but	11	SENT_108	[p3l951t1626r1109b1665],
14	an	DT	O	a	det	16	SENT_108	[p3l1120t1635r1158b1656],
15	increased	VBN	O	increase	amod	16	SENT_108	[p3l1170t1625r1326b1657],
16	sensitivity	NN	O	sensitivity	dobj	13	SENT_108	[p3l1338t1625r1507b1665],
17	to	TO	O	to	_	0	SENT_108	[p3l1520t1631r1551b1657],
18	the	DT	O	the	det	19	SENT_108	[p3l1564t1626r1613b1657],
19	CNS	NN	O	cn	prep_to	13	SENT_108	[p3l1625t1626r1704b1657],
20	toxin	NN	O	toxin	nn	26	SENT_108	[p3l1717t1626r1801b1657],
21	ivermectin	NN	O	ivermectin	nn	26	SENT_108	[p3l499t1676r677b1707],
22	(	NN	O	(	nn	26	SENT_108	[p3l693t1676r862b1714],
23	100	CD	NUMBER	100	num	26	SENT_108	[p3l693t1676r862b1714],
24	—	CD	NUMBER	—	num	26	SENT_108	[p3l693t1676r862b1714],
25	fold	JJ	O	fold	amod	26	SENT_108	[p3l693t1676r862b1714],
26	)	NN	O	)	dep	19	SENT_108	[p3l693t1676r862b1714],
27	and	CC	O	and	_	0	SENT_108	[p3l878t1676r938b1707],
28	to	TO	O	to	_	0	SENT_108	[p3l953t1681r984b1706],
29	vinblastine	NN	O	vinblastine	conj_and	19	SENT_108	[p3l1000t1676r1181b1707],
30	(	CD	NUMBER	(	num	29	SENT_108	[p3l1198t1676r1333b1713],
31	3-fold	JJ	O	3-fold	amod	32	SENT_108	[p3l1198t1676r1333b1713],
32	)	NN	O	)	dep	13	SENT_108	[p3l1198t1676r1333b1713],
33	.	.	O	.	_	0	SENT_108	[p3l1198t1676r1333b1713],

1	Mdr3	NN	O	mdr3	nsubjpass	3	SENT_109	[p3l1351t1676r1440b1707],
2	was	VBD	O	be	auxpass	3	SENT_109	[p3l1459t1685r1521b1707],
3	found	VBN	O	find	_	0	SENT_109	[p3l1538t1676r1634b1707],
4	to	TO	O	to	aux	8	SENT_109	[p3l1649t1682r1681b1707],
5	be	VB	O	be	cop	8	SENT_109	[p3l1696t1676r1735b1706],
6	the	DT	O	the	det	8	SENT_109	[p3l1751t1677r1802b1707],
7	major	JJ	O	major	amod	8	SENT_109	[p3l500t1727r597b1767],
8	P-glycoprotein	NN	MISC	p-glycoprotein	xcomp	3	SENT_109	[p3l610t1727r857b1766],
9	expressed	VBN	O	express	partmod	8	SENT_109	[p3l871t1727r1034b1765],
10	in	IN	O	in	_	0	SENT_109	[p3l1048t1726r1080b1757],
11	the	DT	O	the	det	14	SENT_109	[p3l1094t1727r1144b1758],
12	capillary	JJ	O	capillary	amod	14	SENT_109	[p3l1158t1726r1302b1766],
13	endothelial	JJ	O	endothelial	amod	14	SENT_109	[p3l1316t1727r1500b1757],
14	cells	NNS	O	cell	prep_in	9	SENT_109	[p3l1515t1727r1590b1758],
15	of	IN	O	of	_	0	SENT_109	[p3l1605t1727r1642b1757],
16	the	DT	O	the	det	17	SENT_109	[p3l1653t1727r1703b1757],
17	brain	NN	O	brain	prep_of	14	SENT_109	[p3l1717t1727r1802b1757],
18	and	CC	O	and	cc	3	SENT_109	[p3l500t1778r568b1813],
19	,	,	O	,	_	0	SENT_109	[p3l500t1778r568b1813],
20	in	IN	O	in	_	0	SENT_109	[p3l583t1778r614b1808],
21	its	PRP$	O	its	poss	22	SENT_109	[p3l628t1778r666b1808],
22	absence	NN	O	absence	prep_in	27	SENT_109	[p3l681t1778r820b1812],
23	,	,	O	,	_	0	SENT_109	[p3l681t1778r820b1812],
24	drug	NN	O	drug	nn	25	SENT_109	[p3l835t1778r911b1817],
25	levels	NNS	O	level	nsubj	27	SENT_109	[p3l925t1777r1019b1808],
26	became	VBD	O	become	cop	27	SENT_109	[p3l1033t1777r1159b1807],
27	elevated	JJ	O	elevated	ccomp	3	SENT_109	[p3l1173t1777r1320b1807],
28	.	.	O	.	_	0	SENT_109	[p3l1173t1777r1320b1807],

1	While	IN	O	while	mark	7	SENT_110	[p3l541t1827r643b1858],
2	increased	VBN	O	increase	amod	4	SENT_110	[p3l653t1827r810b1858],
3	MDR1	NN	O	mdr1	nn	4	SENT_110	[p3l818t1827r926b1857],
4	mRNA	NN	O	mrna	nsubjpass	7	SENT_110	[p3l940t1827r1060b1857],
5	has	VBZ	O	have	aux	7	SENT_110	[p3l1070t1827r1123b1857],
6	been	VBN	O	be	auxpass	7	SENT_110	[p3l1134t1828r1213b1857],
7	observed	VBN	O	observe	advcl	29	SENT_110	[p3l1223t1827r1372b1857],
8	as	IN	O	as	_	0	SENT_110	[p3l1384t1836r1416b1857],
9	a	DT	O	a	det	10	SENT_110	[p3l1428t1835r1446b1856],
10	consequence	NN	O	consequence	prep_as	7	SENT_110	[p3l1456t1836r1668b1865],
11	of	IN	O	of	_	0	SENT_110	[p3l1679t1826r1716b1856],
12	gene	NN	O	gene	nn	13	SENT_110	[p3l1724t1836r1803b1865],
13	amplification	NN	O	amplification	prep_of	10	SENT_110	[p3l501t1878r722b1916],
14	in	IN	O	in	_	0	SENT_110	[p3l733t1878r765b1908],
15	both	CC	O	both	preconj	16	SENT_110	[p3l776t1878r849b1907],
16	rodent	JJ	O	rodent	amod	20	SENT_110	[p3l861t1877r967b1908],
17	and	CC	O	and	_	0	SENT_110	[p3l978t1877r1038b1908],
18	human	JJ	O	human	conj_and	16	SENT_110	[p3l1048t1878r1160b1907],
19	cell	NN	O	cell	nn	20	SENT_110	[p3l1173t1878r1230b1907],
20	lines	NNS	O	line	prep_in	13	SENT_110	[p3l1245t1878r1330b1912],
21	,	,	O	,	_	0	SENT_110	[p3l1245t1878r1330b1912],
22	increases	VBZ	O	increase	csubjpass	29	SENT_110	[p3l1343t1877r1494b1907],
23	in	IN	O	in	_	0	SENT_110	[p3l1507t1878r1537b1907],
24	mRNA	NN	O	mrna	nn	25	SENT_110	[p3l1551t1878r1670b1907],
25	expression	NN	O	expression	prep_in	22	SENT_110	[p3l1681t1886r1802b1915, p3l501t1928r568b1959],
26	have	VBP	O	have	aux	29	SENT_110	[p3l584t1929r662b1958],
27	also	RB	O	also	advmod	29	SENT_110	[p3l678t1928r744b1958],
28	been	VBN	O	be	auxpass	29	SENT_110	[p3l759t1928r836b1958],
29	observed	VBN	O	observe	_	0	SENT_110	[p3l851t1928r1000b1958],
30	in	IN	O	in	_	0	SENT_110	[p3l1015t1928r1047b1958],
31	the	DT	O	the	det	32	SENT_110	[p3l1063t1928r1112b1958],
32	absence	NN	O	absence	prep_in	29	SENT_110	[p3l1128t1928r1258b1958],
33	of	IN	O	of	_	0	SENT_110	[p3l1274t1927r1310b1958],
34	ampliﬁcation	NN	O	ampliﬁcation	prep_of	32	SENT_110	[p3l1322t1927r1553b1966],
35	.	.	O	.	_	0	SENT_110	[p3l1322t1927r1553b1966],

1	Such	JJ	O	such	amod	2	SENT_111	[p3l1570t1927r1651b1958],
2	findings	NNS	O	finding	nsubj	3	SENT_111	[p3l1667t1927r1802b1967],
3	suggest	VBP	O	suggest	_	0	SENT_111	[p3l502t1983r626b2017],
4	that	IN	O	that	complm	11	SENT_111	[p3l643t1977r705b2009],
5	the	DT	O	the	det	7	SENT_111	[p3l722t1978r771b2008],
6	MDR1	NN	O	mdr1	nn	7	SENT_111	[p3l787t1978r895b2008],
7	gene	NN	O	gene	nsubj	11	SENT_111	[p3l917t1986r994b2016],
8	may	MD	O	may	aux	11	SENT_111	[p3l1010t1986r1081b2016],
9	be	VB	O	be	cop	11	SENT_111	[p3l1098t1977r1137b2008],
10	transcriptionally	RB	O	transcriptionally	advmod	11	SENT_111	[p3l1155t1977r1426b2017],
11	and/or	JJ	O	and/or	ccomp	3	SENT_111	[p3l1444t1977r1550b2008],
12	translationally	RB	O	translationally	advmod	13	SENT_111	[p3l1566t1977r1803b2017],
13	regulated	VBN	O	regulate	dep	11	SENT_111	[p3l500t2028r655b2068],
14	(	NN	O	(	tmod	13	SENT_111	[p3l667t2028r730b2065],
15	25	CD	NUMBER	25	num	14	SENT_111	[p3l667t2028r730b2065],
16	,	,	O	,	_	0	SENT_111	[p3l667t2028r730b2065],
17	26	CD	NUMBER	26	num	18	SENT_111	[p3l742t2028r804b2065],
18	)	NN	O	)	appos	14	SENT_111	[p3l742t2028r804b2065],
19	.	.	O	.	_	0	SENT_111	[p3l742t2028r804b2065],

1	The	DT	O	the	det	3	SENT_112	[p3l817t2028r881b2059],
2	MDR1	NN	O	mdr1	nn	3	SENT_112	[p3l891t2029r998b2059],
3	gene	NN	O	gene	nsubj	4	SENT_112	[p3l1013t2037r1091b2068],
4	has	VBZ	O	have	_	0	SENT_112	[p3l1102t2028r1155b2059],
5	at	IN	O	at	quantmod	7	SENT_112	[p3l1168t2032r1198b2058],
6	least	JJS	O	least	mwe	5	SENT_112	[p3l1208t2028r1283b2058],
7	two	CD	NUMBER	two	dobj	4	SENT_112	[p3l1293t2032r1355b2058],
8	promoter	NN	O	promoter	nn	9	SENT_112	[p3l1366t2032r1519b2067],
9	regions	NNS	O	region	nsubj	10	SENT_112	[p3l1529t2028r1650b2067],
10	(	VBP	O	(	rcmod	7	SENT_112	[p3l1663t2028r1802b2066],
11	27-29	CD	NUMBER	27-29	num	12	SENT_112	[p3l1663t2028r1802b2066],
12	)	CD	NUMBER	)	dobj	10	SENT_112	[p3l1663t2028r1802b2066],
13	.	.	O	.	_	0	SENT_112	[p3l1663t2028r1802b2066],

1	Transcription	NN	O	transcription	nsubjpass	9	SENT_113	[p3l500t2079r723b2120],
2	of	IN	O	of	_	0	SENT_113	[p3l736t2080r773b2110],
3	the	DT	O	the	det	6	SENT_113	[p3l782t2079r832b2110],
4	human	JJ	O	human	amod	6	SENT_113	[p3l844t2080r957b2110],
5	MDR1	NN	O	mdr1	nn	6	SENT_113	[p3l969t2079r1075b2109],
6	gene	NN	O	gene	prep_of	1	SENT_113	[p3l1092t2089r1169b2119],
7	may	MD	O	may	aux	9	SENT_113	[p3l1182t2088r1252b2119],
8	be	VB	O	be	auxpass	9	SENT_113	[p3l1264t2080r1304b2110],
9	initiated	VBN	O	initiate	dep	44	SENT_113	[p3l1316t2079r1453b2110],
10	from	IN	O	from	_	0	SENT_113	[p3l1465t2079r1545b2110],
11	a	DT	O	a	det	14	SENT_113	[p3l1558t2088r1575b2109],
12	major	JJ	O	major	amod	14	SENT_113	[p3l1588t2079r1686b2119],
13	downstream	JJ	O	downstream	amod	14	SENT_113	[p3l1697t2079r1802b2110, p3l502t2133r612b2159],
14	promoter	NN	O	promoter	prep_from	9	SENT_113	[p3l629t2133r782b2168],
15	in	IN	O	in	_	0	SENT_113	[p3l799t2128r830b2158],
16	which	WDT	O	which	rel	19	SENT_113	[p3l849t2128r949b2158],
17	transcription	NN	O	transcription	nsubj	19	SENT_113	[p3l968t2128r1175b2167],
18	may	MD	O	may	aux	19	SENT_113	[p3l1194t2136r1264b2167],
19	begin	VB	O	begin	rcmod	14	SENT_113	[p3l1282t2128r1374b2167],
20	at	IN	O	at	_	0	SENT_113	[p3l1392t2133r1421b2158],
21	positions	NNS	O	position	prep_at	19	SENT_113	[p3l1439t2128r1587b2166],
22	136-140	CD	NUMBER	136-140	num	21	SENT_113	[p3l1611t2128r1752b2159],
23	or	CC	O	or	_	0	SENT_113	[p3l1770t2137r1804b2158],
24	155-180	CD	NUMBER	155-180	conj_or	21	SENT_113	[p3l505t2177r646b2208],
25	and	CC	O	and	_	0	SENT_113	[p3l660t2178r719b2208],
26	from	IN	O	from	_	0	SENT_113	[p3l732t2177r813b2208],
27	a	DT	O	a	det	30	SENT_113	[p3l825t2186r843b2207],
28	minor	JJ	O	minor	amod	30	SENT_113	[p3l856t2177r955b2208],
29	upstream	JJ	O	upstream	amod	30	SENT_113	[p3l967t2182r1119b2216],
30	promoter	NN	O	promoter	conj_and	14	SENT_113	[p3l1132t2182r1284b2216],
31	that	WDT	O	that	nsubjpass	33	SENT_113	[p3l1296t2177r1359b2207],
32	is	VBZ	O	be	auxpass	33	SENT_113	[p3l1371t2177r1397b2207],
33	expressed	VBN	O	express	rcmod	30	SENT_113	[p3l1411t2177r1575b2216],
34	in	IN	O	in	_	0	SENT_113	[p3l1588t2177r1619b2207],
35	colchicine	NN	O	colchicine	prep_in	33	SENT_113	[p3l1632t2177r1804b2207],
36	but	CC	O	but	_	0	SENT_113	[p3l500t2227r553b2258],
37	not	RB	O	not	_	0	SENT_113	[p3l565t2232r618b2257],
38	in	IN	O	in	_	0	SENT_113	[p3l631t2227r662b2257],
39	doxorubicin	NN	O	doxorubicin	nn	43	SENT_113	[p3l675t2226r874b2257],
40	or	CC	O	or	_	0	SENT_113	[p3l888t2235r923b2257],
41	vinblastine-selected	JJ	O	vinblastine-selected	conj_or	39	SENT_113	[p3l935t2226r1263b2257],
42	KB	NN	O	kb	nn	43	SENT_113	[p3l1276t2227r1330b2257],
43	cells	NNS	O	cell	conj_negcc	35	SENT_113	[p3l1345t2227r1420b2257],
44	(	VBP	O	(	_	0	SENT_113	[p3l1435t2226r1497b2263],
45	28	CD	NUMBER	28	nsubj	44	SENT_113	[p3l1435t2226r1497b2263],
46	,	,	O	,	_	0	SENT_113	[p3l1435t2226r1497b2263],
47	29	CD	NUMBER	29	num	48	SENT_113	[p3l1512t2227r1574b2263],
48	)	NN	O	)	appos	45	SENT_113	[p3l1512t2227r1574b2263],
49	.	.	O	.	_	0	SENT_113	[p3l1512t2227r1574b2263],

1	Most	JJS	O	most	amod	3	SENT_114	[p3l1589t2227r1675b2257],
2	normal	JJ	O	normal	amod	3	SENT_114	[p3l1687t2227r1803b2256],
3	tissues	NNS	O	tissue	nsubj	4	SENT_114	[p3l501t2276r610b2306],
4	utilize	VBP	O	utilize	_	0	SENT_114	[p3l625t2275r727b2306],
5	the	DT	O	the	det	8	SENT_114	[p3l742t2276r792b2306],
6	downstream	JJ	O	downstream	amod	8	SENT_114	[p3l805t2275r1009b2306],
7	MDR1	NN	O	mdr1	nn	8	SENT_114	[p3l1020t2276r1126b2305],
8	promoter	NN	O	promoter	dobj	4	SENT_114	[p3l1145t2280r1297b2314],
9	(	CD	NUMBER	(	number	10	SENT_114	[p3l1311t2275r1374b2312],
10	15	CD	NUMBER	15	dep	8	SENT_114	[p3l1311t2275r1374b2312],
11	,	,	O	,	_	0	SENT_114	[p3l1311t2275r1374b2312],
12	29	CD	NUMBER	29	num	13	SENT_114	[p3l1389t2275r1452b2311],
13	)	NN	O	)	appos	8	SENT_114	[p3l1389t2275r1452b2311],
14	.	.	O	.	_	0	SENT_114	[p3l1389t2275r1452b2311],

1	Several	JJ	O	several	amod	5	SENT_115	[p3l543t2325r667b2355],
2	potential	JJ	O	potential	amod	5	SENT_115	[p3l677t2324r821b2363],
3	transcriptional	JJ	O	transcriptional	amod	5	SENT_115	[p3l831t2324r1069b2363],
4	regulatory	JJ	O	regulatory	amod	5	SENT_115	[p3l1080t2325r1249b2363],
5	elements	NNS	O	element	nsubjpass	8	SENT_115	[p3l1260t2325r1406b2355],
6	have	VBP	O	have	aux	8	SENT_115	[p3l1416t2324r1494b2354],
7	been	VBN	O	be	auxpass	8	SENT_115	[p3l1503t2325r1581b2354],
8	found	VBN	O	find	_	0	SENT_115	[p3l1593t2324r1689b2354],
9	within	IN	O	within	_	0	SENT_115	[p3l1699t2324r1803b2354],
10	the	DT	O	the	det	13	SENT_115	[p3l502t2375r551b2404],
11	human	JJ	O	human	amod	13	SENT_115	[p3l565t2374r677b2404],
12	MDR1	NN	O	mdr1	nn	13	SENT_115	[p3l689t2374r796b2403],
13	gene	NN	O	gene	prep_within	8	SENT_115	[p3l814t2383r900b2413],
14	,	,	O	,	_	0	SENT_115	[p3l814t2383r900b2413],
15	including	VBG	O	include	_	0	SENT_115	[p3l915t2374r1070b2412],
16	several	JJ	O	several	amod	20	SENT_115	[p3l1084t2374r1199b2404],
17	heat	NN	O	heat	nn	20	SENT_115	[p3l1214t2374r1281b2404],
18	shock	NN	O	shock	nn	20	SENT_115	[p3l1295t2374r1392b2403],
19	consensus	NN	O	consensus	nn	20	SENT_115	[p3l1404t2382r1571b2404],
20	elements	NNS	O	element	prep_including	8	SENT_115	[p3l1585t2373r1731b2403],
21	and	CC	O	and	_	0	SENT_115	[p3l1745t2374r1805b2403],
22	a	DT	O	a	det	26	SENT_115	[p3l502t2432r519b2454],
23	phorbol	NN	O	phorbol	nn	26	SENT_115	[p3l533t2422r663b2462],
24	ester	NN	O	ester	nn	26	SENT_115	[p3l677t2427r755b2453],
25	response	NN	O	response	nn	26	SENT_115	[p3l768t2431r914b2462],
26	element	NN	O	element	prep_including	8	SENT_115	[p3l928t2422r1059b2453],
27	(	CD	NUMBER	(	number	28	SENT_115	[p3l1074t2422r1137b2460],
28	30	CD	NUMBER	30	dep	26	SENT_115	[p3l1074t2422r1137b2460],
29	,	,	O	,	_	0	SENT_115	[p3l1074t2422r1137b2460],
30	31	CD	NUMBER	31	num	31	SENT_115	[p3l1153t2422r1215b2459],
31	)	NN	O	)	appos	26	SENT_115	[p3l1153t2422r1215b2459],
32	.	.	O	.	_	0	SENT_115	[p3l1153t2422r1215b2459],

1	Treatment	NN	O	treatment	nsubjpass	19	SENT_116	[p3l1230t2423r1401b2453],
2	of	IN	O	of	_	0	SENT_116	[p3l1415t2422r1452b2452],
3	human	JJ	O	human	amod	7	SENT_116	[p3l1463t2422r1575b2453],
4	colon	NN	O	colon	nn	7	SENT_116	[p3l1590t2422r1682b2453],
5	cancer	NN	O	cancer	nn	7	SENT_116	[p3l1697t2431r1805b2453],
6	cell	NN	O	cell	nn	7	SENT_116	[p3l501t2471r560b2502],
7	lines	NNS	O	line	prep_of	1	SENT_116	[p3l577t2471r654b2502],
8	with	IN	O	with	_	0	SENT_116	[p3l672t2471r744b2502],
9	differentiating	VBG	O	differentiate	prepc_with	7	SENT_116	[p3l761t2470r997b2510],
10	agents	NNS	O	agent	dobj	9	SENT_116	[p3l1013t2475r1117b2510],
11	such	JJ	O	such	_	0	SENT_116	[p3l1135t2470r1209b2501],
12	as	IN	O	as	_	0	SENT_116	[p3l1225t2480r1257b2501],
13	DMSO	NN	ORGANIZATION	dmso	nn	16	SENT_116	[p3l1274t2470r1394b2501],
14	or	CC	O	or	_	0	SENT_116	[p3l1410t2480r1445b2501],
15	sodium	NN	O	sodium	nn	16	SENT_116	[p3l1461t2470r1582b2501],
16	butyrate	NN	O	butyrate	prep_such_as	10	SENT_116	[p3l1597t2470r1732b2510],
17	has	VBZ	O	have	aux	19	SENT_116	[p3l1749t2470r1803b2501],
18	been	VBN	O	be	auxpass	19	SENT_116	[p3l501t2522r579b2552],
19	shown	VBN	O	show	_	0	SENT_116	[p3l592t2522r699b2552],
20	to	TO	O	to	aux	21	SENT_116	[p3l710t2526r741b2551],
21	increase	VB	O	increase	xcomp	19	SENT_116	[p3l752t2521r888b2551],
22	MDR1	NN	O	mdr1	nn	24	SENT_116	[p3l897t2521r1004b2551],
23	gene	NN	O	gene	nn	24	SENT_116	[p3l1019t2530r1096b2560],
24	expression	NN	O	expression	iobj	21	SENT_116	[p3l1108t2521r1283b2560],
25	(	CD	NUMBER	(	number	26	SENT_116	[p3l1296t2520r1372b2558],
26	32	CD	NUMBER	32	num	27	SENT_116	[p3l1296t2520r1372b2558],
27	)	NN	O	)	dobj	21	SENT_116	[p3l1296t2520r1372b2558],
28	.	.	O	.	_	0	SENT_116	[p3l1296t2520r1372b2558],

1	Treatment	NN	O	treatment	_	0	SENT_117	[p3l1384t2521r1555b2551],
2	with	IN	O	with	dep	1	SENT_117	[p3l1567t2520r1639b2550],
3	cytotoxic	JJ	O	cytotoxic	pobj	2	SENT_117	[p3l1651t2520r1805b2560],

1	Annual	JJ	SET	annual	amod	2	SENT_118	[p3l442t2641r563b2670],
2	Reviews	NNS	O	review	nsubj	3	SENT_118	[p3l575t2641r716b2678],
3	_	VBP	O	_	_	0	SENT_118	[p3l949t2674r954b2678],
4	www.annualrev1ews.org/aronline	NN	O	www.annualrev1ews.org/aronline	dobj	3	SENT_118	[p3l443t2674r996b2712],

1	P	NN	O	p	_	0	SENT_119	[p3l895t2776r1234b2805],
2	.	.	O	.	_	0	SENT_119	[p3l895t2776r1234b2805],

1	—	NN	O	—	_	0	SENT_120	[p3l895t2776r1234b2805],
2	.	.	O	.	_	0	SENT_120	[p3l895t2776r1234b2805],

1	GLYCOPROTEINS	NNS	O	glycoprotein	_	0	SENT_121	[p3l895t2776r1234b2805],
2	AND	CC	O	and	_	0	SENT_121	[p3l1245t2777r1325b2805],
3	DRUG	NN	O	drug	nn	4	SENT_121	[p3l1335t2777r1441b2805],
4	RESISTANCE	NN	O	resistance	conj_and	1	SENT_121	[p3l1451t2777r1679b2805],
5	165	CD	NUMBER	165	dep	1	SENT_121	[p3l1752t2776r1803b2805],

1	agents	NNS	O	agent	nsubjpass	12	SENT_122	[p3l500t2879r616b2913],
2	,	,	O	,	_	0	SENT_122	[p3l500t2879r616b2913],
3	UV	NN	O	uv	nn	4	SENT_122	[p3l629t2875r689b2905],
4	radiation	NN	O	radiation	nsubjpass	12	SENT_122	[p3l701t2874r860b2910],
5	,	,	O	,	_	0	SENT_122	[p3l701t2874r860b2910],
6	or	CC	O	or	_	0	SENT_122	[p3l872t2883r908b2905],
7	partial	JJ	O	partial	amod	8	SENT_122	[p3l919t2874r1026b2913],
8	hepatectomy	NN	O	hepatectomy	nsubjpass	12	SENT_122	[p3l1037t2875r1250b2914],
9	has	VBZ	O	have	aux	12	SENT_122	[p3l1262t2875r1316b2905],
10	also	RB	O	also	advmod	12	SENT_122	[p3l1330t2875r1396b2905],
11	been	VBN	O	be	auxpass	12	SENT_122	[p3l1409t2875r1487b2905],
12	shown	VBN	O	show	_	0	SENT_122	[p3l1501t2875r1609b2905],
13	to	TO	O	to	aux	14	SENT_122	[p3l1622t2880r1653b2906],
14	increase	VB	O	increase	xcomp	12	SENT_122	[p3l1667t2875r1804b2905],
15	MDR1	NN	O	mdr1	nn	16	SENT_122	[p3l498t2924r607b2954],
16	expression	NN	O	expression	dobj	14	SENT_122	[p3l622t2924r802b2962],
17	in	IN	O	in	_	0	SENT_122	[p3l814t2923r846b2954],
18	both	CC	O	both	preconj	19	SENT_122	[p3l858t2923r932b2954],
19	rodent	JJ	O	rodent	amod	23	SENT_122	[p3l945t2923r1052b2954],
20	and	CC	O	and	_	0	SENT_122	[p3l1065t2923r1125b2954],
21	human	JJ	O	human	conj_and	19	SENT_122	[p3l1137t2924r1251b2954],
22	cells	NNS	O	cell	nn	23	SENT_122	[p3l1264t2924r1338b2954],
23	lines	NNS	O	line	prep_in	14	SENT_122	[p3l1353t2924r1430b2955],
24	(	CD	NUMBER	(	number	25	SENT_122	[p3l1445t2924r1584b2961],
25	33-37	CD	NUMBER	33-37	num	26	SENT_122	[p3l1445t2924r1584b2961],
26	)	NN	O	)	dep	23	SENT_122	[p3l1445t2924r1584b2961],
27	.	.	O	.	_	0	SENT_122	[p3l1445t2924r1584b2961],

1	Because	IN	O	because	mark	6	SENT_123	[p3l541t2972r680b3002],
2	several	JJ	O	several	amod	3	SENT_123	[p3l692t2972r809b3002],
3	lines	NNS	O	line	nsubj	6	SENT_123	[p3l822t2972r900b3002],
4	of	IN	O	of	_	0	SENT_123	[p3l912t2973r950b3002],
5	evidence	NN	O	evidence	prep_of	3	SENT_123	[p3l959t2972r1107b3002],
6	suggest	VBP	O	suggest	advcl	29	SENT_123	[p3l1120t2978r1244b3011],
7	that	IN	O	that	complm	19	SENT_123	[p3l1256t2973r1317b3002],
8	the	DT	O	the	det	12	SENT_123	[p3l1329t2973r1380b3003],
9	major	JJ	O	major	amod	12	SENT_123	[p3l1393t2973r1490b3011],
10	regulatory	JJ	O	regulatory	amod	12	SENT_123	[p3l1501t2973r1672b3011],
11	control	NN	O	control	nn	12	SENT_123	[p3l1685t2973r1803b3003],
12	mechanism	NN	O	mechanism	nsubj	19	SENT_123	[p3l500t3020r691b3051],
13	of	IN	O	of	_	0	SENT_123	[p3l702t3019r740b3050],
14	P-glycoprotein	NN	O	p-glycoprotein	nn	15	SENT_123	[p3l750t3020r998b3059],
15	overexpression	NN	O	overexpression	prep_of	12	SENT_123	[p3l1011t3020r1262b3059],
16	in	IN	O	in	_	0	SENT_123	[p3l1276t3020r1308b3050],
17	human	JJ	O	human	amod	18	SENT_123	[p3l1321t3021r1434b3051],
18	tumors	NNS	O	tumor	prep_in	15	SENT_123	[p3l1448t3025r1562b3051],
19	is	VBZ	O	be	ccomp	6	SENT_123	[p3l1577t3020r1603b3050],
20	at	IN	O	at	_	0	SENT_123	[p3l1618t3025r1648b3051],
21	the	DT	O	the	det	23	SENT_123	[p3l1660t3020r1710b3051],
22	transcriptional	JJ	O	transcriptional	amod	23	SENT_123	[p3l1725t3025r1802b3051, p3l500t3069r675b3109],
23	level	NN	O	level	prep_at	19	SENT_123	[p3l684t3070r775b3105],
24	,	,	O	,	_	0	SENT_123	[p3l684t3070r775b3105],
25	there	EX	O	there	expl	29	SENT_123	[p3l784t3070r867b3100],
26	has	VBZ	O	have	aux	29	SENT_123	[p3l875t3070r931b3099],
27	been	VBN	O	be	cop	29	SENT_123	[p3l938t3070r1019b3100],
28	considerable	JJ	O	considerable	amod	29	SENT_123	[p3l1027t3069r1237b3100],
29	interest	NN	O	interest	_	0	SENT_123	[p3l1247t3070r1369b3100],
30	in	IN	O	in	_	0	SENT_123	[p3l1378t3070r1409b3099],
31	the	DT	O	the	det	32	SENT_123	[p3l1418t3071r1469b3100],
32	role	NN	O	role	prep_in	29	SENT_123	[p3l1477t3071r1542b3100],
33	of	IN	O	of	_	0	SENT_123	[p3l1551t3070r1589b3100],
34	p53	NN	O	p53	prep_of	32	SENT_123	[p3l1591t3070r1657b3108],
35	in	IN	O	in	_	0	SENT_123	[p3l1666t3070r1699b3099],
36	MDR	NN	ORGANIZATION	mdr	prep_in	34	SENT_123	[p3l1708t3070r1802b3100],
37	because	IN	O	because	_	0	SENT_123	[p3l499t3119r632b3151],
38	of	IN	O	of	_	0	SENT_123	[p3l647t3119r685b3150],
39	its	PRP$	O	its	poss	40	SENT_123	[p3l698t3119r737b3150],
40	role	NN	O	role	prep_because_of	29	SENT_123	[p3l752t3120r817b3150],
41	in	IN	O	in	_	0	SENT_123	[p3l833t3120r866b3150],
42	transcriptional	JJ	O	transcriptional	amod	43	SENT_123	[p3l881t3119r1121b3159],
43	regulation	NN	O	regulation	prep_in	40	SENT_123	[p3l1137t3119r1313b3159],
44	.	.	O	.	_	0	SENT_123	[p3l1137t3119r1313b3159],

1	Wild	NNP	O	Wild	nsubj	5	SENT_124	[p3l1330t3119r1500b3159],
2	—	CD	NUMBER	—	num	4	SENT_124	[p3l1330t3119r1500b3159],
3	type	NN	O	type	nn	4	SENT_124	[p3l1330t3119r1500b3159],
4	p53	NN	O	p53	dep	1	SENT_124	[p3l1512t3119r1577b3158],
5	repressed	VBD	O	repress	_	0	SENT_124	[p3l1593t3120r1751b3159],
6	Pglycoprotein	NN	O	pglycoprotein	nn	8	SENT_124	[p3l1767t3120r1802b3149, p3l500t3169r710b3208],
7	promoter	NN	O	promoter	nn	8	SENT_124	[p3l723t3174r877b3208],
8	activity	NN	O	activity	dobj	5	SENT_124	[p3l890t3169r1023b3208],
9	,	,	O	,	_	0	SENT_124	[p3l890t3169r1023b3208],
10	whereas	IN	O	whereas	mark	13	SENT_124	[p3l1038t3169r1173b3200],
11	mutant	JJ	O	mutant	amod	12	SENT_124	[p3l1189t3174r1303b3200],
12	forms	NNS	O	form	nsubj	13	SENT_124	[p3l1316t3169r1412b3200],
13	enhanced	VBN	O	enhance	advcl	5	SENT_124	[p3l1427t3169r1585b3200],
14	activity	NN	O	activity	dobj	13	SENT_124	[p3l1600t3169r1723b3209],
15	(	CD	NUMBER	(	number	16	SENT_124	[p3l1739t3169r1802b3206],
16	38	CD	NUMBER	38	dep	14	SENT_124	[p3l1739t3169r1802b3206],
17	,	,	O	,	_	0	SENT_124	[p3l1739t3169r1802b3206],
18	39	CD	NUMBER	39	num	19	SENT_124	[p3l500t3218r564b3257],
19	)	NN	O	)	appos	14	SENT_124	[p3l500t3218r564b3257],
20	.	.	O	.	_	0	SENT_124	[p3l500t3218r564b3257],

1	El	NNP	O	El	nn	2	SENT_125	[p3l578t3218r614b3250],
2	Rouby	NNP	O	Rouby	nsubj	5	SENT_125	[p3l627t3219r738b3259],
3	et	FW	O	et	nn	4	SENT_125	[p3l752t3224r782b3250],
4	al	FW	O	al	dep	2	SENT_125	[p3l794t3218r825b3250],
5	investigated	VBD	O	investigate	_	0	SENT_125	[p3l837t3219r1038b3259],
6	the	DT	O	the	det	8	SENT_125	[p3l1050t3219r1101b3250],
7	clinical	JJ	O	clinical	amod	8	SENT_125	[p3l1114t3219r1236b3250],
8	relevance	NN	O	relevance	dobj	5	SENT_125	[p3l1249t3219r1407b3250],
9	of	IN	O	of	_	0	SENT_125	[p3l1421t3219r1458b3251],
10	p53	NN	O	p53	nn	12	SENT_125	[p3l1464t3219r1530b3259],
11	gene	NN	O	gene	nn	12	SENT_125	[p3l1544t3228r1621b3259],
12	regulation	NN	O	regulation	prep_of	8	SENT_125	[p3l1635t3218r1803b3259],
13	in	IN	O	in	_	0	SENT_125	[p3l499t3268r532b3299],
14	the	DT	O	the	det	15	SENT_125	[p3l542t3269r593b3300],
15	expression	NN	O	expression	prep_in	12	SENT_125	[p3l602t3268r780b3309],
16	of	IN	O	of	_	0	SENT_125	[p3l790t3268r828b3299],
17	MDR1	NN	O	mdr1	prep_of	15	SENT_125	[p3l832t3268r941b3300],
18	and	CC	O	and	_	0	SENT_125	[p3l954t3268r1014b3300],
19	MDR3	NN	O	mdr3	conj_and	17	SENT_125	[p3l1022t3268r1132b3300],
20	in	IN	O	in	_	0	SENT_125	[p3l1145t3268r1176b3300],
21	B	NN	O	b	nn	23	SENT_125	[p3l1187t3268r1288b3300],
22	~	NN	O	~	nn	23	SENT_125	[p3l1187t3268r1288b3300],
23	cel1	NN	O	cel1	prep_in	5	SENT_125	[p3l1187t3268r1288b3300],
24	chronic	JJ	O	chronic	amod	26	SENT_125	[p3l1298t3268r1421b3300],
25	lymphocytic	JJ	O	lymphocytic	amod	26	SENT_125	[p3l1432t3269r1640b3309],
26	leukemia	NN	O	leukemia	dep	23	SENT_125	[p3l1651t3268r1804b3300],
27	(	CD	NUMBER	(	number	28	SENT_125	[p3l501t3319r578b3356],
28	40	CD	NUMBER	40	num	29	SENT_125	[p3l501t3319r578b3356],
29	)	NN	O	)	dep	26	SENT_125	[p3l501t3319r578b3356],
30	.	.	O	.	_	0	SENT_125	[p3l501t3319r578b3356],

1	Expression	NN	O	expression	nsubj	8	SENT_126	[p3l598t3319r783b3358],
2	of	IN	O	of	_	0	SENT_126	[p3l802t3319r839b3349],
3	both	CC	O	both	preconj	4	SENT_126	[p3l855t3319r929b3349],
4	MDR1	NN	O	mdr1	prep_of	1	SENT_126	[p3l946t3319r1054b3349],
5	and	CC	O	and	_	0	SENT_126	[p3l1076t3319r1137b3350],
6	MDR3	NN	O	mdr3	prep_of	1	SENT_126	[p3l1154t3319r1264b3350],
7	was	VBD	O	be	cop	8	SENT_126	[p3l1285t3328r1348b3350],
8	independent	JJ	O	independent	_	0	SENT_126	[p3l1368t3319r1572b3358],
9	of	IN	O	of	_	0	SENT_126	[p3l1591t3319r1628b3350],
10	p53	NN	O	p53	nn	12	SENT_126	[p3l1640t3318r1705b3358],
11	gene	NN	O	gene	nn	12	SENT_126	[p3l1726t3328r1804b3358],
12	mutation	NN	O	mutation	prep_of	8	SENT_126	[p3l500t3369r648b3400],
13	or	CC	O	or	_	0	SENT_126	[p3l657t3379r693b3400],
14	prior	JJ	O	prior	amod	16	SENT_126	[p3l702t3370r783b3408],
15	drug	NN	O	drug	nn	16	SENT_126	[p3l793t3369r868b3408],
16	treatment	NN	O	treatment	conj_or	12	SENT_126	[p3l879t3374r1037b3400],
17	and	CC	O	and	_	0	SENT_126	[p3l1046t3369r1105b3400],
18	did	VBD	O	do	aux	20	SENT_126	[p3l1116t3370r1168b3400],
19	not	RB	O	not	neg	20	SENT_126	[p3l1179t3375r1232b3400],
20	predict	VB	O	predict	conj_and	8	SENT_126	[p3l1241t3369r1357b3409],
21	clinical	JJ	O	clinical	amod	22	SENT_126	[p3l1366t3369r1488b3400],
22	response	NN	O	response	dobj	20	SENT_126	[p3l1498t3378r1653b3408],
23	.	.	O	.	_	0	SENT_126	[p3l1498t3378r1653b3408],

1	The	DT	O	the	det	2	SENT_127	[p3l1664t3369r1729b3400],
2	role	NN	O	role	nsubj	8	SENT_127	[p3l1739t3369r1804b3400],
3	of	IN	O	of	_	0	SENT_127	[p3l500t3419r538b3449],
4	p53	NN	O	p53	prep_of	2	SENT_127	[p3l543t3419r609b3457],
5	in	IN	O	in	_	0	SENT_127	[p3l622t3419r656b3450],
6	MDR	NN	ORGANIZATION	mdr	prep_in	4	SENT_127	[p3l667t3420r764b3449],
7	remains	VBZ	O	remain	cop	8	SENT_127	[p3l776t3420r907b3449],
8	controversial	JJ	O	controversial	_	0	SENT_127	[p3l920t3419r1145b3450],
9	.	.	O	.	_	0	SENT_127	[p3l920t3419r1145b3450],

1	CHARACTERIZATION	NN	O	characterization	_	0	SENT_128	[p3l500t3584r1006b3622],
2	OF	IN	O	of	_	0	SENT_128	[p3l1023t3585r1087b3622],
3	THE	DT	O	the	det	4	SENT_128	[p3l1101t3585r1200b3621],
4	P-GLYCOPROTEIN	NN	O	p-glycoprotein	prep_of	1	SENT_128	[p3l1215t3584r1643b3622],

1	Annu	NNP	PERSON	Annu	_	0	SENT_129	[p4l352t848r375b928],
2	.	.	O	.	_	0	SENT_129	[p4l352t848r375b928],

1	Rev.	NNP	O	Rev.	nn	2	SENT_130	[p4l352t778r375b837],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_130	[p4l352t618r375b767],
3	.	.	O	.	_	0	SENT_130	[p4l352t618r375b767],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_131	[p4l352t498r375b608],
2	.	.	O	.	_	0	SENT_131	[p4l352t498r375b608],

1	1996.36:16	CD	NUMBER	1996.36:16	_	0	SENT_132	[p4l352t253r376b484],
2	l-183	NN	O	l-183	dep	1	SENT_132	[p4l352t253r376b484],
3	.	.	O	.	_	0	SENT_132	[p4l352t253r376b484],

1	Downloaded	VBN	O	download	_	0	SENT_133	[p4l352t72r375b242],
2	fro	NN	O	fro	dobj	1	SENT_133	[p4l352t25r375b63],

1	An	DT	O	a	det	2	SENT_134	[p4l350t3294r373b3334],
2	nu	NN	O	nu	_	0	SENT_134	[p4l357t3243r373b3282],
3	.	.	O	.	_	0	SENT_134	[p4l357t3243r373b3282],

1	Rev.	NNP	O	Rev.	nn	2	SENT_135	[p4l350t3173r373b3232],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_135	[p4l350t3013r373b3162],
3	.	.	O	.	_	0	SENT_135	[p4l350t3013r373b3162],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_136	[p4l350t2893r373b3003],
2	.	.	O	.	_	0	SENT_136	[p4l350t2893r373b3003],

1	1996.36	CD	NUMBER	1996.36	_	0	SENT_137	[p4l350t2768r374b2879],
2	:	:	O	:	_	0	SENT_137	[p4l350t2768r374b2879],
3	161-183	CD	NUMBER	161-183	dep	1	SENT_137	[p4l350t2648r373b2761],
4	.	.	O	.	_	0	SENT_137	[p4l350t2648r373b2761],

1	Downloaded	VBN	O	download	_	0	SENT_138	[p4l350t2467r373b2637],
2	from	IN	O	from	_	0	SENT_138	[p4l350t2393r373b2458],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_138	[p4l350t2060r380b2384],
4	by	IN	O	by	_	0	SENT_138	[p4l385t761r416b793],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_138	[p4l385t612r416b751],
6	of	IN	ORGANIZATION	of	_	0	SENT_138	[p4l385t573r409b602],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_138	[p4l385t426r409b566],
8	-	:	O	-	_	0	SENT_138	[p4l399t408r402b416],
9	Madison	NNP	O	Madison	prep_by	1	SENT_138	[p4l385t282r409b398],
10	on	IN	O	on	_	0	SENT_138	[p4l393t240r409b273],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_138	[p4l385t106r409b231],
12	.	.	O	.	_	0	SENT_138	[p4l385t106r409b231],

1	For	IN	O	for	dep	8	SENT_139	[p4l386t49r409b96],
2	p	NN	O	p	pobj	1	SENT_139	[p4l393t25r416b41],
3	by	IN	O	by	_	0	SENT_139	[p4l383t3156r414b3188],
4	University	NNP	ORGANIZATION	University	prep_by	2	SENT_139	[p4l383t3007r414b3146],
5	of	IN	ORGANIZATION	of	_	0	SENT_139	[p4l383t2968r407b2997],
6	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	4	SENT_139	[p4l383t2821r407b2961],
7	-	:	O	-	_	0	SENT_139	[p4l397t2802r400b2811],
8	Madison	NNP	O	Madison	_	0	SENT_139	[p4l383t2676r407b2793],
9	on	IN	O	on	_	0	SENT_139	[p4l391t2635r407b2667],
10	01/05/14	CD	DATE	01/05/14	prep_on	8	SENT_139	[p4l383t2501r407b2625],
11	.	.	O	.	_	0	SENT_139	[p4l383t2501r407b2625],

1	For	IN	O	for	_	0	SENT_140	[p4l384t2444r407b2491],
2	personal	JJ	O	personal	amod	3	SENT_140	[p4l383t2324r414b2436],
3	use	NN	O	use	pobj	1	SENT_140	[p4l391t2271r407b2315],
4	only	RB	O	only	advmod	3	SENT_140	[p4l383t2196r414b2261],
5	.	.	O	.	_	0	SENT_140	[p4l383t2196r414b2261],

1	Structure	NN	O	structure	nn	4	SENT_141	[p4l499t82r685b119],
2	and	CC	O	and	_	0	SENT_141	[p4l701t81r779b119],
3	Function	NN	O	function	conj_and	1	SENT_141	[p4l793t82r973b119],
4	P	NN	O	p	nsubj	11	SENT_141	[p4l500t148r758b188],
5	—	CD	NUMBER	—	num	6	SENT_141	[p4l500t148r758b188],
6	glycoprotein	NN	O	glycoprotein	dep	4	SENT_141	[p4l500t148r758b188],
7	is	VBZ	O	be	cop	11	SENT_141	[p4l774t148r801b179],
8	a	DT	O	a	det	11	SENT_141	[p4l818t157r837b179],
9	1280-amino	JJ	O	1280-amino	amod	11	SENT_141	[p4l856t148r1066b180],
10	acid	NN	O	acid	nn	11	SENT_141	[p4l1081t148r1153b179],
11	protein	NN	O	protein	_	0	SENT_141	[p4l1169t148r1290b188],
12	that	WDT	O	that	nsubjpass	14	SENT_141	[p4l1306t149r1371b179],
13	is	VBZ	O	be	auxpass	14	SENT_141	[p4l1386t148r1413b179],
14	expressed	VBN	O	express	rcmod	11	SENT_141	[p4l1430t148r1600b188],
15	as	IN	O	as	_	0	SENT_141	[p4l1616t157r1651b179],
16	a	DT	O	a	det	19	SENT_141	[p4l1667t157r1685b179],
17	single	JJ	O	single	amod	19	SENT_141	[p4l1702t148r1804b188],
18	polypeptide	NN	O	polypeptide	nn	19	SENT_141	[p4l500t199r704b239],
19	chain	NN	O	chain	prep_as	14	SENT_141	[p4l726t198r819b231],
20	containing	VBG	O	contain	partmod	19	SENT_141	[p4l840t198r1022b239],
21	two	CD	NUMBER	two	num	23	SENT_141	[p4l1044t203r1107b230],
22	homologous	JJ	O	homologous	amod	23	SENT_141	[p4l1128t198r1339b239],
23	portions	NNS	O	portion	dobj	20	SENT_141	[p4l1362t198r1501b239],
24	of	IN	O	of	_	0	SENT_141	[p4l1525t198r1562b231],
25	equal	JJ	O	equal	amod	26	SENT_141	[p4l1581t198r1674b239],
26	length	NN	O	length	prep_of	23	SENT_141	[p4l1696t198r1803b239],
27	(	CD	NUMBER	(	num	29	SENT_141	[p4l502t249r646b287],
28	41-43	CD	NUMBER	41-43	num	29	SENT_141	[p4l502t249r646b287],
29	)	NN	O	)	dep	26	SENT_141	[p4l502t249r646b287],
30	.	.	O	.	_	0	SENT_141	[p4l502t249r646b287],

1	Two	CD	NUMBER	two	num	6	SENT_142	[p4l660t250r739b281],
2	cytoplasmic	JJ	O	cytoplasmic	amod	6	SENT_142	[p4l751t250r960b289],
3	nucleotide	NN	O	nucleotide	nn	6	SENT_142	[p4l974t249r1307b289],
4	—	NN	O	—	nn	6	SENT_142	[p4l974t249r1307b289],
5	binding	NN	O	binding	nn	6	SENT_142	[p4l974t249r1307b289],
6	regions	NNS	O	region	nsubjpass	26	SENT_142	[p4l1321t249r1446b289],
7	are	VBP	O	be	cop	8	SENT_142	[p4l1461t258r1513b280],
8	located	JJ	O	located	_	0	SENT_142	[p4l1526t250r1651b281],
9	near	IN	O	near	_	0	SENT_142	[p4l1665t258r1740b281],
10	the	DT	O	the	det	12	SENT_142	[p4l1752t250r1803b280],
11	carboxy-terminal	JJ	O	carboxy-terminal	amod	12	SENT_142	[p4l500t299r799b338],
12	portion	NN	O	portion	prep_near	8	SENT_142	[p4l813t299r938b338],
13	of	IN	O	of	_	0	SENT_142	[p4l954t298r991b329],
14	the	DT	O	the	det	15	SENT_142	[p4l1004t299r1056b330],
15	P-glycoprotein	NN	O	p-glycoprotein	prep_of	12	SENT_142	[p4l1070t298r1328b339],
16	on	IN	O	on	_	0	SENT_142	[p4l1343t308r1385b330],
17	the	DT	O	the	det	18	SENT_142	[p4l1401t299r1452b330],
18	inside	NN	O	inside	prep_on	15	SENT_142	[p4l1469t299r1571b330],
19	of	IN	O	of	_	0	SENT_142	[p4l1587t299r1624b330],
20	the	DT	O	the	det	23	SENT_142	[p4l1637t299r1689b330],
21	mem	NN	O	mem	nn	23	SENT_142	[p4l1705t308r1803b330],
22	~	NN	O	~	nn	23	SENT_142	[p4l1705t308r1803b330],
23	brane	NN	O	brane	prep_of	18	SENT_142	[p4l500t349r597b380],
24	and	CC	O	and	_	0	SENT_142	[p4l610t349r673b379],
25	are	VBP	O	be	auxpass	26	SENT_142	[p4l687t358r739b380],
26	involved	VBN	O	involve	conj_and	8	SENT_142	[p4l753t349r904b379],
27	in	IN	O	in	_	0	SENT_142	[p4l918t349r952b379],
28	ATP	NN	O	atp	nn	29	SENT_142	[p4l966t349r1045b380],
29	binding	NN	O	binding	prep_in	26	SENT_142	[p4l1058t349r1190b388],
30	and	CC	O	and	_	0	SENT_142	[p4l1206t349r1266b380],
31	hydrolysis	NN	O	hydrolysis	prep_in	26	SENT_142	[p4l1281t349r1458b388],
32	(	CD	NUMBER	(	number	33	SENT_142	[p4l1475t349r1555b386],
33	44	CD	NUMBER	44	num	34	SENT_142	[p4l1475t349r1555b386],
34	)	NN	O	)	dobj	8	SENT_142	[p4l1475t349r1555b386],
35	.	.	O	.	_	0	SENT_142	[p4l1475t349r1555b386],

1	The	DT	O	the	det	3	SENT_143	[p4l1571t349r1637b380],
2	polypeptide	NN	O	polypeptide	nn	3	SENT_143	[p4l1651t349r1803b389, p4l500t398r565b429],
3	component	NN	O	component	nsubj	7	SENT_143	[p4l584t403r776b437],
4	of	IN	O	of	_	0	SENT_143	[p4l794t399r832b429],
5	the	DT	O	the	det	6	SENT_143	[p4l848t399r900b429],
6	P-glycoprotein	NN	MISC	p-glycoprotein	prep_of	3	SENT_143	[p4l919t399r1175b437],
7	has	VBZ	O	have	_	0	SENT_143	[p4l1194t399r1250b429],
8	a	DT	O	a	det	10	SENT_143	[p4l1271t408r1289b428],
9	molecular	JJ	O	molecular	amod	10	SENT_143	[p4l1308t399r1480b429],
10	weight	NN	O	weight	dobj	7	SENT_143	[p4l1499t399r1615b438],
11	of	IN	O	of	_	0	SENT_143	[p4l1634t399r1672b429],
12	120	CD	NUMBER	120	number	14	SENT_143	[p4l1693t399r1752b429],
13	to	TO	O	to	dep	14	SENT_143	[p4l1771t404r1804b430],
14	140	CD	NUMBER	140	num	15	SENT_143	[p4l505t449r565b479],
15	kDa	NN	O	kda	prep_of	10	SENT_143	[p4l585t448r665b478],
16	.	.	O	.	_	0	SENT_143	[p4l585t448r665b478],

1	The	DT	O	the	det	5	SENT_144	[p4l686t448r753b478],
2	predicted	VBN	O	predict	amod	5	SENT_144	[p4l773t448r934b487],
3	amino	NN	O	amino	nn	5	SENT_144	[p4l954t448r1061b478],
4	acid	NN	O	acid	nn	5	SENT_144	[p4l1080t448r1152b478],
5	sequence	NN	O	sequence	nsubj	11	SENT_144	[p4l1173t457r1328b487],
6	and	CC	O	and	_	0	SENT_144	[p4l1349t448r1410b478],
7	structure	NN	O	structure	conj_and	5	SENT_144	[p4l1431t453r1580b479],
8	of	IN	O	of	_	0	SENT_144	[p4l1601t448r1639b479],
9	Pglycoprotein	NN	O	pglycoprotein	prep_of	7	SENT_144	[p4l1656t449r1804b488, p4l500t498r622b538],
10	are	VBP	O	be	cop	11	SENT_144	[p4l641t508r694b529],
11	similar	JJ	O	similar	_	0	SENT_144	[p4l712t498r833b529],
12	to	TO	O	to	_	0	SENT_144	[p4l850t504r883b529],
13	those	DT	O	those	prep_to	11	SENT_144	[p4l901t498r992b529],
14	of	IN	O	of	_	0	SENT_144	[p4l1010t499r1048b529],
15	other	JJ	O	other	amod	18	SENT_144	[p4l1062t498r1152b529],
16	membrane-associated	JJ	O	membrane-associated	amod	18	SENT_144	[p4l1170t498r1542b530],
17	transport	NN	O	transport	nn	18	SENT_144	[p4l1562t504r1716b539],
18	proteins	NNS	O	protein	prep_of	13	SENT_144	[p4l1734t508r1804b539, p4l501t551r593b587],
19	,	,	O	,	_	0	SENT_144	[p4l1734t508r1804b539, p4l501t551r593b587],
20	such	JJ	O	such	_	0	SENT_144	[p4l612t550r691b582],
21	as	IN	O	as	_	0	SENT_144	[p4l708t559r742b582],
22	the	DT	O	the	det	27	SENT_144	[p4l761t550r814b581],
23	bacterial	JJ	O	bacterial	amod	27	SENT_144	[p4l831t550r981b581],
24	transport	NN	O	transport	nn	27	SENT_144	[p4l999t555r1153b590],
25	protein	NN	O	protein	nn	27	SENT_144	[p4l1171t550r1292b590],
26	hemolysin	NN	O	hemolysin	nn	27	SENT_144	[p4l1311t550r1490b591],
27	B	NN	O	b	prep_such_as	13	SENT_144	[p4l1508t551r1533b581],
28	(	CD	NUMBER	(	number	29	SENT_144	[p4l1554t550r1634b588],
29	42	CD	NUMBER	42	num	30	SENT_144	[p4l1554t550r1634b588],
30	)	NN	O	)	dep	27	SENT_144	[p4l1554t550r1634b588],
31	.	.	O	.	_	0	SENT_144	[p4l1554t550r1634b588],

1	Findings	NNS	O	finding	nsubj	5	SENT_145	[p4l1654t550r1803b590],
2	such	JJ	O	such	_	0	SENT_145	[p4l502t602r580b631],
3	as	IN	O	as	_	0	SENT_145	[p4l604t610r638b632],
4	this	DT	O	this	prep_such_as	1	SENT_145	[p4l664t601r726b631],
5	have	VBP	O	have	_	0	SENT_145	[p4l751t602r832b632],
6	further	JJ	O	further	dobj	5	SENT_145	[p4l856t601r975b631],
7	supported	VBD	O	support	rcmod	6	SENT_145	[p4l999t601r1169b640],
8	the	DT	O	the	det	9	SENT_145	[p4l1194t601r1245b631],
9	role	NN	O	role	dobj	7	SENT_145	[p4l1270t602r1336b631],
10	of	IN	O	of	_	0	SENT_145	[p4l1362t601r1400b631],
11	P-glycoprotein	NN	O	p-glycoprotein	prep_of	9	SENT_145	[p4l1422t601r1679b640],
12	as	IN	O	as	_	0	SENT_145	[p4l1705t611r1738b632],
13	an	DT	O	a	det	15	SENT_145	[p4l1765t610r1804b632],
14	energy	NN	O	energy	nn	15	SENT_145	[p4l501t652r813b690],
15	—	NN	O	—	prep_as	7	SENT_145	[p4l501t652r813b690],
16	dependent	JJ	O	dependent	amod	19	SENT_145	[p4l501t652r813b690],
17	drug	NN	O	drug	nn	19	SENT_145	[p4l829t652r906b690],
18	efﬂux	NN	O	efﬂux	nn	19	SENT_145	[p4l924t651r1027b682],
19	pump	NN	O	pump	dep	15	SENT_145	[p4l1044t660r1150b690],
20	.	.	O	.	_	0	SENT_145	[p4l1044t660r1150b690],

1	Based	VBN	O	base	_	0	SENT_146	[p4l543t702r646b732],
2	on	IN	O	on	prepc_based_on	13	SENT_146	[p4l664t711r707b732],
3	its	PRP$	O	its	pobj	13	SENT_146	[p4l726t702r764b732],
4	deduced	VBN	O	deduce	partmod	3	SENT_146	[p4l785t702r924b732],
5	protein	NN	O	protein	nn	6	SENT_146	[p4l944t702r1062b740],
6	sequence	NN	O	sequence	dobj	4	SENT_146	[p4l1082t711r1244b740],
7	,	,	O	,	_	0	SENT_146	[p4l1082t711r1244b740],
8	the	DT	O	the	det	9	SENT_146	[p4l1265t702r1314b732],
9	topology	NN	O	topology	nsubjpass	13	SENT_146	[p4l1335t703r1482b741],
10	of	IN	O	of	_	0	SENT_146	[p4l1504t702r1539b733],
11	P-glycoprotein	NN	O	p-glycoprotein	prep_of	9	SENT_146	[p4l1558t702r1805b741],
12	was	VBD	O	be	auxpass	13	SENT_146	[p4l502t760r566b781],
13	proposed	VBN	O	propose	_	0	SENT_146	[p4l588t752r741b790],
14	to	TO	O	to	aux	15	SENT_146	[p4l762t756r794b781],
15	contain	VB	O	contain	xcomp	13	SENT_146	[p4l815t751r937b781],
16	12	CD	NUMBER	12	num	18	SENT_146	[p4l962t751r1000b781],
17	transmembrane	JJ	O	transmembrane	amod	18	SENT_146	[p4l1021t751r1277b781],
18	domains	NNS	O	domain	dobj	15	SENT_146	[p4l1299t751r1438b781],
19	with	IN	O	with	_	0	SENT_146	[p4l1461t751r1534b782],
20	6	CD	NUMBER	6	num	22	SENT_146	[p4l1556t751r1575b781],
21	extracellular	JJ	O	extracellular	amod	22	SENT_146	[p4l1598t751r1806b782],
22	loops	NNS	O	loop	prep_with	15	SENT_146	[p4l502t801r591b840],
23	and	CC	O	and	_	0	SENT_146	[p4l606t802r666b832],
24	2	CD	NUMBER	2	num	27	SENT_146	[p4l680t801r700b831],
25	cytoplasmic	JJ	O	cytoplasmic	amod	27	SENT_146	[p4l715t801r916b840],
26	ATP-binding	JJ	O	atp-binding	amod	27	SENT_146	[p4l930t801r1149b841],
27	domains	NNS	O	domain	prep_with	15	SENT_146	[p4l1164t801r1312b832],
28	.	.	O	.	_	0	SENT_146	[p4l1164t801r1312b832],

1	Although	IN	O	although	mark	14	SENT_147	[p4l1329t802r1486b841],
2	the	DT	O	the	det	5	SENT_147	[p4l1500t802r1549b832],
3	12	CD	NUMBER	12	num	5	SENT_147	[p4l1569t802r1804b832, p4l500t851r594b882],
4	—	NN	O	—	nn	5	SENT_147	[p4l1569t802r1804b832, p4l500t851r594b882],
5	transmembrane	NN	O	transmembrane	nsubj	14	SENT_147	[p4l1569t802r1804b832, p4l500t851r594b882],
6	domain	NN	O	domain	nn	7	SENT_147	[p4l609t851r735b882],
7	model	NN	O	model	nsubjpass	9	SENT_147	[p4l750t851r854b882],
8	is	VBZ	O	be	auxpass	9	SENT_147	[p4l870t851r897b881],
9	supported	VBN	O	support	rcmod	5	SENT_147	[p4l914t852r1077b890],
10	by	IN	O	by	_	0	SENT_147	[p4l1093t851r1134b891],
11	antibody	NN	O	antibody	nn	13	SENT_147	[p4l1152t851r1296b890],
12	localization	NN	O	localization	nn	13	SENT_147	[p4l1312t851r1506b882],
13	data	NNS	O	datum	agent	9	SENT_147	[p4l1523t852r1592b882],
14	(	VBP	O	(	advcl	20	SENT_147	[p4l1609t852r1686b889],
15	45	CD	NUMBER	45	number	16	SENT_147	[p4l1609t852r1686b889],
16	)	CD	NUMBER	)	dobj	14	SENT_147	[p4l1609t852r1686b889],
17	,	,	O	,	_	0	SENT_147	[p4l1609t852r1686b889],
18	recent	JJ	O	recent	amod	19	SENT_147	[p4l1704t858r1806b883],
19	studies	NNS	O	study	nsubj	20	SENT_147	[p4l502t901r616b931],
20	suggest	VBP	O	suggest	_	0	SENT_147	[p4l640t906r766b940],
21	an	DT	O	a	det	24	SENT_147	[p4l789t910r827b931],
22	alternative	JJ	O	alternative	amod	24	SENT_147	[p4l851t901r1027b931],
23	topological	JJ	O	topological	amod	24	SENT_147	[p4l1049t901r1235b940],
24	model	NN	O	model	dobj	20	SENT_147	[p4l1261t901r1373b936],
25	,	,	O	,	_	0	SENT_147	[p4l1261t901r1373b936],
26	as	IN	O	as	mark	27	SENT_147	[p4l1398t911r1430b932],
27	shown	VBN	O	show	dep	24	SENT_147	[p4l1455t901r1563b932],
28	in	IN	O	in	_	0	SENT_147	[p4l1587t901r1619b932],
29	Figure	NNP	O	Figure	prep_in	27	SENT_147	[p4l1643t901r1752b940],
30	1	CD	NUMBER	1	num	29	SENT_147	[p4l1779t902r1804b932],
31	.	.	O	.	_	0	SENT_147	[p4l1779t902r1804b932],

1	Evaluation	NN	O	evaluation	nsubj	21	SENT_148	[p4l501t951r681b981],
2	of	IN	O	of	_	0	SENT_148	[p4l695t951r733b981],
3	the	DT	O	the	det	5	SENT_148	[p4l745t951r796b981],
4	murine	JJ	O	murine	amod	5	SENT_148	[p4l811t950r928b981],
5	mdrl	NN	O	mdrl	prep_of	1	SENT_148	[p4l941t950r1027b981],
6	or	CC	O	or	_	0	SENT_148	[p4l1044t959r1079b981],
7	human	JJ	O	human	amod	10	SENT_148	[p4l1093t950r1206b981],
8	MDRl	NN	O	mdrl	nn	10	SENT_148	[p4l1220t951r1327b981],
9	gene	NN	O	gene	nn	10	SENT_148	[p4l1346t960r1424b990],
10	products	NNS	O	product	conj_or	5	SENT_148	[p4l1438t951r1580b990],
11	translated	VBN	O	translate	dep	10	SENT_148	[p4l1596t951r1759b982],
12	in	IN	O	in	_	0	SENT_148	[p4l1773t951r1805b982],
13	a	DT	O	a	det	15	SENT_148	[p4l502t1010r520b1031],
14	cell-free	JJ	O	cell-free	amod	15	SENT_148	[p4l534t1001r673b1032],
15	system	NN	O	system	prep_in	11	SENT_148	[p4l689t1006r805b1041],
16	or	CC	O	or	_	0	SENT_148	[p4l818t1011r853b1032],
17	expressed	VBN	O	express	conj_or	11	SENT_148	[p4l867t1002r1032b1041],
18	in	IN	O	in	_	0	SENT_148	[p4l1045t1001r1078b1032],
19	Xenopus	NN	O	xenopus	nn	20	SENT_148	[p4l1091t1000r1235b1040],
20	oocytes	NNS	O	oocyte	prep_in	17	SENT_148	[p4l1251t1006r1376b1042],
21	revealed	VBD	O	reveal	_	0	SENT_148	[p4l1391t1001r1532b1033],
22	a	DT	O	a	det	24	SENT_148	[p4l1548t1011r1566b1032],
23	glycosylation	NN	O	glycosylation	nn	24	SENT_148	[p4l1582t1001r1805b1042],
24	site	NN	O	site	dobj	21	SENT_148	[p4l502t1050r559b1081],
25	in	IN	O	in	_	0	SENT_148	[p4l581t1051r613b1080],
26	the	DT	O	the	det	28	SENT_148	[p4l636t1051r688b1081],
27	second	JJ	DATE	second	amod	28	SENT_148	[p4l711t1052r826b1081],
28	half	NN	DATE	half	prep_in	24	SENT_148	[p4l848t1050r916b1081],
29	of	IN	DATE	of	_	0	SENT_148	[p4l936t1051r974b1081],
30	the	DT	DATE	the	det	31	SENT_148	[p4l993t1051r1045b1082],
31	P-glycoprotein	NN	DATE	p-glycoprotein	prep_of	28	SENT_148	[p4l1066t1051r1322b1091],
32	,	,	O	,	_	0	SENT_148	[p4l1066t1051r1322b1091],
33	as	RB	O	as	_	0	SENT_148	[p4l1347t1061r1380b1081],
34	well	RB	O	well	_	0	SENT_148	[p4l1405t1052r1475b1082],
35	as	IN	O	as	_	0	SENT_148	[p4l1499t1061r1531b1082],
36	the	DT	O	the	det	39	SENT_148	[p4l1556t1052r1606b1082],
37	previously	RB	DATE	previously	advmod	38	SENT_148	[p4l1629t1051r1804b1091],
38	reported	VBN	O	report	amod	39	SENT_148	[p4l501t1101r641b1140],
39	sites	NNS	O	site	conj_and	24	SENT_148	[p4l651t1101r724b1131],
40	in	IN	O	in	_	0	SENT_148	[p4l735t1101r767b1131],
41	the	DT	O	the	det	47	SENT_148	[p4l778t1101r828b1132],
42	first	JJ	ORDINAL	first	amod	47	SENT_148	[p4l839t1101r907b1132],
43	extracellular	JJ	O	extracellular	amod	47	SENT_148	[p4l916t1101r1125b1131],
44	loop	NN	O	loop	nn	47	SENT_148	[p4l1136t1101r1208b1140],
45	(	NN	O	(	nn	47	SENT_148	[p4l1220t1101r1358b1139],
46	46-48	CD	NUMBER	46-48	num	47	SENT_148	[p4l1220t1101r1358b1139],
47	)	NN	O	)	prep_in	39	SENT_148	[p4l1220t1101r1358b1139],
48	.	.	O	.	_	0	SENT_148	[p4l1220t1101r1358b1139],

1	This	DT	DATE	this	det	5	SENT_149	[p4l1370t1101r1443b1132],
2	second	JJ	DATE	second	amod	5	SENT_149	[p4l1456t1102r1571b1132],
3	glycosylation	NN	O	glycosylation	nn	5	SENT_149	[p4l1581t1101r1805b1141],
4	site	NN	O	site	nn	5	SENT_149	[p4l502t1149r558b1180],
5	links	NNS	O	link	nsubj	19	SENT_149	[p4l583t1150r664b1180],
6	transmembrane	JJ	O	transmembrane	amod	7	SENT_149	[p4l689t1150r946b1181],
7	domains	NNS	O	domain	dep	5	SENT_149	[p4l971t1150r1111b1181],
8	8	CD	NUMBER	8	dep	5	SENT_149	[p4l1138t1151r1156b1181],
9	and	CC	O	and	_	0	SENT_149	[p4l1183t1151r1242b1181],
10	9	CD	NUMBER	9	dep	5	SENT_149	[p4l1268t1151r1287b1181],
11	in	IN	O	in	_	0	SENT_149	[p4l1313t1151r1344b1181],
12	the	DT	O	the	det	14	SENT_149	[p4l1370t1151r1419b1181],
13	traditional	JJ	O	traditional	amod	14	SENT_149	[p4l1445t1151r1615b1181],
14	model	NN	O	model	prep_in	8	SENT_149	[p4l1641t1151r1746b1181],
15	of	IN	O	of	_	0	SENT_149	[p4l1771t1152r1807b1181],
16	P-glycoprotein	NN	MISC	p-glycoprotein	nn	17	SENT_149	[p4l502t1199r749b1238],
17	topology	NN	O	topology	prep_of	14	SENT_149	[p4l761t1199r917b1237],
18	,	,	O	,	_	0	SENT_149	[p4l761t1199r917b1237],
19	suggesting	VBG	O	suggest	_	0	SENT_149	[p4l930t1199r1107b1238],
20	that	IN	O	that	complm	23	SENT_149	[p4l1119t1200r1182b1229],
21	they	PRP	O	they	nsubj	23	SENT_149	[p4l1193t1200r1264b1238],
22	are	VBP	O	be	cop	23	SENT_149	[p4l1277t1208r1326b1229],
23	located	JJ	O	located	ccomp	19	SENT_149	[p4l1339t1199r1458b1230],
24	extracellularly	RB	O	extracellularly	advmod	23	SENT_149	[p4l1470t1199r1718b1238],
25	.	.	O	.	_	0	SENT_149	[p4l1470t1199r1718b1238],

1	This	DT	O	this	nsubj	2	SENT_150	[p4l1733t1199r1804b1230],
2	raises	VBZ	O	raise	_	0	SENT_150	[p4l501t1248r594b1278],
3	the	DT	O	the	det	4	SENT_150	[p4l608t1249r659b1278],
4	possibility	NN	O	possibility	dobj	2	SENT_150	[p4l671t1247r845b1287],
5	that	IN	O	that	complm	9	SENT_150	[p4l858t1248r921b1278],
6	the	DT	O	the	det	7	SENT_150	[p4l933t1248r983b1278],
7	P-glycoprotein	NN	O	p-glycoprotein	nsubj	9	SENT_150	[p4l995t1248r1243b1287],
8	may	MD	O	may	aux	9	SENT_150	[p4l1256t1257r1326b1288],
9	exist	VB	O	exist	ccomp	2	SENT_150	[p4l1340t1248r1419b1279],
10	in	IN	O	in	_	0	SENT_150	[p4l1431t1249r1462b1279],
11	different	JJ	O	different	amod	12	SENT_150	[p4l1476t1248r1620b1279],
12	topologies	NNS	O	topology	prep_in	9	SENT_150	[p4l1631t1248r1804b1287],
13	that	WDT	O	that	nsubj	15	SENT_150	[p4l501t1297r565b1328],
14	may	MD	O	may	aux	15	SENT_150	[p4l581t1306r652b1337],
15	impact	VB	O	impact	rcmod	12	SENT_150	[p4l669t1297r784b1337],
16	its	PRP$	O	its	poss	17	SENT_150	[p4l800t1297r838b1328],
17	function	NN	O	function	dobj	15	SENT_150	[p4l855t1297r1002b1328],
18	.	.	O	.	_	0	SENT_150	[p4l855t1297r1002b1328],

1	Currently	RB	DATE	currently	advmod	5	SENT_151	[p4l1020t1298r1189b1336],
2	,	,	O	,	_	0	SENT_151	[p4l1020t1298r1189b1336],
3	it	PRP	O	it	nsubj	5	SENT_151	[p4l1207t1298r1230b1328],
4	is	VBZ	O	be	cop	5	SENT_151	[p4l1247t1298r1273b1328],
5	unknown	JJ	O	unknown	_	0	SENT_151	[p4l1291t1298r1445b1328],
6	whether	IN	O	whether	complm	10	SENT_151	[p4l1463t1298r1597b1328],
7	this	DT	DATE	this	det	9	SENT_151	[p4l1614t1297r1672b1328],
8	second	JJ	DATE	second	amod	9	SENT_151	[p4l1691t1298r1806b1329],
9	isoform	NN	O	isoform	nsubj	10	SENT_151	[p4l501t1345r632b1377],
10	exists	VBZ	O	exist	ccomp	5	SENT_151	[p4l646t1346r740b1377],
11	as	IN	O	as	_	0	SENT_151	[p4l756t1355r791b1376],
12	a	DT	O	a	det	15	SENT_151	[p4l807t1355r825b1377],
13	mature	JJ	O	mature	amod	14	SENT_151	[p4l841t1351r956b1377],
14	functional	JJ	O	functional	amod	15	SENT_151	[p4l972t1346r1140b1377],
15	molecule	NN	O	molecule	prep_as	10	SENT_151	[p4l1157t1346r1307b1377],
16	at	IN	O	at	_	0	SENT_151	[p4l1324t1351r1354b1377],
17	the	DT	O	the	det	19	SENT_151	[p4l1370t1346r1420b1377],
18	plasma	NN	O	plasma	nn	19	SENT_151	[p4l1436t1347r1554b1386],
19	membrane	NN	O	membrane	prep_at	15	SENT_151	[p4l1571t1346r1754b1377],
20	.	.	O	.	_	0	SENT_151	[p4l1571t1346r1754b1377],

1	Annual	JJ	SET	annual	amod	2	SENT_152	[p4l440t1466r561b1495],
2	Reviews	NNS	O	review	nsubj	3	SENT_152	[p4l573t1466r714b1504],
3	_	VBP	O	_	_	0	SENT_152	[p4l947t1499r952b1504],
4	www.annualreV1ews.org/aronline	NN	O	www.annualrev1ews.org/aronline	dobj	3	SENT_152	[p4l440t1499r994b1537],

1	166	CD	NUMBER	166	num	2	SENT_153	[p4l507t1553r559b1581],
2	BELLAMY	NN	O	bellamy	_	0	SENT_153	[p4l629t1553r811b1582],

1	P-glycoprotein	NN	O	p-glycoprotein	_	0	SENT_154	[p4l1045t1657r1262b1688],

1	Lumen	NN	O	luman	_	0	SENT_155	[p4l777t1691r858b1711],

1	Form	NN	O	form	nn	2	SENT_156	[p4l1412t1721r1489b1746],
2	I	NN	O	i	_	0	SENT_156	[p4l1501t1722r1507b1746],

1	cytoplasm	NN	O	cytoplasm	_	0	SENT_157	[p4l776t2060r886b2083],
2	'	''	O	'	_	0	SENT_157	[p4l1457t2056r1468b2062],

1	mm	NN	O	mm	nn	3	SENT_158	[p4l773t2270r853b2290],
2	"	''	O	"	punct	3	SENT_158	[p4l773t2270r853b2290],
3	Form	NN	O	form	_	0	SENT_158	[p4l1413t2289r1489b2315],
4	II	CD	NUMBER	ii	dep	3	SENT_158	[p4l1501t2290r1516b2315],

1	cvtophsm	NN	O	cvtophsm	nn	2	SENT_159	[p4l770t2718r880b2739],
2	Figure	NN	O	figure	_	0	SENT_159	[p4l1470t2694r1480b2699, p4l504t2856r593b2886],

1	I	PRP	O	I	nsubj	3	SENT_160	[p4l604t2855r617b2880],
2	Topological	JJ	O	topological	amod	3	SENT_160	[p4l649t2857r810b2889],
3	models	NNS	O	model	_	0	SENT_160	[p4l819t2858r914b2883],
4	of	IN	O	of	_	0	SENT_160	[p4l923t2858r953b2882],
5	P-glycoprotein	NN	O	p-glycoprotein	prep_of	3	SENT_160	[p4l959t2858r1162b2890],
6	.	.	O	.	_	0	SENT_160	[p4l959t2858r1162b2890],

1	The	DT	O	the	det	4	SENT_161	[p4l1172t2859r1224b2883],
2	proposed	VBN	O	propose	amod	4	SENT_161	[p4l1232t2860r1353b2890],
3	topological	JJ	O	topological	amod	4	SENT_161	[p4l1362t2860r1510b2891],
4	models	NNS	O	model	nsubjpass	16	SENT_161	[p4l1521t2860r1615b2885],
5	for	IN	O	for	_	0	SENT_161	[p4l1625t2861r1663b2886],
6	the	DT	O	the	det	9	SENT_161	[p4l1671t2862r1711b2886],
7	MDRI	NN	ORGANIZATION	mdrus	nn	9	SENT_161	[p4l1719t2861r1805b2885],
8	gene	NN	O	gene	nn	9	SENT_161	[p4l504t2902r566b2927],
9	product	NN	O	product	prep_for	4	SENT_161	[p4l579t2895r680b2927],
10	based	VBN	O	base	partmod	9	SENT_161	[p4l693t2897r768b2922],
11	on	IN	O	on	_	0	SENT_161	[p4l780t2904r813b2922],
12	the	DT	O	the	det	14	SENT_161	[p4l825t2897r866b2922],
13	hydropathy	NN	O	hydropathy	nn	14	SENT_161	[p4l877t2897r1027b2930],
14	proﬁle	NN	O	proﬁle	prep_on	10	SENT_161	[p4l1041t2898r1128b2930],
15	is	VBZ	O	be	auxpass	16	SENT_161	[p4l1140t2898r1162b2923],
16	presented	VBN	O	present	dep	38	SENT_161	[p4l1174t2899r1301b2930],
17	at	IN	O	at	_	0	SENT_161	[p4l1314t2903r1337b2924],
18	the	DT	O	the	det	19	SENT_161	[p4l1349t2899r1390b2924],
19	top	JJ	O	top	prep_at	16	SENT_161	[p4l1402t2904r1444b2931],
20	as	IN	O	as	_	0	SENT_161	[p4l1456t2907r1483b2924],
21	form	NN	O	form	nn	22	SENT_161	[p4l1495t2900r1560b2924],
22	I.	NN	O	i.	prep_as	19	SENT_161	[p4l1573t2900r1589b2924],
23	The	DT	O	the	det	25	SENT_161	[p4l1604t2900r1656b2926],
24	alternative	JJ	O	alternative	amod	25	SENT_161	[p4l1668t2900r1807b2926],
25	structure	NN	O	structure	dobj	16	SENT_161	[p4l504t2939r619b2959],
26	based	VBN	O	base	partmod	25	SENT_161	[p4l627t2935r702b2961],
27	on	IN	O	on	_	0	SENT_161	[p4l710t2944r745b2961],
28	the	DT	O	the	det	29	SENT_161	[p4l752t2937r792b2961],
29	evidence	NN	O	evidence	prep_on	26	SENT_161	[p4l800t2937r918b2961],
30	by	IN	O	by	_	0	SENT_161	[p4l925t2937r958b2968],
31	Zhang	NNP	PERSON	Zhang	prep_by	29	SENT_161	[p4l965t2937r1050b2969],
32	et	FW	O	et	nn	34	SENT_161	[p4l1057t2941r1082b2962],
33	al	FW	O	al	nn	34	SENT_161	[p4l1089t2938r1113b2961],
34	(	FW	O	(	dobj	26	SENT_161	[p4l1121t2938r1175b2967],
35	46	CD	NUMBER	46	num	36	SENT_161	[p4l1121t2938r1175b2967],
36	)	NN	O	)	nsubjpass	38	SENT_161	[p4l1121t2938r1175b2967],
37	is	VBZ	O	be	auxpass	38	SENT_161	[p4l1184t2937r1205b2962],
38	presented	VBN	O	present	_	0	SENT_161	[p4l1212t2939r1341b2968],
39	at	IN	O	at	_	0	SENT_161	[p4l1348t2943r1372b2963],
40	the	DT	O	the	det	41	SENT_161	[p4l1379t2939r1420b2963],
41	bottom	NN	O	bottom	prep_at	38	SENT_161	[p4l1426t2939r1521b2963],
42	as	IN	O	as	_	0	SENT_161	[p4l1529t2946r1556b2964],
43	form	NN	O	form	prep_as	41	SENT_161	[p4l1565t2939r1629b2963],
44	II	CD	NUMBER	ii	num	43	SENT_161	[p4l1637t2940r1665b2964],
45	.	.	O	.	_	0	SENT_161	[p4l1637t2940r1665b2964],

1	Solid	JJ	O	solid	amod	2	SENT_162	[p4l1677t2940r1745b2964],
2	bars	NNS	O	bar	nsubj	3	SENT_162	[p4l1753t2941r1807b2965],
3	represent	VBP	O	represent	_	0	SENT_162	[p4l505t2976r626b3004],
4	transmembrane	JJ	O	transmembrane	amod	5	SENT_162	[p4l638t2975r842b2999],
5	domains	NNS	O	domain	dobj	3	SENT_162	[p4l855t2974r974b3002],
6	,	,	O	,	_	0	SENT_162	[p4l855t2974r974b3002],
7	while	IN	O	while	mark	10	SENT_162	[p4l988t2975r1061b3000],
8	solid	JJ	O	solid	amod	9	SENT_162	[p4l1073t2975r1137b2999],
9	circles	NNS	O	circle	nsubj	10	SENT_162	[p4l1148t2975r1235b2999],
10	represent	VBP	O	represent	advcl	3	SENT_162	[p4l1246t2981r1368b3007],
11	ATP-binding	JJ	O	atp-binding	amod	12	SENT_162	[p4l1380t2976r1555b3007],
12	regions	NNS	O	region	dobj	10	SENT_162	[p4l1568t2977r1671b3008],
13	.	.	O	.	_	0	SENT_162	[p4l1568t2977r1671b3008],

1	(	NN	O	(	_	0	SENT_163	[p4l1686t2978r1809b3010],
2	Adapted	VBN	O	adapt	partmod	1	SENT_163	[p4l1686t2978r1809b3010],
3	from	IN	O	from	_	0	SENT_163	[p4l504t3012r568b3036],
4	Reference	NNP	O	Reference	prep_from	2	SENT_163	[p4l577t3011r710b3038],
5	46	CD	NUMBER	46	num	4	SENT_163	[p4l719t3014r771b3043],
6	.	.	O	.	_	0	SENT_163	[p4l719t3014r771b3043],
7	)	SYM	O	)	dep	1	SENT_163	[p4l719t3014r771b3043],

1	Drug	NN	O	drug	nn	2	SENT_164	[p4l503t3172r608b3219],
2	Transport	NN	O	transport	nsubj	20	SENT_164	[p4l627t3172r827b3220],
3	and	CC	O	and	_	0	SENT_164	[p4l841t3173r918b3210],
4	Binding	NN	O	binding	conj_and	2	SENT_164	[p4l931t3174r1090b3221],
5	One	CD	NUMBER	one	num	4	SENT_164	[p4l505t3244r573b3277],
6	of	IN	O	of	_	0	SENT_164	[p4l589t3244r626b3277],
7	the	DT	O	the	det	8	SENT_164	[p4l640t3245r690b3279],
8	earliest	JJS	O	earliest	prep_of	4	SENT_164	[p4l706t3247r827b3279],
9	and	CC	O	and	_	0	SENT_164	[p4l842t3247r902b3278],
10	most	RBS	O	most	advmod	11	SENT_164	[p4l918t3251r999b3278],
11	consistent	JJ	O	consistent	amod	12	SENT_164	[p4l1014t3247r1180b3279],
12	alterations	NNS	O	alteration	prep_of	4	SENT_164	[p4l1195t3247r1367b3280],
13	observed	VBN	O	observe	partmod	12	SENT_164	[p4l1383t3249r1534b3281],
14	in	IN	O	in	_	0	SENT_164	[p4l1551t3249r1581b3280],
15	MDR	NN	ORGANIZATION	mdr	nn	17	SENT_164	[p4l1598t3250r1693b3282],
16	tumor	NN	O	tumor	nn	17	SENT_164	[p4l1709t3255r1809b3282],
17	cells	NNS	O	cell	prep_in	13	SENT_164	[p4l503t3307r578b3339],
18	was	VBD	O	be	cop	20	SENT_164	[p4l597t3316r659b3339],
19	a	DT	O	a	det	20	SENT_164	[p4l678t3318r696b3340],
20	decrease	NN	O	decrease	_	0	SENT_164	[p4l713t3309r856b3340],
21	in	IN	O	in	_	0	SENT_164	[p4l872t3309r905b3339],
22	drug	NN	O	drug	nn	23	SENT_164	[p4l921t3310r998b3348],
23	accumulation	NN	O	accumulation	prep_in	20	SENT_164	[p4l1014t3309r1246b3341],
24	.	.	O	.	_	0	SENT_164	[p4l1014t3309r1246b3341],

1	Considerable	JJ	O	considerable	amod	2	SENT_165	[p4l1265t3310r1484b3343],
2	evidence	NN	O	evidence	nsubj	3	SENT_165	[p4l1500t3311r1649b3343],
3	suggests	VBZ	O	suggest	_	0	SENT_165	[p4l1668t3317r1806b3352],
4	that	IN	O	that	complm	11	SENT_165	[p4l504t3358r566b3389],
5	the	DT	O	the	det	9	SENT_165	[p4l578t3359r627b3389],
6	MDR	NN	O	mdr	nn	9	SENT_165	[p4l638t3359r747b3389],
7	]	NN	O	]	nn	9	SENT_165	[p4l638t3359r747b3389],
8	gene	NN	O	gene	nn	9	SENT_165	[p4l764t3369r842b3398],
9	product	NN	O	product	nsubjpass	11	SENT_165	[p4l854t3360r981b3398],
10	is	VBZ	O	be	auxpass	11	SENT_165	[p4l992t3361r1019b3392],
11	involved	VBN	O	involve	ccomp	3	SENT_165	[p4l1032t3362r1177b3392],
12	in	IN	O	in	_	0	SENT_165	[p4l1190t3361r1221b3391],
13	removal	NN	O	removal	prep_in	11	SENT_165	[p4l1233t3363r1369b3392],
14	of	IN	O	of	_	0	SENT_165	[p4l1381t3363r1419b3393],
15	drug	NN	O	drug	prep_of	13	SENT_165	[p4l1428t3363r1504b3401],
16	from	IN	O	from	_	0	SENT_165	[p4l1516t3363r1598b3393],
17	the	DT	O	the	det	18	SENT_165	[p4l1610t3363r1660b3394],
18	cell	NN	O	cell	prep_from	11	SENT_165	[p4l1673t3364r1741b3399],
19	,	,	O	,	_	0	SENT_165	[p4l1673t3364r1741b3399],
20	but	CC	O	but	_	0	SENT_165	[p4l1755t3364r1809b3394],
21	exactly	RB	O	exactly	advmod	22	SENT_165	[p4l503t3410r622b3448],
22	how	WRB	O	how	advmod	24	SENT_165	[p4l637t3409r707b3440],
23	it	PRP	O	it	nsubj	24	SENT_165	[p4l721t3410r746b3440],
24	carries	VBZ	O	carry	ccomp	3	SENT_165	[p4l757t3411r867b3440],
25	out	RP	O	out	prt	24	SENT_165	[p4l881t3415r935b3440],
26	this	DT	O	this	det	27	SENT_165	[p4l947t3410r1006b3441],
27	task	NN	O	task	nsubj	30	SENT_165	[p4l1019t3413r1087b3442],
28	is	VBZ	O	be	cop	30	SENT_165	[p4l1099t3412r1125b3441],
29	still	RB	O	still	advmod	30	SENT_165	[p4l1140t3412r1202b3441],
30	open	JJ	O	open	ccomp	24	SENT_165	[p4l1214t3421r1295b3450],
31	to	TO	O	to	_	0	SENT_165	[p4l1307t3416r1340b3442],
32	interpretation	NN	O	interpretation	prep_to	30	SENT_165	[p4l1352t3413r1586b3451],
33	.	.	O	.	_	0	SENT_165	[p4l1352t3413r1586b3451],

1	The	DT	O	the	det	3	SENT_166	[p4l546t3458r610b3488],
2	prevailing	VBG	O	prevail	amod	3	SENT_166	[p4l626t3458r796b3498],
3	hypothesis	NN	O	hypothesis	nsubj	4	SENT_166	[p4l812t3458r989b3498],
4	is	VBZ	O	be	_	0	SENT_166	[p4l1005t3461r1032b3491],
5	that	IN	O	that	complm	8	SENT_166	[p4l1049t3461r1112b3491],
6	the	DT	O	the	det	7	SENT_166	[p4l1128t3461r1178b3491],
7	P-glycoprotein	NN	MISC	p-glycoprotein	nsubj	8	SENT_166	[p4l1194t3461r1441b3500],
8	functions	VBZ	O	function	ccomp	4	SENT_166	[p4l1457t3461r1612b3492],
9	as	IN	O	as	_	0	SENT_166	[p4l1629t3471r1662b3493],
10	a	DT	O	a	det	13	SENT_166	[p4l1680t3472r1698b3493],
11	transmembrane	JJ	O	transmembrane	amod	13	SENT_166	[p4l1714t3468r1807b3493, p4l504t3509r679b3539],
12	pore	NN	O	pore	nn	13	SENT_166	[p4l688t3509r911b3548],
13	—	NN	O	—	prep_as	8	SENT_166	[p4l688t3509r911b3548],
14	forming	VBG	O	form	partmod	13	SENT_166	[p4l688t3509r911b3548],
15	protein	NN	O	protein	dobj	14	SENT_166	[p4l919t3511r1047b3548],
16	,	,	O	,	_	0	SENT_166	[p4l919t3511r1047b3548],
17	leading	VBG	O	lead	partmod	14	SENT_166	[p4l1056t3511r1179b3550],
18	to	TO	O	to	_	0	SENT_166	[p4l1187t3515r1220b3541],
19	an	DT	O	a	det	23	SENT_166	[p4l1229t3520r1268b3541],
20	energy-dependent	JJ	O	energy-dependent	amod	23	SENT_166	[p4l1277t3512r1577b3551],
21	outward	JJ	O	outward	amod	23	SENT_166	[p4l1586t3513r1723b3543],
22	drug	NN	O	drug	nn	23	SENT_166	[p4l1732t3513r1807b3551],
23	efﬂux	NN	O	efﬂux	prep_to	17	SENT_166	[p4l505t3558r612b3589],
24	.	.	O	.	_	0	SENT_166	[p4l505t3558r612b3589],

1	The	DT	O	the	det	2	SENT_167	[p4l630t3558r694b3590],
2	identiﬁcation	NN	O	identiﬁcation	dep	7	SENT_167	[p4l710t3559r932b3590],
3	of	IN	O	of	advmod	4	SENT_167	[p4l948t3559r985b3590],
4	A	DT	O	a	amod	2	SENT_167	[p4l998t3562r1129b3591],
5	'	''	O	'	_	0	SENT_167	[p4l998t3562r1129b3591],
6	I	PRP	O	I	nsubj	7	SENT_167	[p4l998t3562r1129b3591],
7	‘	VBP	O	‘	_	0	SENT_167	[p4l998t3562r1129b3591],
8	Pase	NN	O	pase	nn	9	SENT_167	[p4l998t3562r1129b3591],
9	activity	NN	O	activity	nsubj	14	SENT_167	[p4l1144t3561r1269b3601],
10	associated	VBN	O	associate	partmod	9	SENT_167	[p4l1284t3562r1456b3593],
11	with	IN	O	with	_	0	SENT_167	[p4l1471t3563r1545b3593],
12	P-glycoprotein	NN	MISC	p-glycoprotein	prep_with	10	SENT_167	[p4l1562t3563r1808b3602],
13	was	VBD	O	be	cop	14	SENT_167	[p4l505t3617r568b3638],
14	signiﬁcant	JJ	O	signiﬁcant	ccomp	7	SENT_167	[p4l583t3608r759b3646],
15	because	IN	O	because	_	0	SENT_167	[p4l772t3609r904b3639],
16	this	DT	O	this	prep_because	14	SENT_167	[p4l918t3610r976b3639],
17	provided	VBN	O	provide	partmod	16	SENT_167	[p4l990t3611r1138b3649],
18	a	DT	O	a	det	19	SENT_167	[p4l1151t3620r1170b3641],
19	mechanism	NN	O	mechanism	dobj	17	SENT_167	[p4l1183t3611r1374b3642],
20	by	IN	O	by	_	0	SENT_167	[p4l1385t3613r1427b3651],
21	which	WDT	O	which	dobj	25	SENT_167	[p4l1441t3612r1543b3642],
22	energy	NN	O	energy	nsubjpass	25	SENT_167	[p4l1557t3621r1670b3652],
23	may	MD	O	may	aux	25	SENT_167	[p4l1684t3622r1755b3652],
24	be	VB	O	be	auxpass	25	SENT_167	[p4l1769t3613r1809b3643],
25	transduced	VBN	O	transduce	agent	17	SENT_167	[p4l503t3659r683b3690],
26	for	IN	O	for	_	0	SENT_167	[p4l701t3660r751b3690],
27	active	JJ	O	active	amod	29	SENT_167	[p4l767t3660r867b3690],
28	drug	NN	O	drug	nn	29	SENT_167	[p4l884t3660r960b3699],
29	efﬂux	NN	O	efﬂux	prep_for	25	SENT_167	[p4l978t3660r1085b3691],
30	.	.	O	.	_	0	SENT_167	[p4l978t3660r1085b3691],

1	Initially	RB	O	initially	advmod	4	SENT_168	[p4l1105t3660r1236b3700],
2	it	PRP	O	it	nsubjpass	4	SENT_168	[p4l1253t3661r1277b3691],
3	was	VBD	O	be	auxpass	4	SENT_168	[p4l1294t3670r1358b3693],
4	believed	VBN	O	believe	_	0	SENT_168	[p4l1375t3662r1518b3693],
5	that	IN	O	that	complm	8	SENT_168	[p4l1537t3663r1598b3693],
6	drugs	NNS	O	drug	nsubjpass	8	SENT_168	[p4l1616t3664r1707b3703],
7	were	VBD	O	be	auxpass	8	SENT_168	[p4l1727t3673r1807b3694],
8	removed	VBN	O	remove	ccomp	4	SENT_168	[p4l504t3709r649b3739],
9	from	IN	O	from	_	0	SENT_168	[p4l662t3710r743b3740],
10	the	DT	O	the	det	11	SENT_168	[p4l753t3710r804b3740],
11	cytoplasm	NN	O	cytoplasm	prep_from	8	SENT_168	[p4l815t3710r988b3749],
12	through	IN	O	through	_	0	SENT_168	[p4l997t3711r1126b3750],
13	a	DT	O	a	det	15	SENT_168	[p4l1138t3720r1157b3741],
14	single	JJ	O	single	amod	15	SENT_168	[p4l1167t3711r1266b3750],
15	pore	NN	O	pore	prep_through	8	SENT_168	[p4l1276t3720r1351b3751],
16	formed	VBN	O	form	partmod	15	SENT_168	[p4l1361t3713r1482b3744],
17	by	IN	O	by	_	0	SENT_168	[p4l1493t3713r1535b3753],
18	the	DT	O	the	det	19	SENT_168	[p4l1547t3713r1597b3743],
19	PglycoproAnnu	NNP	O	PglycoproAnnu	agent	16	SENT_168	[p4l1609t3714r1807b3754, p5l354t2012r377b2092],
20	.	.	O	.	_	0	SENT_168	[p4l1609t3714r1807b3754, p5l354t2012r377b2092],

1	Rev.	NNP	O	Rev.	nn	2	SENT_169	[p5l354t1942r377b2001],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_169	[p5l354t1782r377b1931],
3	.	.	O	.	_	0	SENT_169	[p5l354t1782r377b1931],

1	Toxieol	NNP	O	Toxieol	_	0	SENT_170	[p5l354t1662r377b1772],
2	.	.	O	.	_	0	SENT_170	[p5l354t1662r377b1772],

1	1996.3	CD	NUMBER	1996.3	_	0	SENT_171	[p5l354t1562r378b1648],
2	62161-1	CD	NUMBER	62161-1	num	3	SENT_171	[p5l354t1401r377b1498],
3	83	CD	NUMBER	83	dep	1	SENT_171	[p5l354t1294r377b1332],
4	.	.	O	.	_	0	SENT_171	[p5l354t1294r377b1332],

1	Downloaded	VBN	O	download	_	0	SENT_172	[p5l354t1112r377b1283],
2	from	IN	O	from	_	0	SENT_172	[p5l354t1039r377b1103],
3	www	NN	O	www	prep_from	1	SENT_172	[p5l361t929r377b1030],
4	.	.	O	.	_	0	SENT_172	[p5l361t929r377b1030],

1	a1	NN	O	a1	nn	3	SENT_173	[p5l361t929r377b1030],
2	Madiso	NN	O	madiso	nn	3	SENT_173	[p5l387t1402r411b1501],
3	w.annualreviews.org	NN	O	w.annualreviews.org	_	0	SENT_173	[p5l356t3227r386b3499],
4	1	CD	NUMBER	1	num	5	SENT_173	[p5l389t3491r412b3499],
5	use	NN	O	use	dep	3	SENT_173	[p5l397t3438r413b3482],
6	only	RB	O	only	advmod	5	SENT_173	[p5l389t3364r420b3429],
7	.	.	O	.	_	0	SENT_173	[p5l389t3364r420b3429],

1	inualreviewsorg	NN	O	inualreviewsorg	nsubj	3	SENT_174	[p5l354t643r384b867],
2	e	SYM	O	e	dep	3	SENT_174	[p5l395t854r411b867],
3	only	RB	O	only	_	0	SENT_174	[p5l387t779r418b844],
4	.	.	O	.	_	0	SENT_174	[p5l387t779r418b844],

1	by	IN	O	by	dep	6	SENT_175	[p5l387t1925r418b1957],
2	University	NNP	ORGANIZATION	University	pobj	1	SENT_175	[p5l387t1776r418b1915],
3	of	IN	ORGANIZATION	of	_	0	SENT_175	[p5l387t1737r411b1766],
4	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	2	SENT_175	[p5l387t1590r411b1730],
5	-	:	O	-	_	0	SENT_175	[p5l401t1572r404b1580],
6	n	NN	O	n	_	0	SENT_175	[p5l395t1323r410b1339],
7	on	IN	O	on	_	0	SENT_175	[p5l395t1281r411b1313],
8	01/05/14	CD	DATE	01/05/14	prep_on	6	SENT_175	[p5l387t1147r411b1272],
9	.	.	O	.	_	0	SENT_175	[p5l387t1147r411b1272],

1	For	IN	O	for	dep	3	SENT_176	[p5l388t1090r411b1136],
2	personal	JJ	O	personal	pobj	1	SENT_176	[p5l387t969r418b1081],
3	us	PRP	O	we	_	0	SENT_176	[p5l395t931r411b960],

1	Annual	JJ	SET	annual	amod	2	SENT_177	[p5l444t50r565b79],
2	Reviews	NNS	O	review	_	0	SENT_177	[p5l577t50r718b88],
3	.	.	O	.	_	0	SENT_177	[p5l951t83r956b88],

1	www.annualrev1ews.org/aronlrne	NN	O	www.annualrev1ews.org/aronlrne	_	0	SENT_178	[p5l444t83r998b121],

1	P	NN	O	p	_	0	SENT_179	[p5l889t183r1229b211],
2	~	SYM	O	~	dep	3	SENT_179	[p5l889t183r1229b211],
3	GLYCOPROTElNS	NNPS	O	GLYCOPROTElNS	rcmod	1	SENT_179	[p5l889t183r1229b211],
4	AND	CC	O	and	cc	5	SENT_179	[p5l1240t184r1320b211],
5	DRUG	NN	O	drug	dep	1	SENT_179	[p5l1331t183r1437b211],
6	RESISTANCE	NN	O	resistance	dep	5	SENT_179	[p5l1446t184r1674b211],
7	167	CD	NUMBER	167	num	6	SENT_179	[p5l1748t184r1799b212],

1	tein	NN	O	tein	_	0	SENT_180	[p5l495t281r565b311],
2	.	.	O	.	_	0	SENT_180	[p5l495t281r565b311],

1	Several	JJ	O	several	amod	2	SENT_181	[p5l583t281r707b311],
2	aspects	NNS	O	aspect	nsubjpass	9	SENT_181	[p5l721t286r841b319],
3	of	IN	O	of	_	0	SENT_181	[p5l855t281r893b311],
4	drug	NN	O	drug	nn	5	SENT_181	[p5l903t281r979b320],
5	transport	NN	O	transport	prep_of	2	SENT_181	[p5l994t286r1142b319],
6	are	VBP	O	be	auxpass	9	SENT_181	[p5l1156t290r1205b311],
7	not	RB	O	not	neg	9	SENT_181	[p5l1220t286r1274b311],
8	fully	RB	O	fully	advmod	9	SENT_181	[p5l1288t282r1364b320],
9	explained	VBN	O	explain	_	0	SENT_181	[p5l1379t282r1541b320],
10	by	IN	O	by	_	0	SENT_181	[p5l1555t282r1596b320],
11	this	DT	O	this	det	12	SENT_181	[p5l1612t282r1670b312],
12	model	NN	O	model	agent	9	SENT_181	[p5l1686t282r1799b317],
13	,	,	O	,	_	0	SENT_181	[p5l1686t282r1799b317],
14	including	VBG	O	include	_	0	SENT_181	[p5l494t330r652b368],
15	the	DT	O	the	det	18	SENT_181	[p5l666t331r718b360],
16	broad	JJ	O	broad	amod	18	SENT_181	[p5l732t330r827b360],
17	substrate	NN	O	substrate	nn	18	SENT_181	[p5l842t330r988b360],
18	speciﬁcity	NN	O	speciﬁcity	prep_including	9	SENT_181	[p5l1004t330r1175b369],
19	of	IN	O	of	_	0	SENT_181	[p5l1192t330r1228b360],
20	the	DT	O	the	det	21	SENT_181	[p5l1242t330r1291b360],
21	molecule	NN	O	molecule	prep_of	18	SENT_181	[p5l1307t330r1457b360],
22	and	CC	O	and	_	0	SENT_181	[p5l1474t330r1532b360],
23	the	DT	O	the	det	24	SENT_181	[p5l1547t330r1598b360],
24	inability	NN	O	inability	conj_and	18	SENT_181	[p5l1613t330r1752b369],
25	to	TO	O	to	aux	26	SENT_181	[p5l1767t336r1798b361],
26	correlate	VB	O	correlate	infmod	24	SENT_181	[p5l494t379r641b409],
27	the	DT	O	the	det	29	SENT_181	[p5l653t380r704b409],
28	initial	JJ	O	initial	amod	29	SENT_181	[p5l718t379r814b409],
29	rate	NN	O	rate	dobj	26	SENT_181	[p5l827t384r890b409],
30	of	IN	O	of	_	0	SENT_181	[p5l902t378r941b408],
31	drug	NN	O	drug	nn	32	SENT_181	[p5l950t380r1026b417],
32	efflux	NN	O	efflux	prep_of	29	SENT_181	[p5l1039t379r1137b409],
33	with	IN	O	with	_	0	SENT_181	[p5l1152t379r1225b409],
34	the	DT	O	the	det	35	SENT_181	[p5l1238t379r1288b409],
35	P	NN	O	p	prep_with	26	SENT_181	[p5l1302t379r1549b418],
36	—	CD	NUMBER	—	num	38	SENT_181	[p5l1302t379r1549b418],
37	glycoprotein	NN	O	glycoprotein	nn	38	SENT_181	[p5l1302t379r1549b418],
38	concentration	NN	O	concentration	dep	35	SENT_181	[p5l1562t379r1798b409],
39	.	.	O	.	_	0	SENT_181	[p5l1562t379r1798b409],

1	To	TO	O	to	aux	2	SENT_182	[p5l494t428r541b457],
2	explain	VB	O	explain	purpcl	9	SENT_182	[p5l554t427r677b465],
3	such	JJ	O	such	amod	4	SENT_182	[p5l692t427r767b456],
4	discrepancies	NNS	O	discrepancy	dobj	2	SENT_182	[p5l780t427r1014b465],
5	,	,	O	,	_	0	SENT_182	[p5l780t427r1014b465],
6	Higgins	NNP	PERSON	Higgins	nsubj	9	SENT_182	[p5l1029t427r1158b465],
7	and	CC	O	and	_	0	SENT_182	[p5l1174t427r1233b456],
8	Gottesman	NNP	PERSON	Gottesman	nsubj	9	SENT_182	[p5l1247t427r1425b457],
9	hypothesized	VBD	O	hypothesize	_	0	SENT_182	[p5l1439t427r1659b466],
10	that	IN	O	that	complm	15	SENT_182	[p5l1674t428r1737b457],
11	the	DT	O	the	det	13	SENT_182	[p5l1750t428r1800b457],
12	Mdr	NNP	O	Mdr	nn	13	SENT_182	[p5l493t476r568b506],
13	transporter	NN	O	transporter	nsubj	15	SENT_182	[p5l577t481r757b515],
14	might	MD	O	might	aux	15	SENT_182	[p5l767t477r865b515],
15	function	VB	O	function	ccomp	9	SENT_182	[p5l874t476r1013b506],
16	as	IN	O	as	_	0	SENT_182	[p5l1024t485r1057b506],
17	a	DT	O	a	det	20	SENT_182	[p5l1068t485r1086b505],
18	“	NN	O	“	nn	20	SENT_182	[p5l1098t476r1323b515],
19	hydrophobic	JJ	O	hydrophobic	amod	20	SENT_182	[p5l1098t476r1323b515],
20	vacuum	NN	O	vacuum	prep_as	15	SENT_182	[p5l1336t485r1467b506],
21	cleaner	JJR	O	cleaner	amod	20	SENT_182	[p5l1477t477r1615b506],
22	”	CD	NUMBER	”	dobj	15	SENT_182	[p5l1477t477r1615b506],
23	by	IN	O	by	_	0	SENT_182	[p5l1627t477r1668b515],
24	removing	VBG	O	remove	prepc_by	22	SENT_182	[p5l1679t485r1798b506, p5l495t526r548b565],
25	drugs	NNS	O	drug	dobj	24	SENT_182	[p5l561t526r653b565],
26	from	IN	O	from	_	0	SENT_182	[p5l666t526r747b556],
27	the	DT	O	the	det	29	SENT_182	[p5l759t526r809b556],
28	plasma	NN	O	plasma	nn	29	SENT_182	[p5l822t526r940b565],
29	membrane	NN	O	membrane	prep_from	24	SENT_182	[p5l953t526r1128b557],
30	before	IN	O	before	mark	32	SENT_182	[p5l1141t526r1248b556],
31	they	PRP	O	they	nsubj	32	SENT_182	[p5l1260t526r1330b565],
32	reached	VBD	O	reach	advcl	24	SENT_182	[p5l1344t526r1474b557],
33	the	DT	O	the	det	35	SENT_182	[p5l1487t526r1537b556],
34	cytoplasm	NN	O	cytoplasm	nn	35	SENT_182	[p5l1550t526r1722b565],
35	(	NN	O	(	dobj	32	SENT_182	[p5l1736t526r1799b563],
36	49	CD	NUMBER	49	tmod	32	SENT_182	[p5l1736t526r1799b563],
37	,	,	O	,	_	0	SENT_182	[p5l1736t526r1799b563],
38	50	CD	NUMBER	50	num	39	SENT_182	[p5l496t575r559b613],
39	)	NN	O	)	appos	36	SENT_182	[p5l496t575r559b613],
40	.	.	O	.	_	0	SENT_182	[p5l496t575r559b613],

1	Under	IN	O	under	_	0	SENT_183	[p5l572t575r677b606],
2	this	DT	O	this	det	3	SENT_183	[p5l689t575r749b606],
3	model	NN	O	model	prep_under	14	SENT_183	[p5l761t576r874b611],
4	,	,	O	,	_	0	SENT_183	[p5l761t576r874b611],
5	the	DT	O	the	det	7	SENT_183	[p5l887t575r937b606],
6	primary	JJ	O	primary	amod	7	SENT_183	[p5l950t576r1081b615],
7	determinant	NN	O	determinant	nsubj	14	SENT_183	[p5l1094t575r1292b607],
8	of	IN	O	of	_	0	SENT_183	[p5l1304t575r1340b606],
9	substrate	JJ	O	substrate	amod	10	SENT_183	[p5l1351t575r1498b606],
10	specificity	NN	O	specificity	prep_of	7	SENT_183	[p5l1512t575r1683b615],
11	would	MD	O	would	aux	14	SENT_183	[p5l1696t576r1800b606],
12	be	VB	O	be	cop	14	SENT_183	[p5l494t626r535b656],
13	the	DT	O	the	det	14	SENT_183	[p5l550t625r601b656],
14	ability	NN	O	ability	_	0	SENT_183	[p5l617t625r723b665],
15	of	IN	O	of	_	0	SENT_183	[p5l740t625r778b656],
16	a	DT	O	a	det	17	SENT_183	[p5l792t634r810b656],
17	drug	NN	O	drug	prep_of	14	SENT_183	[p5l825t626r901b665],
18	to	TO	O	to	aux	19	SENT_183	[p5l917t630r950b655],
19	interact	VB	O	interact	infmod	17	SENT_183	[p5l966t626r1090b656],
20	with	IN	O	with	_	0	SENT_183	[p5l1108t626r1180b656],
21	the	DT	O	the	det	23	SENT_183	[p5l1197t626r1248b656],
22	lipid	NN	O	lipid	nn	23	SENT_183	[p5l1264t625r1339b665],
23	bilayer	NN	O	bilayer	prep_with	19	SENT_183	[p5l1355t626r1471b665],
24	and	CC	O	and	_	0	SENT_183	[p5l1488t626r1547b656],
25	the	DT	O	the	det	27	SENT_183	[p5l1563t625r1614b657],
26	secondary	JJ	O	secondary	amod	27	SENT_183	[p5l1632t626r1798b666],
27	determinant	NN	O	determinant	prep_with	19	SENT_183	[p5l495t675r703b710],
28	,	,	O	,	_	0	SENT_183	[p5l495t675r703b710],
29	its	PRP$	O	its	poss	30	SENT_183	[p5l717t675r754b705],
30	ability	NN	O	ability	nsubj	32	SENT_183	[p5l767t675r872b714],
31	to	TO	O	to	aux	32	SENT_183	[p5l884t680r915b705],
32	interact	VB	O	interact	xcomp	19	SENT_183	[p5l927t675r1052b705],
33	with	IN	O	with	_	0	SENT_183	[p5l1062t675r1136b705],
34	the	DT	O	the	det	36	SENT_183	[p5l1148t676r1197b705],
35	binding	NN	O	binding	nn	36	SENT_183	[p5l1210t675r1336b714],
36	site	NN	O	site	prep_with	32	SENT_183	[p5l1349t676r1405b705],
37	of	IN	O	of	_	0	SENT_183	[p5l1416t676r1454b706],
38	the	DT	O	the	det	39	SENT_183	[p5l1463t676r1513b706],
39	transporter	NN	O	transporter	prep_of	36	SENT_183	[p5l1524t680r1714b715],
40	.	.	O	.	_	0	SENT_183	[p5l1524t680r1714b715],

1	This	DT	O	this	nsubj	3	SENT_184	[p5l1727t676r1799b706],
2	is	VBZ	O	be	cop	3	SENT_184	[p5l496t725r523b756],
3	consistent	JJ	O	consistent	_	0	SENT_184	[p5l536t725r703b756],
4	with	IN	O	with	_	0	SENT_184	[p5l714t725r787b755],
5	the	DT	O	the	det	6	SENT_184	[p5l800t726r850b756],
6	observation	NN	O	observation	prep_with	3	SENT_184	[p5l862t725r1057b756],
7	that	IN	O	that	complm	14	SENT_184	[p5l1067t725r1130b756],
8	P	NN	O	p	nsubj	14	SENT_184	[p5l1142t725r1389b765],
9	—	CD	NUMBER	—	num	11	SENT_184	[p5l1142t725r1389b765],
10	glycoprotein	NN	O	glycoprotein	nn	11	SENT_184	[p5l1142t725r1389b765],
11	substrates	NNS	O	substrate	dep	8	SENT_184	[p5l1403t726r1564b756],
12	are	VBP	O	be	cop	14	SENT_184	[p5l1579t734r1628b756],
13	lipophilic	JJ	O	lipophilic	amod	14	SENT_184	[p5l1641t725r1800b764],
14	compounds	NNS	O	compound	ccomp	3	SENT_184	[p5l495t775r686b814],
15	and	CC	O	and	_	0	SENT_184	[p5l699t775r760b806],
16	that	IN	O	that	complm	36	SENT_184	[p5l771t775r834b806],
17	the	DT	O	the	det	19	SENT_184	[p5l846t775r897b806],
18	major	JJ	O	major	amod	19	SENT_184	[p5l909t776r1006b815],
19	determinant	NN	O	determinant	nsubj	36	SENT_184	[p5l1018t775r1217b806],
20	of	IN	O	of	_	0	SENT_184	[p5l1229t774r1266b806],
21	the	DT	O	the	det	22	SENT_184	[p5l1275t775r1324b806],
22	ability	NN	O	ability	prep_of	19	SENT_184	[p5l1339t775r1443b814],
23	of	IN	O	of	_	0	SENT_184	[p5l1456t775r1493b806],
24	a	DT	O	a	det	26	SENT_184	[p5l1503t784r1521b806],
25	given	VBN	O	give	amod	26	SENT_184	[p5l1533t775r1624b814],
26	substance	NN	O	substance	prep_of	22	SENT_184	[p5l1639t775r1800b806],
27	to	TO	O	to	aux	29	SENT_184	[p5l495t830r528b856],
28	be	VB	O	be	auxpass	29	SENT_184	[p5l538t825r578b856],
29	transported	VBN	O	transport	infmod	26	SENT_184	[p5l589t825r776b865],
30	is	VBZ	O	be	cop	36	SENT_184	[p5l788t825r815b856],
31	its	PRP$	O	its	poss	36	SENT_184	[p5l827t826r865b856],
32	relative	JJ	O	relative	amod	36	SENT_184	[p5l877t825r1002b857],
33	hydrophobicity	NN	O	hydrophobicity	nn	36	SENT_184	[p5l1012t825r1266b865],
34	(	NN	O	(	nn	36	SENT_184	[p5l1279t826r1354b863],
35	51	CD	NUMBER	51	num	36	SENT_184	[p5l1279t826r1354b863],
36	)	NN	O	)	conj_and	14	SENT_184	[p5l1279t826r1354b863],
37	.	.	O	.	_	0	SENT_184	[p5l1279t826r1354b863],

1	Transport	NN	O	transport	_	0	SENT_185	[p5l1368t826r1529b865],
2	kinetic	JJ	O	kinetic	amod	3	SENT_185	[p5l1541t825r1653b857],
3	discrepancies	NNS	O	discrepancy	dep	1	SENT_185	[p5l1667t826r1799b865, p5l496t937r599b968],

1	are	VBP	O	be	auxpass	2	SENT_186	[p5l612t946r663b968],
2	explained	VBN	O	explain	_	0	SENT_186	[p5l674t937r837b976],
3	in	IN	O	in	_	0	SENT_186	[p5l848t937r881b967],
4	this	DT	O	this	det	5	SENT_186	[p5l892t937r952b967],
5	model	NN	O	model	prep_in	2	SENT_186	[p5l965t937r1067b967],
6	by	IN	O	by	_	0	SENT_186	[p5l1079t937r1120b976],
7	the	DT	O	the	det	8	SENT_186	[p5l1135t937r1184b967],
8	observation	NN	O	observation	agent	2	SENT_186	[p5l1197t937r1390b967],
9	that	IN	O	that	complm	12	SENT_186	[p5l1402t937r1465b968],
10	drugs	NNS	O	drug	nsubj	19	SENT_186	[p5l1476t937r1567b976],
11	first	RB	ORDINAL	first	advmod	12	SENT_186	[p5l1581t937r1648b968],
12	partition	NN	O	partition	ccomp	2	SENT_186	[p5l1660t937r1800b976],
13	into	IN	O	into	_	0	SENT_186	[p5l496t988r561b1017],
14	the	DT	O	the	det	16	SENT_186	[p5l570t988r621b1017],
15	lipid	NN	O	lipid	nn	16	SENT_186	[p5l632t987r708b1027],
16	bilayer	NN	O	bilayer	prep_into	12	SENT_186	[p5l717t987r834b1026],
17	and	CC	O	and	_	0	SENT_186	[p5l844t988r904b1017],
18	then	RB	O	then	advmod	19	SENT_186	[p5l913t988r985b1017],
19	interact	VBP	O	interact	ccomp	2	SENT_186	[p5l995t981r1120b1017],
20	with	IN	O	with	_	0	SENT_186	[p5l1130t988r1203b1017],
21	the	DT	O	the	det	24	SENT_186	[p5l1213t988r1263b1017],
22	P	NN	O	p	nn	24	SENT_186	[p5l1274t987r1529b1026],
23	—	CD	NUMBER	—	num	24	SENT_186	[p5l1274t987r1529b1026],
24	glycoprotein	NN	O	glycoprotein	prep_with	19	SENT_186	[p5l1274t987r1529b1026],
25	.	.	O	.	_	0	SENT_186	[p5l1274t987r1529b1026],

1	The	DT	O	the	det	4	SENT_187	[p5l1540t986r1604b1018],
2	actual	JJ	O	actual	amod	4	SENT_187	[p5l1615t988r1714b1017],
3	drug	NN	O	drug	nn	4	SENT_187	[p5l1725t987r1800b1026],
4	concentration	NN	O	concentration	nsubj	16	SENT_187	[p5l495t1038r722b1068],
5	that	WDT	O	that	nsubjpass	8	SENT_187	[p5l739t1038r802b1068],
6	is	VBZ	O	be	auxpass	8	SENT_187	[p5l818t1038r844b1068],
7	“	RB	O	“	advmod	8	SENT_187	[p5l862t1038r972b1068],
8	seen	VBN	O	see	rcmod	4	SENT_187	[p5l862t1038r972b1068],
9	”	NN	O	”	dobj	8	SENT_187	[p5l862t1038r972b1068],
10	by	IN	O	by	_	0	SENT_187	[p5l988t1038r1030b1077],
11	the	DT	O	the	det	12	SENT_187	[p5l1047t1038r1097b1068],
12	transporter	NN	O	transporter	agent	8	SENT_187	[p5l1114t1042r1293b1077],
13	would	MD	O	would	dep	12	SENT_187	[p5l1310t1038r1413b1068],
14	not	RB	O	not	neg	13	SENT_187	[p5l1431t1043r1482b1068],
15	necessarily	RB	O	necessarily	advmod	16	SENT_187	[p5l1500t1038r1683b1076],
16	correspond	VBP	O	correspond	_	0	SENT_187	[p5l1701t1047r1799b1068, p5l497t1088r595b1128],
17	to	TO	O	to	_	0	SENT_187	[p5l610t1092r642b1118],
18	the	DT	O	the	det	19	SENT_187	[p5l657t1089r708b1119],
19	concentration	NN	O	concentration	prep_to	16	SENT_187	[p5l723t1088r950b1119],
20	of	IN	O	of	_	0	SENT_187	[p5l965t1088r1003b1119],
21	drug	NN	O	drug	prep_of	19	SENT_187	[p5l1014t1088r1090b1127],
22	being	VBG	O	be	auxpass	23	SENT_187	[p5l1105t1088r1197b1127],
23	used	VBN	O	use	xcomp	16	SENT_187	[p5l1213t1088r1288b1118],
24	in	IN	O	in	_	0	SENT_187	[p5l1303t1088r1335b1118],
25	the	DT	O	the	det	26	SENT_187	[p5l1350t1088r1399b1118],
26	experiment	NN	O	experiment	prep_in	23	SENT_187	[p5l1415t1088r1612b1127],
27	,	,	O	,	_	0	SENT_187	[p5l1415t1088r1612b1127],
28	but	CC	O	but	_	0	SENT_187	[p5l1628t1088r1681b1118],
29	would	MD	O	would	aux	30	SENT_187	[p5l1697t1088r1800b1118],
30	depend	VB	O	depend	conj_but	16	SENT_187	[p5l496t1139r616b1180],
31	on	IN	O	on	_	0	SENT_187	[p5l630t1148r671b1171],
32	the	DT	O	the	det	33	SENT_187	[p5l684t1140r734b1171],
33	ability	NN	O	ability	prep_on	30	SENT_187	[p5l749t1139r854b1180],
34	of	IN	O	of	_	0	SENT_187	[p5l867t1139r904b1171],
35	the	DT	O	the	det	36	SENT_187	[p5l915t1139r965b1171],
36	drug	NN	O	drug	prep_of	33	SENT_187	[p5l978t1140r1054b1180],
37	to	TO	O	to	_	0	SENT_187	[p5l1067t1144r1099b1170],
38	partition	NN	O	partition	prep_to	30	SENT_187	[p5l1113t1139r1253b1180],
39	into	IN	O	into	_	0	SENT_187	[p5l1267t1139r1330b1171],
40	the	DT	O	the	det	42	SENT_187	[p5l1343t1140r1393b1170],
41	lipid	NN	O	lipid	nn	42	SENT_187	[p5l1407t1139r1482b1180],
42	bilayer	NN	O	bilayer	prep_into	38	SENT_187	[p5l1496t1139r1621b1179],
43	,	,	O	,	_	0	SENT_187	[p5l1496t1139r1621b1179],
44	as	RB	O	as	_	0	SENT_187	[p5l1636t1149r1668b1171],
45	well	RB	O	well	_	0	SENT_187	[p5l1684t1139r1754b1171],
46	as	IN	O	as	_	0	SENT_187	[p5l1768t1149r1800b1171],
47	on	IN	O	on	_	0	SENT_187	[p5l496t1200r538b1222],
48	the	DT	O	the	det	50	SENT_187	[p5l550t1191r601b1222],
49	lipid	NN	O	lipid	nn	50	SENT_187	[p5l614t1191r690b1231],
50	composition	NN	O	composition	prep_on	38	SENT_187	[p5l704t1191r909b1230],
51	of	IN	O	of	_	0	SENT_187	[p5l922t1190r959b1221],
52	the	DT	O	the	det	53	SENT_187	[p5l970t1191r1020b1222],
53	membrane	NN	O	membrane	prep_of	50	SENT_187	[p5l1033t1191r1216b1222],
54	.	.	O	.	_	0	SENT_187	[p5l1033t1191r1216b1222],

1	Progress	NNP	O	Progress	nsubjpass	4	SENT_188	[p5l538t1242r680b1279],
2	has	VBZ	O	have	aux	4	SENT_188	[p5l693t1242r747b1271],
3	been	VBN	O	be	auxpass	4	SENT_188	[p5l760t1242r838b1272],
4	made	VBN	O	make	_	0	SENT_188	[p5l851t1242r940b1271],
5	in	IN	O	in	_	0	SENT_188	[p5l952t1241r985b1271],
6	identifying	VBG	O	identify	prepc_in	4	SENT_188	[p5l996t1241r1178b1280],
7	the	DT	O	the	det	10	SENT_188	[p5l1191t1242r1241b1271],
8	drug	NN	O	drug	nn	10	SENT_188	[p5l1254t1241r1328b1280],
9	binding	NN	O	binding	nn	10	SENT_188	[p5l1340t1241r1467b1280],
10	site	NN	O	site	dobj	6	SENT_188	[p5l1480t1242r1535b1271],
11	on	IN	O	on	_	0	SENT_188	[p5l1548t1250r1589b1271],
12	P	NN	O	p	nn	14	SENT_188	[p5l1602t1242r1800b1280, p5l496t1291r560b1321],
13	—	CD	NUMBER	—	num	14	SENT_188	[p5l1602t1242r1800b1280, p5l496t1291r560b1321],
14	glycoprotein	NN	O	glycoprotein	prep_on	10	SENT_188	[p5l1602t1242r1800b1280, p5l496t1291r560b1321],
15	by	IN	O	by	_	0	SENT_188	[p5l575t1291r616b1329],
16	examining	VBG	O	examine	prepc_by	6	SENT_188	[p5l632t1291r808b1329],
17	proteolytic	JJ	O	proteolytic	amod	18	SENT_188	[p5l823t1291r1002b1329],
18	fragments	NNS	O	fragment	dobj	16	SENT_188	[p5l1019t1291r1184b1329],
19	of	IN	O	of	_	0	SENT_188	[p5l1201t1291r1238b1320],
20	azidopine	NN	O	azidopine	nn	23	SENT_188	[p5l1252t1291r1412b1329],
21	or	CC	O	or	_	0	SENT_188	[p5l1428t1301r1462b1321],
22	azidoprazosin	NN	O	azidoprazosin	nn	23	SENT_188	[p5l1478t1291r1709b1329],
23	photoafﬁnity	NN	O	photoafﬁnity	prep_of	18	SENT_188	[p5l1725t1292r1800b1329, p5l496t1402r650b1440],

1	labeled	VBN	O	label	_	0	SENT_189	[p5l672t1403r792b1432],
2	human	JJ	O	human	amod	4	SENT_189	[p5l813t1404r926b1432],
3	MDR	NN	O	mdr	nn	4	SENT_189	[p5l947t1403r1053b1432],
4	]	NN	O	]	dobj	1	SENT_189	[p5l947t1403r1053b1432],
5	and	CC	O	and	_	0	SENT_189	[p5l1079t1403r1139b1432],
6	murine	JJ	O	murine	amod	7	SENT_189	[p5l1161t1403r1278b1432],
7	mdrI	NN	O	mdrus	conj_and	4	SENT_189	[p5l1299t1402r1383b1432],
8	(	CD	NUMBER	(	number	9	SENT_189	[p5l1408t1403r1471b1439],
9	49	CD	NUMBER	49	dep	4	SENT_189	[p5l1408t1403r1471b1439],
10	,	,	O	,	_	0	SENT_189	[p5l1408t1403r1471b1439],
11	52	CD	NUMBER	52	num	12	SENT_189	[p5l1495t1403r1558b1439],
12	)	NN	O	)	appos	4	SENT_189	[p5l1495t1403r1558b1439],
13	.	.	O	.	_	0	SENT_189	[p5l1495t1403r1558b1439],

1	Photoafﬁnity	NN	O	photoafﬁnity	nn	2	SENT_190	[p5l1581t1402r1800b1441],
2	binding	NN	O	binding	_	0	SENT_190	[p5l496t1452r623b1491],
3	has	VBZ	O	have	aux	5	SENT_190	[p5l641t1453r695b1483],
4	been	VBN	O	be	cop	5	SENT_190	[p5l712t1452r791b1482],
5	localized	JJ	O	localized	dep	2	SENT_190	[p5l808t1452r959b1483],
6	to	TO	O	to	_	0	SENT_190	[p5l976t1457r1007b1483],
7	two	CD	NUMBER	two	num	8	SENT_190	[p5l1025t1457r1086b1482],
8	regions	NNS	O	region	prep_to	5	SENT_190	[p5l1103t1452r1234b1491],
9	:	:	O	:	_	0	SENT_190	[p5l1103t1452r1234b1491],
10	(	CD	NUMBER	(	dep	2	SENT_190	[p5l1255t1452r1301b1489],
11	a	DT	O	a	det	12	SENT_190	[p5l1255t1452r1301b1489],
12	)	NN	O	)	dep	10	SENT_190	[p5l1255t1452r1301b1489],
13	the	DT	O	the	det	15	SENT_190	[p5l1319t1452r1368b1483],
14	transmembrane	NN	O	transmembrane	nn	15	SENT_190	[p5l1386t1452r1643b1483],
15	domains	NNS	O	domain	dep	10	SENT_190	[p5l1661t1452r1800b1483],

1	(	NN	O	(	nn	2	SENT_191	[p5l498t1564r587b1600],
2	TM	NN	MISC	tm	nsubj	17	SENT_191	[p5l498t1564r587b1600],
3	)	CD	NUMBER	)	number	4	SENT_191	[p5l498t1564r587b1600],
4	5	CD	NUMBER	5	dep	2	SENT_191	[p5l599t1563r617b1593],
5	and	CC	O	and	_	0	SENT_191	[p5l632t1563r692b1593],
6	6	CD	NUMBER	6	nsubj	17	SENT_191	[p5l703t1563r723b1593],
7	or	CC	O	or	_	0	SENT_191	[p5l735t1572r771b1592],
8	the	DT	O	the	det	10	SENT_191	[p5l782t1563r833b1593],
9	cytoplasmic	JJ	O	cytoplasmic	amod	10	SENT_191	[p5l844t1563r1045b1601],
10	domain	NN	O	domain	conj_and	2	SENT_191	[p5l1057t1563r1180b1592],
11	immediately	RB	O	immediately	advmod	17	SENT_191	[p5l1194t1563r1400b1601],
12	following	VBG	O	follow	_	0	SENT_191	[p5l1414t1562r1574b1601],
13	TM6	NN	O	tm6	nn	16	SENT_191	[p5l1586t1563r1670b1593],
14	and	CC	O	and	_	0	SENT_191	[p5l1683t1563r1742b1592],
15	(	NN	O	(	nn	16	SENT_191	[p5l1755t1563r1800b1599],
16	b	NN	O	b	prep_following	17	SENT_191	[p5l1755t1563r1800b1599],
17	)	VBD	O	)	_	0	SENT_191	[p5l1755t1563r1800b1599],
18	a	DT	O	a	det	19	SENT_191	[p5l497t1623r516b1644],
19	region	NN	O	region	dobj	17	SENT_191	[p5l535t1613r641b1652],
20	within	IN	O	within	_	0	SENT_191	[p5l663t1613r769b1643],
21	the	DT	O	the	det	23	SENT_191	[p5l790t1614r840b1643],
22	transmembrane	JJ	O	transmembrane	amod	23	SENT_191	[p5l861t1613r1118b1643],
23	domain	NN	O	domain	prep_within	17	SENT_191	[p5l1140t1613r1262b1643],
24	12	CD	NUMBER	12	dep	23	SENT_191	[p5l1289t1613r1324b1643],
25	or	CC	O	or	_	0	SENT_191	[p5l1347t1622r1381b1643],
26	the	DT	O	the	det	28	SENT_191	[p5l1401t1613r1452b1643],
27	cytoplasmic	JJ	O	cytoplasmic	amod	28	SENT_191	[p5l1473t1613r1673b1652],
28	region	NN	O	region	prep_within	17	SENT_191	[p5l1695t1613r1801b1651],
29	immediately	RB	O	immediately	advmod	28	SENT_191	[p5l497t1663r705b1702],
30	following	VBG	O	follow	_	0	SENT_191	[p5l716t1663r878b1702],
31	TM12	NN	O	tm12	prep_following	28	SENT_191	[p5l888t1663r993b1693],
32	(	CD	NUMBER	(	num	31	SENT_191	[p5l1004t1663r1080b1700],
33	49	CD	NUMBER	49	num	34	SENT_191	[p5l1004t1663r1080b1700],
34	)	NN	O	)	dep	31	SENT_191	[p5l1004t1663r1080b1700],
35	.	.	O	.	_	0	SENT_191	[p5l1004t1663r1080b1700],

1	This	DT	O	this	det	3	SENT_192	[p5l1093t1663r1166b1693],
2	labeling	NN	O	labeling	nn	3	SENT_192	[p5l1180t1662r1311b1702],
3	pattern	NN	O	pattern	nsubj	5	SENT_192	[p5l1323t1668r1438b1701],
4	is	VBZ	O	be	cop	5	SENT_192	[p5l1450t1663r1476b1693],
5	consistent	JJ	O	consistent	_	0	SENT_192	[p5l1488t1662r1655b1693],
6	with	IN	O	with	_	0	SENT_192	[p5l1667t1662r1740b1692],
7	the	DT	O	the	det	8	SENT_192	[p5l1752t1664r1802b1693],
8	presence	NN	O	presence	prep_with	5	SENT_192	[p5l497t1723r643b1755],
9	of	IN	O	of	_	0	SENT_192	[p5l659t1714r697b1745],
10	two	CD	NUMBER	two	num	13	SENT_192	[p5l709t1719r772b1745],
11	different	JJ	O	different	amod	13	SENT_192	[p5l788t1714r932b1745],
12	drug-binding	JJ	O	drug-binding	amod	13	SENT_192	[p5l947t1713r1163b1754],
13	sites	NNS	O	site	prep_of	8	SENT_192	[p5l1181t1713r1253b1745],
14	or	CC	O	or	_	0	SENT_192	[p5l1270t1723r1304b1745],
15	the	DT	O	the	det	16	SENT_192	[p5l1321t1714r1370b1745],
16	presence	NN	O	presence	prep_with	5	SENT_192	[p5l1387t1723r1532b1753],
17	of	IN	O	of	_	0	SENT_192	[p5l1549t1713r1586b1744],
18	one	CD	NUMBER	one	num	20	SENT_192	[p5l1599t1723r1658b1745],
19	binding	NN	O	binding	nn	20	SENT_192	[p5l1674t1713r1801b1754],
20	site	NN	O	site	prep_of	16	SENT_192	[p5l497t1767r554b1797],
21	that	WDT	O	that	nsubjpass	23	SENT_192	[p5l567t1766r630b1797],
22	is	VBZ	O	be	auxpass	23	SENT_192	[p5l642t1767r670b1797],
23	formed	VBN	O	form	rcmod	20	SENT_192	[p5l684t1766r804b1797],
24	by	IN	O	by	_	0	SENT_192	[p5l816t1767r857b1806],
25	two	CD	NUMBER	two	num	27	SENT_192	[p5l871t1771r934b1796],
26	homologous	JJ	O	homologous	amod	27	SENT_192	[p5l945t1766r1150b1805],
27	halves	NNS	O	half	agent	23	SENT_192	[p5l1164t1766r1269b1796],
28	of	IN	O	of	_	0	SENT_192	[p5l1284t1766r1320b1797],
29	the	DT	O	the	det	30	SENT_192	[p5l1331t1766r1381b1796],
30	molecule	NN	O	molecule	prep_of	27	SENT_192	[p5l1396t1766r1556b1797],
31	.	.	O	.	_	0	SENT_192	[p5l1396t1766r1556b1797],

1	Using	VBG	O	use	partmod	12	SENT_193	[p5l540t1816r638b1855],
2	nonfunctional	JJ	O	nonfunctional	amod	4	SENT_193	[p5l651t1816r882b1847],
3	replacement	NN	O	replacement	nn	4	SENT_193	[p5l895t1816r1098b1855],
4	regions	NNS	O	region	dobj	1	SENT_193	[p5l1111t1817r1242b1856],
5	,	,	O	,	_	0	SENT_193	[p5l1111t1817r1242b1856],
6	Zhang	NNP	PERSON	Zhang	nsubj	12	SENT_193	[p5l1255t1817r1360b1855],
7	et	FW	O	et	dep	6	SENT_193	[p5l1374t1821r1404b1846],
8	al	FW	O	al	nn	11	SENT_193	[p5l1416t1817r1445b1847],
9	(	FW	O	(	dep	11	SENT_193	[p5l1459t1817r1525b1854],
10	53	CD	NUMBER	53	num	11	SENT_193	[p5l1459t1817r1525b1854],
11	)	NN	O	)	advmod	12	SENT_193	[p5l1459t1817r1525b1854],
12	determined	VBD	O	determine	_	0	SENT_193	[p5l1540t1816r1727b1847],
13	that	IN	O	that	complm	15	SENT_193	[p5l1741t1817r1803b1847],
14	replacements	NNS	O	replacement	nsubj	15	SENT_193	[p5l497t1867r717b1906],
15	limited	VBN	O	limit	ccomp	12	SENT_193	[p5l731t1866r849b1897],
16	to	TO	O	to	_	0	SENT_193	[p5l861t1872r893b1897],
17	the	DT	O	the	det	26	SENT_193	[p5l906t1867r956b1897],
18	last	JJ	O	last	amod	26	SENT_193	[p5l971t1867r1029b1897],
19	transmembrane	JJ	O	transmembrane	amod	26	SENT_193	[p5l1041t1867r1296b1897],
20	region	NN	O	region	dep	19	SENT_193	[p5l1309t1867r1416b1906],
21	(	CD	NUMBER	(	num	20	SENT_193	[p5l1430t1867r1560b1904],
22	TM12	NN	O	tm12	nn	26	SENT_193	[p5l1430t1867r1560b1904],
23	)	NN	O	)	nn	26	SENT_193	[p5l1430t1867r1560b1904],
24	markedly	RB	O	markedly	advmod	25	SENT_193	[p5l1574t1867r1730b1906],
25	impaired	JJ	O	impaired	amod	26	SENT_193	[p5l1746t1868r1801b1897, p5l497t1917r601b1956],
26	resistance	NN	O	resistance	prep_to	15	SENT_193	[p5l618t1917r783b1947],
27	to	TO	O	to	_	0	SENT_193	[p5l799t1922r832b1947],
28	actinomycin	NN	O	actinomycin	nn	29	SENT_193	[p5l850t1917r1054b1955],
29	D	NN	O	d	prep_to	26	SENT_193	[p5l1072t1917r1111b1951],
30	,	,	O	,	_	0	SENT_193	[p5l1072t1917r1111b1951],
31	vincristine	NN	O	vincristine	prep_to	26	SENT_193	[p5l1131t1917r1313b1952],
32	,	,	O	,	_	0	SENT_193	[p5l1131t1917r1313b1952],
33	and	CC	O	and	_	0	SENT_193	[p5l1332t1917r1392b1947],
34	doxorubicin	NN	O	doxorubicin	prep_to	26	SENT_193	[p5l1409t1917r1610b1948],
35	but	CC	O	but	_	0	SENT_193	[p5l1628t1918r1681b1947],
36	not	RB	O	not	_	0	SENT_193	[p5l1700t1922r1752b1948],
37	to	TO	O	to	_	0	SENT_193	[p5l1770t1922r1801b1947],
38	colchicine	NN	O	colchicine	conj_negcc	26	SENT_193	[p5l497t1966r678b1996],
39	.	.	O	.	_	0	SENT_193	[p5l497t1966r678b1996],

1	In	IN	O	in	_	0	SENT_194	[p5l689t1967r723b1996],
2	contrast	NN	O	contrast	prep_in	13	SENT_194	[p5l732t1971r872b2001],
3	,	,	O	,	_	0	SENT_194	[p5l732t1971r872b2001],
4	replacement	NN	O	replacement	nsubj	13	SENT_194	[p5l884t1966r1087b2004],
5	of	IN	O	of	_	0	SENT_194	[p5l1097t1967r1134b1996],
6	the	DT	O	the	det	8	SENT_194	[p5l1141t1967r1191b1996],
7	transmembrane	NN	O	transmembrane	nn	8	SENT_194	[p5l1200t1967r1456b1997],
8	loop	NN	O	loop	prep_of	4	SENT_194	[p5l1466t1967r1539b2005],
9	between	IN	O	between	_	0	SENT_194	[p5l1549t1966r1688b1997],
10	TM11	NN	O	tm11	prep_between	8	SENT_194	[p5l1698t1967r1797b1997],
11	and	CC	O	and	_	0	SENT_194	[p5l498t2016r558b2046],
12	TM12	NN	O	tm12	conj_and	10	SENT_194	[p5l574t2017r678b2046],
13	appeared	VBD	O	appear	_	0	SENT_194	[p5l695t2017r846b2054],
14	to	TO	O	to	aux	15	SENT_194	[p5l862t2021r894b2046],
15	create	VB	O	create	xcomp	13	SENT_194	[p5l910t2022r1010b2046],
16	a	DT	O	a	det	20	SENT_194	[p5l1027t2025r1045b2046],
17	more	RBR	O	more	advmod	18	SENT_194	[p5l1061t2025r1146b2046],
18	efficient	JJ	O	efficient	amod	20	SENT_194	[p5l1164t2016r1301b2046],
19	drug	NN	O	drug	nn	20	SENT_194	[p5l1318t2017r1393b2055],
20	pump	NN	O	pump	dobj	15	SENT_194	[p5l1410t2025r1504b2055],
21	for	IN	O	for	_	0	SENT_194	[p5l1521t2017r1570b2046],
22	actinomycin	NN	O	actinomycin	prep_for	15	SENT_194	[p5l1587t2017r1801b2054],
23	,	,	O	,	_	0	SENT_194	[p5l1587t2017r1801b2054],
24	colchicine	NN	O	colchicine	prep_for	15	SENT_194	[p5l497t2066r678b2102],
25	,	,	O	,	_	0	SENT_194	[p5l497t2066r678b2102],
26	and	CC	O	and	_	0	SENT_194	[p5l692t2067r752b2096],
27	doxorubicin	NN	O	doxorubicin	prep_for	15	SENT_194	[p5l766t2066r965b2097],
28	but	CC	O	but	_	0	SENT_194	[p5l978t2067r1032b2097],
29	not	RB	O	not	_	0	SENT_194	[p5l1046t2071r1098b2096],
30	for	IN	O	for	_	0	SENT_194	[p5l1111t2067r1160b2096],
31	vincristine	NN	O	vincristine	conj_negcc	22	SENT_194	[p5l1173t2066r1355b2097],
32	.	.	O	.	_	0	SENT_194	[p5l1173t2066r1355b2097],

1	Expression	NN	O	expression	nsubj	19	SENT_195	[p5l540t2115r724b2153],
2	of	IN	O	of	_	0	SENT_195	[p5l739t2115r776b2145],
3	cDNAs	NNS	O	cdna	prep_of	1	SENT_195	[p5l787t2116r912b2145],
4	encoding	VBG	O	encode	partmod	3	SENT_195	[p5l926t2115r1078b2154],
5	the	DT	O	the	det	9	SENT_195	[p5l1093t2115r1143b2145],
6	amino	NN	O	amino	nn	9	SENT_195	[p5l1159t2115r1262b2145],
7	or	CC	O	or	_	0	SENT_195	[p5l1277t2125r1310b2145],
8	carboxy	NN	O	carboxy	nn	9	SENT_195	[p5l1324t2115r1610b2154],
9	—	NN	O	—	nsubj	12	SENT_195	[p5l1324t2115r1610b2154],
10	terrninal	JJ	O	terrninal	amod	12	SENT_195	[p5l1324t2115r1610b2154],
11	half	NN	O	half	nn	12	SENT_195	[p5l1626t2115r1693b2145],
12	molecules	NNS	O	molecule	xcomp	4	SENT_195	[p5l1706t2116r1801b2146, p5l498t2165r583b2196],
13	of	IN	O	of	_	0	SENT_195	[p5l595t2164r632b2195],
14	human	JJ	O	human	amod	15	SENT_195	[p5l640t2165r754b2195],
15	MDRI	NN	ORGANIZATION	mdrus	prep_of	12	SENT_195	[p5l765t2166r872b2196],
16	in	IN	O	in	_	0	SENT_195	[p5l888t2165r920b2195],
17	Sf9	NN	O	sf9	nn	18	SENT_195	[p5l932t2165r990b2196],
18	cells	NNS	O	cell	prep_in	15	SENT_195	[p5l1001t2165r1076b2195],
19	revealed	VBD	O	reveal	_	0	SENT_195	[p5l1089t2165r1230b2196],
20	that	IN	O	that	complm	24	SENT_195	[p5l1242t2165r1304b2196],
21	each	DT	O	each	det	23	SENT_195	[p5l1316t2165r1391b2196],
22	half	NN	O	half	nn	23	SENT_195	[p5l1404t2165r1470b2196],
23	molecule	NN	O	molecule	nsubj	24	SENT_195	[p5l1481t2165r1632b2196],
24	had	VBD	O	have	ccomp	19	SENT_195	[p5l1644t2165r1706b2195],
25	basal	JJ	O	basal	amod	27	SENT_195	[p5l1717t2165r1803b2196],
26	ATPase	NN	O	atpase	nn	27	SENT_195	[p5l498t2216r630b2246],
27	activity	NN	O	activity	dobj	24	SENT_195	[p5l650t2216r775b2255],
28	(	CD	NUMBER	(	number	29	SENT_195	[p5l796t2216r872b2253],
29	54	CD	NUMBER	54	num	30	SENT_195	[p5l796t2216r872b2253],
30	)	NN	O	)	dep	27	SENT_195	[p5l796t2216r872b2253],
31	.	.	O	.	_	0	SENT_195	[p5l796t2216r872b2253],

1	Drug	NN	O	drug	nn	2	SENT_196	[p5l894t2216r1166b2255],
2	—	NN	O	—	nsubj	3	SENT_196	[p5l894t2216r1166b2255],
3	stimulated	VBD	O	stimulate	_	0	SENT_196	[p5l894t2216r1166b2255],
4	ATPase	NN	MISC	atpase	nn	5	SENT_196	[p5l1187t2216r1317b2247],
5	activity	NN	O	activity	nsubj	11	SENT_196	[p5l1338t2216r1471b2255],
6	,	,	O	,	_	0	SENT_196	[p5l1338t2216r1471b2255],
7	however	RB	O	however	advmod	11	SENT_196	[p5l1492t2216r1645b2252],
8	,	,	O	,	_	0	SENT_196	[p5l1492t2216r1645b2252],
9	was	VBD	O	be	cop	11	SENT_196	[p5l1666t2225r1730b2246],
10	not	RB	O	not	neg	11	SENT_196	[p5l1751t2221r1804b2247],
11	present	JJ	DATE	present	ccomp	3	SENT_196	[p5l498t2269r618b2304],
12	until	IN	O	until	mark	19	SENT_196	[p5l631t2265r706b2295],
13	both	DT	O	both	det	14	SENT_196	[p5l720t2265r795b2295],
14	halves	NNS	O	half	nsubjpass	19	SENT_196	[p5l808t2266r914b2295],
15	of	IN	O	of	_	0	SENT_196	[p5l927t2265r964b2295],
16	the	DT	O	the	det	17	SENT_196	[p5l975t2265r1025b2295],
17	molecule	NN	O	molecule	prep_of	14	SENT_196	[p5l1038t2265r1190b2295],
18	were	VBD	O	be	auxpass	19	SENT_196	[p5l1204t2274r1284b2296],
19	expressed	VBN	O	express	advcl	11	SENT_196	[p5l1297t2266r1462b2304],
20	together	RB	O	together	advmod	19	SENT_196	[p5l1475t2265r1619b2304],
21	.	.	O	.	_	0	SENT_196	[p5l1475t2265r1619b2304],

1	Point	NN	O	point	nn	2	SENT_197	[p5l1635t2265r1723b2295],
2	mutations	NNS	O	mutation	nsubj	26	SENT_197	[p5l1736t2275r1801b2295, p5l498t2314r609b2344],
3	in	IN	O	in	_	0	SENT_197	[p5l623t2314r655b2344],
4	either	DT	O	either	prep_in	2	SENT_197	[p5l670t2315r766b2344],
5	of	IN	O	of	_	0	SENT_197	[p5l780t2315r817b2345],
6	the	DT	O	the	det	7	SENT_197	[p5l828t2315r879b2345],
7	two	CD	NUMBER	two	prep_of	4	SENT_197	[p5l894t2319r956b2344],
8	conserved	VBN	O	conserve	partmod	2	SENT_197	[p5l970t2315r1139b2345],
9	glycine	NN	O	glycine	nn	12	SENT_197	[p5l1154t2314r1276b2353],
10	and	CC	O	and	_	0	SENT_197	[p5l1291t2315r1349b2345],
11	valine	NN	O	valine	nn	12	SENT_197	[p5l1365t2315r1466b2345],
12	residues	NNS	O	residue	dobj	8	SENT_197	[p5l1481t2315r1615b2345],
13	within	IN	O	within	_	0	SENT_197	[p5l1632t2314r1737b2345],
14	the	DT	O	the	det	16	SENT_197	[p5l1752t2315r1803b2345],
15	A	NN	O	a	nn	16	SENT_197	[p5l499t2364r529b2394],
16	fold	NN	O	fold	prep_within	8	SENT_197	[p5l543t2363r609b2394],
17	of	IN	O	of	_	0	SENT_197	[p5l624t2364r661b2394],
18	the	DT	O	the	det	21	SENT_197	[p5l672t2364r724b2394],
19	Walker	NNP	O	Walker	nn	21	SENT_197	[p5l737t2364r861b2394],
20	consensus	NN	O	consensus	nn	21	SENT_197	[p5l874t2373r1042b2394],
21	sequences	NNS	O	sequence	prep_of	16	SENT_197	[p5l1057t2373r1225b2403],
22	in	IN	O	in	_	0	SENT_197	[p5l1241t2363r1272b2394],
23	the	DT	O	the	det	25	SENT_197	[p5l1286t2364r1336b2394],
24	mdrl	NN	O	mdrl	nn	25	SENT_197	[p5l1351t2363r1435b2394],
25	gene	NN	O	gene	prep_in	8	SENT_197	[p5l1454t2373r1531b2403],
26	resulted	VBD	O	result	_	0	SENT_197	[p5l1547t2364r1678b2395],
27	in	IN	O	in	_	0	SENT_197	[p5l1694t2364r1724b2394],
28	loss	NN	O	loss	prep_in	26	SENT_197	[p5l1740t2364r1802b2395],
29	of	IN	O	of	_	0	SENT_197	[p5l498t2412r536b2442],
30	biological	JJ	O	biological	amod	31	SENT_197	[p5l543t2412r709b2451],
31	function	NN	O	function	prep_of	28	SENT_197	[p5l720t2412r858b2443],
32	despite	IN	O	despite	_	0	SENT_197	[p5l868t2412r986b2450],
33	persistent	JJ	O	persistent	amod	34	SENT_197	[p5l996t2412r1156b2451],
34	binding	NN	O	binding	prep_despite	26	SENT_197	[p5l1165t2412r1291b2452],
35	of	IN	O	of	_	0	SENT_197	[p5l1303t2413r1340b2442],
36	azido	NN	O	azido	nn	37	SENT_197	[p5l1348t2413r1437b2443],
37	ATP	NN	O	atp	prep_of	34	SENT_197	[p5l1448t2413r1527b2442],
38	(	CD	NUMBER	(	number	39	SENT_197	[p5l1538t2413r1614b2449],
39	55	CD	NUMBER	55	num	40	SENT_197	[p5l1538t2413r1614b2449],
40	)	NN	O	)	dep	26	SENT_197	[p5l1538t2413r1614b2449],
41	.	.	O	.	_	0	SENT_197	[p5l1538t2413r1614b2449],

1	This	DT	O	this	det	2	SENT_198	[p5l1626t2413r1699b2442],
2	result	NN	O	result	nsubj	3	SENT_198	[p5l1711t2413r1803b2443],
3	agrees	VBZ	O	agree	_	0	SENT_198	[p5l499t2471r604b2500],
4	with	IN	O	with	_	0	SENT_198	[p5l619t2462r692b2492],
5	vesicle	NN	O	vesicle	nn	6	SENT_198	[p5l708t2462r823b2492],
6	studies	NNS	O	study	prep_with	3	SENT_198	[p5l838t2462r951b2492],
7	in	IN	O	in	_	0	SENT_198	[p5l967t2462r998b2491],
8	which	WDT	O	which	rel	16	SENT_198	[p5l1013t2461r1114b2491],
9	ATP	NN	O	atp	nn	10	SENT_198	[p5l1129t2462r1206b2491],
10	hydrolysis	NN	O	hydrolysis	nsubj	16	SENT_198	[p5l1220t2462r1392b2500],
11	and	CC	O	and	_	0	SENT_198	[p5l1407t2463r1467b2492],
12	not	RB	O	not	neg	13	SENT_198	[p5l1482t2466r1535b2492],
13	simply	RB	O	simply	conj_and	10	SENT_198	[p5l1550t2461r1661b2500],
14	binding	VBG	O	bind	amod	13	SENT_198	[p5l1675t2462r1802b2501],
15	was	VBD	O	be	cop	16	SENT_198	[p5l499t2520r564b2541],
16	necessary	JJ	O	necessary	rcmod	6	SENT_198	[p5l580t2520r742b2550],
17	for	IN	O	for	_	0	SENT_198	[p5l759t2511r809b2541],
18	P	NN	O	p	nn	21	SENT_198	[p5l824t2511r1071b2550],
19	—	CD	NUMBER	—	num	21	SENT_198	[p5l824t2511r1071b2550],
20	glycoprotein	NN	O	glycoprotein	nn	21	SENT_198	[p5l824t2511r1071b2550],
21	function	NN	O	function	prep_for	16	SENT_198	[p5l1090t2510r1235b2541],
22	.	.	O	.	_	0	SENT_198	[p5l1090t2510r1235b2541],

1	In	IN	O	in	_	0	SENT_199	[p5l1256t2511r1288b2541],
2	separate	JJ	O	separate	amod	3	SENT_199	[p5l1307t2516r1442b2550],
3	studies	NNS	O	study	pobj	1	SENT_199	[p5l1461t2511r1584b2546],
4	,	,	O	,	_	0	SENT_199	[p5l1461t2511r1584b2546],
5	deletions	NNS	O	deletion	appos	3	SENT_199	[p5l1602t2511r1751b2542],
6	of	IN	O	of	prep	5	SENT_199	[p5l1770t2511r1806b2542],

1	Annual	JJ	SET	annual	amod	2	SENT_200	[p5l446t2631r567b2660],
2	Reviews	NNS	O	review	_	0	SENT_200	[p5l579t2631r720b2669],
3	.	.	O	.	_	0	SENT_200	[p5l953t2664r958b2669],

1	www.annualrev1ews.org/aronlrne	NN	O	www.annualrev1ews.org/aronlrne	_	0	SENT_201	[p5l446t2664r1000b2702],

1	168	CD	NUMBER	168	num	2	SENT_202	[p5l498t2748r551b2776],
2	BELLAMY	NN	O	bellamy	_	0	SENT_202	[p5l620t2749r803b2777],

1	either	CC	O	either	prep	13	SENT_203	[p5l495t2846r592b2876],
2	the	DT	O	the	det	3	SENT_203	[p5l606t2846r658b2876],
3	carboxy	NN	O	carboxy	dep	1	SENT_203	[p5l673t2846r821b2884],
4	-	:	O	-	_	0	SENT_203	[p5l673t2846r821b2884],
5	or	CC	O	or	_	0	SENT_203	[p5l837t2855r873b2876],
6	amino-terminal	JJ	O	amino-terminal	amod	7	SENT_203	[p5l888t2845r1144b2876],
7	half	NN	O	half	conj_or	3	SENT_203	[p5l1160t2845r1228b2876],
8	of	IN	O	of	_	0	SENT_203	[p5l1240t2846r1278b2876],
9	the	DT	O	the	det	12	SENT_203	[p5l1291t2846r1341b2876],
10	P	NN	O	p	nn	12	SENT_203	[p5l1357t2846r1604b2884],
11	—	CD	NUMBER	—	num	12	SENT_203	[p5l1357t2846r1604b2884],
12	glycoprotein	NN	O	glycoprotein	prep_of	7	SENT_203	[p5l1357t2846r1604b2884],
13	resulted	VBD	O	result	_	0	SENT_203	[p5l1620t2846r1752b2876],
14	in	IN	O	in	_	0	SENT_203	[p5l1768t2846r1799b2876],
15	loss	NN	O	loss	prep_in	13	SENT_203	[p5l496t2894r559b2925],
16	of	IN	O	of	_	0	SENT_203	[p5l572t2895r611b2925],
17	transport	NN	O	transport	prep_of	15	SENT_203	[p5l620t2899r769b2934],
18	(	CD	NUMBER	(	num	17	SENT_203	[p5l781t2895r858b2931],
19	56	CD	NUMBER	56	num	20	SENT_203	[p5l781t2895r858b2931],
20	)	NN	O	)	nsubj	13	SENT_203	[p5l781t2895r858b2931],
21	.	.	O	.	_	0	SENT_203	[p5l781t2895r858b2931],

1	ABC	NNP	ORGANIZATION	ABC	nn	2	SENT_204	[p5l495t3006r596b3042],
2	SUPERFAMILY	NNP	O	SUPERFAMILY	_	0	SENT_204	[p5l615t3006r962b3042],
3	OF	IN	O	of	_	0	SENT_204	[p5l978t3006r1043b3041],
4	TRANSPORTERS	NNP	O	TRANSPORTERS	prep_of	2	SENT_204	[p5l1056t3006r1439b3042],

1	Mammalian	JJ	MISC	mammalian	amod	3	SENT_205	[p5l496t3103r698b3134],
2	MDR	NN	O	mdr	nn	3	SENT_205	[p5l711t3103r807b3133],
3	genes	NNS	O	gene	nsubj	5	SENT_205	[p5l819t3112r913b3142],
4	are	VBP	O	be	cop	5	SENT_205	[p5l927t3111r977b3134],
5	related	JJ	O	related	_	0	SENT_205	[p5l990t3103r1104b3134],
6	to	TO	O	to	prep	5	SENT_205	[p5l1118t3108r1149b3134],
7	an	DT	O	a	det	8	SENT_205	[p5l1163t3111r1202b3133],
8	evolutionarily	RB	O	evolutionarily	pobj	6	SENT_205	[p5l1215t3102r1447b3142],
9	conserved	VBN	O	conserve	dep	8	SENT_205	[p5l1461t3102r1631b3134],
10	family	NN	O	family	dobj	9	SENT_205	[p5l1644t3102r1752b3143],
11	of	IN	O	of	_	0	SENT_205	[p5l1766t3103r1803b3134],
12	MDR-like	JJ	O	mdr-like	amod	13	SENT_205	[p5l496t3153r667b3184],
13	genes	NNS	O	gene	prep_of	10	SENT_205	[p5l680t3162r774b3193],
14	in	IN	O	in	_	0	SENT_205	[p5l786t3153r819b3183],
15	nonmarmnalian	JJ	O	nonmarmnalian	amod	16	SENT_205	[p5l831t3153r1089b3184],
16	species	NNS	O	species	prep_in	9	SENT_205	[p5l1103t3152r1221b3193],
17	known	VBN	O	know	partmod	16	SENT_205	[p5l1234t3153r1347b3184],
18	as	IN	O	as	_	0	SENT_205	[p5l1360t3162r1393b3184],
19	the	DT	O	the	det	26	SENT_205	[p5l1406t3153r1456b3183],
20	ABC	NNP	ORGANIZATION	ABC	nn	26	SENT_205	[p5l1468t3153r1554b3184],
21	(	CD	NUMBER	(	num	26	SENT_205	[p5l1568t3153r1800b3193],
22	ATP-binding	JJ	O	atp-binding	amod	26	SENT_205	[p5l1568t3153r1800b3193],
23	cassette	NN	O	cassette	nn	26	SENT_205	[p5l495t3203r638b3240],
24	)	NN	O	)	nn	26	SENT_205	[p5l495t3203r638b3240],
25	superfamily	NN	O	superfamily	nn	26	SENT_205	[p5l650t3201r848b3243],
26	(	NN	O	(	prep_as	17	SENT_205	[p5l859t3202r923b3240],
27	18	CD	NUMBER	18	num	8	SENT_205	[p5l859t3202r923b3240],
28	,	,	O	,	_	0	SENT_205	[p5l859t3202r923b3240],
29	57	CD	NUMBER	57	num	30	SENT_205	[p5l934t3201r998b3240],
30	)	NN	O	)	appos	8	SENT_205	[p5l934t3201r998b3240],
31	.	.	O	.	_	0	SENT_205	[p5l934t3201r998b3240],

1	To	TO	O	to	_	0	SENT_206	[p5l1009t3202r1055b3233],
2	date	NN	O	date	prep_to	5	SENT_206	[p5l1065t3202r1144b3239],
3	,	,	O	,	_	0	SENT_206	[p5l1065t3202r1144b3239],
4	there	EX	O	there	expl	5	SENT_206	[p5l1156t3201r1238b3234],
5	are	VBP	O	be	_	0	SENT_206	[p5l1249t3211r1299b3234],
6	over	IN	O	over	_	0	SENT_206	[p5l1310t3211r1384b3234],
7	50	CD	NUMBER	50	num	8	SENT_206	[p5l1394t3201r1435b3234],
8	members	NNS	O	member	prep_over	5	SENT_206	[p5l1446t3202r1597b3234],
9	of	IN	O	of	_	0	SENT_206	[p5l1608t3201r1646b3234],
10	the	DT	O	the	det	12	SENT_206	[p5l1654t3202r1704b3234],
11	ABC	NNP	ORGANIZATION	ABC	nn	12	SENT_206	[p5l1715t3202r1799b3234],
12	family	NN	O	family	prep_of	8	SENT_206	[p5l496t3252r605b3292],
13	that	WDT	O	that	nsubjpass	16	SENT_206	[p5l618t3253r680b3284],
14	have	VBP	O	have	aux	16	SENT_206	[p5l692t3253r771b3284],
15	been	VBN	O	be	auxpass	16	SENT_206	[p5l783t3252r863b3284],
16	identiﬁed	VBN	O	identiﬁed	rcmod	8	SENT_206	[p5l875t3252r1034b3284],
17	and	CC	O	and	_	0	SENT_206	[p5l1046t3253r1106b3284],
18	are	VBP	O	be	auxpass	19	SENT_206	[p5l1120t3262r1169b3284],
19	involved	VBN	O	involve	conj_and	5	SENT_206	[p5l1183t3252r1328b3284],
20	in	IN	O	in	_	0	SENT_206	[p5l1341t3253r1372b3284],
21	the	DT	O	the	det	22	SENT_206	[p5l1385t3252r1435b3284],
22	transport	NN	O	transport	prep_in	19	SENT_206	[p5l1449t3257r1595b3292],
23	of	IN	O	of	_	0	SENT_206	[p5l1608t3252r1646b3284],
24	a	DT	O	a	det	25	SENT_206	[p5l1655t3261r1673b3283],
25	variety	NN	O	variety	prep_of	22	SENT_206	[p5l1686t3253r1801b3293],
26	of	IN	O	of	_	0	SENT_206	[p5l496t3302r534b3333],
27	substrates	NNS	O	substrate	prep_of	25	SENT_206	[p5l540t3303r713b3339],
28	,	,	O	,	_	0	SENT_206	[p5l540t3303r713b3339],
29	including	VBG	O	include	conj_and	5	SENT_206	[p5l722t3302r880b3342],
30	peptides	NNS	O	peptide	pobj	29	SENT_206	[p5l888t3302r1036b3343],
31	,	,	O	,	_	0	SENT_206	[p5l888t3302r1036b3343],
32	amino	NN	O	amino	nn	33	SENT_206	[p5l1045t3303r1148b3334],
33	acids	NNS	O	acid	pobj	29	SENT_206	[p5l1158t3302r1251b3339],
34	,	,	O	,	_	0	SENT_206	[p5l1158t3302r1251b3339],
35	and	CC	O	and	_	0	SENT_206	[p5l1260t3303r1321b3333],
36	inorganic	JJ	O	inorganic	amod	37	SENT_206	[p5l1328t3302r1485b3342],
37	anions	NNS	O	anion	pobj	29	SENT_206	[p5l1495t3303r1611b3334],
38	.	.	O	.	_	0	SENT_206	[p5l1495t3303r1611b3334],

1	In	IN	O	in	_	0	SENT_207	[p5l1622t3303r1655b3333],
2	addition	NN	O	addition	_	0	SENT_207	[p5l1665t3302r1800b3334],
3	to	TO	O	to	_	0	SENT_207	[p5l496t3356r529b3383],
4	the	DT	O	the	det	7	SENT_207	[p5l538t3352r589b3383],
5	P	NN	O	p	nn	7	SENT_207	[p5l599t3352r856b3392],
6	—	CD	NUMBER	—	num	7	SENT_207	[p5l599t3352r856b3392],
7	glycoprotein	NN	O	glycoprotein	prep_in_addition_to	13	SENT_207	[p5l599t3352r856b3392],
8	,	,	O	,	_	0	SENT_207	[p5l599t3352r856b3392],
9	members	NNS	O	member	nsubj	13	SENT_207	[p5l866t3352r1017b3383],
10	of	IN	O	of	_	0	SENT_207	[p5l1027t3352r1065b3383],
11	this	DT	O	this	det	12	SENT_207	[p5l1071t3352r1130b3383],
12	family	NN	O	family	prep_of	9	SENT_207	[p5l1141t3352r1249b3391],
13	include	VBP	O	include	_	0	SENT_207	[p5l1259t3352r1380b3383],
14	several	JJ	O	several	amod	17	SENT_207	[p5l1392t3352r1507b3383],
15	bacterial	JJ	O	bacterial	amod	17	SENT_207	[p5l1518t3351r1660b3383],
16	nutrient	NN	O	nutrient	nn	17	SENT_207	[p5l1672t3352r1802b3383],
17	transporters	NNS	O	transporter	dobj	13	SENT_207	[p5l496t3406r703b3442],
18	,	,	O	,	_	0	SENT_207	[p5l496t3406r703b3442],
19	a	DT	O	a	det	21	SENT_207	[p5l717t3411r736b3433],
20	pigment	NN	O	pigment	nn	21	SENT_207	[p5l750t3402r887b3441],
21	transporter	NN	O	transporter	appos	17	SENT_207	[p5l901t3407r1082b3441],
22	in	IN	O	in	_	0	SENT_207	[p5l1096t3402r1126b3433],
23	Drosophila	FW	LOCATION	drosophila	nn	24	SENT_207	[p5l1141t3402r1329b3441],
24	melanogaster	FW	O	melanogaster	prep_in	21	SENT_207	[p5l1345t3402r1580b3441],
25	,	,	O	,	_	0	SENT_207	[p5l1345t3402r1580b3441],
26	a	DT	O	a	det	27	SENT_207	[p5l1597t3412r1615b3433],
27	pump	NN	O	pump	appos	17	SENT_207	[p5l1629t3411r1723b3441],
28	that	WDT	O	that	nsubj	29	SENT_207	[p5l1739t3402r1802b3433],
29	appears	VBZ	O	appear	rcmod	27	SENT_207	[p5l496t3461r623b3492],
30	to	TO	O	to	aux	31	SENT_207	[p5l635t3457r666b3484],
31	mediate	VB	O	mediate	xcomp	29	SENT_207	[p5l678t3452r810b3483],
32	chloroquine	NN	O	chloroquine	nn	33	SENT_207	[p5l820t3451r1019b3492],
33	resistance	NN	O	resistance	nsubj	38	SENT_207	[p5l1029t3452r1194b3483],
34	in	IN	O	in	_	0	SENT_207	[p5l1205t3451r1236b3483],
35	Plasmodiumfalciparum	NNP	O	Plasmodiumfalciparum	prep_in	33	SENT_207	[p5l1247t3451r1649b3491],
36	(	CD	NUMBER	(	num	35	SENT_207	[p5l1662t3452r1800b3492],
37	pfmdr	NN	O	pfmdr	nn	38	SENT_207	[p5l1662t3452r1800b3492],
38	)	NN	O	)	xcomp	31	SENT_207	[p5l1662t3452r1800b3492],
39	,	,	O	,	_	0	SENT_207	[p5l1662t3452r1800b3492],

1	Annu	NNP	PERSON	Annu	_	0	SENT_208	[p6l356t955r379b1035],
2	.	.	O	.	_	0	SENT_208	[p6l356t955r379b1035],

1	Rev.	NNP	O	Rev.	nn	2	SENT_209	[p6l356t885r379b944],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_209	[p6l356t725r379b874],
3	.	.	O	.	_	0	SENT_209	[p6l356t725r379b874],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_210	[p6l356t605r379b715],
2	.	.	O	.	_	0	SENT_210	[p6l356t605r379b715],

1	1996.36	CD	NUMBER	1996.36	_	0	SENT_211	[p6l356t480r380b591],
2	:	:	O	:	_	0	SENT_211	[p6l356t480r380b591],
3	161-183	CD	NUMBER	161-183	dep	1	SENT_211	[p6l356t360r379b473],
4	.	.	O	.	_	0	SENT_211	[p6l356t360r379b473],

1	Downloaded	VBN	O	download	_	0	SENT_212	[p6l356t179r379b349],
2	from	IN	O	from	_	0	SENT_212	[p6l356t106r379b170],
3	wwv	NN	O	wwv	prep_from	1	SENT_212	[p6l364t44r379b97],
4	by	IN	O	by	_	0	SENT_212	[p6l389t868r420b900],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_212	[p6l389t719r420b858],
6	of	IN	ORGANIZATION	of	_	0	SENT_212	[p6l389t680r413b709],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_212	[p6l389t533r413b673],
8	-	:	O	-	_	0	SENT_212	[p6l403t515r406b523],
9	Madison	NNP	O	Madison	prep_by	1	SENT_212	[p6l389t389r413b505],
10	on	IN	O	on	_	0	SENT_212	[p6l397t347r413b379],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_212	[p6l389t213r413b338],
12	.	.	O	.	_	0	SENT_212	[p6l389t213r413b338],

1	For	IN	O	for	_	0	SENT_213	[p6l390t156r413b203],
2	persona	NN	O	persona	nn	3	SENT_213	[p6l397t45r420b148],
3	Annu	NNP	PERSON	Annu	pobj	1	SENT_213	[p6l341t3338r364b3418],
4	.	.	O	.	_	0	SENT_213	[p6l341t3338r364b3418],

1	Rev.	NNP	O	Rev.	nn	2	SENT_214	[p6l341t3268r364b3327],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_214	[p6l341t3108r364b3257],
3	.	.	O	.	_	0	SENT_214	[p6l341t3108r364b3257],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_215	[p6l341t2988r364b3098],
2	.	.	O	.	_	0	SENT_215	[p6l341t2988r364b3098],

1	1996362161-183	CD	NUMBER	1996362161-183	_	0	SENT_216	[p6l341t2742r365b2974],
2	.	.	O	.	_	0	SENT_216	[p6l341t2742r365b2974],

1	Downloaded	VBN	O	download	_	0	SENT_217	[p6l341t2562r364b2731],
2	from	IN	O	from	_	0	SENT_217	[p6l341t2488r364b2553],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_217	[p6l341t2155r371b2479],
4	by	IN	O	by	_	0	SENT_217	[p6l374t3251r405b3283],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_217	[p6l374t3102r405b3241],
6	of	IN	ORGANIZATION	of	_	0	SENT_217	[p6l374t3063r398b3092],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_217	[p6l374t2916r398b3056],
8	-	:	O	-	_	0	SENT_217	[p6l388t2898r391b2906],
9	Madison	NNP	O	Madison	prep_by	1	SENT_217	[p6l374t2771r398b2888],
10	on	IN	O	on	_	0	SENT_217	[p6l382t2729r398b2762],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_217	[p6l374t2596r398b2720],
12	.	.	O	.	_	0	SENT_217	[p6l374t2596r398b2720],

1	For	IN	O	for	_	0	SENT_218	[p6l375t2539r398b2585],
2	personal	JJ	O	personal	amod	3	SENT_218	[p6l374t2419r405b2531],
3	use	NN	O	use	pobj	1	SENT_218	[p6l382t2366r398b2409],
4	only	RB	O	only	advmod	3	SENT_218	[p6l374t2291r405b2356],
5	.	.	O	.	_	0	SENT_218	[p6l374t2291r405b2356],

1	a	DT	O	a	det	2	SENT_219	[p6l497t56r516b78],
2	transporter	NN	O	transporter	_	0	SENT_219	[p6l528t51r710b87],
3	for	IN	O	for	_	0	SENT_219	[p6l723t46r772b78],
4	the	DT	O	the	det	8	SENT_219	[p6l785t47r836b78],
5	alpha	NN	O	alpha	amod	8	SENT_219	[p6l850t47r941b87],
6	peptide	NN	O	peptide	nn	8	SENT_219	[p6l952t47r1075b87],
7	mating	NN	O	mating	nn	8	SENT_219	[p6l1088t47r1204b87],
8	factor	NN	O	factor	prep_for	2	SENT_219	[p6l1218t46r1315b78],
9	of	IN	O	of	_	0	SENT_219	[p6l1328t47r1365b78],
10	yeast	NN	O	yeast	nn	13	SENT_219	[p6l1376t51r1462b88],
11	(	JJ	O	(	amod	13	SENT_219	[p6l1477t47r1605b85],
12	STE6	NN	O	ste6	nn	13	SENT_219	[p6l1477t47r1605b85],
13	)	NN	O	)	prep_of	8	SENT_219	[p6l1477t47r1605b85],
14	,	,	O	,	_	0	SENT_219	[p6l1477t47r1605b85],
15	two	CD	NUMBER	two	num	17	SENT_219	[p6l1622t51r1683b78],
16	linked	VBN	O	link	amod	17	SENT_219	[p6l1697t47r1801b78],
17	genes	NNS	O	gene	appos	2	SENT_219	[p6l497t107r591b138],
18	associated	VBN	O	associate	partmod	17	SENT_219	[p6l604t98r774b130],
19	with	IN	O	with	_	0	SENT_219	[p6l785t98r859b129],
20	transport	NN	O	transport	prep_with	18	SENT_219	[p6l871t102r1017b138],
21	of	IN	O	of	_	0	SENT_219	[p6l1028t98r1066b129],
22	peptides	NNS	O	peptide	prep_of	20	SENT_219	[p6l1073t97r1211b139],
23	into	IN	O	into	_	0	SENT_219	[p6l1224t98r1287b129],
24	the	DT	O	the	det	26	SENT_219	[p6l1299t98r1348b130],
25	endoplasmic	JJ	O	endoplasmic	amod	26	SENT_219	[p6l1361t98r1570b138],
26	reticulum	NN	O	reticulum	prep_into	18	SENT_219	[p6l1582t97r1742b130],
27	for	IN	O	for	_	0	SENT_219	[p6l1753t98r1802b130],
28	class	NN	O	class	nn	31	SENT_219	[p6l496t149r577b180],
29	I	CD	NUMBER	i	num	31	SENT_219	[p6l592t150r606b180],
30	antigen	NN	O	antigen	nn	31	SENT_219	[p6l620t149r744b190],
31	presentation	NN	O	presentation	prep_for	26	SENT_219	[p6l757t149r962b189],
32	(	CD	NUMBER	(	num	33	SENT_219	[p6l976t149r1078b189],
33	Tap-l	NN	O	tap-l	dep	26	SENT_219	[p6l976t149r1078b189],
34	and	CC	O	and	_	0	SENT_219	[p6l1095t149r1154b180],
35	Tap-2	NN	O	tap-2	nn	36	SENT_219	[p6l1169t149r1291b189],
36	)	NN	O	)	dep	26	SENT_219	[p6l1169t149r1291b189],
37	,	,	O	,	_	0	SENT_219	[p6l1169t149r1291b189],
38	and	CC	O	and	_	0	SENT_219	[p6l1307t149r1367b180],
39	the	DT	O	the	det	40	SENT_219	[p6l1382t149r1432b180],
40	product	NN	O	product	prep_into	18	SENT_219	[p6l1447t149r1574b189],
41	of	IN	O	of	_	0	SENT_219	[p6l1589t148r1627b181],
42	the	DT	O	the	det	48	SENT_219	[p6l1639t149r1690b180],
43	cystic	JJ	O	cystic	amod	48	SENT_219	[p6l1704t149r1801b189],
44	ﬁbrosis	NN	O	ﬁbrosis	nn	48	SENT_219	[p6l496t199r620b231],
45	gene	NN	O	gene	nn	48	SENT_219	[p6l633t209r712b240],
46	(	CD	NUMBER	(	num	48	SENT_219	[p6l725t199r855b237],
47	CFI‘R	NN	O	cfi‘r	nn	48	SENT_219	[p6l725t199r855b237],
48	)	NN	O	)	prep_of	40	SENT_219	[p6l725t199r855b237],
49	and	CC	O	and	_	0	SENT_219	[p6l868t200r927b231],
50	the	DT	O	the	det	53	SENT_219	[p6l940t199r989b230],
51	MRP	NN	ORGANIZATION	mrp	nn	53	SENT_219	[p6l1000t200r1090b230],
52	gene	NN	O	gene	nn	53	SENT_219	[p6l1102t208r1180b240],
53	product	NN	O	product	conj_and	48	SENT_219	[p6l1192t199r1328b239],
54	.	.	O	.	_	0	SENT_219	[p6l1192t199r1328b239],

1	For	IN	O	for	_	0	SENT_220	[p6l1342t200r1400b231],
2	a	DT	O	a	det	5	SENT_220	[p6l1411t208r1429b230],
3	more	RBR	O	more	advmod	4	SENT_220	[p6l1443t208r1526b231],
4	detailed	JJ	O	detailed	amod	5	SENT_220	[p6l1540t199r1671b231],
5	discussion	NN	O	discussion	prep_for	14	SENT_220	[p6l1684t199r1800b231, p6l498t250r566b281],
6	of	IN	O	of	_	0	SENT_220	[p6l580t250r618b281],
7	the	DT	O	the	det	9	SENT_220	[p6l628t250r679b281],
8	ABC	NNP	ORGANIZATION	ABC	nn	9	SENT_220	[p6l692t250r777b281],
9	superfamily	NN	O	superfamily	prep_of	5	SENT_220	[p6l791t249r999b289],
10	,	,	O	,	_	0	SENT_220	[p6l791t249r999b289],
11	the	DT	O	the	det	12	SENT_220	[p6l1012t250r1062b281],
12	reader	NN	O	reader	nsubjpass	14	SENT_220	[p6l1076t250r1181b281],
13	is	VBZ	O	be	auxpass	14	SENT_220	[p6l1195t249r1220b280],
14	referred	VBN	O	refer	_	0	SENT_220	[p6l1234t249r1365b281],
15	to	TO	O	to	_	0	SENT_220	[p6l1379t255r1411b281],
16	the	DT	O	the	det	17	SENT_220	[p6l1425t249r1474b280],
17	review	NN	O	review	prep_to	14	SENT_220	[p6l1488t250r1600b281],
18	by	IN	O	by	_	0	SENT_220	[p6l1615t250r1656b289],
19	Higgins	NNP	PERSON	Higgins	agent	14	SENT_220	[p6l1671t249r1800b289],
20	(	CD	NUMBER	(	number	21	SENT_220	[p6l498t300r575b337],
21	57	CD	NUMBER	57	num	22	SENT_220	[p6l498t300r575b337],
22	)	NN	O	)	dep	14	SENT_220	[p6l498t300r575b337],
23	.	.	O	.	_	0	SENT_220	[p6l498t300r575b337],

1	Recently	RB	DATE	recently	advmod	11	SENT_221	[p6l539t350r688b390],
2	an	DT	O	a	det	4	SENT_221	[p6l697t358r737b381],
3	additional	JJ	O	additional	amod	4	SENT_221	[p6l747t349r913b380],
4	member	NN	O	member	nsubjpass	11	SENT_221	[p6l923t349r1060b380],
5	of	IN	O	of	_	0	SENT_221	[p6l1069t349r1107b380],
6	the	DT	O	the	det	8	SENT_221	[p6l1114t350r1163b380],
7	ABC	NNP	ORGANIZATION	ABC	nn	8	SENT_221	[p6l1175t349r1259b380],
8	superfamily	NN	O	superfamily	prep_of	4	SENT_221	[p6l1271t349r1467b389],
9	has	VBZ	O	have	aux	11	SENT_221	[p6l1478t349r1532b380],
10	been	VBN	O	be	auxpass	11	SENT_221	[p6l1543t350r1622b381],
11	identified	VBN	O	identify	_	0	SENT_221	[p6l1632t349r1800b380],
12	.	.	O	.	_	0	SENT_221	[p6l1632t349r1800b380],

1	Referred	VBN	O	refer	partmod	12	SENT_222	[p6l497t399r644b430],
2	to	TO	O	to	xcomp	1	SENT_222	[p6l652t404r685b431],
3	as	IN	O	as	_	0	SENT_222	[p6l693t408r728b431],
4	sister	NN	O	sister	prep_as	1	SENT_222	[p6l738t399r825b430],
5	of	IN	O	of	_	0	SENT_222	[p6l833t399r871b430],
6	P-glycoprotein	NN	O	p-glycoprotein	nn	9	SENT_222	[p6l877t399r1124b439],
7	(	CD	NUMBER	(	num	9	SENT_222	[p6l1134t399r1269b437],
8	SPGP	NN	O	spgp	nn	9	SENT_222	[p6l1134t399r1269b437],
9	)	NN	O	)	prep_of	4	SENT_222	[p6l1134t399r1269b437],
10	,	,	O	,	_	0	SENT_222	[p6l1134t399r1269b437],
11	it	PRP	O	it	nsubj	12	SENT_222	[p6l1279t399r1301b430],
12	has	VBZ	O	have	_	0	SENT_222	[p6l1310t400r1365b430],
13	a	DT	O	a	det	15	SENT_222	[p6l1375t409r1393b430],
14	high	JJ	O	high	amod	15	SENT_222	[p6l1402t399r1475b438],
15	degree	NN	O	degree	dobj	12	SENT_222	[p6l1485t399r1595b438],
16	of	IN	O	of	_	0	SENT_222	[p6l1606t399r1642b430],
17	sequence	NN	O	sequence	nn	18	SENT_222	[p6l1650t408r1802b438],
18	identity	NN	O	identity	prep_of	15	SENT_222	[p6l497t448r624b488],
19	to	TO	O	to	_	0	SENT_222	[p6l635t454r668b479],
20	P-glycoprotein	NN	O	p-glycoprotein	amod	24	SENT_222	[p6l679t449r927b488],
21	(	CD	PERCENT	(	num	20	SENT_222	[p6l939t448r1027b485],
22	61	CD	PERCENT	61	num	23	SENT_222	[p6l939t448r1027b485],
23	%	NN	PERCENT	%	dep	20	SENT_222	[p6l939t448r1027b485],
24	identity	NN	O	identity	prep_to	18	SENT_222	[p6l1039t448r1166b488],
25	with	IN	O	with	_	0	SENT_222	[p6l1180t448r1252b478],
26	human	JJ	O	human	amod	27	SENT_222	[p6l1265t449r1377b479],
27	MDR1	NN	O	mdr1	prep_with	24	SENT_222	[p6l1388t448r1496b478],
28	at	IN	O	at	_	0	SENT_222	[p6l1513t454r1542b479],
29	the	DT	O	the	det	33	SENT_222	[p6l1553t449r1604b479],
30	amino	NN	O	amino	nn	33	SENT_222	[p6l1617t448r1720b479],
31	acid	NN	O	acid	nn	33	SENT_222	[p6l1733t449r1801b479],
32	level	NN	O	level	nn	33	SENT_222	[p6l498t498r592b535],
33	)	NN	O	)	prep_at	27	SENT_222	[p6l498t498r592b535],
34	but	CC	O	but	_	0	SENT_222	[p6l603t499r659b529],
35	is	VBZ	O	be	cop	38	SENT_222	[p6l670t499r696b530],
36	not	RB	O	not	neg	38	SENT_222	[p6l709t503r762b529],
37	a	DT	O	a	det	38	SENT_222	[p6l773t508r792b529],
38	member	NN	O	member	conj_but	12	SENT_222	[p6l803t499r941b529],
39	of	IN	O	of	_	0	SENT_222	[p6l952t498r989b528],
40	the	DT	O	the	det	42	SENT_222	[p6l998t498r1048b528],
41	P-glycoprotein	NN	MISC	p-glycoprotein	nn	42	SENT_222	[p6l1059t498r1307b538],
42	family	NN	O	family	prep_of	38	SENT_222	[p6l1319t498r1426b537],
43	(	CD	NUMBER	(	number	44	SENT_222	[p6l1440t498r1517b535],
44	58	CD	NUMBER	58	num	45	SENT_222	[p6l1440t498r1517b535],
45	)	NN	O	)	dep	42	SENT_222	[p6l1440t498r1517b535],
46	.	.	O	.	_	0	SENT_222	[p6l1440t498r1517b535],

1	It	PRP	O	it	nsubjpass	3	SENT_223	[p6l1530t499r1556b529],
2	is	VBZ	O	be	auxpass	3	SENT_223	[p6l1567t499r1593b529],
3	proposed	VBN	O	propose	_	0	SENT_223	[p6l1606t499r1759b538],
4	to	TO	O	to	aux	7	SENT_223	[p6l1771t503r1802b529],
5	be	VB	O	be	cop	7	SENT_223	[p6l497t549r537b580],
6	the	DT	O	the	det	7	SENT_223	[p6l547t550r598b580],
7	product	NN	O	product	xcomp	3	SENT_223	[p6l609t550r737b589],
8	of	IN	O	of	_	0	SENT_223	[p6l747t549r785b580],
9	an	DT	O	a	det	12	SENT_223	[p6l792t558r832b580],
10	earlier	JJR	O	earlier	amod	12	SENT_223	[p6l842t550r949b580],
11	gene	NN	O	gene	nn	12	SENT_223	[p6l960t558r1038b588],
12	duplication	NN	O	duplication	prep_of	7	SENT_223	[p6l1048t548r1243b589],
13	.	.	O	.	_	0	SENT_223	[p6l1048t548r1243b589],

1	Based	VBN	O	base	_	0	SENT_224	[p6l1256t549r1358b580],
2	on	IN	O	on	prepc_based_on	11	SENT_224	[p6l1369t558r1410b580],
3	Northem	NN	O	northem	nn	5	SENT_224	[p6l1421t549r1571b580],
4	blot	NN	O	blot	nn	5	SENT_224	[p6l1582t550r1646b580],
5	analysis	NN	O	analysis	pobj	11	SENT_224	[p6l1658t549r1801b589],
6	,	,	O	,	_	0	SENT_224	[p6l1658t549r1801b589],
7	the	DT	O	the	det	9	SENT_224	[p6l497t600r547b631],
8	SPGP	NN	O	spgp	nn	9	SENT_224	[p6l563t601r663b631],
9	message	NN	O	message	nsubjpass	11	SENT_224	[p6l676t609r817b639],
10	was	VBD	O	be	auxpass	11	SENT_224	[p6l831t610r896b631],
11	estimated	VBN	O	estimate	_	0	SENT_224	[p6l910t600r1069b631],
12	to	TO	O	to	aux	15	SENT_224	[p6l1082t605r1115b631],
13	be	VB	O	be	cop	15	SENT_224	[p6l1129t600r1168b631],
14	5.4	CD	NUMBER	5.4	num	15	SENT_224	[p6l1183t600r1233b630],
15	kb	NN	O	kb	xcomp	11	SENT_224	[p6l1248t600r1298b636],
16	,	,	O	,	_	0	SENT_224	[p6l1248t600r1298b636],
17	which	WDT	O	which	nsubj	20	SENT_224	[p6l1314t600r1415b631],
18	is	VBZ	O	be	cop	20	SENT_224	[p6l1430t600r1456b630],
19	slightly	RB	O	slightly	advmod	20	SENT_224	[p6l1472t600r1594b640],
20	longer	JJR	O	longer	rcmod	15	SENT_224	[p6l1611t601r1717b640],
21	than	IN	O	than	_	0	SENT_224	[p6l1731t601r1801b631],
22	the	DT	O	the	det	23	SENT_224	[p6l497t650r547b682],
23	MDR1	NN	O	mdr1	prep_than	20	SENT_224	[p6l565t651r686b683],
24	.	.	O	.	_	0	SENT_224	[p6l565t651r686b683],

1	Although	IN	O	although	mark	5	SENT_225	[p6l705t650r863b691],
2	Mdrl	NN	O	mdrl	nn	3	SENT_225	[p6l880t651r970b682],
3	isoforms	NNS	O	isoform	nsubjpass	5	SENT_225	[p6l990t650r1135b682],
4	are	VBP	O	be	auxpass	5	SENT_225	[p6l1154t659r1204b682],
5	expressed	VBN	O	express	advcl	11	SENT_225	[p6l1222t651r1385b691],
6	in	IN	O	in	_	0	SENT_225	[p6l1404t650r1435b682],
7	many	JJ	O	many	amod	8	SENT_225	[p6l1453t660r1545b691],
8	tissues	NNS	O	tissue	prep_in	5	SENT_225	[p6l1564t651r1683b688],
9	,	,	O	,	_	0	SENT_225	[p6l1564t651r1683b688],
10	SPGP	NN	O	spgp	nsubj	11	SENT_225	[p6l1703t650r1802b683],
11	appears	VBZ	O	appear	_	0	SENT_225	[p6l498t711r625b742],
12	only	RB	O	only	advmod	11	SENT_225	[p6l638t703r712b742],
13	to	TO	O	to	aux	15	SENT_225	[p6l724t707r758b733],
14	be	VB	O	be	auxpass	15	SENT_225	[p6l769t703r808b733],
15	expressed	VBN	O	express	xcomp	11	SENT_225	[p6l821t702r985b742],
16	in	IN	O	in	_	0	SENT_225	[p6l996t703r1028b732],
17	the	DT	O	the	det	18	SENT_225	[p6l1041t703r1092b733],
18	liver	NN	O	liver	prep_in	15	SENT_225	[p6l1105t703r1187b733],
19	.	.	O	.	_	0	SENT_225	[p6l1105t703r1187b733],

1	Monoclonal	JJ	O	monoclonal	amod	3	SENT_226	[p6l1204t702r1403b733],
2	antibody	NN	O	antibody	nn	3	SENT_226	[p6l1416t702r1561b742],
3	C-219	NN	O	c-219	nsubj	12	SENT_226	[p6l1575t702r1687b738],
4	,	,	O	,	_	0	SENT_226	[p6l1575t702r1687b738],
5	which	WDT	O	which	nsubjpass	7	SENT_226	[p6l1702t703r1802b733],
6	was	VBD	O	be	auxpass	7	SENT_226	[p6l498t762r562b784],
7	developed	VBN	O	develop	rcmod	3	SENT_226	[p6l583t753r755b793],
8	against	IN	O	against	_	0	SENT_226	[p6l774t754r893b793],
9	P-glycoprotein	NN	O	p-glycoprotein	prep_against	7	SENT_226	[p6l913t753r1168b793],
10	,	,	O	,	_	0	SENT_226	[p6l913t753r1168b793],
11	cross	NN	O	cross	nsubj	12	SENT_226	[p6l1191t762r1274b784],
12	reacts	VBZ	O	react	_	0	SENT_226	[p6l1296t758r1391b785],
13	with	IN	O	with	_	0	SENT_226	[p6l1413t753r1486b784],
14	SPGP	NN	O	spgp	prep_with	12	SENT_226	[p6l1508t753r1615b790],
15	,	,	O	,	_	0	SENT_226	[p6l1508t753r1615b790],
16	and	CC	O	and	_	0	SENT_226	[p6l1637t753r1696b784],
17	other	JJ	O	other	amod	19	SENT_226	[p6l1717t753r1803b784],
18	anti-p-glycoprotein	JJ	O	anti-p-glycoprotein	amod	19	SENT_226	[p6l498t803r820b844],
19	antibodies	NNS	O	antibody	nsubj	20	SENT_226	[p6l833t803r1003b834],
20	may	MD	O	may	conj_and	12	SENT_226	[p6l1017t813r1088b843],
21	as	RB	O	as	advmod	22	SENT_226	[p6l1102t813r1135b834],
22	well	RB	O	well	advmod	20	SENT_226	[p6l1149t803r1229b834],
23	.	.	O	.	_	0	SENT_226	[p6l1149t803r1229b834],

1	This	DT	O	this	det	2	SENT_227	[p6l1243t803r1315b834],
2	pattem	NN	O	pattem	nsubj	8	SENT_227	[p6l1330t808r1445b843],
3	of	IN	O	of	_	0	SENT_227	[p6l1459t803r1496b834],
4	cross	NN	O	cross	nn	5	SENT_227	[p6l1506t812r1590b834],
5	reactivity	NN	O	reactivity	prep_of	2	SENT_227	[p6l1604t803r1761b843],
6	is	VBZ	O	be	cop	8	SENT_227	[p6l1776t803r1801b834],
7	particularly	RB	O	particularly	advmod	8	SENT_227	[p6l497t854r690b893],
8	important	JJ	O	important	_	0	SENT_227	[p6l703t855r866b892],
9	in	IN	O	in	_	0	SENT_227	[p6l878t854r910b884],
10	the	DT	O	the	det	11	SENT_227	[p6l923t855r973b884],
11	liver	NN	O	liver	prep_in	8	SENT_227	[p6l987t854r1072b889],
12	,	,	O	,	_	0	SENT_227	[p6l987t854r1072b889],
13	where	WRB	O	where	advmod	27	SENT_227	[p6l1086t855r1188b884],
14	the	DT	O	the	det	16	SENT_227	[p6l1201t854r1250b883],
15	relative	JJ	O	relative	amod	16	SENT_227	[p6l1263t854r1388b884],
16	contributions	NNS	O	contribution	nsubjpass	27	SENT_227	[p6l1401t854r1620b884],
17	of	IN	O	of	_	0	SENT_227	[p6l1634t853r1671b883],
18	MDR1	NN	O	mdr1	prep_of	16	SENT_227	[p6l1679t855r1801b889],
19	,	,	O	,	_	0	SENT_227	[p6l1679t855r1801b889],
20	MDR3	NN	O	mdr3	conj_and	18	SENT_227	[p6l496t904r618b939],
21	,	,	O	,	_	0	SENT_227	[p6l496t904r618b939],
22	and	CC	O	and	_	0	SENT_227	[p6l630t904r691b934],
23	SPGP	NN	O	spgp	conj_and	18	SENT_227	[p6l701t903r802b935],
24	must	MD	O	must	aux	27	SENT_227	[p6l813t909r895b934],
25	now	RB	DATE	now	advmod	27	SENT_227	[p6l904t913r976b934],
26	be	VB	O	be	auxpass	27	SENT_227	[p6l987t904r1027b933],
27	questioned	VBN	O	question	rcmod	11	SENT_227	[p6l1038t903r1226b942],
28	.	.	O	.	_	0	SENT_227	[p6l1038t903r1226b942],

1	The	DT	O	the	det	3	SENT_228	[p6l1240t904r1304b933],
2	normal	JJ	O	normal	amod	3	SENT_228	[p6l1315t903r1432b934],
3	function	NN	O	function	nsubj	18	SENT_228	[p6l1445t903r1583b933],
4	of	IN	O	of	_	0	SENT_228	[p6l1595t903r1632b934],
5	the	DT	O	the	det	8	SENT_228	[p6l1641t903r1692b933],
6	SPGP	NN	O	spgp	nn	8	SENT_228	[p6l1703t903r1802b934],
7	gene	NN	O	gene	nn	8	SENT_228	[p6l498t962r577b992],
8	product	NN	O	product	prep_of	3	SENT_228	[p6l594t954r724b992],
9	as	RB	O	as	_	0	SENT_228	[p6l741t962r774b983],
10	well	RB	O	well	_	0	SENT_228	[p6l793t954r864b984],
11	as	IN	O	as	_	0	SENT_228	[p6l883t963r917b984],
12	its	PRP$	O	its	poss	14	SENT_228	[p6l935t954r974b984],
13	potential	JJ	O	potential	amod	14	SENT_228	[p6l991t953r1136b992],
14	role	NN	O	role	prep_of	3	SENT_228	[p6l1155t953r1219b983],
15	in	IN	O	in	_	0	SENT_228	[p6l1238t953r1269b983],
16	drug	NN	O	drug	nn	17	SENT_228	[p6l1288t953r1364b992],
17	resistance	NN	O	resistance	prep_in	14	SENT_228	[p6l1382t953r1545b983],
18	remains	VBZ	O	remain	_	0	SENT_228	[p6l1563t952r1695b983],
19	to	TO	O	to	aux	21	SENT_228	[p6l1714t958r1746b983],
20	be	VB	O	be	auxpass	21	SENT_228	[p6l1764t953r1803b983],
21	determined	VBN	O	determine	xcomp	18	SENT_228	[p6l498t1004r695b1035],
22	.	.	O	.	_	0	SENT_228	[p6l498t1004r695b1035],

1	MDR1	NN	O	mdr1	nn	2	SENT_229	[p6l498t1110r633b1145],
2	EXPRESSION	NN	O	expression	_	0	SENT_229	[p6l653t1110r956b1146],

1	Normal	JJ	O	normal	amod	2	SENT_230	[p6l497t1216r653b1252],
2	Tissues	NNS	O	tissue	_	0	SENT_230	[p6l670t1217r814b1253],

1	P-glycoprotein	NN	O	p-glycoprotein	nsubj	4	SENT_231	[p6l498t1288r746b1329],
2	is	VBZ	O	be	cop	4	SENT_231	[p6l759t1289r785b1319],
3	typically	RB	O	typically	advmod	4	SENT_231	[p6l799t1289r944b1329],
4	localized	JJ	O	localized	_	0	SENT_231	[p6l957t1288r1106b1319],
5	to	TO	O	to	_	0	SENT_231	[p6l1119t1293r1150b1320],
6	the	DT	O	the	det	8	SENT_231	[p6l1163t1288r1213b1319],
7	apical	JJ	O	apical	amod	8	SENT_231	[p6l1227t1288r1325b1328],
8	surface	NN	O	surface	prep_to	4	SENT_231	[p6l1338t1288r1457b1319],
9	of	IN	O	of	_	0	SENT_231	[p6l1470t1288r1507b1319],
10	the	DT	O	the	det	11	SENT_231	[p6l1516t1289r1567b1319],
11	cells	NNS	O	cell	prep_of	8	SENT_231	[p6l1580t1288r1655b1319],
12	of	IN	O	of	_	0	SENT_231	[p6l1668t1288r1706b1318],
13	those	DT	O	those	det	14	SENT_231	[p6l1716t1288r1803b1319],
14	tissues	NNS	O	tissue	prep_of	11	SENT_231	[p6l498t1338r608b1369],
15	that	WDT	O	that	nsubj	16	SENT_231	[p6l624t1339r687b1370],
16	express	VBP	O	express	rcmod	14	SENT_231	[p6l702t1348r826b1378],
17	it	PRP	O	it	dobj	16	SENT_231	[p6l842t1339r874b1370],
18	.	.	O	.	_	0	SENT_231	[p6l842t1339r874b1370],

1	High	JJ	O	high	amod	2	SENT_232	[p6l890t1338r973b1379],
2	levels	NNS	O	level	nsubjpass	7	SENT_232	[p6l988t1339r1084b1369],
3	of	IN	O	of	_	0	SENT_232	[p6l1101t1338r1138b1369],
4	expression	NN	O	expression	prep_of	2	SENT_232	[p6l1150t1338r1327b1377],
5	have	VBP	O	have	aux	7	SENT_232	[p6l1342t1339r1420b1370],
6	been	VBN	O	be	auxpass	7	SENT_232	[p6l1436t1338r1514b1369],
7	found	VBN	O	find	_	0	SENT_232	[p6l1530t1338r1627b1369],
8	in	IN	O	in	_	0	SENT_232	[p6l1642t1338r1674b1368],
9	human	JJ	O	human	amod	12	SENT_232	[p6l1689t1338r1802b1368],
10	adrenal	JJ	O	adrenal	amod	12	SENT_232	[p6l499t1389r622b1420],
11	cortical	JJ	O	cortical	amod	12	SENT_232	[p6l638t1389r762b1420],
12	cells	NNS	O	cell	prep_in	7	SENT_232	[p6l778t1389r864b1425],
13	,	,	O	,	_	0	SENT_232	[p6l778t1389r864b1425],
14	the	DT	O	the	det	16	SENT_232	[p6l881t1389r932b1420],
15	brush	NN	O	brush	nn	16	SENT_232	[p6l948t1388r1040b1419],
16	border	NN	O	border	appos	12	SENT_232	[p6l1055t1388r1165b1419],
17	of	IN	O	of	_	0	SENT_232	[p6l1180t1388r1217b1418],
18	renal	JJ	O	renal	amod	21	SENT_232	[p6l1229t1389r1313b1419],
19	proximal	JJ	O	proximal	amod	21	SENT_232	[p6l1329t1388r1478b1428],
20	tubule	NN	O	tubule	nn	21	SENT_232	[p6l1495t1388r1598b1419],
21	epithelium	NN	O	epithelium	prep_of	16	SENT_232	[p6l1615t1388r1802b1427],
22	,	,	O	,	_	0	SENT_232	[p6l1615t1388r1802b1427],
23	the	DT	O	the	det	25	SENT_232	[p6l499t1439r549b1469],
24	lurnenal	JJ	O	lurnenal	amod	25	SENT_232	[p6l563t1439r697b1470],
25	surface	NN	O	surface	appos	21	SENT_232	[p6l710t1439r830b1470],
26	of	IN	O	of	_	0	SENT_232	[p6l842t1439r880b1470],
27	biliary	JJ	O	biliary	amod	28	SENT_232	[p6l888t1439r997b1477],
28	hepatocytes	NNS	O	hepatocyte	prep_of	25	SENT_232	[p6l1009t1439r1215b1478],
29	,	,	O	,	_	0	SENT_232	[p6l1009t1439r1215b1478],
30	small	JJ	O	small	amod	21	SENT_232	[p6l1230t1439r1317b1469],
31	and	CC	O	and	_	0	SENT_232	[p6l1332t1439r1390b1469],
32	large	JJ	O	large	conj_and	30	SENT_232	[p6l1404t1438r1486b1477],
33	intestinal	JJ	O	intestinal	amod	34	SENT_232	[p6l1500t1438r1651b1469],
34	mucosal	JJ	O	mucosal	amod	21	SENT_232	[p6l1665t1439r1803b1469],

1	Annual	JJ	SET	annual	amod	2	SENT_233	[p6l431t1559r552b1588],
2	Reviews	NNS	O	review	nsubj	3	SENT_233	[p6l564t1559r706b1596],
3	_	VBP	O	_	_	0	SENT_233	[p6l938t1592r943b1596],
4	www.annualreviews.org/aronline	NN	O	www.annualreviews.org/aronline	dobj	3	SENT_233	[p6l432t1592r985b1630],

1	P-GLYCOPROTEINS	NNPS	O	P-GLYCOPROTEINS	_	0	SENT_234	[p6l847t1693r1186b1722],
2	AND	CC	O	and	_	0	SENT_234	[p6l1197t1694r1277b1721],
3	DRUG	NN	O	drug	nn	4	SENT_234	[p6l1287t1693r1394b1722],
4	RESISTANCE	NN	O	resistance	conj_and	1	SENT_234	[p6l1403t1693r1631b1722],
5	169	CD	NUMBER	169	dep	1	SENT_234	[p6l1704t1693r1756b1722],

1	cells	NNS	O	cell	nsubj	6	SENT_235	[p6l453t1793r540b1828],
2	,	,	O	,	_	0	SENT_235	[p6l453t1793r540b1828],
3	and	CC	O	and	_	0	SENT_235	[p6l554t1792r614b1823],
4	pancreatic	JJ	O	pancreatic	amod	5	SENT_235	[p6l627t1792r798b1832],
5	ductules	NNS	O	ductule	nsubj	6	SENT_235	[p6l812t1792r951b1823],
6	(	VBP	O	(	_	0	SENT_235	[p6l965t1792r1042b1830],
7	59	CD	NUMBER	59	number	8	SENT_235	[p6l965t1792r1042b1830],
8	)	CD	NUMBER	)	dobj	6	SENT_235	[p6l965t1792r1042b1830],
9	.	.	O	.	_	0	SENT_235	[p6l965t1792r1042b1830],

1	P-glycoprotein	NN	O	p-glycoprotein	nsubjpass	4	SENT_236	[p6l1057t1791r1303b1832],
2	is	VBZ	O	be	auxpass	4	SENT_236	[p6l1318t1792r1343b1823],
3	also	RB	O	also	advmod	4	SENT_236	[p6l1359t1792r1425b1822],
4	expressed	VBN	O	express	_	0	SENT_236	[p6l1439t1792r1603b1831],
5	at	IN	O	at	_	0	SENT_236	[p6l1618t1797r1648b1823],
6	lower	JJR	O	lower	amod	7	SENT_236	[p6l1662t1792r1756b1823],
7	levels	NNS	O	level	prep_at	4	SENT_236	[p6l453t1841r550b1872],
8	in	IN	O	in	_	0	SENT_236	[p6l559t1841r591b1871],
9	capillary	JJ	O	capillary	amod	11	SENT_236	[p6l600t1841r746b1880],
10	endothelial	JJ	O	endothelial	amod	11	SENT_236	[p6l754t1841r939b1872],
11	cells	NNS	O	cell	prep_in	7	SENT_236	[p6l948t1842r1024b1872],
12	of	IN	O	of	_	0	SENT_236	[p6l1034t1841r1071b1871],
13	the	DT	O	the	det	14	SENT_236	[p6l1076t1841r1128b1871],
14	brain	NN	O	brain	prep_of	11	SENT_236	[p6l1136t1841r1222b1872],
15	and	CC	O	and	_	0	SENT_236	[p6l1232t1841r1291b1871],
16	testis	NN	O	testis	prep_of	11	SENT_236	[p6l1300t1841r1384b1872],
17	(	CD	NUMBER	(	number	18	SENT_236	[p6l1395t1841r1459b1878],
18	60	CD	NUMBER	60	dep	14	SENT_236	[p6l1395t1841r1459b1878],
19	,	,	O	,	_	0	SENT_236	[p6l1395t1841r1459b1878],
20	61	CD	NUMBER	61	num	21	SENT_236	[p6l1470t1841r1535b1878],
21	)	NN	O	)	appos	14	SENT_236	[p6l1470t1841r1535b1878],
22	;	:	O	;	_	0	SENT_236	[p6l1470t1841r1535b1878],
23	the	DT	O	the	det	24	SENT_236	[p6l1546t1841r1596b1871],
24	placenta	NN	O	placenta	dep	21	SENT_236	[p6l1605t1842r1754b1880],
25	,	,	O	,	_	0	SENT_236	[p6l1605t1842r1754b1880],
26	lung	NN	O	lung	dep	21	SENT_236	[p6l453t1890r537b1930],
27	,	,	O	,	_	0	SENT_236	[p6l453t1890r537b1930],
28	prostate	NN	O	prostate	dep	21	SENT_236	[p6l548t1895r689b1929],
29	,	,	O	,	_	0	SENT_236	[p6l548t1895r689b1929],
30	and	CC	O	and	_	0	SENT_236	[p6l702t1890r762b1921],
31	stomach	NN	O	stomach	dep	21	SENT_236	[p6l773t1890r911b1921],
32	(	NN	O	(	nn	34	SENT_236	[p6l922t1890r1002b1927],
33	59	CD	NUMBER	59	num	34	SENT_236	[p6l922t1890r1002b1927],
34	)	NN	O	)	dep	24	SENT_236	[p6l922t1890r1002b1927],
35	;	:	O	;	_	0	SENT_236	[p6l922t1890r1002b1927],
36	in	IN	O	in	_	0	SENT_236	[p6l1013t1890r1045b1920],
37	NK	NN	O	nk	prep_in	39	SENT_236	[p6l1056t1890r1118b1920],
38	cells	NNS	O	cell	nsubj	39	SENT_236	[p6l1129t1890r1203b1921],
39	(	VBP	O	(	conj_and	4	SENT_236	[p6l1216t1890r1294b1927],
40	62	CD	NUMBER	62	number	41	SENT_236	[p6l1216t1890r1294b1927],
41	)	CD	NUMBER	)	dobj	39	SENT_236	[p6l1216t1890r1294b1927],
42	;	:	O	;	_	0	SENT_236	[p6l1216t1890r1294b1927],
43	and	CC	O	and	_	0	SENT_236	[p6l1307t1890r1366b1921],
44	in	IN	O	in	_	0	SENT_236	[p6l1378t1890r1410b1920],
45	CD34	NN	O	cd34	prep_in	51	SENT_236	[p6l1421t1890r1521b1921],
46	positive	JJ	O	positive	amod	50	SENT_236	[p6l1531t1890r1663b1929],
47	bone	NN	O	bone	nn	50	SENT_236	[p6l1674t1890r1756b1921],
48	marrow	NN	O	marrow	nn	50	SENT_236	[p6l454t1948r582b1969],
49	stem	NN	O	stem	nn	50	SENT_236	[p6l596t1943r675b1969],
50	cells	NNS	O	cell	nsubj	51	SENT_236	[p6l687t1939r763b1969],
51	(	VBP	O	(	conj_and	4	SENT_236	[p6l777t1939r854b1975],
52	63	CD	NUMBER	63	number	53	SENT_236	[p6l777t1939r854b1975],
53	)	CD	NUMBER	)	dobj	51	SENT_236	[p6l777t1939r854b1975],
54	.	.	O	.	_	0	SENT_236	[p6l777t1939r854b1975],

1	Expression	NN	O	expression	nsubj	8	SENT_237	[p6l495t1987r680b2027],
2	in	IN	O	in	_	0	SENT_237	[p6l688t1988r721b2018],
3	normal	JJ	O	normal	amod	6	SENT_237	[p6l730t1988r847b2018],
4	capillary	JJ	O	capillary	amod	6	SENT_237	[p6l857t1987r1003b2027],
5	endothelial	JJ	O	endothelial	amod	6	SENT_237	[p6l1013t1987r1197b2018],
6	cells	NNS	O	cell	prep_in	1	SENT_237	[p6l1207t1987r1282b2018],
7	is	VBZ	O	be	cop	8	SENT_237	[p6l1292t1988r1319b2018],
8	relevant	JJ	O	relevant	_	0	SENT_237	[p6l1329t1988r1464b2018],
9	because	IN	O	because	mark	12	SENT_237	[p6l1472t1988r1605b2018],
10	this	DT	DATE	this	nsubj	12	SENT_237	[p6l1615t1988r1673b2018],
11	may	MD	DATE	may	aux	12	SENT_237	[p6l1685t1996r1754b2026],
12	explain	VB	O	explain	advcl	8	SENT_237	[p6l453t2037r576b2078],
13	blood-brain	JJ	O	blood-brain	amod	17	SENT_237	[p6l584t2037r780b2069],
14	and	CC	O	and	_	0	SENT_237	[p6l789t2038r850b2069],
15	blood	NN	O	blood	conj_and	13	SENT_237	[p6l858t2037r1051b2068],
16	—	NN	O	—	nn	17	SENT_237	[p6l858t2037r1051b2068],
17	testis	NN	O	testis	dobj	12	SENT_237	[p6l858t2037r1051b2068],
18	type	NN	O	type	nn	19	SENT_237	[p6l1061t2042r1134b2077],
19	barriers	NNS	O	barrier	tmod	12	SENT_237	[p6l1143t2037r1269b2068],
20	that	WDT	O	that	nsubj	21	SENT_237	[p6l1280t2038r1342b2068],
21	affect	VBP	O	affect	rcmod	19	SENT_237	[p6l1352t2037r1446b2068],
22	drug	NN	O	drug	nn	23	SENT_237	[p6l1456t2038r1532b2077],
23	levels	NNS	O	level	nsubj	24	SENT_237	[p6l1543t2037r1639b2068],
24	attainable	JJ	O	attainable	xcomp	21	SENT_237	[p6l1650t2037r1754b2068, p6l454t2087r524b2118],
25	in	IN	O	in	_	0	SENT_237	[p6l537t2087r570b2117],
26	the	DT	O	the	det	29	SENT_237	[p6l583t2087r635b2117],
27	central	JJ	O	central	amod	29	SENT_237	[p6l648t2087r762b2118],
28	nervous	JJ	O	nervous	amod	29	SENT_237	[p6l775t2095r907b2118],
29	system	NN	O	system	prep_in	24	SENT_237	[p6l922t2091r1036b2126],
30	and	CC	O	and	_	0	SENT_237	[p6l1050t2086r1116b2127],
31	testis	NN	O	testis	prep_in	24	SENT_237	[p6l1125t2086r1209b2117],
32	(	CD	NUMBER	(	number	33	SENT_237	[p6l1225t2086r1301b2124],
33	60	CD	NUMBER	60	num	34	SENT_237	[p6l1225t2086r1301b2124],
34	)	NN	O	)	dep	31	SENT_237	[p6l1225t2086r1301b2124],
35	.	.	O	.	_	0	SENT_237	[p6l1225t2086r1301b2124],

1	The	DT	O	the	det	3	SENT_238	[p6l1316t2087r1381b2117],
2	blood-brain	JJ	O	blood-brain	amod	3	SENT_238	[p6l1395t2086r1589b2117],
3	barrier	NN	O	barrier	nsubjpass	5	SENT_238	[p6l1602t2086r1715b2117],
4	is	VBZ	O	be	auxpass	5	SENT_238	[p6l1730t2086r1755b2116],
5	maintained	VBN	O	maintain	_	0	SENT_238	[p6l453t2136r639b2169],
6	primarily	RB	O	primarily	advmod	5	SENT_238	[p6l650t2136r804b2178],
7	by	IN	O	by	_	0	SENT_238	[p6l814t2137r857b2178],
8	capillary	JJ	O	capillary	amod	10	SENT_238	[p6l868t2136r1014b2178],
9	endothelial	JJ	O	endothelial	amod	10	SENT_238	[p6l1024t2136r1208b2169],
10	cells	NNS	O	cell	agent	5	SENT_238	[p6l1221t2136r1294b2168],
11	with	IN	O	with	_	0	SENT_238	[p6l1306t2136r1379b2168],
12	continuous	JJ	O	continuous	amod	15	SENT_238	[p6l1392t2137r1573b2168],
13	interce1lular	JJ	O	interce1lular	amod	15	SENT_238	[p6l1586t2136r1755b2168, p6l453t2186r498b2219],
14	tight	JJ	O	tight	amod	15	SENT_238	[p6l507t2186r583b2227],
15	junctions	NNS	O	junction	prep_with	10	SENT_238	[p6l589t2184r746b2227],
16	and	CC	O	and	_	0	SENT_238	[p6l756t2187r816b2219],
17	speciﬁc	NN	O	speciﬁc	nn	21	SENT_238	[p6l827t2186r954b2227],
18	plasma	NN	O	plasma	nn	21	SENT_238	[p6l964t2187r1082b2228],
19	membrane	NN	O	membrane	nn	21	SENT_238	[p6l1092t2186r1267b2219],
20	transport	NN	O	transport	nn	21	SENT_238	[p6l1277t2190r1424b2227],
21	systems	NNS	O	system	nsubj	22	SENT_238	[p6l1436t2191r1565b2227],
22	(	VBP	O	(	conj_and	5	SENT_238	[p6l1577t2186r1653b2225],
23	64	CD	NUMBER	64	num	24	SENT_238	[p6l1577t2186r1653b2225],
24	)	CD	NUMBER	)	dobj	22	SENT_238	[p6l1577t2186r1653b2225],
25	.	.	O	.	_	0	SENT_238	[p6l1577t2186r1653b2225],

1	Studies	NNS	O	study	nsubj	11	SENT_239	[p6l1666t2186r1754b2222, p6l453t2237r499b2269],
2	by	IN	O	by	_	0	SENT_239	[p6l516t2238r558b2277],
3	Tsuji	NNP	PERSON	Tsuji	prep_by	1	SENT_239	[p6l575t2238r660b2277],
4	et	FW	O	et	nn	5	SENT_239	[p6l678t2243r708b2268],
5	al	FW	O	al	dep	3	SENT_239	[p6l726t2238r754b2268],
6	and	CC	O	and	_	0	SENT_239	[p6l773t2238r832b2268],
7	Hegmann	NNP	PERSON	Hegmann	prep_by	1	SENT_239	[p6l849t2238r1010b2278],
8	et	FW	O	et	nn	9	SENT_239	[p6l1027t2242r1058b2268],
9	al	FW	O	al	dep	7	SENT_239	[p6l1074t2237r1103b2267],
10	have	VBP	O	have	aux	11	SENT_239	[p6l1121t2238r1200b2268],
11	shown	VBN	O	show	_	0	SENT_239	[p6l1218t2237r1324b2268],
12	that	IN	O	that	complm	19	SENT_239	[p6l1342t2238r1405b2268],
13	rhodamine	NN	O	rhodamine	nsubjpass	19	SENT_239	[p6l1421t2237r1599b2268],
14	123	CD	NUMBER	123	num	13	SENT_239	[p6l1621t2238r1677b2268],
15	and	CC	O	and	_	0	SENT_239	[p6l1697t2237r1756b2268],
16	vincristine	NN	O	vincristine	conj_and	13	SENT_239	[p6l454t2288r630b2318],
17	are	VBP	O	be	auxpass	19	SENT_239	[p6l642t2297r692b2319],
18	actively	RB	O	actively	advmod	19	SENT_239	[p6l704t2288r835b2327],
19	transported	VBN	O	transport	ccomp	11	SENT_239	[p6l848t2279r1034b2326],
20	out	IN	O	out	_	0	SENT_239	[p6l1045t2292r1098b2318],
21	of	IN	O	of	_	0	SENT_239	[p6l1110t2288r1147b2318],
22	these	DT	O	these	det	23	SENT_239	[p6l1155t2288r1242b2318],
23	cells	NNS	O	cell	prep_out_of	19	SENT_239	[p6l1254t2288r1338b2323],
24	,	,	O	,	_	0	SENT_239	[p6l1254t2288r1338b2323],
25	thereby	RB	O	thereby	advmod	26	SENT_239	[p6l1351t2287r1475b2327],
26	demonstrating	VBG	O	demonstrate	xcomp	11	SENT_239	[p6l1488t2287r1726b2326],
27	a	DT	O	a	det	29	SENT_239	[p6l1739t2296r1757b2318],
28	functional	JJ	O	functional	amod	29	SENT_239	[p6l453t2337r622b2368],
29	component	NN	O	component	dobj	26	SENT_239	[p6l641t2343r827b2377],
30	of	IN	O	of	_	0	SENT_239	[p6l845t2338r883b2368],
31	P-glycoprotein	NN	O	p-glycoprotein	nn	32	SENT_239	[p6l899t2337r1145b2377],
32	expression	NN	O	expression	prep_of	29	SENT_239	[p6l1165t2338r1341b2376],
33	(	CD	NUMBER	(	number	34	SENT_239	[p6l1362t2337r1426b2375],
34	65	CD	NUMBER	65	dep	32	SENT_239	[p6l1362t2337r1426b2375],
35	,	,	O	,	_	0	SENT_239	[p6l1362t2337r1426b2375],
36	66	CD	NUMBER	66	num	37	SENT_239	[p6l1447t2338r1510b2375],
37	)	NN	O	)	appos	32	SENT_239	[p6l1447t2338r1510b2375],
38	.	.	O	.	_	0	SENT_239	[p6l1447t2338r1510b2375],

1	As	IN	O	as	mark	2	SENT_240	[p6l1531t2338r1576b2367],
2	discussed	VBN	O	discuss	advcl	11	SENT_240	[p6l1596t2337r1756b2368],
3	earlier	RBR	O	earlier	advmod	2	SENT_240	[p6l453t2388r569b2422],
4	,	,	O	,	_	0	SENT_240	[p6l453t2388r569b2422],
5	the	DT	O	the	det	10	SENT_240	[p6l583t2387r636b2417],
6	murine	JJ	O	murine	amod	10	SENT_240	[p6l649t2387r767b2417],
7	mdr3	NN	O	mdr3	nn	10	SENT_240	[p6l781t2388r868b2418],
8	gene	NN	O	gene	nn	10	SENT_240	[p6l882t2396r962b2426],
9	knockout	NN	O	knockout	nn	10	SENT_240	[p6l974t2387r1130b2417],
10	studies	NNS	O	study	nsubj	11	SENT_240	[p6l1145t2387r1258b2417],
11	revealed	VBD	O	reveal	_	0	SENT_240	[p6l1272t2387r1412b2417],
12	markedly	RB	O	markedly	advmod	11	SENT_240	[p6l1428t2387r1584b2425],
13	increased	VBN	O	increase	dep	12	SENT_240	[p6l1599t2387r1756b2417],
14	levels	NNS	O	level	dobj	13	SENT_240	[p6l454t2437r551b2468],
15	of	IN	O	of	_	0	SENT_240	[p6l561t2437r599b2467],
16	drug	NN	O	drug	prep_of	14	SENT_240	[p6l606t2437r683b2477],
17	in	IN	O	in	_	0	SENT_240	[p6l693t2437r725b2467],
18	the	DT	O	the	det	19	SENT_240	[p6l735t2437r785b2467],
19	CNS	NN	ORGANIZATION	cn	prep_in	13	SENT_240	[p6l796t2437r886b2472],
20	,	,	O	,	_	0	SENT_240	[p6l796t2437r886b2472],
21	which	WDT	O	which	nsubjpass	23	SENT_240	[p6l897t2437r998b2468],
22	was	VBD	O	be	auxpass	23	SENT_240	[p6l1008t2446r1073b2467],
23	associated	VBN	O	associate	rcmod	19	SENT_240	[p6l1083t2437r1253b2468],
24	with	IN	O	with	_	0	SENT_240	[p6l1264t2437r1336b2467],
25	an	DT	O	a	det	27	SENT_240	[p6l1348t2446r1385b2467],
26	increased	VBN	O	increase	amod	27	SENT_240	[p6l1397t2437r1554b2467],
27	neurotoxicity	NN	O	neurotoxicity	prep_with	23	SENT_240	[p6l1565t2437r1755b2467, p6l453t2487r497b2527],
28	in	IN	O	in	_	0	SENT_240	[p6l514t2487r547b2518],
29	these	DT	O	these	det	30	SENT_240	[p6l563t2487r647b2518],
30	animals	NNS	O	animal	prep_in	27	SENT_240	[p6l664t2487r793b2518],
31	(	CD	NUMBER	(	number	32	SENT_240	[p6l810t2488r886b2525],
32	24	CD	NUMBER	24	num	33	SENT_240	[p6l810t2488r886b2525],
33	)	NN	O	)	dep	30	SENT_240	[p6l810t2488r886b2525],
34	.	.	O	.	_	0	SENT_240	[p6l810t2488r886b2525],

1	Thus	RB	O	thus	advmod	11	SENT_241	[p6l905t2487r998b2523],
2	,	,	O	,	_	0	SENT_241	[p6l905t2487r998b2523],
3	in	IN	O	in	_	0	SENT_241	[p6l1015t2487r1047b2518],
4	the	DT	O	the	det	5	SENT_241	[p6l1063t2487r1114b2517],
5	brain	NN	O	brain	prep_in	11	SENT_241	[p6l1130t2487r1215b2518],
6	and	CC	O	and	_	0	SENT_241	[p6l1233t2488r1291b2518],
7	testis	NN	O	testis	prep_in	11	SENT_241	[p6l1308t2487r1402b2523],
8	,	,	O	,	_	0	SENT_241	[p6l1308t2487r1402b2523],
9	P-glycoprotein	NN	O	p-glycoprotein	nsubj	11	SENT_241	[p6l1420t2487r1668b2527],
10	may	MD	O	may	aux	11	SENT_241	[p6l1686t2496r1755b2526],
11	serve	VB	O	serve	_	0	SENT_241	[p6l454t2546r542b2569],
12	to	TO	O	to	aux	13	SENT_241	[p6l554t2542r586b2568],
13	keep	VB	O	keep	xcomp	11	SENT_241	[p6l598t2537r678b2577],
14	toxic	JJ	O	toxic	amod	15	SENT_241	[p6l692t2537r773b2568],
15	metabolites	NNS	O	metabolite	dobj	13	SENT_241	[p6l787t2537r978b2568],
16	and	CC	O	and	_	0	SENT_241	[p6l991t2537r1052b2568],
17	xenobiotics	NNS	O	xenobiotic	conj_and	15	SENT_241	[p6l1064t2537r1254b2568],
18	out	IN	O	out	_	0	SENT_241	[p6l1268t2543r1322b2568],
19	of	IN	O	of	_	0	SENT_241	[p6l1334t2537r1371b2568],
20	the	DT	O	the	det	21	SENT_241	[p6l1382t2538r1431b2567],
21	tissues	NNS	O	tissue	prep_out_of	13	SENT_241	[p6l1446t2538r1564b2568],
22	.	.	O	.	_	0	SENT_241	[p6l1446t2538r1564b2568],

1	Tumor	NN	O	tumor	nn	2	SENT_242	[p6l456t2617r590b2653],
2	Expression	NN	O	expression	_	0	SENT_242	[p6l603t2617r825b2663],

1	There	EX	O	there	expl	2	SENT_243	[p6l453t2689r550b2720],
2	is	VBZ	O	be	_	0	SENT_243	[p6l567t2688r593b2720],
3	a	DT	O	a	det	5	SENT_243	[p6l611t2697r629b2719],
4	general	JJ	O	general	amod	5	SENT_243	[p6l644t2689r767b2729],
5	consensus	NN	O	consensus	nsubj	2	SENT_243	[p6l783t2697r950b2720],
6	that	WDT	O	that	dobj	17	SENT_243	[p6l967t2689r1030b2720],
7	measurement	NN	O	measurement	nsubj	17	SENT_243	[p6l1045t2693r1266b2720],
8	of	IN	O	of	_	0	SENT_243	[p6l1282t2688r1318b2720],
9	P-glycoprotein	NN	O	p-glycoprotein	nn	12	SENT_243	[p6l1332t2688r1578b2729],
10	or	CC	O	or	_	0	SENT_243	[p6l1596t2697r1630b2720],
11	MDR1	NN	O	mdr1	nn	12	SENT_243	[p6l1645t2688r1752b2720],
12	expression	NN	O	expression	prep_of	7	SENT_243	[p6l454t2739r632b2779],
13	in	IN	O	in	_	0	SENT_243	[p6l640t2739r673b2770],
14	tumor	NN	O	tumor	nn	15	SENT_243	[p6l683t2744r783b2770],
15	samples	NNS	O	sample	prep_in	12	SENT_243	[p6l792t2739r924b2778],
16	is	VBZ	O	be	cop	17	SENT_243	[p6l933t2738r961b2770],
17	likely	JJ	O	likely	rcmod	5	SENT_243	[p6l970t2739r1063b2778],
18	to	TO	O	to	aux	20	SENT_243	[p6l1074t2743r1106b2769],
19	be	VB	O	be	cop	20	SENT_243	[p6l1114t2739r1154b2770],
20	beneficial	JJ	O	beneficial	xcomp	17	SENT_243	[p6l1163t2738r1334b2770],
21	.	.	O	.	_	0	SENT_243	[p6l1163t2738r1334b2770],

1	Tumors	NNS	O	tumor	nsubj	2	SENT_244	[p6l1346t2739r1474b2770],
2	found	VBD	O	find	_	0	SENT_244	[p6l1484t2739r1581b2770],
3	to	TO	O	to	aux	4	SENT_244	[p6l1591t2743r1622b2770],
4	express	VB	O	express	xcomp	2	SENT_244	[p6l1632t2747r1755b2778],
5	the	DT	O	the	det	6	SENT_244	[p6l454t2790r505b2819],
6	P-glycoprotein	NN	MISC	p-glycoprotein	nsubjpass	9	SENT_244	[p6l515t2789r762b2828],
7	have	VBP	O	have	aux	9	SENT_244	[p6l770t2789r849b2819],
8	been	VBN	O	be	auxpass	9	SENT_244	[p6l858t2789r937b2819],
9	shown	VBN	O	show	ccomp	4	SENT_244	[p6l946t2790r1054b2820],
10	to	TO	O	to	aux	11	SENT_244	[p6l1062t2794r1095b2819],
11	have	VB	O	have	xcomp	9	SENT_244	[p6l1103t2789r1182b2819],
12	a	DT	O	a	det	14	SENT_244	[p6l1190t2798r1209b2819],
13	poor	JJ	O	poor	amod	14	SENT_244	[p6l1219t2798r1295b2828],
14	prognosis	NN	O	prognosis	dobj	11	SENT_244	[p6l1303t2789r1473b2828],
15	.	.	O	.	_	0	SENT_244	[p6l1303t2789r1473b2828],

1	Chan	NNP	PERSON	Chan	nn	3	SENT_245	[p6l1485t2789r1572b2820],
2	et	NNP	O	et	nn	3	SENT_245	[p6l1581t2794r1612b2820],
3	al	NNP	O	al	nsubj	4	SENT_245	[p6l1621t2790r1651b2819],
4	found	VBD	O	find	_	0	SENT_245	[p6l1660t2789r1757b2819],
5	a	DT	O	a	det	7	SENT_245	[p6l454t2848r473b2870],
6	significant	JJ	O	significant	amod	7	SENT_245	[p6l490t2839r664b2879],
7	correlation	NN	O	correlation	nsubj	16	SENT_245	[p6l680t2839r861b2870],
8	between	IN	O	between	_	0	SENT_245	[p6l876t2839r1015b2871],
9	P-glycoprotein	NN	MISC	p-glycoprotein	nn	10	SENT_245	[p6l1031t2839r1277b2879],
10	expression	NN	O	expression	prep_between	7	SENT_245	[p6l1294t2839r1471b2879],
11	and	CC	O	and	_	0	SENT_245	[p6l1489t2839r1548b2870],
12	outcome	NN	O	outcome	conj_and	10	SENT_245	[p6l1565t2844r1707b2871],
13	in	IN	O	in	_	0	SENT_245	[p6l1725t2839r1756b2870],
14	childhood	NN	O	childhood	nn	15	SENT_245	[p6l454t2889r621b2919],
15	sarcomas	NNS	O	sarcoma	prep_in	10	SENT_245	[p6l636t2897r790b2919],
16	(	VBP	O	(	ccomp	4	SENT_245	[p6l806t2889r883b2926],
17	67	CD	NUMBER	67	number	18	SENT_245	[p6l806t2889r883b2926],
18	)	CD	NUMBER	)	dobj	16	SENT_245	[p6l806t2889r883b2926],
19	.	.	O	.	_	0	SENT_245	[p6l806t2889r883b2926],

1	Both	CC	O	both	preconj	4	SENT_246	[p6l899t2889r980b2919],
2	the	DT	O	the	det	4	SENT_246	[p6l994t2889r1045b2919],
3	disease-free	JJ	O	disease-free	amod	4	SENT_246	[p6l1060t2888r1257b2919],
4	survival	NN	O	survival	nsubjpass	11	SENT_246	[p6l1273t2889r1405b2919],
5	and	CC	O	and	_	0	SENT_246	[p6l1422t2890r1482b2919],
6	the	DT	O	the	det	8	SENT_246	[p6l1497t2889r1547b2919],
7	overall	JJ	O	overall	amod	8	SENT_246	[p6l1562t2889r1678b2919],
8	survival	NN	O	survival	conj_and	4	SENT_246	[p6l1694t2898r1756b2919, p6l455t2938r539b2968],
9	were	VBD	O	be	auxpass	11	SENT_246	[p6l552t2947r631b2968],
10	signiﬁcantly	RB	O	signiﬁcantly	advmod	11	SENT_246	[p6l645t2938r851b2977],
11	reduced	VBN	O	reduce	_	0	SENT_246	[p6l864t2938r996b2968],
12	in	IN	O	in	_	0	SENT_246	[p6l1008t2938r1040b2968],
13	the	DT	O	the	det	14	SENT_246	[p6l1053t2938r1103b2968],
14	group	NN	O	group	prep_in	11	SENT_246	[p6l1117t2948r1213b2977],
15	whose	WP$	O	whose	poss	16	SENT_246	[p6l1226t2938r1330b2969],
16	tumors	NNS	O	tumor	nsubj	18	SENT_246	[p6l1344t2943r1458b2969],
17	were	VBD	O	be	cop	18	SENT_246	[p6l1472t2948r1552b2983],
18	positive	JJ	O	positive	rcmod	14	SENT_246	[p6l1565t2938r1697b2977],
19	for	IN	O	for	_	0	SENT_246	[p6l1710t2938r1758b2968],
20	P-glycoprotein	NN	O	p-glycoprotein	prep_for	18	SENT_246	[p6l454t2989r712b3028],
21	;	:	O	;	_	0	SENT_246	[p6l454t2989r712b3028],
22	other	JJ	O	other	amod	24	SENT_246	[p6l723t2988r809b3018],
23	prognostic	JJ	O	prognostic	amod	24	SENT_246	[p6l818t2989r994b3027],
24	factors	NNS	O	factor	nsubj	42	SENT_246	[p6l1005t2988r1118b3018],
25	such	JJ	O	such	_	0	SENT_246	[p6l1129t2989r1204b3019],
26	as	IN	O	as	_	0	SENT_246	[p6l1217t2998r1249b3018],
27	age	NN	O	age	prep_such_as	24	SENT_246	[p6l1262t2997r1326b3028],
28	,	,	O	,	_	0	SENT_246	[p6l1262t2997r1326b3028],
29	pretreatment	NN	O	pretreatment	nn	31	SENT_246	[p6l1339t2993r1549b3028],
30	lymphocyte	NN	O	lymphocyte	nn	31	SENT_246	[p6l1560t2988r1757b3028],
31	counts	NNS	O	count	conj_or	27	SENT_246	[p6l454t3044r572b3075],
32	,	,	O	,	_	0	SENT_246	[p6l454t3044r572b3075],
33	size	NN	O	size	prep_such_as	24	SENT_246	[p6l584t3039r648b3070],
34	of	IN	O	of	_	0	SENT_246	[p6l659t3039r695b3070],
35	tumor	NN	O	tumor	prep_of	33	SENT_246	[p6l703t3044r804b3070],
36	or	CC	O	or	_	0	SENT_246	[p6l813t3048r848b3070],
37	unfavorable	JJ	O	unfavorable	amod	38	SENT_246	[p6l857t3039r1056b3070],
38	histology	NN	O	histology	prep_such_as	24	SENT_246	[p6l1066t3039r1220b3079],
39	were	VBD	O	be	cop	42	SENT_246	[p6l1232t3048r1311b3070],
40	not	RB	O	not	neg	42	SENT_246	[p6l1322t3044r1375b3070],
41	significantly	RB	O	significantly	advmod	42	SENT_246	[p6l1386t3039r1592b3079],
42	different	JJ	O	different	parataxis	11	SENT_246	[p6l1604t3039r1756b3070],
43	.	.	O	.	_	0	SENT_246	[p6l1604t3039r1756b3070],

1	Salmon	NNP	O	Salmon	nsubj	7	SENT_247	[p6l456t3091r582b3122],
2	et	FW	O	et	dep	1	SENT_247	[p6l593t3095r623b3120],
3	al	FW	O	al	nn	6	SENT_247	[p6l635t3091r663b3121],
4	(	FW	O	(	dep	6	SENT_247	[p6l676t3090r744b3128],
5	68	CD	NUMBER	68	num	6	SENT_247	[p6l676t3090r744b3128],
6	)	NN	O	)	advmod	7	SENT_247	[p6l676t3090r744b3128],
7	established	VBD	O	establish	_	0	SENT_247	[p6l756t3090r940b3121],
8	a	DT	O	a	det	11	SENT_247	[p6l951t3100r970b3121],
9	highly	RB	O	highly	advmod	10	SENT_247	[p6l981t3090r1086b3130],
10	significant	JJ	O	significant	amod	11	SENT_247	[p6l1099t3090r1273b3130],
11	correlation	NN	O	correlation	dobj	7	SENT_247	[p6l1285t3090r1464b3121],
12	between	IN	O	between	_	0	SENT_247	[p6l1475t3091r1614b3121],
13	positive	JJ	O	positive	amod	15	SENT_247	[p6l1626t3090r1758b3130],
14	immunohistochemical	JJ	O	immunohistochemical	amod	15	SENT_247	[p6l454t3141r823b3172],
15	staining	NN	O	staining	prep_between	11	SENT_247	[p6l834t3141r964b3181],
16	for	IN	O	for	_	0	SENT_247	[p6l973t3141r1023b3172],
17	P-glycoprotein	NN	O	p-glycoprotein	prep_for	7	SENT_247	[p6l1030t3141r1276b3181],
18	in	IN	O	in	_	0	SENT_247	[p6l1287t3142r1317b3172],
19	primary	JJ	O	primary	amod	21	SENT_247	[p6l1328t3141r1459b3181],
20	human	JJ	O	human	amod	21	SENT_247	[p6l1468t3142r1582b3172],
21	myeloma	NN	O	myeloma	nn	33	SENT_247	[p6l1591t3142r1756b3181],
22	,	,	O	,	_	0	SENT_247	[p6l1591t3142r1756b3181],
23	lymphoma	NN	O	lymphoma	conj_and	21	SENT_247	[p6l455t3191r642b3230],
24	,	,	O	,	_	0	SENT_247	[p6l455t3191r642b3230],
25	and	CC	O	and	_	0	SENT_247	[p6l656t3192r716b3222],
26	breast	NN	O	breast	nn	27	SENT_247	[p6l728t3192r829b3222],
27	tumors	NNS	O	tumor	conj_and	21	SENT_247	[p6l840t3196r955b3222],
28	and	CC	O	and	_	0	SENT_247	[p6l969t3192r1028b3222],
29	in	FW	O	in	nn	30	SENT_247	[p6l1041t3192r1073b3221],
30	vitro	FW	O	vitro	advmod	31	SENT_247	[p6l1087t3191r1164b3222],
31	tumor	NN	O	tumor	conj_and	21	SENT_247	[p6l1178t3197r1277b3222],
32	cell	NN	O	cell	nn	33	SENT_247	[p6l1290t3192r1348b3222],
33	resistance	NN	O	resistance	prep_in	17	SENT_247	[p6l1362t3192r1536b3227],
34	,	,	O	,	_	0	SENT_247	[p6l1362t3192r1536b3227],
35	as	IN	O	as	mark	36	SENT_247	[p6l1551t3201r1583b3222],
36	measured	VBN	O	measure	advcl	7	SENT_247	[p6l1598t3192r1757b3222],
37	by	IN	O	by	_	0	SENT_247	[p6l454t3240r496b3280],
38	the	DT	O	the	det	41	SENT_247	[p6l508t3241r560b3272],
39	clonogenic	JJ	O	clonogenic	amod	41	SENT_247	[p6l570t3240r754b3280],
40	assay	NN	O	assay	nn	41	SENT_247	[p6l766t3249r855b3280],
41	system	NN	O	system	prep_by	36	SENT_247	[p6l867t3245r983b3280],
42	and	CC	O	and	_	0	SENT_247	[p6l994t3241r1054b3272],
43	tritiated	JJ	O	tritiated	amod	45	SENT_247	[p6l1065t3240r1194b3272],
44	thymidine	NN	O	thymidine	nn	45	SENT_247	[p6l1207t3241r1373b3280],
45	incorporation	NN	O	incorporation	prep_by	36	SENT_247	[p6l1386t3241r1619b3281],
46	.	.	O	.	_	0	SENT_247	[p6l1386t3241r1619b3281],

1	Grogan	NNP	PERSON	Grogan	nsubj	8	SENT_248	[p6l1633t3242r1757b3281],
2	et	FW	O	et	dep	1	SENT_248	[p6l454t3296r485b3321],
3	al	FW	O	al	nn	6	SENT_248	[p6l494t3291r525b3321],
4	(	FW	O	(	dep	6	SENT_248	[p6l535t3291r602b3328],
5	69	CD	NUMBER	69	num	6	SENT_248	[p6l535t3291r602b3328],
6	)	CD	NUMBER	)	advmod	8	SENT_248	[p6l535t3291r602b3328],
7	have	VBP	O	have	aux	8	SENT_248	[p6l613t3291r692b3321],
8	demonstrated	VBN	O	demonstrate	_	0	SENT_248	[p6l703t3291r927b3321],
9	a	DT	O	a	det	11	SENT_248	[p6l937t3300r956b3322],
10	strong	JJ	O	strong	amod	11	SENT_248	[p6l967t3296r1069b3329],
11	correlation	NN	O	correlation	dobj	8	SENT_248	[p6l1079t3291r1259b3322],
12	in	IN	O	in	_	0	SENT_248	[p6l1270t3291r1301b3321],
13	multiple	JJ	O	multiple	amod	15	SENT_248	[p6l1313t3291r1451b3330],
14	myeloma	NN	O	myeloma	nn	15	SENT_248	[p6l1462t3292r1617b3330],
15	patients	NNS	O	patient	prep_in	8	SENT_248	[p6l1627t3292r1756b3330],
16	between	IN	O	between	_	0	SENT_248	[p6l454t3340r593b3371],
17	P-glycoprotein	NN	MISC	p-glycoprotein	nn	18	SENT_248	[p6l609t3341r857b3380],
18	expression	NN	O	expression	prep_between	15	SENT_248	[p6l872t3341r1051b3379],
19	and	CC	O	and	_	0	SENT_248	[p6l1067t3342r1127b3371],
20	prior	JJ	O	prior	amod	21	SENT_248	[p6l1143t3341r1223b3380],
21	chemotherapy	NN	O	chemotherapy	conj_and	8	SENT_248	[p6l1240t3341r1474b3381],
22	with	IN	O	with	_	0	SENT_248	[p6l1492t3341r1564b3371],
23	vincristine	NN	O	vincristine	prep_with	21	SENT_248	[p6l1582t3341r1758b3372],
24	or	CC	O	or	_	0	SENT_248	[p6l454t3400r491b3421],
25	doxorubicin	NN	O	doxorubicin	prep_with	21	SENT_248	[p6l502t3390r711b3421],
26	.	.	O	.	_	0	SENT_248	[p6l502t3390r711b3421],

1	They	PRP	O	they	nsubj	2	SENT_249	[p6l725t3390r810b3430],
2	studied	VBD	O	study	_	0	SENT_249	[p6l823t3390r943b3421],
3	a	DT	O	a	det	4	SENT_249	[p6l955t3400r974b3421],
4	series	NN	O	series	dobj	2	SENT_249	[p6l987t3390r1079b3421],
5	of	IN	O	of	_	0	SENT_249	[p6l1094t3391r1130b3421],
6	106	CD	NUMBER	106	num	10	SENT_249	[p6l1142t3391r1202b3421],
7	consecutive	JJ	O	consecutive	amod	10	SENT_249	[p6l1213t3391r1409b3421],
8	bone	NN	O	bone	nn	10	SENT_249	[p6l1423t3391r1503b3422],
9	marrow	NN	O	marrow	nn	10	SENT_249	[p6l1517t3399r1645b3422],
10	specimens	NNS	O	specimen	prep_of	4	SENT_249	[p6l1660t3391r1756b3430, p6l455t3449r543b3471],
11	from	IN	O	from	_	0	SENT_249	[p6l554t3440r635b3471],
12	104	CD	NUMBER	104	num	14	SENT_249	[p6l649t3440r707b3471],
13	myeloma	NN	O	myeloma	nn	14	SENT_249	[p6l717t3441r872b3479],
14	patients	NNS	O	patient	prep_from	2	SENT_249	[p6l881t3440r1019b3480],
15	.	.	O	.	_	0	SENT_249	[p6l881t3440r1019b3480],

1	Myeloma	NN	O	myeloma	nn	2	SENT_250	[p6l1031t3440r1191b3479],
2	patients	NNS	O	patient	nsubj	7	SENT_250	[p6l1201t3440r1328b3480],
3	with	IN	O	with	_	0	SENT_250	[p6l1341t3440r1414b3471],
4	no	DT	O	no	det	6	SENT_250	[p6l1426t3450r1466b3471],
5	prior	JJ	O	prior	amod	6	SENT_250	[p6l1477t3441r1558b3481],
6	chemotherapy	NN	O	chemotherapy	prep_with	2	SENT_250	[p6l1568t3441r1757b3471, p6l455t3500r514b3530],
7	had	VBD	O	have	_	0	SENT_250	[p6l529t3490r589b3521],
8	a	DT	O	a	det	10	SENT_250	[p6l605t3499r624b3521],
9	low	JJ	O	low	amod	10	SENT_250	[p6l638t3491r700b3522],
10	incidence	NN	O	incidence	nsubj	16	SENT_250	[p6l715t3490r875b3522],
11	of	IN	O	of	_	0	SENT_250	[p6l889t3490r927b3521],
12	P-glycoprotein	NN	O	p-glycoprotein	nn	13	SENT_250	[p6l939t3491r1185b3531],
13	expression	NN	O	expression	prep_of	10	SENT_250	[p6l1200t3491r1378b3530],
14	(	CD	PERCENT	(	num	16	SENT_250	[p6l1394t3490r1485b3529],
15	6	CD	PERCENT	6	num	16	SENT_250	[p6l1394t3490r1485b3529],
16	%	NN	PERCENT	%	xcomp	7	SENT_250	[p6l1394t3490r1485b3529],
17	)	CD	NUMBER	)	tmod	16	SENT_250	[p6l1394t3490r1485b3529],
18	,	,	O	,	_	0	SENT_250	[p6l1394t3490r1485b3529],
19	while	IN	O	while	mark	23	SENT_250	[p6l1502t3490r1593b3522],
20	those	DT	O	those	nsubj	23	SENT_250	[p6l1609t3491r1697b3522],
21	receiving	VBG	O	receive	partmod	20	SENT_250	[p6l1711t3500r1756b3522, p6l455t3540r577b3579],
22	chemotherapy	NN	O	chemotherapy	dobj	21	SENT_250	[p6l591t3540r827b3580],
23	had	VBD	O	have	dep	17	SENT_250	[p6l840t3540r901b3571],
24	a	DT	O	a	det	27	SENT_250	[p6l915t3549r934b3571],
25	signiﬁcantly	RB	O	signiﬁcantly	advmod	26	SENT_250	[p6l947t3540r1154b3581],
26	higher	JJR	O	higher	amod	27	SENT_250	[p6l1167t3540r1274b3580],
27	incidence	NN	O	incidence	dobj	23	SENT_250	[p6l1289t3541r1448b3572],
28	of	IN	O	of	_	0	SENT_250	[p6l1463t3541r1498b3572],
29	P-glycoprotein	NN	O	p-glycoprotein	nn	30	SENT_250	[p6l1511t3541r1757b3580],
30	positivity	NN	O	positivity	prep_of	27	SENT_250	[p6l455t3590r612b3630],
31	(	CD	PERCENT	(	num	33	SENT_250	[p6l626t3590r737b3628],
32	43	CD	PERCENT	43	num	33	SENT_250	[p6l626t3590r737b3628],
33	%	NN	PERCENT	%	tmod	7	SENT_250	[p6l626t3590r737b3628],
34	)	CD	NUMBER	)	dep	33	SENT_250	[p6l626t3590r737b3628],
35	.	.	O	.	_	0	SENT_250	[p6l626t3590r737b3628],

1	When	WRB	O	when	advmod	7	SENT_251	[p6l753t3591r851b3621],
2	the	DT	O	the	det	4	SENT_251	[p6l865t3590r917b3621],
3	total	JJ	O	total	amod	4	SENT_251	[p6l929t3591r1004b3621],
4	dose	NN	O	dose	nsubj	7	SENT_251	[p6l1016t3591r1092b3621],
5	of	IN	O	of	_	0	SENT_251	[p6l1107t3591r1143b3621],
6	vincristine	NN	O	vincristine	prep_of	4	SENT_251	[p6l1155t3591r1329b3621],
7	surpassed	VBD	O	surpass	advcl	11	SENT_251	[p6l1343t3591r1505b3630],
8	20mg	JJ	O	20mg	acomp	7	SENT_251	[p6l1518t3591r1622b3630],
9	,	,	O	,	_	0	SENT_251	[p6l1518t3591r1622b3630],
10	expression	NN	O	expression	nsubj	11	SENT_251	[p6l1636t3600r1757b3630, p6l455t3640r523b3670],
11	increased	VBD	O	increase	_	0	SENT_251	[p6l533t3639r690b3670],
12	to	TO	O	to	_	0	SENT_251	[p6l698t3644r731b3670],
13	50	CD	PERCENT	50	num	14	SENT_251	[p6l739t3639r824b3675],
14	%	NN	PERCENT	%	prep_to	11	SENT_251	[p6l739t3639r824b3675],
15	,	,	O	,	_	0	SENT_251	[p6l739t3639r824b3675],
16	and	CC	O	and	_	0	SENT_251	[p6l835t3640r895b3670],
17	when	WRB	O	when	advmod	19	SENT_251	[p6l904t3640r993b3670],
18	doxorubicin	NN	O	doxorubicin	nsubj	19	SENT_251	[p6l1002t3640r1202b3670],
19	exceeded	VBD	O	exceed	advcl	25	SENT_251	[p6l1211t3640r1366b3671],
20	340mg	CD	NUMBER	340mg	dobj	19	SENT_251	[p6l1377t3640r1500b3679],
21	,	,	O	,	_	0	SENT_251	[p6l1377t3640r1500b3679],
22	P-glycoprotein	NN	O	p-glycoprotein	nn	23	SENT_251	[p6l1511t3640r1757b3679],
23	expression	NN	O	expression	nsubjpass	25	SENT_251	[p6l455t3687r633b3726],
24	was	VBD	O	be	auxpass	25	SENT_251	[p6l642t3697r707b3718],
25	observed	VBN	O	observe	conj_and	11	SENT_251	[p6l717t3688r866b3718],
26	in	IN	O	in	_	0	SENT_251	[p6l876t3688r908b3717],
27	83	CD	PERCENT	83	num	28	SENT_251	[p6l920t3688r1004b3719],
28	%	NN	PERCENT	%	prep_in	25	SENT_251	[p6l920t3688r1004b3719],
29	.	.	O	.	_	0	SENT_251	[p6l920t3688r1004b3719],

1	When	WRB	O	when	advmod	3	SENT_252	[p6l1015t3688r1113b3718],
2	patients	NNS	O	patient	nsubj	3	SENT_252	[p6l1125t3688r1252b3727],
3	received	VBD	O	receive	advcl	18	SENT_252	[p6l1263t3688r1405b3719],
4	both	CC	O	both	prep	3	SENT_252	[p6l1414t3688r1488b3719],
5	high	JJ	O	high	amod	6	SENT_252	[p6l1499t3689r1572b3727],
6	vincristine	NN	O	vincristine	dep	4	SENT_252	[p6l1583t3688r1758b3719],
7	and	CC	O	and	_	0	SENT_252	[p6l455t3737r515b3767],
8	doxorubicin	NN	O	doxorubicin	nn	9	SENT_252	[p6l537t3737r737b3767],
9	dosages	NNS	O	dosage	dep	4	SENT_252	[p6l758t3737r898b3776],
10	,	,	O	,	_	0	SENT_252	[p6l758t3737r898b3776],
11	the	DT	O	the	det	12	SENT_252	[p6l920t3737r970b3767],
12	incidence	NN	O	incidence	nsubj	18	SENT_252	[p6l991t3737r1151b3768],
13	of	IN	O	of	_	0	SENT_252	[p6l1172t3737r1209b3767],
14	P-glycoprotein	NN	O	p-glycoprotein	nn	15	SENT_252	[p6l1228t3738r1474b3776],
15	expression	NN	O	expression	prep_of	12	SENT_252	[p6l1495t3738r1672b3776],
16	was	VBD	O	be	cop	18	SENT_252	[p6l1695t3747r1757b3767],
17	100	CD	PERCENT	100	num	18	SENT_252	[p6l458t3786r560b3816],
18	%	NN	PERCENT	%	_	0	SENT_252	[p6l458t3786r560b3816],
19	.	.	O	.	_	0	SENT_252	[p6l458t3786r560b3816],

1	Disease	NN	O	disease	nn	2	SENT_253	[p6l574t3786r702b3816],
2	duration	NN	O	duration	nsubj	10	SENT_253	[p6l714t3786r853b3816],
3	was	VBD	O	be	aux	7	SENT_253	[p6l865t3795r928b3816],
4	not	RB	O	not	neg	7	SENT_253	[p6l940t3791r994b3816],
5	a	DT	O	a	det	7	SENT_253	[p6l1005t3796r1023b3816],
6	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_253	[p6l1034t3786r1211b3825],
7	variable	NN	O	variable	_	0	SENT_253	[p6l1223t3787r1365b3821],
8	,	,	O	,	_	0	SENT_253	[p6l1223t3787r1365b3821],
9	nor	CC	O	nor	_	0	SENT_253	[p6l1378t3795r1434b3816],
10	did	VBD	O	do	conj_nor	7	SENT_253	[p6l1446t3787r1498b3817],
11	P-glycoprotein	NN	O	p-glycoprotein	dobj	10	SENT_253	[p6l1511t3787r1757b3825],

1	Annu	NNP	PERSON	Annu	_	0	SENT_254	[p7l356t1910r379b1990],
2	.	.	O	.	_	0	SENT_254	[p7l356t1910r379b1990],

1	Rev.	NNP	O	Rev.	nn	2	SENT_255	[p7l356t1840r379b1899],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_255	[p7l356t1680r379b1829],
3	.	.	O	.	_	0	SENT_255	[p7l356t1680r379b1829],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_256	[p7l356t1560r379b1670],
2	.	.	O	.	_	0	SENT_256	[p7l356t1560r379b1670],

1	1996.36	CD	NUMBER	1996.36	_	0	SENT_257	[p7l356t1435r380b1546],
2	:	:	O	:	_	0	SENT_257	[p7l356t1435r380b1546],
3	161-1	CD	NUMBER	161-1	num	4	SENT_257	[p7l356t1359r379b1429],
4	83	CD	NUMBER	83	dep	1	SENT_257	[p7l356t1315r379b1353],
5	.	.	O	.	_	0	SENT_257	[p7l356t1315r379b1353],

1	Downloaded	VBN	O	download	_	0	SENT_258	[p7l356t1135r379b1304],
2	from	IN	O	from	_	0	SENT_258	[p7l356t1061r379b1126],
3	www.annua1reviews.org	NN	O	www.annua1reviews.org	prep_from	1	SENT_258	[p7l356t728r386b1053],
4	by	IN	O	by	_	0	SENT_258	[p7l389t1823r420b1855],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_258	[p7l389t1674r420b1813],
6	of	IN	ORGANIZATION	of	_	0	SENT_258	[p7l389t1635r413b1664],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_258	[p7l389t1488r413b1629],
8	-	:	O	-	_	0	SENT_258	[p7l403t1470r406b1478],
9	Madison	NNP	O	Madison	prep_by	1	SENT_258	[p7l389t1344r413b1460],
10	on	IN	O	on	_	0	SENT_258	[p7l397t1302r413b1335],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_258	[p7l389t1169r413b1293],
12	.	.	O	.	_	0	SENT_258	[p7l389t1169r413b1293],

1	For	IN	O	for	_	0	SENT_259	[p7l390t1112r413b1158],
2	personal	JJ	O	personal	amod	3	SENT_259	[p7l389t992r420b1104],
3	use	NN	O	use	pobj	1	SENT_259	[p7l397t939r413b983],
4	only	RB	O	only	advmod	3	SENT_259	[p7l389t864r420b929],
5	.	.	O	.	_	0	SENT_259	[p7l389t864r420b929],

1	wnloaded	VBN	O	wnload	_	0	SENT_260	[p7l355t3524r378b3652],
2	from	IN	O	from	_	0	SENT_260	[p7l355t3450r378b3515],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_260	[p7l355t3117r385b3442],
4	/	:	O	/	punct	5	SENT_260	[p7l388t3558r412b3650],
5	05/14	CD	NUMBER	05/14	dep	3	SENT_260	[p7l388t3558r412b3650],
6	.	.	O	.	_	0	SENT_260	[p7l388t3558r412b3650],

1	For	IN	O	for	_	0	SENT_261	[p7l389t3501r412b3547],
2	personal	JJ	O	personal	amod	3	SENT_261	[p7l388t3381r419b3493],
3	use	NN	O	use	pobj	1	SENT_261	[p7l396t3328r412b3372],
4	only	RB	O	only	advmod	3	SENT_261	[p7l388t3254r419b3319],
5	.	.	O	.	_	0	SENT_261	[p7l388t3254r419b3319],

1	correlate	VB	O	correlate	_	0	SENT_262	[p7l455t11r601b42],
2	with	IN	O	with	_	0	SENT_262	[p7l614t11r687b42],
3	immunophenotypic	JJ	O	immunophenotypic	amod	7	SENT_262	[p7l701t11r1023b51],
4	or	CC	O	or	_	0	SENT_262	[p7l1037t20r1072b42],
5	other	JJ	O	other	amod	7	SENT_262	[p7l1084t12r1170b43],
6	clinical	JJ	O	clinical	amod	7	SENT_262	[p7l1182t11r1303b43],
7	factors	NNS	O	factor	prep_with	1	SENT_262	[p7l1317t12r1439b53],
8	.	.	O	.	_	0	SENT_262	[p7l1317t12r1439b53],

1	Annual	JJ	SET	annual	amod	2	SENT_263	[p7l446t132r567b161],
2	Reviews	NNS	O	review	nsubj	3	SENT_263	[p7l579t132r720b169],
3	_	VBP	O	_	_	0	SENT_263	[p7l953t165r958b169],
4	www.annualrev1ews.org/aronline	NN	O	www.annualrev1ews.org/aronline	dobj	3	SENT_263	[p7l447t165r1000b203],

1	170	CD	NUMBER	170	num	2	SENT_264	[p7l498t270r552b298],
2	BELLAMY	NN	O	bellamy	_	0	SENT_264	[p7l620t270r802b297],

1	In	IN	O	in	_	0	SENT_265	[p7l537t368r572b397],
2	addition	NN	O	addition	_	0	SENT_265	[p7l581t368r719b398],
3	to	TO	O	to	_	0	SENT_265	[p7l728t372r761b397],
4	its	PRP$	O	its	poss	5	SENT_265	[p7l771t367r810b397],
5	role	NN	O	role	prep_in_addition_to	18	SENT_265	[p7l820t368r885b398],
6	in	IN	O	in	_	0	SENT_265	[p7l894t367r927b397],
7	antineoplastic	JJ	O	antineoplastic	amod	9	SENT_265	[p7l937t366r1166b406],
8	drug	NN	O	drug	nn	9	SENT_265	[p7l1178t368r1253b406],
9	resistance	NN	O	resistance	prep_in	5	SENT_265	[p7l1263t368r1436b403],
10	,	,	O	,	_	0	SENT_265	[p7l1263t368r1436b403],
11	enrichment	NN	O	enrichment	nsubj	18	SENT_265	[p7l1447t368r1635b398],
12	of	IN	O	of	_	0	SENT_265	[p7l1645t368r1682b398],
13	cancer	NN	O	cancer	nn	14	SENT_265	[p7l1690t376r1799b398],
14	cells	NNS	O	cell	prep_of	11	SENT_265	[p7l495t416r571b446],
15	with	IN	O	with	_	0	SENT_265	[p7l584t417r658b447],
16	P-glycoprotein	NN	O	p-glycoprotein	prep_with	14	SENT_265	[p7l671t416r919b455],
17	may	MD	O	may	aux	18	SENT_265	[p7l932t425r1004b454],
18	alter	VB	O	alter	_	0	SENT_265	[p7l1017t416r1092b446],
19	their	PRP$	O	they	poss	21	SENT_265	[p7l1105t416r1181b446],
20	biological	JJ	O	biological	amod	21	SENT_265	[p7l1194t416r1360b455],
21	behavior	NN	O	behavior	dobj	18	SENT_265	[p7l1373t416r1528b447],
22	.	.	O	.	_	0	SENT_265	[p7l1373t416r1528b447],

1	Weinstein	NNP	PERSON	Weinstein	nsubj	25	SENT_266	[p7l1543t416r1711b447],
2	et	FW	O	et	nn	3	SENT_266	[p7l1725t422r1756b447],
3	al	FW	O	al	dep	1	SENT_266	[p7l1769t417r1798b447],
4	studied	VBN	O	study	partmod	1	SENT_266	[p7l495t465r615b496],
5	the	DT	O	the	det	6	SENT_266	[p7l628t466r679b496],
6	relationship	NN	O	relationship	dobj	4	SENT_266	[p7l692t465r889b504],
7	of	IN	O	of	_	0	SENT_266	[p7l902t465r939b495],
8	P-glycoprotein	NN	O	p-glycoprotein	nn	9	SENT_266	[p7l949t465r1196b504],
9	expression	NN	O	expression	prep_of	6	SENT_266	[p7l1209t465r1386b504],
10	in	IN	O	in	_	0	SENT_266	[p7l1400t465r1431b496],
11	invasive	JJ	O	invasive	amod	13	SENT_266	[p7l1445t465r1584b496],
12	colon	NN	O	colon	nn	13	SENT_266	[p7l1597t466r1689b496],
13	carcinomas	NNS	O	carcinoma	prep_in	9	SENT_266	[p7l1703t465r1797b496, p7l495t523r603b544],
14	to	TO	O	to	_	0	SENT_266	[p7l614t519r647b544],
15	tumor	NN	O	tumor	nn	16	SENT_266	[p7l656t519r756b544],
16	dissemination	NN	O	dissemination	prep_to	4	SENT_266	[p7l765t513r995b544],
17	in	IN	O	in	_	0	SENT_266	[p7l1005t514r1038b544],
18	a	DT	O	a	det	19	SENT_266	[p7l1048t523r1067b544],
19	series	NN	O	series	prep_in	4	SENT_266	[p7l1077t513r1169b544],
20	of	IN	O	of	_	0	SENT_266	[p7l1181t514r1218b544],
21	95	CD	NUMBER	95	num	24	SENT_266	[p7l1224t514r1264b545],
22	primary	JJ	O	primary	amod	24	SENT_266	[p7l1276t514r1407b553],
23	colon	NN	O	colon	nn	24	SENT_266	[p7l1418t514r1509b544],
24	carcinomas	NNS	O	carcinoma	prep_of	19	SENT_266	[p7l1519t514r1708b545],
25	(	VBP	O	(	_	0	SENT_266	[p7l1720t514r1797b552],
26	70	CD	NUMBER	70	number	27	SENT_266	[p7l1720t514r1797b552],
27	)	CD	NUMBER	)	dobj	25	SENT_266	[p7l1720t514r1797b552],
28	.	.	O	.	_	0	SENT_266	[p7l1720t514r1797b552],

1	They	PRP	O	they	nsubj	2	SENT_267	[p7l495t563r581b602],
2	found	VBD	O	find	_	0	SENT_267	[p7l593t563r692b594],
3	a	DT	O	a	det	5	SENT_267	[p7l704t572r723b593],
4	strong	JJ	O	strong	amod	5	SENT_267	[p7l735t568r839b603],
5	association	NN	O	association	dobj	2	SENT_267	[p7l851t563r1035b594],
6	between	IN	O	between	_	0	SENT_267	[p7l1047t563r1186b594],
7	the	DT	O	the	det	8	SENT_267	[p7l1200t563r1249b594],
8	presence	NN	O	presence	prep_between	5	SENT_267	[p7l1262t572r1408b603],
9	of	IN	O	of	_	0	SENT_267	[p7l1421t564r1458b594],
10	anti	JJ	O	anti	prep_of	8	SENT_267	[p7l1468t564r1798b604],
11	.	.	O	.	_	0	SENT_267	[p7l1468t564r1798b604],

1	—	NN	O	—	_	0	SENT_268	[p7l1468t564r1798b604],
2	.	.	O	.	_	0	SENT_268	[p7l1468t564r1798b604],

1	.	.	O	.	_	0	SENT_269	[p7l1468t564r1798b604],

1	—	NN	O	—	_	0	SENT_270	[p7l1468t564r1798b604],
2	.	.	O	.	_	0	SENT_270	[p7l1468t564r1798b604],

1	P	NN	O	p	_	0	SENT_271	[p7l1468t564r1798b604],
2	.	.	O	.	_	0	SENT_271	[p7l1468t564r1798b604],

1	—	NN	O	—	_	0	SENT_272	[p7l1468t564r1798b604],
2	.	.	O	.	_	0	SENT_272	[p7l1468t564r1798b604],

1	glycoprotein	NN	O	glycoprotein	nn	4	SENT_273	[p7l1468t564r1798b604],
2	monoclonal	JJ	O	monoclonal	amod	4	SENT_273	[p7l495t613r692b644],
3	antibody	NN	O	antibody	nn	4	SENT_273	[p7l704t613r851b653],
4	reactivity	NN	O	reactivity	npadvmod	24	SENT_273	[p7l862t613r1019b653],
5	in	IN	O	in	_	0	SENT_273	[p7l1031t613r1063b644],
6	invading	VBG	O	invade	prepc_in	24	SENT_273	[p7l1076t613r1220b653],
7	tumor	NN	O	tumor	nn	8	SENT_273	[p7l1233t618r1332b645],
8	cells	NNS	O	cell	dobj	6	SENT_273	[p7l1344t614r1419b644],
9	at	IN	O	at	_	0	SENT_273	[p7l1433t618r1463b645],
10	the	DT	O	the	det	12	SENT_273	[p7l1475t614r1525b645],
11	leading	VBG	O	lead	amod	12	SENT_273	[p7l1538t614r1660b654],
12	edge	NN	O	edge	prep_at	6	SENT_273	[p7l1673t615r1751b654],
13	of	IN	O	of	_	0	SENT_273	[p7l1764t614r1801b645],
14	the	DT	O	the	det	15	SENT_273	[p7l495t663r545b693],
15	tumor	NN	O	tumor	prep_of	12	SENT_273	[p7l565t668r666b694],
16	and	CC	O	and	_	0	SENT_273	[p7l683t663r744b693],
17	both	DT	O	both	det	18	SENT_273	[p7l761t663r836b694],
18	vessel	NN	O	vessel	prep_of	12	SENT_273	[p7l855t663r956b694],
19	invasion	NN	O	invasion	nn	23	SENT_273	[p7l975t663r1115b694],
20	and	CC	O	and	_	0	SENT_273	[p7l1136t663r1194b693],
21	lymph	NN	O	lymph	nn	23	SENT_273	[p7l1214t663r1319b703],
22	node	NN	O	node	nn	23	SENT_273	[p7l1338t663r1419b694],
23	metastases	NNS	O	metastase	nsubj	24	SENT_273	[p7l1439t668r1615b694],
24	(	VBP	O	(	_	0	SENT_273	[p7l1637t664r1713b701],
25	70	CD	NUMBER	70	number	26	SENT_273	[p7l1637t664r1713b701],
26	)	CD	NUMBER	)	dobj	24	SENT_273	[p7l1637t664r1713b701],
27	.	.	O	.	_	0	SENT_273	[p7l1637t664r1713b701],

1	The	DT	O	the	det	3	SENT_274	[p7l1734t664r1799b695],
2	mechanistic	JJ	O	mechanistic	amod	3	SENT_274	[p7l494t713r694b744],
3	basis	NN	O	basis	nsubj	7	SENT_274	[p7l703t713r787b744],
4	of	IN	O	of	_	0	SENT_274	[p7l797t713r834b744],
5	this	DT	O	this	det	6	SENT_274	[p7l841t713r901b744],
6	phenomenon	NN	O	phenomenon	prep_of	3	SENT_274	[p7l910t713r1125b752],
7	remains	VBZ	O	remain	_	0	SENT_274	[p7l1136t713r1266b744],
8	to	TO	O	to	aux	10	SENT_274	[p7l1277t718r1308b744],
9	be	VB	O	be	auxpass	10	SENT_274	[p7l1319t713r1357b743],
10	elucidated	VBN	O	elucidate	xcomp	7	SENT_274	[p7l1367t713r1548b749],
11	,	,	O	,	_	0	SENT_274	[p7l1367t713r1548b749],
12	but	CC	O	but	_	0	SENT_274	[p7l1559t713r1612b744],
13	it	PRP	O	it	nsubjpass	16	SENT_274	[p7l1622t713r1645b744],
14	has	VBZ	O	have	aux	16	SENT_274	[p7l1655t714r1709b744],
15	been	VBN	O	be	auxpass	16	SENT_274	[p7l1720t714r1798b745],
16	suggested	VBN	O	suggest	conj_but	7	SENT_274	[p7l496t763r660b803],
17	that	IN	O	that	complm	26	SENT_274	[p7l674t762r738b793],
18	the	DT	O	the	det	19	SENT_274	[p7l751t762r802b794],
19	insertion	NN	O	insertion	nsubj	26	SENT_274	[p7l816t762r962b794],
20	of	IN	O	of	_	0	SENT_274	[p7l976t762r1013b794],
21	P-glycoprotein	NN	MISC	p-glycoprotein	prep_of	19	SENT_274	[p7l1024t763r1271b803],
22	into	IN	O	into	_	0	SENT_274	[p7l1286t763r1350b794],
23	the	DT	O	the	det	25	SENT_274	[p7l1365t763r1415b794],
24	plasma	NN	O	plasma	nn	25	SENT_274	[p7l1430t763r1548b803],
25	membrane	NN	O	membrane	prep_into	21	SENT_274	[p7l1563t763r1737b795],
26	inﬂuences	VBZ	O	inﬂuences	ccomp	16	SENT_274	[p7l1753t763r1798b795, p7l495t812r633b843],
27	cell	NN	O	cell	nn	28	SENT_274	[p7l647t812r707b843],
28	locomotion	NN	O	locomotion	dobj	26	SENT_274	[p7l720t812r909b843],
29	and	CC	O	and	_	0	SENT_274	[p7l921t812r981b843],
30	intercellular	JJ	O	intercellular	amod	31	SENT_274	[p7l993t812r1195b843],
31	adhesion	NN	O	adhesion	dobj	26	SENT_274	[p7l1207t812r1354b844],
32	(	CD	NUMBER	(	number	33	SENT_274	[p7l1368t812r1445b850],
33	70	CD	NUMBER	70	num	34	SENT_274	[p7l1368t812r1445b850],
34	)	NN	O	)	dep	31	SENT_274	[p7l1368t812r1445b850],
35	,	,	O	,	_	0	SENT_274	[p7l1368t812r1445b850],
36	both	DT	O	both	dep	37	SENT_274	[p7l1458t812r1531b844],
37	of	IN	O	of	nsubj	40	SENT_274	[p7l1545t812r1582b843],
38	which	WDT	O	which	pobj	37	SENT_274	[p7l1593t812r1693b843],
39	could	MD	O	could	aux	40	SENT_274	[p7l1707t812r1799b844],
40	result	VB	O	result	rcmod	28	SENT_274	[p7l495t862r589b893],
41	in	IN	O	in	_	0	SENT_274	[p7l602t862r635b893],
42	the	DT	O	the	det	43	SENT_274	[p7l650t862r702b893],
43	enhancement	NN	O	enhancement	prep_in	40	SENT_274	[p7l716t862r937b893],
44	of	IN	O	of	_	0	SENT_274	[p7l951t861r989b892],
45	tumor	NN	O	tumor	nn	46	SENT_274	[p7l1001t866r1101b893],
46	aggressiveness	NN	O	aggressiveness	prep_of	43	SENT_274	[p7l1115t862r1361b901],
47	by	IN	O	by	_	0	SENT_274	[p7l1375t861r1417b901],
48	P-glycoprotein	NN	O	p-glycoprotein	prep_by	40	SENT_274	[p7l1433t862r1688b901],
49	.	.	O	.	_	0	SENT_274	[p7l1433t862r1688b901],

1	Thus	RB	O	thus	advmod	6	SENT_275	[p7l1705t862r1798b898],
2	,	,	O	,	_	0	SENT_275	[p7l1705t862r1798b898],
3	P-glycoprotein	NN	O	p-glycoprotein	nn	4	SENT_275	[p7l495t911r743b951],
4	expression	NN	O	expression	nsubj	6	SENT_275	[p7l762t911r939b951],
5	may	MD	O	may	aux	6	SENT_275	[p7l959t921r1030b951],
6	represent	VB	O	represent	_	0	SENT_275	[p7l1049t916r1202b951],
7	a	DT	O	a	det	9	SENT_275	[p7l1221t921r1238b942],
8	two-edged	JJ	O	two-edged	amod	9	SENT_275	[p7l1258t911r1433b951],
9	sword	NN	O	sword	dobj	6	SENT_275	[p7l1454t912r1554b943],
10	by	IN	O	by	_	0	SENT_275	[p7l1573t911r1615b951],
11	endowing	VBG	O	endow	prepc_by	6	SENT_275	[p7l1634t912r1798b951],
12	tumor	NN	O	tumor	nn	13	SENT_275	[p7l496t966r596b991],
13	cells	NNS	O	cell	dobj	11	SENT_275	[p7l608t962r684b992],
14	with	IN	O	with	_	0	SENT_275	[p7l697t962r771b991],
15	a	DT	O	a	det	16	SENT_275	[p7l783t971r802b991],
16	means	NN	O	means	prep_with	11	SENT_275	[p7l814t970r920b991],
17	for	IN	O	for	_	0	SENT_275	[p7l934t961r982b991],
18	resisting	VBG	O	resist	prepc_for	16	SENT_275	[p7l994t962r1134b1000],
19	certain	JJ	O	certain	amod	20	SENT_275	[p7l1147t962r1260b991],
20	forms	NNS	O	form	dobj	18	SENT_275	[p7l1273t961r1368b992],
21	of	IN	O	of	_	0	SENT_275	[p7l1382t962r1420b991],
22	anti-cancer	JJ	O	anti-cancer	amod	23	SENT_275	[p7l1430t961r1616b992],
23	therapy	NN	O	therapy	prep_of	20	SENT_275	[p7l1628t962r1752b1001],
24	as	RB	O	as	_	0	SENT_275	[p7l1766t971r1799b991],
25	well	RB	O	well	_	0	SENT_275	[p7l496t1012r567b1042],
26	as	IN	O	as	_	0	SENT_275	[p7l580t1021r615b1042],
27	facilitating	VBG	O	facilitate	conj_and	11	SENT_275	[p7l628t1011r809b1051],
28	their	PRP$	O	they	poss	29	SENT_275	[p7l821t1012r898b1042],
29	dissemination	NN	O	dissemination	dobj	27	SENT_275	[p7l910t1011r1149b1042],
30	.	.	O	.	_	0	SENT_275	[p7l910t1011r1149b1042],

1	MDR1	NN	O	mdr1	nn	2	SENT_276	[p7l495t1122r631b1159],
2	MODULATION	NN	O	modulation	_	0	SENT_276	[p7l650t1122r989b1159],

1	One	CD	NUMBER	one	nsubj	10	SENT_277	[p7l497t1219r566b1249],
2	of	IN	O	of	_	0	SENT_277	[p7l575t1219r614b1250],
3	the	DT	O	the	det	4	SENT_277	[p7l621t1220r672b1250],
4	goals	NNS	O	goal	prep_of	1	SENT_277	[p7l682t1219r769b1258],
5	of	IN	O	of	_	0	SENT_277	[p7l780t1219r818b1249],
6	drug	NN	O	drug	nn	9	SENT_277	[p7l825t1219r1077b1259],
7	—	NN	O	—	nn	9	SENT_277	[p7l825t1219r1077b1259],
8	resistance	NN	O	resistance	nn	9	SENT_277	[p7l825t1219r1077b1259],
9	studies	NNS	O	study	prep_of	4	SENT_277	[p7l1088t1219r1202b1249],
10	is	VBZ	O	be	_	0	SENT_277	[p7l1214t1219r1239b1249],
11	to	TO	O	to	aux	12	SENT_277	[p7l1250t1224r1283b1250],
12	ﬁnd	VB	O	ﬁnd	xcomp	10	SENT_277	[p7l1294t1219r1360b1250],
13	a	DT	O	a	det	14	SENT_277	[p7l1370t1228r1388b1249],
14	means	NN	O	means	dobj	12	SENT_277	[p7l1398t1229r1503b1250],
15	of	IN	O	of	_	0	SENT_277	[p7l1515t1219r1552b1250],
16	circumventing	VBG	O	circumvent	amod	18	SENT_277	[p7l1559t1219r1800b1258],
17	drug	NN	O	drug	nn	18	SENT_277	[p7l496t1269r572b1308],
18	resistance	NN	O	resistance	prep_of	14	SENT_277	[p7l580t1269r755b1305],
19	,	,	O	,	_	0	SENT_277	[p7l580t1269r755b1305],
20	which	WDT	O	which	nsubj	22	SENT_277	[p7l763t1269r865b1300],
21	is	VBZ	O	be	cop	22	SENT_277	[p7l874t1270r901b1300],
22	applicable	JJ	O	applicable	rcmod	18	SENT_277	[p7l910t1269r1080b1308],
23	to	TO	O	to	_	0	SENT_277	[p7l1089t1274r1120b1300],
24	the	DT	O	the	det	26	SENT_277	[p7l1130t1269r1180b1299],
25	clinical	JJ	O	clinical	amod	26	SENT_277	[p7l1189t1269r1310b1300],
26	setting	NN	O	setting	prep_to	22	SENT_277	[p7l1320t1269r1438b1308],
27	.	.	O	.	_	0	SENT_277	[p7l1320t1269r1438b1308],

1	Efforts	NNS	O	effort	nsubjpass	10	SENT_278	[p7l1448t1269r1562b1300],
2	to	TO	O	to	aux	3	SENT_278	[p7l1572t1273r1604b1300],
3	circumvent	VB	O	circumvent	infmod	1	SENT_278	[p7l1612t1269r1801b1300],
4	or	CC	O	or	_	0	SENT_278	[p7l496t1328r532b1349],
5	modulate	VB	O	modulate	infmod	1	SENT_278	[p7l539t1319r694b1350],
6	MDR1-mediated	JJ	O	mdr1-mediated	amod	7	SENT_278	[p7l703t1318r985b1350],
7	multidrug	JJ	O	multidrug	amod	8	SENT_278	[p7l994t1319r1158b1357],
8	resistance	NN	O	resistance	dobj	3	SENT_278	[p7l1166t1319r1329b1350],
9	are	VBP	O	be	auxpass	10	SENT_278	[p7l1339t1327r1388b1349],
10	justiﬁed	VBN	O	justiﬁed	_	0	SENT_278	[p7l1394t1319r1542b1358],
11	.	.	O	.	_	0	SENT_278	[p7l1394t1319r1542b1358],

1	Although	IN	O	although	mark	4	SENT_279	[p7l1554t1319r1710b1358],
2	solid	JJ	O	solid	amod	3	SENT_279	[p7l1720t1318r1800b1350],
3	tumors	NNS	O	tumor	nsubj	4	SENT_279	[p7l497t1373r612b1400],
4	pose	VBP	O	pose	advcl	27	SENT_279	[p7l623t1377r700b1408],
5	more	JJR	O	more	amod	7	SENT_279	[p7l710t1378r796b1399],
6	technical	JJ	O	technical	amod	7	SENT_279	[p7l806t1368r956b1400],
7	problems	NNS	O	problem	dobj	4	SENT_279	[p7l967t1369r1120b1408],
8	than	IN	O	than	mark	9	SENT_279	[p7l1131t1368r1202b1399],
9	do	VBP	O	do	advcl	4	SENT_279	[p7l1213t1369r1254b1399],
10	hematological	JJ	O	hematological	amod	11	SENT_279	[p7l1265t1369r1501b1408],
11	ones	NNS	O	one	dobj	9	SENT_279	[p7l1511t1377r1596b1404],
12	,	,	O	,	_	0	SENT_279	[p7l1511t1377r1596b1404],
13	particularly	RB	O	particularly	advmod	9	SENT_279	[p7l1609t1368r1800b1408],
14	in	IN	O	in	_	0	SENT_279	[p7l497t1417r529b1448],
15	terms	NNS	O	term	prep_in	9	SENT_279	[p7l550t1422r641b1449],
16	of	IN	O	of	_	0	SENT_279	[p7l663t1417r701b1449],
17	drug	NN	O	drug	nn	18	SENT_279	[p7l718t1417r794b1457],
18	disposition	NN	O	disposition	prep_of	15	SENT_279	[p7l814t1417r995b1457],
19	and	CC	O	and	_	0	SENT_279	[p7l1016t1418r1076b1448],
20	tumor	NN	O	tumor	nn	22	SENT_279	[p7l1097t1422r1196b1448],
21	cell	NN	O	cell	nn	22	SENT_279	[p7l1216t1417r1275b1448],
22	heterogeneity	NN	O	heterogeneity	conj_and	18	SENT_279	[p7l1297t1418r1533b1457],
23	,	,	O	,	_	0	SENT_279	[p7l1297t1418r1533b1457],
24	it	PRP	O	it	nsubjpass	27	SENT_279	[p7l1554t1417r1578b1448],
25	is	VBZ	O	be	auxpass	27	SENT_279	[p7l1598t1417r1624b1448],
26	generally	RB	O	generally	advmod	27	SENT_279	[p7l1646t1417r1800b1457],
27	accepted	VBN	O	accept	_	0	SENT_279	[p7l497t1468r643b1506],
28	that	IN	O	that	complm	43	SENT_279	[p7l653t1468r716b1498],
29	reversal	NN	O	reversal	nsubj	43	SENT_279	[p7l726t1468r858b1497],
30	or	CC	O	or	_	0	SENT_279	[p7l869t1476r905b1498],
31	inhibition	NN	O	inhibition	nsubj	43	SENT_279	[p7l916t1467r1076b1497],
32	of	IN	O	of	_	0	SENT_279	[p7l1087t1466r1124b1498],
33	P-glycoprotein	NN	O	p-glycoprotein	nn	34	SENT_279	[p7l1132t1467r1379b1506],
34	function	NN	O	function	prep_of	29	SENT_279	[p7l1390t1467r1528b1498],
35	in	IN	O	in	_	0	SENT_279	[p7l1540t1467r1571b1498],
36	both	DT	O	both	det	37	SENT_279	[p7l1582t1467r1655b1497],
37	types	NNS	O	type	prep_in	34	SENT_279	[p7l1668t1473r1754b1506],
38	of	IN	O	of	_	0	SENT_279	[p7l1767t1467r1803b1497],
39	tumors	NNS	O	tumor	prep_of	37	SENT_279	[p7l496t1522r611b1547],
40	is	VBZ	O	be	cop	43	SENT_279	[p7l625t1517r651b1547],
41	an	DT	O	a	det	43	SENT_279	[p7l665t1526r705b1547],
42	important	JJ	O	important	amod	43	SENT_279	[p7l717t1517r880b1555],
43	goal	NN	O	goal	ccomp	27	SENT_279	[p7l892t1517r973b1555],
44	.	.	O	.	_	0	SENT_279	[p7l892t1517r973b1555],

1	Non	NNP	O	Non	_	0	SENT_280	[p7l495t1644r923b1681],
2	.	.	O	.	_	0	SENT_280	[p7l495t1644r923b1681],

1	—	NN	O	—	_	0	SENT_281	[p7l495t1644r923b1681],
2	.	.	O	.	_	0	SENT_281	[p7l495t1644r923b1681],

1	Cross-Resistant	JJ	O	cross-resistant	amod	2	SENT_282	[p7l495t1644r923b1681],
2	Chemotherapy	NNP	O	Chemotherapy	nsubjpass	14	SENT_282	[p7l940t1643r1230b1690],
3	The	DT	O	the	det	4	SENT_282	[p7l496t1717r561b1747],
4	use	NN	O	use	dep	2	SENT_282	[p7l572t1726r628b1747],
5	of	IN	O	of	_	0	SENT_282	[p7l639t1717r677b1747],
6	non	JJ	O	non	amod	7	SENT_282	[p7l685t1716r1006b1747],
7	—	NN	O	—	prep_of	4	SENT_282	[p7l685t1716r1006b1747],
8	cross-resistant	JJ	O	cross-resistant	amod	10	SENT_282	[p7l685t1716r1006b1747],
9	therapeutic	JJ	O	therapeutic	amod	10	SENT_282	[p7l1017t1717r1201b1756],
10	regimens	NNS	O	regimen	dep	2	SENT_282	[p7l1213t1717r1364b1756],
11	is	VBZ	O	be	auxpass	14	SENT_282	[p7l1376t1716r1403b1746],
12	perhaps	RB	O	perhaps	advmod	14	SENT_282	[p7l1415t1717r1543b1756],
13	best	RB	O	best	advmod	14	SENT_282	[p7l1556t1717r1623b1747],
14	illustrated	VBN	O	illustrate	_	0	SENT_282	[p7l1634t1717r1800b1748],
15	in	IN	O	in	_	0	SENT_282	[p7l497t1767r529b1797],
16	regimens	NNS	O	regimen	prep_in	14	SENT_282	[p7l538t1767r691b1807],
17	employed	VBN	O	employ	partmod	16	SENT_282	[p7l700t1767r865b1806],
18	against	IN	O	against	_	0	SENT_282	[p7l874t1767r992b1806],
19	Hodgkin	NN	PERSON	hodgkin	poss	21	SENT_282	[p7l1001t1766r1176b1806],
20	’s	POS	O	’s	_	0	SENT_282	[p7l1001t1766r1176b1806],
21	disease	NN	O	disease	prep_against	17	SENT_282	[p7l1186t1767r1314b1798],
22	.	.	O	.	_	0	SENT_282	[p7l1186t1767r1314b1798],

1	In	IN	O	in	_	0	SENT_283	[p7l1326t1767r1359b1797],
2	this	DT	O	this	det	3	SENT_283	[p7l1370t1767r1428b1797],
3	example	NN	O	example	prep_in	22	SENT_283	[p7l1439t1767r1589b1807],
4	,	,	O	,	_	0	SENT_283	[p7l1439t1767r1589b1807],
5	the	DT	O	the	det	8	SENT_283	[p7l1600t1767r1650b1797],
6	standard	JJ	O	standard	amod	8	SENT_283	[p7l1661t1767r1800b1798],
7	therapeutic	JJ	O	therapeutic	amod	8	SENT_283	[p7l497t1817r682b1856],
8	regimen	NN	O	regimen	nsubjpass	22	SENT_283	[p7l695t1817r832b1855],
9	of	IN	O	of	_	0	SENT_283	[p7l845t1817r883b1847],
10	mechlorethamine	NN	O	mechlorethamine	prep_of	8	SENT_283	[p7l892t1816r1189b1851],
11	,	,	O	,	_	0	SENT_283	[p7l892t1816r1189b1851],
12	vincristine	NN	O	vincristine	conj_and	10	SENT_283	[p7l1205t1816r1387b1852],
13	,	,	O	,	_	0	SENT_283	[p7l1205t1816r1387b1852],
14	procarbazine	NN	O	procarbazine	conj_and	10	SENT_283	[p7l1402t1816r1626b1855],
15	,	,	O	,	_	0	SENT_283	[p7l1402t1816r1626b1855],
16	and	CC	O	and	_	0	SENT_283	[p7l1641t1817r1700b1847],
17	prednisone	NN	O	prednisone	conj_and	10	SENT_283	[p7l1714t1817r1800b1856, p7l497t1867r606b1897],
18	(	CD	NUMBER	(	num	19	SENT_283	[p7l618t1866r757b1904],
19	MOPP	NNP	ORGANIZATION	MOPP	dep	10	SENT_283	[p7l618t1866r757b1904],
20	)	CD	NUMBER	)	num	19	SENT_283	[p7l618t1866r757b1904],
21	is	VBZ	O	be	auxpass	22	SENT_283	[p7l768t1867r795b1896],
22	altemated	VBN	O	altemate	_	0	SENT_283	[p7l806t1866r970b1897],
23	with	IN	O	with	_	0	SENT_283	[p7l980t1867r1053b1896],
24	a	DT	DURATION	a	det	26	SENT_283	[p7l1064t1876r1083b1897],
25	second	JJ	DURATION	second	amod	26	SENT_283	[p7l1095t1867r1208b1897],
26	regimen	NN	O	regimen	prep_with	22	SENT_283	[p7l1218t1867r1355b1905],
27	consisting	VBG	O	consist	partmod	26	SENT_283	[p7l1366t1867r1534b1906],
28	of	IN	O	of	_	0	SENT_283	[p7l1545t1866r1582b1896],
29	doxorubicin	NN	O	doxorubicin	prep_of	27	SENT_283	[p7l1589t1866r1800b1902],
30	,	,	O	,	_	0	SENT_283	[p7l1589t1866r1800b1902],
31	bleomycin	NN	O	bleomycin	prep_of	27	SENT_283	[p7l497t1917r682b1957],
32	,	,	O	,	_	0	SENT_283	[p7l497t1917r682b1957],
33	vinblastine	NN	O	vinblastine	prep_of	27	SENT_283	[p7l698t1917r890b1953],
34	,	,	O	,	_	0	SENT_283	[p7l698t1917r890b1953],
35	and	CC	O	and	_	0	SENT_283	[p7l905t1917r965b1946],
36	dacarbazine	NN	O	dacarbazine	prep_of	27	SENT_283	[p7l978t1916r1177b1947],
37	(	CD	NUMBER	(	num	38	SENT_283	[p7l1192t1917r1336b1954],
38	ABVD	NN	O	abvd	dep	29	SENT_283	[p7l1192t1917r1336b1954],
39	)	CD	NUMBER	)	number	40	SENT_283	[p7l1192t1917r1336b1954],
40	(	CD	NUMBER	(	dep	29	SENT_283	[p7l1353t1917r1416b1954],
41	71	CD	NUMBER	71	dep	40	SENT_283	[p7l1353t1917r1416b1954],
42	,	,	O	,	_	0	SENT_283	[p7l1353t1917r1416b1954],
43	72	CD	NUMBER	72	num	44	SENT_283	[p7l1431t1917r1493b1954],
44	)	NN	O	)	appos	29	SENT_283	[p7l1431t1917r1493b1954],
45	.	.	O	.	_	0	SENT_283	[p7l1431t1917r1493b1954],

1	The	DT	O	the	det	2	SENT_284	[p7l1511t1918r1575b1947],
2	goal	NN	O	goal	nsubj	6	SENT_284	[p7l1590t1917r1661b1956],
3	of	IN	O	of	_	0	SENT_284	[p7l1677t1917r1713b1947],
4	such	JJ	O	such	amod	5	SENT_284	[p7l1725t1917r1800b1948],
5	regimens	NNS	O	regimen	prep_of	2	SENT_284	[p7l497t1967r649b2007],
6	is	VBZ	O	be	_	0	SENT_284	[p7l663t1967r689b1998],
7	to	TO	O	to	aux	8	SENT_284	[p7l703t1971r736b1997],
8	utilize	VB	O	utilize	xcomp	6	SENT_284	[p7l748t1966r851b1998],
9	the	DT	O	the	det	11	SENT_284	[p7l865t1967r916b1998],
10	largest	JJS	O	largest	amod	11	SENT_284	[p7l929t1966r1039b2007],
11	number	NN	O	number	dobj	8	SENT_284	[p7l1051t1966r1179b1998],
12	of	IN	O	of	_	0	SENT_284	[p7l1191t1966r1228b1997],
13	active	JJ	O	active	amod	14	SENT_284	[p7l1238t1966r1337b1998],
14	agents	NNS	O	agent	prep_of	11	SENT_284	[p7l1351t1972r1455b2006],
15	at	IN	O	at	_	0	SENT_284	[p7l1469t1972r1499b1998],
16	the	DT	O	the	det	18	SENT_284	[p7l1513t1967r1562b1998],
17	highest	JJS	O	highest	amod	18	SENT_284	[p7l1576t1966r1696b2007],
18	doses	NNS	O	dose	prep_at	8	SENT_284	[p7l1709t1967r1800b1998],
19	possible	JJ	O	possible	amod	18	SENT_284	[p7l497t2018r644b2056],
20	,	,	O	,	_	0	SENT_284	[p7l497t2018r644b2056],
21	assuming	VBG	O	assume	partmod	8	SENT_284	[p7l659t2017r815b2057],
22	that	IN	O	that	complm	29	SENT_284	[p7l829t2018r891b2048],
23	mutations	NNS	O	mutation	nsubj	29	SENT_284	[p7l905t2017r1067b2048],
24	conferring	VBG	O	confer	partmod	23	SENT_284	[p7l1081t2017r1254b2057],
25	drug	NN	O	drug	nn	26	SENT_284	[p7l1269t2018r1344b2057],
26	resistance	NN	O	resistance	dobj	24	SENT_284	[p7l1358t2018r1521b2048],
27	will	MD	O	will	aux	29	SENT_284	[p7l1537t2017r1599b2047],
28	not	RB	O	not	neg	29	SENT_284	[p7l1615t2023r1667b2048],
29	convey	VB	O	convey	ccomp	21	SENT_284	[p7l1681t2026r1800b2056],
30	resistance	NN	O	resistance	dobj	29	SENT_284	[p7l497t2067r661b2098],
31	to	TO	O	to	_	0	SENT_284	[p7l674t2072r707b2098],
32	all	DT	O	all	prep_to	29	SENT_284	[p7l720t2067r760b2097],
33	of	IN	O	of	_	0	SENT_284	[p7l775t2067r811b2097],
34	the	DT	O	the	det	35	SENT_284	[p7l822t2068r872b2097],
35	agents	NNS	O	agent	prep_of	32	SENT_284	[p7l885t2072r990b2106],
36	in	IN	O	in	_	0	SENT_284	[p7l1004t2067r1036b2097],
37	the	DT	O	the	det	38	SENT_284	[p7l1049t2068r1099b2097],
38	regimen	NN	O	regimen	prep_in	35	SENT_284	[p7l1114t2067r1257b2106],
39	.	.	O	.	_	0	SENT_284	[p7l1114t2067r1257b2106],

1	High-Dose	JJ	MISC	high-dose	amod	2	SENT_285	[p7l496t2181r716b2226],
2	Chemotherapy	NNP	MISC	Chemotherapy	nsubj	28	SENT_285	[p7l735t2181r1027b2226],
3	High-dose	JJ	MISC	high-dose	amod	5	SENT_285	[p7l498t2253r671b2292],
4	chemotherapy	NN	O	chemotherapy	nn	5	SENT_285	[p7l683t2253r918b2292],
5	(	NN	O	(	rcmod	2	SENT_285	[p7l930t2253r979b2290],
6	or	CC	O	or	_	0	SENT_285	[p7l930t2253r979b2290],
7	radiation	NN	O	radiation	nn	9	SENT_285	[p7l988t2253r1135b2283],
8	therapy	NN	O	therapy	nn	9	SENT_285	[p7l1148t2253r1284b2292],
9	)	NN	O	)	conj_or	5	SENT_285	[p7l1148t2253r1284b2292],
10	in	IN	O	in	_	0	SENT_285	[p7l1297t2253r1328b2283],
11	conjunction	NN	O	conjunction	prep_in	5	SENT_285	[p7l1340t2253r1535b2292],
12	with	IN	O	with	dep	5	SENT_285	[p7l1547t2252r1620b2283],
13	bone	NN	O	bone	nn	15	SENT_285	[p7l1632t2253r1712b2283],
14	marrow	NN	O	marrow	nn	15	SENT_285	[p7l1724t2261r1801b2283, p7l497t2311r562b2332],
15	transplantation	NN	O	transplantation	pobj	12	SENT_285	[p7l576t2302r834b2341],
16	,	,	O	,	_	0	SENT_285	[p7l576t2302r834b2341],
17	such	JJ	O	such	_	0	SENT_285	[p7l849t2302r924b2332],
18	as	IN	O	as	_	0	SENT_285	[p7l939t2311r972b2332],
19	used	VBN	O	use	dep	26	SENT_285	[p7l986t2302r1062b2332],
20	in	IN	O	in	_	0	SENT_285	[p7l1076t2302r1108b2332],
21	chronic	JJ	O	chronic	amod	23	SENT_285	[p7l1123t2302r1246b2332],
22	myelogenous	JJ	O	myelogenous	amod	23	SENT_285	[p7l1261t2302r1482b2341],
23	leukemia	NN	O	leukemia	prep_in	19	SENT_285	[p7l1497t2302r1649b2332],
24	and	CC	O	and	_	0	SENT_285	[p7l1664t2303r1722b2332],
25	malignant	JJ	O	malignant	dep	26	SENT_285	[p7l1738t2311r1801b2332, p7l498t2351r614b2390],
26	lymphomas	NNS	O	lymphoma	prep_such_as	2	SENT_285	[p7l632t2351r834b2391],
27	,	,	O	,	_	0	SENT_285	[p7l632t2351r834b2391],
28	represents	VBZ	O	represent	_	0	SENT_285	[p7l853t2356r1020b2390],
29	another	DT	O	another	det	30	SENT_285	[p7l1040t2351r1164b2381],
30	approach	NN	O	approach	dobj	28	SENT_285	[p7l1183t2352r1333b2390],
31	to	TO	O	to	_	0	SENT_285	[p7l1352t2355r1384b2381],
32	overcoming	VBG	O	overcome	amod	34	SENT_285	[p7l1402t2350r1599b2390],
33	drug	NN	O	drug	nn	34	SENT_285	[p7l1618t2351r1694b2390],
34	resistance	NN	O	resistance	prep_to	28	SENT_285	[p7l1712t2350r1800b2381, p7l498t2407r595b2433],
35	.	.	O	.	_	0	SENT_285	[p7l1712t2350r1800b2381, p7l498t2407r595b2433],

1	This	DT	O	this	det	2	SENT_286	[p7l616t2403r689b2433],
2	approach	NN	O	approach	nsubj	3	SENT_286	[p7l710t2402r861b2441],
3	assumes	VBZ	O	assume	_	0	SENT_286	[p7l881t2411r1018b2432],
4	that	IN	O	that	advmod	3	SENT_286	[p7l1039t2402r1102b2433],
5	despite	IN	O	despite	_	0	SENT_286	[p7l1122t2402r1239b2441],
6	resistance	NN	O	resistance	prep_despite	4	SENT_286	[p7l1259t2402r1422b2433],
7	to	TO	O	to	_	0	SENT_286	[p7l1443t2407r1473b2432],
8	standard	JJ	O	standard	amod	9	SENT_286	[p7l1495t2402r1635b2433],
9	doses	NNS	O	dose	prep_to	3	SENT_286	[p7l1655t2402r1746b2432],
10	of	IN	O	of	prep	9	SENT_286	[p7l1768t2401r1804b2432],

1	Annual	JJ	SET	annual	amod	2	SENT_287	[p7l445t2521r566b2550],
2	Reviews	NNS	O	review	nsubj	3	SENT_287	[p7l578t2521r720b2558],
3	_	VBP	O	_	_	0	SENT_287	[p7l952t2554r957b2558],
4	www.annualreviews.org/aronline	NN	O	www.annualreviews.org/aronline	dobj	3	SENT_287	[p7l446t2554r999b2592],

1	P-GLYCOPROTEINS	NNPS	O	P-GLYCOPROTEINS	_	0	SENT_288	[p7l892t2662r1232b2690],
2	AND	CC	O	and	_	0	SENT_288	[p7l1242t2663r1323b2690],
3	DRUG	NN	O	drug	nn	4	SENT_288	[p7l1333t2662r1439b2690],
4	RESISTANCE	NN	O	resistance	conj_and	1	SENT_288	[p7l1448t2662r1676b2690],
5	171	CD	NUMBER	171	dep	1	SENT_288	[p7l1749t2663r1798b2690],

1	antineoplastic	JJ	O	antineoplastic	amod	2	SENT_289	[p7l498t2760r728b2798],
2	agents	NNS	O	agent	nsubj	8	SENT_289	[p7l740t2766r856b2799],
3	,	,	O	,	_	0	SENT_289	[p7l740t2766r856b2799],
4	a	DT	O	a	det	6	SENT_289	[p7l868t2770r887b2790],
5	dose-response	JJ	O	dose-response	amod	6	SENT_289	[p7l896t2760r1132b2799],
6	relationship	NN	O	relationship	appos	2	SENT_289	[p7l1143t2760r1338b2799],
7	still	RB	O	still	advmod	8	SENT_289	[p7l1350t2760r1410b2791],
8	exists	VBZ	O	exist	_	0	SENT_289	[p7l1423t2761r1516b2791],
9	for	IN	O	for	dep	8	SENT_289	[p7l1528t2761r1578b2792],
10	these	DT	O	these	det	11	SENT_289	[p7l1588t2761r1673b2791],
11	tumors	NNS	O	tumor	pobj	9	SENT_289	[p7l1684t2766r1799b2791],
12	and	CC	O	and	_	0	SENT_289	[p7l498t2810r558b2840],
13	that	IN	O	that	complm	19	SENT_289	[p7l573t2809r635b2840],
14	high	JJ	O	high	amod	15	SENT_289	[p7l649t2809r723b2849],
15	doses	NNS	O	dose	nsubj	19	SENT_289	[p7l738t2810r830b2840],
16	of	IN	O	of	_	0	SENT_289	[p7l845t2809r882b2840],
17	chemotherapy	NN	O	chemotherapy	prep_of	15	SENT_289	[p7l893t2810r1128b2849],
18	might	MD	O	might	aux	19	SENT_289	[p7l1144t2810r1240b2848],
19	overcome	VB	O	overcome	dep	8	SENT_289	[p7l1255t2819r1417b2841],
20	this	DT	O	this	det	21	SENT_289	[p7l1433t2810r1491b2841],
21	resistance	NN	O	resistance	dobj	19	SENT_289	[p7l1506t2810r1680b2841],
22	.	.	O	.	_	0	SENT_289	[p7l1506t2810r1680b2841],

1	A	DT	O	a	det	3	SENT_290	[p7l1696t2811r1726b2841],
2	different	JJ	O	different	amod	3	SENT_290	[p7l1740t2810r1799b2841, p7l498t2859r596b2889],
3	strategy	NN	O	strategy	nsubj	15	SENT_290	[p7l610t2863r751b2898],
4	,	,	O	,	_	0	SENT_290	[p7l610t2863r751b2898],
5	which	WDT	O	which	nsubjpass	8	SENT_290	[p7l766t2858r868b2889],
6	has	VBZ	O	have	aux	8	SENT_290	[p7l881t2859r938b2889],
7	been	VBN	O	be	auxpass	8	SENT_290	[p7l951t2859r1031b2889],
8	supported	VBN	O	support	rcmod	3	SENT_290	[p7l1046t2859r1209b2898],
9	by	IN	O	by	_	0	SENT_290	[p7l1223t2859r1265b2898],
10	animal	NN	O	animal	nn	11	SENT_290	[p7l1281t2859r1392b2890],
11	studies	NNS	O	study	agent	8	SENT_290	[p7l1409t2859r1532b2895],
12	,	,	O	,	_	0	SENT_290	[p7l1409t2859r1532b2895],
13	is	VBZ	O	be	cop	15	SENT_290	[p7l1548t2860r1574b2890],
14	the	DT	O	the	det	15	SENT_290	[p7l1590t2860r1639b2890],
15	insertion	NN	O	insertion	_	0	SENT_290	[p7l1655t2859r1800b2890],
16	of	IN	O	of	_	0	SENT_290	[p7l498t2907r536b2937],
17	the	DT	O	the	det	19	SENT_290	[p7l549t2908r599b2937],
18	MDR1	NN	O	mdr1	nn	19	SENT_290	[p7l615t2908r723b2937],
19	gene	NN	O	gene	prep_of	15	SENT_290	[p7l743t2916r822b2946],
20	itself	PRP	O	itself	advmod	19	SENT_290	[p7l839t2907r924b2937],
21	into	IN	O	into	_	0	SENT_290	[p7l937t2907r1001b2937],
22	normal	JJ	O	normal	amod	26	SENT_290	[p7l1018t2908r1135b2937],
23	human	JJ	O	human	amod	26	SENT_290	[p7l1151t2908r1264b2938],
24	bone	NN	O	bone	nn	26	SENT_290	[p7l1281t2908r1362b2938],
25	marrow	NN	O	marrow	nn	26	SENT_290	[p7l1378t2917r1506b2938],
26	cells	NNS	O	cell	prep_into	15	SENT_290	[p7l1525t2908r1600b2938],
27	by	IN	O	by	_	0	SENT_290	[p7l1616t2908r1658b2946],
28	using	VBG	O	use	prepc_by	15	SENT_290	[p7l1676t2908r1765b2947],
29	a	DT	O	a	det	34	SENT_290	[p7l1783t2917r1801b2937],
30	retroviral	JJ	O	retroviral	amod	34	SENT_290	[p7l497t2955r653b2987],
31	vector	NN	O	vector	nn	34	SENT_290	[p7l662t2960r767b2987],
32	(	CD	NUMBER	(	number	33	SENT_290	[p7l776t2956r853b2993],
33	73	CD	NUMBER	73	num	34	SENT_290	[p7l776t2956r853b2993],
34	)	NN	O	)	dobj	28	SENT_290	[p7l776t2956r853b2993],
35	.	.	O	.	_	0	SENT_290	[p7l776t2956r853b2993],

1	Because	IN	O	because	mark	7	SENT_291	[p7l862t2957r1002b2986],
2	myelotoxicity	NN	O	myelotoxicity	nsubj	7	SENT_291	[p7l1010t2956r1241b2995],
3	is	VBZ	O	be	cop	7	SENT_291	[p7l1251t2957r1277b2987],
4	the	DT	O	the	det	7	SENT_291	[p7l1287t2956r1336b2987],
5	usual	JJ	O	usual	amod	7	SENT_291	[p7l1345t2957r1432b2987],
6	dose-limiting	JJ	O	dose-limiting	amod	7	SENT_291	[p7l1443t2957r1664b2995],
7	toxicity	NN	O	toxicity	advcl	25	SENT_291	[p7l1673t2957r1799b2995],
8	associated	VBN	O	associate	partmod	7	SENT_291	[p7l499t3005r670b3037],
9	with	IN	O	with	_	0	SENT_291	[p7l689t3006r763b3036],
10	many	JJ	O	many	amod	12	SENT_291	[p7l783t3014r875b3045],
11	chemotherapeutic	JJ	O	chemotherapeutic	amod	12	SENT_291	[p7l895t3006r1191b3045],
12	drugs	NNS	O	drug	prep_with	8	SENT_291	[p7l1211t3005r1312b3046],
13	,	,	O	,	_	0	SENT_291	[p7l1211t3005r1312b3046],
14	rendering	VBG	O	render	csubj	25	SENT_291	[p7l1332t3006r1491b3045],
15	the	DT	O	the	det	18	SENT_291	[p7l1512t3006r1561b3037],
16	nomial	JJ	O	nomial	amod	18	SENT_291	[p7l1582t3007r1699b3037],
17	bone	NN	O	bone	nn	18	SENT_291	[p7l1719t3006r1801b3037],
18	marrow	NN	O	marrow	nsubj	19	SENT_291	[p7l498t3064r627b3086],
19	resistant	JJ	O	resistant	xcomp	14	SENT_291	[p7l644t3055r783b3086],
20	to	TO	O	to	_	0	SENT_291	[p7l800t3060r832b3086],
21	the	DT	O	the	det	23	SENT_291	[p7l849t3055r900b3085],
22	toxic	JJ	O	toxic	amod	23	SENT_291	[p7l916t3055r999b3085],
23	effects	NNS	O	effect	prep_to	19	SENT_291	[p7l1016t3054r1125b3086],
24	may	MD	O	may	aux	25	SENT_291	[p7l1143t3064r1214b3094],
25	enable	VB	O	enable	_	0	SENT_291	[p7l1232t3055r1339b3086],
26	patients	NNS	O	patient	nsubj	28	SENT_291	[p7l1357t3055r1486b3094],
27	to	TO	O	to	aux	28	SENT_291	[p7l1503t3060r1535b3086],
28	tolerate	VB	O	tolerate	xcomp	25	SENT_291	[p7l1552t3055r1677b3086],
29	higher	JJR	O	higher	amod	31	SENT_291	[p7l1694t3055r1801b3095],
30	therapeutic	JJ	O	therapeutic	amod	31	SENT_291	[p7l498t3105r683b3144],
31	doses	NNS	O	dose	dobj	28	SENT_291	[p7l696t3105r788b3136],
32	of	IN	O	of	_	0	SENT_291	[p7l801t3105r839b3136],
33	the	DT	O	the	det	34	SENT_291	[p7l848t3105r900b3136],
34	drugs	NNS	O	drug	prep_of	31	SENT_291	[p7l912t3104r1014b3145],
35	.	.	O	.	_	0	SENT_291	[p7l912t3104r1014b3145],

1	Protein	NN	O	protein	nsubj	16	SENT_292	[p7l498t3226r662b3262],
2	-	:	O	-	_	0	SENT_292	[p7l498t3226r662b3262],
3	and	CC	O	and	_	0	SENT_292	[p7l680t3226r758b3262],
4	Gene-Directed	JJ	O	gene-directed	amod	5	SENT_292	[p7l772t3225r1070b3262],
5	Therapy	NN	O	therapy	nsubj	16	SENT_292	[p7l1084t3226r1248b3271],
6	A	DT	O	a	det	8	SENT_292	[p7l499t3306r529b3334],
7	third	JJ	ORDINAL	third	amod	8	SENT_292	[p7l545t3305r624b3334],
8	strategy	NN	O	strategy	dep	5	SENT_292	[p7l639t3311r770b3343],
9	for	IN	O	for	_	0	SENT_292	[p7l787t3305r837b3335],
10	overcoming	VBG	O	overcome	prepc_for	5	SENT_292	[p7l852t3305r1050b3343],
11	drug	NN	O	drug	nn	12	SENT_292	[p7l1066t3305r1141b3343],
12	resistance	NN	O	resistance	nsubj	13	SENT_292	[p7l1158t3305r1321b3335],
13	due	JJ	O	due	xcomp	10	SENT_292	[p7l1339t3305r1397b3335],
14	to	TO	O	to	_	0	SENT_292	[p7l1414t3310r1446b3335],
15	P-glycoprotein	NN	O	p-glycoprotein	prep_to	13	SENT_292	[p7l1462t3305r1709b3343],
16	is	VBZ	O	be	_	0	SENT_292	[p7l1727t3305r1752b3334],
17	to	TO	O	to	aux	19	SENT_292	[p7l1770t3310r1801b3334],
18	speciﬁcally	RB	O	speciﬁcally	advmod	19	SENT_292	[p7l499t3354r689b3393],
19	target	VB	O	target	xcomp	16	SENT_292	[p7l708t3359r804b3393],
20	overexpressing	VBG	O	overexpress	amod	21	SENT_292	[p7l822t3354r1074b3392],
21	cells	NNS	O	cell	dobj	19	SENT_292	[p7l1093t3355r1167b3384],
22	with	IN	O	with	_	0	SENT_292	[p7l1188t3354r1260b3384],
23	anti	JJ	O	anti	prep_with	21	SENT_292	[p7l1280t3355r1465b3384],
24	.	.	O	.	_	0	SENT_292	[p7l1280t3355r1465b3384],

1	—	NN	O	—	_	0	SENT_293	[p7l1280t3355r1465b3384],
2	.	.	O	.	_	0	SENT_293	[p7l1280t3355r1465b3384],

1	MDR1	NN	O	mdr1	_	0	SENT_294	[p7l1280t3355r1465b3384],
2	antisense	JJ	O	antisense	amod	3	SENT_294	[p7l1489t3356r1641b3384],
3	oligonucleotides	NNS	O	oligonucleotide	dep	1	SENT_294	[p7l1661t3355r1800b3393, p7l499t3404r657b3438],
4	,	,	O	,	_	0	SENT_294	[p7l1661t3355r1800b3393, p7l499t3404r657b3438],
5	anti-MDR1	JJ	O	anti-mdr1	amod	6	SENT_294	[p7l670t3404r858b3434],
6	ribozymes	NNS	O	ribozyme	dep	1	SENT_294	[p7l875t3404r1047b3442],
7	or	CC	O	or	_	0	SENT_294	[p7l1060t3413r1095b3433],
8	anti-Mdrl	JJ	O	anti-mdrl	amod	10	SENT_294	[p7l1109t3404r1272b3434],
9	monoclonal	JJ	O	monoclonal	amod	10	SENT_294	[p7l1290t3405r1484b3434],
10	antibodies	NNS	O	antibody	conj_or	3	SENT_294	[p7l1499t3404r1678b3434],
11	.	.	O	.	_	0	SENT_294	[p7l1499t3404r1678b3434],

1	MRK16	NN	O	mrk16	nsubjpass	17	SENT_295	[p7l1694t3404r1800b3434, p7l504t3452r551b3488],
2	,	,	O	,	_	0	SENT_295	[p7l1694t3404r1800b3434, p7l504t3452r551b3488],
3	a	DT	O	a	det	5	SENT_295	[p7l569t3461r587b3483],
4	monoclonal	JJ	O	monoclonal	amod	5	SENT_295	[p7l604t3451r799b3483],
5	antibody	NN	O	antibody	appos	1	SENT_295	[p7l817t3451r962b3492],
6	developed	VBN	O	develop	partmod	5	SENT_295	[p7l978t3452r1149b3492],
7	against	IN	O	against	_	0	SENT_295	[p7l1167t3451r1284b3492],
8	an	DT	O	a	det	10	SENT_295	[p7l1301t3461r1339b3483],
9	extemal	JJ	O	extemal	amod	10	SENT_295	[p7l1356t3452r1489b3484],
10	epitope	NN	O	epitope	prep_against	6	SENT_295	[p7l1507t3452r1629b3492],
11	of	IN	O	of	_	0	SENT_295	[p7l1647t3452r1684b3483],
12	the	DT	O	the	det	13	SENT_295	[p7l1698t3452r1748b3483],
13	Pglycoprotein	NN	LOCATION	pglycoprotein	prep_of	10	SENT_295	[p7l1765t3452r1801b3483, p7l499t3503r719b3543],
14	,	,	O	,	_	0	SENT_295	[p7l1765t3452r1801b3483, p7l499t3503r719b3543],
15	has	VBZ	O	have	aux	17	SENT_295	[p7l737t3503r791b3533],
16	been	VBN	O	be	auxpass	17	SENT_295	[p7l808t3503r886b3534],
17	shown	VBN	O	show	_	0	SENT_295	[p7l903t3502r1012b3534],
18	to	TO	O	to	aux	19	SENT_295	[p7l1028t3507r1061b3534],
19	inhibit	VB	O	inhibit	xcomp	17	SENT_295	[p7l1078t3502r1186b3534],
20	tumor	NN	O	tumor	nn	21	SENT_295	[p7l1203t3507r1302b3534],
21	formation	NN	O	formation	dobj	19	SENT_295	[p7l1318t3502r1481b3534],
22	and	CC	O	and	_	0	SENT_295	[p7l1499t3503r1558b3534],
23	reduce	VB	O	reduce	conj_and	19	SENT_295	[p7l1574t3503r1685b3534],
24	tumor	NN	O	tumor	nn	25	SENT_295	[p7l1703t3508r1802b3534],
25	volume	NN	O	volume	dobj	23	SENT_295	[p7l500t3554r624b3585],
26	when	WRB	O	when	advmod	27	SENT_295	[p7l635t3554r725b3585],
27	administered	VBN	O	administer	advcl	23	SENT_295	[p7l735t3553r949b3585],
28	to	TO	O	to	_	0	SENT_295	[p7l959t3558r991b3585],
29	mice	NNS	O	mouse	prep_to	27	SENT_295	[p7l1002t3553r1082b3585],
30	bearing	VBG	O	bear	_	0	SENT_295	[p7l1093t3553r1217b3594],
31	multidrug-resistant	JJ	O	multidrug-resistant	amod	35	SENT_295	[p7l1228t3554r1544b3595],
32	human	JJ	O	human	amod	35	SENT_295	[p7l1553t3554r1666b3585],
33	ovarian	JJ	O	ovarian	amod	35	SENT_295	[p7l1678t3553r1801b3585],
34	cancer	NN	O	cancer	nn	35	SENT_295	[p7l499t3613r610b3636],
35	xenografts	NNS	O	xenograft	prep_bearing	29	SENT_295	[p7l621t3604r795b3645],
36	(	VBP	O	(	dep	35	SENT_295	[p7l808t3604r947b3643],
37	74	CD	NUMBER	74	dobj	36	SENT_295	[p7l808t3604r947b3643],
38	-	:	O	-	_	0	SENT_295	[p7l808t3604r947b3643],
39	'	''	DATE	'	_	0	SENT_295	[p7l808t3604r947b3643],
40	77	CD	DATE	77	num	41	SENT_295	[p7l808t3604r947b3643],
41	)	NN	O	)	dobj	19	SENT_295	[p7l808t3604r947b3643],
42	.	.	O	.	_	0	SENT_295	[p7l808t3604r947b3643],

1	Fogler	NNP	PERSON	Fogler	dep	8	SENT_296	[p7l961t3604r1071b3644],
2	et	FW	O	et	dep	1	SENT_296	[p7l1082t3610r1111b3636],
3	al	FW	O	al	nn	6	SENT_296	[p7l1123t3604r1152b3636],
4	(	FW	O	(	dep	6	SENT_296	[p7l1166t3604r1232b3642],
5	76	CD	NUMBER	76	num	6	SENT_296	[p7l1166t3604r1232b3642],
6	)	CD	NUMBER	)	advmod	8	SENT_296	[p7l1166t3604r1232b3642],
7	have	VBP	O	have	aux	8	SENT_296	[p7l1244t3605r1322b3636],
8	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_296	[p7l1334t3604r1505b3636],
9	and	CC	O	and	_	0	SENT_296	[p7l1518t3605r1577b3636],
10	extended	VBN	O	extend	conj_and	8	SENT_296	[p7l1589t3604r1740b3636],
11	the	DT	O	the	nsubj	8	SENT_296	[p7l1752t3604r1803b3636],

1	Annu	NNP	PERSON	Annu	_	0	SENT_297	[p8l355t654r378b734],
2	.	.	O	.	_	0	SENT_297	[p8l355t654r378b734],

1	Rev.	NNP	O	Rev.	nn	2	SENT_298	[p8l355t584r378b644],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_298	[p8l355t425r378b573],
3	.	.	O	.	_	0	SENT_298	[p8l355t425r378b573],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_299	[p8l355t304r378b414],
2	.	.	O	.	_	0	SENT_299	[p8l355t304r378b414],

1	1996362161-183	CD	NUMBER	1996362161-183	_	0	SENT_300	[p8l355t58r379b290],
2	.	.	O	.	_	0	SENT_300	[p8l355t58r379b290],

1	Do	VB	O	do	_	0	SENT_301	[p8l355t8r378b47],

1	Annu	NNP	PERSON	Annu	_	0	SENT_302	[p8l356t3056r379b3137],
2	.	.	O	.	_	0	SENT_302	[p8l356t3056r379b3137],

1	Rev.	NNP	O	Rev.	nn	2	SENT_303	[p8l356t2986r379b3046],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_303	[p8l356t2826r379b2975],
3	.	.	O	.	_	0	SENT_303	[p8l356t2826r379b2975],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_304	[p8l356t2706r379b2815],
2	.	.	O	.	_	0	SENT_304	[p8l356t2706r379b2815],

1	1996.36	CD	NUMBER	1996.36	_	0	SENT_305	[p8l356t2580r380b2692],
2	:	:	O	:	_	0	SENT_305	[p8l356t2580r380b2692],
3	161-183	CD	NUMBER	161-183	dep	1	SENT_305	[p8l356t2460r379b2574],
4	.	.	O	.	_	0	SENT_305	[p8l356t2460r379b2574],

1	Downloaded	VBN	O	download	_	0	SENT_306	[p8l356t2279r379b2449],
2	from	IN	O	from	_	0	SENT_306	[p8l356t2206r379b2270],
3	www.annualreviews.or	NN	O	www.annualreviews.or	nn	4	SENT_306	[p8l356t1890r379b2197],
4	g	NN	O	g	prep_from	1	SENT_306	[p8l363t1868r386b1883],
5	by	IN	O	by	_	0	SENT_306	[p8l388t567r419b599],
6	University	NNP	ORGANIZATION	University	dep	10	SENT_306	[p8l388t418r419b558],
7	of	IN	ORGANIZATION	of	_	0	SENT_306	[p8l388t379r412b408],
8	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	6	SENT_306	[p8l388t232r412b373],
9	-	:	O	-	_	0	SENT_306	[p8l402t214r405b222],
10	Madison	NNP	O	Madison	prep_by	1	SENT_306	[p8l388t87r412b204],
11	on	IN	O	on	_	0	SENT_306	[p8l396t45r412b78],
12	01	CD	NUMBER	01	prep_on	1	SENT_306	[p8l388t7r412b36],

1	by	IN	O	by	dep	6	SENT_307	[p8l389t2968r420b3001],
2	University	NNP	ORGANIZATION	University	pobj	1	SENT_307	[p8l389t2819r420b2959],
3	of	IN	ORGANIZATION	of	_	0	SENT_307	[p8l389t2781r413b2810],
4	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	2	SENT_307	[p8l389t2634r413b2774],
5	-	:	O	-	_	0	SENT_307	[p8l403t2615r406b2624],
6	Madison	NNP	O	Madison	_	0	SENT_307	[p8l389t2489r413b2605],
7	on	IN	O	on	_	0	SENT_307	[p8l397t2447r413b2480],
8	01/05/14	CD	DATE	01/05/14	prep_on	6	SENT_307	[p8l389t2314r413b2438],
9	.	.	O	.	_	0	SENT_307	[p8l389t2314r413b2438],

1	For	IN	O	for	_	0	SENT_308	[p8l390t2257r413b2303],
2	personal	JJ	O	personal	amod	3	SENT_308	[p8l389t2136r420b2249],
3	use	NN	O	use	pobj	1	SENT_308	[p8l397t2083r413b2127],
4	only	RB	O	only	advmod	3	SENT_308	[p8l389t2009r420b2074],
5	.	.	O	.	_	0	SENT_308	[p8l389t2009r420b2074],

1	earlier	JJR	O	earlier	amod	2	SENT_309	[p8l499t9r606b41],
2	observations	NNS	O	observation	_	0	SENT_309	[p8l617t9r826b41],
3	of	IN	O	of	_	0	SENT_309	[p8l839t9r877b41],
4	Pearson	NNP	PERSON	Pearson	prep_of	2	SENT_309	[p8l885t10r1018b41],
5	et	FW	O	et	dep	2	SENT_309	[p8l1029t14r1060b40],
6	al	FW	O	al	nn	9	SENT_309	[p8l1071t10r1101b41],
7	(	FW	O	(	dep	9	SENT_309	[p8l1114t10r1181b47],
8	77	CD	NUMBER	77	num	9	SENT_309	[p8l1114t10r1181b47],
9	)	CD	NUMBER	)	advmod	10	SENT_309	[p8l1114t10r1181b47],
10	demonstrating	VBG	O	demonstrate	partmod	2	SENT_309	[p8l1194t9r1430b50],
11	that	IN	O	that	complm	30	SENT_309	[p8l1443t10r1505b41],
12	monoclonal	JJ	O	monoclonal	amod	14	SENT_309	[p8l1518t9r1713b41],
13	antibody	NN	O	antibody	nn	14	SENT_309	[p8l1726t9r1800b41, p8l499t61r582b100],
14	MRK-I6	NN	O	mrk-i6	nsubj	30	SENT_309	[p8l593t61r752b96],
15	,	,	O	,	_	0	SENT_309	[p8l593t61r752b96],
16	when	WRB	O	when	advmod	17	SENT_309	[p8l765t61r854b91],
17	used	VBN	O	use	dep	14	SENT_309	[p8l864t61r941b91],
18	in	IN	O	in	_	0	SENT_309	[p8l951t61r984b91],
19	combination	NN	O	combination	prep_in	17	SENT_309	[p8l994t61r1201b91],
20	with	IN	O	with	_	0	SENT_309	[p8l1213t61r1286b92],
21	recombinant	JJ	O	recombinant	amod	23	SENT_309	[p8l1297t61r1504b92],
22	human	JJ	O	human	amod	23	SENT_309	[p8l1513t61r1627b92],
23	interferon	NN	O	interferon	prep_with	19	SENT_309	[p8l1639t61r1802b92],
24	01.1	CD	NUMBER	01.1	dep	23	SENT_309	[p8l500t117r559b148],
25	,	,	O	,	_	0	SENT_309	[p8l500t117r559b148],
26	,	,	O	,	_	0	SENT_309	[p8l500t117r559b148],
27	was	VBD	O	be	cop	30	SENT_309	[p8l576t118r641b140],
28	signiﬁcantly	RB	O	signiﬁcantly	advmod	30	SENT_309	[p8l658t109r865b149],
29	more	RBR	O	more	advmod	30	SENT_309	[p8l882t118r967b140],
30	effective	JJ	O	effective	ccomp	10	SENT_309	[p8l983t109r1127b140],
31	than	IN	O	than	_	0	SENT_309	[p8l1145t110r1216b140],
32	MRK-16	NN	MISC	mrk-16	prep_than	30	SENT_309	[p8l1232t109r1381b140],
33	alone	RB	O	alone	advmod	30	SENT_309	[p8l1398t110r1488b141],
34	in	IN	O	in	_	0	SENT_309	[p8l1505t110r1536b141],
35	reversing	VBG	O	reverse	prepc_in	30	SENT_309	[p8l1554t110r1707b149],
36	multidrug	JJ	O	multidrug	amod	37	SENT_309	[p8l1725t110r1801b140, p8l499t159r598b198],
37	resistance	NN	O	resistance	dobj	35	SENT_309	[p8l611t159r775b190],
38	in	FW	O	in	nn	39	SENT_309	[p8l788t158r821b189],
39	vitro	FW	O	vitro	dep	37	SENT_309	[p8l835t159r912b189],
40	and	CC	O	and	_	0	SENT_309	[p8l925t160r985b189],
41	in	FW	O	in	dep	37	SENT_309	[p8l997t159r1029b189],
42	vivo	FW	O	vivo	pobj	41	SENT_309	[p8l1043t159r1116b190],
43	to	TO	O	to	_	0	SENT_309	[p8l1129t164r1161b190],
44	human	JJ	O	human	amod	45	SENT_309	[p8l1174t159r1287b190],
45	xenografts	NNS	O	xenograft	prep_to	35	SENT_309	[p8l1301t159r1484b199],
46	.	.	O	.	_	0	SENT_309	[p8l1301t159r1484b199],

1	Such	JJ	O	such	amod	2	SENT_310	[p8l542t208r624b239],
2	results	NNS	O	result	nsubjpass	5	SENT_310	[p8l645t208r752b239],
3	should	MD	O	should	aux	5	SENT_310	[p8l773t208r883b239],
4	be	VB	O	be	auxpass	5	SENT_310	[p8l904t208r942b238],
5	interpreted	VBN	O	interpret	_	0	SENT_310	[p8l964t208r1142b247],
6	with	IN	O	with	_	0	SENT_310	[p8l1163t208r1235b239],
7	caution	NN	O	caution	prep_with	5	SENT_310	[p8l1256t208r1386b245],
8	,	,	O	,	_	0	SENT_310	[p8l1256t208r1386b245],
9	however	RB	O	however	advmod	5	SENT_310	[p8l1408t209r1559b240],
10	.	.	O	.	_	0	SENT_310	[p8l1408t209r1559b240],

1	The	DT	O	the	det	3	SENT_311	[p8l1581t209r1646b239],
2	MRK16	NN	O	mrk16	nn	3	SENT_311	[p8l1666t208r1802b239],
3	antibody	NN	O	antibody	nsubj	13	SENT_311	[p8l500t257r645b297],
4	is	VBZ	O	be	cop	5	SENT_311	[p8l663t258r689b289],
5	speciﬁc	NN	O	speciﬁc	_	0	SENT_311	[p8l707t257r835b297],
6	for	IN	O	for	_	0	SENT_311	[p8l853t257r902b289],
7	the	DT	O	the	det	9	SENT_311	[p8l917t257r968b289],
8	human	JJ	O	human	amod	9	SENT_311	[p8l984t258r1096b289],
9	P-glycoprotein	NN	MISC	p-glycoprotein	prep_for	5	SENT_311	[p8l1114t258r1360b298],
10	and	CC	O	and	_	0	SENT_311	[p8l1378t258r1437b289],
11	therefore	RB	O	therefore	advmod	13	SENT_311	[p8l1454t258r1603b289],
12	may	MD	O	may	aux	13	SENT_311	[p8l1621t266r1691b298],
13	target	VB	O	target	conj_and	5	SENT_311	[p8l1709t262r1804b297],
14	MDR1	NN	O	mdr1	nn	17	SENT_311	[p8l498t308r809b348],
15	—	NN	O	—	nn	17	SENT_311	[p8l498t308r809b348],
16	expressing	NN	O	expressing	nn	17	SENT_311	[p8l498t308r809b348],
17	cells	NNS	O	cell	dobj	13	SENT_311	[p8l823t308r899b338],
18	in	IN	O	in	_	0	SENT_311	[p8l916t307r946b338],
19	normal	JJ	O	normal	amod	20	SENT_311	[p8l961t307r1078b338],
20	tissues	NNS	O	tissue	prep_in	13	SENT_311	[p8l1094t308r1203b338],
21	as	RB	O	as	_	0	SENT_311	[p8l1219t316r1252b338],
22	well	RB	O	well	_	0	SENT_311	[p8l1269t308r1338b338],
23	as	IN	O	as	_	0	SENT_311	[p8l1354t316r1386b338],
24	in	IN	O	in	_	0	SENT_311	[p8l1402t308r1434b338],
25	tumor	NN	O	tumor	nn	26	SENT_311	[p8l1449t313r1548b339],
26	cells	NNS	O	cell	prep_in	13	SENT_311	[p8l1562t308r1648b343],
27	,	,	O	,	_	0	SENT_311	[p8l1562t308r1648b343],
28	thus	RB	O	thus	dep	29	SENT_311	[p8l1664t308r1732b339],
29	potentially	RB	O	potentially	dep	26	SENT_311	[p8l1747t317r1801b347, p8l500t358r635b398],
30	leading	VBG	O	lead	dep	29	SENT_311	[p8l651t358r772b398],
31	to	TO	O	to	_	0	SENT_311	[p8l787t362r819b390],
32	unacceptable	JJ	O	unacceptable	amod	33	SENT_311	[p8l833t358r1050b399],
33	toxicities	NNS	O	toxicity	prep_to	30	SENT_311	[p8l1065t358r1215b390],
34	that	WDT	O	that	nsubjpass	37	SENT_311	[p8l1230t358r1292b390],
35	would	MD	O	would	aux	37	SENT_311	[p8l1307t358r1409b390],
36	be	VB	O	be	auxpass	37	SENT_311	[p8l1424t358r1463b390],
37	missed	VBN	O	miss	rcmod	26	SENT_311	[p8l1478t357r1592b390],
38	in	IN	O	in	_	0	SENT_311	[p8l1607t358r1638b389],
39	a	DT	O	a	det	41	SENT_311	[p8l1654t367r1672b390],
40	murine	JJ	O	murine	amod	41	SENT_311	[p8l1686t358r1803b390],
41	model	NN	O	model	prep_in	37	SENT_311	[p8l501t409r614b441],
42	.	.	O	.	_	0	SENT_311	[p8l501t409r614b441],

1	The	DT	O	the	det	2	SENT_312	[p8l630t409r695b441],
2	issue	NN	O	issue	nsubj	16	SENT_312	[p8l711t409r794b441],
3	of	IN	O	of	_	0	SENT_312	[p8l809t409r847b441],
4	delivery	NN	O	delivery	prep_of	2	SENT_312	[p8l859t409r995b450],
5	of	IN	O	of	_	0	SENT_312	[p8l1011t408r1049b441],
6	the	DT	O	the	det	7	SENT_312	[p8l1062t409r1111b441],
7	antibody	NN	O	antibody	prep_of	4	SENT_312	[p8l1128t408r1271b450],
8	to	TO	O	to	_	0	SENT_312	[p8l1288t414r1320b441],
9	the	DT	O	the	det	10	SENT_312	[p8l1335t409r1385b441],
10	tumor	NN	O	tumor	prep_to	7	SENT_312	[p8l1402t414r1501b441],
11	is	VBZ	O	be	cop	13	SENT_312	[p8l1516t409r1543b442],
12	also	RB	O	also	advmod	13	SENT_312	[p8l1560t409r1626b441],
13	important	JJ	O	important	_	0	SENT_312	[p8l1642t409r1804b450],
14	and	CC	O	and	_	0	SENT_312	[p8l500t461r560b493],
15	may	MD	O	may	aux	16	SENT_312	[p8l583t471r653b501],
16	present	VB	DATE	present	conj_and	13	SENT_312	[p8l677t466r798b502],
17	a	DT	O	a	det	18	SENT_312	[p8l820t472r839b492],
18	problem	NN	O	problem	dobj	16	SENT_312	[p8l861t461r1008b501],
19	.	.	O	.	_	0	SENT_312	[p8l861t461r1008b501],

1	Studies	NNS	O	study	nsubj	9	SENT_313	[p8l1033t461r1153b493],
2	carried	VBD	O	carry	partmod	1	SENT_313	[p8l1177t461r1292b493],
3	out	RP	O	out	prt	2	SENT_313	[p8l1316t466r1369b492],
4	in	IN	O	in	_	0	SENT_313	[p8l1391t461r1422b493],
5	animal	NN	O	animal	nn	6	SENT_313	[p8l1446t461r1558b493],
6	models	NNS	O	model	prep_in	2	SENT_313	[p8l1582t461r1700b493],
7	have	VBP	O	have	aux	9	SENT_313	[p8l1725t462r1803b493],
8	primarily	RB	O	primarily	advmod	9	SENT_313	[p8l500t513r654b553],
9	utilized	VBN	O	utilize	_	0	SENT_313	[p8l673t513r799b544],
10	intraperitoneally	RB	O	intraperitoneally	advmod	11	SENT_313	[p8l818t513r1092b552],
11	grown	VBN	O	grow	ccomp	9	SENT_313	[p8l1112t523r1217b553],
12	tumors	NNS	O	tumor	dobj	11	SENT_313	[p8l1236t519r1350b544],
13	treated	VBN	O	treat	partmod	12	SENT_313	[p8l1370t514r1483b544],
14	with	IN	O	with	_	0	SENT_313	[p8l1503t514r1576b544],
15	intraperitoneally	RB	O	intraperitoneally	advmod	16	SENT_313	[p8l1595t514r1802b553, p8l499t564r580b602],
16	administered	VBN	O	administer	amod	17	SENT_313	[p8l603t563r817b594],
17	antibodies	NNS	O	antibody	prep_with	13	SENT_313	[p8l840t563r1019b594],
18	.	.	O	.	_	0	SENT_313	[p8l840t563r1019b594],

1	The	DT	O	the	det	2	SENT_314	[p8l1042t563r1107b594],
2	distribution	NN	O	distribution	_	0	SENT_314	[p8l1130t563r1320b594],
3	of	IN	O	of	_	0	SENT_314	[p8l1343t563r1379b593],
4	the	DT	O	the	det	5	SENT_314	[p8l1399t564r1448b594],
5	anti	JJ	O	anti	prep_of	2	SENT_314	[p8l1473t564r1802b603],
6	.	.	O	.	_	0	SENT_314	[p8l1473t564r1802b603],

1	—	NN	O	—	_	0	SENT_315	[p8l1473t564r1802b603],
2	.	.	O	.	_	0	SENT_315	[p8l1473t564r1802b603],

1	P-glycoprotein	NN	O	p-glycoprotein	nn	2	SENT_316	[p8l1473t564r1802b603],
2	antibodies	NNS	O	antibody	nsubj	5	SENT_316	[p8l500t613r671b644],
3	will	MD	O	will	aux	5	SENT_316	[p8l685t613r748b643],
4	be	VB	O	be	cop	5	SENT_316	[p8l762t613r802b644],
5	different	JJ	O	different	_	0	SENT_316	[p8l816t613r960b644],
6	if	IN	O	if	mark	7	SENT_316	[p8l972t614r1001b643],
7	given	VBN	O	give	advcl	5	SENT_316	[p8l1011t613r1102b652],
8	intravenously	RB	O	intravenously	advmod	7	SENT_316	[p8l1117t614r1351b652],
9	,	,	O	,	_	0	SENT_316	[p8l1117t614r1351b652],
10	and	CC	O	and	_	0	SENT_316	[p8l1368t614r1426b644],
11	their	PRP$	O	they	poss	12	SENT_316	[p8l1441t614r1518b644],
12	efficacy	NN	O	efficacy	nsubjpass	15	SENT_316	[p8l1531t614r1664b652],
13	may	MD	O	may	aux	15	SENT_316	[p8l1679t623r1750b653],
14	be	VB	O	be	auxpass	15	SENT_316	[p8l1764t614r1803b644],
15	diminished	VBN	O	diminish	conj_and	5	SENT_316	[p8l500t662r685b694],
16	in	IN	O	in	_	0	SENT_316	[p8l704t663r736b693],
17	animals	NNS	O	animal	prep_in	15	SENT_316	[p8l756t663r885b693],
18	bearing	VBG	O	bear	partmod	17	SENT_316	[p8l904t662r1028b702],
19	tumors	NNS	O	tumor	dobj	18	SENT_316	[p8l1049t667r1162b694],
20	established	VBN	O	establish	partmod	19	SENT_316	[p8l1182t662r1365b694],
21	at	IN	O	at	_	0	SENT_316	[p8l1386t668r1415b694],
22	distal	JJ	O	distal	amod	23	SENT_316	[p8l1434t663r1523b694],
23	sites	NNS	O	site	prep_at	20	SENT_316	[p8l1544t663r1625b694],
24	.	.	O	.	_	0	SENT_316	[p8l1544t663r1625b694],

1	Although	IN	O	although	mark	4	SENT_317	[p8l1646t663r1803b702],
2	these	DT	O	these	det	3	SENT_317	[p8l500t712r585b742],
3	problems	NNS	O	problem	nsubj	4	SENT_317	[p8l603t712r757b750],
4	remain	VBP	O	remain	advcl	16	SENT_317	[p8l774t712r890b742],
5	to	TO	O	to	aux	7	SENT_317	[p8l908t716r939b741],
6	be	VB	O	be	auxpass	7	SENT_317	[p8l956t712r996b741],
7	solved	VBN	O	solve	xcomp	4	SENT_317	[p8l1015t712r1131b747],
8	,	,	O	,	_	0	SENT_317	[p8l1015t712r1131b747],
9	the	DT	O	the	det	10	SENT_317	[p8l1150t712r1200b741],
10	promise	NN	O	promise	nsubj	16	SENT_317	[p8l1217t712r1351b750],
11	of	IN	O	of	_	0	SENT_317	[p8l1369t712r1406b742],
12	such	PDT	O	such	predet	14	SENT_317	[p8l1422t712r1496b742],
13	an	DT	O	a	det	14	SENT_317	[p8l1515t722r1552b742],
14	approach	NN	O	approach	prep_of	10	SENT_317	[p8l1571t713r1722b750],
15	still	RB	O	still	advmod	16	SENT_317	[p8l1742t712r1803b742],
16	bears	VBZ	O	bear	_	0	SENT_317	[p8l499t761r588b791],
17	its	PRP$	O	its	poss	18	SENT_317	[p8l604t760r642b790],
18	continuance	NN	O	continuance	dobj	16	SENT_317	[p8l658t760r867b791],
19	.	.	O	.	_	0	SENT_317	[p8l658t760r867b791],

1	A	DT	O	a	det	3	SENT_318	[p8l543t810r573b840],
2	different	JJ	O	different	amod	3	SENT_318	[p8l585t809r728b840],
3	approach	NN	O	approach	nsubjpass	6	SENT_318	[p8l741t810r893b848],
4	has	VBZ	O	have	aux	6	SENT_318	[p8l905t810r960b840],
5	been	VBN	O	be	auxpass	6	SENT_318	[p8l972t810r1052b840],
6	utilized	VBN	O	utilize	dep	13	SENT_318	[p8l1064t810r1189b840],
7	by	IN	O	by	_	0	SENT_318	[p8l1199t810r1241b848],
8	several	JJ	O	several	amod	9	SENT_318	[p8l1256t810r1371b840],
9	groups	NNS	O	group	agent	6	SENT_318	[p8l1384t819r1496b849],
10	studying	VBG	O	study	xcomp	6	SENT_318	[p8l1510t810r1652b849],
11	genedirected	JJ	O	genedirected	amod	12	SENT_318	[p8l1666t810r1802b849, p8l500t858r602b889],
12	therapies	NNS	O	therapy	dobj	10	SENT_318	[p8l620t858r770b898],
13	(	VBP	O	(	_	0	SENT_318	[p8l791t858r930b896],
14	78	CD	NUMBER	78	num	15	SENT_318	[p8l791t858r930b896],
15	—	CD	NUMBER	—	dobj	13	SENT_318	[p8l791t858r930b896],
16	80	CD	NUMBER	80	num	17	SENT_318	[p8l791t858r930b896],
17	)	NN	O	)	nsubj	13	SENT_318	[p8l791t858r930b896],
18	.	.	O	.	_	0	SENT_318	[p8l791t858r930b896],

1	Scanlon	NNP	PERSON	Scanlon	nsubj	8	SENT_319	[p8l951t859r1084b889],
2	et	FW	O	et	dep	1	SENT_319	[p8l1104t863r1133b889],
3	al	FW	O	al	nn	4	SENT_319	[p8l1151t859r1182b889],
4	(	FW	O	(	dep	1	SENT_319	[p8l1202t858r1268b896],
5	80	CD	NUMBER	80	number	6	SENT_319	[p8l1202t858r1268b896],
6	)	CD	NUMBER	)	dep	4	SENT_319	[p8l1202t858r1268b896],
7	have	VBP	O	have	aux	8	SENT_319	[p8l1289t859r1367b889],
8	been	VBN	O	be	_	0	SENT_319	[p8l1385t859r1464b889],
9	at	IN	O	at	_	0	SENT_319	[p8l1484t863r1514b889],
10	the	DT	O	the	det	11	SENT_319	[p8l1533t859r1583b890],
11	forefront	NN	O	forefront	prep_at	8	SENT_319	[p8l1603t859r1751b890],
12	of	IN	O	of	_	0	SENT_319	[p8l1770t859r1805b889],
13	utilizing	VBG	O	utilize	prepc_of	11	SENT_319	[p8l500t908r639b948],
14	ribozyme	NN	O	ribozyme	nn	15	SENT_319	[p8l651t909r810b948],
15	technology	NN	O	technology	dobj	13	SENT_319	[p8l823t909r1007b948],
16	to	TO	O	to	aux	17	SENT_319	[p8l1021t914r1052b939],
17	reverse	VB	O	reverse	xcomp	13	SENT_319	[p8l1066t918r1186b939],
18	drug	NN	O	drug	nn	19	SENT_319	[p8l1200t908r1275b949],
19	resistance	NN	O	resistance	dobj	17	SENT_319	[p8l1287t908r1460b940],
20	.	.	O	.	_	0	SENT_319	[p8l1287t908r1460b940],

1	They	PRP	O	they	nsubj	4	SENT_320	[p8l1475t909r1558b949],
2	have	VBP	O	have	aux	4	SENT_320	[p8l1573t909r1651b939],
3	successfully	RB	O	successfully	advmod	4	SENT_320	[p8l1666t918r1802b940, p8l501t958r579b997],
4	employed	VBN	O	employ	_	0	SENT_320	[p8l595t958r759b997],
5	both	CC	O	both	preconj	8	SENT_320	[p8l774t958r848b988],
6	anti	JJ	O	anti	amod	8	SENT_320	[p8l864t958r1031b988],
7	—	NN	O	—	nn	8	SENT_320	[p8l864t958r1031b988],
8	mdr1	NN	O	mdr1	nsubj	13	SENT_320	[p8l864t958r1031b988],
9	and	CC	O	and	_	0	SENT_320	[p8l1050t959r1110b989],
10	anti-fos	JJ	O	anti-fos	amod	11	SENT_320	[p8l1126t958r1252b989],
11	ribozymes	NNS	O	ribozyme	conj_and	8	SENT_320	[p8l1268t959r1440b997],
12	to	TO	O	to	aux	13	SENT_320	[p8l1456t963r1488b989],
13	reverse	VB	O	reverse	xcomp	4	SENT_320	[p8l1504t967r1624b989],
14	multidrug	JJ	O	multidrug	amod	15	SENT_320	[p8l1640t959r1803b997],
15	resistance	NN	O	resistance	nsubj	21	SENT_320	[p8l500t1007r663b1037],
16	in	IN	O	in	_	0	SENT_320	[p8l684t1007r716b1037],
17	human	JJ	O	human	amod	20	SENT_320	[p8l735t1007r849b1037],
18	tumor	NN	O	tumor	nn	20	SENT_320	[p8l869t1012r969b1037],
19	cell	NN	O	cell	nn	20	SENT_320	[p8l987t1008r1048b1037],
20	lines	NNS	O	line	prep_in	15	SENT_320	[p8l1068t1007r1145b1037],
21	(	VBP	O	(	ccomp	13	SENT_320	[p8l1166t1007r1242b1044],
22	80	CD	NUMBER	80	number	23	SENT_320	[p8l1166t1007r1242b1044],
23	)	CD	NUMBER	)	dobj	21	SENT_320	[p8l1166t1007r1242b1044],
24	.	.	O	.	_	0	SENT_320	[p8l1166t1007r1242b1044],

1	Although	IN	O	although	mark	4	SENT_321	[p8l1265t1008r1420b1047],
2	ribozyme	NN	O	ribozyme	nn	3	SENT_321	[p8l1441t1008r1598b1047],
3	technology	NN	O	technology	nsubj	4	SENT_321	[p8l1619t1008r1802b1047],
4	represents	VBZ	O	represent	advcl	26	SENT_321	[p8l500t1062r668b1095],
5	a	DT	O	a	det	10	SENT_321	[p8l681t1066r700b1086],
6	very	RB	O	very	advmod	7	SENT_321	[p8l712t1066r784b1095],
7	promising	JJ	O	promising	amod	10	SENT_321	[p8l796t1057r964b1096],
8	and	CC	O	and	_	0	SENT_321	[p8l976t1057r1037b1087],
9	novel	JJ	O	novel	conj_and	7	SENT_321	[p8l1048t1057r1140b1087],
10	approach	NN	O	approach	dobj	4	SENT_321	[p8l1153t1058r1304b1095],
11	to	TO	O	to	aux	12	SENT_321	[p8l1316t1062r1347b1087],
12	reverse	VB	O	reverse	xcomp	4	SENT_321	[p8l1359t1066r1479b1087],
13	drug	NN	O	drug	nn	14	SENT_321	[p8l1492t1057r1566b1096],
14	resistance	NN	O	resistance	dobj	12	SENT_321	[p8l1579t1057r1751b1092],
15	,	,	O	,	_	0	SENT_321	[p8l1579t1057r1751b1092],
16	an	DT	O	a	det	18	SENT_321	[p8l1766t1066r1803b1087],
17	effective	JJ	O	effective	amod	18	SENT_321	[p8l501t1105r646b1136],
18	means	NNS	O	means	nsubjpass	26	SENT_321	[p8l667t1115r773b1136],
19	of	IN	O	of	_	0	SENT_321	[p8l794t1106r831b1136],
20	delivery	NN	O	delivery	prep_of	18	SENT_321	[p8l849t1106r985b1145],
21	to	TO	O	to	_	0	SENT_321	[p8l1005t1111r1037b1136],
22	the	DT	O	the	det	23	SENT_321	[p8l1057t1106r1108b1136],
23	tumor	NN	O	tumor	prep_to	20	SENT_321	[p8l1129t1111r1228b1136],
24	must	MD	O	must	aux	26	SENT_321	[p8l1248t1111r1328b1137],
25	be	VB	O	be	auxpass	26	SENT_321	[p8l1348t1106r1386b1137],
26	developed	VBN	O	develop	_	0	SENT_321	[p8l1408t1106r1579b1146],
27	prior	RB	O	prior	_	0	SENT_321	[p8l1600t1106r1681b1146],
28	to	TO	O	to	_	0	SENT_321	[p8l1701t1112r1733b1136],
29	the	DT	O	the	det	30	SENT_321	[p8l1754t1107r1804b1136],
30	initiation	NN	O	initiation	prep_prior_to	26	SENT_321	[p8l500t1153r650b1184],
31	of	IN	O	of	_	0	SENT_321	[p8l664t1154r700b1184],
32	clinical	JJ	O	clinical	amod	33	SENT_321	[p8l711t1154r834b1185],
33	trials	NNS	O	trial	prep_of	30	SENT_321	[p8l847t1154r938b1185],
34	.	.	O	.	_	0	SENT_321	[p8l847t1154r938b1185],

1	Annual	JJ	SET	annual	amod	2	SENT_322	[p8l446t1265r567b1294],
2	Reviews	NNS	O	review	_	0	SENT_322	[p8l579t1265r720b1303],
3	.	.	O	.	_	0	SENT_322	[p8l953t1298r958b1303],

1	www.annualrev1ews.org/aronlrne	NN	O	www.annualrev1ews.org/aronlrne	_	0	SENT_323	[p8l446t1298r1000b1336],

1	172	CD	NUMBER	172	num	2	SENT_324	[p8l499t1420r552b1449],
2	BELLAMY	NN	O	bellamy	_	0	SENT_324	[p8l621t1420r803b1449],

1	Chemosensitization	NN	O	chemosensitization	_	0	SENT_325	[p8l498t1513r887b1552],

1	The	DT	O	the	det	2	SENT_326	[p8l495t1584r561b1614],
2	approach	NN	O	approach	nsubj	3	SENT_326	[p8l569t1583r723b1623],
3	receiving	VBG	O	receive	dep	10	SENT_326	[p8l730t1584r887b1623],
4	the	DT	O	the	dobj	3	SENT_326	[p8l894t1583r945b1613],
5	most	RBS	O	most	advmod	4	SENT_326	[p8l953t1588r1035b1614],
6	attention	NN	O	attention	nsubj	10	SENT_326	[p8l1042t1583r1188b1614],
7	has	VBZ	O	have	aux	10	SENT_326	[p8l1197t1584r1251b1614],
8	been	VBN	O	be	cop	10	SENT_326	[p8l1260t1584r1339b1614],
9	the	DT	O	the	det	10	SENT_326	[p8l1348t1583r1398b1614],
10	use	NN	O	use	_	0	SENT_326	[p8l1407t1593r1463b1614],
11	of	IN	O	of	_	0	SENT_326	[p8l1471t1584r1509b1614],
12	chemosensitizers	NNS	O	chemosensitizer	prep_of	10	SENT_326	[p8l1514t1584r1798b1615],
13	to	TO	O	to	aux	14	SENT_326	[p8l496t1633r529b1659],
14	reverse	VB	O	reverse	infmod	12	SENT_326	[p8l539t1638r661b1660],
15	Mdrl-mediated	JJ	MISC	mdrl-mediated	amod	17	SENT_326	[p8l672t1628r931b1659],
16	drug	NN	O	drug	nn	17	SENT_326	[p8l941t1628r1017b1668],
17	resistance	NN	O	resistance	dobj	14	SENT_326	[p8l1027t1629r1201b1659],
18	.	.	O	.	_	0	SENT_326	[p8l1027t1629r1201b1659],

1	This	DT	O	this	det	2	SENT_327	[p8l1213t1629r1286b1659],
2	work	NN	O	work	nsubjpass	4	SENT_327	[p8l1299t1628r1385b1659],
3	is	VBZ	O	be	auxpass	4	SENT_327	[p8l1396t1628r1422b1659],
4	based	VBN	O	base	_	0	SENT_327	[p8l1433t1629r1529b1660],
5	on	IN	O	on	_	0	SENT_327	[p8l1541t1637r1582b1659],
6	the	DT	O	the	det	7	SENT_327	[p8l1594t1629r1644b1659],
7	observations	NNS	O	observation	prep_on	4	SENT_327	[p8l1655t1629r1798b1660, p8l497t1673r578b1704],
8	by	IN	O	by	_	0	SENT_327	[p8l587t1674r631b1713],
9	Tsuruo	NNP	PERSON	Tsuruo	prep_by	7	SENT_327	[p8l640t1673r759b1704],
10	et	FW	O	et	nn	12	SENT_327	[p8l769t1678r799b1704],
11	al	FW	O	al	nn	12	SENT_327	[p8l809t1674r840b1704],
12	(	FW	O	(	dobj	4	SENT_327	[p8l850t1673r915b1711],
13	81	CD	NUMBER	81	npadvmod	4	SENT_327	[p8l850t1673r915b1711],
14	,	,	O	,	_	0	SENT_327	[p8l850t1673r915b1711],
15	82	CD	NUMBER	82	num	16	SENT_327	[p8l927t1673r990b1710],
16	)	NN	O	)	appos	13	SENT_327	[p8l927t1673r990b1710],
17	,	,	O	,	_	0	SENT_327	[p8l927t1673r990b1710],
18	who	WP	O	who	nsubj	19	SENT_327	[p8l1002t1674r1074b1704],
19	reported	VBD	O	report	rcmod	13	SENT_327	[p8l1083t1674r1222b1712],
20	that	IN	O	that	complm	32	SENT_327	[p8l1234t1674r1295b1704],
21	certain	JJ	O	certain	amod	22	SENT_327	[p8l1306t1673r1419b1704],
22	compounds	NNS	O	compound	nsubj	32	SENT_327	[p8l1430t1674r1631b1713],
23	,	,	O	,	_	0	SENT_327	[p8l1430t1674r1631b1713],
24	including	VBG	O	include	_	0	SENT_327	[p8l1642t1674r1799b1713],
25	the	DT	O	the	det	29	SENT_327	[p8l496t1722r547b1754],
26	calcium	NN	O	calcium	nn	29	SENT_327	[p8l560t1723r693b1754],
27	channel	NN	O	channel	nn	29	SENT_327	[p8l704t1722r833b1753],
28	blocker	NN	O	blocker	nn	29	SENT_327	[p8l845t1722r972b1754],
29	verapamil	NN	O	verapamil	prep_including	22	SENT_327	[p8l982t1722r1157b1763],
30	,	,	O	,	_	0	SENT_327	[p8l982t1722r1157b1763],
31	were	VBD	O	be	cop	32	SENT_327	[p8l1172t1732r1251b1754],
32	able	JJ	O	able	ccomp	19	SENT_327	[p8l1264t1723r1332b1754],
33	to	TO	O	to	aux	34	SENT_327	[p8l1346t1727r1377b1753],
34	reverse	VB	O	reverse	xcomp	32	SENT_327	[p8l1390t1732r1510b1754],
35	vincristine	NN	O	vincristine	nn	36	SENT_327	[p8l1523t1722r1697b1754],
36	resistance	NN	O	resistance	dobj	34	SENT_327	[p8l1710t1722r1798b1754, p8l496t1784r585b1811],
37	in	IN	O	in	_	0	SENT_327	[p8l598t1779r630b1810],
38	murine	JJ	O	murine	amod	40	SENT_327	[p8l643t1779r762b1811],
39	leukemia	NN	O	leukemia	nn	40	SENT_327	[p8l775t1778r927b1811],
40	cells	NNS	O	cell	prep_in	4	SENT_327	[p8l940t1779r1025b1810],
41	.	.	O	.	_	0	SENT_327	[p8l940t1779r1025b1810],

1	This	DT	O	this	nsubj	2	SENT_328	[p8l1038t1779r1112b1810],
2	opened	VBD	O	open	_	0	SENT_328	[p8l1127t1780r1246b1819],
3	the	DT	O	the	det	4	SENT_328	[p8l1259t1780r1310b1811],
4	door	NN	O	door	dobj	2	SENT_328	[p8l1322t1779r1399b1810],
5	for	IN	O	for	_	0	SENT_328	[p8l1412t1779r1460b1810],
6	the	DT	O	the	det	7	SENT_328	[p8l1473t1780r1523b1811],
7	development	NN	O	development	prep_for	2	SENT_328	[p8l1536t1779r1752b1820],
8	of	IN	O	of	_	0	SENT_328	[p8l1766t1779r1802b1810],
9	new	JJ	O	new	amod	10	SENT_328	[p8l496t1844r566b1868],
10	strategies	NNS	O	strategy	prep_of	7	SENT_328	[p8l582t1835r737b1876],
11	to	TO	O	to	aux	12	SENT_328	[p8l751t1840r785b1867],
12	overcome	VB	O	overcome	xcomp	2	SENT_328	[p8l799t1844r962b1868],
13	P-glycoprotein	NN	O	p-glycoprotein	nn	14	SENT_328	[p8l976t1835r1397b1877],
14	—	NN	O	—	nsubj	15	SENT_328	[p8l976t1835r1397b1877],
15	mediated	VBD	O	mediate	ccomp	12	SENT_328	[p8l976t1835r1397b1877],
16	MDR	NNP	O	MDR	dobj	15	SENT_328	[p8l1412t1836r1514b1868],
17	.	.	O	.	_	0	SENT_328	[p8l1412t1836r1514b1868],

1	To	TO	O	to	_	0	SENT_329	[p8l1531t1836r1577b1868],
2	date	NN	O	date	prep_to	21	SENT_329	[p8l1592t1836r1669b1873],
3	,	,	O	,	_	0	SENT_329	[p8l1592t1836r1669b1873],
4	a	DT	O	a	det	6	SENT_329	[p8l1686t1845r1705b1868],
5	wide	JJ	O	wide	amod	6	SENT_329	[p8l1719t1836r1800b1868],
6	variety	NN	O	variety	nsubj	21	SENT_329	[p8l496t1892r613b1934],
7	of	IN	O	of	_	0	SENT_329	[p8l629t1892r666b1925],
8	compounds	NNS	O	compound	prep_of	6	SENT_329	[p8l679t1893r871b1933],
9	representing	VBG	O	represent	partmod	8	SENT_329	[p8l887t1893r1093b1934],
10	several	JJ	O	several	amod	13	SENT_329	[p8l1110t1893r1226b1924],
11	different	JJ	O	different	amod	13	SENT_329	[p8l1242t1893r1386b1925],
12	drug	NN	O	drug	nn	13	SENT_329	[p8l1402t1893r1477b1934],
13	classes	NNS	O	class	nsubjpass	16	SENT_329	[p8l1494t1893r1608b1925],
14	have	VBP	O	have	aux	16	SENT_329	[p8l1625t1893r1704b1925],
15	been	VBN	O	be	auxpass	16	SENT_329	[p8l1721t1893r1799b1925],
16	shown	VBN	O	show	ccomp	9	SENT_329	[p8l498t1942r607b1973],
17	to	TO	O	to	aux	18	SENT_329	[p8l626t1947r658b1973],
18	modulate	VB	O	modulate	xcomp	16	SENT_329	[p8l677t1941r832b1973],
19	P-glycoprotein	NN	O	p-glycoprotein	nn	20	SENT_329	[p8l851t1941r1271b1981],
20	—	NN	O	—	dobj	18	SENT_329	[p8l851t1941r1271b1981],
21	mediated	VBD	O	mediate	_	0	SENT_329	[p8l851t1941r1271b1981],
22	MDR	NNP	ORGANIZATION	MDR	nsubj	26	SENT_329	[p8l1291t1942r1386b1973],
23	in	FW	O	in	prep	22	SENT_329	[p8l1406t1942r1436b1972],
24	vitro	FW	O	vitro	nn	25	SENT_329	[p8l1457t1942r1535b1973],
25	(	FW	O	(	pobj	23	SENT_329	[p8l1556t1942r1622b1979],
26	see	VB	O	see	ccomp	21	SENT_329	[p8l1556t1942r1622b1979],
27	Table	NNP	O	Table	nsubj	29	SENT_329	[p8l1641t1942r1736b1973],
28	4	CD	NUMBER	4	num	29	SENT_329	[p8l1755t1942r1799b1979],
29	)	CD	NUMBER	)	xcomp	26	SENT_329	[p8l1755t1942r1799b1979],
30	.	.	O	.	_	0	SENT_329	[p8l1755t1942r1799b1979],

1	Although	IN	O	although	mark	14	SENT_330	[p8l497t1992r655b2032],
2	the	DT	O	the	det	3	SENT_330	[p8l673t1992r724b2022],
3	mechanism	NN	O	mechanism	nsubjpass	14	SENT_330	[p8l742t1993r933b2022],
4	of	IN	O	of	_	0	SENT_330	[p8l950t1992r986b2022],
5	reversal	NN	O	reversal	prep_of	3	SENT_330	[p8l1001t1992r1133b2023],
6	of	IN	O	of	_	0	SENT_330	[p8l1151t1992r1189b2022],
7	MDR	NN	ORGANIZATION	mdr	prep_of	5	SENT_330	[p8l1204t1993r1299b2022],
8	by	IN	O	by	_	0	SENT_330	[p8l1317t1992r1357b2031],
9	these	DT	O	these	det	10	SENT_330	[p8l1376t1993r1462b2022],
10	agents	NNS	O	agent	prep_by	7	SENT_330	[p8l1480t1997r1585b2031],
11	is	VBZ	O	be	auxpass	14	SENT_330	[p8l1605t1993r1631b2022],
12	not	RB	O	not	neg	14	SENT_330	[p8l1651t1998r1703b2023],
13	fully	RB	O	fully	advmod	14	SENT_330	[p8l1723t1993r1800b2031],
14	understood	VBN	O	understand	advcl	18	SENT_330	[p8l497t2041r692b2077],
15	,	,	O	,	_	0	SENT_330	[p8l497t2041r692b2077],
16	it	PRP	O	it	nsubj	18	SENT_330	[p8l707t2041r731b2072],
17	likely	RB	O	likely	advmod	18	SENT_330	[p8l745t2041r839b2081],
18	involves	VBZ	O	involve	_	0	SENT_330	[p8l854t2041r994b2072],
19	the	DT	O	the	det	20	SENT_330	[p8l1009t2042r1060b2072],
20	alteration	NN	O	alteration	dobj	18	SENT_330	[p8l1075t2041r1231b2072],
21	of	IN	O	of	_	0	SENT_330	[p8l1246t2042r1283b2072],
22	drug	NN	O	drug	nn	23	SENT_330	[p8l1295t2042r1370b2080],
23	transport	NN	O	transport	prep_of	20	SENT_330	[p8l1385t2046r1534b2081],
24	by	IN	O	by	_	0	SENT_330	[p8l1547t2042r1588b2080],
25	competitive	JJ	O	competitive	amod	26	SENT_330	[p8l1603t2042r1801b2081],
26	binding	NN	O	binding	prep_by	18	SENT_330	[p8l497t2091r625b2132],
27	to	TO	O	to	_	0	SENT_330	[p8l645t2097r678b2123],
28	P-glycoprotein	NN	O	p-glycoprotein	nn	30	SENT_330	[p8l698t2091r945b2131],
29	and/or	NN	O	and/or	nn	30	SENT_330	[p8l965t2092r1072b2122],
30	alteration	NN	O	alteration	prep_to	26	SENT_330	[p8l1094t2091r1249b2122],
31	of	IN	O	of	_	0	SENT_330	[p8l1270t2092r1307b2122],
32	the	DT	O	the	det	34	SENT_330	[p8l1325t2091r1375b2122],
33	intracellular	JJ	O	intracellular	amod	34	SENT_330	[p8l1396t2091r1598b2123],
34	binding	NN	O	binding	prep_of	30	SENT_330	[p8l1618t2092r1745b2131],
35	of	IN	O	of	_	0	SENT_330	[p8l1766t2092r1803b2122],
36	chemotherapeutic	JJ	O	chemotherapeutic	amod	37	SENT_330	[p8l498t2142r794b2181],
37	agents	NNS	O	agent	prep_of	34	SENT_330	[p8l804t2146r919b2181],
38	.	.	O	.	_	0	SENT_330	[p8l804t2146r919b2181],

1	For	IN	O	for	_	0	SENT_331	[p8l930t2142r989b2172],
2	a	DT	O	a	det	5	SENT_331	[p8l996t2151r1015b2172],
3	more	RBR	O	more	advmod	5	SENT_331	[p8l1024t2151r1109b2173],
4	thorough	JJ	O	thorough	amod	5	SENT_331	[p8l1119t2142r1268b2181],
5	discussion	NN	O	discussion	prep_for	13	SENT_331	[p8l1278t2142r1450b2173],
6	of	IN	O	of	_	0	SENT_331	[p8l1461t2142r1498b2173],
7	these	DT	O	these	det	8	SENT_331	[p8l1504t2143r1589b2173],
8	compounds	NNS	O	compound	prep_of	5	SENT_331	[p8l1599t2142r1800b2181],
9	,	,	O	,	_	0	SENT_331	[p8l1599t2142r1800b2181],
10	the	DT	O	the	det	11	SENT_331	[p8l498t2191r549b2222],
11	reader	NN	O	reader	nsubjpass	13	SENT_331	[p8l562t2192r668b2222],
12	is	VBZ	O	be	auxpass	13	SENT_331	[p8l679t2191r706b2222],
13	referred	VBN	O	refer	_	0	SENT_331	[p8l719t2191r851b2222],
14	to	TO	O	to	_	0	SENT_331	[p8l863t2196r896b2222],
15	two	CD	NUMBER	two	num	17	SENT_331	[p8l909t2195r971b2222],
16	recent	JJ	O	recent	amod	17	SENT_331	[p8l983t2196r1085b2222],
17	reviews	NNS	O	review	prep_to	13	SENT_331	[p8l1099t2191r1226b2223],
18	on	IN	O	on	_	0	SENT_331	[p8l1240t2200r1281b2222],
19	the	DT	O	the	det	25	SENT_331	[p8l1295t2192r1345b2223],
20	subject	JJ	O	subject	amod	25	SENT_331	[p8l1359t2191r1476b2231],
21	(	NN	O	(	tmod	20	SENT_331	[p8l1489t2192r1554b2230],
22	83	CD	NUMBER	83	num	21	SENT_331	[p8l1489t2192r1554b2230],
23	,	,	O	,	_	0	SENT_331	[p8l1489t2192r1554b2230],
24	84	CD	NUMBER	84	appos	21	SENT_331	[p8l1569t2191r1631b2229],
25	)	NN	O	)	prep_on	17	SENT_331	[p8l1569t2191r1631b2229],
26	.	.	O	.	_	0	SENT_331	[p8l1569t2191r1631b2229],

1	Several	JJ	O	several	amod	2	SENT_332	[p8l541t2242r665b2274],
2	new	JJ	O	new	nsubjpass	8	SENT_332	[p8l675t2250r744b2273],
3	in	FW	O	in	prep	2	SENT_332	[p8l754t2241r786b2273],
4	vivo	FW	O	vivo	nn	5	SENT_332	[p8l795t2242r869b2274],
5	models	NNS	O	model	pobj	3	SENT_332	[p8l879t2241r998b2274],
6	have	VBP	O	have	aux	8	SENT_332	[p8l1007t2242r1086b2274],
7	been	VBN	O	be	auxpass	8	SENT_332	[p8l1095t2242r1174b2274],
8	introduced	VBN	O	introduce	_	0	SENT_332	[p8l1184t2242r1361b2274],
9	to	TO	O	to	aux	10	SENT_332	[p8l1371t2246r1403b2274],
10	study	VB	O	study	xcomp	8	SENT_332	[p8l1413t2242r1501b2282],
11	Mdrl	JJ	O	mdrl	amod	12	SENT_332	[p8l1512t2242r1600b2274],
12	modulators	NNS	O	modulator	nsubj	13	SENT_332	[p8l1615t2242r1800b2274],
13	(	VBP	O	(	ccomp	10	SENT_332	[p8l499t2292r638b2331],
14	85-87	CD	NUMBER	85-87	num	15	SENT_332	[p8l499t2292r638b2331],
15	)	CD	NUMBER	)	dobj	13	SENT_332	[p8l499t2292r638b2331],
16	.	.	O	.	_	0	SENT_332	[p8l499t2292r638b2331],

1	Mickisch	NNP	O	Mickisch	nsubj	5	SENT_333	[p8l651t2292r806b2325],
2	et	FW	O	et	nn	3	SENT_333	[p8l817t2297r849b2324],
3	al	FW	O	al	dep	1	SENT_333	[p8l859t2292r889b2324],
4	have	VBP	O	have	aux	5	SENT_333	[p8l899t2292r978b2324],
5	developed	VBN	O	develop	_	0	SENT_333	[p8l989t2292r1160b2333],
6	a	DT	O	a	det	8	SENT_333	[p8l1171t2301r1189b2324],
7	transgenic	JJ	O	transgenic	amod	8	SENT_333	[p8l1201t2292r1370b2333],
8	mouse	NN	O	mouse	dobj	5	SENT_333	[p8l1382t2302r1491b2325],
9	in	IN	O	in	_	0	SENT_333	[p8l1503t2293r1533b2324],
10	which	WDT	O	which	rel	17	SENT_333	[p8l1546t2292r1646b2324],
11	the	DT	O	the	det	14	SENT_333	[p8l1659t2293r1709b2324],
12	bone	NN	O	bone	nn	14	SENT_333	[p8l1719t2293r1801b2325],
13	marrow	NN	O	marrow	nn	14	SENT_333	[p8l499t2352r628b2375],
14	cells	NNS	O	cell	nsubjpass	17	SENT_333	[p8l641t2342r718b2375],
15	have	VBP	O	have	aux	17	SENT_333	[p8l731t2342r810b2374],
16	been	VBN	O	be	auxpass	17	SENT_333	[p8l822t2343r901b2375],
17	transfected	VBN	O	transfect	rcmod	8	SENT_333	[p8l914t2342r1096b2375],
18	with	IN	O	with	_	0	SENT_333	[p8l1111t2342r1183b2374],
19	the	DT	O	the	det	23	SENT_333	[p8l1197t2343r1247b2375],
20	human	JJ	O	human	amod	23	SENT_333	[p8l1260t2343r1373b2375],
21	MDR	NN	O	mdr	nn	23	SENT_333	[p8l1385t2343r1493b2374],
22	]	NN	O	]	nn	23	SENT_333	[p8l1385t2343r1493b2374],
23	gene	NN	O	gene	prep_with	17	SENT_333	[p8l1511t2352r1589b2384],
24	(	CD	NUMBER	(	number	25	SENT_333	[p8l1603t2342r1680b2381],
25	86	CD	NUMBER	86	num	26	SENT_333	[p8l1603t2342r1680b2381],
26	)	NN	O	)	dep	17	SENT_333	[p8l1603t2342r1680b2381],
27	.	.	O	.	_	0	SENT_333	[p8l1603t2342r1680b2381],

1	In	IN	O	in	_	0	SENT_334	[p8l1695t2343r1729b2374],
2	this	DT	O	this	det	3	SENT_334	[p8l1742t2342r1801b2375],
3	model	NN	O	model	prep_in	11	SENT_334	[p8l499t2394r613b2430],
4	,	,	O	,	_	0	SENT_334	[p8l499t2394r613b2430],
5	the	DT	O	the	det	6	SENT_334	[p8l632t2394r683b2425],
6	measurement	NN	O	measurement	nsubj	11	SENT_334	[p8l700t2398r923b2425],
7	of	IN	O	of	_	0	SENT_334	[p8l939t2393r976b2424],
8	white	JJ	O	white	amod	10	SENT_334	[p8l991t2394r1082b2425],
9	blood	NN	O	blood	nn	10	SENT_334	[p8l1100t2393r1195b2424],
10	cell	NN	O	cell	prep_of	6	SENT_334	[p8l1213t2394r1272b2425],
11	counts	VBZ	O	count	_	0	SENT_334	[p8l1291t2398r1398b2425],
12	provides	VBZ	O	provide	ccomp	11	SENT_334	[p8l1417t2394r1559b2433],
13	a	DT	O	a	det	17	SENT_334	[p8l1578t2402r1596b2424],
14	simple	JJ	O	simple	amod	17	SENT_334	[p8l1614t2393r1724b2433],
15	and	CC	O	and	_	0	SENT_334	[p8l1742t2394r1802b2425],
16	reliable	JJ	O	reliable	conj_and	14	SENT_334	[p8l498t2444r624b2475],
17	means	NNS	O	means	nsubj	25	SENT_334	[p8l641t2453r747b2475],
18	of	IN	O	of	_	0	SENT_334	[p8l764t2444r801b2474],
19	assessing	VBG	O	assess	prepc_of	17	SENT_334	[p8l815t2444r969b2483],
20	the	DT	O	the	det	21	SENT_334	[p8l985t2445r1035b2474],
21	potency	NN	O	potency	dobj	19	SENT_334	[p8l1052t2449r1183b2483],
22	of	IN	O	of	_	0	SENT_334	[p8l1201t2444r1238b2474],
23	MDR-reversing	JJ	O	mdr-reversing	amod	24	SENT_334	[p8l1251t2444r1515b2483],
24	agents	NNS	O	agent	prep_of	21	SENT_334	[p8l1532t2449r1637b2482],
25	(	VBP	O	(	ccomp	12	SENT_334	[p8l1656t2444r1719b2481],
26	86	CD	NUMBER	86	dobj	25	SENT_334	[p8l1656t2444r1719b2481],
27	,	,	O	,	_	0	SENT_334	[p8l1656t2444r1719b2481],
28	88	CD	NUMBER	88	num	29	SENT_334	[p8l1738t2444r1800b2480],
29	)	NN	O	)	appos	26	SENT_334	[p8l1738t2444r1800b2480],
30	.	.	O	.	_	0	SENT_334	[p8l1738t2444r1800b2480],

1	Unfortunately	RB	O	unfortunately	advmod	7	SENT_335	[p8l499t2493r732b2531],
2	this	DT	O	this	det	3	SENT_335	[p8l750t2493r809b2523],
3	model	NN	O	model	nsubj	7	SENT_335	[p8l826t2493r929b2523],
4	does	VBZ	O	do	aux	7	SENT_335	[p8l947t2493r1023b2523],
5	not	RB	O	not	neg	7	SENT_335	[p8l1039t2498r1094b2523],
6	directly	RB	O	directly	advmod	7	SENT_335	[p8l1110t2492r1235b2531],
7	assess	VB	O	assess	_	0	SENT_335	[p8l1254t2501r1354b2523],
8	the	DT	O	the	det	9	SENT_335	[p8l1371t2493r1422b2523],
9	ability	NN	O	ability	dobj	7	SENT_335	[p8l1440t2493r1544b2532],
10	of	IN	O	of	_	0	SENT_335	[p8l1563t2492r1599b2522],
11	these	DT	O	these	det	12	SENT_335	[p8l1614t2493r1699b2523],
12	compounds	NNS	O	compound	prep_of	9	SENT_335	[p8l1717t2501r1801b2523, p8l498t2543r619b2582],
13	to	TO	O	to	aux	14	SENT_335	[p8l632t2547r665b2573],
14	eradicate	VB	O	eradicate	xcomp	7	SENT_335	[p8l677t2542r827b2573],
15	the	DT	O	the	det	17	SENT_335	[p8l840t2543r892b2573],
16	tumor	NN	O	tumor	nn	17	SENT_335	[p8l904t2546r1004b2572],
17	population	NN	O	population	dobj	14	SENT_335	[p8l1016t2542r1202b2582],
18	.	.	O	.	_	0	SENT_335	[p8l1016t2542r1202b2582],

1	We	PRP	O	we	nsubj	3	SENT_336	[p8l542t2593r600b2624],
2	have	VBP	O	have	aux	3	SENT_336	[p8l611t2593r690b2624],
3	established	VBN	O	establish	_	0	SENT_336	[p8l702t2592r887b2624],
4	a	DT	O	a	det	8	SENT_336	[p8l899t2601r918b2623],
5	reproducible	JJ	O	reproducible	dep	8	SENT_336	[p8l929t2592r1138b2632],
6	in	FW	O	in	nn	7	SENT_336	[p8l1151t2592r1183b2623],
7	vivo	FW	O	vivo	dep	5	SENT_336	[p8l1195t2593r1268b2624],
8	model	NN	O	model	dobj	3	SENT_336	[p8l1280t2592r1384b2624],
9	of	IN	O	of	_	0	SENT_336	[p8l1396t2592r1432b2623],
10	human	JJ	O	human	amod	12	SENT_336	[p8l1442t2593r1555b2624],
11	multiple	JJ	O	multiple	amod	12	SENT_336	[p8l1567t2592r1705b2632],
12	myeloma	NN	O	myeloma	prep_of	8	SENT_336	[p8l1718t2601r1802b2633, p8l500t2642r584b2673],
13	in	IN	O	in	_	0	SENT_336	[p8l598t2643r630b2673],
14	the	DT	O	the	det	21	SENT_336	[p8l645t2643r696b2673],
15	severe	JJ	O	severe	amod	21	SENT_336	[p8l711t2651r817b2673],
16	combined	JJ	O	combined	amod	21	SENT_336	[p8l831t2642r995b2673],
17	immunodeﬁcient	JJ	O	immunodeﬁcient	amod	21	SENT_336	[p8l1009t2642r1293b2673],
18	(	NN	O	(	nn	21	SENT_336	[p8l1308t2642r1429b2680],
19	SCID	NN	ORGANIZATION	scid	nn	21	SENT_336	[p8l1308t2642r1429b2680],
20	)	NN	O	)	nn	21	SENT_336	[p8l1308t2642r1429b2680],
21	mouse	NN	O	mouse	prep_in	3	SENT_336	[p8l1445t2651r1553b2673],
22	by	IN	O	by	_	0	SENT_336	[p8l1568t2642r1609b2681],
23	using	VBG	O	use	prepc_by	3	SENT_336	[p8l1624t2642r1713b2682],
24	both	CC	O	both	preconj	30	SENT_336	[p8l1728t2642r1802b2673],
25	the	DT	O	the	det	30	SENT_336	[p8l500t2693r550b2724],
26	RPMI	NN	O	rpmus	nn	30	SENT_336	[p8l568t2693r671b2724],
27	8226	CD	DATE	8226	num	30	SENT_336	[p8l688t2692r769b2724],
28	human	JJ	O	human	amod	30	SENT_336	[p8l786t2693r900b2724],
29	myeloma	NN	O	myeloma	nn	30	SENT_336	[p8l917t2693r1072b2732],
30	cell	NN	O	cell	dobj	23	SENT_336	[p8l1087t2692r1147b2724],
31	line	NN	O	line	dep	30	SENT_336	[p8l1166t2692r1226b2723],
32	and	CC	O	and	_	0	SENT_336	[p8l1245t2693r1304b2725],
33	a	DT	O	a	det	35	SENT_336	[p8l1321t2702r1339b2725],
34	P-glycoprotein	NN	O	p-glycoprotein	nn	35	SENT_336	[p8l1357t2693r1802b2733],
35	—	NN	O	—	conj_and	30	SENT_336	[p8l1357t2693r1802b2733],
36	expressing	VBG	O	express	partmod	35	SENT_336	[p8l1357t2693r1802b2733],
37	multidrug	JJ	O	multidrug	amod	40	SENT_336	[p8l500t2743r817b2785],
38	—	NN	O	—	nn	40	SENT_336	[p8l500t2743r817b2785],
39	resistant	JJ	O	resistant	amod	40	SENT_336	[p8l500t2743r817b2785],
40	subline	NN	O	subline	dobj	36	SENT_336	[p8l824t2743r945b2775],
41	(	NN	O	(	tmod	36	SENT_336	[p8l953t2743r1016b2781],
42	87	CD	NUMBER	87	num	41	SENT_336	[p8l953t2743r1016b2781],
43	,	,	O	,	_	0	SENT_336	[p8l953t2743r1016b2781],
44	89	CD	NUMBER	89	num	45	SENT_336	[p8l1025t2744r1090b2782],
45	)	NN	O	)	appos	41	SENT_336	[p8l1025t2744r1090b2782],
46	.	.	O	.	_	0	SENT_336	[p8l1025t2744r1090b2782],

1	When	WRB	O	when	advmod	5	SENT_337	[p8l1099t2743r1197b2775],
2	SCID	NN	O	scid	nn	3	SENT_337	[p8l1207t2743r1300b2776],
3	mice	NNS	O	mouse	nsubjpass	5	SENT_337	[p8l1308t2743r1388b2776],
4	were	VBD	O	be	auxpass	5	SENT_337	[p8l1397t2753r1478b2775],
5	injected	VBN	O	inject	advcl	19	SENT_337	[p8l1486t2744r1618b2785],
6	with	IN	O	with	_	0	SENT_337	[p8l1626t2743r1699b2775],
7	either	CC	O	either	preconj	10	SENT_337	[p8l1708t2744r1803b2776],
8	8226	CD	NUMBER	8226	num	10	SENT_337	[p8l502t2793r584b2827],
9	drug	NN	O	drug	nn	10	SENT_337	[p8l602t2794r837b2836],
10	—	NN	O	—	prep_with	5	SENT_337	[p8l602t2794r837b2836],
11	sensitive	JJ	O	sensitive	amod	10	SENT_337	[p8l602t2794r837b2836],
12	or	CC	O	or	_	0	SENT_337	[p8l854t2803r891b2827],
13	multidrug-resistant	JJ	O	multidrug-resistant	amod	15	SENT_337	[p8l908t2793r1222b2836],
14	myeloma	NN	O	myeloma	nn	15	SENT_337	[p8l1241t2794r1396b2836],
15	cells	NNS	O	cell	prep_with	5	SENT_337	[p8l1414t2794r1499b2832],
16	,	,	O	,	_	0	SENT_337	[p8l1414t2794r1499b2832],
17	tumors	NNS	O	tumor	nsubjpass	19	SENT_337	[p8l1518t2799r1633b2827],
18	were	VBD	O	be	auxpass	19	SENT_337	[p8l1652t2804r1732b2827],
19	detected	VBN	O	detect	_	0	SENT_337	[p8l1750t2794r1802b2827, p8l500t2846r601b2878],
20	within	IN	O	within	_	0	SENT_337	[p8l615t2845r722b2878],
21	5	CD	DURATION	5	num	22	SENT_337	[p8l737t2846r756b2878],
22	days	NNS	NUMBER	day	tmod	23	SENT_337	[p8l772t2846r848b2887],
23	aﬁer	JJ	O	aﬁer	amod	24	SENT_337	[p8l864t2845r941b2878],
24	injection	NN	O	injection	prep_within	19	SENT_337	[p8l955t2846r1100b2887],
25	by	IN	O	by	_	0	SENT_337	[p8l1115t2845r1156b2886],
26	the	DT	O	the	det	27	SENT_337	[p8l1172t2846r1222b2877],
27	presence	NN	O	presence	agent	19	SENT_337	[p8l1237t2855r1382b2887],
28	of	IN	O	of	_	0	SENT_337	[p8l1398t2846r1435b2878],
29	human	JJ	O	human	amod	32	SENT_337	[p8l1447t2846r1560b2878],
30	lambda	NN	O	lambda	nn	32	SENT_337	[p8l1576t2846r1699b2878],
31	lightchain	NN	O	lightchain	nn	32	SENT_337	[p8l1713t2846r1802b2887, p8l500t2897r591b2929],
32	excretion	NN	O	excretion	prep_of	27	SENT_337	[p8l610t2896r765b2929],
33	in	IN	O	in	_	0	SENT_337	[p8l784t2897r817b2928],
34	the	DT	O	the	det	36	SENT_337	[p8l836t2897r887b2929],
35	mouse	NN	O	mouse	nn	36	SENT_337	[p8l907t2906r1014b2928],
36	urine	NN	O	urine	prep_in	32	SENT_337	[p8l1033t2897r1127b2928],
37	.	.	O	.	_	0	SENT_337	[p8l1033t2897r1127b2928],

1	Successful	JJ	O	successful	amod	2	SENT_338	[p8l1150t2897r1326b2928],
2	treatment	NN	O	treatment	nsubj	6	SENT_338	[p8l1345t2901r1502b2928],
3	in	IN	O	in	_	0	SENT_338	[p8l1522t2897r1553b2928],
4	this	DT	O	this	det	5	SENT_338	[p8l1574t2897r1632b2928],
5	model	NN	O	model	prep_in	2	SENT_338	[p8l1653t2897r1755b2928],
6	is	VBZ	O	be	_	0	SENT_338	[p8l1777t2896r1802b2928],

1	Table	NNP	O	Table	nn	3	SENT_339	[p8l577t3042r659b3067],
2	4	CD	NUMBER	4	num	3	SENT_339	[p8l668t3042r686b3066],
3	Agents	NNS	O	agent	_	0	SENT_339	[p8l716t3043r810b3073],
4	that	WDT	O	that	nsubj	5	SENT_339	[p8l820t3043r871b3067],
5	reverse	VBP	O	reverse	rcmod	3	SENT_339	[p8l880t3049r976b3067],
6	multidrug	JJ	O	multidrug	amod	8	SENT_339	[p8l986t3043r1117b3073],
7	resistance	NN	O	resistance	nn	8	SENT_339	[p8l1128t3037r1269b3066],
8	‘	NN	O	‘	dobj	5	SENT_339	[p8l1128t3037r1269b3066],

1	Class	NNP	O	Class	nn	2	SENT_340	[p8l577t3132r650b3158],
2	Examples	NNS	O	example	_	0	SENT_340	[p8l1000t3133r1131b3164],

1	Anthracycline	NNP	MISC	Anthracycline	nn	2	SENT_341	[p8l577t3202r765b3234],
2	Analogs	NNS	MISC	analog	dep	7	SENT_341	[p8l776t3203r887b3235],
3	Cyanomorpholino-doxorubicin	NN	MISC	cyanomorpholino-doxorubicin	dep	2	SENT_341	[p8l1000t3202r1419b3234],
4	,	,	O	,	_	0	SENT_341	[p8l1000t3202r1419b3234],
5	N-acetyldaunorubicin	NN	O	n-acetyldaunorubicin	appos	3	SENT_341	[p8l1430t3202r1719b3235],
6	Antibiotics	NNS	O	antibiotic	dep	7	SENT_341	[p8l578t3242r727b3268],
7	Cepharanthidine	NNP	O	Cepharanthidine	dep	28	SENT_341	[p8l1001t3242r1227b3275],
8	,	,	O	,	_	0	SENT_341	[p8l1001t3242r1227b3275],
9	Cefoperazone	NNP	O	Cefoperazone	appos	7	SENT_341	[p8l1239t3243r1430b3275],
10	,	,	O	,	_	0	SENT_341	[p8l1239t3243r1430b3275],
11	Erythromycin	NNP	O	Erythromycin	nn	13	SENT_341	[p8l1441t3242r1626b3275],
12	Antimalarials	NNP	O	Antimalarials	nn	13	SENT_341	[p8l578t3282r759b3307],
13	Chloroquine	NNP	O	Chloroquine	appos	7	SENT_341	[p8l1001t3282r1173b3314],
14	,	,	O	,	_	0	SENT_341	[p8l1001t3282r1173b3314],
15	Quinidine	NNP	O	Quinidine	appos	7	SENT_341	[p8l1186t3282r1324b3312],
16	,	,	O	,	_	0	SENT_341	[p8l1186t3282r1324b3312],
17	Quinine	NNP	ORGANIZATION	Quinine	nn	21	SENT_341	[p8l1337t3282r1443b3312],
18	Calcium	NN	ORGANIZATION	calcium	nn	21	SENT_341	[p8l578t3321r692b3346],
19	Channel	NNP	ORGANIZATION	Channel	nn	21	SENT_341	[p8l701t3321r811b3346],
20	Blockers	NNP	ORGANIZATION	Blockers	nn	21	SENT_341	[p8l822t3321r940b3346],
21	Verapamil	NNP	ORGANIZATION	Verapamil	appos	7	SENT_341	[p8l1001t3321r1149b3353],
22	,	,	O	,	_	0	SENT_341	[p8l1001t3321r1149b3353],
23	Nicardapine	NNP	O	Nicardapine	appos	7	SENT_341	[p8l1160t3321r1328b3353],
24	,	,	O	,	_	0	SENT_341	[p8l1160t3321r1328b3353],
25	Diltiazem	NNP	O	Diltiazem	nn	27	SENT_341	[p8l1341t3321r1472b3345],
26	Calmodulin	NN	O	calmodulin	nn	27	SENT_341	[p8l578t3360r735b3386],
27	Inhibitors	NNS	O	inhibitor	appos	7	SENT_341	[p8l746t3361r874b3385],
28	Chlorpromazine	NNP	O	Chlorpromazine	_	0	SENT_341	[p8l1001t3360r1223b3392],
29	,	,	O	,	_	0	SENT_341	[p8l1001t3360r1223b3392],
30	Triﬂuoperazine	NNP	ORGANIZATION	Triﬂuoperazine	nn	33	SENT_341	[p8l1234t3360r1441b3391],
31	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	33	SENT_341	[p8l578t3399r780b3424],
32	Drugs	NNPS	ORGANIZATION	Drugs	nn	33	SENT_341	[p8l790t3400r871b3431],
33	Prorxanolol	NNP	ORGANIZATION	Prorxanolol	appos	28	SENT_341	[p8l1001t3399r1164b3431],
34	,	,	O	,	_	0	SENT_341	[p8l1001t3399r1164b3431],
35	Amiodarone	NNP	O	Amiodarone	appos	28	SENT_341	[p8l1177t3399r1348b3427],
36	,	,	O	,	_	0	SENT_341	[p8l1177t3399r1348b3427],
37	Dipyridamole	NNP	O	Dipyridamole	nn	40	SENT_341	[p8l1361t3399r1545b3430],
38	Immunosuppressants	NNPS	O	Immunosuppressants	nn	40	SENT_341	[p8l579t3439r859b3469],
39	Cyclosporin	NN	O	cyclosporin	nn	40	SENT_341	[p8l1002t3438r1164b3470],
40	A	NN	O	a	appos	28	SENT_341	[p8l1175t3439r1205b3466],
41	,	,	O	,	_	0	SENT_341	[p8l1175t3439r1205b3466],
42	FK	NN	O	fk	appos	28	SENT_341	[p8l1216t3439r1259b3462],
43	506	CD	NUMBER	506	num	42	SENT_341	[p8l1270t3439r1325b3467],
44	,	,	O	,	_	0	SENT_341	[p8l1270t3439r1325b3467],
45	PSC	NN	ORGANIZATION	psc	appos	28	SENT_341	[p8l1338t3438r1396b3462],
46	833	CD	NUMBER	833	num	47	SENT_341	[p8l1408t3438r1455b3462],
47	Steroids	NNS	MISC	steroid	dep	45	SENT_341	[p8l579t3477r688b3502],
48	and	CC	O	and	_	0	SENT_341	[p8l699t3478r747b3501],
49	Derivatives	NNS	O	derivative	nn	50	SENT_341	[p8l757t3478r910b3502],
50	Progesterone	NN	O	progesterone	appos	28	SENT_341	[p8l1002t3478r1182b3508],
51	,	,	O	,	_	0	SENT_341	[p8l1002t3478r1182b3508],
52	Tamoxifen	NN	O	tamoxifen	nn	54	SENT_341	[p8l1193t3478r1339b3502],
53	Surfactams	NNP	O	Surfactams	nn	54	SENT_341	[p8l579t3516r729b3541],
54	Tween	NNP	O	Tween	appos	50	SENT_341	[p8l1001t3516r1093b3540],
55	80	CD	NUMBER	80	num	54	SENT_341	[p8l1103t3515r1143b3544],
56	,	,	O	,	_	0	SENT_341	[p8l1103t3515r1143b3544],
57	Solutol	NNP	O	Solutol	nn	58	SENT_341	[p8l1155t3515r1249b3540],
58	HS-15	NNP	O	HS-15	appos	28	SENT_341	[p8l1261t3515r1346b3540],

1	Annual	JJ	SET	annual	amod	2	SENT_342	[p8l444t3661r565b3690],
2	Reviews	NNS	O	review	nsubj	3	SENT_342	[p8l577t3661r719b3699],
3	_	VBP	O	_	_	0	SENT_342	[p8l951t3694r956b3699],
4	www.annualrev1ews.org/aronlrne	NN	O	www.annualrev1ews.org/aronlrne	dobj	3	SENT_342	[p8l444t3694r998b3732],

1	Annu	NNP	PERSON	Annu	_	0	SENT_343	[p9l354t1700r377b1780],
2	.	.	O	.	_	0	SENT_343	[p9l354t1700r377b1780],

1	Rev.	NNP	O	Rev.	nn	2	SENT_344	[p9l354t1631r377b1690],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_344	[p9l354t1471r377b1620],
3	.	.	O	.	_	0	SENT_344	[p9l354t1471r377b1620],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_345	[p9l354t1351r377b1461],
2	.	.	O	.	_	0	SENT_345	[p9l354t1351r377b1461],

1	1996362161-183	CD	NUMBER	1996362161-183	_	0	SENT_346	[p9l354t1105r378b1337],
2	.	.	O	.	_	0	SENT_346	[p9l354t1105r378b1337],

1	Do	VB	O	do	_	0	SENT_347	[p9l354t1043r377b1094],
2	»	CD	NUMBER	»	dobj	1	SENT_347	[p9l354t1043r377b1094],
3	vnloaded	VBN	O	vnload	partmod	2	SENT_347	[p9l354t907r377b1026],
4	from	IN	O	from	_	0	SENT_347	[p9l354t833r377b898],
5	www.annua1reviews.org	NN	O	www.annua1reviews.org	prep_from	3	SENT_347	[p9l354t500r384b825],

1	1996.36	CD	NUMBER	1996.36	_	0	SENT_348	[p9l355t3630r379b3741],
2	:	:	O	:	_	0	SENT_348	[p9l355t3630r379b3741],
3	161-183	CD	NUMBER	161-183	dep	1	SENT_348	[p9l355t3509r378b3623],
4	.	.	O	.	_	0	SENT_348	[p9l355t3509r378b3623],

1	Downloaded	VBN	O	download	_	0	SENT_349	[p9l355t3329r378b3498],
2	from	IN	O	from	_	0	SENT_349	[p9l355t3256r378b3320],
3	www.annualreviews.org	NN	O	www.annualreviews.org	nn	4	SENT_349	[p9l355t2922r385b3247],
4	onsin	NN	O	onsin	prep_from	1	SENT_349	[p9l388t3683r412b3754],
5	-	:	O	-	_	0	SENT_349	[p9l402t3665r405b3674],
6	Madison	NNP	O	Madison	dep	4	SENT_349	[p9l388t3538r412b3655],
7	on	IN	O	on	_	0	SENT_349	[p9l396t3496r412b3529],
8	01/05/14	CD	DATE	01/05/14	prep_on	6	SENT_349	[p9l388t3363r412b3487],
9	.	.	O	.	_	0	SENT_349	[p9l388t3363r412b3487],

1	For	IN	O	for	_	0	SENT_350	[p9l389t3306r412b3352],
2	personal	JJ	O	personal	amod	3	SENT_350	[p9l388t3186r419b3298],
3	use	NN	O	use	pobj	1	SENT_350	[p9l396t3133r412b3177],
4	only	RB	O	only	advmod	3	SENT_350	[p9l388t3059r419b3124],
5	.	.	O	.	_	0	SENT_350	[p9l388t3059r419b3124],

1	by	IN	O	by	_	0	SENT_351	[p9l387t1614r418b1646],
2	University	NNP	ORGANIZATION	University	pobj	1	SENT_351	[p9l387t1464r418b1604],
3	of	IN	ORGANIZATION	of	_	0	SENT_351	[p9l387t1426r411b1455],
4	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	2	SENT_351	[p9l387t1279r411b1419],
5	-	:	O	-	_	0	SENT_351	[p9l401t1261r404b1269],
6	Madison	NNP	PERSON	Madison	dep	4	SENT_351	[p9l387t1134r411b1251],
7	on	IN	O	on	_	0	SENT_351	[p9l395t1092r411b1125],
8	01	CD	NUMBER	01	prep_on	6	SENT_351	[p9l387t1043r411b1083],
9	/	:	O	/	punct	6	SENT_351	[p9l387t1043r411b1083],
10	'	''	O	'	_	0	SENT_351	[p9l387t941r411b1026],
11	05/14	CD	NUMBER	05/14	tmod	1	SENT_351	[p9l387t941r411b1026],
12	.	.	O	.	_	0	SENT_351	[p9l387t941r411b1026],

1	For	IN	O	for	_	0	SENT_352	[p9l388t884r411b931],
2	personal	JJ	O	personal	amod	3	SENT_352	[p9l387t764r418b876],
3	use	NN	O	use	pobj	1	SENT_352	[p9l395t711r411b755],
4	only	RB	O	only	advmod	3	SENT_352	[p9l387t636r418b701],
5	.	.	O	.	_	0	SENT_352	[p9l387t636r418b701],

1	P	NN	O	p	_	0	SENT_353	[p9l893t32r1233b61],
2	.	.	O	.	_	0	SENT_353	[p9l893t32r1233b61],

1	—	NN	O	—	_	0	SENT_354	[p9l893t32r1233b61],
2	.	.	O	.	_	0	SENT_354	[p9l893t32r1233b61],

1	GLYCOPROTEINS	NNS	O	glycoprotein	_	0	SENT_355	[p9l893t32r1233b61],
2	AND	CC	O	and	_	0	SENT_355	[p9l1243t32r1324b60],
3	DRUG	NN	O	drug	nn	4	SENT_355	[p9l1333t32r1440b60],
4	RESISTANCE	NN	O	resistance	conj_and	1	SENT_355	[p9l1449t32r1678b61],
5	173	CD	NUMBER	173	dep	1	SENT_355	[p9l1751t32r1802b60],

1	measured	VBN	O	measure	_	0	SENT_356	[p9l497t130r656b162],
2	by	IN	O	by	_	0	SENT_356	[p9l665t130r707b170],
3	a	DT	O	a	det	4	SENT_356	[p9l716t139r735b161],
4	decline	NN	O	decline	prep_by	1	SENT_356	[p9l743t130r864b161],
5	in	IN	O	in	_	0	SENT_356	[p9l873t130r905b161],
6	the	DT	O	the	det	7	SENT_356	[p9l914t131r964b162],
7	concentration	NN	O	concentration	prep_in	4	SENT_356	[p9l974t129r1200b162],
8	of	IN	O	of	_	0	SENT_356	[p9l1208t130r1246b161],
9	human	JJ	O	human	amod	11	SENT_356	[p9l1252t130r1365b161],
10	light	JJ	O	light	amod	11	SENT_356	[p9l1373t130r1451b170],
11	chain	NN	O	chain	prep_of	7	SENT_356	[p9l1458t130r1549b162],
12	being	VBG	O	be	auxpass	13	SENT_356	[p9l1558t130r1651b170],
13	excreted	VBN	O	excrete	partmod	11	SENT_356	[p9l1659t130r1802b161],
14	in	IN	O	in	_	0	SENT_356	[p9l497t181r530b213],
15	the	DT	O	the	det	17	SENT_356	[p9l550t181r601b212],
16	mouse	NN	O	mouse	nn	17	SENT_356	[p9l622t190r731b213],
17	urine	NN	O	urine	prep_in	13	SENT_356	[p9l751t181r837b213],
18	and	CC	O	and	_	0	SENT_356	[p9l858t181r918b213],
19	an	DT	O	a	det	20	SENT_356	[p9l939t190r978b212],
20	increase	NN	O	increase	prep_in	13	SENT_356	[p9l998t180r1134b213],
21	in	IN	O	in	_	0	SENT_356	[p9l1154t180r1186b213],
22	animal	NN	O	animal	nn	23	SENT_356	[p9l1207t181r1320b213],
23	survival	NN	O	survival	prep_in	13	SENT_356	[p9l1341t180r1483b213],
24	.	.	O	.	_	0	SENT_356	[p9l1341t180r1483b213],

1	Doxorubicin	NN	O	doxorubicin	nsubj	12	SENT_357	[p9l1506t180r1717b220],
2	was	VBD	O	be	cop	3	SENT_357	[p9l1738t190r1801b212],
3	effective	JJ	O	effective	_	0	SENT_357	[p9l498t231r644b264],
4	in	IN	O	in	_	0	SENT_357	[p9l656t232r689b263],
5	treating	VBG	O	treat	prepc_in	3	SENT_357	[p9l702t232r830b272],
6	the	DT	O	the	det	10	SENT_357	[p9l842t232r894b263],
7	drug-sensitive	JJ	O	drug-sensitive	amod	10	SENT_357	[p9l906t232r1141b272],
8	8226	CD	NUMBER	8226	num	10	SENT_357	[p9l1156t232r1238b264],
9	human-SCID	JJ	O	human-scid	amod	10	SENT_357	[p9l1250t232r1473b264],
10	xenografts	NNS	O	xenograft	dobj	5	SENT_357	[p9l1486t232r1662b273],
11	but	CC	O	but	_	0	SENT_357	[p9l1675t232r1731b264],
12	had	VBD	O	have	conj_but	3	SENT_357	[p9l1742t232r1802b263],
13	no	DT	O	no	det	14	SENT_357	[p9l497t291r539b313],
14	effect	NN	O	effect	iobj	12	SENT_357	[p9l550t281r646b313],
15	on	IN	O	on	_	0	SENT_357	[p9l655t291r698b313],
16	the	DT	O	the	det	18	SENT_357	[p9l709t282r760b313],
17	multidrug	JJ	O	multidrug	amod	18	SENT_357	[p9l772t281r1088b322],
18	—	NN	O	—	prep_on	14	SENT_357	[p9l772t281r1088b322],
19	resistant	JJ	O	resistant	amod	22	SENT_357	[p9l772t281r1088b322],
20	human-SCID	NN	O	human-scid	nn	22	SENT_357	[p9l1097t282r1506b321],
21	‘	NN	O	‘	nn	22	SENT_357	[p9l1097t282r1506b321],
22	xenografts	NNS	O	xenograft	dobj	12	SENT_357	[p9l1097t282r1506b321],
23	in	IN	O	in	_	0	SENT_357	[p9l1517t282r1550b313],
24	the	DT	O	the	det	25	SENT_357	[p9l1561t282r1613b314],
25	absence	NN	O	absence	prep_in	12	SENT_357	[p9l1623t282r1756b313],
26	of	IN	O	of	_	0	SENT_357	[p9l1768t282r1804b313],
27	a	DT	O	a	det	28	SENT_357	[p9l498t341r517b363],
28	chemomodulator	NN	O	chemomodulator	prep_of	25	SENT_357	[p9l526t332r818b363],
29	.	.	O	.	_	0	SENT_357	[p9l526t332r818b363],

1	The	DT	O	the	det	2	SENT_358	[p9l829t332r894b362],
2	combination	NN	O	combination	nsubj	7	SENT_358	[p9l905t331r1112b363],
3	of	IN	O	of	_	0	SENT_358	[p9l1122t331r1160b363],
4	verapamil	NN	O	verapamil	prep_of	2	SENT_358	[p9l1168t332r1334b371],
5	and	CC	O	and	_	0	SENT_358	[p9l1344t332r1405b363],
6	doxorubicin	NN	O	doxorubicin	prep_of	2	SENT_358	[p9l1415t332r1616b363],
7	resulted	VBD	O	result	_	0	SENT_358	[p9l1627t332r1760b363],
8	in	IN	O	in	_	0	SENT_358	[p9l1770t332r1802b362],
9	both	CC	O	both	preconj	11	SENT_358	[p9l496t382r571b414],
10	a	DT	O	a	det	11	SENT_358	[p9l587t391r605b413],
11	decrease	NN	O	decrease	prep_in	7	SENT_358	[p9l620t382r763b414],
12	in	IN	O	in	_	0	SENT_358	[p9l777t382r810b414],
13	light-chain	JJ	O	light-chain	amod	14	SENT_358	[p9l824t381r1005b422],
14	excretion	NN	O	excretion	prep_in	11	SENT_358	[p9l1019t381r1174b414],
15	and	CC	O	and	_	0	SENT_358	[p9l1188t382r1248b414],
16	an	DT	O	a	det	17	SENT_358	[p9l1263t391r1302b414],
17	increase	NN	O	increase	prep_in	7	SENT_358	[p9l1317t382r1453b414],
18	in	IN	O	in	_	0	SENT_358	[p9l1468t382r1500b413],
19	survival	NN	O	survival	prep_in	7	SENT_358	[p9l1516t382r1650b414],
20	of	IN	O	of	_	0	SENT_358	[p9l1664t381r1701b413],
21	those	DT	O	those	det	22	SENT_358	[p9l1714t382r1802b414],
22	animals	NNS	O	animal	prep_of	19	SENT_358	[p9l498t431r626b463],
23	bearing	VBG	O	bear	xcomp	7	SENT_358	[p9l639t431r765b471],
24	the	DT	O	the	det	29	SENT_358	[p9l777t432r828b463],
25	drug-resistant	JJ	O	drug-resistant	amod	29	SENT_358	[p9l842t431r1071b472],
26	tumor	NN	O	tumor	nn	29	SENT_358	[p9l1082t436r1182b463],
27	(	NN	O	(	nn	29	SENT_358	[p9l1195t432r1273b470],
28	89	CD	NUMBER	89	num	29	SENT_358	[p9l1195t432r1273b470],
29	)	NN	O	)	dobj	23	SENT_358	[p9l1195t432r1273b470],
30	.	.	O	.	_	0	SENT_358	[p9l1195t432r1273b470],

1	In	IN	O	in	_	0	SENT_359	[p9l540t483r574b513],
2	addition	NN	O	addition	_	0	SENT_359	[p9l594t482r730b514],
3	to	TO	O	to	_	0	SENT_359	[p9l751t486r784b514],
4	assessing	VBG	O	assess	prepc_in_addition_to	18	SENT_359	[p9l804t482r958b522],
5	the	DT	O	the	det	6	SENT_359	[p9l978t482r1029b513],
6	efﬁcacy	NN	O	efﬁcacy	dobj	4	SENT_359	[p9l1049t482r1182b522],
7	of	IN	O	of	_	0	SENT_359	[p9l1203t482r1241b513],
8	new	JJ	O	new	amod	10	SENT_359	[p9l1257t491r1326b513],
9	‘	NN	O	‘	nn	10	SENT_359	[p9l1341t482r1655b518],
10	chemomodulators	NNS	O	chemomodulator	prep_of	6	SENT_359	[p9l1341t482r1655b518],
11	,	,	O	,	_	0	SENT_359	[p9l1341t482r1655b518],
12	in	FW	O	in	prep	6	SENT_359	[p9l1676t482r1708b513],
13	vivo	FW	O	vivo	pobj	12	SENT_359	[p9l1728t482r1802b513],
14	models	NNS	O	model	nsubj	18	SENT_359	[p9l497t532r617b564],
15	are	VBP	O	be	cop	18	SENT_359	[p9l639t542r689b564],
16	an	DT	O	a	det	18	SENT_359	[p9l710t542r750b563],
17	important	JJ	O	important	amod	18	SENT_359	[p9l770t533r933b572],
18	means	NNS	O	means	_	0	SENT_359	[p9l953t542r1059b564],
19	of	IN	O	of	_	0	SENT_359	[p9l1080t532r1118b563],
20	identifying	VBG	O	identify	prepc_of	18	SENT_359	[p9l1135t532r1317b572],
21	the	DT	O	the	dobj	20	SENT_359	[p9l1338t533r1389b563],
22	limiting	VBG	O	limit	partmod	21	SENT_359	[p9l1410t532r1542b572],
23	organ	NN	O	organ	nn	26	SENT_359	[p9l1563t532r1802b572],
24	—	NN	O	—	nn	26	SENT_359	[p9l1563t532r1802b572],
25	speciﬁc	NN	O	speciﬁc	nn	26	SENT_359	[p9l1563t532r1802b572],
26	toxicities	NNS	O	toxicity	dobj	22	SENT_359	[p9l497t583r649b614],
27	of	IN	O	of	_	0	SENT_359	[p9l670t583r707b614],
28	new	JJ	O	new	amod	29	SENT_359	[p9l724t592r793b613],
29	chemomodulators	NNS	O	chemomodulator	prep_of	26	SENT_359	[p9l813t583r1121b618],
30	,	,	O	,	_	0	SENT_359	[p9l813t583r1121b618],
31	both	DT	O	both	appos	29	SENT_359	[p9l1139t583r1214b613],
32	when	WRB	O	when	advmod	33	SENT_359	[p9l1235t583r1325b613],
33	administered	VBN	O	administer	advcl	22	SENT_359	[p9l1344t583r1560b613],
34	alone	RB	O	alone	advmod	33	SENT_359	[p9l1579t584r1669b613],
35	and	CC	O	and	_	0	SENT_359	[p9l1689t583r1751b613],
36	in	IN	O	in	advcl	22	SENT_359	[p9l1771t583r1802b613],
37	combination	NN	O	combination	pobj	36	SENT_359	[p9l498t634r706b666],
38	with	IN	O	with	_	0	SENT_359	[p9l726t633r800b666],
39	chemotherapeutic	JJ	O	chemotherapeutic	amod	40	SENT_359	[p9l819t634r1114b674],
40	agents	NNS	O	agent	prep_with	36	SENT_359	[p9l1134t639r1249b674],
41	.	.	O	.	_	0	SENT_359	[p9l1134t639r1249b674],

1	Because	IN	O	because	mark	4	SENT_360	[p9l1269t634r1408b666],
2	Mdrl	NNP	O	Mdrl	nsubjpass	4	SENT_360	[p9l1428t634r1516b665],
3	is	VBZ	O	be	auxpass	4	SENT_360	[p9l1540t634r1566b665],
4	expressed	VBN	O	express	advcl	11	SENT_360	[p9l1586t634r1751b674],
5	in	IN	O	in	_	0	SENT_360	[p9l1771t634r1802b665],
6	normal	JJ	O	normal	amod	7	SENT_360	[p9l497t685r614b717],
7	tissues	NNS	O	tissue	prep_in	4	SENT_360	[p9l625t685r747b721],
8	,	,	O	,	_	0	SENT_360	[p9l625t685r747b721],
9	it	PRP	O	it	nsubj	11	SENT_360	[p9l758t685r782b717],
10	is	VBZ	O	be	cop	11	SENT_360	[p9l791t685r819b717],
11	conceivable	JJ	O	conceivable	_	0	SENT_360	[p9l831t685r1030b717],
12	that	IN	O	that	complm	20	SENT_360	[p9l1041t685r1104b717],
13	toxicity	NN	O	toxicity	nsubjpass	20	SENT_360	[p9l1113t685r1240b725],
14	from	IN	O	from	_	0	SENT_360	[p9l1251t685r1331b716],
15	the	DT	O	the	det	17	SENT_360	[p9l1341t685r1392b716],
16	chemotherapeutic	JJ	O	chemotherapeutic	amod	17	SENT_360	[p9l1403t685r1700b725],
17	agent	NN	O	agent	prep_from	13	SENT_360	[p9l1712t690r1803b725],
18	might	MD	O	might	aux	20	SENT_360	[p9l498t735r595b775],
19	be	VB	O	be	auxpass	20	SENT_360	[p9l604t735r642b767],
20	increased	VBN	O	increase	ccomp	11	SENT_360	[p9l651t735r809b766],
21	in	IN	O	in	_	0	SENT_360	[p9l818t735r850b766],
22	these	DT	O	these	det	23	SENT_360	[p9l858t735r944b767],
23	tissues	NNS	O	tissue	prep_in	20	SENT_360	[p9l952t735r1062b766],
24	in	IN	O	in	_	0	SENT_360	[p9l1072t735r1103b766],
25	the	DT	O	the	det	26	SENT_360	[p9l1112t735r1163b766],
26	presence	NN	O	presence	prep_in	23	SENT_360	[p9l1172t744r1318b775],
27	of	IN	O	of	_	0	SENT_360	[p9l1326t735r1363b766],
28	a	DT	O	a	det	29	SENT_360	[p9l1369t744r1388b766],
29	chemosensitizer	NN	O	chemosensitizer	prep_of	26	SENT_360	[p9l1396t735r1674b766],
30	.	.	O	.	_	0	SENT_360	[p9l1396t735r1674b766],

1	Horton	NNP	PERSON	Horton	dep	4	SENT_361	[p9l1685t735r1802b766],
2	et	FW	O	et	nn	4	SENT_361	[p9l497t790r528b816],
3	al	FW	O	al	nn	4	SENT_361	[p9l539t785r570b816],
4	(	FW	O	(	dep	7	SENT_361	[p9l583t785r651b823],
5	85	CD	NUMBER	85	num	6	SENT_361	[p9l583t785r651b823],
6	)	NN	O	)	nsubj	20	SENT_361	[p9l583t785r651b823],
7	studied	VBD	O	study	_	0	SENT_361	[p9l664t785r784b816],
8	the	DT	O	the	det	9	SENT_361	[p9l797t786r848b816],
9	effect	NN	O	effect	dobj	7	SENT_361	[p9l859t785r955b816],
10	of	IN	O	of	_	0	SENT_361	[p9l967t785r1005b816],
11	verapamil	NN	O	verapamil	prep_of	9	SENT_361	[p9l1014t786r1179b824],
12	on	IN	O	on	_	0	SENT_361	[p9l1192t794r1234b816],
13	vincristine	NN	O	vincristine	nn	14	SENT_361	[p9l1247t785r1421b816],
14	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	7	SENT_361	[p9l1434t785r1729b825],
15	and	CC	O	and	_	0	SENT_361	[p9l1743t785r1802b816],
16	toxicities	NNS	O	toxicity	prep_on	7	SENT_361	[p9l497t835r649b866],
17	in	IN	O	in	_	0	SENT_361	[p9l661t835r693b865],
18	mice	NNS	O	mouse	prep_in	7	SENT_361	[p9l703t835r785b866],
19	and	CC	O	and	_	0	SENT_361	[p9l796t835r856b865],
20	found	VBD	O	find	conj_and	7	SENT_361	[p9l866t834r963b866],
21	that	IN	O	that	complm	25	SENT_361	[p9l973t835r1037b866],
22	verapamil	NN	O	verapamil	nsubj	25	SENT_361	[p9l1047t835r1212b874],
23	markedly	RB	O	markedly	advmod	24	SENT_361	[p9l1223t835r1379b874],
24	‘	RB	O	‘	amod	22	SENT_361	[p9l1384t830r1548b866],
25	increased	VBD	O	increase	ccomp	20	SENT_361	[p9l1384t830r1548b866],
26	the	DT	O	the	det	27	SENT_361	[p9l1558t836r1609b866],
27	uptake	NN	O	uptake	dobj	25	SENT_361	[p9l1619t836r1731b874],
28	and	CC	O	and	_	0	SENT_361	[p9l1743t835r1802b865],
29	retention	NN	O	retention	conj_and	27	SENT_361	[p9l497t884r646b915],
30	of	IN	O	of	_	0	SENT_361	[p9l654t884r692b915],
31	vincristine	NN	O	vincristine	prep_of	27	SENT_361	[p9l698t884r873b915],
32	in	IN	O	in	_	0	SENT_361	[p9l882t883r913b915],
33	the	DT	O	the	det	35	SENT_361	[p9l921t884r973b915],
34	small	JJ	O	small	amod	35	SENT_361	[p9l982t884r1072b915],
35	intestine	NN	O	intestine	prep_in	25	SENT_361	[p9l1079t884r1230b920],
36	,	,	O	,	_	0	SENT_361	[p9l1079t884r1230b920],
37	liver	NN	O	liver	prep_in	25	SENT_361	[p9l1238t884r1324b920],
38	,	,	O	,	_	0	SENT_361	[p9l1238t884r1324b920],
39	and	CC	O	and	_	0	SENT_361	[p9l1334t884r1394b915],
40	kidney	NN	O	kidney	prep_in	25	SENT_361	[p9l1402t884r1524b923],
41	.	.	O	.	_	0	SENT_361	[p9l1402t884r1524b923],

1	Our	PRP$	O	we	poss	3	SENT_362	[p9l1534t884r1600b915],
2	own	JJ	O	own	amod	3	SENT_362	[p9l1607t893r1678b915],
3	studies	NNS	O	study	nsubj	5	SENT_362	[p9l1687t884r1802b915],
4	have	VBP	O	have	aux	5	SENT_362	[p9l497t934r576b965],
5	demonstrated	VBN	O	demonstrate	_	0	SENT_362	[p9l588t933r813b965],
6	increased	VBN	O	increase	amod	7	SENT_362	[p9l824t934r981b965],
7	levels	NNS	O	level	dobj	5	SENT_362	[p9l993t934r1088b965],
8	of	IN	O	of	_	0	SENT_362	[p9l1100t933r1137b964],
9	doxorubicin	NN	O	doxorubicin	prep_of	7	SENT_362	[p9l1145t933r1346b965],
10	in	IN	O	in	_	0	SENT_362	[p9l1358t934r1391b964],
11	both	CC	O	both	preconj	13	SENT_362	[p9l1401t934r1476b965],
12	the	DT	O	the	det	13	SENT_362	[p9l1488t934r1538b964],
13	heart	NN	O	heart	prep_in	9	SENT_362	[p9l1550t934r1634b965],
14	and	CC	O	and	_	0	SENT_362	[p9l1645t935r1706b964],
15	brain	NN	O	brain	conj_and	13	SENT_362	[p9l1716t934r1802b965],
16	of	IN	O	of	_	0	SENT_362	[p9l498t984r536b1015],
17	SCID	NN	O	scid	nn	18	SENT_362	[p9l550t984r643b1015],
18	mice	NNS	O	mouse	prep_of	7	SENT_362	[p9l659t984r740b1015],
19	receiving	VBG	O	receive	partmod	18	SENT_362	[p9l756t984r911b1024],
20	the	DT	O	the	det	21	SENT_362	[p9l927t985r978b1015],
21	combination	NN	O	combination	dobj	19	SENT_362	[p9l993t984r1202b1015],
22	of	IN	O	of	_	0	SENT_362	[p9l1218t984r1255b1015],
23	doxorubicin	NN	O	doxorubicin	prep_of	21	SENT_362	[p9l1269t984r1470b1015],
24	and	CC	O	and	_	0	SENT_362	[p9l1485t984r1546b1015],
25	cyclosporin	NN	O	cyclosporin	nn	26	SENT_362	[p9l1561t985r1757b1024],
26	A	NN	O	a	dobj	19	SENT_362	[p9l1773t984r1803b1014],
27	(	CD	NUMBER	(	number	28	SENT_362	[p9l499t1051r577b1089],
28	90	CD	NUMBER	90	num	29	SENT_362	[p9l499t1051r577b1089],
29	)	NN	O	)	dep	26	SENT_362	[p9l499t1051r577b1089],
30	.	.	O	.	_	0	SENT_362	[p9l499t1051r577b1089],

1	Studies	NNS	O	study	nsubj	2	SENT_363	[p9l589t1051r711b1082],
2	carried	VBD	O	carry	dep	10	SENT_363	[p9l722t1051r839b1082],
3	out	RP	O	out	prt	2	SENT_363	[p9l849t1057r903b1082],
4	in	IN	O	in	_	0	SENT_363	[p9l913t1051r944b1082],
5	the	DT	O	the	det	8	SENT_363	[p9l956t1051r1007b1082],
6	mdr	NN	O	mdr	nn	8	SENT_363	[p9l1017t1052r1085b1082],
7	knockout	NN	O	knockout	nn	8	SENT_363	[p9l1095t1051r1251b1082],
8	mice	NNS	O	mouse	prep_in	2	SENT_363	[p9l1262t1052r1341b1082],
9	have	VBP	O	have	aux	10	SENT_363	[p9l1352t1051r1432b1081],
10	revealed	VBN	O	reveal	_	0	SENT_363	[p9l1441t1051r1584b1082],
11	an	DT	O	a	det	13	SENT_363	[p9l1595t1061r1634b1082],
12	increased	VBN	O	increase	amod	13	SENT_363	[p9l1645t1051r1803b1082],
13	sensitivity	NN	O	sensitivity	dobj	10	SENT_363	[p9l498t1102r669b1142],
14	to	TO	O	to	_	0	SENT_363	[p9l685t1107r717b1133],
15	the	DT	O	the	det	17	SENT_363	[p9l733t1102r783b1133],
16	neurotoxic	JJ	O	neurotoxic	amod	17	SENT_363	[p9l800t1102r978b1134],
17	effects	NNS	O	effect	prep_to	10	SENT_363	[p9l994t1102r1103b1133],
18	of	IN	O	of	_	0	SENT_363	[p9l1120t1102r1158b1133],
19	ivermectin	NN	O	ivermectin	nn	22	SENT_363	[p9l1170t1103r1348b1134],
20	and	CC	O	and	_	0	SENT_363	[p9l1363t1102r1423b1133],
21	vinblastine	NN	O	vinblastine	conj_and	19	SENT_363	[p9l1440t1102r1622b1134],
22	(	NN	O	(	prep_of	17	SENT_363	[p9l1639t1102r1717b1140],
23	24	CD	NUMBER	24	num	24	SENT_363	[p9l1639t1102r1717b1140],
24	)	NN	O	)	nsubj	10	SENT_363	[p9l1639t1102r1717b1140],
25	.	.	O	.	_	0	SENT_363	[p9l1639t1102r1717b1140],

1	It	PRP	O	it	nsubj	3	SENT_364	[p9l1734t1103r1761b1133],
2	is	VBZ	O	be	cop	3	SENT_364	[p9l1776t1102r1802b1133],
3	noteworthy	JJ	O	noteworthy	_	0	SENT_364	[p9l498t1154r687b1193],
4	that	IN	O	that	complm	20	SENT_364	[p9l701t1153r764b1184],
5	in	IN	O	in	mark	9	SENT_364	[p9l776t1154r808b1184],
6	the	DT	O	the	det	8	SENT_364	[p9l821t1154r871b1184],
7	clinical	JJ	O	clinical	amod	8	SENT_364	[p9l883t1153r1007b1185],
8	studies	NNS	O	study	nsubj	9	SENT_364	[p9l1020t1153r1134b1185],
9	perfomied	VBD	O	perfomy	advcl	20	SENT_364	[p9l1147t1153r1321b1193],
10	to	TO	O	to	_	0	SENT_364	[p9l1332t1158r1364b1185],
11	date	NN	O	date	prep_to	9	SENT_364	[p9l1377t1153r1457b1190],
12	,	,	O	,	_	0	SENT_364	[p9l1377t1153r1457b1190],
13	no	DT	O	no	det	17	SENT_364	[p9l1469t1162r1511b1185],
14	untoward	JJ	O	untoward	amod	17	SENT_364	[p9l1523t1153r1682b1185],
15	neurological	JJ	O	neurological	amod	17	SENT_364	[p9l1694t1162r1802b1185, p9l498t1204r612b1244],
16	side	NN	O	side	nn	17	SENT_364	[p9l629t1204r696b1235],
17	effects	NNS	O	effect	nsubjpass	20	SENT_364	[p9l713t1203r825b1235],
18	have	VBP	O	have	aux	20	SENT_364	[p9l842t1204r922b1235],
19	been	VBN	O	be	auxpass	20	SENT_364	[p9l939t1205r1018b1234],
20	reported	VBN	O	report	ccomp	3	SENT_364	[p9l1035t1205r1175b1244],
21	with	IN	O	with	_	0	SENT_364	[p9l1192t1204r1266b1234],
22	the	DT	O	the	det	24	SENT_364	[p9l1284t1205r1334b1235],
23	vinca	NN	O	vinca	nn	24	SENT_364	[p9l1352t1204r1444b1235],
24	alkaloids	NNS	O	alkaloid	prep_with	20	SENT_364	[p9l1461t1204r1610b1235],
25	and	CC	O	and	_	0	SENT_364	[p9l1629t1204r1689b1235],
26	MDR	NN	ORGANIZATION	mdr	nn	27	SENT_364	[p9l1707t1205r1802b1235],
27	chemomodulators	NNS	O	chemomodulator	conj_and	24	SENT_364	[p9l498t1254r805b1286],
28	.	.	O	.	_	0	SENT_364	[p9l498t1254r805b1286],

1	The	DT	O	the	det	2	SENT_365	[p9l822t1255r887b1285],
2	use	NN	O	use	nsubj	10	SENT_365	[p9l902t1264r958b1285],
3	of	IN	O	of	_	0	SENT_365	[p9l974t1255r1012b1285],
4	clinically	RB	O	clinically	advmod	5	SENT_365	[p9l1024t1255r1179b1295],
5	relevant	JJ	O	relevant	amod	7	SENT_365	[p9l1194t1255r1329b1286],
6	animal	NN	O	animal	nn	7	SENT_365	[p9l1344t1255r1457b1286],
7	models	NNS	O	model	prep_of	2	SENT_365	[p9l1474t1255r1592b1286],
8	is	VBZ	O	be	cop	10	SENT_365	[p9l1609t1255r1636b1285],
9	therefore	RB	O	therefore	advmod	10	SENT_365	[p9l1651t1255r1803b1286],
10	necessary	JJ	O	necessary	_	0	SENT_365	[p9l498t1314r660b1345],
11	for	IN	O	for	_	0	SENT_365	[p9l673t1305r723b1336],
12	development	NN	O	development	prep_for	10	SENT_365	[p9l734t1305r951b1345],
13	of	IN	O	of	_	0	SENT_365	[p9l962t1305r1000b1336],
14	new	JJ	O	new	amod	16	SENT_365	[p9l1010t1314r1079b1336],
15	MDR	NN	O	mdr	nn	16	SENT_365	[p9l1092t1306r1188b1336],
16	chemomodulators	NNS	O	chemomodulator	prep_of	12	SENT_365	[p9l1199t1305r1506b1336],
17	.	.	O	.	_	0	SENT_365	[p9l1199t1305r1506b1336],

1	Clinical	JJ	O	clinical	amod	2	SENT_366	[p9l501t1424r661b1461],
2	Studies	NNS	O	study	_	0	SENT_366	[p9l675t1424r820b1461],

1	The	DT	O	the	det	2	SENT_367	[p9l497t1505r563b1535],
2	majority	NN	O	majority	nsubj	10	SENT_367	[p9l577t1504r717b1544],
3	of	IN	O	of	_	0	SENT_367	[p9l731t1505r768b1535],
4	clinical	JJ	O	clinical	amod	5	SENT_367	[p9l778t1504r900b1535],
5	studies	NNS	O	study	prep_of	2	SENT_367	[p9l915t1504r1030b1535],
6	to	TO	O	to	aux	7	SENT_367	[p9l1043t1510r1076b1535],
7	modulate	VB	O	modulate	infmod	2	SENT_367	[p9l1089t1505r1244b1535],
8	MDR	NN	ORGANIZATION	mdr	dobj	7	SENT_367	[p9l1257t1505r1352b1535],
9	have	VBP	O	have	aux	10	SENT_367	[p9l1364t1505r1443b1536],
10	employed	VBN	O	employ	_	0	SENT_367	[p9l1457t1505r1622b1544],
11	verapamil	NN	O	verapamil	nn	14	SENT_367	[p9l1635t1504r1803b1544],
12	or	CC	O	or	_	0	SENT_367	[p9l498t1565r534b1586],
13	cyclosporin	NN	O	cyclosporin	conj_or	11	SENT_367	[p9l545t1555r740b1595],
14	A	NN	O	a	dobj	10	SENT_367	[p9l753t1556r783b1586],
15	as	IN	O	as	_	0	SENT_367	[p9l796t1565r829b1586],
16	chemomodulators	NNS	O	chemomodulator	prep_as	10	SENT_367	[p9l843t1555r1140b1586],
17	and	CC	O	and	_	0	SENT_367	[p9l1153t1556r1214b1586],
18	have	VBP	O	have	aux	20	SENT_367	[p9l1225t1555r1305b1586],
19	been	VBN	O	be	auxpass	20	SENT_367	[p9l1316t1556r1396b1586],
20	conducted	VBN	O	conduct	conj_and	10	SENT_367	[p9l1408t1556r1580b1586],
21	in	IN	O	in	_	0	SENT_367	[p9l1592t1556r1624b1586],
22	myeloma	NN	O	myeloma	nn	24	SENT_367	[p9l1637t1556r1802b1594],
23	,	,	O	,	_	0	SENT_367	[p9l1637t1556r1802b1594],
24	lymphoma	NN	O	lymphoma	prep_in	20	SENT_367	[p9l498t1605r686b1645],
25	,	,	O	,	_	0	SENT_367	[p9l498t1605r686b1645],
26	and	CC	O	and	_	0	SENT_367	[p9l701t1605r761b1635],
27	leukemia	NN	O	leukemia	nn	28	SENT_367	[p9l775t1605r928b1636],
28	patients	NNS	O	patient	conj_and	24	SENT_367	[p9l941t1605r1071b1645],
29	(	CD	NUMBER	(	num	31	SENT_367	[p9l1085t1605r1225b1642],
30	91-93	CD	NUMBER	91-93	num	31	SENT_367	[p9l1085t1605r1225b1642],
31	)	NN	O	)	dobj	10	SENT_367	[p9l1085t1605r1225b1642],
32	.	.	O	.	_	0	SENT_367	[p9l1085t1605r1225b1642],

1	Although	IN	O	although	mark	6	SENT_368	[p9l1240t1605r1397b1645],
2	verapamil	NN	O	verapamil	nsubj	6	SENT_368	[p9l1411t1606r1578b1645],
3	was	VBD	O	be	cop	6	SENT_368	[p9l1592t1615r1656b1636],
4	the	DT	O	the	det	6	SENT_368	[p9l1670t1606r1721b1636],
5	ﬁrst	NN	O	ﬁrst	nn	6	SENT_368	[p9l1737t1606r1804b1636],
6	chemomodulator	NN	O	chemomodulator	advcl	19	SENT_368	[p9l498t1656r782b1687],
7	studied	VBN	O	study	partmod	6	SENT_368	[p9l791t1656r911b1687],
8	in	IN	O	in	_	0	SENT_368	[p9l920t1657r953b1687],
9	the	DT	O	the	det	10	SENT_368	[p9l962t1656r1013b1687],
10	clinic	NN	O	clinic	prep_in	7	SENT_368	[p9l1022t1656r1114b1687],
11	(	CD	NUMBER	(	num	13	SENT_368	[p9l1125t1656r1203b1693],
12	91	CD	NUMBER	91	num	13	SENT_368	[p9l1125t1656r1203b1693],
13	)	NN	O	)	dep	10	SENT_368	[p9l1125t1656r1203b1693],
14	,	,	O	,	_	0	SENT_368	[p9l1125t1656r1203b1693],
15	cyclosporin	NN	O	cyclosporin	nn	16	SENT_368	[p9l1213t1656r1407b1696],
16	A	NN	O	a	nsubj	19	SENT_368	[p9l1417t1657r1447b1687],
17	is	VBZ	O	be	cop	19	SENT_368	[p9l1456t1657r1484b1687],
18	the	DT	O	the	det	19	SENT_368	[p9l1493t1657r1544b1687],
19	compound	NN	O	compound	_	0	SENT_368	[p9l1554t1657r1732b1696],
20	that	WDT	O	that	nsubj	22	SENT_368	[p9l1740t1657r1804b1687],
21	has	VBZ	O	have	aux	22	SENT_368	[p9l498t1707r553b1737],
22	received	VBN	O	receive	rcmod	19	SENT_368	[p9l565t1706r707b1737],
23	the	DT	O	the	det	26	SENT_368	[p9l719t1706r769b1737],
24	most	RBS	O	most	advmod	26	SENT_368	[p9l781t1710r862b1736],
25	clinical	JJ	O	clinical	amod	26	SENT_368	[p9l872t1706r995b1737],
26	attention	NN	O	attention	dobj	22	SENT_368	[p9l1007t1706r1151b1737],
27	to	TO	O	to	_	0	SENT_368	[p9l1163t1711r1194b1737],
28	date	NN	O	date	prep_to	22	SENT_368	[p9l1206t1706r1276b1737],
29	(	CD	NUMBER	(	num	28	SENT_368	[p9l1287t1706r1427b1744],
30	93-95	CD	NUMBER	93-95	num	31	SENT_368	[p9l1287t1706r1427b1744],
31	)	NN	O	)	dep	28	SENT_368	[p9l1287t1706r1427b1744],
32	.	.	O	.	_	0	SENT_368	[p9l1287t1706r1427b1744],

1	Although	IN	O	although	mark	6	SENT_369	[p9l1439t1707r1597b1746],
2	cyclosporin	NN	O	cyclosporin	nn	3	SENT_369	[p9l1609t1707r1803b1746],
3	A	NN	O	a	nsubj	6	SENT_369	[p9l498t1757r528b1786],
4	has	VBZ	O	have	aux	6	SENT_369	[p9l541t1756r597b1786],
5	successfully	RB	O	successfully	advmod	6	SENT_369	[p9l612t1755r813b1795],
6	modulated	VBN	O	modulate	advcl	11	SENT_369	[p9l827t1756r1003b1787],
7	MDR	NN	ORGANIZATION	mdr	dobj	6	SENT_369	[p9l1014t1756r1120b1791],
8	,	,	O	,	_	0	SENT_369	[p9l1014t1756r1120b1791],
9	it	PRP	O	it	nsubj	11	SENT_369	[p9l1133t1756r1158b1786],
10	has	VBZ	O	have	aux	11	SENT_369	[p9l1169t1757r1225b1786],
11	altered	VBN	O	alter	_	0	SENT_369	[p9l1239t1756r1351b1787],
12	the	DT	O	the	det	13	SENT_369	[p9l1364t1756r1415b1787],
13	pharmacokinetics	NNS	O	pharmacokinetic	dobj	11	SENT_369	[p9l1428t1756r1722b1796],
14	of	IN	O	of	_	0	SENT_369	[p9l1736t1756r1775b1787],
15	a	DT	O	a	det	16	SENT_369	[p9l1785t1766r1803b1787],
16	number	NN	O	number	prep_of	13	SENT_369	[p9l498t1805r626b1837],
17	of	IN	O	of	_	0	SENT_369	[p9l641t1805r679b1837],
18	anlineoplastic	JJ	O	anlineoplastic	amod	19	SENT_369	[p9l690t1805r921b1846],
19	agents	NNS	O	agent	prep_of	16	SENT_369	[p9l937t1811r1053b1846],
20	,	,	O	,	_	0	SENT_369	[p9l937t1811r1053b1846],
21	including	VBG	O	include	_	0	SENT_369	[p9l1069t1806r1225b1846],
22	VP-16	NNP	O	VP-16	prep_including	13	SENT_369	[p9l1241t1806r1348b1837],
23	and	CC	O	and	_	0	SENT_369	[p9l1364t1806r1424b1837],
24	doxorubicin	NN	O	doxorubicin	prep_including	13	SENT_369	[p9l1439t1806r1641b1838],
25	(	CD	NUMBER	(	number	26	SENT_369	[p9l1657t1806r1722b1844],
26	96	CD	NUMBER	96	dep	24	SENT_369	[p9l1657t1806r1722b1844],
27	,	,	O	,	_	0	SENT_369	[p9l1657t1806r1722b1844],
28	97	CD	NUMBER	97	num	29	SENT_369	[p9l1738t1807r1802b1844],
29	)	NN	O	)	appos	24	SENT_369	[p9l1738t1807r1802b1844],
30	.	.	O	.	_	0	SENT_369	[p9l1738t1807r1802b1844],

1	Lum	NNP	PERSON	Lum	nn	3	SENT_370	[p9l498t1857r577b1888],
2	et	NNP	O	et	nn	3	SENT_370	[p9l585t1860r616b1887],
3	al	NNP	O	al	nsubj	4	SENT_370	[p9l623t1857r652b1888],
4	reported	VBD	O	report	_	0	SENT_370	[p9l661t1857r801b1896],
5	that	IN	O	that	complm	8	SENT_370	[p9l809t1856r871b1887],
6	cyclosporin	NN	O	cyclosporin	nn	7	SENT_370	[p9l879t1857r1074b1897],
7	A	NN	O	a	nsubj	8	SENT_370	[p9l1082t1857r1112b1887],
8	increased	VBD	O	increase	ccomp	4	SENT_370	[p9l1120t1856r1277b1888],
9	the	DT	O	the	det	10	SENT_370	[p9l1285t1857r1335b1888],
10	area	NN	O	area	dobj	8	SENT_370	[p9l1344t1865r1415b1887],
11	under	IN	O	under	_	0	SENT_370	[p9l1422t1857r1518b1888],
12	the	DT	O	the	det	16	SENT_370	[p9l1526t1857r1577b1888],
13	curve	NN	O	curve	nn	16	SENT_370	[p9l1585t1866r1678b1888],
14	(	CD	NUMBER	(	num	16	SENT_370	[p9l1687t1857r1801b1895],
15	AUC	NN	O	auc	nn	16	SENT_370	[p9l1687t1857r1801b1895],
16	)	NN	O	)	prep_under	8	SENT_370	[p9l1687t1857r1801b1895],
17	for	IN	O	for	_	0	SENT_370	[p9l498t1906r548b1937],
18	VP	NN	O	vp	nn	19	SENT_370	[p9l560t1905r670b1937],
19	~	NN	O	~	prep_for	16	SENT_370	[p9l560t1905r670b1937],
20	16	CD	NUMBER	16	num	19	SENT_370	[p9l560t1905r670b1937],
21	by	IN	O	by	_	0	SENT_370	[p9l682t1906r725b1945],
22	decreasing	VBG	O	decrease	prepc_by	8	SENT_370	[p9l738t1905r916b1946],
23	both	CC	O	both	preconj	24	SENT_370	[p9l930t1906r1005b1937],
24	renal	JJ	O	renal	amod	27	SENT_370	[p9l1018t1906r1101b1937],
25	and	CC	O	and	_	0	SENT_370	[p9l1116t1907r1176b1937],
26	nonrenal	JJ	O	nonrenal	amod	27	SENT_370	[p9l1189t1906r1334b1937],
27	clearance	NN	O	clearance	dobj	22	SENT_370	[p9l1348t1906r1506b1937],
28	of	IN	O	of	_	0	SENT_370	[p9l1520t1906r1558b1937],
29	the	DT	O	the	det	33	SENT_370	[p9l1568t1907r1618b1937],
30	drug	NN	O	drug	nn	33	SENT_370	[p9l1632t1906r1710b1946],
31	(	NN	O	(	nn	33	SENT_370	[p9l1725t1907r1802b1944],
32	97	CD	NUMBER	97	num	33	SENT_370	[p9l1725t1907r1802b1944],
33	)	NN	O	)	prep_of	27	SENT_370	[p9l1725t1907r1802b1944],
34	.	.	O	.	_	0	SENT_370	[p9l1725t1907r1802b1944],

1	The	DT	O	the	det	2	SENT_371	[p9l498t1956r564b1987],
2	AUC	NN	O	auc	nsubjpass	7	SENT_371	[p9l578t1955r665b1987],
3	for	IN	O	for	_	0	SENT_371	[p9l679t1955r729b1987],
4	doxorubicin	NN	O	doxorubicin	prep_for	2	SENT_371	[p9l743t1955r943b1988],
5	was	VBD	O	be	auxpass	7	SENT_371	[p9l958t1965r1022b1987],
6	also	RB	O	also	advmod	7	SENT_371	[p9l1037t1956r1103b1987],
7	increased	VBN	O	increase	_	0	SENT_371	[p9l1116t1955r1274b1988],
8	in	IN	O	in	_	0	SENT_371	[p9l1288t1957r1321b1988],
9	the	DT	O	the	det	10	SENT_371	[p9l1334t1956r1386b1987],
10	presence	NN	O	presence	prep_in	7	SENT_371	[p9l1399t1965r1546b1996],
11	of	IN	O	of	_	0	SENT_371	[p9l1559t1956r1598b1988],
12	cyclosporin	NN	O	cyclosporin	nn	13	SENT_371	[p9l1608t1956r1803b1996],
13	A	NN	O	a	prep_of	10	SENT_371	[p9l498t2007r528b2038],
14	by	IN	O	by	_	0	SENT_371	[p9l541t2006r583b2046],
15	a	DT	O	a	det	16	SENT_371	[p9l596t2015r615b2037],
16	decrease	NN	O	decrease	agent	7	SENT_371	[p9l626t2006r771b2038],
17	in	IN	O	in	_	0	SENT_371	[p9l783t2006r816b2038],
18	the	DT	O	the	det	19	SENT_371	[p9l828t2006r879b2038],
19	clearance	NN	O	clearance	prep_in	16	SENT_371	[p9l893t2006r1050b2038],
20	of	IN	O	of	_	0	SENT_371	[p9l1062t2006r1100b2038],
21	the	DT	O	the	det	25	SENT_371	[p9l1109t2006r1159b2038],
22	drug	NN	O	drug	nn	25	SENT_371	[p9l1172t2007r1249b2047],
23	(	NN	O	(	nn	25	SENT_371	[p9l1262t2006r1339b2045],
24	96	CD	NUMBER	96	num	25	SENT_371	[p9l1262t2006r1339b2045],
25	)	NN	O	)	prep_of	19	SENT_371	[p9l1262t2006r1339b2045],
26	.	.	O	.	_	0	SENT_371	[p9l1262t2006r1339b2045],

1	Such	JJ	O	such	amod	2	SENT_372	[p9l1354t2006r1437b2038],
2	observations	NNS	O	observation	nsubj	3	SENT_372	[p9l1449t2007r1660b2038],
3	identify	VBP	O	identify	_	0	SENT_372	[p9l1673t2006r1802b2047],
4	confounding	JJ	O	confounding	amod	5	SENT_372	[p9l498t2056r709b2097],
5	variables	NNS	O	variable	dobj	3	SENT_372	[p9l728t2057r876b2088],
6	when	WRB	O	when	advmod	39	SENT_372	[p9l895t2057r985b2088],
7	attempting	VBG	O	attempt	csubj	39	SENT_372	[p9l1004t2056r1181b2097],
8	to	TO	O	to	aux	9	SENT_372	[p9l1199t2062r1231b2088],
9	assess	VB	O	assess	xcomp	7	SENT_372	[p9l1249t2066r1349b2089],
10	whether	IN	O	whether	complm	16	SENT_372	[p9l1367t2057r1502b2089],
11	the	DT	O	the	det	14	SENT_372	[p9l1520t2057r1571b2089],
12	observed	VBN	O	observe	amod	14	SENT_372	[p9l1588t2057r1740b2089],
13	response	NN	O	response	nn	14	SENT_372	[p9l1757t2066r1802b2089, p9l500t2116r613b2148],
14	rates	NNS	O	rate	nsubj	16	SENT_372	[p9l622t2112r700b2139],
15	are	VBP	O	be	cop	16	SENT_372	[p9l711t2116r762b2139],
16	due	JJ	O	due	ccomp	9	SENT_372	[p9l771t2108r831b2139],
17	to	TO	O	to	_	0	SENT_372	[p9l840t2112r873b2139],
18	inhibition	NN	O	inhibition	prep_to	16	SENT_372	[p9l883t2107r1045b2139],
19	of	IN	O	of	_	0	SENT_372	[p9l1054t2107r1091b2139],
20	the	DT	O	the	det	21	SENT_372	[p9l1098t2107r1149b2139],
21	P-glycoprotein	NN	O	p-glycoprotein	prep_of	18	SENT_372	[p9l1158t2107r1405b2149],
22	or	CC	O	or	_	0	SENT_372	[p9l1415t2118r1451b2140],
23	to	TO	O	to	_	0	SENT_372	[p9l1459t2113r1492b2139],
24	a	DT	O	a	det	26	SENT_372	[p9l1502t2117r1521b2139],
25	secondary	JJ	O	secondary	amod	26	SENT_372	[p9l1530t2108r1698b2148],
26	effect	NN	O	effect	prep_to	16	SENT_372	[p9l1709t2108r1805b2140],
27	resulting	VBG	O	result	partmod	26	SENT_372	[p9l498t2158r643b2198],
28	from	IN	O	from	_	0	SENT_372	[p9l657t2158r738b2189],
29	the	DT	O	the	det	32	SENT_372	[p9l750t2159r801b2189],
30	higher	JJR	O	higher	amod	32	SENT_372	[p9l814t2158r922b2198],
31	systemic	JJ	O	systemic	amod	32	SENT_372	[p9l934t2159r1079b2198],
32	levels	NNS	O	level	prep_from	27	SENT_372	[p9l1091t2158r1188b2189],
33	of	IN	O	of	_	0	SENT_372	[p9l1201t2158r1238b2189],
34	the	DT	O	the	det	37	SENT_372	[p9l1249t2158r1299b2190],
35	cytotoxic	JJ	O	cytotoxic	amod	37	SENT_372	[p9l1312t2159r1466b2198],
36	agent	NN	O	agent	nn	37	SENT_372	[p9l1481t2160r1623b2198],
37	(	NN	O	(	prep_of	32	SENT_372	[p9l1481t2160r1623b2198],
38	s	VBZ	O	s	cop	39	SENT_372	[p9l1481t2160r1623b2198],
39	)	CD	NUMBER	)	advcl	3	SENT_372	[p9l1481t2160r1623b2198],
40	.	.	O	.	_	0	SENT_372	[p9l1481t2160r1623b2198],

1	The	DT	O	the	det	2	SENT_373	[p9l540t2208r606b2238],
2	reader	NN	O	reader	nsubjpass	4	SENT_373	[p9l618t2208r723b2239],
3	is	VBZ	O	be	auxpass	4	SENT_373	[p9l736t2207r762b2239],
4	referred	VBN	O	refer	_	0	SENT_373	[p9l776t2208r907b2239],
5	to	TO	O	to	_	0	SENT_373	[p9l919t2213r952b2239],
6	two	CD	NUMBER	two	num	8	SENT_373	[p9l965t2213r1027b2239],
7	recent	JJ	O	recent	amod	8	SENT_373	[p9l1040t2212r1142b2239],
8	reviews	NNS	O	review	prep_to	4	SENT_373	[p9l1153t2208r1283b2239],
9	on	IN	O	on	_	0	SENT_373	[p9l1295t2218r1337b2240],
10	clinical	JJ	O	clinical	amod	12	SENT_373	[p9l1349t2208r1472b2240],
11	reversal	NN	O	reversal	nn	12	SENT_373	[p9l1485t2209r1617b2240],
12	studies	NNS	O	study	prep_on	4	SENT_373	[p9l1630t2209r1745b2240],
13	(	VBP	O	(	dep	12	SENT_373	[p9l1760t2208r1803b2246],
14	9	CD	NUMBER	9	dobj	13	SENT_373	[p9l1760t2208r1803b2246],
15	,	,	O	,	_	0	SENT_373	[p9l1760t2208r1803b2246],

1	Annual	JJ	SET	annual	amod	2	SENT_374	[p9l445t2326r566b2355],
2	Reviews	NNS	O	review	_	0	SENT_374	[p9l578t2326r719b2364],
3	.	.	O	.	_	0	SENT_374	[p9l952t2359r957b2364],

1	www.annualreV1ews.org/aronline	NN	O	www.annualrev1ews.org/aronline	_	0	SENT_375	[p9l445t2359r999b2397],

1	174	CD	NUMBER	174	num	2	SENT_376	[p9l497t2457r550b2484],
2	BELLAMY	NN	O	bellamy	_	0	SENT_376	[p9l619t2457r801b2484],

1	98	CD	NUMBER	98	_	0	SENT_377	[p9l494t2556r558b2593],
2	)	NN	O	)	dep	1	SENT_377	[p9l494t2556r558b2593],
3	.	.	O	.	_	0	SENT_377	[p9l494t2556r558b2593],

1	In	IN	O	in	_	0	SENT_378	[p9l574t2557r609b2586],
2	general	JJ	O	general	prep_in	7	SENT_378	[p9l623t2556r755b2596],
3	,	,	O	,	_	0	SENT_378	[p9l623t2556r755b2596],
4	the	DT	O	the	det	5	SENT_378	[p9l770t2556r821b2587],
5	studies	NNS	O	study	nsubj	7	SENT_378	[p9l835t2555r949b2587],
6	have	VBP	O	have	aux	7	SENT_378	[p9l963t2556r1042b2587],
7	been	VBN	O	be	_	0	SENT_378	[p9l1054t2556r1134b2587],
8	of	IN	O	of	_	0	SENT_378	[p9l1149t2556r1185b2586],
9	limited	JJ	O	limited	amod	10	SENT_378	[p9l1197t2556r1315b2587],
10	duration	NN	O	duration	prep_of	7	SENT_378	[p9l1329t2556r1475b2592],
11	,	,	O	,	_	0	SENT_378	[p9l1329t2556r1475b2592],
12	although	IN	O	although	mark	16	SENT_378	[p9l1492t2556r1637b2596],
13	there	EX	O	there	expl	16	SENT_378	[p9l1652t2556r1733b2587],
14	are	VBP	O	be	cop	16	SENT_378	[p9l1748t2565r1799b2587],
15	notable	JJ	O	notable	amod	16	SENT_378	[p9l494t2606r617b2636],
16	exceptions	NNS	O	exception	advcl	7	SENT_378	[p9l635t2606r812b2645],
17	in	IN	O	in	_	0	SENT_378	[p9l830t2606r863b2636],
18	lymphoma	NN	O	lymphoma	prep_in	16	SENT_378	[p9l881t2605r1066b2645],
19	,	,	O	,	_	0	SENT_378	[p9l881t2605r1066b2645],
20	but	CC	O	but	_	0	SENT_378	[p9l1084t2607r1139b2636],
21	are	VBP	O	be	cop	22	SENT_378	[p9l1156t2615r1206b2636],
22	encouraging	VBG	O	encourage	advcl	7	SENT_378	[p9l1223t2606r1429b2645],
23	enough	RB	O	enough	advmod	22	SENT_378	[p9l1446t2606r1569b2645],
24	to	TO	O	to	aux	25	SENT_378	[p9l1587t2611r1618b2636],
25	warrant	VB	O	warrant	xcomp	22	SENT_378	[p9l1637t2611r1764b2637],
26	a	DT	O	a	det	28	SENT_378	[p9l1782t2615r1800b2636],
27	continued	JJ	O	continued	amod	28	SENT_378	[p9l494t2655r659b2685],
28	effort	NN	O	effort	dobj	25	SENT_378	[p9l672t2655r765b2685],
29	in	IN	O	in	_	0	SENT_378	[p9l776t2655r810b2685],
30	this	DT	O	this	det	31	SENT_378	[p9l822t2655r881b2685],
31	arena	NN	O	arena	prep_in	25	SENT_378	[p9l895t2664r994b2685],
32	.	.	O	.	_	0	SENT_378	[p9l895t2664r994b2685],

1	NON	NNP	O	NON	_	0	SENT_379	[p9l494t2760r1342b2796],
2	.	.	O	.	_	0	SENT_379	[p9l494t2760r1342b2796],

1	—	NN	O	—	_	0	SENT_380	[p9l494t2760r1342b2796],
2	.	.	O	.	_	0	SENT_380	[p9l494t2760r1342b2796],

1	P-GLYCOPROTEIN	NN	O	p-glycoprotein	_	0	SENT_381	[p9l494t2760r1342b2796],
2	.	.	O	.	_	0	SENT_381	[p9l494t2760r1342b2796],

1	—	NN	O	—	_	0	SENT_382	[p9l494t2760r1342b2796],
2	.	.	O	.	_	0	SENT_382	[p9l494t2760r1342b2796],

1	MEDIATED	VBN	O	mediate	_	0	SENT_383	[p9l494t2760r1342b2796],
2	MULTIDRUG	JJ	O	multidrug	amod	3	SENT_383	[p9l1359t2761r1659b2797],
3	RESISTANCE	NN	O	resistance	dobj	1	SENT_383	[p9l494t2810r799b2847],

1	AT-MDR	NN	O	at-mdr	_	0	SENT_384	[p9l492t2915r679b2951],

1	Studies	NNS	O	study	_	0	SENT_385	[p9l496t2987r617b3018],
2	by	IN	O	by	_	0	SENT_385	[p9l629t2988r672b3027],
3	Beck	NNP	PERSON	Beck	prep_by	1	SENT_385	[p9l684t2987r770b3018],
4	et	FW	O	et	nn	6	SENT_385	[p9l782t2992r812b3018],
5	al	FW	O	al	nn	6	SENT_385	[p9l824t2988r853b3018],
6	(	FW	O	(	dep	3	SENT_385	[p9l866t2987r934b3025],
7	99	CD	NUMBER	99	num	8	SENT_385	[p9l866t2987r934b3025],
8	)	NN	O	)	dobj	6	SENT_385	[p9l866t2987r934b3025],
9	and	CC	O	and	_	0	SENT_385	[p9l947t2988r1006b3018],
10	Danks	NNP	PERSON	Danks	conj_and	8	SENT_385	[p9l1018t2988r1124b3018],
11	et	FW	O	et	dep	6	SENT_385	[p9l1137t2992r1167b3018],
12	al	FW	O	al	nn	15	SENT_385	[p9l1179t2987r1208b3018],
13	(	FW	O	(	dep	15	SENT_385	[p9l1221t2988r1309b3025],
14	100	CD	NUMBER	100	num	15	SENT_385	[p9l1221t2988r1309b3025],
15	)	CD	NUMBER	)	advmod	17	SENT_385	[p9l1221t2988r1309b3025],
16	have	VBP	O	have	aux	17	SENT_385	[p9l1322t2987r1400b3018],
17	demonstrated	VBN	O	demonstrate	dep	11	SENT_385	[p9l1413t2988r1637b3018],
18	a	DT	O	a	det	19	SENT_385	[p9l1650t2997r1667b3018],
19	non	JJ	O	non	dobj	17	SENT_385	[p9l1679t2988r1799b3018],
20	.	.	O	.	_	0	SENT_385	[p9l1679t2988r1799b3018],

1	—	NN	O	—	_	0	SENT_386	[p9l1679t2988r1799b3018],
2	.	.	O	.	_	0	SENT_386	[p9l1679t2988r1799b3018],

1	.	.	O	.	_	0	SENT_387	[p9l1679t2988r1799b3018],

1	—	NN	O	—	_	0	SENT_388	[p9l1679t2988r1799b3018],
2	.	.	O	.	_	0	SENT_388	[p9l1679t2988r1799b3018],

1	P	NN	O	p	nn	3	SENT_389	[p9l1679t2988r1799b3018],
2	glycoprotein	NN	O	glycoprotein	nn	3	SENT_389	[p9l495t3037r880b3077],
3	—	NN	O	—	nsubj	4	SENT_389	[p9l495t3037r880b3077],
4	mediated	VBD	O	mediate	_	0	SENT_389	[p9l495t3037r880b3077],
5	multidrug	JJ	O	multidrug	amod	6	SENT_389	[p9l894t3037r1208b3077],
6	—	NN	O	—	dobj	4	SENT_389	[p9l894t3037r1208b3077],
7	resistant	JJ	O	resistant	amod	6	SENT_389	[p9l894t3037r1208b3077],
8	subline	NN	O	subline	dep	7	SENT_389	[p9l1222t3038r1341b3068],
9	of	IN	O	of	_	0	SENT_389	[p9l1355t3037r1391b3068],
10	the	DT	O	the	det	11	SENT_389	[p9l1402t3038r1451b3068],
11	CCRF/CEM	NN	O	ccrf/cem	prep_of	8	SENT_389	[p9l1465t3037r1673b3069],
12	human	JJ	O	human	amod	15	SENT_389	[p9l1686t3038r1799b3069],
13	T-cell	NN	MISC	t-cell	nn	15	SENT_389	[p9l494t3087r595b3118],
14	leukemia	NN	O	leukemia	nn	15	SENT_389	[p9l606t3087r759b3118],
15	line	NN	O	line	dep	8	SENT_389	[p9l771t3087r842b3123],
16	,	,	O	,	_	0	SENT_389	[p9l771t3087r842b3123],
17	VM-5	NN	O	vm-5	appos	8	SENT_389	[p9l854t3087r965b3123],
18	,	,	O	,	_	0	SENT_389	[p9l854t3087r965b3123],
19	which	WDT	O	which	nsubjpass	21	SENT_389	[p9l977t3087r1078b3118],
20	was	VBD	O	be	auxpass	21	SENT_389	[p9l1092t3096r1154b3117],
21	selected	VBN	O	select	rcmod	17	SENT_389	[p9l1167t3087r1300b3118],
22	for	IN	O	for	_	0	SENT_389	[p9l1311t3086r1359b3118],
23	resistance	NN	O	resistance	prep_for	21	SENT_389	[p9l1370t3087r1534b3118],
24	to	TO	O	to	_	0	SENT_389	[p9l1547t3091r1578b3118],
25	the	DT	O	the	det	27	SENT_389	[p9l1590t3087r1640b3118],
26	epipodophyllotoxin	NN	O	epipodophyllotoxin	nn	27	SENT_389	[p9l1653t3087r1799b3127, p9l495t3137r689b3177],
27	VM-26	NN	O	vm-26	prep_to	21	SENT_389	[p9l702t3137r833b3168],
28	.	.	O	.	_	0	SENT_389	[p9l702t3137r833b3168],

1	Although	IN	O	although	mark	7	SENT_390	[p9l848t3137r1004b3177],
2	this	DT	O	this	det	4	SENT_390	[p9l1018t3137r1077b3168],
3	cell	NN	O	cell	nn	4	SENT_390	[p9l1092t3137r1150b3168],
4	line	NN	O	line	nsubj	7	SENT_390	[p9l1166t3137r1227b3168],
5	does	VBZ	O	do	aux	7	SENT_390	[p9l1240t3137r1315b3169],
6	not	RB	O	not	neg	7	SENT_390	[p9l1329t3141r1383b3168],
7	express	VB	O	express	advcl	14	SENT_390	[p9l1396t3146r1519b3177],
8	the	DT	O	the	det	11	SENT_390	[p9l1534t3137r1585b3168],
9	MDR1	NN	O	mdr1	nn	11	SENT_390	[p9l1596t3138r1704b3168],
10	gene	NN	O	gene	nn	11	SENT_390	[p9l1723t3146r1801b3177],
11	product	NN	O	product	dobj	7	SENT_390	[p9l495t3187r633b3226],
12	,	,	O	,	_	0	SENT_390	[p9l495t3187r633b3226],
13	it	PRP	O	it	nsubj	14	SENT_390	[p9l643t3188r667b3218],
14	displayed	VBD	O	display	_	0	SENT_390	[p9l675t3187r834b3227],
15	a	DT	O	a	det	17	SENT_390	[p9l844t3196r863b3218],
16	cross-resistant	JJ	O	cross-resistant	amod	17	SENT_390	[p9l871t3187r1108b3218],
17	proﬁle	NN	O	proﬁle	dobj	14	SENT_390	[p9l1117t3187r1226b3226],
18	that	WDT	O	that	nsubj	21	SENT_390	[p9l1237t3187r1298b3218],
19	was	VBD	O	be	cop	21	SENT_390	[p9l1309t3195r1371b3218],
20	very	RB	O	very	advmod	21	SENT_390	[p9l1382t3196r1455b3226],
21	similar	JJ	O	similar	rcmod	17	SENT_390	[p9l1465t3187r1580b3218],
22	to	TO	O	to	_	0	SENT_390	[p9l1588t3191r1621b3218],
23	the	DT	O	the	det	25	SENT_390	[p9l1630t3187r1680b3218],
24	MDR1	NN	O	mdr1	nn	25	SENT_390	[p9l1689t3187r1796b3217],
25	phenotype	NN	O	phenotype	prep_to	21	SENT_390	[p9l495t3236r678b3275],
26	,	,	O	,	_	0	SENT_390	[p9l495t3236r678b3275],
27	with	IN	O	with	_	0	SENT_390	[p9l691t3236r765b3266],
28	several	JJ	O	several	amod	30	SENT_390	[p9l776t3235r893b3267],
29	important	JJ	O	important	amod	30	SENT_390	[p9l903t3236r1065b3275],
30	exceptions	NNS	O	exception	prep_with	21	SENT_390	[p9l1075t3236r1261b3275],
31	.	.	O	.	_	0	SENT_390	[p9l1075t3236r1261b3275],

1	First	RB	ORDINAL	first	advmod	18	SENT_391	[p9l1274t3236r1359b3271],
2	,	,	O	,	_	0	SENT_391	[p9l1274t3236r1359b3271],
3	in	IN	O	in	_	0	SENT_391	[p9l1370t3236r1402b3266],
4	contrast	NN	O	contrast	prep_in	18	SENT_391	[p9l1414t3240r1545b3267],
5	to	TO	O	to	_	0	SENT_391	[p9l1555t3240r1587b3266],
6	the	DT	O	the	det	9	SENT_391	[p9l1599t3236r1649b3267],
7	classical	JJ	O	classical	amod	9	SENT_391	[p9l1660t3236r1801b3267],
8	MDR	NN	O	mdr	nn	9	SENT_391	[p9l495t3286r592b3315],
9	phenotype	NN	O	phenotype	prep_to	4	SENT_391	[p9l608t3286r792b3324],
10	,	,	O	,	_	0	SENT_391	[p9l608t3286r792b3324],
11	these	DT	O	these	det	12	SENT_391	[p9l809t3286r894b3316],
12	cells	NNS	O	cell	nsubj	24	SENT_391	[p9l912t3285r986b3315],
13	remained	VBD	O	remain	cop	18	SENT_391	[p9l1003t3285r1159b3316],
14	sensitive	JJ	O	sensitive	amod	18	SENT_391	[p9l1178t3285r1321b3316],
15	to	TO	O	to	_	0	SENT_391	[p9l1338t3290r1370b3315],
16	the	DT	O	the	det	17	SENT_391	[p9l1387t3285r1438b3316],
17	vinca	NN	O	vinca	prep_to	14	SENT_391	[p9l1456t3286r1545b3316],
18	alkaloids	NNS	O	alkaloid	_	0	SENT_391	[p9l1564t3285r1722b3321],
19	,	,	O	,	_	0	SENT_391	[p9l1564t3285r1722b3321],
20	and	CC	O	and	_	0	SENT_391	[p9l1741t3286r1800b3316],
21	second	JJ	ORDINAL	second	ccomp	24	SENT_391	[p9l496t3336r620b3372],
22	,	,	O	,	_	0	SENT_391	[p9l496t3336r620b3372],
23	there	EX	O	there	expl	24	SENT_391	[p9l635t3336r719b3366],
24	appeared	VBD	O	appear	conj_and	18	SENT_391	[p9l733t3335r883b3374],
25	to	TO	O	to	aux	28	SENT_391	[p9l898t3340r929b3365],
26	be	VB	O	be	cop	28	SENT_391	[p9l943t3336r983b3366],
27	no	DT	O	no	det	28	SENT_391	[p9l997t3345r1037b3366],
28	alteration	NN	O	alteration	xcomp	24	SENT_391	[p9l1052t3335r1208b3366],
29	in	IN	O	in	_	0	SENT_391	[p9l1222t3336r1254b3366],
30	drug	NN	O	drug	nn	31	SENT_391	[p9l1269t3336r1344b3374],
31	accumulation	NN	O	accumulation	prep_in	28	SENT_391	[p9l1359t3335r1582b3366],
32	between	IN	O	between	_	0	SENT_391	[p9l1596t3336r1735b3366],
33	the	DT	O	the	det	35	SENT_391	[p9l1750t3336r1801b3365],
34	drug-resistant	JJ	O	drug-resistant	amod	35	SENT_391	[p9l496t3386r726b3425],
35	cells	NNS	O	cell	prep_between	31	SENT_391	[p9l741t3386r816b3416],
36	and	CC	O	and	_	0	SENT_391	[p9l832t3385r892b3416],
37	their	PRP$	O	they	poss	39	SENT_391	[p9l907t3385r983b3415],
38	drug-sensitive	JJ	O	drug-sensitive	amod	39	SENT_391	[p9l997t3385r1232b3425],
39	counterparts	NNS	O	counterpart	conj_and	35	SENT_391	[p9l1247t3390r1461b3424],
40	.	.	O	.	_	0	SENT_391	[p9l1247t3390r1461b3424],

1	This	DT	O	this	det	2	SENT_392	[p9l1478t3386r1551b3416],
2	form	NN	O	form	nsubjpass	6	SENT_392	[p9l1567t3385r1648b3416],
3	of	IN	O	of	_	0	SENT_392	[p9l1663t3386r1699b3416],
4	resistance	NN	O	resistance	prep_of	2	SENT_392	[p9l1712t3385r1800b3416, p9l496t3441r584b3466],
5	is	VBZ	O	be	auxpass	6	SENT_392	[p9l595t3437r623b3466],
6	referred	VBN	O	refer	_	0	SENT_392	[p9l635t3436r768b3467],
7	to	TO	O	to	xcomp	6	SENT_392	[p9l779t3441r812b3467],
8	as	IN	O	as	mark	9	SENT_392	[p9l823t3446r857b3466],
9	At	IN	O	at	advcl	6	SENT_392	[p9l869t3436r1029b3472],
10	.	.	O	.	_	0	SENT_392	[p9l869t3436r1029b3472],

1	—	NN	O	—	_	0	SENT_393	[p9l869t3436r1029b3472],
2	.	.	O	.	_	0	SENT_393	[p9l869t3436r1029b3472],

1	MDR	NN	ORGANIZATION	mdr	_	0	SENT_394	[p9l869t3436r1029b3472],
2	,	,	O	,	_	0	SENT_394	[p9l869t3436r1029b3472],
3	and	CC	O	and	dep	1	SENT_394	[p9l1042t3436r1102b3467],
4	it	PRP	O	it	nsubj	5	SENT_394	[p9l1114t3436r1137b3465],
5	appears	VBZ	O	appear	dep	1	SENT_394	[p9l1149t3445r1273b3475],
6	to	TO	O	to	aux	9	SENT_394	[p9l1287t3442r1318b3467],
7	be	VB	O	be	cop	9	SENT_394	[p9l1330t3436r1369b3466],
8	the	DT	O	the	det	9	SENT_394	[p9l1382t3436r1431b3466],
9	result	NN	O	result	xcomp	5	SENT_394	[p9l1443t3437r1535b3467],
10	of	IN	O	of	_	0	SENT_394	[p9l1547t3436r1584b3466],
11	an	DT	O	a	det	12	SENT_394	[p9l1594t3445r1632b3466],
12	alteration	NN	O	alteration	prep_of	9	SENT_394	[p9l1644t3436r1801b3467],
13	in	IN	O	in	_	0	SENT_394	[p9l496t3487r529b3517],
14	the	DT	O	the	det	19	SENT_394	[p9l539t3488r589b3518],
15	enzyme	NN	O	enzyme	nn	19	SENT_394	[p9l600t3496r729b3527],
16	DNA	NN	O	dna	nn	19	SENT_394	[p9l740t3488r831b3518],
17	topoisomerase	NN	O	topoisomerase	nn	19	SENT_394	[p9l839t3487r1079b3527],
18	H	NN	O	h	nn	19	SENT_394	[p9l1091t3488r1117b3518],
19	(	NN	O	(	prep_in	12	SENT_394	[p9l1128t3487r1212b3524],
20	101	CD	NUMBER	101	dep	19	SENT_394	[p9l1128t3487r1212b3524],
21	,	,	O	,	_	0	SENT_394	[p9l1128t3487r1212b3524],
22	102	CD	NUMBER	102	number	23	SENT_394	[p9l1228t3488r1308b3524],
23	)	CD	NUMBER	)	appos	20	SENT_394	[p9l1228t3488r1308b3524],
24	.	.	O	.	_	0	SENT_394	[p9l1228t3488r1308b3524],

1	The	DT	O	the	det	3	SENT_395	[p9l1319t3488r1383b3517],
2	clinical	JJ	O	clinical	amod	3	SENT_395	[p9l1394t3488r1516b3518],
3	relevance	NN	O	relevance	nsubj	9	SENT_395	[p9l1527t3488r1686b3518],
4	of	IN	O	of	_	0	SENT_395	[p9l1697t3488r1734b3518],
5	this	DT	O	this	det	6	SENT_395	[p9l1742t3487r1800b3518],
6	phenotype	NN	O	phenotype	prep_of	3	SENT_395	[p9l496t3538r671b3577],
7	is	VBZ	O	be	cop	9	SENT_395	[p9l684t3537r710b3567],
8	currently	RB	DATE	currently	advmod	9	SENT_395	[p9l723t3538r874b3577],
9	unknown	JJ	O	unknown	_	0	SENT_395	[p9l887t3537r1050b3568],
10	.	.	O	.	_	0	SENT_395	[p9l887t3537r1050b3568],

1	MRP	NN	O	mrp	_	0	SENT_396	[p9l495t3635r601b3670],

1	A	DT	O	a	det	2	SENT_397	[p9l497t3706r527b3736],
2	number	NN	O	number	nsubj	11	SENT_397	[p9l539t3706r668b3737],
3	of	IN	O	of	_	0	SENT_397	[p9l678t3705r716b3736],
4	other	JJ	O	other	amod	9	SENT_397	[p9l725t3706r811b3736],
5	putative	JJ	O	putative	amod	9	SENT_397	[p9l822t3705r956b3745],
6	non-P-glycoprotein	JJ	O	non-p-glycoprotein	amod	9	SENT_397	[p9l967t3705r1298b3746],
7	drug	NN	O	drug	nn	9	SENT_397	[p9l1310t3705r1386b3745],
8	efﬂux	NN	O	efﬂux	nn	9	SENT_397	[p9l1399t3706r1497b3736],
9	pumps	NNS	O	pump	prep_of	2	SENT_397	[p9l1510t3714r1620b3746],
10	have	VBP	O	have	aux	11	SENT_397	[p9l1633t3706r1711b3737],
11	been	VBN	O	be	_	0	SENT_397	[p9l1723t3706r1801b3737],

1	Annu	NNP	PERSON	Annu	_	0	SENT_398	[p10l355t357r378b437],
2	.	.	O	.	_	0	SENT_398	[p10l355t357r378b437],

1	Rev.	NNP	O	Rev.	nn	2	SENT_399	[p10l355t287r378b347],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_399	[p10l355t128r378b276],
3	.	.	O	.	_	0	SENT_399	[p10l355t128r378b276],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_400	[p10l355t7r378b117],
2	.	.	O	.	_	0	SENT_400	[p10l355t7r378b117],

1	by	IN	O	by	_	0	SENT_401	[p10l388t270r419b302],
2	University	NNP	ORGANIZATION	University	pobj	1	SENT_401	[p10l388t121r419b261],
3	of	IN	ORGANIZATION	of	_	0	SENT_401	[p10l388t82r412b111],
4	Wise	NNP	ORGANIZATION	Wise	nn	5	SENT_401	[p10l388t8r412b76],
5	Annu	NNP	ORGANIZATION	Annu	prep_of	2	SENT_401	[p10l356t2738r379b2818],
6	.	.	O	.	_	0	SENT_401	[p10l356t2738r379b2818],

1	Rev.	NNP	O	Rev.	nn	2	SENT_402	[p10l356t2668r379b2728],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_402	[p10l356t2509r379b2657],
3	.	.	O	.	_	0	SENT_402	[p10l356t2509r379b2657],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_403	[p10l356t2388r379b2498],
2	.	.	O	.	_	0	SENT_403	[p10l356t2388r379b2498],

1	1996.36	CD	NUMBER	1996.36	_	0	SENT_404	[p10l356t2263r380b2374],
2	:	:	O	:	_	0	SENT_404	[p10l356t2263r380b2374],
3	161-18	CD	NUMBER	161-18	number	4	SENT_404	[p10l356t2166r379b2256],
4	3	CD	NUMBER	3	dep	1	SENT_404	[p10l356t2134r379b2155],
5	.	.	O	.	_	0	SENT_404	[p10l356t2134r379b2155],

1	Downloaded	VBN	O	download	csubj	15	SENT_405	[p10l356t1953r379b2123],
2	from	IN	O	from	_	0	SENT_405	[p10l356t1879r379b1944],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_405	[p10l356t1545r386b1870],
4	by	IN	O	by	_	0	SENT_405	[p10l389t2651r420b2683],
5	University	NNP	ORGANIZATION	University	prep_by	1	SENT_405	[p10l390t2502r420b2642],
6	of	IN	ORGANIZATION	of	_	0	SENT_405	[p10l389t2463r413b2492],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	8	SENT_405	[p10l390t2316r413b2457],
8	Madison	NNP	ORGANIZATION	Madison	prep_of	5	SENT_405	[p10l389t2170r413b2288],
9	on	IN	O	on	_	0	SENT_405	[p10l397t2121r413b2153],
10	01/05/14	NN	DATE	01/05/14	prep_on	8	SENT_405	[p10l389t1994r413b2112],
11	For	IN	O	for	_	0	SENT_405	[p10l390t1930r413b1976],
12	personal	JJ	O	personal	amod	13	SENT_405	[p10l389t1809r420b1922],
13	use	NN	O	use	prep_for	1	SENT_405	[p10l397t1757r413b1800],
14	only	RB	O	only	advmod	15	SENT_405	[p10l389t1689r420b1747],
15	proposed	VBD	O	propose	_	0	SENT_405	[p10l496t9r659b47],
16	,	,	O	,	_	0	SENT_405	[p10l496t9r659b47],
17	but	CC	O	but	_	0	SENT_405	[p10l675t8r729b38],
18	to	TO	O	to	_	0	SENT_405	[p10l744t12r776b38],
19	date	NN	O	date	prep_to	32	SENT_405	[p10l791t8r871b43],
20	,	,	O	,	_	0	SENT_405	[p10l791t8r871b43],
21	the	DT	O	the	det	28	SENT_405	[p10l887t7r938b37],
22	multidrug-resistance	JJ	O	multidrug-resistance	amod	28	SENT_405	[p10l953t7r1428b46],
23	—	NN	O	—	nn	28	SENT_405	[p10l953t7r1428b46],
24	related	JJ	O	related	amod	28	SENT_405	[p10l953t7r1428b46],
25	protein	NN	O	protein	nn	28	SENT_405	[p10l1443t8r1561b47],
26	(	CD	NUMBER	(	num	28	SENT_405	[p10l1578t8r1692b45],
27	MRP	NN	ORGANIZATION	mrp	nn	28	SENT_405	[p10l1578t8r1692b45],
28	)	NN	O	)	nsubj	32	SENT_405	[p10l1578t8r1692b45],
29	is	VBZ	O	be	cop	32	SENT_405	[p10l1708t8r1734b38],
30	the	DT	O	the	det	32	SENT_405	[p10l1751t8r1802b38],
31	only	RB	O	only	quantmod	32	SENT_405	[p10l497t57r571b97],
32	one	CD	NUMBER	one	conj_but	15	SENT_405	[p10l584t67r644b89],
33	that	WDT	O	that	nsubjpass	36	SENT_405	[p10l655t57r719b89],
34	has	VBZ	O	have	aux	36	SENT_405	[p10l729t57r785b88],
35	been	VBN	O	be	auxpass	36	SENT_405	[p10l797t57r876b88],
36	conﬁrmed	VBN	O	conﬁrmed	rcmod	32	SENT_405	[p10l888t57r1058b88],
37	(	NN	O	(	nn	39	SENT_405	[p10l1071t56r1170b95],
38	103	CD	NUMBER	103	num	39	SENT_405	[p10l1071t56r1170b95],
39	)	NN	O	)	dobj	36	SENT_405	[p10l1071t56r1170b95],
40	.	.	O	.	_	0	SENT_405	[p10l1071t56r1170b95],

1	The	DT	O	the	det	3	SENT_406	[p10l1183t57r1247b88],
2	MRP	NN	ORGANIZATION	mrp	nn	3	SENT_406	[p10l1260t57r1349b88],
3	gene	NN	O	gene	nsubjpass	14	SENT_406	[p10l1360t66r1437b97],
4	is	VBZ	O	be	cop	6	SENT_406	[p10l1450t57r1476b88],
5	distantly	RB	O	distantly	advmod	6	SENT_406	[p10l1490t57r1632b97],
6	related	JJ	O	related	_	0	SENT_406	[p10l1645t56r1758b89],
7	to	TO	O	to	_	0	SENT_406	[p10l1771t61r1802b88],
8	the	DT	O	the	det	10	SENT_406	[p10l497t107r548b138],
9	MDR1	NN	O	mdr1	nn	10	SENT_406	[p10l557t108r666b138],
10	gene	NN	O	gene	prep_to	6	SENT_406	[p10l682t116r760b147],
11	and	CC	O	and	_	0	SENT_406	[p10l771t107r831b138],
12	was	VBD	O	be	auxpass	14	SENT_406	[p10l843t116r906b139],
13	initially	RB	O	initially	advmod	14	SENT_406	[p10l918t106r1046b147],
14	found	VBN	O	find	conj_and	6	SENT_406	[p10l1056t106r1154b138],
15	overexpressed	VBN	O	overexpress	dep	14	SENT_406	[p10l1165t107r1403b148],
16	in	IN	O	in	_	0	SENT_406	[p10l1414t107r1445b138],
17	a	DT	O	a	det	26	SENT_406	[p10l1457t116r1475b138],
18	multidrug-resistant	JJ	O	multidrug-resistant	amod	26	SENT_406	[p10l1486t106r1803b147],
19	human	JJ	O	human	amod	26	SENT_406	[p10l497t158r610b190],
20	lung	NN	O	lung	nn	26	SENT_406	[p10l623t159r697b198],
21	cancer	NN	O	cancer	nn	26	SENT_406	[p10l710t167r820b190],
22	cell	NN	O	cell	nn	26	SENT_406	[p10l831t158r890b190],
23	line	NN	O	line	nn	26	SENT_406	[p10l904t158r964b189],
24	(	NN	O	(	nn	26	SENT_406	[p10l978t158r1076b197],
25	103	CD	NUMBER	103	num	26	SENT_406	[p10l978t158r1076b197],
26	)	NN	O	)	prep_in	15	SENT_406	[p10l978t158r1076b197],
27	.	.	O	.	_	0	SENT_406	[p10l978t158r1076b197],

1	MRP	NN	O	mrp	nn	2	SENT_407	[p10l1090t158r1179b190],
2	codes	NNS	O	code	_	0	SENT_407	[p10l1191t158r1283b190],
3	for	IN	O	for	_	0	SENT_407	[p10l1297t158r1346b190],
4	a	DT	O	a	det	5	SENT_407	[p10l1357t167r1375b189],
5	message	NN	O	message	prep_for	2	SENT_407	[p10l1388t167r1528b199],
6	of	IN	O	of	_	0	SENT_407	[p10l1541t158r1578b189],
7	7.8	CD	NUMBER	7.8	number	9	SENT_407	[p10l1588t158r1638b190],
8	to	TO	O	to	dep	9	SENT_407	[p10l1653t163r1683b190],
9	8.2	CD	NUMBER	8.2	num	10	SENT_407	[p10l1698t158r1748b190],
10	kb	NN	O	kb	prep_of	5	SENT_407	[p10l1761t158r1802b190],
11	and	CC	O	and	_	0	SENT_407	[p10l497t211r557b241],
12	has	VBZ	O	have	aux	14	SENT_407	[p10l566t211r622b241],
13	been	VBN	O	be	cop	14	SENT_407	[p10l631t211r711b241],
14	localized	JJ	O	localized	conj_and	2	SENT_407	[p10l721t210r871b241],
15	to	TO	O	to	_	0	SENT_407	[p10l880t215r912b240],
16	chromosome	NN	O	chromosome	nn	17	SENT_407	[p10l921t210r1136b241],
17	16p13	NN	O	16p13	prep_to	14	SENT_407	[p10l1151t210r1276b250],
18	.1	CD	NUMBER	.1	num	19	SENT_407	[p10l1151t210r1276b250],
19	(	NN	O	(	dep	17	SENT_407	[p10l1291t210r1389b249],
20	103	CD	NUMBER	103	num	21	SENT_407	[p10l1291t210r1389b249],
21	)	NN	O	)	dep	19	SENT_407	[p10l1291t210r1389b249],
22	.	.	O	.	_	0	SENT_407	[p10l1291t210r1389b249],

1	The	DT	O	the	det	2	SENT_408	[p10l1399t211r1464b241],
2	product	NN	O	product	nsubj	12	SENT_408	[p10l1473t210r1601b250],
3	of	IN	O	of	_	0	SENT_408	[p10l1610t210r1648b241],
4	the	DT	O	the	det	6	SENT_408	[p10l1655t211r1704b241],
5	MRP	NN	ORGANIZATION	mrp	nn	6	SENT_408	[p10l1714t211r1802b241],
6	gene	NN	O	gene	prep_of	2	SENT_408	[p10l498t271r577b301],
7	is	VBZ	O	be	cop	12	SENT_408	[p10l589t261r615b292],
8	a	DT	O	a	det	12	SENT_408	[p10l627t271r646b292],
9	190-kDa	JJ	O	190-kda	amod	12	SENT_408	[p10l661t261r803b292],
10	membrane-bound	JJ	O	membrane-bound	amod	12	SENT_408	[p10l814t261r1108b292],
11	glycoprotein	NN	O	glycoprotein	nn	12	SENT_408	[p10l1119t261r1328b301],
12	(	NN	O	(	_	0	SENT_408	[p10l1340t261r1428b299],
13	104	CD	NUMBER	104	number	14	SENT_408	[p10l1340t261r1428b299],
14	)	CD	NUMBER	)	num	15	SENT_408	[p10l1340t261r1428b299],
15	(	NN	O	(	nsubj	16	SENT_408	[p10l1442t262r1507b299],
16	see	VBP	O	see	rcmod	12	SENT_408	[p10l1442t262r1507b299],
17	Figure	NN	O	figure	nn	19	SENT_408	[p10l1519t261r1626b300],
18	2	CD	NUMBER	2	num	19	SENT_408	[p10l1640t262r1681b299],
19	)	NN	O	)	dobj	16	SENT_408	[p10l1640t262r1681b299],
20	.	.	O	.	_	0	SENT_408	[p10l1640t262r1681b299],

1	Transfection	NN	O	transfection	nn	2	SENT_409	[p10l1695t262r1802b292, p10l498t312r614b343],
2	studies	NNS	O	study	nsubj	4	SENT_409	[p10l628t312r742b343],
3	have	VBP	O	have	aux	4	SENT_409	[p10l756t313r835b343],
4	demonstrated	VBN	O	demonstrate	_	0	SENT_409	[p10l849t313r1073b343],
5	a	DT	O	a	det	7	SENT_409	[p10l1086t322r1105b343],
6	causative	JJ	O	causative	amod	7	SENT_409	[p10l1119t312r1273b343],
7	role	NN	O	role	nsubj	15	SENT_409	[p10l1287t312r1351b343],
8	for	IN	O	for	_	0	SENT_409	[p10l1365t312r1414b343],
9	MRP	NN	ORGANIZATION	mrp	prep_for	7	SENT_409	[p10l1427t313r1515b343],
10	in	IN	O	in	_	0	SENT_409	[p10l1529t313r1559b343],
11	drug-resistant	JJ	O	drug-resistant	amod	14	SENT_409	[p10l1574t312r1804b351],
12	tumor	NN	O	tumor	nn	14	SENT_409	[p10l498t366r598b393],
13	cell	NN	O	cell	nn	14	SENT_409	[p10l613t361r673b393],
14	lines	NNS	O	line	prep_in	9	SENT_409	[p10l689t362r767b393],
15	(	VBP	O	(	ccomp	4	SENT_409	[p10l783t361r964b400],
16	105-107	CD	NUMBER	105-107	num	17	SENT_409	[p10l783t361r964b400],
17	)	CD	NUMBER	)	dobj	15	SENT_409	[p10l783t361r964b400],
18	.	.	O	.	_	0	SENT_409	[p10l783t361r964b400],

1	These	DT	O	these	det	2	SENT_410	[p10l981t362r1081b393],
2	transfectants	NNS	O	transfectant	nsubjpass	5	SENT_410	[p10l1097t361r1305b393],
3	have	VBP	O	have	aux	5	SENT_410	[p10l1322t361r1400b393],
4	been	VBN	O	be	auxpass	5	SENT_410	[p10l1415t362r1494b393],
5	observed	VBN	O	observe	_	0	SENT_410	[p10l1510t362r1660b394],
6	to	TO	O	to	aux	7	SENT_410	[p10l1676t366r1708b393],
7	have	VB	O	have	xcomp	5	SENT_410	[p10l1724t362r1803b393],
8	an	DT	O	a	det	10	SENT_410	[p10l498t421r537b443],
9	elevated	JJ	O	elevated	amod	10	SENT_410	[p10l550t412r689b443],
10	level	NN	O	level	dobj	7	SENT_410	[p10l702t412r782b443],
11	of	IN	O	of	_	0	SENT_410	[p10l795t412r833b443],
12	resistance	NN	O	resistance	prep_of	10	SENT_410	[p10l842t412r1006b444],
13	to	TO	O	to	_	0	SENT_410	[p10l1019t417r1051b443],
14	natural	JJ	O	natural	amod	15	SENT_410	[p10l1064t411r1179b443],
15	products	NNS	O	product	prep_to	7	SENT_410	[p10l1192t412r1334b452],
16	as	RB	O	as	_	0	SENT_410	[p10l1349t421r1382b443],
17	well	RB	O	well	_	0	SENT_410	[p10l1396t412r1466b443],
18	as	IN	O	as	_	0	SENT_410	[p10l1480t421r1514b443],
19	to	TO	O	to	_	0	SENT_410	[p10l1527t417r1559b443],
20	several	JJ	O	several	amod	23	SENT_410	[p10l1573t412r1689b443],
21	heavy	JJ	O	heavy	amod	23	SENT_410	[p10l1703t412r1801b451],
22	metal	NN	O	metal	nn	23	SENT_410	[p10l498t463r590b492],
23	anions	NNS	O	anion	prep_to	7	SENT_410	[p10l599t463r717b497],
24	,	,	O	,	_	0	SENT_410	[p10l599t463r717b497],
25	including	VBG	O	include	_	0	SENT_410	[p10l727t462r884b502],
26	arsenite	NN	O	arsenite	prep_including	7	SENT_410	[p10l894t463r1032b498],
27	,	,	O	,	_	0	SENT_410	[p10l894t463r1032b498],
28	arsenate	NN	O	arsenate	prep_including	7	SENT_410	[p10l1042t467r1187b498],
29	,	,	O	,	_	0	SENT_410	[p10l1042t467r1187b498],
30	and	CC	O	and	_	0	SENT_410	[p10l1198t463r1257b492],
31	trivalent	JJ	O	trivalent	amod	33	SENT_410	[p10l1267t462r1405b492],
32	antimony	JJ	O	antimony	amod	33	SENT_410	[p10l1414t463r1570b501],
33	(	NN	O	(	prep_including	7	SENT_410	[p10l1581t462r1677b499],
34	108	CD	NUMBER	108	num	35	SENT_410	[p10l1581t462r1677b499],
35	)	NN	O	)	dep	33	SENT_410	[p10l1581t462r1677b499],
36	.	.	O	.	_	0	SENT_410	[p10l1581t462r1677b499],

1	Monoclonal	JJ	O	monoclonal	amod	2	SENT_411	[p10l1689t463r1801b493, p10l498t512r600b541],
2	antibodies	NNS	O	antibody	nsubj	4	SENT_411	[p10l610t511r781b542],
3	have	VBP	O	have	aux	4	SENT_411	[p10l791t512r870b542],
4	revealed	VBN	O	reveal	_	0	SENT_411	[p10l879t512r1020b542],
5	that	IN	O	that	complm	8	SENT_411	[p10l1029t512r1093b542],
6	MRP	NN	ORGANIZATION	mrp	nsubj	8	SENT_411	[p10l1102t512r1191b541],
7	is	VBZ	O	be	cop	8	SENT_411	[p10l1199t511r1226b541],
8	localized	JJ	O	localized	ccomp	4	SENT_411	[p10l1237t511r1387b542],
9	to	TO	O	to	_	0	SENT_411	[p10l1397t516r1428b541],
10	the	DT	O	the	det	11	SENT_411	[p10l1439t512r1489b542],
11	plasma	NN	O	plasma	prep_to	8	SENT_411	[p10l1499t512r1617b550],
12	membrane	NN	O	membrane	nsubj	17	SENT_411	[p10l1627t512r1803b542],
13	with	IN	O	with	_	0	SENT_411	[p10l498t560r572b590],
14	some	DT	O	some	det	15	SENT_411	[p10l584t569r672b590],
15	expression	NN	O	expression	prep_with	12	SENT_411	[p10l682t560r860b599],
16	also	RB	O	also	advmod	17	SENT_411	[p10l872t560r939b591],
17	observed	VBN	O	observe	rcmod	11	SENT_411	[p10l949t560r1098b590],
18	in	IN	O	in	_	0	SENT_411	[p10l1109t559r1141b589],
19	the	DT	O	the	det	21	SENT_411	[p10l1153t560r1201b590],
20	golgi	NN	O	golgus	nn	21	SENT_411	[p10l1213t560r1297b599],
21	region	NN	O	region	prep_in	17	SENT_411	[p10l1309t559r1415b598],
22	(	CD	NUMBER	(	number	23	SENT_411	[p10l1428t560r1512b597],
23	107	CD	NUMBER	107	dobj	17	SENT_411	[p10l1428t560r1512b597],
24	,	,	O	,	_	0	SENT_411	[p10l1428t560r1512b597],
25	109	CD	NUMBER	109	appos	23	SENT_411	[p10l1528t559r1596b595],
26	,	,	O	,	_	0	SENT_411	[p10l1528t559r1596b595],
27	110	CD	NUMBER	110	num	28	SENT_411	[p10l1612t560r1691b597],
28	)	NN	O	)	appos	25	SENT_411	[p10l1612t560r1691b597],
29	.	.	O	.	_	0	SENT_411	[p10l1612t560r1691b597],

1	MRP	NN	ORGANIZATION	mrp	nsubj	18	SENT_412	[p10l1705t560r1802b595],
2	,	,	O	,	_	0	SENT_412	[p10l1705t560r1802b595],
3	which	WDT	O	which	nsubjpass	5	SENT_412	[p10l498t609r600b639],
4	is	VBZ	O	be	auxpass	5	SENT_412	[p10l620t610r647b640],
5	produced	VBN	O	produce	rcmod	1	SENT_412	[p10l668t609r822b648],
6	in	IN	O	in	_	0	SENT_412	[p10l843t610r875b640],
7	both	CC	O	both	advmod	8	SENT_412	[p10l895t609r969b639],
8	the	DT	O	the	prep_in	5	SENT_412	[p10l988t610r1039b640],
9	transfected	VBN	O	transfect	partmod	8	SENT_412	[p10l1059t609r1241b640],
10	and	CC	O	and	_	0	SENT_412	[p10l1262t610r1321b639],
11	drug-selected	JJ	O	drug-selected	amod	13	SENT_412	[p10l1341t609r1566b648],
12	cell	NN	O	cell	nn	13	SENT_412	[p10l1587t609r1645b639],
13	lines	NNS	O	line	prep_in	5	SENT_412	[p10l1667t609r1755b645],
14	,	,	O	,	_	0	SENT_412	[p10l1667t609r1755b645],
15	is	VBZ	O	be	cop	16	SENT_412	[p10l1776t609r1802b639],
16	N-glycosylated	JJ	O	n-glycosylated	_	0	SENT_412	[p10l497t659r752b698],
17	and	CC	O	and	_	0	SENT_412	[p10l768t659r828b689],
18	undergoes	VBZ	O	undergo	conj_and	16	SENT_412	[p10l843t659r1012b698],
19	phosphorylation	NN	O	phosphorylation	nn	20	SENT_412	[p10l1028t658r1298b698],
20	(	NN	O	(	dobj	18	SENT_412	[p10l1315t658r1413b695],
21	111	CD	NUMBER	111	num	22	SENT_412	[p10l1315t658r1413b695],
22	)	NN	O	)	dobj	16	SENT_412	[p10l1315t658r1413b695],
23	.	.	O	.	_	0	SENT_412	[p10l1315t658r1413b695],

1	MRP	NN	ORGANIZATION	mrp	nn	2	SENT_413	[p10l1430t659r1518b689],
2	phosphorylation	NN	O	phosphorylation	nsubj	4	SENT_413	[p10l1533t658r1803b698],
3	apparently	RB	O	apparently	advmod	4	SENT_413	[p10l499t708r675b747],
4	occurs	VBZ	O	occur	_	0	SENT_413	[p10l691t717r799b738],
5	only	RB	O	only	advmod	4	SENT_413	[p10l816t708r889b748],
6	on	IN	O	on	_	0	SENT_413	[p10l905t717r947b738],
7	serine	NN	O	serine	nn	8	SENT_413	[p10l962t707r1060b738],
8	residues	NNS	O	residue	prep_on	4	SENT_413	[p10l1075t707r1221b743],
9	,	,	O	,	_	0	SENT_413	[p10l1075t707r1221b743],
10	and	CC	O	and	_	0	SENT_413	[p10l1239t708r1298b738],
11	the	DT	O	the	det	13	SENT_413	[p10l1314t707r1365b738],
12	protein	NN	O	protein	nn	13	SENT_413	[p10l1381t707r1498b746],
13	kinase	NN	O	kinase	nsubj	18	SENT_413	[p10l1515t707r1621b738],
14	that	WDT	O	that	nsubj	16	SENT_413	[p10l1637t708r1699b738],
15	is	VBZ	O	be	cop	16	SENT_413	[p10l1715t708r1741b738],
16	responsible	JJ	O	responsible	rcmod	13	SENT_413	[p10l1758t716r1802b738, p10l499t757r656b796],
17	is	VBZ	O	be	cop	18	SENT_413	[p10l669t757r695b787],
18	unknown	JJ	O	unknown	conj_and	4	SENT_413	[p10l709t758r873b793],
19	,	,	O	,	_	0	SENT_413	[p10l709t758r873b793],
20	although	IN	O	although	mark	22	SENT_413	[p10l887t757r1032b796],
21	evidence	NN	O	evidence	nsubj	22	SENT_413	[p10l1044t757r1192b788],
22	suggests	VBZ	O	suggest	advcl	18	SENT_413	[p10l1206t762r1343b796],
23	a	DT	O	a	det	24	SENT_413	[p10l1359t766r1376b787],
24	role	NN	O	role	dobj	22	SENT_413	[p10l1388t757r1452b787],
25	for	IN	O	for	_	0	SENT_413	[p10l1466t757r1515b787],
26	protein	NN	O	protein	nn	28	SENT_413	[p10l1527t757r1644b796],
27	kinase	NN	O	kinase	nn	28	SENT_413	[p10l1657t757r1763b787],
28	C	NN	O	c	prep_for	24	SENT_413	[p10l1776t757r1802b787],
29	(	CD	NUMBER	(	number	30	SENT_413	[p10l499t807r529b843],
30	1	CD	NUMBER	1	dep	28	SENT_413	[p10l499t807r529b843],
31	12	CD	NUMBER	12	num	32	SENT_413	[p10l538t807r598b843],
32	)	NN	O	)	dep	30	SENT_413	[p10l538t807r598b843],
33	.	.	O	.	_	0	SENT_413	[p10l538t807r598b843],

1	Using	VBG	O	use	partmod	10	SENT_414	[p10l541t855r640b895],
2	cat	NN	O	cat	nn	4	SENT_414	[p10l653t860r703b886],
3	reporter	NN	O	reporter	nn	4	SENT_414	[p10l716t860r848b894],
4	constructs	NNS	O	construct	dobj	1	SENT_414	[p10l861t860r1038b890],
5	,	,	O	,	_	0	SENT_414	[p10l861t860r1038b890],
6	ﬂan	NN	O	ﬂan	nsubj	10	SENT_414	[p10l1052t856r1119b885],
7	&	CC	O	&	_	0	SENT_414	[p10l1134t855r1165b885],
8	Center	NNP	O	Center	nsubj	10	SENT_414	[p10l1179t855r1290b885],
9	have	VBP	O	have	aux	10	SENT_414	[p10l1303t856r1381b885],
10	identiﬁed	VBN	O	identiﬁed	_	0	SENT_414	[p10l1395t854r1554b885],
11	the	DT	O	the	det	13	SENT_414	[p10l1568t855r1619b885],
12	MRP	NN	O	mrp	nn	13	SENT_414	[p10l1633t855r1721b885],
13	proAnnual	NN	O	proannual	dobj	10	SENT_414	[p10l1734t864r1802b894, p10l446t973r567b1002],

1	Reviews	NNS	O	review	nsubj	2	SENT_415	[p10l579t973r721b1011],
2	_	VBP	O	_	_	0	SENT_415	[p10l953t1006r958b1011],
3	www.annualreviews.org/aronline	NN	O	www.annualreviews.org/aronline	dobj	2	SENT_415	[p10l446t1006r1000b1044],

1	P-GLYCOPROTEINS	NNPS	O	P-GLYCOPROTEINS	_	0	SENT_416	[p10l891t1106r1231b1136],
2	AND	CC	O	and	_	0	SENT_416	[p10l1240t1108r1322b1136],
3	DRUG	NN	O	drug	conj_and	1	SENT_416	[p10l1331t1107r1438b1137],
4	RESISTANCE	NN	O	resistance	dep	1	SENT_416	[p10l1446t1107r1675b1137],

1	MRP	NN	O	mrp	_	0	SENT_417	[p10l1120t1212r1242b1256],

1	Lumen	NN	O	luman	_	0	SENT_418	[p10l576t1244r683b1270],

1	Nucleotide	NN	O	nucleotide	nn	2	SENT_419	[p10l1077t1802r1220b1826],
2	Binding	NN	O	binding	_	0	SENT_419	[p10l1229t1803r1332b1832],

1	Domain	NN	O	domain	_	0	SENT_420	[p10l1142t1833r1243b1856],
2	1	CD	NUMBER	1	num	1	SENT_420	[p10l1253t1835r1264b1856],

1	Nucleotide	NN	O	nucleotide	nn	2	SENT_421	[p10l1476t1918r1620b1942],
2	Binding	NN	O	binding	_	0	SENT_421	[p10l1629t1918r1730b1947],

1	Domain	NN	O	domain	_	0	SENT_422	[p10l1541t1950r1643b1974],
2	2	CD	NUMBER	2	num	1	SENT_422	[p10l1652t1951r1667b1973],

1	Figure	NN	O	figure	_	0	SENT_423	[p10l496t2019r586b2051],
2	2	CD	NUMBER	2	num	1	SENT_423	[p10l595t2019r611b2044],
3	The	DT	O	the	det	5	SENT_423	[p10l641t2020r694b2045],
4	proposed	VBN	O	propose	amod	5	SENT_423	[p10l702t2020r825b2053],
5	structure	NN	O	structure	dep	1	SENT_423	[p10l833t2024r948b2045],
6	for	IN	O	for	_	0	SENT_423	[p10l956t2020r996b2045],
7	the	DT	O	the	det	9	SENT_423	[p10l1003t2020r1044b2045],
8	multidrug-associated	JJ	O	multidrug-associated	amod	9	SENT_423	[p10l1053t2020r1330b2052],
9	protein	NN	O	protein	prep_for	1	SENT_423	[p10l1338t2021r1439b2052],
10	,	,	O	,	_	0	SENT_423	[p10l1338t2021r1439b2052],
11	MRP	NN	O	mrp	appos	9	SENT_423	[p10l1448t2021r1526b2045],
12	.	.	O	.	_	0	SENT_423	[p10l1448t2021r1526b2045],

1	Solid	JJ	O	solid	amod	2	SENT_424	[p10l1536t2021r1607b2046],
2	bars	NNS	O	bar	nsubj	3	SENT_424	[p10l1614t2021r1670b2045],
3	represent	VBP	O	represent	_	0	SENT_424	[p10l1679t2025r1801b2052],
4	transmembrane	JJ	O	transmembrane	amod	5	SENT_424	[p10l496t2059r701b2084],
5	domains	NNS	O	domain	dobj	3	SENT_424	[p10l719t2059r839b2087],
6	,	,	O	,	_	0	SENT_424	[p10l719t2059r839b2087],
7	while	IN	O	while	mark	10	SENT_424	[p10l858t2060r931b2084],
8	solid	JJ	O	solid	amod	9	SENT_424	[p10l951t2059r1016b2084],
9	circles	NNS	O	circle	nsubj	10	SENT_424	[p10l1032t2060r1118b2084],
10	represent	VBP	O	represent	advcl	3	SENT_424	[p10l1137t2064r1258b2090],
11	ATP-binding	JJ	O	atp-binding	amod	12	SENT_424	[p10l1277t2059r1451b2091],
12	regions	NNS	O	region	dobj	10	SENT_424	[p10l1470t2059r1574b2091],
13	.	.	O	.	_	0	SENT_424	[p10l1470t2059r1574b2091],

1	(	NN	O	(	_	0	SENT_425	[p10l1594t2060r1719b2091],
2	Adapted	VBN	O	adapt	partmod	1	SENT_425	[p10l1594t2060r1719b2091],
3	from	IN	O	from	prep	2	SENT_425	[p10l1736t2060r1801b2085],
4	Reference	NNP	O	Reference	dep	3	SENT_425	[p10l497t2098r632b2123],
5	11	CD	NUMBER	11	num	6	SENT_425	[p10l643t2098r670b2123],
6	1	CD	NUMBER	1	dep	4	SENT_425	[p10l677t2098r708b2127],
7	.	.	O	.	_	0	SENT_425	[p10l677t2098r708b2127],
8	)	SYM	O	)	dep	1	SENT_425	[p10l677t2098r708b2127],

1	moter	NN	O	moter	nn	2	SENT_426	[p10l496t2292r594b2318],
2	(	NN	O	(	_	0	SENT_426	[p10l610t2287r708b2324],
3	113	CD	NUMBER	113	num	4	SENT_426	[p10l610t2287r708b2324],
4	)	NN	O	)	dep	2	SENT_426	[p10l610t2287r708b2324],
5	.	.	O	.	_	0	SENT_426	[p10l610t2287r708b2324],

1	Primer	NN	O	primer	nn	3	SENT_427	[p10l724t2287r838b2317],
2	extension	NN	O	extension	nn	3	SENT_427	[p10l852t2287r1012b2318],
3	analysis	NN	O	analysis	nsubj	7	SENT_427	[p10l1028t2287r1160b2327],
4	of	IN	O	of	_	0	SENT_427	[p10l1176t2286r1214b2317],
5	this	DT	O	this	det	6	SENT_427	[p10l1226t2287r1286b2318],
6	region	NN	O	region	prep_of	3	SENT_427	[p10l1301t2287r1407b2326],
7	revealed	VBD	O	reveal	_	0	SENT_427	[p10l1422t2288r1565b2318],
8	the	DT	O	the	det	9	SENT_427	[p10l1579t2288r1631b2318],
9	lack	NN	O	lack	dobj	7	SENT_427	[p10l1646t2287r1717b2318],
10	of	IN	O	of	_	0	SENT_427	[p10l1732t2288r1770b2318],
11	a	DT	O	a	det	13	SENT_427	[p10l1783t2296r1801b2318],
12	TATA	NN	O	ta	nn	13	SENT_427	[p10l496t2337r608b2368],
13	box	NN	O	box	prep_of	9	SENT_427	[p10l617t2337r678b2368],
14	and	CC	O	and	_	0	SENT_427	[p10l688t2337r749b2368],
15	the	DT	O	the	det	16	SENT_427	[p10l758t2337r809b2368],
16	presence	NN	O	presence	dobj	7	SENT_427	[p10l818t2345r963b2376],
17	of	IN	O	of	_	0	SENT_427	[p10l973t2336r1011b2368],
18	multiple	JJ	O	multiple	amod	22	SENT_427	[p10l1017t2337r1154b2377],
19	major	JJ	O	major	amod	22	SENT_427	[p10l1164t2337r1263b2377],
20	transcription	NN	O	transcription	nn	22	SENT_427	[p10l1270t2336r1480b2378],
21	start	NN	O	start	nn	22	SENT_427	[p10l1490t2341r1562b2368],
22	sites	NNS	O	site	prep_of	16	SENT_427	[p10l1570t2338r1653b2368],
23	.	.	O	.	_	0	SENT_427	[p10l1570t2338r1653b2368],

1	Putative	JJ	O	putative	dep	2	SENT_428	[p10l1664t2337r1801b2369],
2	positive	JJ	O	positive	amod	6	SENT_428	[p10l496t2388r628b2428],
3	and	CC	O	and	_	0	SENT_428	[p10l638t2387r699b2419],
4	negative	JJ	O	negative	conj_and	2	SENT_428	[p10l708t2388r850b2429],
5	regulatory	JJ	O	regulatory	amod	6	SENT_428	[p10l859t2388r1031b2429],
6	elements	NNS	O	element	nsubjpass	8	SENT_428	[p10l1042t2388r1188b2420],
7	were	VBD	O	be	auxpass	8	SENT_428	[p10l1199t2397r1279b2420],
8	found	VBN	O	find	_	0	SENT_428	[p10l1290t2388r1387b2419],
9	to	TO	O	to	aux	10	SENT_428	[p10l1397t2393r1429b2420],
10	include	VB	O	include	xcomp	8	SENT_428	[p10l1440t2388r1563b2420],
11	a	DT	O	a	det	14	SENT_428	[p10l1572t2398r1591b2420],
12	cyclic	JJ	O	cyclic	amod	14	SENT_428	[p10l1600t2388r1700b2429],
13	AMP	NN	ORGANIZATION	amp	nn	14	SENT_428	[p10l1711t2388r1801b2420],
14	response	NN	O	response	dobj	10	SENT_428	[p10l497t2447r643b2479],
15	element	NN	O	element	nn	18	SENT_428	[p10l656t2438r790b2470],
16	(	CD	NUMBER	(	num	18	SENT_428	[p10l802t2438r921b2477],
17	CRE	NN	ORGANIZATION	cre	nn	18	SENT_428	[p10l802t2438r921b2477],
18	)	NN	O	)	dep	14	SENT_428	[p10l802t2438r921b2477],
19	;	:	O	;	_	0	SENT_428	[p10l802t2438r921b2477],
20	an	DT	O	a	det	23	SENT_428	[p10l935t2447r974b2470],
21	estrogen	NN	O	estrogen	npadvmod	22	SENT_428	[p10l988t2442r1129b2479],
22	responsive	JJ	O	responsive	amod	23	SENT_428	[p10l1141t2438r1319b2479],
23	element	NN	O	element	dep	14	SENT_428	[p10l1332t2438r1466b2471],
24	(	CD	NUMBER	(	num	26	SENT_428	[p10l1479t2439r1595b2477],
25	ERE	NN	O	ere	nn	26	SENT_428	[p10l1479t2439r1595b2477],
26	)	NN	O	)	dep	23	SENT_428	[p10l1479t2439r1595b2477],
27	;	:	O	;	_	0	SENT_428	[p10l1479t2439r1595b2477],
28	a	DT	O	a	det	31	SENT_428	[p10l1609t2448r1628b2470],
29	glucocorticoid	NN	O	glucocorticoid	npadvmod	30	SENT_428	[p10l1641t2439r1800b2479, p10l496t2489r592b2522],
30	responsive	JJ	O	responsive	amod	31	SENT_428	[p10l606t2490r784b2530],
31	element	NN	O	element	dep	14	SENT_428	[p10l798t2490r931b2521],
32	(	CD	NUMBER	(	num	34	SENT_428	[p10l946t2490r1065b2528],
33	GRE	NN	ORGANIZATION	gre	nn	34	SENT_428	[p10l946t2490r1065b2528],
34	)	NN	O	)	dep	31	SENT_428	[p10l946t2490r1065b2528],
35	;	:	O	;	_	0	SENT_428	[p10l946t2490r1065b2528],
36	binding	VBG	O	bind	amod	37	SENT_428	[p10l1081t2490r1208b2530],
37	sites	NNS	O	site	dep	14	SENT_428	[p10l1224t2490r1296b2522],
38	for	IN	O	for	_	0	SENT_428	[p10l1312t2490r1360b2521],
39	AP-1	NN	O	ap-1	prep_for	37	SENT_428	[p10l1374t2491r1472b2527],
40	,	,	O	,	_	0	SENT_428	[p10l1374t2491r1472b2527],
41	AP	NN	O	ap	nn	42	SENT_428	[p10l1488t2491r1584b2527],
42	—	NN	O	—	conj_and	39	SENT_428	[p10l1488t2491r1584b2527],
43	2	CD	NUMBER	2	dep	42	SENT_428	[p10l1488t2491r1584b2527],
44	,	,	O	,	_	0	SENT_428	[p10l1488t2491r1584b2527],
45	and	CC	O	and	_	0	SENT_428	[p10l1600t2490r1660b2522],
46	SP	NN	O	sp	nn	47	SENT_428	[p10l1675t2490r1767b2527],
47	—	NN	O	—	prep_for	37	SENT_428	[p10l1675t2490r1767b2527],
48	l	NN	O	l	tmod	47	SENT_428	[p10l1675t2490r1767b2527],
49	;	:	O	;	_	0	SENT_428	[p10l1675t2490r1767b2527],
50	a	DT	O	a	det	57	SENT_428	[p10l1784t2500r1802b2522],
51	putative	JJ	O	putative	amod	57	SENT_428	[p10l496t2541r630b2580],
52	negative	JJ	O	negative	amod	57	SENT_428	[p10l640t2541r781b2580],
53	regulatory	JJ	O	regulatory	amod	57	SENT_428	[p10l790t2540r962b2581],
54	element	NN	O	element	nn	57	SENT_428	[p10l971t2541r1104b2572],
55	(	CD	NUMBER	(	num	57	SENT_428	[p10l1113t2541r1240b2579],
56	NE-1	NN	O	ne-1	nn	57	SENT_428	[p10l1113t2541r1240b2579],
57	)	NN	O	)	prep_for	37	SENT_428	[p10l1113t2541r1240b2579],
58	;	:	O	;	_	0	SENT_428	[p10l1113t2541r1240b2579],
59	and	CC	O	and	_	0	SENT_428	[p10l1250t2541r1311b2572],
60	a	DT	O	a	det	66	SENT_428	[p10l1319t2550r1338b2572],
61	positive	JJ	O	positive	amod	66	SENT_428	[p10l1346t2541r1479b2581],
62	regulatory	JJ	O	regulatory	amod	66	SENT_428	[p10l1487t2542r1659b2581],
63	element	NN	O	element	nn	66	SENT_428	[p10l1669t2541r1802b2573],
64	(	CD	NUMBER	(	num	66	SENT_428	[p10l498t2590r611b2628],
65	PRE	NN	O	pre	nn	66	SENT_428	[p10l498t2590r611b2628],
66	)	NN	O	)	prep_for	37	SENT_428	[p10l498t2590r611b2628],
67	.	.	O	.	_	0	SENT_428	[p10l498t2590r611b2628],

1	Thus	RB	O	thus	advmod	17	SENT_429	[p10l625t2590r719b2627],
2	,	,	O	,	_	0	SENT_429	[p10l625t2590r719b2627],
3	as	IN	O	as	prep	17	SENT_429	[p10l734t2600r767b2621],
4	with	IN	O	with	pcomp	3	SENT_429	[p10l782t2590r855b2621],
5	the	DT	O	the	det	7	SENT_429	[p10l869t2591r920b2621],
6	Mdrl	NN	O	mdrl	nn	7	SENT_429	[p10l935t2591r1023b2621],
7	gene	NN	O	gene	pobj	4	SENT_429	[p10l1041t2600r1129b2631],
8	,	,	O	,	_	0	SENT_429	[p10l1041t2600r1129b2631],
9	regulation	NN	O	regulation	nsubj	17	SENT_429	[p10l1143t2591r1312b2630],
10	of	IN	O	of	_	0	SENT_429	[p10l1326t2590r1364b2628],
11	the	DT	O	the	det	12	SENT_429	[p10l1374t2592r1425b2622],
12	MRP	NN	ORGANIZATION	mrp	prep_of	9	SENT_429	[p10l1439t2591r1528b2622],
13	is	VBZ	O	be	cop	17	SENT_429	[p10l1542t2591r1569b2622],
14	complex	JJ	O	complex	amod	17	SENT_429	[p10l1582t2591r1727b2630],
15	and	CC	O	and	_	0	SENT_429	[p10l1741t2591r1801b2622],
16	likely	JJ	O	likely	conj_and	14	SENT_429	[p10l496t2640r591b2680],
17	subject	NN	O	subject	_	0	SENT_429	[p10l605t2640r723b2680],
18	to	TO	O	to	_	0	SENT_429	[p10l735t2646r767b2672],
19	numerous	JJ	O	numerous	amod	21	SENT_429	[p10l780t2649r943b2672],
20	environmental	JJ	O	environmental	amod	21	SENT_429	[p10l957t2640r1197b2672],
21	stimuli	NNS	O	stimulus	prep_to	17	SENT_429	[p10l1210t2641r1333b2673],
22	.	.	O	.	_	0	SENT_429	[p10l1210t2641r1333b2673],

1	A	DT	O	a	det	3	SENT_430	[p10l539t2692r570b2722],
2	physiological	JJ	O	physiological	amod	3	SENT_430	[p10l585t2691r810b2731],
3	role	NN	O	role	nsubjpass	9	SENT_430	[p10l825t2691r889b2722],
4	for	IN	O	for	_	0	SENT_430	[p10l905t2691r955b2722],
5	the	DT	O	the	det	6	SENT_430	[p10l970t2691r1020b2722],
6	MRP	NN	ORGANIZATION	mrp	prep_for	3	SENT_430	[p10l1035t2691r1124b2722],
7	has	VBZ	O	have	aux	9	SENT_430	[p10l1139t2692r1194b2722],
8	been	VBN	O	be	auxpass	9	SENT_430	[p10l1209t2691r1289b2723],
9	suggested	VBN	O	suggest	_	0	SENT_430	[p10l1305t2692r1469b2731],
10	based	VBN	O	base	_	0	SENT_430	[p10l1483t2692r1579b2723],
11	on	IN	O	on	prepc_based_on	9	SENT_430	[p10l1594t2701r1636b2723],
12	evidence	NN	O	evidence	pobj	9	SENT_430	[p10l1651t2691r1801b2723],
13	that	IN	O	that	complm	17	SENT_430	[p10l497t2739r561b2770],
14	it	PRP	O	it	nsubj	17	SENT_430	[p10l578t2740r601b2770],
15	may	MD	O	may	aux	17	SENT_430	[p10l618t2749r688b2778],
16	be	VB	O	be	aux	17	SENT_430	[p10l705t2741r746b2771],
17	acting	VBG	O	act	ccomp	9	SENT_430	[p10l762t2740r864b2779],
18	as	IN	O	as	_	0	SENT_430	[p10l881t2750r915b2771],
19	an	DT	O	a	det	24	SENT_430	[p10l933t2750r972b2770],
20	ATP	NN	O	atp	nn	24	SENT_430	[p10l990t2740r1254b2779],
21	—	NN	O	—	nn	24	SENT_430	[p10l990t2740r1254b2779],
22	dependent	JJ	O	dependent	amod	24	SENT_430	[p10l990t2740r1254b2779],
23	export	NN	O	export	nn	24	SENT_430	[p10l1269t2745r1377b2779],
24	pump	NN	O	pump	prep_as	17	SENT_430	[p10l1392t2750r1488b2781],
25	for	IN	O	for	_	0	SENT_430	[p10l1505t2740r1554b2771],
26	conjugates	NNS	O	conjugate	prep_for	17	SENT_430	[p10l1570t2741r1749b2780],
27	of	IN	O	of	_	0	SENT_430	[p10l1768t2741r1804b2771],
28	lipophilic	JJ	O	lipophilic	amod	29	SENT_430	[p10l496t2790r656b2830],
29	compounds	NNS	O	compound	prep_of	26	SENT_430	[p10l671t2790r863b2830],
30	with	IN	O	with	_	0	SENT_430	[p10l879t2791r952b2822],
31	glutathione	NN	O	glutathione	prep_with	29	SENT_430	[p10l968t2791r1164b2830],
32	.	.	O	.	_	0	SENT_430	[p10l968t2791r1164b2830],

1	Leier	NNP	O	Leier	nsubj	5	SENT_431	[p10l1180t2791r1269b2822],
2	et	FW	O	et	nn	3	SENT_431	[p10l1284t2796r1314b2822],
3	al	FW	O	al	dep	1	SENT_431	[p10l1328t2790r1359b2822],
4	have	VBP	O	have	aux	5	SENT_431	[p10l1373t2790r1453b2822],
5	demonstrated	VBN	O	demonstrate	_	0	SENT_431	[p10l1468t2791r1693b2822],
6	ATPdependent	NN	O	atpdependent	nn	7	SENT_431	[p10l1709t2791r1800b2822, p10l497t2840r668b2881],
7	transport	NN	O	transport	dobj	5	SENT_431	[p10l687t2845r836b2881],
8	of	IN	O	of	_	0	SENT_431	[p10l854t2841r892b2872],
9	leukotriene	NN	O	leukotriene	nn	10	SENT_431	[p10l908t2841r1095b2873],
10	C4	NN	O	c4	prep_of	7	SENT_431	[p10l1113t2841r1172b2877],
11	,	,	O	,	_	0	SENT_431	[p10l1113t2841r1172b2877],
12	LTD4	NN	O	ltd4	conj_and	10	SENT_431	[p10l1191t2841r1302b2878],
13	,	,	O	,	_	0	SENT_431	[p10l1191t2841r1302b2878],
14	LTE4	NN	O	lte4	conj_and	10	SENT_431	[p10l1322t2841r1429b2878],
15	,	,	O	,	_	0	SENT_431	[p10l1322t2841r1429b2878],
16	and	CC	O	and	_	0	SENT_431	[p10l1449t2841r1509b2873],
17	S	NN	O	s	nn	18	SENT_431	[p10l1529t2841r1800b2880, p10l496t2890r812b2931],
18	~	NN	O	~	conj_and	10	SENT_431	[p10l1529t2841r1800b2880, p10l496t2890r812b2931],
19	(	CD	NUMBER	(	number	20	SENT_431	[p10l1529t2841r1800b2880, p10l496t2890r812b2931],
20	2,4	CD	NUMBER	2,4	dep	18	SENT_431	[p10l1529t2841r1800b2880, p10l496t2890r812b2931],
21	,	,	O	,	_	0	SENT_431	[p10l1529t2841r1800b2880, p10l496t2890r812b2931],
22	diniotrophenyl	NN	O	diniotrophenyl	nn	24	SENT_431	[p10l1529t2841r1800b2880, p10l496t2890r812b2931],
23	)	NN	O	)	nn	24	SENT_431	[p10l1529t2841r1800b2880, p10l496t2890r812b2931],
24	glutathione	NN	O	glutathione	appos	7	SENT_431	[p10l1529t2841r1800b2880, p10l496t2890r812b2931],
25	into	IN	O	into	_	0	SENT_431	[p10l835t2891r899b2923],
26	MRI	NNP	O	MRI	prep_into	24	SENT_431	[p10l920t2891r1199b2932],
27	’	SYM	O	’	dep	24	SENT_431	[p10l920t2891r1199b2932],
28	-	:	O	-	_	0	SENT_431	[p10l920t2891r1199b2932],
29	expressing	VBG	O	express	xcomp	5	SENT_431	[p10l920t2891r1199b2932],
30	vesicles	NNS	O	vesicle	nsubj	33	SENT_431	[p10l1222t2892r1352b2923],
31	(	CD	NUMBER	(	number	32	SENT_431	[p10l1376t2892r1474b2930],
32	114	CD	NUMBER	114	num	33	SENT_431	[p10l1376t2892r1474b2930],
33	)	NN	O	)	xcomp	29	SENT_431	[p10l1376t2892r1474b2930],
34	.	.	O	.	_	0	SENT_431	[p10l1376t2892r1474b2930],

1	Conﬁrming	VBG	O	conﬁrming	partmod	8	SENT_432	[p10l1498t2892r1693b2932],
2	these	DT	O	these	det	3	SENT_432	[p10l1716t2893r1802b2924],
3	studies	NNS	O	study	dobj	1	SENT_432	[p10l498t2942r622b2978],
4	,	,	O	,	_	0	SENT_432	[p10l498t2942r622b2978],
5	Gekeler	NNP	O	Gekeler	nsubj	8	SENT_432	[p10l641t2941r774b2974],
6	et	FW	O	et	nn	7	SENT_432	[p10l791t2946r821b2973],
7	al	FW	O	al	dep	5	SENT_432	[p10l840t2942r868b2973],
8	found	VBN	O	find	_	0	SENT_432	[p10l886t2942r984b2974],
9	that	IN	O	that	complm	17	SENT_432	[p10l1002t2942r1065b2974],
10	the	DT	O	the	det	12	SENT_432	[p10l1082t2942r1133b2974],
11	leukouiene	NN	O	leukouiene	nn	12	SENT_432	[p10l1150t2942r1338b2974],
12	LTD4	NN	O	ltd4	nsubj	17	SENT_432	[p10l1355t2943r1457b2974],
13	receptor	NN	O	receptor	nn	15	SENT_432	[p10l1475t2948r1613b2983],
14	antagonist	NN	O	antagonist	nn	15	SENT_432	[p10l1631t2943r1803b2983],
15	MK57l	NN	O	mk57l	dep	12	SENT_432	[p10l496t2993r622b3025],
16	was	VBD	O	be	cop	17	SENT_432	[p10l640t3002r705b3024],
17	able	JJ	O	able	ccomp	8	SENT_432	[p10l719t2993r788b3025],
18	to	TO	O	to	aux	19	SENT_432	[p10l802t2997r835b3024],
19	reverse	VB	O	reverse	xcomp	17	SENT_432	[p10l847t3002r968b3025],
20	vincristine	NN	O	vincristine	nn	21	SENT_432	[p10l982t2993r1157b3025],
21	resistance	NN	O	resistance	dobj	19	SENT_432	[p10l1170t2994r1334b3025],
22	in	IN	O	in	_	0	SENT_432	[p10l1348t2993r1379b3024],
23	human	JJ	O	human	amod	25	SENT_432	[p10l1392t2994r1508b3025],
24	cell	NN	O	cell	nn	25	SENT_432	[p10l1521t2994r1580b3025],
25	lines	NNS	O	line	prep_in	19	SENT_432	[p10l1594t2994r1673b3025],
26	known	VBN	O	know	partmod	25	SENT_432	[p10l1687t2994r1801b3026],
27	to	TO	O	to	aux	28	SENT_432	[p10l497t3047r530b3073],
28	overexpress	VB	O	overexpress	xcomp	26	SENT_432	[p10l542t3051r740b3082],
29	MRP	NN	O	mrp	nn	30	SENT_432	[p10l754t3044r843b3074],
30	(	NN	O	(	dobj	28	SENT_432	[p10l855t3043r953b3081],
31	115	CD	NUMBER	115	num	32	SENT_432	[p10l855t3043r953b3081],
32	)	NN	O	)	dep	30	SENT_432	[p10l855t3043r953b3081],
33	.	.	O	.	_	0	SENT_432	[p10l855t3043r953b3081],

1	There	EX	O	there	expl	2	SENT_433	[p10l539t3093r636b3124],
2	is	VBZ	O	be	_	0	SENT_433	[p10l649t3093r677b3124],
3	considerable	JJ	O	considerable	amod	4	SENT_433	[p10l691t3093r901b3125],
4	interest	NN	O	interest	nsubj	2	SENT_433	[p10l914t3093r1038b3125],
5	in	IN	O	in	_	0	SENT_433	[p10l1051t3094r1083b3125],
6	the	DT	O	the	det	7	SENT_433	[p10l1096t3094r1148b3125],
7	expression	NN	O	expression	prep_in	4	SENT_433	[p10l1161t3094r1338b3134],
8	of	IN	O	of	_	0	SENT_433	[p10l1352t3093r1389b3125],
9	MRP	NN	O	mrp	prep_of	7	SENT_433	[p10l1400t3095r1489b3126],
10	in	IN	O	in	_	0	SENT_433	[p10l1503t3094r1535b3125],
11	human	JJ	O	human	amod	12	SENT_433	[p10l1548t3094r1663b3126],
12	tumors	NNS	O	tumor	prep_in	9	SENT_433	[p10l1676t3098r1801b3126],
13	.	.	O	.	_	0	SENT_433	[p10l1676t3098r1801b3126],

1	Hart	NNP	PERSON	Hart	nsubj	4	SENT_434	[p10l497t3143r570b3175],
2	et	FW	O	et	nn	3	SENT_434	[p10l583t3148r612b3175],
3	al	FW	O	al	dep	1	SENT_434	[p10l624t3143r653b3175],
4	examined	VBN	O	examine	_	0	SENT_434	[p10l666t3143r829b3175],
5	MRP	NN	ORGANIZATION	mrp	nn	6	SENT_434	[p10l839t3144r928b3175],
6	expression	NN	O	expression	dobj	4	SENT_434	[p10l939t3144r1117b3184],
7	in	IN	O	in	_	0	SENT_434	[p10l1129t3144r1161b3175],
8	105	CD	NUMBER	105	num	9	SENT_434	[p10l1178t3144r1234b3177],
9	samples	NNS	O	sample	prep_in	6	SENT_434	[p10l1248t3144r1380b3184],
10	from	IN	O	from	_	0	SENT_434	[p10l1393t3144r1475b3176],
11	patients	NNS	O	patient	prep_from	9	SENT_434	[p10l1485t3144r1615b3185],
12	with	IN	O	with	_	0	SENT_434	[p10l1628t3144r1701b3176],
13	acute	JJ	O	acute	amod	14	SENT_434	[p10l1713t3150r1802b3177],
14	leukemia	NN	O	leukemia	prep_with	11	SENT_434	[p10l497t3193r658b3229],
15	,	,	O	,	_	0	SENT_434	[p10l497t3193r658b3229],
16	both	DT	O	both	preconj	4	SENT_434	[p10l668t3193r743b3225],
17	at	IN	O	at	_	0	SENT_434	[p10l752t3198r782b3225],
18	presentation	NN	O	presentation	prep_at	4	SENT_434	[p10l791t3194r994b3233],
19	and	CC	O	and	_	0	SENT_434	[p10l1003t3195r1063b3225],
20	at	IN	O	at	_	0	SENT_434	[p10l1072t3199r1102b3225],
21	relapse	NN	O	relapse	nn	22	SENT_434	[p10l1110t3194r1229b3233],
22	(	NN	O	(	conj_and	18	SENT_434	[p10l1238t3194r1336b3232],
23	116	CD	NUMBER	116	num	24	SENT_434	[p10l1238t3194r1336b3232],
24	)	NN	O	)	dep	22	SENT_434	[p10l1238t3194r1336b3232],
25	.	.	O	.	_	0	SENT_434	[p10l1238t3194r1336b3232],

1	MRP	NN	O	mrp	nn	2	SENT_435	[p10l1346t3194r1434b3226],
2	expression	NN	O	expression	_	0	SENT_435	[p10l1442t3195r1622b3234],
3	in	IN	O	in	dep	2	SENT_435	[p10l1631t3195r1663b3226],
4	patients	NNS	O	patient	pobj	3	SENT_435	[p10l1672t3195r1801b3234],
5	with	IN	O	with	_	0	SENT_435	[p10l498t3244r570b3275],
6	acute	JJ	O	acute	amod	8	SENT_435	[p10l583t3249r671b3275],
7	lymphocytic	JJ	O	lymphocytic	amod	8	SENT_435	[p10l682t3244r889b3285],
8	leukemia	NN	O	leukemia	prep_with	4	SENT_435	[p10l902t3244r1056b3276],
9	(	CD	NUMBER	(	num	11	SENT_435	[p10l1067t3245r1173b3283],
10	ALL	NN	O	all	nn	11	SENT_435	[p10l1067t3245r1173b3283],
11	)	NN	O	)	nsubj	14	SENT_435	[p10l1067t3245r1173b3283],
12	was	VBD	O	be	cop	14	SENT_435	[p10l1186t3254r1249b3276],
13	markedly	RB	O	markedly	advmod	14	SENT_435	[p10l1262t3244r1418b3286],
14	elevated	JJ	O	elevated	rcmod	8	SENT_435	[p10l1430t3246r1578b3282],
15	,	,	O	,	_	0	SENT_435	[p10l1430t3246r1578b3282],
16	as	IN	O	as	mark	17	SENT_435	[p10l1592t3255r1625b3277],
17	compared	VBN	O	compare	advcl	14	SENT_435	[p10l1637t3246r1802b3285],

1	Annual	JJ	SET	annual	amod	2	SENT_436	[p10l446t3364r567b3393],
2	Reviews	NNS	O	review	nsubj	3	SENT_436	[p10l579t3364r721b3402],
3	_	VBP	O	_	_	0	SENT_436	[p10l953t3397r958b3402],
4	www	NN	O	www	dobj	3	SENT_436	[p10l446t3397r1000b3435],
5	.	.	O	.	_	0	SENT_436	[p10l446t3397r1000b3435],

1	annualreviewsorg/aronline	NN	O	annualreviewsorg/aronline	_	0	SENT_437	[p10l446t3397r1000b3435],

1	176	CD	NUMBER	176	num	2	SENT_438	[p10l497t3497r550b3525],
2	BELLAMY	NN	O	bellamy	_	0	SENT_438	[p10l619t3497r801b3525],

1	Annu	NNP	PERSON	Annu	_	0	SENT_439	[p11l356t1651r379b1731],
2	.	.	O	.	_	0	SENT_439	[p11l356t1651r379b1731],

1	Rev.	NNP	O	Rev.	nn	2	SENT_440	[p11l356t1581r379b1641],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_440	[p11l356t1422r379b1570],
3	.	.	O	.	_	0	SENT_440	[p11l356t1422r379b1570],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_441	[p11l356t1301r379b1411],
2	.	.	O	.	_	0	SENT_441	[p11l356t1301r379b1411],

1	1996362161-183	CD	NUMBER	1996362161-183	_	0	SENT_442	[p11l356t1056r380b1287],
2	.	.	O	.	_	0	SENT_442	[p11l356t1056r380b1287],

1	Downloaded	VBN	O	download	_	0	SENT_443	[p11l356t875r379b1045],
2	from	IN	O	from	_	0	SENT_443	[p11l356t801r379b866],
3	www	NN	O	www	prep_from	1	SENT_443	[p11l363t698r379b793],
4	.	.	O	.	_	0	SENT_443	[p11l363t698r379b793],

1	a	DT	O	a	_	0	SENT_444	[p11l363t698r379b793],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_445	[p11l357t3695r380b3805],
2	.	.	O	.	_	0	SENT_445	[p11l357t3695r380b3805],

1	1996.36	CD	NUMBER	1996.36	_	0	SENT_446	[p11l357t3570r381b3681],
2	:	:	O	:	_	0	SENT_446	[p11l357t3570r381b3681],
3	161-183	CD	NUMBER	161-183	dep	1	SENT_446	[p11l357t3450r380b3564],
4	.	.	O	.	_	0	SENT_446	[p11l357t3450r380b3564],

1	Downloaded	VBN	O	download	_	0	SENT_447	[p11l357t3269r380b3439],
2	from	IN	O	from	_	0	SENT_447	[p11l357t3196r380b3260],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_447	[p11l357t2863r387b3187],
4	of	IN	O	of	_	0	SENT_447	[p11l390t3770r414b3799],
5	Wisconsin	NNP	LOCATION	Wisconsin	prep_of	3	SENT_447	[p11l390t3623r414b3764],
6	-	:	O	-	_	0	SENT_447	[p11l404t3605r407b3613],
7	Madison	NNP	O	Madison	dep	3	SENT_447	[p11l390t3479r414b3595],
8	on	IN	O	on	_	0	SENT_447	[p11l398t3437r414b3469],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_447	[p11l390t3303r414b3428],
10	.	.	O	.	_	0	SENT_447	[p11l390t3303r414b3428],

1	For	IN	O	for	_	0	SENT_448	[p11l391t3246r414b3293],
2	personal	JJ	O	personal	amod	3	SENT_448	[p11l390t3126r421b3238],
3	use	NN	O	use	pobj	1	SENT_448	[p11l398t3073r414b3117],
4	only	RB	O	only	advmod	3	SENT_448	[p11l390t2999r421b3064],
5	.	.	O	.	_	0	SENT_448	[p11l390t2999r421b3064],

1	nnualreviews.org	NN	O	nnualreviews.org	_	0	SENT_449	[p11l356t404r386b632],
2	‘	CD	NUMBER	‘	num	3	SENT_449	[p11l397t615r413b632],
3	.6	CD	NUMBER	.6	npadvmod	4	SENT_449	[p11l397t615r413b632],
4	only	RB	O	only	dep	1	SENT_449	[p11l389t540r420b605],
5	.	.	O	.	_	0	SENT_449	[p11l389t540r420b605],

1	by	IN	O	by	dep	6	SENT_450	[p11l389t1564r420b1596],
2	University	NNP	ORGANIZATION	University	pobj	1	SENT_450	[p11l389t1415r420b1555],
3	of	IN	ORGANIZATION	of	_	0	SENT_450	[p11l389t1376r413b1405],
4	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	2	SENT_450	[p11l389t1229r413b1370],
5	-	:	O	-	_	0	SENT_450	[p11l403t1211r406b1219],
6	Madison	NNP	O	Madison	_	0	SENT_450	[p11l389t1085r413b1201],
7	on	IN	O	on	_	0	SENT_450	[p11l397t1043r413b1075],
8	01/05/14	CD	DATE	01/05/14	prep_on	6	SENT_450	[p11l389t909r413b1034],
9	.	.	O	.	_	0	SENT_450	[p11l389t909r413b1034],

1	For	IN	O	for	_	0	SENT_451	[p11l390t852r413b899],
2	personal	JJ	O	personal	amod	9	SENT_451	[p11l389t732r420b844],
3	us	PRP	O	we	dep	2	SENT_451	[p11l397t696r413b723],
4	to	TO	O	to	_	0	SENT_451	[p11l493t46r527b72],
5	normal	JJ	O	normal	amod	7	SENT_451	[p11l545t41r663b71],
6	peripheral	JJ	O	peripheral	amod	7	SENT_451	[p11l681t41r850b80],
7	blood	NN	O	blood	prep_to	3	SENT_451	[p11l868t41r964b71],
8	mononuclear	JJ	O	mononuclear	amod	9	SENT_451	[p11l981t41r1199b71],
9	cells	NNS	O	cell	prep_for	12	SENT_451	[p11l1217t41r1292b71],
10	and	CC	O	and	_	0	SENT_451	[p11l1311t41r1371b72],
11	patients	NNS	O	patient	conj_and	9	SENT_451	[p11l1389t41r1518b79],
12	diagnosed	VBD	O	diagnose	_	0	SENT_451	[p11l1537t41r1706b80],
13	with	IN	O	with	_	0	SENT_451	[p11l1725t41r1799b71],
14	acute	JJ	O	acute	amod	16	SENT_451	[p11l494t94r582b120],
15	myelogenous	JJ	O	myelogenous	amod	16	SENT_451	[p11l595t90r817b129],
16	leukemia	NN	O	leukemia	prep_with	12	SENT_451	[p11l831t90r983b120],
17	(	CD	NUMBER	(	num	19	SENT_451	[p11l996t90r1123b127],
18	AML	NN	ORGANIZATION	aml	nn	19	SENT_451	[p11l996t90r1123b127],
19	)	NN	O	)	nsubj	12	SENT_451	[p11l996t90r1123b127],
20	.	.	O	.	_	0	SENT_451	[p11l996t90r1123b127],

1	Although	IN	O	although	mark	5	SENT_452	[p11l1138t90r1295b129],
2	MRP	NN	O	mrp	nn	3	SENT_452	[p11l1309t90r1398b120],
3	expression	NN	O	expression	nsubj	5	SENT_452	[p11l1410t90r1588b128],
4	was	VBD	O	be	cop	5	SENT_452	[p11l1601t98r1665b119],
5	highest	JJS	O	highest	advcl	16	SENT_452	[p11l1678t89r1800b129],
6	for	IN	O	for	_	0	SENT_452	[p11l493t138r544b169],
7	ALL	NN	O	all	nn	8	SENT_452	[p11l554t139r636b169],
8	samples	NNS	O	sample	prep_for	5	SENT_452	[p11l646t139r780b178],
9	in	IN	O	in	_	0	SENT_452	[p11l791t138r823b168],
10	this	DT	O	this	det	11	SENT_452	[p11l835t138r894b169],
11	study	NN	O	study	prep_in	8	SENT_452	[p11l906t139r1004b178],
12	,	,	O	,	_	0	SENT_452	[p11l906t139r1004b178],
13	the	DT	O	the	det	14	SENT_452	[p11l1017t139r1068b169],
14	overexpression	NN	O	overexpression	nsubj	16	SENT_452	[p11l1077t139r1330b177],
15	was	VBD	O	be	cop	16	SENT_452	[p11l1341t147r1406b168],
16	independent	JJ	O	independent	_	0	SENT_452	[p11l1418t138r1621b178],
17	of	IN	O	of	_	0	SENT_452	[p11l1633t138r1670b168],
18	disease	NN	O	disease	nn	19	SENT_452	[p11l1677t138r1799b169],
19	subtype	NN	O	subtype	prep_of	16	SENT_452	[p11l494t187r624b227],
20	or	CC	O	or	_	0	SENT_452	[p11l636t197r672b218],
21	stage	NN	O	stage	conj_or	19	SENT_452	[p11l682t192r768b227],
22	or	CC	O	or	_	0	SENT_452	[p11l779t196r815b217],
23	prior	JJ	O	prior	amod	24	SENT_452	[p11l825t187r908b226],
24	chemotherapy	NN	O	chemotherapy	conj_or	19	SENT_452	[p11l919t187r1163b226],
25	.	.	O	.	_	0	SENT_452	[p11l919t187r1163b226],

1	Using	VBG	O	use	partmod	12	SENT_453	[p11l1177t187r1275b227],
2	quantitative	JJ	O	quantitative	amod	4	SENT_453	[p11l1287t187r1483b227],
3	RT-PCR	NN	O	rt-pcr	nn	4	SENT_453	[p11l1496t187r1643b219],
4	analysis	NN	O	analysis	dobj	1	SENT_453	[p11l1655t188r1798b227],
5	,	,	O	,	_	0	SENT_453	[p11l1655t188r1798b227],
6	Schneider	NNP	PERSON	Schneider	nsubj	12	SENT_453	[p11l494t238r661b269],
7	et	FW	O	et	dep	6	SENT_453	[p11l678t243r709b269],
8	al	FW	O	al	nn	11	SENT_453	[p11l727t238r756b269],
9	(	FW	O	(	dep	11	SENT_453	[p11l775t238r864b275],
10	117	CD	NUMBER	117	num	11	SENT_453	[p11l775t238r864b275],
11	)	NN	O	)	advmod	12	SENT_453	[p11l775t238r864b275],
12	examined	VBD	O	examine	_	0	SENT_453	[p11l882t238r1045b269],
13	a	DT	O	a	det	14	SENT_453	[p11l1062t246r1080b268],
14	series	NN	O	series	dobj	12	SENT_453	[p11l1099t237r1192b268],
15	of	IN	O	of	_	0	SENT_453	[p11l1211t238r1248b268],
16	newly	RB	O	newly	advmod	17	SENT_453	[p11l1263t237r1364b277],
17	diagnosed	VBN	O	diagnose	amod	20	SENT_453	[p11l1383t237r1551b277],
18	and	CC	O	and	_	0	SENT_453	[p11l1571t238r1630b269],
19	recurrent	JJ	O	recurrent	conj_and	17	SENT_453	[p11l1648t243r1800b269],
20	AML	NN	ORGANIZATION	aml	prep_of	14	SENT_453	[p11l493t288r594b319],
21	.	.	O	.	_	0	SENT_453	[p11l493t288r594b319],

1	Levels	NNS	O	level	nsubj	10	SENT_454	[p11l612t288r723b319],
2	of	IN	O	of	_	0	SENT_454	[p11l738t288r777b319],
3	MRP	NN	ORGANIZATION	mrp	nn	4	SENT_454	[p11l789t288r878b318],
4	expression	NN	O	expression	prep_of	1	SENT_454	[p11l892t288r1070b327],
5	in	IN	O	in	_	0	SENT_454	[p11l1085t287r1118b318],
6	newly	RB	O	newly	advmod	7	SENT_454	[p11l1134t288r1234b327],
7	diagnosed	VBN	O	diagnose	amod	8	SENT_454	[p11l1251t288r1420b328],
8	cases	NNS	O	case	prep_in	4	SENT_454	[p11l1435t297r1522b319],
9	were	VBD	O	be	cop	10	SENT_454	[p11l1539t297r1619b319],
10	similar	JJ	O	similar	_	0	SENT_454	[p11l1637t288r1752b319],
11	to	TO	O	to	_	0	SENT_454	[p11l1767t293r1798b319],
12	those	DT	O	those	prep_to	10	SENT_454	[p11l494t337r583b368],
13	observed	VBN	O	observe	partmod	12	SENT_454	[p11l592t337r743b368],
14	in	IN	O	in	_	0	SENT_454	[p11l752t337r784b367],
15	normal	JJ	O	normal	amod	17	SENT_454	[p11l793t337r911b367],
16	bone	NN	O	bone	nn	17	SENT_454	[p11l920t337r1001b367],
17	marrow	NN	O	marrow	prep_in	13	SENT_454	[p11l1010t345r1150b372],
18	,	,	O	,	_	0	SENT_454	[p11l1010t345r1150b372],
19	as	IN	O	as	mark	20	SENT_454	[p11l1161t346r1193b367],
20	observed	VBN	O	observe	dep	17	SENT_454	[p11l1203t336r1353b367],
21	in	IN	O	in	_	0	SENT_454	[p11l1363t336r1395b367],
22	the	DT	O	the	det	24	SENT_454	[p11l1405t337r1455b367],
23	Hart	NNP	PERSON	Hart	nn	24	SENT_454	[p11l1466t337r1540b367],
24	study	NN	O	study	prep_in	20	SENT_454	[p11l1550t337r1646b376],
25	.	.	O	.	_	0	SENT_454	[p11l1550t337r1646b376],

1	Samples	NNS	O	sample	_	0	SENT_455	[p11l1659t337r1799b376],
2	of	IN	O	of	_	0	SENT_455	[p11l494t386r533b417],
3	AMI	NNP	O	AMI	prep_of	1	SENT_455	[p11l537t387r631b416],
4	.	.	O	.	_	0	SENT_455	[p11l537t387r631b416],

1	.	.	O	.	_	0	SENT_456	[p11l537t387r631b416],

1	obtained	VBN	O	obtain	csubj	7	SENT_457	[p11l638t386r782b417],
2	at	IN	O	at	_	0	SENT_457	[p11l790t390r820b416],
3	the	DT	O	the	det	4	SENT_457	[p11l828t386r879b416],
4	time	NN	O	time	prep_at	1	SENT_457	[p11l887t386r960b416],
5	of	IN	O	of	_	0	SENT_457	[p11l968t386r1007b417],
6	relapse	NN	O	relapse	prep_of	4	SENT_457	[p11l1010t387r1128b424],
7	contained	VBD	O	contain	_	0	SENT_457	[p11l1136t386r1298b417],
8	approximately	RB	O	approximately	advmod	10	SENT_457	[p11l1307t386r1547b425],
9	twofold	RB	O	twofold	advmod	10	SENT_457	[p11l1555t386r1685b417],
10	higher	JJR	O	higher	amod	11	SENT_457	[p11l1692t386r1800b425],
11	levels	NNS	O	level	dobj	7	SENT_457	[p11l494t436r591b467],
12	of	IN	O	of	_	0	SENT_457	[p11l608t435r645b466],
13	MRP	NN	O	mrp	nn	14	SENT_457	[p11l658t437r747b466],
14	RNA	NN	O	rna	prep_of	11	SENT_457	[p11l762t436r859b466],
15	.	.	O	.	_	0	SENT_457	[p11l762t436r859b466],

1	The	DT	O	the	det	2	SENT_458	[p11l876t436r941b466],
2	increase	NN	O	increase	nsubjpass	4	SENT_458	[p11l956t436r1093b466],
3	was	VBD	O	be	auxpass	4	SENT_458	[p11l1109t444r1172b466],
4	observed	VBN	O	observe	_	0	SENT_458	[p11l1190t435r1339b466],
5	in	IN	O	in	_	0	SENT_458	[p11l1355t435r1387b465],
6	80	CD	PERCENT	80	num	7	SENT_458	[p11l1404t435r1477b466],
7	%	NN	PERCENT	%	prep_in	4	SENT_458	[p11l1404t435r1477b466],
8	of	IN	O	of	_	0	SENT_458	[p11l1495t436r1532b466],
9	paired	JJ	O	paired	amod	10	SENT_458	[p11l1545t435r1649b475],
10	samples	NNS	O	sample	prep_of	7	SENT_458	[p11l1666t436r1798b475],
11	examined	VBN	O	examine	partmod	10	SENT_458	[p11l494t486r666b518],
12	.	.	O	.	_	0	SENT_458	[p11l494t486r666b518],

1	Therefore	RB	O	therefore	advmod	22	SENT_459	[p11l680t485r853b522],
2	,	,	O	,	_	0	SENT_459	[p11l680t485r853b522],
3	although	IN	O	although	mark	5	SENT_459	[p11l869t486r1013b526],
4	it	PRP	O	it	nsubj	5	SENT_459	[p11l1027t486r1049b518],
5	appears	VBZ	O	appear	advcl	22	SENT_459	[p11l1063t495r1189b526],
6	to	TO	O	to	aux	7	SENT_459	[p11l1203t491r1234b518],
7	be	VB	O	be	xcomp	5	SENT_459	[p11l1248t486r1287b518],
8	of	IN	O	of	_	0	SENT_459	[p11l1300t485r1338b518],
9	prognostic	JJ	O	prognostic	amod	10	SENT_459	[p11l1348t486r1522b526],
10	importance	NN	O	importance	prep_of	7	SENT_459	[p11l1538t486r1733b527],
11	,	,	O	,	_	0	SENT_459	[p11l1538t486r1733b527],
12	the	DT	O	the	det	15	SENT_459	[p11l1748t486r1800b518],
13	true	JJ	O	true	amod	15	SENT_459	[p11l494t542r559b568],
14	clinical	JJ	O	clinical	amod	15	SENT_459	[p11l571t536r694b567],
15	relevance	NN	O	relevance	nsubjpass	22	SENT_459	[p11l707t537r867b567],
16	in	IN	O	in	_	0	SENT_459	[p11l881t536r913b567],
17	acute	JJ	O	acute	amod	18	SENT_459	[p11l926t541r1014b567],
18	leukernias	NNS	O	leukernia	prep_in	15	SENT_459	[p11l1026t536r1194b567],
19	is	VBZ	O	be	auxpass	22	SENT_459	[p11l1208t536r1234b567],
20	not	RB	O	not	neg	22	SENT_459	[p11l1248t541r1302b567],
21	fully	RB	O	fully	advmod	22	SENT_459	[p11l1315t535r1391b575],
22	known	VBN	O	know	_	0	SENT_459	[p11l1406t536r1528b567],
23	.	.	O	.	_	0	SENT_459	[p11l1406t536r1528b567],

1	In	IN	O	in	_	0	SENT_460	[p11l537t586r572b617],
2	chronic	JJ	O	chronic	amod	5	SENT_460	[p11l592t586r717b617],
3	B-cell	NN	MISC	b-cell	nn	5	SENT_460	[p11l738t585r840b617],
4	lymphocytic	JJ	O	lymphocytic	amod	5	SENT_460	[p11l861t585r1068b626],
5	leukemia	NN	O	leukemia	prep_in	11	SENT_460	[p11l1089t586r1250b623],
6	,	,	O	,	_	0	SENT_460	[p11l1089t586r1250b623],
7	63	CD	PERCENT	63	num	8	SENT_460	[p11l1273t586r1347b618],
8	%	NN	PERCENT	%	nsubj	11	SENT_460	[p11l1273t586r1347b618],
9	of	IN	O	of	_	0	SENT_460	[p11l1369t586r1407b617],
10	patients	NNS	O	patient	prep_of	8	SENT_460	[p11l1425t586r1553b626],
11	demonstrated	VBD	O	demonstrate	_	0	SENT_460	[p11l1576t586r1800b618],
12	increased	VBN	O	increase	amod	14	SENT_460	[p11l494t700r653b731],
13	MRP	NN	O	mrp	nn	14	SENT_460	[p11l670t700r758b731],
14	expression	NN	O	expression	nsubj	37	SENT_460	[p11l774t699r960b739],
15	,	,	O	,	_	0	SENT_460	[p11l774t699r960b739],
16	which	WDT	O	which	nsubjpass	18	SENT_460	[p11l979t699r1080b731],
17	was	VBD	O	be	auxpass	18	SENT_460	[p11l1099t708r1162b731],
18	observed	VBN	O	observe	rcmod	14	SENT_460	[p11l1180t700r1330b731],
19	to	TO	O	to	aux	21	SENT_460	[p11l1346t704r1378b731],
20	be	VB	O	be	cop	21	SENT_460	[p11l1395t700r1435b731],
21	independent	JJ	O	independent	xcomp	18	SENT_460	[p11l1452t700r1656b740],
22	of	IN	O	of	_	0	SENT_460	[p11l1672t699r1710b730],
23	their	PRP$	O	they	poss	25	SENT_460	[p11l1724t700r1801b731],
24	treatment	NN	O	treatment	nn	25	SENT_460	[p11l494t755r653b783],
25	status	NN	O	status	prep_of	21	SENT_460	[p11l668t756r773b788],
26	,	,	O	,	_	0	SENT_460	[p11l668t756r773b788],
27	although	IN	O	although	mark	30	SENT_460	[p11l788t750r935b790],
28	the	DT	O	the	det	29	SENT_460	[p11l950t751r1000b782],
29	treatment	NN	O	treatment	nsubj	30	SENT_460	[p11l1015t755r1173b782],
30	consisted	VBD	O	consist	advcl	21	SENT_460	[p11l1189t750r1342b783],
31	of	IN	O	of	_	0	SENT_460	[p11l1358t751r1396b782],
32	chlorambucil	NN	O	chlorambucil	prep_of	30	SENT_460	[p11l1409t749r1637b787],
33	,	,	O	,	_	0	SENT_460	[p11l1409t749r1637b787],
34	an	DT	O	a	det	35	SENT_460	[p11l1656t760r1693b781],
35	agent	NN	O	agent	npadvmod	36	SENT_460	[p11l1710t756r1801b791],
36	not	RB	O	not	neg	37	SENT_460	[p11l494t805r549b833],
37	recognized	VBN	O	recognize	ccomp	11	SENT_460	[p11l565t801r749b841],
38	as	IN	O	as	_	0	SENT_460	[p11l768t810r801b833],
39	being	VBG	O	be	auxpass	40	SENT_460	[p11l821t801r913b841],
40	involved	VBN	O	involve	prepc_as	37	SENT_460	[p11l932t801r1077b833],
41	in	IN	O	in	_	0	SENT_460	[p11l1097t801r1127b832],
42	the	DT	O	the	det	47	SENT_460	[p11l1147t801r1196b832],
43	MDR	NN	ORGANIZATION	mdr	nn	47	SENT_460	[p11l1216t802r1311b832],
44	phenotype	NN	O	phenotype	nn	47	SENT_460	[p11l1329t801r1503b841],
45	(	NN	O	(	nn	47	SENT_460	[p11l1522t802r1620b840],
46	118	CD	NUMBER	118	num	47	SENT_460	[p11l1522t802r1620b840],
47	)	NN	O	)	prep_in	40	SENT_460	[p11l1522t802r1620b840],
48	.	.	O	.	_	0	SENT_460	[p11l1522t802r1620b840],

1	Increased	VBN	O	increase	amod	2	SENT_461	[p11l1640t801r1799b833],
2	expression	NN	O	expression	nsubjpass	5	SENT_461	[p11l494t851r673b892],
3	was	VBD	O	be	auxpass	5	SENT_461	[p11l689t861r752b883],
4	also	RB	O	also	advmod	5	SENT_461	[p11l769t851r836b883],
5	observed	VBN	O	observe	_	0	SENT_461	[p11l851t852r1001b883],
6	in	IN	O	in	_	0	SENT_461	[p11l1016t852r1049b883],
7	40	CD	PERCENT	40	num	8	SENT_461	[p11l1065t851r1140b883],
8	%	NN	PERCENT	%	prep_in	5	SENT_461	[p11l1065t851r1140b883],
9	of	IN	O	of	_	0	SENT_461	[p11l1158t851r1193b883],
10	untreated	JJ	O	untreated	amod	11	SENT_461	[p11l1207t851r1361b883],
11	patients	NNS	O	patient	prep_of	8	SENT_461	[p11l1378t851r1507b891],
12	with	IN	O	with	_	0	SENT_461	[p11l1523t851r1596b883],
13	B-cell	NN	MISC	b-cell	nn	15	SENT_461	[p11l1613t851r1713b882],
14	promyelocytic	JJ	O	promyelocytic	amod	15	SENT_461	[p11l1730t861r1799b892, p11l494t903r679b943],
15	leukerrria	NN	O	leukerrrium	prep_with	5	SENT_461	[p11l695t903r856b939],
16	,	,	O	,	_	0	SENT_461	[p11l695t903r856b939],
17	while	IN	O	while	mark	23	SENT_461	[p11l873t903r963b933],
18	low	JJ	O	low	amod	19	SENT_461	[p11l978t904r1040b933],
19	levels	NNS	O	level	nsubjpass	23	SENT_461	[p11l1056t903r1151b932],
20	of	IN	O	of	_	0	SENT_461	[p11l1167t903r1203b933],
21	expression	NN	O	expression	prep_of	19	SENT_461	[p11l1215t902r1392b943],
22	were	VBD	O	be	auxpass	23	SENT_461	[p11l1408t912r1487b933],
23	observed	VBN	O	observe	dep	15	SENT_461	[p11l1503t903r1653b933],
24	in	IN	O	in	_	0	SENT_461	[p11l1668t903r1699b932],
25	hairy	JJ	O	hairy	amod	27	SENT_461	[p11l1714t903r1799b943],
26	cell	NN	O	cell	nn	27	SENT_461	[p11l495t954r556b985],
27	leukemia	NN	O	leukemia	prep_in	23	SENT_461	[p11l569t954r731b990],
28	,	,	O	,	_	0	SENT_461	[p11l569t954r731b990],
29	non-Hodgkin	JJ	O	non-hodgkin	poss	31	SENT_461	[p11l744t953r996b993],
30	’s	POS	O	’s	_	0	SENT_461	[p11l744t953r996b993],
31	lymphoma	NN	O	lymphoma	prep_in	23	SENT_461	[p11l1010t953r1195b993],
32	,	,	O	,	_	0	SENT_461	[p11l1010t953r1195b993],
33	and	CC	O	and	_	0	SENT_461	[p11l1211t954r1270b984],
34	multiple	JJ	O	multiple	amod	35	SENT_461	[p11l1283t953r1422b992],
35	myeloma	NN	O	myeloma	prep_in	23	SENT_461	[p11l1435t953r1599b992],
36	.	.	O	.	_	0	SENT_461	[p11l1435t953r1599b992],

1	LRP-56	NN	O	lrp-56	_	0	SENT_462	[p11l494t1071r652b1108],

1	Scheper	NNP	PERSON	Scheper	nsubj	5	SENT_463	[p11l495t1151r631b1191],
2	et	FW	O	et	nn	3	SENT_463	[p11l641t1156r672b1182],
3	al	FW	O	al	dep	1	SENT_463	[p11l682t1151r713b1182],
4	have	VBP	O	have	aux	5	SENT_463	[p11l723t1151r802b1182],
5	reported	VBN	O	report	_	0	SENT_463	[p11l813t1151r952b1190],
6	the	DT	O	the	det	7	SENT_463	[p11l963t1151r1014b1182],
7	overexpression	NN	O	overexpression	dobj	5	SENT_463	[p11l1026t1151r1276b1190],
8	of	IN	O	of	_	0	SENT_463	[p11l1288t1151r1325b1182],
9	a	DT	O	a	det	14	SENT_463	[p11l1334t1159r1352b1181],
10	110	CD	NUMBER	110	number	11	SENT_463	[p11l1368t1151r1509b1182],
11	—	CD	NUMBER	—	num	12	SENT_463	[p11l1368t1151r1509b1182],
12	kDa	NN	O	kda	npadvmod	13	SENT_463	[p11l1368t1151r1509b1182],
13	vesicular	JJ	O	vesicular	amod	14	SENT_463	[p11l1521t1150r1671b1182],
14	protein	NN	O	protein	prep_of	7	SENT_463	[p11l1682t1151r1800b1191],
15	in	IN	O	in	_	0	SENT_463	[p11l496t1202r529b1234],
16	several	JJ	O	several	amod	17	SENT_463	[p11l542t1202r659b1233],
17	non	JJ	O	non	prep_in	14	SENT_463	[p11l673t1201r1003b1242],
18	.	.	O	.	_	0	SENT_463	[p11l673t1201r1003b1242],

1	—	NN	O	—	_	0	SENT_464	[p11l673t1201r1003b1242],
2	.	.	O	.	_	0	SENT_464	[p11l673t1201r1003b1242],

1	P-glycoprotein	NN	O	p-glycoprotein	nn	4	SENT_465	[p11l673t1201r1003b1242],
2	MDR	NN	O	mdr	nn	4	SENT_465	[p11l1016t1202r1112b1233],
3	cell	NN	O	cell	nn	4	SENT_465	[p11l1125t1201r1185b1233],
4	lines	NNS	O	line	_	0	SENT_465	[p11l1198t1202r1275b1233],
5	(	NN	O	(	nn	7	SENT_465	[p11l1290t1201r1388b1241],
6	119	CD	NUMBER	119	num	7	SENT_465	[p11l1290t1201r1388b1241],
7	)	NN	O	)	dep	4	SENT_465	[p11l1290t1201r1388b1241],
8	.	.	O	.	_	0	SENT_465	[p11l1290t1201r1388b1241],

1	This	DT	O	this	det	2	SENT_466	[p11l1402t1202r1476b1233],
2	molecule	NN	O	molecule	nsubj	4	SENT_466	[p11l1491t1201r1643b1234],
3	was	VBD	O	be	cop	4	SENT_466	[p11l1657t1211r1720b1233],
4	ﬁrst	JJ	O	ﬁrst	_	0	SENT_466	[p11l1735t1202r1802b1234],
5	observed	VBN	O	observe	ccomp	4	SENT_466	[p11l496t1252r647b1284],
6	in	IN	O	in	_	0	SENT_466	[p11l662t1252r695b1283],
7	lung	NN	O	lung	nn	10	SENT_466	[p11l711t1253r784b1293],
8	cancer	NN	O	cancer	nn	10	SENT_466	[p11l799t1261r909b1283],
9	cell	NN	O	cell	nn	10	SENT_466	[p11l923t1252r983b1283],
10	lines	NNS	O	line	prep_in	5	SENT_466	[p11l999t1252r1076b1283],
11	associated	VBN	O	associate	partmod	10	SENT_466	[p11l1093t1252r1263b1283],
12	with	IN	O	with	_	0	SENT_466	[p11l1278t1252r1351b1283],
13	a	DT	O	a	det	14	SENT_466	[p11l1368t1261r1386b1283],
14	non	JJ	O	non	prep_with	11	SENT_466	[p11l1402t1252r1732b1293],
15	.	.	O	.	_	0	SENT_466	[p11l1402t1252r1732b1293],

1	—	NN	O	—	_	0	SENT_467	[p11l1402t1252r1732b1293],
2	.	.	O	.	_	0	SENT_467	[p11l1402t1252r1732b1293],

1	P-glycoprotein	NN	O	p-glycoprotein	nn	2	SENT_468	[p11l1402t1252r1732b1293],
2	decrease	NN	O	decrease	nsubjpass	9	SENT_468	[p11l1748t1252r1800b1283, p11l495t1312r600b1335],
3	in	IN	O	in	_	0	SENT_468	[p11l608t1303r642b1334],
4	drug	NN	O	drug	dep	5	SENT_468	[p11l650t1303r725b1344],
5	accumulation	NN	O	accumulation	prep_in	2	SENT_468	[p11l735t1303r959b1335],
6	and	CC	O	and	cc	5	SENT_468	[p11l968t1303r1028b1334],
7	is	VBZ	O	be	auxpass	9	SENT_468	[p11l1037t1303r1063b1334],
8	thus	RB	O	thus	advmod	9	SENT_468	[p11l1074t1303r1141b1334],
9	referred	VBN	O	refer	_	0	SENT_468	[p11l1152t1302r1282b1334],
10	to	TO	O	to	xcomp	9	SENT_468	[p11l1292t1308r1323b1335],
11	as	IN	O	as	_	0	SENT_468	[p11l1334t1311r1366b1334],
12	the	DT	O	the	det	16	SENT_468	[p11l1376t1303r1427b1334],
13	lung	NN	O	lung	nn	16	SENT_468	[p11l1436t1303r1509b1343],
14	cancer	NN	O	cancer	nn	16	SENT_468	[p11l1519t1312r1628b1335],
15	resistance	NN	O	resistance	nn	16	SENT_468	[p11l1637t1302r1801b1334],
16	protein	NN	O	protein	prep_as	9	SENT_468	[p11l495t1354r624b1395],
17	,	,	O	,	_	0	SENT_468	[p11l495t1354r624b1395],
18	or	CC	O	or	_	0	SENT_468	[p11l641t1363r677b1386],
19	LRP-56	NN	O	lrp-56	prep_as	9	SENT_468	[p11l692t1353r833b1385],
20	.	.	O	.	_	0	SENT_468	[p11l692t1353r833b1385],

1	The	DT	O	the	det	3	SENT_469	[p11l850t1354r915b1385],
2	LRP-56	NN	MISC	lrp-56	nn	3	SENT_469	[p11l932t1353r1062b1386],
3	gene	NN	O	gene	nsubj	8	SENT_469	[p11l1080t1362r1157b1393],
4	has	VBZ	O	have	aux	6	SENT_469	[p11l1175t1353r1228b1385],
5	been	VBN	O	be	auxpass	6	SENT_469	[p11l1246t1354r1324b1386],
6	cloned	VBN	O	clone	_	0	SENT_469	[p11l1341t1353r1452b1385],
7	and	CC	O	and	_	0	SENT_469	[p11l1469t1354r1529b1385],
8	demonstrates	VBZ	O	demonstrate	conj_and	6	SENT_469	[p11l1546t1354r1765b1386],
9	a	DT	O	a	det	13	SENT_469	[p11l1784t1363r1802b1386],
10	60	CD	PERCENT	60	number	11	SENT_469	[p11l496t1404r572b1436],
11	%	NN	PERCENT	%	amod	13	SENT_469	[p11l496t1404r572b1436],
12	sequence	NN	O	sequence	nn	13	SENT_469	[p11l587t1413r738b1444],
13	identity	NN	O	identity	dobj	8	SENT_469	[p11l752t1404r879b1443],
14	at	IN	O	at	_	0	SENT_469	[p11l894t1408r924b1435],
15	the	DT	O	the	det	18	SENT_469	[p11l937t1404r987b1435],
16	amino	NN	O	amino	nn	18	SENT_469	[p11l1001t1403r1105b1435],
17	acid	NN	O	acid	nn	18	SENT_469	[p11l1119t1403r1188b1435],
18	level	NN	O	level	prep_at	13	SENT_469	[p11l1202t1404r1281b1435],
19	with	IN	O	with	_	0	SENT_469	[p11l1296t1403r1369b1435],
20	the	DT	O	the	det	24	SENT_469	[p11l1383t1404r1433b1435],
21	104-kDa	JJ	O	104-kda	amod	24	SENT_469	[p11l1452t1404r1593b1435],
22	major	JJ	O	major	amod	24	SENT_469	[p11l1607t1403r1705b1444],
23	vault	NN	O	vault	nn	24	SENT_469	[p11l1718t1404r1802b1435],
24	protein	NN	O	protein	prep_with	8	SENT_469	[p11l495t1456r614b1495],
25	from	IN	O	from	_	0	SENT_469	[p11l629t1455r711b1486],
26	Dictyostelium	NNP	MISC	Dictyostelium	nn	28	SENT_469	[p11l725t1454r957b1493],
27	discoideum	NN	O	discoideum	nn	28	SENT_469	[p11l971t1454r1161b1485],
28	(	NN	O	(	prep_from	24	SENT_469	[p11l1179t1454r1274b1492],
29	120	CD	NUMBER	120	num	30	SENT_469	[p11l1179t1454r1274b1492],
30	)	NN	O	)	dobj	6	SENT_469	[p11l1179t1454r1274b1492],
31	.	.	O	.	_	0	SENT_469	[p11l1179t1454r1274b1492],

1	Vault	NNP	O	Vault	nn	2	SENT_470	[p11l1293t1454r1386b1485],
2	proteins	NNS	O	protein	nsubj	4	SENT_470	[p11l1400t1454r1534b1494],
3	are	VBP	O	be	cop	4	SENT_470	[p11l1551t1464r1600b1486],
4	large	JJ	O	large	_	0	SENT_470	[p11l1617t1454r1699b1494],
5	cytoplasmic	JJ	O	cytoplasmic	amod	7	SENT_470	[p11l1715t1459r1800b1494, p11l496t1506r626b1545],
6	ribonucleoprotein	NN	O	ribonucleoprotein	nn	7	SENT_470	[p11l636t1506r932b1543],
7	structures	NNS	O	structure	nsubj	14	SENT_470	[p11l943t1511r1103b1535],
8	found	VBN	O	find	partmod	7	SENT_470	[p11l1114t1505r1211b1535],
9	in	IN	O	in	_	0	SENT_470	[p11l1221t1506r1252b1535],
10	nearly	RB	O	nearly	quantmod	11	SENT_470	[p11l1264t1505r1367b1543],
11	all	DT	O	all	num	13	SENT_470	[p11l1378t1505r1418b1534],
12	eukaryotic	JJ	O	eukaryotic	amod	13	SENT_470	[p11l1428t1506r1604b1544],
13	cells	NNS	O	cell	prep_in	8	SENT_470	[p11l1615t1505r1690b1535],
14	(	VBP	O	(	ccomp	4	SENT_470	[p11l1702t1505r1800b1541],
15	121	CD	NUMBER	121	number	16	SENT_470	[p11l1702t1505r1800b1541],
16	)	CD	NUMBER	)	dobj	14	SENT_470	[p11l1702t1505r1800b1541],
17	.	.	O	.	_	0	SENT_470	[p11l1702t1505r1800b1541],

1	There	EX	O	there	expl	2	SENT_471	[p11l496t1554r593b1585],
2	are	VBP	O	be	_	0	SENT_471	[p11l604t1563r655b1585],
3	three	CD	NUMBER	three	num	6	SENT_471	[p11l664t1555r748b1585],
4	minor	JJ	O	minor	amod	6	SENT_471	[p11l758t1554r858b1585],
5	vault	NN	O	vault	nn	6	SENT_471	[p11l868t1554r951b1584],
6	proteins	NNS	O	protein	nsubj	2	SENT_471	[p11l959t1554r1093b1593],
7	of	IN	O	of	_	0	SENT_471	[p11l1103t1554r1141b1584],
8	210	CD	NUMBER	210	prep_of	6	SENT_471	[p11l1149t1554r1219b1589],
9	,	,	O	,	_	0	SENT_471	[p11l1149t1554r1219b1589],
10	192	CD	NUMBER	192	num	8	SENT_471	[p11l1235t1554r1301b1590],
11	,	,	O	,	_	0	SENT_471	[p11l1235t1554r1301b1590],
12	and	CC	NUMBER	and	_	0	SENT_471	[p11l1313t1554r1372b1585],
13	54	CD	NUMBER	54	prep_of	6	SENT_471	[p11l1384t1554r1424b1584],
14	kDa	NN	O	kda	dep	8	SENT_471	[p11l1434t1554r1504b1584],
15	and	CC	O	and	_	0	SENT_471	[p11l1513t1554r1573b1584],
16	a	DT	O	a	det	19	SENT_471	[p11l1584t1563r1601b1585],
17	major	JJ	O	major	amod	19	SENT_471	[p11l1612t1553r1709b1592],
18	vault	NN	O	vault	nn	19	SENT_471	[p11l1719t1554r1803b1585],
19	protein	NN	O	protein	prep_of	6	SENT_471	[p11l495t1605r615b1645],
20	of	IN	O	of	_	0	SENT_471	[p11l628t1605r666b1636],
21	104	CD	NUMBER	104	num	22	SENT_471	[p11l680t1605r739b1636],
22	kDa	NN	O	kda	prep_of	19	SENT_471	[p11l751t1605r822b1635],
23	found	VBN	O	find	partmod	22	SENT_471	[p11l835t1604r932b1635],
24	in	IN	O	in	_	0	SENT_471	[p11l945t1604r976b1635],
25	the	DT	O	the	det	30	SENT_471	[p11l990t1605r1041b1635],
26	rat	NN	O	rat	nn	30	SENT_471	[p11l1054t1609r1099b1635],
27	liver	NN	O	liver	nn	30	SENT_471	[p11l1111t1604r1189b1635],
28	(	NN	O	(	nn	30	SENT_471	[p11l1201t1605r1299b1642],
29	122	CD	NUMBER	122	num	30	SENT_471	[p11l1201t1605r1299b1642],
30	)	NN	O	)	prep_in	23	SENT_471	[p11l1201t1605r1299b1642],
31	.	.	O	.	_	0	SENT_471	[p11l1201t1605r1299b1642],

1	These	DT	O	these	det	2	SENT_472	[p11l1313t1604r1413b1635],
2	proteins	NNS	O	protein	nsubj	3	SENT_472	[p11l1426t1605r1560b1643],
3	form	VBP	O	form	_	0	SENT_472	[p11l1574t1605r1655b1635],
4	a	DT	O	a	det	6	SENT_472	[p11l1668t1613r1686b1635],
5	multisubunit	JJ	O	multisubunit	amod	6	SENT_472	[p11l1700t1604r1800b1635, p11l497t1654r620b1686],
6	organelle	NN	O	organelle	dobj	3	SENT_472	[p11l636t1655r791b1695],
7	that	WDT	O	that	nsubjpass	9	SENT_472	[p11l809t1654r871b1685],
8	is	VBZ	O	be	auxpass	9	SENT_472	[p11l889t1654r915b1685],
9	associated	VBN	O	associate	rcmod	6	SENT_472	[p11l933t1654r1103b1686],
10	with	IN	O	with	_	0	SENT_472	[p11l1122t1654r1194b1685],
11	cytoplasmic	JJ	O	cytoplasmic	amod	13	SENT_472	[p11l1211t1653r1411b1695],
12	vesicle	NN	O	vesicle	nn	13	SENT_472	[p11l1430t1654r1544b1686],
13	structures	NNS	O	structure	prep_with	9	SENT_472	[p11l1563t1658r1723b1686],
14	and	CC	O	and	_	0	SENT_472	[p11l1742t1654r1801b1685],
15	nuclear	JJ	O	nuclear	amod	17	SENT_472	[p11l496t1705r620b1737],
16	pore	NN	O	pore	nn	17	SENT_472	[p11l629t1715r703b1746],
17	complexes	NNS	O	complex	nsubj	18	SENT_472	[p11l715t1704r892b1745],
18	(	VBP	O	(	conj_and	3	SENT_472	[p11l905t1705r1001b1743],
19	123	CD	NUMBER	123	number	20	SENT_472	[p11l905t1705r1001b1743],
20	)	CD	NUMBER	)	dobj	18	SENT_472	[p11l905t1705r1001b1743],
21	.	.	O	.	_	0	SENT_472	[p11l905t1705r1001b1743],

1	Electron	NN	O	electron	nn	3	SENT_473	[p11l1014t1705r1155b1736],
2	microscopy	NN	O	microscopy	nn	3	SENT_473	[p11l1167t1705r1360b1746],
3	studies	NNS	O	study	nsubj	5	SENT_473	[p11l1372t1704r1485b1736],
4	have	VBP	O	have	aux	5	SENT_473	[p11l1497t1705r1576b1737],
5	revealed	VBN	O	reveal	_	0	SENT_473	[p11l1587t1704r1728b1737],
6	that	IN	O	that	complm	10	SENT_473	[p11l1740t1705r1802b1736],
7	the	DT	O	the	det	9	SENT_473	[p11l496t1756r547b1788],
8	vault	NN	O	vault	nn	9	SENT_473	[p11l562t1756r646b1787],
9	proteins	NNS	O	protein	nsubj	10	SENT_473	[p11l657t1757r792b1796],
10	have	VBP	O	have	ccomp	5	SENT_473	[p11l805t1756r884b1787],
11	a	DT	O	a	det	13	SENT_473	[p11l897t1765r916b1787],
12	barrel-like	JJ	O	barrel-like	amod	13	SENT_473	[p11l928t1755r1102b1787],
13	morphology	NN	O	morphology	dobj	10	SENT_473	[p11l1114t1756r1327b1796],
14	,	,	O	,	_	0	SENT_473	[p11l1114t1756r1327b1796],
15	which	WDT	O	which	nsubj	16	SENT_473	[p11l1342t1756r1443b1787],
16	appears	VBZ	O	appear	rcmod	13	SENT_473	[p11l1457t1765r1583b1795],
17	to	TO	O	to	aux	20	SENT_473	[p11l1598t1761r1630b1787],
18	be	VB	O	be	auxpass	20	SENT_473	[p11l1643t1756r1682b1786],
19	highly	RB	O	highly	advmod	20	SENT_473	[p11l1695t1756r1801b1795],
20	conserved	VBN	O	conserve	xcomp	16	SENT_473	[p11l496t1807r667b1837],
21	across	IN	O	across	_	0	SENT_473	[p11l685t1815r789b1837],
22	species	NNS	O	species	prep_across	20	SENT_473	[p11l808t1806r927b1845],
23	(	CD	NUMBER	(	number	24	SENT_473	[p11l948t1806r1044b1843],
24	132	CD	NUMBER	132	num	25	SENT_473	[p11l948t1806r1044b1843],
25	)	NN	O	)	dep	20	SENT_473	[p11l948t1806r1044b1843],
26	.	.	O	.	_	0	SENT_473	[p11l948t1806r1044b1843],

1	Each	DT	O	each	det	2	SENT_474	[p11l1065t1806r1148b1836],
2	vault	NN	O	vault	nsubj	3	SENT_474	[p11l1167t1806r1250b1836],
3	comprises	VBZ	O	comprise	_	0	SENT_474	[p11l1269t1805r1436b1844],
4	a	DT	O	a	det	7	SENT_474	[p11l1457t1815r1475b1836],
5	hollow	JJ	O	hollow	amod	7	SENT_474	[p11l1494t1806r1608b1837],
6	barrel-like	JJ	O	barrel-like	amod	7	SENT_474	[p11l1628t1806r1803b1836],
7	structure	NN	O	structure	dobj	3	SENT_474	[p11l497t1860r643b1886],
8	composed	VBN	O	compose	partmod	7	SENT_474	[p11l654t1855r823b1894],
9	of	IN	O	of	_	0	SENT_474	[p11l835t1855r874b1885],
10	two	CD	NUMBER	two	num	12	SENT_474	[p11l881t1860r944b1885],
11	identical	JJ	O	identical	amod	12	SENT_474	[p11l956t1855r1098b1885],
12	cup	NN	O	cup	prep_of	8	SENT_474	[p11l1110t1855r1247b1894],
13	—	CD	NUMBER	—	nsubj	16	SENT_474	[p11l1110t1855r1247b1894],
14	like	IN	O	like	_	0	SENT_474	[p11l1110t1855r1247b1894],
15	halves	NNS	O	half	prep_like	13	SENT_474	[p11l1259t1856r1364b1885],
16	joined	VBD	O	join	rcmod	12	SENT_474	[p11l1373t1855r1480b1894],
17	at	IN	O	at	_	0	SENT_474	[p11l1493t1860r1522b1885],
18	their	PRP$	O	they	poss	20	SENT_474	[p11l1534t1856r1611b1885],
19	open	JJ	O	open	amod	20	SENT_474	[p11l1623t1864r1703b1893],
20	ends	NNS	O	end	prep_at	16	SENT_474	[p11l1716t1855r1801b1885],
21	.	.	O	.	_	0	SENT_474	[p11l1716t1855r1801b1885],

1	Each	DT	O	each	det	2	SENT_475	[p11l496t1905r579b1936],
2	half	NN	O	half	nsubjpass	9	SENT_475	[p11l596t1905r663b1935],
3	of	IN	O	of	_	0	SENT_475	[p11l676t1905r714b1936],
4	the	DT	O	the	det	5	SENT_475	[p11l726t1906r778b1936],
5	vault	NN	O	vault	prep_of	2	SENT_475	[p11l793t1905r877b1935],
6	in	IN	O	in	_	0	SENT_475	[p11l892t1905r924b1935],
7	turn	NN	O	turn	prep_in	5	SENT_475	[p11l940t1910r1006b1935],
8	is	VBZ	O	be	auxpass	9	SENT_475	[p11l1022t1905r1049b1936],
9	composed	VBN	O	compose	dep	23	SENT_475	[p11l1065t1905r1234b1944],
10	of	IN	O	of	_	0	SENT_475	[p11l1250t1905r1287b1936],
11	a	DT	O	a	det	14	SENT_475	[p11l1299t1915r1318b1936],
12	single	JJ	O	single	amod	14	SENT_475	[p11l1335t1905r1434b1944],
13	eight-petaled	JJ	O	eight-petaled	amod	14	SENT_475	[p11l1450t1905r1667b1945],
14	ﬂower	NN	O	ﬂower	prep_of	9	SENT_475	[p11l1683t1904r1801b1941],
15	,	,	O	,	_	0	SENT_475	[p11l1683t1904r1801b1941],
16	which	WDT	O	which	nsubjpass	18	SENT_475	[p11l496t1955r599b1986],
17	is	VBZ	O	be	auxpass	18	SENT_475	[p11l611t1955r639b1985],
18	folded	VBN	O	fold	rcmod	14	SENT_475	[p11l651t1955r758b1986],
19	into	IN	O	into	_	0	SENT_475	[p11l771t1955r835b1985],
20	the	DT	O	the	det	22	SENT_475	[p11l848t1955r899b1985],
21	cup	NN	O	cup	nn	22	SENT_475	[p11l911t1964r971b1994],
22	shape	NN	O	shape	prep_into	18	SENT_475	[p11l984t1955r1078b1994],
23	(	VBD	O	(	_	0	SENT_475	[p11l1093t1955r1190b1991],
24	124	CD	NUMBER	124	num	25	SENT_475	[p11l1093t1955r1190b1991],
25	)	NN	O	)	nsubj	23	SENT_475	[p11l1093t1955r1190b1991],
26	.	.	O	.	_	0	SENT_475	[p11l1093t1955r1190b1991],

1	The	DT	O	the	det	2	SENT_476	[p11l1204t1955r1268b1985],
2	function	NN	O	function	nsubj	5	SENT_476	[p11l1282t1954r1420b1985],
3	of	IN	O	of	_	0	SENT_476	[p11l1432t1954r1470b1985],
4	LRP-56	NN	MISC	lrp-56	prep_of	2	SENT_476	[p11l1480t1954r1612b1986],
5	remains	VBZ	O	remain	_	0	SENT_476	[p11l1625t1954r1755b1985],
6	to	TO	O	to	aux	8	SENT_476	[p11l1770t1959r1801b1985],
7	be	VB	O	be	auxpass	8	SENT_476	[p11l495t2005r536b2034],
8	determined	VBN	O	determine	xcomp	5	SENT_476	[p11l548t2004r746b2039],
9	,	,	O	,	_	0	SENT_476	[p11l548t2004r746b2039],
10	however	RB	O	however	advmod	8	SENT_476	[p11l759t2004r913b2039],
11	,	,	O	,	_	0	SENT_476	[p11l759t2004r913b2039],
12	and	CC	O	and	_	0	SENT_476	[p11l926t2004r986b2034],
13	a	DT	O	a	det	15	SENT_476	[p11l998t2013r1017b2034],
14	causative	JJ	O	causative	amod	15	SENT_476	[p11l1029t2003r1184b2034],
15	role	NN	O	role	nsubj	19	SENT_476	[p11l1196t2004r1261b2034],
16	in	IN	O	in	_	0	SENT_476	[p11l1275t2004r1306b2034],
17	drug	NN	O	drug	nn	18	SENT_476	[p11l1320t2003r1395b2042],
18	resistance	NN	O	resistance	prep_in	15	SENT_476	[p11l1408t2003r1572b2034],
19	has	VBZ	O	have	conj_and	5	SENT_476	[p11l1585t2004r1640b2033],
20	yet	RB	O	yet	advmod	19	SENT_476	[p11l1654t2008r1705b2042],
21	to	TO	O	to	aux	24	SENT_476	[p11l1718t2008r1750b2033],
22	be	VB	O	be	auxpass	24	SENT_476	[p11l1763t2004r1802b2033],
23	deﬁnitively	RB	O	deﬁnitively	advmod	24	SENT_476	[p11l497t2053r690b2092],
24	demonstrated	VBN	O	demonstrate	xcomp	19	SENT_476	[p11l701t2053r936b2089],
25	,	,	O	,	_	0	SENT_476	[p11l701t2053r936b2089],
26	although	IN	O	although	mark	32	SENT_476	[p11l948t2053r1093b2092],
27	overexpression	NN	O	overexpression	nsubjpass	32	SENT_476	[p11l1106t2053r1357b2092],
28	of	IN	O	of	_	0	SENT_476	[p11l1369t2052r1407b2083],
29	LRP-56	NN	O	lrp-56	prep_of	27	SENT_476	[p11l1417t2053r1547b2084],
30	has	VBZ	O	have	aux	32	SENT_476	[p11l1559t2053r1614b2084],
31	been	VBN	O	be	auxpass	32	SENT_476	[p11l1626t2052r1705b2083],
32	associated	VBN	O	associate	advcl	19	SENT_476	[p11l1717t2061r1801b2083, p11l496t2102r597b2133],
33	with	IN	O	with	_	0	SENT_476	[p11l608t2103r682b2133],
34	an	DT	O	a	det	37	SENT_476	[p11l693t2112r731b2133],
35	unfavorable	JJ	O	unfavorable	amod	37	SENT_476	[p11l741t2102r941b2133],
36	prognostic	JJ	O	prognostic	amod	37	SENT_476	[p11l951t2102r1125b2142],
37	outcome	NN	O	outcome	prep_with	32	SENT_476	[p11l1137t2107r1279b2133],
38	in	IN	O	in	_	0	SENT_476	[p11l1290t2103r1322b2133],
39	acute	JJ	O	acute	amod	41	SENT_476	[p11l1334t2107r1421b2132],
40	myeloid	JJ	O	myeloid	amod	41	SENT_476	[p11l1433t2102r1568b2141],
41	leukemia	NN	O	leukemia	prep_in	37	SENT_476	[p11l1580t2102r1733b2133],
42	and	CC	O	and	_	0	SENT_476	[p11l1743t2103r1802b2132],
43	ovarian	JJ	O	ovarian	amod	44	SENT_476	[p11l497t2151r622b2183],
44	carcinoma	NN	O	carcinoma	conj_and	41	SENT_476	[p11l634t2152r817b2182],
45	.	.	O	.	_	0	SENT_476	[p11l634t2152r817b2182],

1	(	NN	O	(	_	0	SENT_477	[p11l832t2151r917b2188],
2	125	CD	NUMBER	125	num	1	SENT_477	[p11l832t2151r917b2188],
3	,	,	O	,	_	0	SENT_477	[p11l832t2151r917b2188],
4	126	CD	NUMBER	126	num	5	SENT_477	[p11l936t2151r1015b2188],
5	)	NN	O	)	appos	1	SENT_477	[p11l936t2151r1015b2188],
6	.	.	O	.	_	0	SENT_477	[p11l936t2151r1015b2188],

1	Annual	JJ	SET	annual	amod	2	SENT_478	[p11l447t2269r568b2298],
2	Reviews	NNS	O	review	nsubj	3	SENT_478	[p11l580t2269r722b2307],
3	_	VBP	O	_	_	0	SENT_478	[p11l954t2302r959b2307],
4	www.annualrev1ews.org	NN	O	www.annualrev1ews.org	dobj	3	SENT_478	[p11l447t2302r866b2340],
5	/	:	O	/	punct	6	SENT_478	[p11l447t2302r866b2340],
6	aronlrne	NN	O	aronlrne	dep	4	SENT_478	[p11l867t2302r1001b2331],

1	P-GLYCOPROTEINS	NNPS	O	P-GLYCOPROTEINS	_	0	SENT_479	[p11l889t2402r1229b2431],
2	AND	CC	O	and	_	0	SENT_479	[p11l1240t2402r1321b2431],
3	DRUG	NN	O	drug	nn	4	SENT_479	[p11l1330t2403r1437b2432],
4	RESISTANCE	NN	O	resistance	conj_and	1	SENT_479	[p11l1446t2402r1674b2432],
5	177	CD	NUMBER	177	dep	1	SENT_479	[p11l1746t2402r1798b2432],

1	CONCLUSION	NN	O	conclusion	_	0	SENT_480	[p11l495t2496r817b2534],

1	Several	JJ	O	several	amod	3	SENT_481	[p11l496t2590r620b2621],
2	research	NN	O	research	nn	3	SENT_481	[p11l633t2590r773b2621],
3	areas	NNS	O	area	nsubjpass	6	SENT_481	[p11l786t2598r872b2621],
4	have	VBP	O	have	aux	6	SENT_481	[p11l884t2590r964b2621],
5	been	VBN	O	be	auxpass	6	SENT_481	[p11l977t2590r1056b2620],
6	identified	VBN	O	identify	_	0	SENT_481	[p11l1070t2590r1229b2621],
7	that	WDT	O	that	nsubj	9	SENT_481	[p11l1244t2590r1306b2621],
8	are	VBP	O	be	cop	9	SENT_481	[p11l1320t2599r1370b2621],
9	important	JJ	O	important	ccomp	6	SENT_481	[p11l1384t2590r1546b2629],
10	to	TO	O	to	_	0	SENT_481	[p11l1560t2595r1592b2621],
11	the	DT	O	the	det	12	SENT_481	[p11l1606t2591r1656b2621],
12	transfer	NN	O	transfer	prep_to	9	SENT_481	[p11l1671t2591r1798b2621],
13	of	IN	O	of	_	0	SENT_481	[p11l496t2638r534b2670],
14	the	DT	O	the	det	15	SENT_481	[p11l542t2639r595b2669],
15	discovery	NN	O	discovery	prep_of	12	SENT_481	[p11l607t2639r768b2678],
16	of	IN	O	of	_	0	SENT_481	[p11l781t2638r820b2669],
17	the	DT	O	the	det	20	SENT_481	[p11l828t2639r879b2670],
18	MDR	NN	ORGANIZATION	mdr	nn	20	SENT_481	[p11l890t2639r999b2669],
19	]	NN	O	]	nn	20	SENT_481	[p11l890t2639r999b2669],
20	gene	NN	O	gene	prep_of	15	SENT_481	[p11l1016t2648r1095b2678],
21	and	CC	O	and	_	0	SENT_481	[p11l1107t2639r1167b2670],
22	its	PRP$	O	its	poss	24	SENT_481	[p11l1180t2639r1218b2669],
23	protein	NN	O	protein	nn	24	SENT_481	[p11l1231t2639r1348b2678],
24	product	NN	O	product	prep_of	12	SENT_481	[p11l1362t2639r1489b2679],
25	from	IN	O	from	_	0	SENT_481	[p11l1502t2638r1582b2671],
26	the	DT	O	the	det	28	SENT_481	[p11l1595t2639r1647b2670],
27	research	NN	O	research	nn	28	SENT_481	[p11l1659t2639r1798b2671],
28	laboratory	NN	O	laboratory	prep_from	24	SENT_481	[p11l495t2688r666b2728],
29	to	TO	O	to	_	0	SENT_481	[p11l680t2693r712b2719],
30	the	DT	O	the	det	32	SENT_481	[p11l726t2688r778b2718],
31	clinical	JJ	O	clinical	amod	32	SENT_481	[p11l791t2687r913b2719],
32	environment	NN	O	environment	prep_to	9	SENT_481	[p11l928t2688r1148b2719],
33	.	.	O	.	_	0	SENT_481	[p11l928t2688r1148b2719],

1	There	EX	O	there	expl	2	SENT_482	[p11l1162t2688r1259b2718],
2	is	VBZ	O	be	_	0	SENT_482	[p11l1273t2688r1300b2719],
3	an	DT	O	a	det	5	SENT_482	[p11l1315t2698r1352b2719],
4	immediate	JJ	O	immediate	amod	5	SENT_482	[p11l1368t2688r1542b2719],
5	need	NN	O	need	nsubj	2	SENT_482	[p11l1558t2688r1635b2719],
6	for	IN	O	for	_	0	SENT_482	[p11l1650t2688r1699b2719],
7	comprehensive	JJ	O	comprehensive	amod	8	SENT_482	[p11l1712t2697r1797b2719, p11l495t2736r675b2775],
8	information	NN	O	information	prep_for	5	SENT_482	[p11l696t2736r892b2767],
9	on	IN	O	on	_	0	SENT_482	[p11l911t2745r953b2767],
10	the	DT	O	the	det	11	SENT_482	[p11l972t2736r1024b2766],
11	prevalence	NN	O	prevalence	prep_on	8	SENT_482	[p11l1043t2737r1223b2775],
12	and	CC	O	and	_	0	SENT_482	[p11l1245t2737r1304b2767],
13	levels	NNS	O	level	prep_for	5	SENT_482	[p11l1324t2737r1419b2767],
14	of	IN	O	of	_	0	SENT_482	[p11l1440t2736r1478b2767],
15	expression	NN	O	expression	prep_of	13	SENT_482	[p11l1495t2737r1673b2776],
16	of	IN	O	of	_	0	SENT_482	[p11l1693t2736r1730b2767],
17	the	DT	O	the	det	20	SENT_482	[p11l1747t2737r1798b2768],
18	human	JJ	O	human	amod	20	SENT_482	[p11l495t2785r609b2816],
19	MDR	NN	ORGANIZATION	mdr	nn	20	SENT_482	[p11l624t2786r720b2816],
20	genes	NNS	O	gene	prep_of	15	SENT_482	[p11l734t2794r828b2824],
21	and	CC	O	and	_	0	SENT_482	[p11l844t2785r905b2816],
22	their	PRP$	O	they	poss	24	SENT_482	[p11l918t2785r997b2816],
23	protein	NN	O	protein	nn	24	SENT_482	[p11l1010t2785r1128b2824],
24	products	NNS	O	product	prep_of	13	SENT_482	[p11l1143t2785r1286b2825],
25	in	IN	O	in	_	0	SENT_482	[p11l1302t2786r1332b2816],
26	human	JJ	O	human	amod	27	SENT_482	[p11l1348t2786r1461b2816],
27	organs	NNS	O	organ	prep_in	24	SENT_482	[p11l1477t2794r1587b2826],
28	and	CC	O	and	_	0	SENT_482	[p11l1603t2786r1662b2817],
29	tissues	NNS	O	tissue	conj_and	27	SENT_482	[p11l1678t2785r1797b2817],
30	.	.	O	.	_	0	SENT_482	[p11l1678t2785r1797b2817],

1	Data	NNS	O	datum	nsubjpass	3	SENT_483	[p11l496t2835r576b2866],
2	is	VBZ	O	be	auxpass	3	SENT_483	[p11l591t2834r619b2866],
3	needed	VBN	O	need	_	0	SENT_483	[p11l635t2835r754b2866],
4	on	IN	O	on	_	0	SENT_483	[p11l770t2843r812b2865],
5	P-glycoprotein	NN	O	p-glycoprotein	nn	6	SENT_483	[p11l828t2834r1076b2875],
6	levels	NNS	O	level	prep_on	3	SENT_483	[p11l1091t2835r1188b2866],
7	in	IN	O	in	_	0	SENT_483	[p11l1205t2834r1236b2865],
8	speciﬁc	NN	O	speciﬁc	nn	9	SENT_483	[p11l1254t2835r1382b2874],
9	subpopulations	NNS	O	subpopulation	nsubj	10	SENT_483	[p11l1400t2834r1650b2875],
10	(	VBP	O	(	prepc_in	3	SENT_483	[p11l1668t2835r1730b2873],
11	i.e.	FW	O	i.e.	dobj	10	SENT_483	[p11l1668t2835r1730b2873],
12	according	VBG	O	accord	_	0	SENT_483	[p11l1748t2844r1798b2867, p11l496t2883r624b2925],
13	to	TO	O	to	prepc_according_to	10	SENT_483	[p11l637t2889r671b2916],
14	age	NN	O	age	pobj	10	SENT_483	[p11l685t2893r751b2925],
15	,	,	O	,	_	0	SENT_483	[p11l685t2893r751b2925],
16	sex	NN	O	sex	pobj	10	SENT_483	[p11l768t2893r832b2921],
17	,	,	O	,	_	0	SENT_483	[p11l768t2893r832b2921],
18	race	NN	O	race	pobj	10	SENT_483	[p11l846t2893r926b2921],
19	,	,	O	,	_	0	SENT_483	[p11l846t2893r926b2921],
20	diet	NN	O	diet	pobj	10	SENT_483	[p11l940t2883r1012b2921],
21	,	,	O	,	_	0	SENT_483	[p11l940t2883r1012b2921],
22	etc	FW	O	etc	nn	23	SENT_483	[p11l1027t2884r1099b2923],
23	)	FW	O	)	conj_and	14	SENT_483	[p11l1027t2884r1099b2923],
24	,	,	O	,	_	0	SENT_483	[p11l1027t2884r1099b2923],
25	and	CC	O	and	_	0	SENT_483	[p11l1114t2884r1174b2916],
26	the	DT	O	the	det	27	SENT_483	[p11l1188t2883r1239b2916],
27	study	NN	O	study	conj_and	14	SENT_483	[p11l1254t2884r1342b2925],
28	of	IN	O	of	_	0	SENT_483	[p11l1356t2883r1394b2916],
29	heterogeneity	NN	O	heterogeneity	prep_of	27	SENT_483	[p11l1405t2883r1631b2925],
30	and	CC	O	and	_	0	SENT_483	[p11l1647t2883r1706b2916],
31	variability	NN	O	variability	nsubjpass	42	SENT_483	[p11l1721t2884r1798b2917, p11l496t2934r602b2975],
32	of	IN	O	of	_	0	SENT_483	[p11l620t2935r658b2967],
33	expression	NN	O	expression	prep_of	31	SENT_483	[p11l672t2934r851b2975],
34	of	IN	O	of	_	0	SENT_483	[p11l867t2934r905b2967],
35	P-glycoprotein	NN	O	p-glycoprotein	prep_of	33	SENT_483	[p11l920t2934r1167b2976],
36	in	IN	O	in	_	0	SENT_483	[p11l1186t2934r1217b2966],
37	normal	JJ	O	normal	amod	39	SENT_483	[p11l1235t2935r1352b2967],
38	human	JJ	O	human	amod	39	SENT_483	[p11l1370t2934r1483b2967],
39	tissues	NNS	O	tissue	prep_in	35	SENT_483	[p11l1502t2934r1611b2967],
40	should	MD	O	should	aux	42	SENT_483	[p11l1631t2934r1741b2967],
41	be	VB	O	be	auxpass	42	SENT_483	[p11l1759t2935r1799b2967],
42	given	VBN	O	give	prepc_in	3	SENT_483	[p11l496t2985r589b3026],
43	a	DT	O	a	det	45	SENT_483	[p11l602t2995r621b3017],
44	high	JJ	O	high	amod	45	SENT_483	[p11l632t2986r706b3026],
45	priority	NN	O	priority	dobj	42	SENT_483	[p11l719t2986r853b3027],
46	.	.	O	.	_	0	SENT_483	[p11l719t2986r853b3027],

1	Because	IN	O	because	mark	5	SENT_484	[p11l538t3035r678b3067],
2	early	JJ	O	early	amod	3	SENT_484	[p11l688t3036r771b3076],
3	studies	NNS	O	study	nsubj	5	SENT_484	[p11l783t3036r897b3068],
4	have	VBP	O	have	aux	5	SENT_484	[p11l909t3036r988b3067],
5	indicated	VBN	O	indicate	advcl	26	SENT_484	[p11l1000t3035r1152b3067],
6	some	DT	O	some	det	7	SENT_484	[p11l1163t3044r1250b3067],
7	successes	NNS	O	success	dobj	5	SENT_484	[p11l1263t3044r1420b3067],
8	in	IN	O	in	_	0	SENT_484	[p11l1432t3035r1463b3066],
9	identifying	VBG	O	identify	prepc_in	5	SENT_484	[p11l1475t3035r1658b3076],
10	patients	NNS	O	patient	dobj	9	SENT_484	[p11l1669t3034r1798b3076],
11	with	IN	O	with	_	0	SENT_484	[p11l497t3085r571b3117],
12	classic	JJ	O	classic	amod	14	SENT_484	[p11l582t3085r692b3117],
13	multidrug	JJ	O	multidrug	amod	14	SENT_484	[p11l704t3086r868b3127],
14	resistance	NN	O	resistance	prep_with	9	SENT_484	[p11l879t3085r1043b3117],
15	who	WP	O	who	nsubj	18	SENT_484	[p11l1055t3086r1127b3117],
16	might	MD	O	might	aux	18	SENT_484	[p11l1139t3085r1236b3126],
17	be	VB	O	be	cop	18	SENT_484	[p11l1247t3085r1286b3116],
18	responsive	JJ	O	responsive	rcmod	14	SENT_484	[p11l1297t3085r1475b3126],
19	to	TO	O	to	_	0	SENT_484	[p11l1487t3089r1519b3117],
20	chemosensitization	NN	O	chemosensitization	prep_to	18	SENT_484	[p11l1531t3085r1798b3117, p11l496t3135r571b3172],
21	,	,	O	,	_	0	SENT_484	[p11l1531t3085r1798b3117, p11l496t3135r571b3172],
22	clinical	JJ	O	clinical	amod	23	SENT_484	[p11l583t3136r706b3168],
23	research	NN	O	research	nsubj	26	SENT_484	[p11l717t3136r857b3168],
24	will	MD	O	will	aux	26	SENT_484	[p11l868t3136r932b3168],
25	undoubtedly	RB	O	undoubtedly	advmod	26	SENT_484	[p11l945t3135r1152b3176],
26	accelerate	VB	O	accelerate	_	0	SENT_484	[p11l1165t3135r1330b3168],
27	in	IN	O	in	_	0	SENT_484	[p11l1343t3135r1375b3168],
28	this	DT	O	this	det	29	SENT_484	[p11l1387t3135r1446b3168],
29	area	NN	O	area	prep_in	26	SENT_484	[p11l1459t3144r1537b3168],
30	.	.	O	.	_	0	SENT_484	[p11l1459t3144r1537b3168],

1	The	DT	O	the	det	3	SENT_485	[p11l1550t3136r1615b3168],
2	next	JJ	O	next	amod	3	SENT_485	[p11l1627t3139r1699b3167],
3	wave	NN	O	wave	nsubj	20	SENT_485	[p11l1711t3143r1799b3168],
4	of	IN	O	of	_	0	SENT_485	[p11l496t3185r534b3217],
5	clinical	JJ	O	clinical	amod	6	SENT_485	[p11l550t3184r673b3217],
6	studies	NNS	O	study	prep_of	3	SENT_485	[p11l693t3185r808b3217],
7	will	MD	O	will	aux	8	SENT_485	[p11l828t3185r893b3217],
8	provide	VB	O	provide	_	0	SENT_485	[p11l912t3185r1040b3226],
9	clinical	JJ	O	clinical	amod	10	SENT_485	[p11l1060t3185r1182b3217],
10	investigators	NNS	O	investigator	dobj	8	SENT_485	[p11l1202t3185r1413b3226],
11	with	IN	O	with	_	0	SENT_485	[p11l1433t3185r1507b3216],
12	opportunities	NNS	O	opportunity	prep_with	8	SENT_485	[p11l1528t3184r1746b3226],
13	to	TO	O	to	aux	14	SENT_485	[p11l1768t3190r1799b3218],
14	develop	VB	O	develop	xcomp	8	SENT_485	[p11l496t3235r629b3276],
15	and	CC	O	and	_	0	SENT_485	[p11l637t3236r697b3267],
16	evaluate	VB	O	evaluate	xcomp	8	SENT_485	[p11l705t3235r844b3267],
17	P-glycoprotein	NN	MISC	p-glycoprotein	nn	18	SENT_485	[p11l853t3235r1099b3276],
18	tests	NNS	O	test	dobj	14	SENT_485	[p11l1108t3240r1181b3267],
19	and	CC	O	and	_	0	SENT_485	[p11l1190t3235r1250b3267],
20	correlate	VBP	O	correlate	conj_and	8	SENT_485	[p11l1259t3235r1402b3267],
21	test	NN	O	test	nsubj	22	SENT_485	[p11l1412t3240r1470b3267],
22	results	VBZ	O	result	ccomp	20	SENT_485	[p11l1478t3236r1585b3267],
23	with	IN	O	with	_	0	SENT_485	[p11l1595t3235r1668b3267],
24	clinical	JJ	O	clinical	amod	25	SENT_485	[p11l1677t3234r1800b3267],
25	outcomes	NNS	O	outcome	prep_with	22	SENT_485	[p11l497t3290r665b3318],
26	.	.	O	.	_	0	SENT_485	[p11l497t3290r665b3318],

1	Although	IN	O	although	mark	5	SENT_486	[p11l539t3335r697b3376],
2	the	DT	O	the	det	3	SENT_486	[p11l710t3335r762b3367],
3	P-glycoprotein	NN	O	p-glycoprotein	nsubjpass	5	SENT_486	[p11l775t3335r1022b3376],
4	is	VBZ	O	be	auxpass	5	SENT_486	[p11l1037t3335r1062b3367],
5	expressed	VBN	O	express	advcl	22	SENT_486	[p11l1077t3335r1241b3376],
6	in	IN	O	in	_	0	SENT_486	[p11l1255t3335r1286b3367],
7	many	JJ	O	many	amod	9	SENT_486	[p11l1301t3345r1391b3376],
8	cell	NN	O	cell	nn	9	SENT_486	[p11l1405t3335r1466b3367],
9	lines	NNS	O	line	prep_in	5	SENT_486	[p11l1480t3335r1557b3368],
10	and	CC	O	and	_	0	SENT_486	[p11l1573t3335r1632b3367],
11	occurs	VBZ	O	occur	advcl	22	SENT_486	[p11l1646t3344r1753b3367],
12	in	IN	O	in	_	0	SENT_486	[p11l1769t3336r1800b3367],
13	patient	NN	O	patient	nn	14	SENT_486	[p11l496t3386r612b3428],
14	tumors	NNS	O	tumor	prep_in	11	SENT_486	[p11l620t3392r745b3424],
15	,	,	O	,	_	0	SENT_486	[p11l620t3392r745b3424],
16	its	PRP$	O	its	poss	17	SENT_486	[p11l756t3386r794b3418],
17	expression	NN	O	expression	nsubj	22	SENT_486	[p11l805t3386r982b3428],
18	is	VBZ	O	be	cop	22	SENT_486	[p11l992t3386r1019b3418],
19	not	RB	O	not	neg	22	SENT_486	[p11l1029t3392r1082b3419],
20	a	DT	O	a	det	22	SENT_486	[p11l1093t3396r1111b3419],
21	universal	JJ	O	universal	amod	22	SENT_486	[p11l1120t3386r1271b3418],
22	feature	NN	O	feature	_	0	SENT_486	[p11l1283t3386r1396b3419],
23	of	IN	O	of	_	0	SENT_486	[p11l1407t3385r1444b3418],
24	mullidrug	JJ	O	mullidrug	amod	25	SENT_486	[p11l1451t3386r1615b3427],
25	resistance	NN	O	resistance	prep_of	22	SENT_486	[p11l1625t3386r1799b3424],
26	,	,	O	,	_	0	SENT_486	[p11l1625t3386r1799b3424],
27	suggesting	VBG	O	suggest	partmod	22	SENT_486	[p11l498t3439r675b3479],
28	that	IN	O	that	complm	32	SENT_486	[p11l688t3439r750b3469],
29	other	JJ	O	other	amod	30	SENT_486	[p11l762t3438r848b3470],
30	mechanisms	NNS	O	mechanism	nsubj	32	SENT_486	[p11l859t3438r1064b3470],
31	are	VBP	O	be	aux	32	SENT_486	[p11l1078t3448r1127b3470],
32	operating	VBG	O	operate	ccomp	27	SENT_486	[p11l1140t3438r1306b3479],
33	.	.	O	.	_	0	SENT_486	[p11l1140t3438r1306b3479],

1	The	DT	O	the	det	3	SENT_487	[p11l1319t3439r1383b3470],
2	clinical	JJ	O	clinical	amod	3	SENT_487	[p11l1395t3438r1517b3470],
3	relevance	NN	O	relevance	nsubj	9	SENT_487	[p11l1531t3439r1689b3470],
4	of	IN	O	of	_	0	SENT_487	[p11l1703t3438r1740b3470],
5	the	DT	O	the	det	6	SENT_487	[p11l1749t3439r1800b3471],
6	At-MDR	NN	O	at-mdr	prep_of	3	SENT_487	[p11l497t3488r649b3520],
7	and	CC	O	and	_	0	SENT_487	[p11l663t3488r723b3520],
8	MRP	NN	ORGANIZATION	mrp	prep_of	3	SENT_487	[p11l737t3488r827b3519],
9	needs	VBZ	O	need	_	0	SENT_487	[p11l841t3488r934b3520],
10	to	TO	O	to	aux	12	SENT_487	[p11l949t3493r982b3520],
11	be	VB	O	be	auxpass	12	SENT_487	[p11l995t3488r1036b3519],
12	clariﬁed	VBN	O	clariﬁed	xcomp	9	SENT_487	[p11l1050t3488r1197b3524],
13	,	,	O	,	_	0	SENT_487	[p11l1050t3488r1197b3524],
14	and	CC	O	and	_	0	SENT_487	[p11l1214t3488r1273b3519],
15	additional	JJ	O	additional	amod	16	SENT_487	[p11l1289t3488r1453b3520],
16	mechanisms	NNS	O	mechanism	nsubj	17	SENT_487	[p11l1469t3488r1674b3520],
17	sought	VBD	O	seek	conj_and	9	SENT_487	[p11l1691t3488r1802b3529],
18	out	RP	O	out	prt	17	SENT_487	[p11l497t3542r559b3569],
19	.	.	O	.	_	0	SENT_487	[p11l497t3542r559b3569],

1	Annu	NNP	PERSON	Annu	_	0	SENT_488	[p12l6t672r71b896],
2	.	.	O	.	_	0	SENT_488	[p12l6t672r71b896],

1	Rev.	NNP	O	Rev.	nn	2	SENT_489	[p12l7t476r71b642],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_489	[p12l6t31r71b446],
3	.	.	O	.	_	0	SENT_489	[p12l6t31r71b446],

1	by	IN	O	by	_	0	SENT_490	[p12l99t428r184b519],
2	University	NNP	O	University	pobj	1	SENT_490	[p12l99t12r184b402],

1	Literature	NNP	O	Literature	nsubj	2	SENT_491	[p12l398t166r871b256],
2	Cited	VBD	O	cite	_	0	SENT_491	[p12l912t164r1164b256],

1	Kessel	NN	PERSON	kessel	nn	2	SENT_492	[p12l664t421r902b491],
2	D	NN	O	d	_	0	SENT_492	[p12l926t424r1011b502],
3	,	,	O	,	_	0	SENT_492	[p12l926t424r1011b502],
4	Botterill	NNP	PERSON	Botterill	nn	8	SENT_492	[p12l1035t421r1340b491],
5	V	NNP	PERSON	V	nn	8	SENT_492	[p12l1365t424r1449b502],
6	,	,	O	,	_	0	SENT_492	[p12l1365t424r1449b502],
7	Wodinsky	NNP	O	Wodinsky	appos	8	SENT_492	[p12l1471t421r1849b508],
8	I.	NNP	O	I.	appos	2	SENT_492	[p12l1871t421r1919b488],
9	1968	CD	DATE	1968	num	8	SENT_492	[p12l1952t421r2142b494],
10	.	.	O	.	_	0	SENT_492	[p12l1952t421r2142b494],

1	Uptake	NN	O	uptake	_	0	SENT_493	[p12l661t516r927b606],
2	and	CC	O	and	_	0	SENT_493	[p12l954t516r1086b583],
3	retention	NN	O	retention	conj_and	1	SENT_493	[p12l1113t516r1444b583],
4	of	IN	O	of	_	0	SENT_493	[p12l1471t513r1553b583],
5	daunomycin	NN	O	daunomycin	prep_of	1	SENT_493	[p12l1572t516r2028b603],
6	by	IN	O	by	_	0	SENT_493	[p12l2055t516r2148b603],
7	mouse	NN	O	mouse	nn	9	SENT_493	[p12l661t630r899b678],
8	leukemic	JJ	O	leukemic	amod	9	SENT_493	[p12l929t608r1268b678],
9	cells	NNS	O	cell	prep_by	1	SENT_493	[p12l1298t611r1466b678],
10	as	IN	O	as	_	0	SENT_493	[p12l1496t630r1569b678],
11	factors	NNS	O	factor	prep_as	1	SENT_493	[p12l1602t608r1852b678],
12	in	IN	O	in	_	0	SENT_493	[p12l1882t608r1949b676],
13	drug	NN	O	drug	nn	14	SENT_493	[p12l1982t611r2150b695],
14	response	NN	O	response	prep_in	11	SENT_493	[p12l661t722r1002b790],
15	.	.	O	.	_	0	SENT_493	[p12l661t722r1002b790],

1	Cancer	NN	O	cancer	_	0	SENT_494	[p12l1046t703r1321b770],
2	Res	NNP	O	Res	dep	1	SENT_494	[p12l1348t703r1497b771],
3	.	.	O	.	_	0	SENT_494	[p12l1348t703r1497b771],

1	28:938	CD	NUMBER	28:938	num	2	SENT_495	[p12l1541t700r1927b771],
2	-41	CD	NUMBER	-41	_	0	SENT_495	[p12l1541t700r1927b771],
3	Biedler	NNP	O	Biedler	nn	4	SENT_495	[p12l658t795r932b863],
4	JL	NNP	O	JL	dep	2	SENT_495	[p12l982t795r1094b871],
5	.	.	O	.	_	0	SENT_495	[p12l982t795r1094b871],

1	Riehm	NNP	PERSON	Riehm	nn	2	SENT_496	[p12l1153t792r1396b863],
2	H.	NNP	O	H.	_	0	SENT_496	[p12l1449t795r1533b860],
3	1970	CD	DATE	1970	dep	2	SENT_496	[p12l1600t792r1793b863],
4	.	.	O	.	_	0	SENT_496	[p12l1600t792r1793b863],

1	Cellular	JJ	O	cellular	amod	2	SENT_497	[p12l1848t792r2148b863],
2	resistance	NN	O	resistance	_	0	SENT_497	[p12l658t887r1025b955],
3	to	TO	O	to	_	0	SENT_497	[p12l1058t899r1128b952],
4	actinomycin	NN	O	actinomycin	nn	5	SENT_497	[p12l1161t885r1617b974],
5	D	NN	O	d	prep_to	2	SENT_497	[p12l1650t887r1715b952],
6	in	IN	O	in	_	0	SENT_497	[p12l1750t885r1821b952],
7	Chinese	JJ	MISC	chinese	amod	9	SENT_497	[p12l1851t885r2145b955],
8	hamster	NN	O	hamster	nn	9	SENT_497	[p12l658t980r952b1047],
9	cells	NNS	O	cell	prep_in	5	SENT_497	[p12l991t977r1159b1047],
10	in	FW	O	in	nn	11	SENT_497	[p12l1195t977r1268b1044],
11	vitro	FW	O	vitro	dep	9	SENT_497	[p12l1306t977r1497b1047],
12	:	:	O	:	_	0	SENT_497	[p12l1306t977r1497b1047],
13	cross-resistance	NN	O	cross-resistance	dep	2	SENT_497	[p12l1541t977r2145b1058],
14	,	,	O	,	_	0	SENT_497	[p12l1541t977r2145b1058],
15	radioautographic	JJ	O	radioautographic	dep	2	SENT_497	[p12l661t1072r1307b1162],
16	,	,	O	,	_	0	SENT_497	[p12l661t1072r1307b1162],
17	and	CC	O	and	_	0	SENT_497	[p12l1345t1075r1477b1145],
18	cytogenetic	JJ	O	cytogenetic	amod	19	SENT_497	[p12l1505t1072r1933b1165],
19	studies	NNS	O	study	conj_and	13	SENT_497	[p12l1968t1075r2148b1145, p12l661t1167r782b1237],
20	.	.	O	.	_	0	SENT_497	[p12l1968t1075r2148b1145, p12l661t1167r782b1237],

1	Cancer	NN	O	cancer	_	0	SENT_498	[p12l823t1167r1097b1234],
2	Res	NNP	O	Res	dep	1	SENT_498	[p12l1127t1164r1279b1232],
3	.	.	O	.	_	0	SENT_498	[p12l1127t1164r1279b1232],

1	30	CD	NUMBER	30	_	0	SENT_499	[p12l1326t1167r1765b1237],
2	:	:	O	:	_	0	SENT_499	[p12l1326t1167r1765b1237],
3	l174	CD	NUMBER	l174	num	4	SENT_499	[p12l1326t1167r1765b1237],
4	—	CD	NUMBER	—	dep	1	SENT_499	[p12l1326t1167r1765b1237],
5	84	CD	NUMBER	84	num	7	SENT_499	[p12l1326t1167r1765b1237],
6	Bech-Hansen	NN	O	bech-hansen	nn	7	SENT_499	[p12l661t1262r1161b1329],
7	N	NN	O	n	dep	4	SENT_499	[p12l1192t1259r1279b1338],
8	,	,	O	,	_	0	SENT_499	[p12l1192t1259r1279b1338],
9	T1llJE	NN	O	t1llje	appos	7	SENT_499	[p12l1309t1259r1586b1341],
10	,	,	O	,	_	0	SENT_499	[p12l1309t1259r1586b1341],
11	Ling	NNP	O	Ling	nn	12	SENT_499	[p12l1619t1259r1793b1346],
12	V.	NNP	O	V.	appos	7	SENT_499	[p12l1826t1259r1907b1327],
13	1976	CD	DATE	1976	dep	12	SENT_499	[p12l1954t1259r2145b1332],
14	.	.	O	.	_	0	SENT_499	[p12l1954t1259r2145b1332],

1	Pleiotro	NNP	O	Pleiotro	_	0	SENT_500	[p12l664t1355r955b1425],
2	‘	CD	NUMBER	‘	num	4	SENT_500	[p12l1005t1355r1069b1425],
3	c	NN	O	c	nn	4	SENT_500	[p12l1005t1355r1069b1425],
4	phenotype	NN	O	phenotype	dep	1	SENT_500	[p12l1105t1355r1488b1444],
5	of	IN	O	of	_	0	SENT_500	[p12l1524t1355r1606b1425],
6	colchicineresistant	JJ	O	colchicineresistant	amod	8	SENT_500	[p12l1636t1352r2148b1425, p12l661t1444r896b1514],
7	HO	NN	O	ho	nn	8	SENT_500	[p12l993t1444r1125b1514],
8	cells	NNS	O	cell	prep_of	4	SENT_500	[p12l1164t1444r1354b1517],
9	:	:	O	:	_	0	SENT_500	[p12l1164t1444r1354b1517],
10	cross-resistance	NN	O	cross-resistance	dep	1	SENT_500	[p12l1396t1444r1980b1514],
11	and	CC	O	and	_	0	SENT_500	[p12l2016t1447r2150b1514],
12	collateral	NN	O	collateral	nn	13	SENT_500	[p12l661t1540r1002b1610],
13	sensitivity	NN	O	sensitivity	conj_and	10	SENT_500	[p12l1058t1537r1455b1629],
14	.	.	O	.	_	0	SENT_500	[p12l1058t1537r1455b1629],

1	J.	NNP	O	J.	nn	2	SENT_501	[p12l1505t1542r1564b1610],
2	Cell	NNP	O	Cell	_	0	SENT_501	[p12l1628t1540r1793b1610],
3	.	.	O	.	_	0	SENT_501	[p12l1628t1540r1793b1610],

1	Physiol	NNP	O	Physiol	_	0	SENT_502	[p12l1851t1540r2139b1626],
2	.	.	O	.	_	0	SENT_502	[p12l1851t1540r2139b1626],

1	88:23	CD	NUMBER	88:23	num	4	SENT_503	[p12l664t1629r999b1699],
2	-31	CD	NUMBER	-31	num	4	SENT_503	[p12l664t1629r999b1699],
3	Ling	NNP	O	Ling	nn	4	SENT_503	[p12l661t1725r835b1814],
4	V	NNP	O	V	_	0	SENT_503	[p12l882t1728r966b1806],
5	,	,	O	,	_	0	SENT_503	[p12l882t1728r966b1806],
6	Thompson	NNP	PERSON	Thompson	nn	7	SENT_503	[p12l1013t1725r1410b1811],
7	L.	NNP	O	L.	appos	4	SENT_503	[p12l1454t1728r1527b1795],
8	1973	CD	DATE	1973	dep	7	SENT_503	[p12l1586t1725r1779b1795],
9	.	.	O	.	_	0	SENT_503	[p12l1586t1725r1779b1795],

1	Reduced	VBN	O	reduce	amod	2	SENT_504	[p12l1829t1725r2153b1795],
2	permeability	NN	O	permeability	_	0	SENT_504	[p12l664t1814r1131b1906],
3	in	IN	O	in	_	0	SENT_504	[p12l1167t1814r1234b1884],
4	CHO	NN	O	cho	nn	5	SENT_504	[p12l1267t1814r1460b1887],
5	cells	NNS	O	cell	prep_in	2	SENT_504	[p12l1496t1817r1664b1884],
6	as	IN	O	as	_	0	SENT_504	[p12l1700t1836r1773b1884],
7	a	DT	O	a	det	8	SENT_504	[p12l1809t1836r1849b1884],
8	mechanism	NN	O	mechanism	prep_as	5	SENT_504	[p12l1882t1817r2148b1887, p12l664t1912r840b1979],
9	of	IN	O	of	_	0	SENT_504	[p12l868t1912r949b1979],
10	resistance	NN	O	resistance	prep_of	8	SENT_504	[p12l971t1912r1332b1979],
11	to	TO	O	to	_	0	SENT_504	[p12l1359t1926r1432b1979],
12	colchicine	NN	O	colchicine	prep_to	10	SENT_504	[p12l1457t1912r1854b1979],
13	.	.	O	.	_	0	SENT_504	[p12l1457t1912r1854b1979],

1	J.	NNP	O	J.	nn	2	SENT_505	[p12l1885t1909r1941b1976],
2	Cell	NNP	O	Cell	_	0	SENT_505	[p12l1980t1909r2142b1976],
3	.	.	O	.	_	0	SENT_505	[p12l1980t1909r2142b1976],

1	Physiol	NNP	O	Physiol	_	0	SENT_506	[p12l661t2002r949b2089],
2	.	.	O	.	_	0	SENT_506	[p12l661t2002r949b2089],

1	83:103	CD	NUMBER	83:103	_	0	SENT_507	[p12l999t2002r1393b2072],
2	--	:	O	--	_	0	SENT_507	[p12l999t2002r1393b2072],
3	16	CD	NUMBER	16	dep	1	SENT_507	[p12l999t2002r1393b2072],
4	Juliano	NNP	ORGANIZATION	Juliano	nn	8	SENT_507	[p12l661t2095r927b2165],
5	RL	NNP	ORGANIZATION	RL	nn	8	SENT_507	[p12l977t2098r1111b2174],
6	,	,	O	,	_	0	SENT_507	[p12l977t2098r1111b2174],
7	Ling	NNP	PERSON	Ling	appos	8	SENT_507	[p12l1164t2095r1337b2182],
8	V.	NNP	O	V.	dep	3	SENT_507	[p12l1384t2098r1463b2165],
9	1976	CD	DATE	1976	num	8	SENT_507	[p12l1527t2095r1720b2165],
10	.	.	O	.	_	0	SENT_507	[p12l1527t2095r1720b2165],

1	A	DT	O	a	det	3	SENT_508	[p12l1770t2098r1835b2163],
2	surface	NN	O	surface	nn	3	SENT_508	[p12l1887t2095r2148b2165],
3	glycoprotein	NN	O	glycoprotein	_	0	SENT_508	[p12l206t2454r809b2570],
4	modulating	VBG	O	modulate	partmod	3	SENT_508	[p12l885t2454r1430b2570],
5	dmg	NN	O	dmg	nn	6	SENT_508	[p12l1510t2454r1732b2567],
6	permeability	NN	O	permeability	dobj	4	SENT_508	[p12l1804t2479r2142b2567, p12l206t2574r508b2690],
7	in	IN	O	in	_	0	SENT_508	[p12l576t2574r667b2665],
8	Chinese	JJ	MISC	chinese	amod	12	SENT_508	[p12l732t2574r1118b2665],
9	hamster	NN	O	hamster	nn	12	SENT_508	[p12l1186t2577r1568b2665],
10	ovary	NN	O	ovary	nn	12	SENT_508	[p12l1633t2599r1903b2690],
11	cell	NN	O	cell	nn	12	SENT_508	[p12l1971t2577r2142b2665],
12	mutants	NNS	O	mutant	prep_in	6	SENT_508	[p12l209t2707r609b2784],
13	.	.	O	.	_	0	SENT_508	[p12l209t2707r609b2784],

1	Biochim	NNP	O	Biochim	_	0	SENT_509	[p12l674t2693r1096b2784],
2	.	.	O	.	_	0	SENT_509	[p12l674t2693r1096b2784],

1	Biophys	NNS	O	biophy	_	0	SENT_510	[p12l1168t2696r1576b2806],
2	.	.	O	.	_	0	SENT_510	[p12l1168t2696r1576b2806],

1	Acta	NN	PERSON	acta	_	0	SENT_511	[p12l1644t2696r1870b2784],
2	455	CD	NUMBER	455	num	1	SENT_511	[p12l1927t2696r2139b2788],
3	:	:	O	:	_	0	SENT_511	[p12l1927t2696r2139b2788],
4	152-62	CD	NUMBER	152-62	dep	1	SENT_511	[p12l220t2813r558b2904],

1	6	CD	NUMBER	6	_	0	SENT_512	[p12l6t2933r86b3021],
2	.	.	O	.	_	0	SENT_512	[p12l6t2933r86b3021],

1	Kartner	NNP	PERSON	Kartner	nn	2	SENT_513	[p12l206t2933r569b3024],
2	N	NNP	O	N	_	0	SENT_513	[p12l620t2936r733b3035],
3	,	,	O	,	_	0	SENT_513	[p12l620t2936r733b3035],
4	Riordan	NNP	PERSON	Riordan	nn	5	SENT_513	[p12l787t2933r1172b3024],
5	JR.	NNP	O	JR.	appos	2	SENT_513	[p12l1223t2936r1376b3035],
6	.	.	O	.	_	0	SENT_513	[p12l1223t2936r1376b3035],

1	Ling	NNP	O	Ling	nn	2	SENT_514	[p12l1430t2933r1659b3046],
2	V.	NNP	O	V.	_	0	SENT_514	[p12l1706t2936r1815b3021],
3	1983	CD	DATE	1983	dep	2	SENT_514	[p12l1888t2933r2139b3024],
4	.	.	O	.	_	0	SENT_514	[p12l1888t2933r2139b3024],

1	Cell	NN	O	cell	nn	3	SENT_515	[p12l206t3054r402b3145],
2	surface	NN	O	surface	nn	3	SENT_515	[p12l463t3057r809b3141],
3	P-glycoprotein	NN	MISC	p-glycoprotein	nsubj	4	SENT_515	[p12l870t3054r1587b3170],
4	associated	VBN	O	associate	_	0	SENT_515	[p12l1648t3054r2146b3145],
5	with	IN	O	with	_	0	SENT_515	[p12l206t3174r417b3265],
6	multidrug	JJ	O	multidrug	amod	7	SENT_515	[p12l445t3174r918b3286],
7	resistance	NN	O	resistance	prep_with	4	SENT_515	[p12l947t3170r1423b3265],
8	in	IN	O	in	_	0	SENT_515	[p12l1452t3174r1547b3261],
9	mammalian	JJ	O	mammalian	amod	11	SENT_515	[p12l1579t3174r2146b3265],
10	cell	NN	O	cell	nn	11	SENT_515	[p12l206t3292r380b3383],
11	lines	NNS	O	line	prep_in	7	SENT_515	[p12l424t3292r675b3380],
12	.	.	O	.	_	0	SENT_515	[p12l424t3292r675b3380],

1	Science	NNP	O	Science	_	0	SENT_516	[p12l729t3289r1096b3380],
2	221	CD	NUMBER	221	num	1	SENT_516	[p12l1143t3292r1310b3383],
3	:	:	O	:	_	0	SENT_516	[p12l1332t3318r1350b3380],
4	1235-88	CD	NUMBER	1235-88	dep	1	SENT_516	[p12l1372t3289r1775b3383],

1	7	CD	NUMBER	7	_	0	SENT_517	[p13l6t23r90b111],
2	.	.	O	.	_	0	SENT_517	[p13l6t23r90b111],

1	Ling	NNP	O	Ling	nn	2	SENT_518	[p13l206t23r431b140],
2	V.	NNP	O	V.	_	0	SENT_518	[p13l496t23r606b111],
3	1982	CD	DATE	1982	dep	2	SENT_518	[p13l689t23r944b115],
4	.	.	O	.	_	0	SENT_518	[p13l689t23r944b115],

1	Genetic	JJ	O	genetic	amod	2	SENT_519	[p13l1016t23r1390b115],
2	basis	NN	O	basis	_	0	SENT_519	[p13l1455t20r1696b111],
3	of	IN	O	of	_	0	SENT_519	[p13l1764t20r1874b111],
4	drug	NN	O	drug	nn	5	SENT_519	[p13l1928t23r2150b140],
5	resistance	NN	O	resistance	prep_of	2	SENT_519	[p13l209t143r682b235],
6	in	IN	O	in	_	0	SENT_519	[p13l721t143r813b231],
7	mammalian	JJ	O	mammalian	amod	8	SENT_519	[p13l856t143r1427b235],
8	cells	NNS	O	cell	prep_in	2	SENT_519	[p13l1463t143r1710b235],
9	.	.	O	.	_	0	SENT_519	[p13l1463t143r1710b235],

1	In	IN	O	in	_	0	SENT_520	[p13l1753t143r1852b231],
2	Drug	NN	O	drug	nn	5	SENT_520	[p13l1891t140r2153b256],
3	and	CC	O	and	_	0	SENT_520	[p13l209t263r395b355],
4	Hormone	NN	O	hormone	nn	5	SENT_520	[p13l431t263r885b355],
5	Resistance	NN	O	resistance	prep_in	9	SENT_520	[p13l932t263r1445b355],
6	in	IN	O	in	_	0	SENT_520	[p13l1495t267r1583b355],
7	Neoplasia	NN	LOCATION	neoplasium	prep_in	5	SENT_520	[p13l1626t260r2146b376],
8	,	,	O	,	_	0	SENT_520	[p13l1626t260r2146b376],
9	ed	VBN	O	ed	_	0	SENT_520	[p13l206t387r344b475],
10	.	.	O	.	_	0	SENT_520	[p13l206t387r344b475],

1	N	NN	O	n	nn	2	SENT_521	[p13l373t387r457b475],
2	Bruchosky	NNP	O	Bruchosky	_	0	SENT_521	[p13l482t384r1027b500],
3	,	,	O	,	_	0	SENT_521	[p13l482t384r1027b500],
4	J	NNP	O	J	nn	5	SENT_521	[p13l1056t384r1103b475],
5	Goldie	NNP	O	Goldie	appos	2	SENT_521	[p13l1128t384r1481b489],
6	,	,	O	,	_	0	SENT_521	[p13l1128t384r1481b489],
7	1	CD	NUMBER	1	num	9	SENT_521	[p13l1521t387r1594b475],
8	:	:	O	:	_	0	SENT_521	[p13l1521t387r1594b475],
9	1-19	CD	NUMBER	1-19	appos	5	SENT_521	[p13l1619t384r1870b475],
10	.	.	O	.	_	0	SENT_521	[p13l1619t384r1870b475],

1	Bow	NN	O	bow	_	0	SENT_522	[p13l1898t384r2146b475],
2	Raton	NNP	O	Raton	dep	1	SENT_522	[p13l209t503r518b608],
3	.	.	O	.	_	0	SENT_522	[p13l209t503r518b608],

1	FL	NN	O	fl	_	0	SENT_523	[p13l569t503r733b590],
2	:	:	O	:	_	0	SENT_523	[p13l569t503r733b590],
3	CRC	NN	ORGANIZATION	crc	nn	4	SENT_523	[p13l787t503r1027b590],
4	Press	NNP	ORGANIZATION	Press	dep	1	SENT_523	[p13l1077t503r1329b594],

1	8	CD	NUMBER	8	_	0	SENT_524	[p13l9t626r86b717],
2	.	.	O	.	_	0	SENT_524	[p13l9t626r86b717],

1	Beck	NNP	PERSON	Beck	nn	2	SENT_525	[p13l209t626r453b717],
2	WT	NNP	O	WT	_	0	SENT_525	[p13l511t629r722b731],
3	,	,	O	,	_	0	SENT_525	[p13l511t629r722b731],
4	Danks	NNP	PERSON	Danks	nn	5	SENT_525	[p13l790t626r1092b717],
5	MK	NNP	O	MK	appos	2	SENT_525	[p13l1154t629r1369b717],
6	.	.	O	.	_	0	SENT_525	[p13l1154t629r1369b717],

1	1991	CD	DATE	1991	_	0	SENT_526	[p13l1448t626r1699b720],
2	.	.	O	.	_	0	SENT_526	[p13l1448t626r1699b720],

1	Characteristics	NNS	O	characteristic	_	0	SENT_527	[p13l1764t626r2146b720, p13l209t748r580b840],
2	of	IN	O	of	_	0	SENT_527	[p13l631t748r740b840],
3	multidrug	JJ	O	multidrug	amod	4	SENT_527	[p13l787t748r1260b865],
4	resistance	NN	O	resistance	prep_of	1	SENT_527	[p13l1314t748r1790b840],
5	in	IN	O	in	_	0	SENT_527	[p13l1844t745r1939b836],
6	human	JJ	O	human	amod	8	SENT_527	[p13l1989t748r2146b840, p13l209t894r409b960],
7	tumor	NN	O	tumor	nn	8	SENT_527	[p13l453t883r740b956],
8	cells	NNS	O	cell	prep_in	1	SENT_527	[p13l772t868r1016b956],
9	.	.	O	.	_	0	SENT_527	[p13l772t868r1016b956],

1	See	VB	O	see	_	0	SENT_528	[p13l1063t865r1234b960],
2	Ref	NNP	O	Ref	dobj	1	SENT_528	[p13l1274t868r1470b956],
3	.	.	O	.	_	0	SENT_528	[p13l1274t868r1470b956],

1	127	CD	NUMBER	127	_	0	SENT_529	[p13l1524t868r1721b970],
2	,	,	O	,	_	0	SENT_529	[p13l1524t868r1721b970],
3	pp	NN	O	pp	nn	4	SENT_529	[p13l1760t865r2150b981],
4	.3	NN	NUMBER	.3	appos	1	SENT_529	[p13l1760t865r2150b981],
5	—	CD	NUMBER	—	number	6	SENT_529	[p13l1760t865r2150b981],
6	55	CD	NUMBER	55	num	7	SENT_529	[p13l1760t865r2150b981],
7	9	CD	NUMBER	9	dep	4	SENT_529	[p13l9t991r90b1079],
8	.	.	O	.	_	0	SENT_529	[p13l9t991r90b1079],

1	Bellamy	NNP	PERSON	Bellamy	nn	2	SENT_530	[p13l209t991r617b1101],
2	WT	NNP	O	WT	_	0	SENT_530	[p13l671t991r882b1094],
3	,	,	O	,	_	0	SENT_530	[p13l671t991r882b1094],
4	Dalton	NNP	PERSON	Dalton	nn	5	SENT_530	[p13l943t991r1263b1079],
5	WS	NNP	O	WS	appos	2	SENT_530	[p13l1321t991r1525b1079],
6	.	.	O	.	_	0	SENT_530	[p13l1321t991r1525b1079],

1	1994	CD	DATE	1994	_	0	SENT_531	[p13l1597t988r1848b1079],
2	.	.	O	.	_	0	SENT_531	[p13l1597t988r1848b1079],

1	Multidrug	JJ	O	multidrug	amod	2	SENT_532	[p13l1909t991r2146b1079, p13l206t1108r486b1221],
2	resistance	NN	O	resistance	_	0	SENT_532	[p13l547t1108r1020b1196],
3	in	IN	O	in	_	0	SENT_532	[p13l1077t1108r1169b1199],
4	the	DT	O	the	det	5	SENT_532	[p13l1223t1111r1372b1199],
5	laboratory	NN	O	laboratory	prep_in	2	SENT_532	[p13l1426t1108r1917b1221],
6	and	CC	O	and	_	0	SENT_532	[p13l1975t1111r2150b1199],
7	clinic	NN	O	clinic	prep_in	2	SENT_532	[p13l206t1227r497b1318],
8	.	.	O	.	_	0	SENT_532	[p13l206t1227r497b1318],

1	Adv	NNP	O	Adv	_	0	SENT_533	[p13l540t1224r755b1315],
2	.	.	O	.	_	0	SENT_533	[p13l540t1224r755b1315],

1	Clin	NNP	O	Clin	_	0	SENT_534	[p13l819t1224r1038b1315],
2	.	.	O	.	_	0	SENT_534	[p13l819t1224r1038b1315],

1	Chem	NNP	O	Chem	_	0	SENT_535	[p13l1099t1227r1398b1318],
2	.	.	O	.	_	0	SENT_535	[p13l1099t1227r1398b1318],

1	31:1	CD	NUMBER	31:1	num	2	SENT_536	[p13l1455t1224r1837b1318],
2	-61	CD	NUMBER	-61	_	0	SENT_536	[p13l1455t1224r1837b1318],

1	’	NN	O	’	nn	2	SENT_537	[p13l64t1531r133b1663],
2	A	NN	O	a	_	0	SENT_537	[p13l64t1531r133b1663],
3	Annual	JJ	SET	annual	amod	4	SENT_537	[p13l257t1535r595b1616],
4	Reviews	NNS	O	review	dep	2	SENT_537	[p13l627t1535r1022b1640],
5	.	.	O	.	_	0	SENT_537	[p13l1670t1627r1682b1640],

1	ii	LS	O	ii	dep	2	SENT_538	[p13l64t1623r190b1768],
2	www.annualreviews.org/aronline	NN	O	www.annualreviews.org/aronline	_	0	SENT_538	[p13l258t1627r1801b1733],

1	178	CD	NUMBER	178	num	2	SENT_539	[p13l396t1916r540b1995],
2	BELLAMY	NN	O	bellamy	_	0	SENT_539	[p13l736t1916r1242b1995],

1	10	CD	NUMBER	10	_	0	SENT_540	[p13l452t2161r554b2229],
2	.	.	O	.	_	0	SENT_540	[p13l452t2161r554b2229],

1	Nielsen	NNP	PERSON	Nielsen	nn	2	SENT_541	[p13l644t2161r930b2229],
2	D	NNP	PERSON	D	_	0	SENT_541	[p13l965t2161r1047b2237],
3	,	,	O	,	_	0	SENT_541	[p13l965t2161r1047b2237],
4	Skovsgaard	NNP	O	Skovsgaard	nn	5	SENT_541	[p13l1087t2158r1518b2243],
5	T.	NNP	O	T.	appos	2	SENT_541	[p13l1547t2158r1624b2226],
6	1992	CD	DATE	1992	dep	5	SENT_541	[p13l1670t2158r1860b2226],
7	.	.	O	.	_	0	SENT_541	[p13l1670t2158r1860b2226],

1	Pglycoprotein	NN	PERSON	pglycoprotein	_	0	SENT_542	[p13l1898t2158r2128b2243, p13l644t2250r994b2338],
2	as	IN	O	as	_	0	SENT_542	[p13l1051t2270r1128b2318],
3	multidrug	JJ	O	multidrug	amod	4	SENT_542	[p13l1187t2250r1548b2335],
4	transporter	NN	O	transporter	prep_as	1	SENT_542	[p13l1608t2258r2025b2335],
5	:	:	O	:	_	0	SENT_542	[p13l1608t2258r2025b2335],
6	a	DT	O	a	det	8	SENT_542	[p13l2090t2270r2131b2316],
7	critical	JJ	O	critical	amod	8	SENT_542	[p13l644t2344r902b2412],
8	review	NN	O	review	dep	1	SENT_542	[p13l937t2344r1186b2412],
9	of	IN	O	of	_	0	SENT_542	[p13l1224t2344r1306b2412],
10	current	JJ	DATE	current	amod	14	SENT_542	[p13l1335t2355r1599b2409],
11	multidmg	JJ	O	multidmg	amod	14	SENT_542	[p13l1633t2344r1994b2426],
12	resistant	JJ	O	resistant	amod	14	SENT_542	[p13l2026t2363r2128b2409, p13l647t2452r882b2520],
13	cell	NN	O	cell	nn	14	SENT_542	[p13l900t2449r1030b2517],
14	lines	NNS	O	line	prep_of	8	SENT_542	[p13l1054t2449r1247b2517],
15	.	.	O	.	_	0	SENT_542	[p13l1054t2449r1247b2517],

1	Biochim	NNP	O	Biochim	_	0	SENT_543	[p13l1271t2446r1593b2514],
2	.	.	O	.	_	0	SENT_543	[p13l1271t2446r1593b2514],

1	Biophys	NNS	O	biophy	_	0	SENT_544	[p13l1622t2449r1930b2534],
2	.	.	O	.	_	0	SENT_544	[p13l1622t2449r1930b2534],

1	Acta	NNP	PERSON	Acta	_	0	SENT_545	[p13l1954t2446r2128b2512],
2	l139	CD	NUMBER	l139	num	1	SENT_545	[p13l655t2553r1130b2621],
3	:	:	O	:	_	0	SENT_545	[p13l655t2553r1130b2621],
4	l69	CD	NUMBER	l69	dep	1	SENT_545	[p13l655t2553r1130b2621],
5	—	CD	NUMBER	—	number	6	SENT_545	[p13l655t2553r1130b2621],
6	83	CD	NUMBER	83	dep	4	SENT_545	[p13l655t2553r1130b2621],

1	ll	NN	O	ll	_	0	SENT_546	[p13l455t2661r556b2726],
2	.	.	O	.	_	0	SENT_546	[p13l455t2661r556b2726],

1	Gerlach	NNP	PERSON	Gerlach	nn	2	SENT_547	[p13l650t2658r941b2729],
2	JH	NNP	O	JH	_	0	SENT_547	[p13l978t2661r1100b2737],
3	,	,	O	,	_	0	SENT_547	[p13l978t2661r1100b2737],
4	Kartner	NNP	PERSON	Kartner	nn	5	SENT_547	[p13l1143t2661r1423b2726],
5	N	NNP	O	N	appos	2	SENT_547	[p13l1458t2658r1546b2735],
6	,	,	O	,	_	0	SENT_547	[p13l1458t2658r1546b2735],
7	Bell	NNP	ORGANIZATION	Bell	nn	8	SENT_547	[p13l1586t2658r1735b2723],
8	DR	NN	O	dr	appos	2	SENT_547	[p13l1773t2658r1919b2735],
9	,	,	O	,	_	0	SENT_547	[p13l1773t2658r1919b2735],
10	Ling	NNP	O	Ling	nn	11	SENT_547	[p13l1959t2655r2134b2743],
11	V.	NNP	O	V.	appos	2	SENT_547	[p13l650t2766r732b2831],
12	1986	CD	DATE	1986	dep	11	SENT_547	[p13l786t2760r980b2831],
13	.	.	O	.	_	0	SENT_547	[p13l786t2760r980b2831],

1	Multidrug	JJ	O	multidrug	amod	2	SENT_548	[p13l1023t2763r1398b2848],
2	resistance	NN	O	resistance	_	0	SENT_548	[p13l1435t2760r1816b2831],
3	.	.	O	.	_	0	SENT_548	[p13l1435t2760r1816b2831],

1	Cancer	NNP	O	Cancer	nn	2	SENT_549	[p13l1865t2760r2136b2829],
2	Surv	NNP	O	Surv	_	0	SENT_549	[p13l647t2857r829b2925],
3	.	.	O	.	_	0	SENT_549	[p13l647t2857r829b2925],

1	5:25	CD	TIME	5:25	num	2	SENT_550	[p13l875t2854r1178b2922],
2	-46	CD	NUMBER	-46	_	0	SENT_550	[p13l875t2854r1178b2922],

1	12	CD	NUMBER	12	_	0	SENT_551	[p13l455t2948r556b3019],
2	.	.	O	.	_	0	SENT_551	[p13l455t2948r556b3019],

1	Endicott	NNP	O	Endicott	nn	2	SENT_552	[p13l647t2948r960b3019],
2	JA	NNP	O	JA	_	0	SENT_552	[p13l1006t2948r1130b3028],
3	,	,	O	,	_	0	SENT_552	[p13l1006t2948r1130b3028],
4	Ling	NNP	O	Ling	nn	5	SENT_552	[p13l1182t2948r1356b3036],
5	V.	NNP	O	V.	appos	2	SENT_552	[p13l1408t2948r1490b3016],
6	1989	CD	DATE	1989	dep	5	SENT_552	[p13l1552t2948r1741b3019],
7	.	.	O	.	_	0	SENT_552	[p13l1552t2948r1741b3019],

1	The	DT	O	the	det	2	SENT_553	[p13l1795t2948r1936b3016],
2	biochemistry	NN	O	biochemistry	_	0	SENT_553	[p13l1984t2945r2131b3016, p13l647t3053r1013b3143],
3	of	IN	O	of	_	0	SENT_553	[p13l1073t3053r1158b3124],
4	P-glycoprotein-mediated	JJ	O	p-glycoprotein-mediated	amod	6	SENT_553	[p13l1215t3050r2134b3143],
5	multidmg	JJ	O	multidmg	amod	6	SENT_553	[p13l650t3146r1016b3234],
6	resistance	NN	O	resistance	prep_of	2	SENT_553	[p13l1065t3146r1445b3217],
7	.	.	O	.	_	0	SENT_553	[p13l1065t3146r1445b3217],

1	Annu	NNP	PERSON	Annu	_	0	SENT_554	[p13l1494t3146r1707b3214],
2	.	.	O	.	_	0	SENT_554	[p13l1494t3146r1707b3214],

1	Rev.	NNP	O	Rev.	nn	2	SENT_555	[p13l1764t3149r1916b3214],
2	Biochem	NNP	PERSON	Biochem	_	0	SENT_555	[p13l1973t3146r2131b3212, p13l650t3243r860b3314],
3	.	.	O	.	_	0	SENT_555	[p13l1973t3146r2131b3212, p13l650t3243r860b3314],

1	58:13	CD	NUMBER	58:13	_	0	SENT_556	[p13l906t3243r1289b3314],
2	?	.	O	?	_	0	SENT_556	[p13l906t3243r1289b3314],

1	-71	CD	NUMBER	-71	_	0	SENT_557	[p13l906t3243r1289b3314],

1	13	CD	NUMBER	13	_	0	SENT_558	[p13l457t3350r559b3422],
2	.	.	O	.	_	0	SENT_558	[p13l457t3350r559b3422],

1	Gros	NNS	O	gro	nn	2	SENT_559	[p13l650t3350r827b3421],
2	P	NN	O	p	_	0	SENT_559	[p13l864t3350r938b3430],
3	,	,	O	,	_	0	SENT_559	[p13l864t3350r938b3430],
4	Ben	NNP	PERSON	Ben	nn	5	SENT_559	[p13l973t3350r1122b3419],
5	NY	NNP	PERSON	NY	appos	2	SENT_559	[p13l1154t3350r1306b3430],
6	,	,	O	,	_	0	SENT_559	[p13l1154t3350r1306b3430],
7	Croop	NNP	O	Croop	nn	8	SENT_559	[p13l1343t3348r1573b3434],
8	JM	NN	O	jm	appos	2	SENT_559	[p13l1608t3350r1743b3430],
9	,	,	O	,	_	0	SENT_559	[p13l1608t3350r1743b3430],
10	Housman	NNP	PERSON	Housman	nn	11	SENT_559	[p13l1781t3350r2136b3419],
11	DE	NN	O	de	appos	2	SENT_559	[p13l650t3455r790b3527],
12	.	.	O	.	_	0	SENT_559	[p13l650t3455r790b3527],

1	1986	CD	DATE	1986	_	0	SENT_560	[p13l848t3455r1041b3526],
2	.	.	O	.	_	0	SENT_560	[p13l848t3455r1041b3526],

1	Isolation	NN	O	isolation	_	0	SENT_561	[p13l1087t3458r1406b3524],
2	and	CC	O	and	_	0	SENT_561	[p13l1452t3447r1585b3524],
3	expression	NN	O	expression	conj_and	1	SENT_561	[p13l1625t3453r2019b3543],
4	of	IN	O	of	_	0	SENT_561	[p13l2060t3453r2139b3524],
5	ws	NNS	O	w	prep_of	1	SENT_561	[p13l27t3448r71b3546],
6	.	.	O	.	_	0	SENT_561	[p13l27t3275r90b3426],

1	org	NN	O	org	_	0	SENT_562	[p13l27t3275r90b3426],

1	Annu	NNP	PERSON	Annu	_	0	SENT_563	[p14l6t3057r71b3280],
2	.	.	O	.	_	0	SENT_563	[p14l6t3057r71b3280],

1	Rev.	NNP	O	Rev.	nn	2	SENT_564	[p14l7t2861r70b3027],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_564	[p14l6t2417r70b2831],
3	.	.	O	.	_	0	SENT_564	[p14l6t2417r70b2831],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_565	[p14l6t2082r70b2387],
2	.	.	O	.	_	0	SENT_565	[p14l6t2082r70b2387],

1	1996.36	CD	NUMBER	1996.36	_	0	SENT_566	[p14l6t1732r72b2043],
2	:	:	O	:	_	0	SENT_566	[p14l6t1732r72b2043],
3	161	CD	NUMBER	161	num	5	SENT_566	[p14l6t1559r71b1715],
4	-	:	O	-	_	0	SENT_566	[p14l6t1559r71b1715],
5	183	CD	NUMBER	183	dep	1	SENT_566	[p14l6t1397r71b1544],
6	.	.	O	.	_	0	SENT_566	[p14l6t1397r71b1544],

1	Downloaded	VBN	O	download	_	0	SENT_567	[p14l6t893r71b1367],
2	from	IN	O	from	_	0	SENT_567	[p14l6t690r70b868],
3	www	NN	O	www	prep_from	1	SENT_567	[p14l6t10r71b664],
4	.	.	O	.	_	0	SENT_567	[p14l6t10r71b664],

1	annualreVie	NN	O	annualrevie	_	0	SENT_568	[p14l6t10r71b664],
2	by	IN	O	by	_	0	SENT_568	[p14l99t2813r183b2904],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_568	[p14l98t2398r183b2787],
4	of	IN	ORGANIZATION	of	_	0	SENT_568	[p14l98t2291r164b2370],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	7	SENT_568	[p14l98t1881r164b2273],
6	—	NNP	O	—	nn	7	SENT_568	[p14l138t1830r144b1854],
7	Madison	NNP	O	Madison	prep_of	1	SENT_568	[p14l99t1478r164b1802],
8	on	IN	O	on	_	0	SENT_568	[p14l119t1361r164b1452],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_568	[p14l98t989r164b1335],
10	.	.	O	.	_	0	SENT_568	[p14l98t989r164b1335],

1	For	IN	O	for	_	0	SENT_569	[p14l101t831r164b959],
2	personal	JJ	O	personal	amod	3	SENT_569	[p14l99t495r183b808],
3	use	NN	O	use	pobj	1	SENT_569	[p14l119t348r164b470],
4	only	RB	O	only	advmod	3	SENT_569	[p14l99t141r183b321],
5	.	.	O	.	_	0	SENT_569	[p14l99t141r183b321],

1	a	DT	O	a	det	3	SENT_570	[p14l650t32r693b81],
2	complementary	JJ	O	complementary	amod	3	SENT_570	[p14l756t10r1328b100],
3	DNA	NN	O	dna	_	0	SENT_570	[p14l1396t10r1596b78],
4	that	WDT	O	that	nsubj	5	SENT_570	[p14l1661t10r1799b78],
5	confers	VBZ	O	confer	rcmod	3	SENT_570	[p14l1865t7r2133b75],
6	multidrug	JJ	O	multidrug	amod	7	SENT_570	[p14l650t102r1013b190],
7	resistance	NN	O	resistance	dobj	5	SENT_570	[p14l1056t102r1440b170],
8	.	.	O	.	_	0	SENT_570	[p14l1056t102r1440b170],

1	Nature	NNP	O	Nature	_	0	SENT_571	[p14l1486t105r1741b170],
2	3123:72831	CD	NUMBER	3123:72831	dep	1	SENT_571	[p14l1787t102r2139b170, p14l655t197r735b265],

1	Callen	NNP	PERSON	Callen	nn	2	SENT_572	[p14l652t289r893b360],
2	DF	NNP	O	DF	_	0	SENT_572	[p14l962t291r1097b368],
3	,	,	O	,	_	0	SENT_572	[p14l962t291r1097b368],
4	Baker	NNP	PERSON	Baker	nn	5	SENT_572	[p14l1168t291r1387b357],
5	E	NNP	O	E	appos	2	SENT_572	[p14l1452t289r1526b368],
6	,	,	O	,	_	0	SENT_572	[p14l1452t289r1526b368],
7	Simmers	NNP	ORGANIZATION	Simmers	nn	8	SENT_572	[p14l1597t289r1919b357],
8	RN	NNP	ORGANIZATION	RN	appos	2	SENT_572	[p14l1987t289r2134b368],
9	,	,	O	,	_	0	SENT_572	[p14l1987t289r2134b368],
10	Seshadri	NNP	PERSON	Seshadri	nn	11	SENT_572	[p14l653t381r969b452],
11	R	NNP	PERSON	R	appos	2	SENT_572	[p14l1006t383r1086b460],
12	,	,	O	,	_	0	SENT_572	[p14l1006t383r1086b460],
13	Roninson	NNP	O	Roninson	nn	14	SENT_572	[p14l1123t381r1473b449],
14	IB	NNP	O	IB	appos	2	SENT_572	[p14l1511t383r1618b449],
15	.	.	O	.	_	0	SENT_572	[p14l1511t383r1618b449],

1	1987	CD	DATE	1987	_	0	SENT_573	[p14l1667t381r1858b449],
2	.	.	O	.	_	0	SENT_573	[p14l1667t381r1858b449],

1	Localization	NN	O	localization	_	0	SENT_574	[p14l1895t381r2134b446, p14l652t473r905b541],
2	of	IN	O	of	_	0	SENT_574	[p14l939t473r1022b541],
3	the	DT	O	the	det	8	SENT_574	[p14l1051t473r1164b541],
4	human	JJ	O	human	amod	8	SENT_574	[p14l1201t475r1451b541],
5	multiple	JJ	O	multiple	amod	8	SENT_574	[p14l1488t473r1794b560],
6	drug	NN	O	drug	nn	8	SENT_574	[p14l1828t473r1997b558],
7	resistance	NN	O	resistance	nn	8	SENT_574	[p14l2032t492r2134b538, p14l652t570r944b638],
8	gene	NN	O	gene	prep_of	1	SENT_574	[p14l979t590r1172b655],
9	,	,	O	,	_	0	SENT_574	[p14l979t590r1172b655],
10	MDRI	NN	O	mdrus	appos	8	SENT_574	[p14l1210t567r1484b647],
11	,	,	O	,	_	0	SENT_574	[p14l1210t567r1484b647],
12	to	TO	O	to	_	0	SENT_574	[p14l1522t578r1593b636],
13	7q2l	CD	NUMBER	7q2l	prep_to	1	SENT_574	[p14l1628t570r1894b655],
14	.	.	O	.	_	0	SENT_574	[p14l1628t570r1894b655],

1	l.	NN	O	l.	_	0	SENT_575	[p14l1628t570r1894b655],
2	Hum	NNP	O	Hum	dep	1	SENT_575	[p14l1932t567r2128b633],
3	.	.	O	.	_	0	SENT_575	[p14l1932t567r2128b633],

1	Genet	NNP	PERSON	Genet	_	0	SENT_576	[p14l655t662r888b728],
2	.	.	O	.	_	0	SENT_576	[p14l655t662r888b728],

1	77	CD	NUMBER	77	_	0	SENT_577	[p14l931t662r1041b728],
2	:	:	O	:	_	0	SENT_577	[p14l931t662r1041b728],
3	142-44	CD	NUMBER	142-44	dep	1	SENT_577	[p14l1059t662r1328b728],

1	Chin	NNP	O	Chin	nn	2	SENT_578	[p14l655t751r832b822],
2	JE	NNP	O	JE	_	0	SENT_578	[p14l859t754r974b831],
3	,	,	O	,	_	0	SENT_578	[p14l859t754r974b831],
4	Sofﬁr	NNP	O	Sofﬁr	nn	5	SENT_578	[p14l1004t751r1220b820],
5	R	NNP	O	R	appos	2	SENT_578	[p14l1246t754r1325b833],
6	,	,	O	,	_	0	SENT_578	[p14l1246t754r1325b833],
7	Noonan	NNP	PERSON	Noonan	nn	8	SENT_578	[p14l1357t751r1646b817],
8	KB	NN	PERSON	kb	appos	2	SENT_578	[p14l1675t754r1813b831],
9	,	,	O	,	_	0	SENT_578	[p14l1675t754r1813b831],
10	Choi	NNP	PERSON	Choi	nn	11	SENT_578	[p14l1842t751r2019b819],
11	K	NNP	PERSON	K	appos	2	SENT_578	[p14l2051t751r2136b828],
12	,	,	O	,	_	0	SENT_578	[p14l2051t751r2136b828],
13	Roninson	NNP	O	Roninson	nn	14	SENT_578	[p14l655t846r1008b914],
14	IB	NNP	O	IB	appos	2	SENT_578	[p14l1054t849r1161b914],
15	.	.	O	.	_	0	SENT_578	[p14l1054t849r1161b914],

1	1989	CD	DATE	1989	_	0	SENT_579	[p14l1221t846r1412b917],
2	.	.	O	.	_	0	SENT_579	[p14l1221t846r1412b917],

1	Structure	NN	O	structure	_	0	SENT_580	[p14l1463t846r1799b914],
2	and	CC	O	and	_	0	SENT_580	[p14l1842t846r1980b914],
3	expression	NN	O	expression	conj_and	1	SENT_580	[p14l2021t865r2136b911, p14l655t938r958b1028],

1	of	IN	O	of	_	0	SENT_581	[p14l998t938r1080b1006],
2	the	DT	O	the	det	7	SENT_581	[p14l1110t941r1222b1009],
3	human	JJ	O	human	amod	7	SENT_581	[p14l1257t941r1509b1009],
4	MDR	NN	O	mdr	nn	7	SENT_581	[p14l1547t941r1752b1006],
5	(	CD	NUMBER	(	num	7	SENT_581	[p14l1792t938r2136b1026, p14l655t1030r944b1123],
6	Pglycoprotein	NN	O	pglycoprotein	nn	7	SENT_581	[p14l1792t938r2136b1026, p14l655t1030r944b1123],
7	)	NN	O	)	pobj	1	SENT_581	[p14l1792t938r2136b1026, p14l655t1030r944b1123],
8	gene	NN	O	gene	nn	9	SENT_581	[p14l995t1052r1167b1120],
9	family	NN	O	family	dep	7	SENT_581	[p14l1213t1030r1470b1120],
10	.	.	O	.	_	0	SENT_581	[p14l1213t1030r1470b1120],

1	Mol	NNP	O	Mol	_	0	SENT_582	[p14l1522t1033r1682b1101],
2	.	.	O	.	_	0	SENT_582	[p14l1522t1033r1682b1101],

1	Cell	NN	O	cell	_	0	SENT_583	[p14l1742t1030r1905b1101],
2	.	.	O	.	_	0	SENT_583	[p14l1742t1030r1905b1101],

1	Biol	NNP	O	Biol	_	0	SENT_584	[p14l1962t1030r2128b1098],
2	.	.	O	.	_	0	SENT_584	[p14l1962t1030r2128b1098],

1	9:3808	CD	NUMBER	9:3808	_	0	SENT_585	[p14l652t1127r1052b1198],
2	—	CD	NUMBER	—	num	3	SENT_585	[p14l652t1127r1052b1198],
3	20	CD	NUMBER	20	dep	1	SENT_585	[p14l652t1127r1052b1198],

1	Roninson	NNP	O	Roninson	nn	2	SENT_586	[p14l655t1219r1008b1288],
2	IB	NNP	O	IB	_	0	SENT_586	[p14l1043t1222r1153b1288],
3	.	.	O	.	_	0	SENT_586	[p14l1043t1222r1153b1288],

1	1991	CD	DATE	1991	_	0	SENT_587	[p14l1204t1219r1395b1290],
2	.	.	O	.	_	0	SENT_587	[p14l1204t1219r1395b1290],

1	Structure	NN	O	structure	_	0	SENT_588	[p14l1435t1219r1771b1288],
2	and	CC	O	and	_	0	SENT_588	[p14l1809t1219r1941b1288],
3	evolution	NN	O	evolution	conj_and	1	SENT_588	[p14l1973t1239r2136b1285, p14l658t1311r874b1382],

1	of	IN	O	of	_	0	SENT_589	[p14l900t1311r983b1380],
2	P-glycoproteins	NNS	O	p-glycoprotein	pobj	1	SENT_589	[p14l1006t1308r1607b1399],
3	.	.	O	.	_	0	SENT_589	[p14l1006t1308r1607b1399],

1	See	VB	O	see	_	0	SENT_590	[p14l1639t1311r1771b1380],
2	Ref	NNP	O	Ref	dobj	1	SENT_590	[p14l1801t1308r1947b1380],
3	.	.	O	.	_	0	SENT_590	[p14l1801t1308r1947b1380],

1	127	CD	NUMBER	127	_	0	SENT_591	[p14l1987t1311r2136b1391],
2	,	,	O	,	_	0	SENT_591	[p14l1987t1311r2136b1391],
3	pp.l89-211	NN	O	pp.l89-211	nn	5	SENT_591	[p14l658t1407r1086b1498],
4	Gros	NNS	O	gro	nn	5	SENT_591	[p14l658t1502r832b1570],
5	P	NN	O	p	appos	1	SENT_591	[p14l856t1502r930b1579],
6	,	,	O	,	_	0	SENT_591	[p14l856t1502r930b1579],
7	Raymond	NNP	PERSON	Raymond	nn	8	SENT_591	[p14l951t1502r1311b1587],
8	M	NNP	PERSON	M	appos	1	SENT_591	[p14l1327t1502r1431b1579],
9	,	,	O	,	_	0	SENT_591	[p14l1327t1502r1431b1579],
10	Housman	NNP	PERSON	Housman	nn	11	SENT_591	[p14l1455t1502r1802b1568],
11	D.	NNP	O	D.	appos	1	SENT_591	[p14l1826t1502r1911b1568],
12	1991	CD	DATE	1991	dep	11	SENT_591	[p14l1943t1499r2136b1568],
13	.	.	O	.	_	0	SENT_591	[p14l1943t1499r2136b1568],

1	Cloning	NN	O	cloning	_	0	SENT_592	[p14l655t1591r955b1679],
2	and	CC	O	and	_	0	SENT_592	[p14l992t1594r1125b1663],
3	characterization	NN	O	characterization	conj_and	1	SENT_592	[p14l1162t1591r1752b1663],
4	of	IN	O	of	_	0	SENT_592	[p14l1787t1594r1869b1663],
5	mouse	NN	O	mouse	nn	7	SENT_592	[p14l1901t1614r2139b1660],
6	mdr	NN	O	mdr	nn	7	SENT_592	[p14l655t1686r810b1757],
7	genes	NNS	O	gene	prep_of	1	SENT_592	[p14l842t1706r1066b1774],
8	.	.	O	.	_	0	SENT_592	[p14l842t1706r1066b1774],

1	See	VB	O	see	_	0	SENT_593	[p14l1109t1686r1242b1755],
2	Ref	NNP	O	Ref	dobj	1	SENT_593	[p14l1279t1686r1429b1755],
3	.	.	O	.	_	0	SENT_593	[p14l1279t1686r1429b1755],

1	127	CD	NUMBER	127	_	0	SENT_594	[p14l1480t1686r1626b1766],
2	,	,	O	,	_	0	SENT_594	[p14l1480t1686r1626b1766],
3	pp.73-89	NN	O	pp.73-89	nn	5	SENT_594	[p14l1667t1686r2005b1774],
4	Juranka	NN	O	juranka	nn	5	SENT_594	[p14l655t1778r944b1849],
5	PF	NN	O	pf	appos	1	SENT_594	[p14l1006t1781r1128b1858],
6	,	,	O	,	_	0	SENT_594	[p14l1006t1781r1128b1858],
7	Zastawny	NNP	ORGANIZATION	Zastawny	nn	8	SENT_594	[p14l1193t1781r1551b1866],
8	RL	NNP	ORGANIZATION	RL	appos	1	SENT_594	[p14l1617t1781r1749b1858],
9	,	,	O	,	_	0	SENT_594	[p14l1617t1781r1749b1858],
10	Ling	NNP	O	Ling	nn	11	SENT_594	[p14l1814t1775r1986b1863],
11	V.	NNP	O	V.	appos	1	SENT_594	[p14l2051t1778r2136b1844],
12	1989	CD	DATE	1989	dep	11	SENT_594	[p14l669t1873r860b1941],
13	.	.	O	.	_	0	SENT_594	[p14l669t1873r860b1941],

1	P-glycoprotein	NN	O	p-glycoprotein	_	0	SENT_595	[p14l923t1873r1490b1958],
2	:	:	O	:	_	0	SENT_595	[p14l923t1873r1490b1958],
3	muItidrugresistance	NN	O	muitidrugresistance	dep	1	SENT_595	[p14l1552t1873r2142b1958, p14l661t1976r852b2033],
4	and	CC	O	and	_	0	SENT_595	[p14l892t1965r1024b2030],
5	a	DT	O	a	det	6	SENT_595	[p14l1059t1984r1100b2030],
6	superfamily	NN	O	superfamily	dep	1	SENT_595	[p14l1140t1959r1576b2050],
7	of	IN	O	of	_	0	SENT_595	[p14l1611t1962r1693b2030],
8	membraneassociated	JJ	O	membraneassociated	amod	10	SENT_595	[p14l1722t1959r2142b2030, p14l661t2054r1038b2125],
9	transport	NN	O	transport	nn	10	SENT_595	[p14l1070t2065r1398b2142],
10	proteins	NNS	O	protein	prep_of	6	SENT_595	[p14l1427t2054r1741b2142],
11	.	.	O	.	_	0	SENT_595	[p14l1427t2054r1741b2142],

1	FASEB	NNP	O	FASEB	nn	2	SENT_596	[p14l1778t2054r2047b2122],
2	J.	NNP	O	J.	_	0	SENT_596	[p14l2076t2054r2133b2122],
3	3:2583	CD	NUMBER	3:2583	number	4	SENT_596	[p14l661t2151r1055b2223],
4	—	CD	NUMBER	—	dep	2	SENT_596	[p14l661t2151r1055b2223],
5	92	CD	NUMBER	92	dep	4	SENT_596	[p14l661t2151r1055b2223],

1	Ng	NN	PERSON	ng	nn	2	SENT_597	[p14l661t2246r774b2334],
2	WF	NN	PERSON	wf	_	0	SENT_597	[p14l806t2243r960b2323],
3	,	,	O	,	_	0	SENT_597	[p14l806t2243r960b2323],
4	Sarangi	NNP	PERSON	Sarangi	nn	5	SENT_597	[p14l1001t2243r1278b2331],
5	F	NN	O	f	appos	2	SENT_597	[p14l1310t2243r1384b2323],
6	,	,	O	,	_	0	SENT_597	[p14l1310t2243r1384b2323],
7	Zastawny	NNP	ORGANIZATION	Zastawny	nn	8	SENT_597	[p14l1416t2243r1774b2334],
8	RL	NNP	ORGANIZATION	RL	appos	2	SENT_597	[p14l1806t2243r1947b2323],
9	,	,	O	,	_	0	SENT_597	[p14l1806t2243r1947b2323],
10	Veinot	NNP	O	Veinot	nn	11	SENT_597	[p14l1979t2243r2139b2312, p14l661t2349r776b2409],
11	DL	NNP	O	DL	appos	2	SENT_597	[p14l808t2338r949b2418],
12	,	,	O	,	_	0	SENT_597	[p14l808t2338r949b2418],
13	Ling	NNP	O	Ling	nn	14	SENT_597	[p14l984t2338r1158b2426],
14	V.	NNP	O	V.	appos	2	SENT_597	[p14l1188t2341r1270b2409],
15	1989	CD	DATE	1989	dep	14	SENT_597	[p14l1316t2335r1507b2406],
16	.	.	O	.	_	0	SENT_597	[p14l1316t2335r1507b2406],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_598	[p14l1544t2335r2039b2406],
2	of	IN	O	of	_	0	SENT_598	[p14l2068t2335r2147b2406],
3	members	NNS	O	member	prep_of	1	SENT_598	[p14l664t2436r997b2504],
4	of	IN	O	of	_	0	SENT_598	[p14l1059t2436r1142b2504],
5	the	DT	O	the	det	8	SENT_598	[p14l1196t2436r1306b2504],
6	P-glycoprotein	NN	O	p-glycoprotein	nn	8	SENT_598	[p14l1366t2433r1911b2524],
7	multigene	JJ	O	multigene	amod	8	SENT_598	[p14l1973t2433r2142b2501, p14l664t2530r885b2618],
8	family	NN	O	family	prep_of	1	SENT_598	[p14l923t2528r1180b2615],
9	.	.	O	.	_	0	SENT_598	[p14l923t2528r1180b2615],

1	Mal	NNP	PERSON	Mal	_	0	SENT_599	[p14l1215t2528r1384b2596],
2	.	.	O	.	_	0	SENT_599	[p14l1215t2528r1384b2596],

1	Cell	NN	O	cell	_	0	SENT_600	[p14l1427t2528r1590b2596],
2	.	.	O	.	_	0	SENT_600	[p14l1427t2528r1590b2596],

1	Biol	NNP	O	Biol	_	0	SENT_601	[p14l1633t2530r1802b2596],
2	.	.	O	.	_	0	SENT_601	[p14l1633t2530r1802b2596],

1	9	CD	NUMBER	9	_	0	SENT_602	[p14l1845t2528r2150b2599],
2	:	:	O	:	_	0	SENT_602	[p14l1845t2528r2150b2599],
3	l224	CD	NUMBER	l224	dep	1	SENT_602	[p14l1845t2528r2150b2599],
4	—	CD	NUMBER	—	number	5	SENT_602	[p14l1845t2528r2150b2599],
5	32	CD	NUMBER	32	dep	3	SENT_602	[p14l664t2622r751b2693],

1	Buschman	NNP	PERSON	Buschman	nn	2	SENT_603	[p14l661t2717r1052b2785],
2	E	NNP	PERSON	E	_	0	SENT_603	[p14l1079t2717r1155b2797],
3	,	,	O	,	_	0	SENT_603	[p14l1079t2717r1155b2797],
4	Gros	NNP	O	Gros	nn	5	SENT_603	[p14l1187t2717r1364b2785],
5	P.	NNP	O	P.	appos	2	SENT_603	[p14l1396t2714r1465b2783],
6	1994	CD	DATE	1994	dep	5	SENT_603	[p14l1511t2714r1699b2785],
7	.	.	O	.	_	0	SENT_603	[p14l1511t2714r1699b2785],

1	The	DT	O	the	det	2	SENT_604	[p14l1731t2717r1874b2785],
2	inability	NN	O	inability	nsubjpass	13	SENT_604	[p14l1906t2714r2142b2783, p14l661t2809r757b2897],
3	of	IN	O	of	_	0	SENT_604	[p14l797t2806r882b2875],
4	the	DT	O	the	det	7	SENT_604	[p14l917t2809r1027b2875],
5	mouse	NN	O	mouse	nn	7	SENT_604	[p14l1070t2829r1309b2877],
6	mdr2	NN	O	mdr2	nn	7	SENT_604	[p14l1352t2806r1546b2875],
7	gene	NN	O	gene	prep_of	2	SENT_604	[p14l1586t2829r1760b2894],
8	to	TO	O	to	aux	9	SENT_604	[p14l1798t2820r1872b2875],
9	confer	VB	O	confer	infmod	2	SENT_604	[p14l1909t2806r2147b2875],
10	multidrug	JJ	O	multidrug	amod	11	SENT_604	[p14l661t2898r1027b2986],
11	resistance	NN	O	resistance	dobj	9	SENT_604	[p14l1045t2901r1409b2969],
12	is	VBZ	O	be	auxpass	13	SENT_604	[p14l1430t2898r1490b2967],
13	linked	VBN	O	link	_	0	SENT_604	[p14l1514t2898r1743b2967],
14	to	TO	O	to	_	0	SENT_604	[p14l1764t2912r1835b2969],
15	reduced	VBN	O	reduce	amod	17	SENT_604	[p14l1853t2898r2147b2967],
16	drug	NN	O	drug	nn	17	SENT_604	[p14l664t2999r832b3084],
17	binding	NN	O	binding	prep_to	13	SENT_604	[p14l856t2996r1136b3084],
18	to	TO	O	to	_	0	SENT_604	[p14l1160t3007r1233b3064],
19	the	DT	O	the	det	20	SENT_604	[p14l1257t2999r1370b3064],
20	protein	NN	O	protein	prep_to	17	SENT_604	[p14l1394t2996r1671b3084],
21	.	.	O	.	_	0	SENT_604	[p14l1394t2996r1671b3084],

1	Cancer	NN	O	cancer	_	0	SENT_605	[p14l1703t2996r1972b3064],
2	Res	NNP	O	Res	dep	1	SENT_605	[p14l1990t2993r2139b3061],
3	.	.	O	.	_	0	SENT_605	[p14l1990t2993r2139b3061],

1	S4	NN	O	s4	_	0	SENT_606	[p14l664t3088r1100b3156],
2	:4892	CD	NUMBER	:4892	number	3	SENT_606	[p14l664t3088r1100b3156],
3	—	CD	NUMBER	—	dep	1	SENT_606	[p14l664t3088r1100b3156],
4	98	CD	NUMBER	98	dep	3	SENT_606	[p14l664t3088r1100b3156],

1	Melera	NNP	O	Melera	nn	2	SENT_607	[p14l664t3177r927b3248],
2	P	NN	O	p	_	0	SENT_607	[p14l973t3180r1044b3259],
3	,	,	O	,	_	0	SENT_607	[p14l973t3180r1044b3259],
4	Biedler	NNP	O	Biedler	nn	5	SENT_607	[p14l1095t3180r1367b3248],
5	J.	NNP	O	J.	appos	2	SENT_607	[p14l1410t3180r1465b3245],
6	1991	CD	DATE	1991	dep	5	SENT_607	[p14l1525t3180r1716b3248],
7	.	.	O	.	_	0	SENT_607	[p14l1525t3180r1716b3248],

1	Molecular	JJ	O	molecular	amod	4	SENT_608	[p14l1767t3177r2150b3248],
2	and	CC	O	and	_	0	SENT_608	[p14l664t3274r796b3343],
3	cytogenetic	JJ	O	cytogenetic	conj_and	1	SENT_608	[p14l845t3274r1270b3362],
4	analysis	NN	O	analysis	_	0	SENT_608	[p14l1318t3272r1612b3362],
5	of	IN	O	of	_	0	SENT_608	[p14l1661t3274r1743b3343],
6	multidrug	JJ	O	multidrug	amod	9	SENT_608	[p14l1787t3272r2147b3359],
7	resistance-associated	JJ	O	resistance-associated	amod	9	SENT_608	[p14l664t3366r1440b3437],
8	gene	NN	O	gene	nn	9	SENT_608	[p14l1461t3386r1632b3454],
9	ampliﬁcation	NN	O	ampliﬁcation	prep_of	4	SENT_608	[p14l1656t3364r2147b3457],
10	in	IN	O	in	_	0	SENT_608	[p14l664t3461r732b3529],
11	Chinese	JJ	MISC	chinese	amod	12	SENT_608	[p14l756t3458r1050b3529],
12	hamster	NN	O	hamster	prep_in	9	SENT_608	[p14l1070t3461r1381b3540],
13	,	,	O	,	_	0	SENT_608	[p14l1070t3461r1381b3540],
14	mouse	NN	O	mouse	nn	15	SENT_608	[p14l1408t3480r1649b3529],
15	sarcoma	NN	O	sarcoma	conj_and	12	SENT_608	[p14l1667t3480r1991b3540],
16	,	,	O	,	_	0	SENT_608	[p14l1667t3480r1991b3540],
17	and	CC	O	and	_	0	SENT_608	[p14l2015t3461r2150b3526],
18	human	JJ	O	human	amod	20	SENT_608	[p14l666t3557r913b3622],
19	neuroblastoma	NN	O	neuroblastoma	nn	20	SENT_608	[p14l973t3557r1515b3622],
20	cells	NNS	O	cell	prep_in	9	SENT_608	[p14l1564t3554r1749b3622],
21	.	.	O	.	_	0	SENT_608	[p14l1564t3554r1749b3622],

1	See	VB	O	see	_	0	SENT_609	[p14l1812t3557r1941b3622],
2	Ref	NNP	O	Ref	dobj	1	SENT_609	[p14l1993t3554r2145b3619],
3	.	.	O	.	_	0	SENT_609	[p14l1993t3554r2145b3619],

1	127	CD	NUMBER	127	_	0	SENT_610	[p15l675t18r821b98],
2	.	.	O	.	_	0	SENT_610	[p15l675t18r821b98],

1	pp.l17-45	NN	O	pp.l17-45	_	0	SENT_611	[p15l861t21r1250b109],

1	22	CD	NUMBER	22	_	0	SENT_612	[p15l463t112r573b183],
2	.	.	O	.	_	0	SENT_612	[p15l463t112r573b183],

1	Van	NNP	PERSON	Van	nn	4	SENT_613	[p15l666t115r821b183],
2	der	FW	PERSON	der	nn	4	SENT_613	[p15l850t112r969b180],
3	Bliek	NNP	PERSON	Bliek	nn	4	SENT_613	[p15l1001t112r1200b180],
4	AM	NNP	O	AM	_	0	SENT_613	[p15l1235t112r1401b191],
5	,	,	O	,	_	0	SENT_613	[p15l1235t112r1401b191],
6	Baas	NNP	PERSON	Baas	nn	7	SENT_613	[p15l1438t112r1612b180],
7	F	NN	O	f	appos	4	SENT_613	[p15l1645t112r1713b194],
8	,	,	O	,	_	0	SENT_613	[p15l1645t112r1713b194],
9	Ten	CD	NUMBER	ten	num	12	SENT_613	[p15l1750t115r1894b183],
10	I-Ioute	NNP	O	I-Ioute	nn	12	SENT_613	[p15l1926t112r2147b180],
11	de	IN	O	de	amod	12	SENT_613	[p15l664t215r749b280],
12	Lange	NNP	ORGANIZATION	Lange	appos	4	SENT_613	[p15l806t212r1036b297],
13	T	NN	ORGANIZATION	t	dep	12	SENT_613	[p15l1087t212r1164b291],
14	,	,	O	,	_	0	SENT_613	[p15l1087t212r1164b291],
15	Kooiman	NNP	ORGANIZATION	Kooiman	nn	16	SENT_613	[p15l1224t209r1565b280],
16	PM	NNP	ORGANIZATION	PM	appos	4	SENT_613	[p15l1619t212r1771b291],
17	,	,	O	,	_	0	SENT_613	[p15l1619t212r1771b291],
18	Van	NNP	PERSON	Van	nn	20	SENT_613	[p15l1826t212r1980b277],
19	der	FW	PERSON	der	nn	20	SENT_613	[p15l2032t212r2150b277],
20	Velde-Koerts	NNP	PERSON	Velde-Koerts	appos	4	SENT_613	[p15l666t316r1161b384],
21	T	NN	O	t	dep	20	SENT_613	[p15l1221t319r1297b395],
22	,	,	O	,	_	0	SENT_613	[p15l1221t319r1297b395],
23	Borst	NNP	PERSON	Borst	nn	24	SENT_613	[p15l1357t316r1557b381],
24	P.	NNP	O	P.	appos	4	SENT_613	[p15l1614t316r1682b381],
25	1987	CD	DATE	1987	dep	24	SENT_613	[p15l1750t316r1944b384],
26	.	.	O	.	_	0	SENT_613	[p15l1750t316r1944b384],

1	The	DT	O	the	det	4	SENT_614	[p15l2007t316r2147b381],
2	human	JJ	O	human	amod	4	SENT_614	[p15l664t427r913b492],
3	mdr3	NN	O	mdr3	nn	4	SENT_614	[p15l956t421r1153b489],
4	gene	NN	O	gene	nsubj	5	SENT_614	[p15l1190t443r1364b509],
5	encodes	VBZ	O	encode	_	0	SENT_614	[p15l1405t424r1699b489],
6	a	DT	O	a	det	9	SENT_614	[p15l1742t443r1782b489],
7	novel	JJ	O	novel	amod	9	SENT_614	[p15l1823t421r2025b489],
8	Pglycoprotein	NN	O	pglycoprotein	nn	9	SENT_614	[p15l2068t424r2147b489, p15l666t516r1133b604],
9	homologue	NN	O	homologue	dobj	5	SENT_614	[p15l1171t516r1585b601],
10	and	CC	O	and	_	0	SENT_614	[p15l1622t516r1755b581],
11	gives	VBZ	O	give	conj_and	5	SENT_614	[p15l1789t516r1983b604],
12	rise	NN	O	rise	iobj	11	SENT_614	[p15l2018t513r2150b581],
13	to	TO	O	to	_	0	SENT_614	[p15l666t619r740b676],
14	alternatively	RB	O	alternatively	advmod	15	SENT_614	[p15l764t605r1225b696],
15	spliced	VBN	O	splice	prepc_to	12	SENT_614	[p15l1254t605r1512b696],
16	mRNAs	NNS	O	mrna	dobj	11	SENT_614	[p15l1536t608r1835b676],
17	in	IN	O	in	_	0	SENT_614	[p15l1865t608r1936b673],
18	liver	NN	O	liver	prep_in	16	SENT_614	[p15l1959t605r2147b673],
19	.	.	O	.	_	0	SENT_614	[p15l1959t605r2147b673],

1	EMBO	NNP	O	EMBO	nn	2	SENT_615	[p15l666t700r924b765],
2	J.	NNP	O	J.	_	0	SENT_615	[p15l959t700r1016b765],
3	63325-3	CD	NUMBER	63325-3	dep	2	SENT_615	[p15l1059t697r1445b768],
4	!	.	O	!	_	0	SENT_615	[p15l1059t697r1445b768],

1	23	CD	NUMBER	23	_	0	SENT_616	[p15l466t792r576b860],
2	.	.	O	.	_	0	SENT_616	[p15l466t792r576b860],

1	Smit	NNP	PERSON	Smit	_	0	SENT_617	[p15l669t792r841b860],
2	JJ	NN	PERSON	jj	dep	1	SENT_617	[p15l867t792r960b868],
3	,	,	O	,	_	0	SENT_617	[p15l867t792r960b868],
4	Schinkel	NNP	PERSON	Schinkel	nn	5	SENT_617	[p15l992t792r1311b860],
5	AI-I	NNP	O	AI-I	appos	2	SENT_617	[p15l1344t792r1495b868],
6	,	,	O	,	_	0	SENT_617	[p15l1344t792r1495b868],
7	Oude	NNP	O	Oude	nn	8	SENT_617	[p15l1527t792r1727b860],
8	ER	NN	O	er	appos	2	SENT_617	[p15l1753t795r1888b871],
9	,	,	O	,	_	0	SENT_617	[p15l1753t795r1888b871],
10	Groen	NNP	PERSON	Groen	appos	2	SENT_617	[p15l1920t792r2153b857],

1	AK	NNP	O	AK	_	0	SENT_618	[p15l669t897r821b977],
2	,	,	O	,	_	0	SENT_618	[p15l669t897r821b977],
3	Wagcnaar	NNP	O	Wagcnaar	nn	4	SENT_618	[p15l853t897r1225b985],
4	E	NNP	O	E	appos	1	SENT_618	[p15l1254t900r1328b977],
5	,	,	O	,	_	0	SENT_618	[p15l1254t900r1328b977],
6	et	FW	O	et	nn	7	SENT_618	[p15l1360t905r1428b963],
7	al.	FW	O	al.	appos	1	SENT_618	[p15l1455t897r1540b963],
8	1993	CD	DATE	1993	dep	7	SENT_618	[p15l1578t897r1771b965],
9	.	.	O	.	_	0	SENT_618	[p15l1578t897r1771b965],

1	Homozygous	JJ	O	homozygous	_	0	SENT_619	[p15l1803t900r2150b985, p15l258t1275r472b1361],

1	disruption	NN	O	disruption	nsubj	8	SENT_620	[p15l548t1247r1021b1364],
2	of	IN	O	of	_	0	SENT_620	[p15l1093t1250r1196b1336],
3	the	DT	O	the	det	7	SENT_620	[p15l1264t1250r1405b1336],
4	murine	JJ	O	murine	amod	7	SENT_620	[p15l1480t1250r1807b1336],
5	mdr2	NN	O	mdr2	nn	7	SENT_620	[p15l1879t1250r2129b1336],
6	P-glycoprotein	NN	O	p-glycoprotein	nn	7	SENT_620	[p15l258t1366r948b1476],
7	gene	NN	O	gene	prep_of	1	SENT_620	[p15l981t1390r1196b1472],
8	leads	VBZ	O	lead	_	0	SENT_620	[p15l1229t1366r1465b1448],
9	to	TO	O	to	_	0	SENT_620	[p15l1494t1380r1587b1451],
10	a	DT	O	a	det	12	SENT_620	[p15l1617t1387r1667b1448],
11	complete	JJ	O	complete	amod	12	SENT_620	[p15l1701t1366r2125b1472],
12	absence	NN	O	absence	prep_to	8	SENT_620	[p15l258t1485r623b1570],
13	of	IN	O	of	_	0	SENT_620	[p15l670t1485r776b1570],
14	phospholipid	NN	O	phospholipid	prep_of	12	SENT_620	[p15l813t1481r1419b1595],
15	from	IN	O	from	_	0	SENT_620	[p15l1466t1485r1692b1567],
16	bile	NN	O	bile	prep_from	14	SENT_620	[p15l1735t1481r1912b1567],
17	and	CC	O	and	_	0	SENT_620	[p15l1959t1485r2132b1567],
18	to	TO	O	to	_	0	SENT_620	[p15l258t1610r347b1682],
19	liver	NN	O	liver	nn	20	SENT_620	[p15l390t1596r605b1682],
20	disease	NN	O	disease	prep_to	8	SENT_620	[p15l645t1596r1004b1682],
21	.	.	O	.	_	0	SENT_620	[p15l645t1596r1004b1682],

1	Cell	NN	O	cell	_	0	SENT_621	[p15l1061t1593r1252b1679],
2	75:45	CD	NUMBER	75:45	num	3	SENT_621	[p15l1292t1596r1552b1682],
3	1-62	CD	NUMBER	1-62	dep	1	SENT_621	[p15l1575t1593r1786b1679],

1	Schinkel	NNP	PERSON	Schinkel	nn	7	SENT_622	[p15l261t1711r661b1797],
2	AH	NNP	O	AH	nn	7	SENT_622	[p15l691t1711r885b1808],
3	,	,	O	,	_	0	SENT_622	[p15l691t1711r885b1808],
4	Sn1itJM	NNP	O	Sn1itJM	appos	7	SENT_622	[p15l921t1708r1346b1811],
5	,	,	O	,	_	0	SENT_622	[p15l921t1708r1346b1811],
6	Vantclli	NNP	PERSON	Vantclli	appos	7	SENT_622	[p15l1379t1708r1748b1797],
7	O	NNP	PERSON	O	_	0	SENT_622	[p15l1784t1708r1894b1808],
8	,	,	O	,	_	0	SENT_622	[p15l1784t1708r1894b1808],
9	Beijnen	NNP	PERSON	Beijnen	appos	7	SENT_622	[p15l1928t1708r2122b1794, p15l251t1841r455b1948],

1	JH	NN	O	jh	_	0	SENT_623	[p15l499t1844r651b1941],
2	,	,	O	,	_	0	SENT_623	[p15l499t1844r651b1941],
3	Wagenaar	NNP	PERSON	Wagenaar	nn	4	SENT_623	[p15l701t1844r1171b1948],
4	E	NNP	O	E	appos	1	SENT_623	[p15l1211t1844r1308b1941],
5	,	,	O	,	_	0	SENT_623	[p15l1211t1844r1308b1941],
6	et	FW	O	et	nn	7	SENT_623	[p15l1351t1859r1433b1927],
7	al.	FW	O	al.	appos	1	SENT_623	[p15l1477t1841r1580b1927],
8	1994	CD	DATE	1994	dep	7	SENT_623	[p15l1641t1841r1880b1927],
9	.	.	O	.	_	0	SENT_623	[p15l1641t1841r1880b1927],

1	Disruption	NN	O	disruption	nsubj	9	SENT_624	[p15l1928t1841r2129b1927, p15l261t1971r595b2082],
2	of	IN	O	of	_	0	SENT_624	[p15l768t1968r871b2057],
3	the	DT	O	the	det	5	SENT_624	[p15l1037t1971r1178b2057],
4	mouse	NN	O	mouse	nn	5	SENT_624	[p15l1355t1996r1650b2057],
5	mdrl	NN	O	mdrl	prep_of	1	SENT_624	[p15l1826t1971r2062b2057],
6	a	DT	O	a	det	8	SENT_624	[p15l2074t2000r2129b2057],
7	P-glycoprotein	NN	MISC	p-glycoprotein	nn	8	SENT_624	[p15l261t2094r948b2211],
8	gene	NN	O	gene	dep	5	SENT_624	[p15l1023t2122r1241b2208],
9	leads	VBZ	O	lead	_	0	SENT_624	[p15l1313t2097r1549b2187],
10	to	TO	O	to	_	0	SENT_624	[p15l1627t2111r1716b2183],
11	a	DT	O	a	det	12	SENT_624	[p15l1788t2122r1839b2183],
12	deficiency	NN	O	deficiency	prep_to	9	SENT_624	[p15l1910t2097r2125b2183, p15l261t2227r563b2337],
13	in	IN	O	in	_	0	SENT_624	[p15l600t2226r689b2316],
14	the	DT	O	the	det	16	SENT_624	[p15l729t2230r867b2316],
15	blood-brain	JJ	O	blood-brain	amod	16	SENT_624	[p15l907t2226r1447b2316],
16	barrier	NN	O	barrier	prep_in	12	SENT_624	[p15l1484t2223r1800b2316],
17	and	CC	O	and	_	0	SENT_624	[p15l1833t2226r1999b2312],
18	to	TO	O	to	_	0	SENT_624	[p15l2036t2241r2129b2316],
19	increased	VBN	O	increase	amod	20	SENT_624	[p15l261t2353r696b2442],
20	sensitivity	NN	O	sensitivity	conj_and	12	SENT_624	[p15l747t2353r1224b2467],
21	to	TO	O	to	_	0	SENT_624	[p15l1271t2370r1363b2442],
22	drugs	NNS	O	drug	prep_to	20	SENT_624	[p15l1407t2356r1685b2467],
23	.	.	O	.	_	0	SENT_624	[p15l1407t2356r1685b2467],

1	Cell	NN	O	cell	_	0	SENT_625	[p15l1739t2356r1933b2442],
2	77	CD	NUMBER	77	num	1	SENT_625	[p15l1980t2356r2122b2442],
3	:	:	O	:	_	0	SENT_625	[p15l1980t2356r2122b2442],
4	49	CD	NUMBER	49	num	5	SENT_625	[p15l261t2486r375b2575],
5	1-502	CD	NUMBER	1-502	dep	1	SENT_625	[p15l394t2489r668b2575],

1	Bradley	NNP	PERSON	Bradley	nn	2	SENT_626	[p15l265t2608r630b2721],
2	G	NNP	PERSON	G	_	0	SENT_626	[p15l701t2611r811b2715],
3	,	,	O	,	_	0	SENT_626	[p15l701t2611r811b2715],
4	Naik	NNP	PERSON	Naik	nn	8	SENT_626	[p15l886t2608r1115b2697],
5	M	NNP	O	M	nn	8	SENT_626	[p15l1190t2611r1314b2711],
6	,	,	O	,	_	0	SENT_626	[p15l1190t2611r1314b2711],
7	Ling	NNP	O	Ling	appos	8	SENT_626	[p15l1393t2608r1611b2718],
8	V.	NNP	O	V.	appos	2	SENT_626	[p15l1683t2608r1790b2697],
9	1989	CD	DATE	1989	num	8	SENT_626	[p15l1882t2608r2125b2697],
10	.	.	O	.	_	0	SENT_626	[p15l1882t2608r2125b2697],

1	P-glycoprotein	NN	O	p-glycoprotein	nn	2	SENT_627	[p15l265t2723r951b2837],
2	expression	NN	O	expression	_	0	SENT_627	[p15l984t2727r1475b2837],
3	in	IN	O	in	_	0	SENT_627	[p15l1512t2727r1601b2812],
4	multidru	JJ	O	multidru	amod	5	SENT_627	[p15l1634t2723r2034b2812],
5	gresistant	JJ	O	gresistant	amod	10	SENT_627	[p15l2039t2751r2129b2837, p15l265t2842r647b2931],
6	human	JJ	O	human	amod	10	SENT_627	[p15l691t2845r1004b2931],
7	ovarian	JJ	O	ovarian	amod	10	SENT_627	[p15l1047t2842r1391b2928],
8	carcinoma	NN	O	carcinoma	nn	10	SENT_627	[p15l1438t2842r1922b2931],
9	cell	NN	O	cell	nn	10	SENT_627	[p15l1963t2842r2129b2928],
10	lines	NNS	O	line	prep_in	2	SENT_627	[p15l265t2961r504b3047],
11	.	.	O	.	_	0	SENT_627	[p15l265t2961r504b3047],

1	Cancer	NN	O	cancer	_	0	SENT_628	[p15l558t2964r902b3050],
2	Res	NNP	O	Res	dep	1	SENT_628	[p15l935t2961r1126b3047],
3	.	.	O	.	_	0	SENT_628	[p15l935t2961r1126b3047],

1	49:27	CD	NUMBER	49:27	num	2	SENT_629	[p15l1176t2961r1440b3050],
2	90-96	CD	DATE	90-96	_	0	SENT_629	[p15l1449t2961r1734b3050],

1	Shen	VBN	ORGANIZATION	shen	_	0	SENT_630	[p15l265t3093r497b3176],
2	DW	NN	ORGANIZATION	dw	dobj	1	SENT_630	[p15l541t3093r759b3193],
3	,	,	O	,	_	0	SENT_630	[p15l541t3093r759b3193],
4	Fojo	NNP	O	Fojo	nn	5	SENT_630	[p15l810t3090r1021b3200],
5	A	NNP	O	A	appos	2	SENT_630	[p15l1068t3093r1171b3190],
6	,	,	O	,	_	0	SENT_630	[p15l1068t3093r1171b3190],
7	Chin	NNP	O	Chin	nn	8	SENT_630	[p15l1229t3093r1447b3179],
8	JE	NNP	O	JE	appos	2	SENT_630	[p15l1494t3094r1639b3190],
9	,	,	O	,	_	0	SENT_630	[p15l1494t3094r1639b3190],
10	Roninson	NNP	O	Roninson	nn	11	SENT_630	[p15l1687t3093r2132b3176],
11	IB	NNP	O	IB	appos	2	SENT_630	[p15l268t3223r406b3323],
12	,	,	O	,	_	0	SENT_630	[p15l268t3223r406b3323],
13	Richer	NNP	O	Richer	appos	2	SENT_630	[p15l446t3223r787b3309],
14	!	.	O	!	_	0	SENT_630	[p15l446t3223r787b3309],

1	N	NN	O	n	_	0	SENT_631	[p15l824t3223r930b3320],
2	,	,	O	,	_	0	SENT_631	[p15l824t3223r930b3320],
3	et	FW	O	et	nn	4	SENT_631	[p15l974t3233r1056b3305],
4	al.	FW	O	al.	appos	1	SENT_631	[p15l1096t3223r1203b3309],
5	1986	CD	DATE	1986	dep	4	SENT_631	[p15l1253t3223r1496b3309],
6	.	.	O	.	_	0	SENT_631	[p15l1253t3223r1496b3309],

1	Human	JJ	O	human	_	0	SENT_632	[p15l1536t3223r1877b3309],
2	multidrug-resistant	JJ	O	multidrug-resistant	dep	1	SENT_632	[p15l1917t3223r2132b3305, p15l265t3349r969b3459],

1	cell	NN	O	cell	nn	2	SENT_633	[p15l1068t3349r1234b3435],
2	lines	NNS	O	line	_	0	SENT_633	[p15l1341t3349r1584b3438],
3	:	:	O	:	_	0	SENT_633	[p15l1341t3349r1584b3438],
4	increased	VBN	O	increase	amod	6	SENT_633	[p15l1694t3349r2139b3435],
5	mdrl	NN	O	mdrl	nn	6	SENT_633	[p16l265t18r504b104],
6	expression	NN	O	expression	nsubj	8	SENT_633	[p16l551t18r1045b130],
7	can	MD	O	can	aux	8	SENT_633	[p16l1086t42r1252b104],
8	precede	VB	O	precede	dep	2	SENT_633	[p16l1288t18r1650b128],
9	gene	NN	O	gene	nn	10	SENT_633	[p16l1694t42r1908b125],
10	ampliﬁcation	NN	O	ampliﬁcation	dobj	8	SENT_633	[p16l1956t42r2132b104, p16l265t141r766b255],
11	.	.	O	.	_	0	SENT_633	[p16l1956t42r2132b104, p16l265t141r766b255],

1	Science	NNP	O	Science	nn	6	SENT_634	[p16l817t144r1168b234],
2	232:643	CD	NUMBER	232:643	num	6	SENT_634	[p16l1218t144r1765b234],
3	—	CD	NUMBER	—	num	6	SENT_634	[p16l1218t144r1765b234],
4	45	CD	NUMBER	45	num	6	SENT_634	[p16l1218t144r1765b234],
5	Rothenberg	NNP	ORGANIZATION	Rothenberg	nn	6	SENT_634	[p16l265t278r808b389],
6	ML	NNP	ORGANIZATION	ML	_	0	SENT_634	[p16l838t278r1031b378],
7	,	,	O	,	_	0	SENT_634	[p16l838t278r1031b378],
8	Mickley	NNP	LOCATION	Mickley	nn	9	SENT_634	[p16l1068t275r1454b389],
9	LA	NNP	LOCATION	LA	appos	6	SENT_634	[p16l1487t279r1664b375],
10	,	,	O	,	_	0	SENT_634	[p16l1487t279r1664b375],
11	Cole	NNP	O	Cole	nn	12	SENT_634	[p16l1701t275r1919b361],
12	DE	NN	O	de	appos	6	SENT_634	[p16l1952t279r2129b379],
13	,	,	O	,	_	0	SENT_634	[p16l1952t279r2129b379],
14	Balis	NNP	PERSON	Balis	nn	15	SENT_634	[p16l268t407r500b490],
15	FM	NNP	O	FM	appos	6	SENT_634	[p16l558t407r748b507],
16	,	,	O	,	_	0	SENT_634	[p16l558t407r748b507],
17	Tsuruo	NNP	PERSON	Tsuruo	nn	18	SENT_634	[p16l806t407r1136b493],
18	T	NN	PERSON	t	appos	6	SENT_634	[p16l1190t407r1287b504],
19	,	,	O	,	_	0	SENT_634	[p16l1190t407r1287b504],
20	et	FW	O	et	nn	21	SENT_634	[p16l1344t421r1430b493],
21	al.	FW	O	al.	appos	6	SENT_634	[p16l1484t404r1590b493],
22	1989	CD	DATE	1989	dep	21	SENT_634	[p16l1662t404r1905b493],
23	.	.	O	.	_	0	SENT_634	[p16l1662t404r1905b493],

1	Expression	NN	O	expression	_	0	SENT_635	[p16l1963t407r2129b490, p16l268t533r651b643],
2	of	IN	O	of	_	0	SENT_635	[p16l719t536r825b622],
3	the	DT	O	the	det	4	SENT_635	[p16l886t533r1024b619],
4	mdr-1	NN	O	mdr-1	prep_of	1	SENT_635	[p16l1096t533r1692b622],
5	/	:	O	/	punct	1	SENT_635	[p16l1096t533r1692b622],
6	P-170	NN	O	p-170	nn	7	SENT_635	[p16l1096t533r1692b622],
7	gene	NN	O	gene	dep	1	SENT_635	[p16l1760t557r1975b643],
8	in	IN	O	in	_	0	SENT_635	[p16l2046t533r2136b619],
9	patients	NNS	O	patient	prep_in	7	SENT_635	[p16l268t663r626b774],
10	with	IN	O	with	_	0	SENT_635	[p16l684t666r892b752],
11	acute	JJ	O	acute	amod	13	SENT_635	[p16l946t680r1185b749],
12	lymphoblastic	JJ	O	lymphoblastic	amod	13	SENT_635	[p16l1246t663r1898b777],
13	leukemia	NN	O	leukemia	prep_with	9	SENT_635	[p16l1959t663r2132b749, p16l268t796r574b883],
14	.	.	O	.	_	0	SENT_635	[p16l1959t663r2132b749, p16l268t796r574b883],

1	Blood	NN	O	blood	_	0	SENT_636	[p16l624t793r906b883],
2	74	CD	NUMBER	74	num	1	SENT_636	[p16l946t796r1084b883],
3	:	:	O	:	_	0	SENT_636	[p16l946t796r1084b883],
4	1388-95	CD	NUMBER	1388-95	dep	1	SENT_636	[p16l1107t796r1493b886],

1	Ueda	NNP	PERSON	Ueda	nn	2	SENT_637	[p16l268t922r511b1008],
2	K	NNP	PERSON	K	_	0	SENT_637	[p16l555t925r658b1025],
3	,	,	O	,	_	0	SENT_637	[p16l555t925r658b1025],
4	Clark	NNP	PERSON	Clark	nn	5	SENT_637	[p16l708t922r965b1011],
5	DP	NN	O	dp	appos	2	SENT_637	[p16l1002t922r1175b1022],
6	,	,	O	,	_	0	SENT_637	[p16l1002t922r1175b1022],
7	Chen	NNP	PERSON	Chen	nn	9	SENT_637	[p16l1218t922r1461b1011],
8	C	NNP	O	C	nn	9	SENT_637	[p16l1501t922r1646b1022],
9	]	NN	O	]	appos	2	SENT_637	[p16l1501t922r1646b1022],
10	,	,	O	,	_	0	SENT_637	[p16l1501t922r1646b1022],
11	Roninson	NNP	ORGANIZATION	Roninson	nn	12	SENT_637	[p16l1694t922r2136b1008],
12	IB	NNP	ORGANIZATION	IB	appos	2	SENT_637	[p16l268t1055r410b1152],
13	,	,	O	,	_	0	SENT_637	[p16l268t1055r410b1152],
14	Gottesman	NNP	PERSON	Gottesman	nn	15	SENT_637	[p16l443t1056r941b1142],
15	MM	NN	O	mm	appos	2	SENT_637	[p16l970t1055r1203b1152],
16	,	,	O	,	_	0	SENT_637	[p16l970t1055r1203b1152],
17	Pastan	NNP	PERSON	Pastan	nn	18	SENT_637	[p16l1239t1055r1542b1138],
18	I.	NNP	O	I.	appos	2	SENT_637	[p16l1571t1056r1632b1138],
19	1987	CD	DATE	1987	dep	18	SENT_637	[p16l1680t1052r1919b1138],
20	.	.	O	.	_	0	SENT_637	[p16l1680t1052r1919b1138],

1	The	DT	O	the	det	8	SENT_638	[p16l1956t1055r2132b1138],
2	human	JJ	O	human	amod	8	SENT_638	[p16l268t1184r577b1267],
3	multidrug	JJ	O	multidrug	amod	8	SENT_638	[p16l691t1181r1147b1291],
4	resistance	NN	O	resistance	nn	8	SENT_638	[p16l1250t1184r1706b1270],
5	(	NN	O	(	nn	8	SENT_638	[p16l1816t1181r2136b1284],
6	mdrl	NN	O	mdrl	nn	8	SENT_638	[p16l1816t1181r2136b1284],
7	)	NN	O	)	nn	8	SENT_638	[p16l1816t1181r2136b1284],
8	gene	NN	O	gene	_	0	SENT_638	[p16l272t1338r511b1420],
9	.	.	O	.	_	0	SENT_638	[p16l272t1338r511b1420],

1	CDNA	JJ	ORGANIZATION	cdna	amod	2	SENT_639	[p16l572t1313r874b1399],
2	cloning	NN	O	cloning	_	0	SENT_639	[p16l928t1310r1280b1420],
3	and	CC	O	and	_	0	SENT_639	[p16l1334t1313r1496b1399],
4	transcription	NN	O	transcription	conj_and	2	SENT_639	[p16l1554t1310r2143b1420],
5	initiation	NN	O	initiation	dep	2	SENT_639	[p16l271t1442r714b1528],
6	.	.	O	.	_	0	SENT_639	[p16l271t1442r714b1528],

1	J.	NNP	O	J.	nn	2	SENT_640	[p16l757t1446r829b1528],
2	Biol	NNP	O	Biol	_	0	SENT_640	[p16l886t1439r1098b1525],
3	.	.	O	.	_	0	SENT_640	[p16l886t1439r1098b1525],

1	Chem	NNP	O	Chem	_	0	SENT_641	[p16l1159t1442r1444b1528],
2	.	.	O	.	_	0	SENT_641	[p16l1159t1442r1444b1528],

1	262505-58	CD	NUMBER	262505-58	_	0	SENT_642	[p16l1501t1442r2048b1528],

1	Ueda	NNP	PERSON	Ueda	nn	2	SENT_643	[p16l271t1572r514b1658],
2	K	NNP	PERSON	K	_	0	SENT_643	[p16l544t1575r647b1672],
3	,	,	O	,	_	0	SENT_643	[p16l544t1575r647b1672],
4	Pastan	NNP	PERSON	Pastan	appos	2	SENT_643	[p16l673t1576r976b1658],
5	I	PRP	O	I	dep	4	SENT_643	[p16l1002t1572r1063b1668],
6	,	,	O	,	_	0	SENT_643	[p16l1002t1572r1063b1668],
7	Gottesman	NNP	PERSON	Gottesman	nn	8	SENT_643	[p16l1093t1572r1594b1658],
8	MM	NN	O	mm	appos	2	SENT_643	[p16l1620t1572r1849b1655],
9	.	.	O	.	_	0	SENT_643	[p16l1620t1572r1849b1655],

1	1987	CD	DATE	1987	_	0	SENT_644	[p16l1889t1572r2132b1658],
2	.	.	O	.	_	0	SENT_644	[p16l1889t1572r2132b1658],

1	Isolation	NN	O	isolation	_	0	SENT_645	[p16l272t1701r675b1784],
2	and	CC	O	and	_	0	SENT_645	[p16l715t1698r888b1787],
3	sequence	NN	O	sequence	conj_and	1	SENT_645	[p16l928t1726r1349b1808],
4	of	IN	O	of	_	0	SENT_645	[p16l1393t1701r1496b1784],
5	the	DT	O	the	det	7	SENT_645	[p16l1533t1698r1671b1787],
6	promoter	NN	O	promoter	nn	7	SENT_645	[p16l1714t1715r2143b1808],
7	region	NN	O	region	prep_of	1	SENT_645	[p16l272t1827r567b1937],
8	of	IN	O	of	_	0	SENT_645	[p16l635t1830r738b1916],
9	the	DT	O	the	det	15	SENT_645	[p16l796t1830r937b1916],
10	human	JJ	O	human	amod	15	SENT_645	[p16l1005t1830r1325b1916],
11	multidrugresistance	NN	O	multidrugresistance	nn	15	SENT_645	[p16l1390t1827r2136b1937, p16l272t1975r514b2043],
12	(	NN	O	(	nn	15	SENT_645	[p16l596t1957r1356b2071],
13	P-glycoprotein	NN	O	p-glycoprotein	nn	15	SENT_645	[p16l596t1957r1356b2071],
14	)	NN	O	)	nn	15	SENT_645	[p16l596t1957r1356b2071],
15	gene	NN	O	gene	prep_of	1	SENT_645	[p16l1435t1985r1674b2068],
16	.	.	O	.	_	0	SENT_645	[p16l1435t1985r1674b2068],

1	J.	NNP	O	J.	nn	2	SENT_646	[p16l1753t1960r1828b2043],
2	Biol	NNP	O	Biol	_	0	SENT_646	[p16l1914t1960r2129b2043],
3	.	.	O	.	_	0	SENT_646	[p16l1914t1960r2129b2043],

1	Chem	NNP	O	Chem	_	0	SENT_647	[p16l279t2093r563b2176],
2	.	.	O	.	_	0	SENT_647	[p16l279t2093r563b2176],

1	262	CD	NUMBER	262	_	0	SENT_648	[p16l621t2090r1287b2176],
2	:	:	O	:	_	0	SENT_648	[p16l621t2090r1287b2176],
3	l7432	CD	NUMBER	l7432	dep	1	SENT_648	[p16l621t2090r1287b2176],
4	—	CD	NUMBER	—	number	5	SENT_648	[p16l621t2090r1287b2176],
5	36	CD	NUMBER	36	dep	3	SENT_648	[p16l621t2090r1287b2176],

1	Angel	NNP	O	Angel	nn	2	SENT_649	[p16l275t2219r556b2326],
2	P	NN	O	p	_	0	SENT_649	[p16l593t2219r686b2319],
3	,	,	O	,	_	0	SENT_649	[p16l593t2219r686b2319],
4	Imagawa	NNP	PERSON	Imagawa	nn	5	SENT_649	[p16l726t2223r1150b2326],
5	M	NNP	O	M	appos	2	SENT_649	[p16l1187t2219r1314b2319],
6	,	,	O	,	_	0	SENT_649	[p16l1187t2219r1314b2319],
7	Chiu	NNP	PERSON	Chiu	nn	8	SENT_649	[p16l1355t2219r1580b2305],
8	R	NNP	PERSON	R	appos	2	SENT_649	[p16l1620t2219r1720b2316],
9	,	,	O	,	_	0	SENT_649	[p16l1620t2219r1720b2316],
10	Stein	NNP	PERSON	Stein	nn	11	SENT_649	[p16l1760t2216r1999b2302],
11	B	NNP	O	B	appos	2	SENT_649	[p16l2036t2219r2139b2319],
12	,	,	O	,	_	0	SENT_649	[p16l2036t2219r2139b2319],
13	Imbra	NNP	O	Imbra	nn	14	SENT_649	[p16l275t2348r549b2434],
14	RJ	NN	O	rj	appos	2	SENT_649	[p16l589t2348r734b2448],
15	,	,	O	,	_	0	SENT_649	[p16l589t2348r734b2448],
16	et	FW	O	et	nn	17	SENT_649	[p16l778t2362r860b2434],
17	al.	FW	O	al.	appos	2	SENT_649	[p16l897t2345r1004b2431],
18	1987	CD	DATE	1987	dep	17	SENT_649	[p16l1061t2345r1304b2434],
19	.	.	O	.	_	0	SENT_649	[p16l1061t2345r1304b2434],

1	Phorbol	NN	O	phorbol	nn	3	SENT_650	[p16l1348t2345r1709b2434],
2	esterinducible	JJ	O	esterinducible	amod	3	SENT_650	[p16l1753t2345r2139b2431, p16l275t2475r616b2561],
3	genes	NNS	O	gene	nsubj	4	SENT_650	[p16l680t2500r944b2589],
4	contain	VBP	O	contain	_	0	SENT_650	[p16l1012t2478r1353b2561],
5	a	DT	O	a	det	8	SENT_650	[p16l1421t2503r1472b2564],
6	common	JJ	O	common	amod	8	SENT_650	[p16l1540t2500r1943b2564],
7	cis	NN	O	ci	nn	8	SENT_650	[p16l2011t2478r2143b2561],
8	element	NN	O	element	dobj	4	SENT_650	[p16l275t2604r640b2690],
9	recognized	VBN	O	recognize	partmod	8	SENT_650	[p16l708t2601r1213b2715],
10	by	IN	O	by	_	0	SENT_650	[p16l1281t2604r1398b2715],
11	a	DT	O	a	det	14	SENT_650	[p16l1463t2632r1514b2690],
12	TPAmodulated	JJ	O	tpamodulated	amod	14	SENT_650	[p16l1578t2604r2139b2718, p16l275t2734r500b2823],
13	trans-acting	JJ	O	trans-acting	amod	14	SENT_650	[p16l523t2734r1080b2847],
14	factor	NN	O	factor	agent	9	SENT_650	[p16l1103t2734r1395b2823],
15	.	.	O	.	_	0	SENT_650	[p16l1103t2734r1395b2823],

1	Cell	NN	O	cell	dep	6	SENT_651	[p16l1431t2732r1622b2823],
2	49:729	CD	NUMBER	49:729	num	3	SENT_651	[p16l1645t2734r2143b2826],
3	—	CD	NUMBER	—	dep	1	SENT_651	[p16l1645t2734r2143b2826],
4	39	CD	NUMBER	39	num	6	SENT_651	[p16l1645t2734r2143b2826],
5	Chin	NNP	O	Chin	nn	6	SENT_651	[p16l279t2862r500b2948],
6	KV	NN	O	kv	_	0	SENT_651	[p16l537t2865r724b2965],
7	,	,	O	,	_	0	SENT_651	[p16l537t2865r724b2965],
8	Tanaka	NNP	PERSON	Tanaka	nn	9	SENT_651	[p16l761t2862r1108b2951],
9	S	NNP	O	S	appos	6	SENT_651	[p16l1142t2862r1227b2965],
10	,	,	O	,	_	0	SENT_651	[p16l1142t2862r1227b2965],
11	Darlington	NNP	LOCATION	Darlington	nn	12	SENT_651	[p16l1264t2862r1765b2972],
12	G	NNP	O	G	appos	6	SENT_651	[p16l1802t2862r1908b2962],
13	,	,	O	,	_	0	SENT_651	[p16l1802t2862r1908b2962],
14	Pastan	NNP	PERSON	Pastan	appos	6	SENT_651	[p16l1945t2865r2143b2951, p16l275t3009r420b3077],
15	I	PRP	O	I	dep	14	SENT_651	[p16l446t2995r507b3095],
16	,	,	O	,	_	0	SENT_651	[p16l446t2995r507b3095],
17	Gottesman	NNP	PERSON	Gottesman	nn	18	SENT_651	[p16l544t2995r1045b3081],
18	MM	NN	O	mm	appos	6	SENT_651	[p16l1072t2995r1304b3081],
19	.	.	O	.	_	0	SENT_651	[p16l1072t2995r1304b3081],

1	1990	CD	DATE	1990	_	0	SENT_652	[p16l1351t2995r1590b3085],
2	.	.	O	.	_	0	SENT_652	[p16l1351t2995r1590b3085],

1	Heat	NN	O	heat	nn	2	SENT_653	[p16l1631t2995r1846b3081],
2	shock	NN	O	shock	_	0	SENT_653	[p16l1879t2995r2150b3081],
3	and	CC	O	and	_	0	SENT_653	[p16l279t3122r441b3208],
4	arsenite	JJ	O	arsenite	amod	6	SENT_653	[p16l488t3125r850b3211],
5	increase	NN	O	increase	nn	6	SENT_653	[p16l893t3122r1273b3208],
6	expression	NN	O	expression	conj_and	2	SENT_653	[p16l1316t3122r1814b3236],
7	of	IN	O	of	_	0	SENT_653	[p16l1858t3122r1964b3208],
8	the	DT	O	the	det	14	SENT_653	[p16l2005t3126r2143b3211],
9	multidrug	JJ	O	multidrug	amod	14	SENT_653	[p16l279t3251r734b3361],
10	resistance	NN	O	resistance	nn	14	SENT_653	[p16l796t3251r1248b3340],
11	(	CD	NUMBER	(	num	14	SENT_653	[p16l1313t3251r1709b3354],
12	MDR1	NN	O	mdr1	nn	14	SENT_653	[p16l1313t3251r1709b3354],
13	)	NN	O	)	nn	14	SENT_653	[p16l1313t3251r1709b3354],
14	gene	NN	O	gene	prep_of	2	SENT_653	[p16l1774t3275r1992b3361],
15	in	IN	O	in	_	0	SENT_653	[p16l2053t3251r2146b3337],
16	human	JJ	O	human	amod	19	SENT_653	[p16l275t3384r588b3470],
17	renal	JJ	O	renal	amod	19	SENT_653	[p16l649t3384r874b3470],
18	carcinoma	NN	O	carcinoma	nn	19	SENT_653	[p16l939t3384r1423b3470],
19	cells	NNS	O	cell	prep_in	14	SENT_653	[p16l1484t3384r1716b3470],
20	.	.	O	.	_	0	SENT_653	[p16l1484t3384r1716b3470],

1	J.	NNP	O	J.	nn	2	SENT_654	[p16l1777t3388r1853b3470],
2	Biol	NNP	O	Biol	_	0	SENT_654	[p16l1921t3384r2136b3470],
3	.	.	O	.	_	0	SENT_654	[p16l1921t3384r2136b3470],

1	Chem	NNP	O	Chem	_	0	SENT_655	[p16l282t3514r563b3600],
2	.	.	O	.	_	0	SENT_655	[p16l282t3514r563b3600],

1	265:22	CD	NUMBER	265:22	num	2	SENT_656	[p16l621t3514r937b3600],
2	1-26	CD	NUMBER	1-26	_	0	SENT_656	[p16l956t3514r1171b3600],

1	Mickley	NNP	LOCATION	Mickley	nn	2	SENT_657	[p17l279t27r665b141],
2	LA	NNP	LOCATION	LA	_	0	SENT_657	[p17l733t34r913b127],
3	,	,	O	,	_	0	SENT_657	[p17l733t34r913b127],
4	Bates	NNP	PERSON	Bates	nn	5	SENT_657	[p17l984t31r1241b116],
5	SE	NN	PERSON	se	appos	2	SENT_657	[p17l1309t30r1468b131],
6	,	,	O	,	_	0	SENT_657	[p17l1309t30r1468b131],
7	Richert	NNP	PERSON	Richert	nn	8	SENT_657	[p17l1543t27r1881b116],
8	ND	NNP	O	ND	appos	2	SENT_657	[p17l1952t31r2143b131],
9	,	,	O	,	_	0	SENT_657	[p17l1952t31r2143b131],
10	Currier	NNP	PERSON	Currier	nn	11	SENT_657	[p17l279t159r616b242],
11	S	NNP	O	S	appos	2	SENT_657	[p17l649t159r734b259],
12	,	,	O	,	_	0	SENT_657	[p17l649t159r734b259],
13	Tanaka	NNP	PERSON	Tanaka	nn	14	SENT_657	[p17l771t159r1115b245],
14	S	NNP	O	S	appos	2	SENT_657	[p17l1152t159r1238b259],
15	,	,	O	,	_	0	SENT_657	[p17l1152t159r1238b259],
16	et	FW	O	et	nn	17	SENT_657	[p17l1274t173r1360b242],
17	al.	FW	O	al.	appos	2	SENT_657	[p17l1393t159r1496b245],
18	1989	CD	DATE	1989	dep	17	SENT_657	[p17l1554t156r1793b245],
19	.	.	O	.	_	0	SENT_657	[p17l1554t156r1793b245],

1	Modulation	NN	O	modulation	dep	10	SENT_658	[p17l1830t159r2146b242, p17l282t286r542b372],
2	of	IN	O	of	_	0	SENT_658	[p17l586t286r689b375],
3	the	DT	O	the	det	4	SENT_658	[p17l729t290r871b375],
4	expression	NN	O	expression	prep_of	1	SENT_658	[p17l911t286r1412b397],
5	of	IN	O	of	_	0	SENT_658	[p17l1456t290r1559b375],
6	a	DT	O	a	det	8	SENT_658	[p17l1596t311r1650b372],
7	multidrug	JJ	O	multidrug	amod	8	SENT_658	[p17l1690t286r2150b400],
8	resistance	NN	O	resistance	prep_of	4	SENT_658	[p17l279t415r738b504],
9	gene	NN	O	gene	dep	10	SENT_658	[p17l792t439r1007b532],
10	(	CD	NUMBER	(	dep	14	SENT_658	[p17l1061t415r2146b532],
11	mdr-1	NN	O	mdr-1	dep	10	SENT_658	[p17l1061t415r2146b532],
12	/	:	O	/	punct	14	SENT_658	[p17l1061t415r2146b532],
13	P-glycoprotein	NN	O	p-glycoprotein	nn	14	SENT_658	[p17l1061t415r2146b532],
14	)	NN	O	)	_	0	SENT_658	[p17l1061t415r2146b532],
15	by	IN	O	by	_	0	SENT_658	[p17l279t549r392b659],
16	differentiating	VBG	O	differentiate	prepc_by	14	SENT_658	[p17l425t547r1091b659],
17	agents	NNS	O	agent	dobj	16	SENT_658	[p17l1121t563r1440b659],
18	.	.	O	.	_	0	SENT_658	[p17l1121t563r1440b659],

1	J.	NNP	O	J.	nn	2	SENT_659	[p17l1477t552r1549b635],
2	Biol	NNP	O	Biol	_	0	SENT_659	[p17l1592t547r1800b631],
3	.	.	O	.	_	0	SENT_659	[p17l1592t547r1800b631],

1	Chem	NNP	O	Chem	_	0	SENT_660	[p17l1851t549r2136b635],
2	.	.	O	.	_	0	SENT_660	[p17l1851t549r2136b635],

1	264	CD	NUMBER	264	_	0	SENT_661	[p17l279t674r476b763],
2	:	:	O	:	_	0	SENT_661	[p17l279t674r476b763],
3	18031-40	CD	NUMBER	18031-40	dep	1	SENT_661	[p17l499t674r948b763],

1	Burt	NNP	PERSON	Burt	nn	2	SENT_662	[p17l282t806r486b889],
2	RK	NNP	PERSON	RK	_	0	SENT_662	[p17l523t806r710b906],
3	,	,	O	,	_	0	SENT_662	[p17l523t806r710b906],
4	Thorgeirsson	NNP	O	Thorgeirsson	nn	5	SENT_662	[p17l747t803r1360b913],
5	SS	NNP	O	SS	appos	2	SENT_662	[p17l1397t806r1545b892],
6	.	.	O	.	_	0	SENT_662	[p17l1397t806r1545b892],

1	1988	CD	DATE	1988	_	0	SENT_663	[p17l1603t803r1846b889],
2	.	.	O	.	_	0	SENT_663	[p17l1603t803r1846b889],

1	Coinduction	NN	O	coinduction	_	0	SENT_664	[p17l1886t803r2146b889, p17l282t932r630b1018],
2	of	IN	O	of	_	0	SENT_664	[p17l663t932r769b1018],
3	MDR-l	NN	O	mdr-l	prep_of	1	SENT_664	[p17l799t932r1150b1018],
4	multidmg-resistance	JJ	O	multidmg-resistance	amod	8	SENT_664	[p17l1194t932r2146b1042],
5	and	CC	O	and	_	0	SENT_664	[p17l282t1061r448b1147],
6	cytochrome	NN	O	cytochrome	conj_and	4	SENT_664	[p17l478t1061r1024b1172],
7	P-450	NN	MISC	p-450	nn	8	SENT_664	[p17l1058t1061r1339b1147],
8	genes	NNS	O	gene	dep	1	SENT_664	[p17l1365t1086r1629b1175],
9	in	IN	O	in	_	0	SENT_664	[p17l1662t1058r1748b1144],
10	rat	NN	O	rat	nn	11	SENT_664	[p17l1784t1075r1905b1147],
11	liver	NN	O	liver	prep_in	8	SENT_664	[p17l1935t1058r2153b1147],
12	by	IN	O	by	_	0	SENT_664	[p17l282t1194r392b1305],
13	xenobiotics	NNS	O	xenobiotic	prep_by	11	SENT_664	[p17l467t1191r1021b1280],
14	.	.	O	.	_	0	SENT_664	[p17l467t1191r1021b1280],

1	J.	NNP	O	J.	nn	4	SENT_665	[p17l1093t1194r1164b1277],
2	Natl.	NNP	O	Natl.	nn	4	SENT_665	[p17l1239t1194r1461b1280],
3	Cancer	NNP	O	Cancer	nn	4	SENT_665	[p17l1543t1191r1888b1280],
4	Inst	NNP	O	Inst	_	0	SENT_665	[p17l1945t1194r2139b1280],
5	.	.	O	.	_	0	SENT_665	[p17l1945t1194r2139b1280],

1	80:1383	CD	NUMBER	80:1383	_	0	SENT_666	[p17l285t1324r832b1410],
2	—	CD	NUMBER	—	num	3	SENT_666	[p17l285t1324r832b1410],
3	86	CD	NUMBER	86	dep	1	SENT_666	[p17l285t1324r832b1410],

1	Chaudhary	NNP	O	Chaudhary	nn	2	SENT_667	[p17l282t1454r783b1564],
2	PM	NNP	O	PM	_	0	SENT_667	[p17l827t1454r1017b1550],
3	,	,	O	,	_	0	SENT_667	[p17l827t1454r1017b1550],
4	Roninson	NNP	O	Roninson	nn	5	SENT_667	[p17l1061t1454r1503b1540],
5	IB	NNP	O	IB	appos	2	SENT_667	[p17l1540t1454r1674b1540],
6	.	.	O	.	_	0	SENT_667	[p17l1540t1454r1674b1540],

1	1993	CD	DATE	1993	_	0	SENT_668	[p17l1728t1454r1971b1540],
2	.	.	O	.	_	0	SENT_668	[p17l1728t1454r1971b1540],

1	Induction	NN	O	induction	_	0	SENT_669	[p17l2018t1457r2146b1536, p17l286t1583r633b1669],
2	of	IN	O	of	_	0	SENT_669	[p17l684t1583r787b1669],
3	multidrug	JJ	O	multidrug	amod	4	SENT_669	[p17l838t1583r1294b1693],
4	resistance	NN	O	resistance	prep_of	1	SENT_669	[p17l1344t1583r1800b1669],
5	in	IN	O	in	_	0	SENT_669	[p17l1858t1583r1947b1669],
6	human	JJ	O	human	amod	7	SENT_669	[p17l1997t1583r2150b1669, p17l285t1736r479b1798],
7	cells	NNS	O	cell	prep_in	1	SENT_669	[p17l569t1712r780b1798],
8	by	IN	O	by	_	0	SENT_669	[p17l869t1712r979b1822],
9	transient	JJ	O	transient	amod	10	SENT_669	[p17l1072t1712r1472b1798],
10	exposure	NN	O	exposure	prep_by	7	SENT_669	[p17l1557t1736r1975b1822],
11	to	TO	O	to	_	0	SENT_669	[p17l2064t1726r2153b1798],
12	different	JJ	O	different	amod	14	SENT_669	[p17l286t1841r682b1927],
13	chemotherapeutic	JJ	O	chemotherapeutic	amod	14	SENT_669	[p17l775t1841r1601b1951],
14	drugs	NNS	O	drug	prep_to	1	SENT_669	[p17l1694t1841r1971b1948],
15	.	.	O	.	_	0	SENT_669	[p17l1694t1841r1971b1948],

1	J.	NNP	O	J.	nn	4	SENT_670	[p17l2071t1844r2143b1927],
2	Natl.	NNP	O	Natl.	nn	4	SENT_670	[p17l282t1969r500b2052],
3	Cancer	NNP	O	Cancer	nn	4	SENT_670	[p17l562t1969r902b2055],
4	Inst	NNP	O	Inst	_	0	SENT_670	[p17l939t1969r1133b2052],
5	.	.	O	.	_	0	SENT_670	[p17l939t1969r1133b2052],

1	85	CD	NUMBER	85	_	0	SENT_671	[p17l1194t1969r1297b2055],
2	:63	CD	NUMBER	:63	num	3	SENT_671	[p17l1313t1969r1447b2055],
3	2-39	CD	NUMBER	2-39	dep	1	SENT_671	[p17l1456t1966r1681b2055],

1	Chin	NNP	O	Chin	_	0	SENT_672	[p17l286t2095r507b2184],
2	KV	NN	O	kv	dep	1	SENT_672	[p17l561t2098r748b2198],
3	,	,	O	,	_	0	SENT_672	[p17l561t2098r748b2198],
4	Chauhan	NNP	PERSON	Chauhan	nn	5	SENT_672	[p17l803t2095r1217b2184],
5	SS	NNP	O	SS	appos	2	SENT_672	[p17l1267t2095r1419b2198],
6	,	,	O	,	_	0	SENT_672	[p17l1267t2095r1419b2198],
7	Pastan	NNP	O	Pastan	nn	8	SENT_672	[p17l1473t2098r1772b2184],
8	I	NNP	O	I	appos	2	SENT_672	[p17l1823t2095r1884b2195],
9	,	,	O	,	_	0	SENT_672	[p17l1823t2095r1884b2195],
10	GotP-GLYCOPROTElNS	NNP	O	GotP-GLYCOPROTElNS	appos	2	SENT_672	[p17l1938t2095r2150b2184, p17l875t2406r1214b2434],

1	AND	CC	O	and	cc	2	SENT_673	[p17l1225t2407r1305b2434],
2	DRUG	NN	O	drug	_	0	SENT_673	[p17l1315t2407r1421b2435],
3	RESISTANCE	NN	O	resistance	dep	2	SENT_673	[p17l1431t2407r1659b2435],
4	179	CD	NUMBER	179	dep	2	SENT_673	[p17l1732t2407r1784b2435],

1	tesman	NN	O	tesman	_	0	SENT_674	[p17l625t2607r889b2663],
2	MM	NN	O	mm	dep	1	SENT_674	[p17l933t2599r1120b2663],
3	.	.	O	.	_	0	SENT_674	[p17l933t2599r1120b2663],

1	1990	CD	DATE	1990	_	0	SENT_675	[p17l1176t2596r1371b2666],
2	.	.	O	.	_	0	SENT_675	[p17l1176t2596r1371b2666],

1	Regulation	NN	O	regulation	_	0	SENT_676	[p17l1421t2596r1836b2683],
2	of	IN	O	of	_	0	SENT_676	[p17l1875t2596r1959b2666],
3	mdr	NN	O	mdr	nn	5	SENT_676	[p17l1995t2599r2147b2666],
4	RNA	NN	O	rna	nn	5	SENT_676	[p17l625t2690r821b2757],
5	levels	NNS	O	level	prep_of	1	SENT_676	[p17l879t2690r1097b2760],
6	in	IN	O	in	_	0	SENT_676	[p17l1156t2687r1226b2760],
7	response	NN	O	response	prep_in	5	SENT_676	[p17l1284t2710r1614b2780],
8	to	TO	O	to	_	0	SENT_676	[p17l1667t2701r1742b2760],
9	cytotoxic	JJ	O	cytotoxic	amod	10	SENT_676	[p17l1795t2690r2142b2780],
10	drugs	NNS	O	drug	prep_to	1	SENT_676	[p17l625t2786r829b2876],
11	in	IN	O	in	_	0	SENT_676	[p17l868t2786r938b2856],
12	rodent	JJ	O	rodent	amod	13	SENT_676	[p17l973t2786r1217b2856],
13	cells	NNS	O	cell	prep_in	1	SENT_676	[p17l1247t2786r1440b2859],
14	.	.	O	.	_	0	SENT_676	[p17l1247t2786r1440b2859],

1	Cell	NN	O	cell	nn	2	SENT_677	[p17l1481t2786r1637b2856],
2	Growth	NN	O	growth	_	0	SENT_677	[p17l1672t2786r1956b2856],
3	Differ	NNP	O	Differ	dep	2	SENT_677	[p17l1992t2786r2142b2876, p17l608t2892r744b2979],
4	.	.	O	.	_	0	SENT_677	[p17l1992t2786r2142b2876, p17l608t2892r744b2979],

1	1:361	CD	NUMBER	1:361	num	2	SENT_678	[p17l796t2895r1143b2965],
2	-65	CD	NUMBER	-65	_	0	SENT_678	[p17l796t2895r1143b2965],

1	36	CD	NUMBER	36	_	0	SENT_679	[p17l420t2984r532b3057],
2	.	.	O	.	_	0	SENT_679	[p17l420t2984r532b3057],

1	Thorgeirsson	NNP	O	Thorgeirsson	nn	2	SENT_680	[p17l622t2984r1123b3077],
2	SS	NNP	O	SS	_	0	SENT_680	[p17l1162t2987r1286b3068],
3	,	,	O	,	_	0	SENT_680	[p17l1162t2987r1286b3068],
4	Huber	NNP	PERSON	Huber	nsubj	5	SENT_680	[p17l1324t2987r1560b3057],
5	BE	VB	O	be	dep	2	SENT_680	[p17l1598t2987r1736b3071],
6	,	,	O	,	_	0	SENT_680	[p17l1598t2987r1736b3071],
7	Sorrel	NNP	O	Sorrel	nn	9	SENT_680	[p17l1778t2987r2030b3060],
8	]	CD	NUMBER	]	num	9	SENT_680	[p17l1778t2987r2030b3060],
9	S	NN	O	s	appos	2	SENT_680	[p17l2069t2987r2142b3071],
10	,	,	O	,	_	0	SENT_680	[p17l2069t2987r2142b3071],
11	Fojo	NNP	O	Fojo	nn	12	SENT_680	[p17l622t3083r795b3176],
12	A	NNP	O	A	appos	2	SENT_680	[p17l819t3086r909b3167],
13	,	,	O	,	_	0	SENT_680	[p17l819t3086r909b3167],
14	Pastan	NNP	PERSON	Pastan	appos	2	SENT_680	[p17l933t3086r1183b3156],
15	I	PRP	O	I	dep	14	SENT_680	[p17l1207t3086r1260b3167],
16	,	,	O	,	_	0	SENT_680	[p17l1207t3086r1260b3167],
17	Gottestnan	NNP	O	Gottestnan	nn	18	SENT_680	[p17l1287t3083r1691b3156],
18	MM	NN	O	mm	appos	2	SENT_680	[p17l1718t3086r1908b3156],
19	.	.	O	.	_	0	SENT_680	[p17l1718t3086r1908b3156],

1	1987	CD	DATE	1987	_	0	SENT_681	[p17l1946t3086r2139b3159],
2	.	.	O	.	_	0	SENT_681	[p17l1946t3086r2139b3159],

1	Expression	NN	O	expression	_	0	SENT_682	[p17l622t3179r1040b3269],
2	of	IN	O	of	_	0	SENT_682	[p17l1107t3179r1191b3249],
3	the	DT	O	the	det	5	SENT_682	[p17l1247t3179r1363b3249],
4	multidmg-resistant	JJ	O	multidmg-resistant	amod	5	SENT_682	[p17l1427t3179r2144b3269],
5	gene	NN	O	gene	prep_of	1	SENT_682	[p17l622t3295r801b3362],
6	in	IN	O	in	_	0	SENT_682	[p17l825t3272r895b3345],
7	hepatocarcinogenesis	NN	O	hepatocarcinogenesis	prep_in	5	SENT_682	[p17l919t3272r1725b3365],
8	and	CC	O	and	_	0	SENT_682	[p17l1749t3275r1885b3345],
9	regenerating	VBG	O	regenerate	amod	11	SENT_682	[p17l1906t3295r2142b3365, p17l622t3380r883b3470],
10	rat	NN	O	rat	nn	11	SENT_682	[p17l919t3394r1020b3450],
11	liver	NN	O	liver	conj_and	7	SENT_682	[p17l1059t3383r1251b3453],
12	.	.	O	.	_	0	SENT_682	[p17l1059t3383r1251b3453],

1	Science	NNP	O	Science	_	0	SENT_683	[p17l1290t3383r1580b3453],
2	236	CD	NUMBER	236	num	1	SENT_683	[p17l1615t3383r2113b3453],
3	:	:	O	:	_	0	SENT_683	[p17l1615t3383r2113b3453],
4	l120	CD	NUMBER	l120	num	5	SENT_683	[p17l1615t3383r2113b3453],
5	—	CD	NUMBER	—	dep	1	SENT_683	[p17l1615t3383r2113b3453],
6	22	CD	NUMBER	22	number	7	SENT_683	[p17l1615t3383r2113b3453],
7	37	CD	NUMBER	37	dep	5	SENT_683	[p17l420t3488r530b3558],
8	.	.	O	.	_	0	SENT_683	[p17l420t3488r530b3558],

1	Uchiumi	JJ	ORGANIZATION	uchiumi	amod	2	SENT_684	[p17l625t3485r952b3558],
2	T	NN	ORGANIZATION	t	_	0	SENT_684	[p17l1013t3488r1092b3569],
3	,	,	O	,	_	0	SENT_684	[p17l1013t3488r1092b3569],
4	Kohno	NNP	PERSON	Kohno	nn	5	SENT_684	[p17l1159t3488r1417b3558],
5	K	NNP	PERSON	K	appos	2	SENT_684	[p17l1475t3488r1562b3569],
6	,	,	O	,	_	0	SENT_684	[p17l1475t3488r1562b3569],
7	Tanimura	NNP	PERSON	Tanimura	nn	8	SENT_684	[p17l1624t3488r1993b3558],
8	H	NNP	PERSON	H	appos	2	SENT_684	[p17l2055t3488r2142b3569],
9	,	,	O	,	_	0	SENT_684	[p17l2055t3488r2142b3569],
10	Matsuo	NNP	PERSON	Matsuo	nn	11	SENT_684	[p17l622t3581r909b3651],
11	K	NNP	PERSON	K	appos	2	SENT_684	[p17l933t3581r1020b3662],
12	,	,	O	,	_	0	SENT_684	[p17l933t3581r1020b3662],
13	Sato	NNP	PERSON	Sato	nn	14	SENT_684	[p17l1047t3581r1211b3651],
14	S	NNP	O	S	appos	2	SENT_684	[p17l1239t3581r1308b3662],
15	,	,	O	,	_	0	SENT_684	[p17l1239t3581r1308b3662],
16	et	FW	O	et	nn	17	SENT_684	[p17l1336t3592r1403b3651],
17	al.	FW	O	al.	appos	2	SENT_684	[p17l1427t3581r1511b3651],
18	1993	CD	DATE	1993	dep	17	SENT_684	[p17l1550t3581r1745b3653],
19	.	.	O	.	_	0	SENT_684	[p17l1550t3581r1745b3653],

1	Enhanced	VBN	O	enhance	_	0	SENT_685	[p17l1775t3581r2147b3651],

1	Annu	NNP	PERSON	Annu	_	0	SENT_686	[p18l6t3422r72b3650],
2	.	.	O	.	_	0	SENT_686	[p18l6t3422r72b3650],

1	Rev.	NNP	O	Rev.	nn	2	SENT_687	[p18l7t3221r72b3391],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_687	[p18l6t2767r72b3190],
3	.	.	O	.	_	0	SENT_687	[p18l6t2767r72b3190],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_688	[p18l6t2423r72b2736],
2	.	.	O	.	_	0	SENT_688	[p18l6t2423r72b2736],

1	1996.36	CD	NUMBER	1996.36	_	0	SENT_689	[p18l6t2065r73b2383],
2	:	:	O	:	_	0	SENT_689	[p18l6t2065r73b2383],
3	161-183	CD	NUMBER	161-183	dep	1	SENT_689	[p18l6t1724r73b2048],
4	.	.	O	.	_	0	SENT_689	[p18l6t1724r73b2048],

1	Downloaded	VBN	O	download	_	0	SENT_690	[p18l6t1208r73b1692],
2	from	IN	O	from	_	0	SENT_690	[p18l6t999r72b1182],
3	www.annualreViews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_690	[p18l6t49r92b974],
4	by	IN	O	by	_	0	SENT_690	[p18l101t3172r187b3265],
5	University	NNP	ORGANIZATION	University	prep_by	1	SENT_690	[p18l101t2747r187b3145],
6	of	IN	ORGANIZATION	of	_	0	SENT_690	[p18l101t2637r167b2719],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_690	[p18l101t2218r167b2619],
8	-	:	O	-	_	0	SENT_690	[p18l141t2165r148b2190],
9	Madison	NNP	O	Madison	dep	7	SENT_690	[p18l101t1806r167b2137],
10	on	IN	O	on	_	0	SENT_690	[p18l122t1687r167b1779],
11	01/O5	NNP	O	01/O5	prep_on	9	SENT_690	[p18l100t1418r168b1660],
12	/	:	O	/	punct	9	SENT_690	[p18l100t1418r168b1660],
13	14	CD	NUMBER	14	dep	18	SENT_690	[p18l101t1326r166b1409],
14	For	IN	O	for	_	0	SENT_690	[p18l103t1144r167b1275],
15	personal	JJ	O	personal	amod	16	SENT_690	[p18l101t800r187b1121],
16	use	NN	O	use	prep_for	13	SENT_690	[p18l122t650r167b774],
17	only	RB	O	only	advmod	18	SENT_690	[p18l101t457r187b622],
18	expression	NN	O	expression	rcmod	5	SENT_690	[p18l622t16r1029b106],
19	of	IN	O	of	_	0	SENT_690	[p18l1065t16r1149b86],
20	the	DT	O	the	det	25	SENT_690	[p18l1182t16r1297b86],
21	human	JJ	O	human	amod	25	SENT_690	[p18l1336t16r1591b86],
22	multidrug	JJ	O	multidrug	amod	25	SENT_690	[p18l1632t16r2005b106],
23	resistance	NN	O	resistance	nn	25	SENT_690	[p18l2037t39r2142b86, p18l625t110r920b180],
24	1	CD	NUMBER	1	num	25	SENT_690	[p18l962t113r989b180],
25	gene	NN	O	gene	prep_of	18	SENT_690	[p18l1030t133r1209b200],
26	in	IN	O	in	dep	18	SENT_690	[p18l1241t110r1311b180],
27	response	NN	O	response	pobj	26	SENT_690	[p18l1341t133r1671b203],
28	to	TO	O	to	_	0	SENT_690	[p18l1704t124r1776b183],
29	UV	NN	O	uv	nn	31	SENT_690	[p18l1806t113r1942b183],
30	light	NN	O	light	nn	31	SENT_690	[p18l1972t110r2144b203],
31	irradiation	NN	O	irradiation	prep_to	1	SENT_690	[p18l625t204r1035b274],
32	.	.	O	.	_	0	SENT_690	[p18l625t204r1035b274],

1	Cell	NN	O	cell	_	0	SENT_691	[p18l1082t204r1237b271],
2	Growth	NN	O	growth	nn	3	SENT_691	[p18l1276t204r1560b274],
3	Drjfer	NN	O	drjfer	dep	1	SENT_691	[p18l1595t204r1839b291],
4	.	.	O	.	_	0	SENT_691	[p18l1595t204r1839b291],

1	4	CD	NUMBER	4	_	0	SENT_692	[p18l1881t207r1950b274],
2	:	:	O	:	_	0	SENT_692	[p18l1881t207r1950b274],
3	14757	CD	NUMBER	14757	dep	1	SENT_692	[p18l1966t207r2147b274, p18l625t301r712b371],

1	Chin	NNP	O	Chin	_	0	SENT_693	[p18l625t395r806b465],
2	KV	NN	O	kv	dep	1	SENT_693	[p18l836t398r992b476],
3	,	,	O	,	_	0	SENT_693	[p18l836t398r992b476],
4	Ueda	NNP	PERSON	Ueda	nn	5	SENT_693	[p18l1027t395r1229b465],
5	K	NNP	PERSON	K	appos	2	SENT_693	[p18l1259t398r1346b476],
6	,	,	O	,	_	0	SENT_693	[p18l1259t398r1346b476],
7	Pastan	NNP	O	Pastan	appos	2	SENT_693	[p18l1378t398r1622b465],
8	I	PRP	O	I	dep	7	SENT_693	[p18l1652t398r1702b476],
9	,	,	O	,	_	0	SENT_693	[p18l1652t398r1702b476],
10	Gottesman	NNP	PERSON	Gottesman	appos	2	SENT_693	[p18l1738t395r2144b465],

1	MM	NN	O	mm	_	0	SENT_694	[p18l625t492r809b559],
2	.	.	O	.	_	0	SENT_694	[p18l625t492r809b559],

1	1992	CD	DATE	1992	_	0	SENT_695	[p18l873t489r1069b559],
2	.	.	O	.	_	0	SENT_695	[p18l873t489r1069b559],

1	Modulation	NN	O	modulation	_	0	SENT_696	[p18l1122t489r1562b559],
2	of	IN	O	of	_	0	SENT_696	[p18l1609t489r1696b559],
3	activity	NN	O	activity	prep_of	1	SENT_696	[p18l1738t489r2019b579],
4	of	IN	O	of	_	0	SENT_696	[p18l2066t489r2150b559],
5	the	DT	O	the	det	6	SENT_696	[p18l622t586r738b653],
6	promoter	NN	O	promoter	prep_of	1	SENT_696	[p18l765t597r1114b673],
7	of	IN	O	of	_	0	SENT_696	[p18l1142t583r1229b653],
8	the	DT	O	the	det	11	SENT_696	[p18l1250t586r1363b653],
9	human	JJ	O	human	amod	11	SENT_696	[p18l1393t586r1648b653],
10	MDRI	NN	O	mdrus	nn	11	SENT_696	[p18l1675t586r1933b656],
11	gene	NN	O	gene	prep_of	6	SENT_696	[p18l1969t609r2142b673],
12	by	IN	O	by	_	0	SENT_696	[p18l625t680r715b770],
13	Ras	NN	PERSON	ra	prep_by	11	SENT_696	[p18l754t680r892b750],
14	and	CC	O	and	_	0	SENT_696	[p18l930t680r1069b750],
15	p53	NN	O	p53	conj_and	13	SENT_696	[p18l1104t680r1266b770],
16	.	.	O	.	_	0	SENT_696	[p18l1104t680r1266b770],

1	Science	NNP	O	Science	nn	6	SENT_697	[p18l1304t680r1591b750],
2	255:459	CD	NUMBER	255:459	num	6	SENT_697	[p18l1632t680r2079b753],
3	—	CD	NUMBER	—	num	6	SENT_697	[p18l1632t680r2079b753],
4	62	CD	NUMBER	62	num	6	SENT_697	[p18l1632t680r2079b753],
5	Zastawny	NNP	ORGANIZATION	Zastawny	nn	6	SENT_697	[p18l625t777r989b867],
6	RL	NNP	ORGANIZATION	RL	_	0	SENT_697	[p18l1070t777r1209b858],
7	,	,	O	,	_	0	SENT_697	[p18l1070t777r1209b858],
8	Salvino	NNP	PERSON	Salvino	nn	9	SENT_697	[p18l1290t774r1574b847],
9	R	NNP	PERSON	R	appos	6	SENT_697	[p18l1652t777r1734b858],
10	,	,	O	,	_	0	SENT_697	[p18l1652t777r1734b858],
11	Chen	NNP	PERSON	Chen	nn	12	SENT_697	[p18l1812t777r2013b847],
12	J	NNP	PERSON	J	appos	6	SENT_697	[p18l2083t777r2142b858],
13	,	,	O	,	_	0	SENT_697	[p18l2083t777r2142b858],
14	Benchimol	NNP	O	Benchimol	nn	15	SENT_697	[p18l625t874r1035b944],
15	S	NNP	O	S	appos	6	SENT_697	[p18l1084t877r1157b958],
16	,	,	O	,	_	0	SENT_697	[p18l1084t877r1157b958],
17	Ling	NNP	O	Ling	nn	18	SENT_697	[p18l1204t877r1380b967],
18	V	NNP	O	V	appos	6	SENT_697	[p18l1427t877r1491b944],
19	1993	CD	DATE	1993	dep	18	SENT_697	[p18l1547t874r1745b947],
20	.	.	O	.	_	0	SENT_697	[p18l1547t874r1745b947],

1	The	DT	O	the	det	4	SENT_698	[p18l1792t877r1939b944],
2	core	NN	O	core	nn	4	SENT_698	[p18l1983t897r2144b944],
3	promoter	NN	O	promoter	nn	4	SENT_698	[p18l625t982r972b1058],
4	region	NN	O	region	nsubj	10	SENT_698	[p18l1016t971r1257b1061],
5	of	IN	O	of	_	0	SENT_698	[p18l1301t968r1386b1038],
6	the	DT	O	the	det	8	SENT_698	[p18l1427t971r1537b1038],
7	P-glycoprotein	NN	MISC	p-glycoprotein	nn	8	SENT_698	[p18l1584t971r2144b1061],
8	gene	NN	O	gene	prep_of	4	SENT_698	[p18l625t1085r803b1152],
9	is	VBZ	O	be	cop	10	SENT_698	[p18l842t1062r903b1132],
10	sufficient	JJ	O	sufficient	_	0	SENT_698	[p18l945t1062r1297b1132],
11	to	TO	O	to	aux	12	SENT_698	[p18l1338t1077r1411b1132],
12	confer	VB	O	confer	xcomp	10	SENT_698	[p18l1444t1062r1688b1132],
13	differential	JJ	O	differential	amod	14	SENT_698	[p18l1726t1062r2142b1132],
14	responsiveness	NN	O	responsiveness	dobj	12	SENT_698	[p18l625t1159r1189b1249],
15	to	TO	O	to	_	0	SENT_698	[p18l1221t1174r1294b1229],
16	wild	JJ	O	wild	amod	18	SENT_698	[p18l1327t1159r1688b1249],
17	—	NN	O	—	nn	18	SENT_698	[p18l1327t1159r1688b1249],
18	type	NN	O	type	prep_to	12	SENT_698	[p18l1327t1159r1688b1249],
19	and	CC	O	and	_	0	SENT_698	[p18l1718t1159r1853b1229],
20	mutant	JJ	O	mutant	amod	21	SENT_698	[p18l1883t1171r2144b1229],
21	p53	NN	O	p53	conj_and	18	SENT_698	[p18l625t1253r784b1343],
22	.	.	O	.	_	0	SENT_698	[p18l625t1253r784b1343],

1	Oncogene	NN	ORGANIZATION	oncogene	_	0	SENT_699	[p18l828t1256r1211b1340],
2	8	CD	NUMBER	8	num	1	SENT_699	[p18l1250t1253r1648b1326],
3	:	:	O	:	_	0	SENT_699	[p18l1250t1253r1648b1326],
4	l529	CD	NUMBER	l529	num	8	SENT_699	[p18l1250t1253r1648b1326],
5	—	CD	NUMBER	—	num	8	SENT_699	[p18l1250t1253r1648b1326],
6	35	CD	NUMBER	35	num	8	SENT_699	[p18l1250t1253r1648b1326],
7	El	NNP	LOCATION	El	nn	8	SENT_699	[p18l625t1348r704b1418],
8	Rouby	NNP	LOCATION	Rouby	dep	1	SENT_699	[p18l771t1348r1023b1437],
9	S	NN	LOCATION	s	dep	1	SENT_699	[p18l1087t1348r1160b1429],
10	,	,	O	,	_	0	SENT_699	[p18l1087t1348r1160b1429],
11	Thomas	NNP	PERSON	Thomas	nn	12	SENT_699	[p18l1224t1350r1525b1418],
12	A	NNP	PERSON	A	appos	1	SENT_699	[p18l1592t1350r1679b1429],
13	,	,	O	,	_	0	SENT_699	[p18l1592t1350r1679b1429],
14	Costin	NNP	PERSON	Costin	nn	15	SENT_699	[p18l1746t1348r1990b1418],
15	D	NNP	O	D	appos	1	SENT_699	[p18l2057t1350r2142b1429],
16	,	,	O	,	_	0	SENT_699	[p18l2057t1350r2142b1429],
17	Rosenberg	NNP	PERSON	Rosenberg	nn	18	SENT_699	[p18l625t1445r1029b1534],
18	CR	NN	O	cr	appos	1	SENT_699	[p18l1053t1445r1200b1526],
19	,	,	O	,	_	0	SENT_699	[p18l1053t1445r1200b1526],
20	Potesmil	NN	O	potesmil	nn	21	SENT_699	[p18l1233t1445r1562b1515],
21	M	NN	O	m	appos	1	SENT_699	[p18l1589t1447r1691b1526],
22	,	,	O	,	_	0	SENT_699	[p18l1589t1447r1691b1526],
23	et	FW	O	et	nn	24	SENT_699	[p18l1724t1456r1791b1515],
24	al.	FW	O	al.	appos	1	SENT_699	[p18l1818t1445r1905b1515],
25	1993	CD	DATE	1993	dep	24	SENT_699	[p18l1946t1445r2142b1515],
26	.	.	O	.	_	0	SENT_699	[p18l1946t1445r2142b1515],

1	p53	NN	O	p53	nn	3	SENT_700	[p18l625t1539r764b1629],
2	gene	NN	O	gene	nn	3	SENT_700	[p18l822t1559r1000b1629],
3	mutation	NN	O	mutation	nsubj	16	SENT_700	[p18l1059t1539r1394b1609],
4	in	IN	O	in	_	0	SENT_700	[p18l1450t1539r1520b1609],
5	B-cell	NN	MISC	b-cell	nn	8	SENT_700	[p18l1578t1539r1805b1609],
6	chronic	JJ	O	chronic	amod	8	SENT_700	[p18l1863t1539r2144b1609],
7	lymphocytic	JJ	O	lymphocytic	amod	8	SENT_700	[p18l625t1633r1097b1723],
8	leukemia	NN	O	leukemia	prep_in	3	SENT_700	[p18l1122t1633r1465b1703],
9	is	VBZ	O	be	auxpass	10	SENT_700	[p18l1487t1633r1548b1703],
10	associated	VBN	O	associate	_	0	SENT_700	[p18l1570t1633r1962b1703],
11	with	IN	O	with	_	0	SENT_700	[p18l1978t1633r2144b1703],
12	drug	NN	O	drug	nn	13	SENT_700	[p18l625t1733r798b1820],
13	resistance	NN	O	resistance	prep_with	10	SENT_700	[p18l845t1733r1220b1803],
14	and	CC	O	and	_	0	SENT_700	[p18l1267t1733r1400b1800],
15	is	VBZ	O	be	cop	16	SENT_700	[p18l1450t1733r1511b1800],
16	independent	JJ	O	independent	conj_and	10	SENT_700	[p18l1561t1733r2022b1823],
17	of	IN	O	of	_	0	SENT_700	[p18l2069t1733r2150b1800],
18	MDR1/MDR3	NN	O	mdr1/mdr3	nn	20	SENT_700	[p18l625t1827r1177b1897],
19	gene	NN	O	gene	nn	20	SENT_700	[p18l1224t1847r1400b1917],
20	expression	NN	O	expression	prep_of	16	SENT_700	[p18l1450t1824r1871b1917],
21	.	.	O	.	_	0	SENT_700	[p18l1450t1824r1871b1917],

1	Blood	NN	O	blood	_	0	SENT_701	[p18l1920t1824r2153b1894],
2	82:3452	CD	NUMBER	82:3452	num	1	SENT_701	[p18l628t1921r1075b1994],
3	--	:	O	--	_	0	SENT_701	[p18l628t1921r1075b1994],
4	59	CD	NUMBER	59	dep	1	SENT_701	[p18l628t1921r1075b1994],

1	Chen	NNP	PERSON	Chen	nn	3	SENT_702	[p18l625t2018r823b2088],
2	C	NNP	O	C	nn	3	SENT_702	[p18l859t2018r980b2099],
3	]	NN	O	]	_	0	SENT_702	[p18l859t2018r980b2099],
4	,	,	O	,	_	0	SENT_702	[p18l859t2018r980b2099],
5	Chin	NNP	O	Chin	nn	6	SENT_702	[p18l1019t2018r1200b2088],
6	JE	NNP	O	JE	appos	3	SENT_702	[p18l1239t2018r1351b2099],
7	,	,	O	,	_	0	SENT_702	[p18l1239t2018r1351b2099],
8	Ueda	NNP	PERSON	Ueda	nn	9	SENT_702	[p18l1393t2018r1591b2088],
9	K	NNP	O	K	appos	3	SENT_702	[p18l1632t2018r1716b2099],
10	,	,	O	,	_	0	SENT_702	[p18l1632t2018r1716b2099],
11	Clark	NNP	PERSON	Clark	nn	12	SENT_702	[p18l1755t2018r1968b2088],
12	DP	NN	O	dp	appos	9	SENT_702	[p18l2003t2021r2144b2099],
13	,	,	O	,	_	0	SENT_702	[p18l2003t2021r2144b2099],

1	Pastan	NNP	O	Pastan	nn	2	SENT_703	[p18l625t2115r872b2185],
2	I	NNP	O	I	_	0	SENT_703	[p18l896t2115r946b2196],
3	,	,	O	,	_	0	SENT_703	[p18l896t2115r946b2196],
4	et	FW	O	et	nn	5	SENT_703	[p18l973t2124r1037b2185],
5	al.	FW	O	al.	appos	2	SENT_703	[p18l1062t2112r1146b2185],
6	1986	CD	DATE	1986	dep	5	SENT_703	[p18l1182t2112r1380b2185],
7	.	.	O	.	_	0	SENT_703	[p18l1182t2112r1380b2185],

1	Intemal	JJ	O	intemal	amod	2	SENT_704	[p18l1407t2115r1696b2185],
2	duplication	NN	O	duplication	_	0	SENT_704	[p18l1721t2112r2147b2205],
3	and	CC	O	and	_	0	SENT_704	[p18l628t2212r761b2279],
4	homology	NN	O	homology	conj_and	2	SENT_704	[p18l805t2212r1186b2302],
5	with	IN	O	with	_	0	SENT_704	[p18l1233t2212r1400b2279],
6	bacterial	JJ	O	bacterial	amod	8	SENT_704	[p18l1444t2212r1765b2279],
7	transport	NN	O	transport	nn	8	SENT_704	[p18l1812t2224r2147b2302],
8	proteins	NNS	O	protein	prep_with	2	SENT_704	[p18l625t2306r929b2393],
9	in	IN	O	in	_	0	SENT_704	[p18l982t2306r1052b2373],
10	the	DT	O	the	det	15	SENT_704	[p18l1107t2306r1220b2376],
11	mdrl	NN	O	mdrl	nn	15	SENT_704	[p18l1276t2306r1460b2376],
12	(	NN	O	(	nn	15	SENT_704	[p18l1524t2306r2144b2396],
13	P-glycoprotein	NN	O	p-glycoprotein	nn	15	SENT_704	[p18l1524t2306r2144b2396],
14	)	NN	O	)	nn	15	SENT_704	[p18l1524t2306r2144b2396],
15	gene	NN	O	gene	prep_in	2	SENT_704	[p18l625t2420r803b2490],
16	from	IN	O	from	_	0	SENT_704	[p18l865t2400r1046b2470],
17	multidrug-resistant	JJ	O	multidrug-resistant	amod	19	SENT_704	[p18l1110t2400r1828b2490],
18	human	JJ	O	human	amod	19	SENT_704	[p18l1892t2400r2147b2470],
19	cells	NNS	O	cell	prep_from	2	SENT_704	[p18l625t2500r818b2567],
20	.	.	O	.	_	0	SENT_704	[p18l625t2500r818b2567],

1	Cell	NN	O	cell	_	0	SENT_705	[p18l859t2497r1018b2567],
2	47:38	CD	NUMBER	47:38	number	3	SENT_705	[p18l1050t2497r1457b2570],
3	]	CD	NUMBER	]	dep	1	SENT_705	[p18l1050t2497r1457b2570],
4	-89	CD	NUMBER	-89	dep	3	SENT_705	[p18l1050t2497r1457b2570],

1	Gerlach	NNP	PERSON	Gerlach	nn	2	SENT_706	[p18l628t2592r923b2664],
2	JH	NNP	O	JH	_	0	SENT_706	[p18l967t2594r1094b2676],
3	,	,	O	,	_	0	SENT_706	[p18l967t2594r1094b2676],
4	Endicott	NNP	PERSON	Endicott	nn	5	SENT_706	[p18l1144t2592r1463b2664],
5	JA	NNP	O	JA	dep	2	SENT_706	[p18l1507t2594r1631b2676],
6	,	,	O	,	_	0	SENT_706	[p18l1507t2594r1631b2676],
7	Juranka	NNP	PERSON	Juranka	nn	8	SENT_706	[p18l1681t2594r1976b2664],
8	PF	NNP	O	PF	appos	5	SENT_706	[p18l2020t2594r2144b2676],
9	,	,	O	,	_	0	SENT_706	[p18l2020t2594r2144b2676],

1	Henderson	NNP	PERSON	Henderson	nn	2	SENT_707	[p18l625t2689r1037b2758],
2	G	NNP	O	G	_	0	SENT_707	[p18l1084t2689r1172b2767],
3	,	,	O	,	_	0	SENT_707	[p18l1084t2689r1172b2767],
4	Sarangi	NNP	PERSON	Sarangi	nn	5	SENT_707	[p18l1224t2689r1508b2776],
5	F	NN	O	f	appos	2	SENT_707	[p18l1558t2689r1634b2767],
6	,	,	O	,	_	0	SENT_707	[p18l1558t2689r1634b2767],
7	et	FW	O	et	nn	8	SENT_707	[p18l1681t2700r1751b2758],
8	al.	FW	O	al.	appos	2	SENT_707	[p18l1798t2689r1882b2758],
9	1986	CD	DATE	1986	dep	8	SENT_707	[p18l1946t2689r2142b2758],
10	.	.	O	.	_	0	SENT_707	[p18l1946t2689r2142b2758],

1	Homology	NN	O	homology	nsubj	10	SENT_708	[p18l628t2783r1032b2873],
2	between	IN	O	between	_	0	SENT_708	[p18l1062t2786r1377b2853],
3	P-glycoprotein	NN	MISC	p-glycoprotein	prep_between	1	SENT_708	[p18l1415t2783r1976b2873],
4	and	CC	O	and	_	0	SENT_708	[p18l2012t2786r2147b2853],
5	a	DT	O	a	det	9	SENT_708	[p18l628t2897r669b2947],
6	bacterial	JJ	O	bacterial	amod	9	SENT_708	[p18l696t2877r1020b2947],
7	haemolysin	NN	O	haemolysin	nn	9	SENT_708	[p18l1053t2877r1488b2967],
8	transport	NN	O	transport	nn	9	SENT_708	[p18l1515t2888r1851b2967],
9	protein	NN	O	protein	prep_between	1	SENT_708	[p18l1878t2877r2147b2967],
10	suggests	VBZ	O	suggest	_	0	SENT_708	[p18l628t2982r943b3061],
11	a	DT	O	a	det	12	SENT_708	[p18l993t2994r1035b3041],
12	model	NN	O	model	dobj	10	SENT_708	[p18l1082t2974r1317b3041],
13	for	IN	O	for	_	0	SENT_708	[p18l1367t2971r1477b3041],
14	multidrug	JJ	O	multidrug	amod	15	SENT_708	[p18l1527t2971r1896b3064],
15	resistance	NN	O	resistance	prep_for	12	SENT_708	[p18l1946t2971r2144b3041, p18l628t3079r843b3138],
16	.	.	O	.	_	0	SENT_708	[p18l1946t2971r2144b3041, p18l628t3079r843b3138],

1	Nature	NNP	O	Nature	_	0	SENT_709	[p18l885t3071r1149b3138],
2	324:485	CD	NUMBER	324:485	number	3	SENT_709	[p18l1187t3068r1634b3141],
3	—	CD	NUMBER	—	dep	1	SENT_709	[p18l1187t3068r1634b3141],
4	89	CD	NUMBER	89	dep	3	SENT_709	[p18l1187t3068r1634b3141],

1	Gros	NNS	O	gro	nn	2	SENT_710	[p18l628t3162r806b3235],
2	P	NN	O	p	_	0	SENT_710	[p18l862t3165r932b3246],
3	,	,	O	,	_	0	SENT_710	[p18l862t3165r932b3246],
4	Croop	NN	PERSON	croop	nn	5	SENT_710	[p18l987t3165r1223b3255],
5	J	NN	PERSON	j	appos	2	SENT_710	[p18l1273t3165r1328b3246],
6	,	,	O	,	_	0	SENT_710	[p18l1273t3165r1328b3246],
7	Housman	NNP	PERSON	Housman	nn	8	SENT_710	[p18l1381t3165r1745b3235],
8	D.	NNP	O	D.	appos	2	SENT_710	[p18l1795t3165r1879b3235],
9	1986	CD	DATE	1986	dep	8	SENT_710	[p18l1946t3165r2142b3235],
10	.	.	O	.	_	0	SENT_710	[p18l1946t3165r2142b3235],

1	Mammalian	JJ	O	mammalian	amod	4	SENT_711	[p18l625t3259r1083b3329],
2	multidrug	JJ	O	multidrug	amod	4	SENT_711	[p18l1122t3259r1494b3349],
3	resistance	NN	O	resistance	nn	4	SENT_711	[p18l1532t3259r1908b3332],
4	gene	NN	O	gene	_	0	SENT_711	[p18l1943t3282r2139b3349],
5	:	:	O	:	_	0	SENT_711	[p18l1943t3282r2139b3349],
6	Complete	JJ	O	complete	amod	8	SENT_711	[p18l625t3359r995b3449],
7	CDNA	JJ	ORGANIZATION	cdna	amod	8	SENT_711	[p18l1070t3362r1314b3429],
8	sequence	NN	O	sequence	nsubj	9	SENT_711	[p18l1393t3382r1736b3452],
9	indicates	VBZ	O	indicate	dep	4	SENT_711	[p18l1812t3359r2144b3429],
10	strong	JJ	O	strong	amod	11	SENT_711	[p18l628t3464r861b3543],
11	homology	NN	O	homology	dobj	9	SENT_711	[p18l905t3453r1288b3543],
12	to	TO	O	to	_	0	SENT_711	[p18l1330t3467r1403b3523],
13	bacterial	JJ	O	bacterial	amod	15	SENT_711	[p18l1444t3453r1768b3523],
14	transport	NN	O	transport	nn	15	SENT_711	[p18l1815t3467r2147b3546],
15	proteins	NNS	O	protein	prep_to	9	SENT_711	[p18l625t3547r949b3640],
16	.	.	O	.	_	0	SENT_711	[p18l625t3547r949b3640],

1	Cell	NN	O	cell	dep	6	SENT_712	[p18l993t3547r1149b3617],
2	47:371	CD	NUMBER	47:371	dep	1	SENT_712	[p18l1182t3550r1591b3620],
3	—	CD	NUMBER	—	num	4	SENT_712	[p18l1182t3550r1591b3620],
4	8O	NN	O	8o	dep	6	SENT_712	[p18l1182t3550r1591b3620],
5	Ambudkar	NNP	O	Ambudkar	nn	6	SENT_712	[p18l628t3647r1032b3717],
6	SV	NNP	O	SV	_	0	SENT_712	[p18l1087t3647r1229b3731],
7	,	,	O	,	_	0	SENT_712	[p18l1087t3647r1229b3731],
8	Lelong	NNP	PERSON	Lelong	nn	9	SENT_712	[p18l1287t3647r1554b3737],
9	IH	NN	O	ih	appos	6	SENT_712	[p18l1612t3650r1731b3728],
10	,	,	O	,	_	0	SENT_712	[p18l1612t3650r1731b3728],
11	Zhang	NNP	PERSON	Zhang	nn	12	SENT_712	[p18l1789t3647r2030b3737],
12	J	NNP	PERSON	J	appos	6	SENT_712	[p18l2086t3650r2144b3728],
13	,	,	O	,	_	0	SENT_712	[p18l2086t3650r2144b3728],
14	Cardarelli	NNP	ORGANIZATION	Cardarelli	nn	15	SENT_712	[p18l625t3741r1000b3814],
15	Co	NNP	ORGANIZATION	Co	appos	6	SENT_712	[p18l1042t3741r1192b3825],
16	,	,	O	,	_	0	SENT_712	[p18l1042t3741r1192b3825],
17	Gottesman	NNP	PERSON	Gottesman	nn	18	SENT_712	[p18l1233t3744r1639b3814],
18	MM	NN	O	mm	appos	6	SENT_712	[p18l1672t3744r1862b3825],
19	,	,	O	,	_	0	SENT_712	[p18l1672t3744r1862b3825],
20	Pastan	NNP	PERSON	Pastan	appos	6	SENT_712	[p18l1903t3744r2147b3814],

1	I.	NN	O	i.	_	0	SENT_713	[p19l628t14r675b84],
2	1992	CD	DATE	1992	dep	1	SENT_713	[p19l725t14r923b87],
3	.	.	O	.	_	0	SENT_713	[p19l725t14r923b87],

1	Partial	JJ	O	partial	amod	2	SENT_714	[p19l970t11r1214b84],
2	puriﬁcation	NN	O	puriﬁcation	_	0	SENT_714	[p19l1253t14r1694b104],
3	and	CC	O	and	_	0	SENT_714	[p19l1735t14r1868b84],
4	reconstitution	NN	O	reconstitution	conj_and	2	SENT_714	[p19l1909t37r2144b84, p19l628t122r935b192],
5	of	IN	O	of	_	0	SENT_714	[p19l976t122r1057b192],
6	the	DT	O	the	det	9	SENT_714	[p19l1090t122r1206b192],
7	human	JJ	O	human	amod	9	SENT_714	[p19l1244t122r1502b192],
8	multidrugresistance	NN	O	multidrugresistance	nn	9	SENT_714	[p19l1538t122r2144b212, p19l628t238r823b294],
9	pump	NN	O	pump	prep_of	2	SENT_714	[p19l896t247r1132b317],
10	:	:	O	:	_	0	SENT_714	[p19l896t247r1132b317],
11	characterization	NN	O	characterization	dep	2	SENT_714	[p19l1207t227r1813b297],
12	of	IN	O	of	_	0	SENT_714	[p19l1886t227r1968b297],
13	the	DT	O	the	det	16	SENT_714	[p19l2032t230r2144b297],
14	drug-stimulatable	JJ	O	drug-stimulatable	amod	16	SENT_714	[p19l625t332r1294b419],
15	ATP	NN	ORGANIZATION	atp	nn	16	SENT_714	[p19l1427t335r1602b402],
16	hydrolysis	NN	O	hydrolysis	prep_of	11	SENT_714	[p19l1732t332r2142b422],
17	.	.	O	.	_	0	SENT_714	[p19l1732t332r2142b422],

1	Proc	NNP	O	Proc	_	0	SENT_715	[p19l625t429r821b496],
2	.	.	O	.	_	0	SENT_715	[p19l625t429r821b496],

1	Natl.	NNP	O	Natl.	nn	2	SENT_716	[p19l862t426r1040b496],
2	Acad	NNP	O	Acad	_	0	SENT_716	[p19l1073t429r1289b496],
3	.	.	O	.	_	0	SENT_716	[p19l1073t429r1289b496],

1	Sci	NNP	O	Sci	_	0	SENT_717	[p19l1327t429r1454b499],
2	.	.	O	.	_	0	SENT_717	[p19l1327t429r1454b499],

1	USA	NNP	LOCATION	USA	_	0	SENT_718	[p19l1498t429r1662b499],
2	89:8472	CD	NUMBER	89:8472	number	3	SENT_718	[p19l1698t429r2150b502],
3	—	CD	NUMBER	—	dep	1	SENT_718	[p19l1698t429r2150b502],
4	76	CD	NUMBER	76	dep	3	SENT_718	[p19l1698t429r2150b502],

1	45	CD	NUMBER	45	_	0	SENT_719	[p19l417t534r532b604],
2	.	.	O	.	_	0	SENT_719	[p19l417t534r532b604],

1	Yoshimura	NNP	PERSON	Yoshimura	nn	2	SENT_720	[p19l628t534r1046b604],
2	A	NNP	O	A	_	0	SENT_720	[p19l1079t537r1169b615],
3	,	,	O	,	_	0	SENT_720	[p19l1079t537r1169b615],
4	Kuwazunn	NNP	O	Kuwazunn	nn	5	SENT_720	[p19l1207t537r1597b604],
5	Y	NN	O	y	appos	2	SENT_720	[p19l1632t537r1719b615],
6	,	,	O	,	_	0	SENT_720	[p19l1632t537r1719b615],
7	Sumizawa	NNP	PERSON	Sumizawa	appos	2	SENT_720	[p19l1755t534r2147b604],

1	T	NN	O	t	_	0	SENT_721	[p19l625t638r704b719],
2	,	,	O	,	_	0	SENT_721	[p19l625t638r704b719],
3	Ichikawa	NNP	PERSON	Ichikawa	nn	4	SENT_721	[p19l756t638r1100b708],
4	M	NNP	O	M	appos	1	SENT_721	[p19l1147t638r1254b719],
5	,	,	O	,	_	0	SENT_721	[p19l1147t638r1254b719],
6	Ikeda	NNP	PERSON	Ikeda	nn	7	SENT_721	[p19l1304t638r1514b708],
7	S	NNP	O	S	appos	1	SENT_721	[p19l1561t638r1634b719],
8	,	,	O	,	_	0	SENT_721	[p19l1561t638r1634b719],
9	et	FW	O	et	nn	10	SENT_721	[p19l1681t649r1751b708],
10	al.	FW	O	al.	appos	1	SENT_721	[p19l1798t638r1885b708],
11	1989	CD	DATE	1989	dep	10	SENT_721	[p19l1946t638r2142b711],
12	.	.	O	.	_	0	SENT_721	[p19l1946t638r2142b711],

1	Cytoplasmic	JJ	O	cytoplasmic	amod	2	SENT_722	[p19l628t730r1100b820],
2	orientation	NN	O	orientation	nsubj	13	SENT_722	[p19l1170t733r1580b803],
3	and	CC	O	and	_	0	SENT_722	[p19l1649t733r1785b803],
4	twodomain	NN	O	twodomain	nn	5	SENT_722	[p19l1849t733r2144b803, p19l628t826r815b896],
5	structure	NN	O	structure	nsubj	13	SENT_722	[p19l865t837r1192b896],
6	of	IN	O	of	_	0	SENT_722	[p19l1236t826r1320b896],
7	the	DT	O	the	det	9	SENT_722	[p19l1356t826r1471b896],
8	multidrug	JJ	O	multidrug	amod	9	SENT_722	[p19l1518t826r1888b916],
9	transporter	NN	O	transporter	prep_of	2	SENT_722	[p19l1935t837r2144b896, p19l628t942r872b1021],
10	,	,	O	,	_	0	SENT_722	[p19l1935t837r2144b896, p19l628t942r872b1021],
11	p-glycoprotein	NN	O	p-glycoprotein	appos	9	SENT_722	[p19l967t931r1542b1024],
12	,	,	O	,	_	0	SENT_722	[p19l967t931r1542b1024],
13	demonstrated	VBD	O	demonstrate	_	0	SENT_722	[p19l1638t934r2150b1004],
14	with	IN	O	with	_	0	SENT_722	[p19l628t1027r792b1097],
15	sequence-speciﬁc	NN	O	sequence-speciﬁc	nn	16	SENT_722	[p19l868t1027r1531b1120],
16	antibodies	NNS	O	antibody	prep_with	13	SENT_722	[p19l1604t1030r2010b1100],
17	.	.	O	.	_	0	SENT_722	[p19l1604t1030r2010b1100],

1	J.	NNP	O	J.	nn	2	SENT_723	[p19l2080t1033r2139b1100],
2	Biol	NNP	O	Biol	_	0	SENT_723	[p19l625t1123r798b1193],
3	.	.	O	.	_	0	SENT_723	[p19l625t1123r798b1193],

1	Chem	NNP	O	Chem	_	0	SENT_724	[p19l848t1123r1077b1193],
2	.	.	O	.	_	0	SENT_724	[p19l848t1123r1077b1193],

1	264	CD	NUMBER	264	_	0	SENT_725	[p19l1124t1123r1286b1193],
2	:	:	O	:	_	0	SENT_725	[p19l1124t1123r1286b1193],
3	162829	CD	NUMBER	162829	number	4	SENT_725	[p19l1304t1123r1657b1196],
4	]	CD	NUMBER	]	dep	1	SENT_725	[p19l1304t1123r1657b1196],

1	46	CD	NUMBER	46	_	0	SENT_726	[p19l6t1224r148b1310],
2	.	.	O	.	_	0	SENT_726	[p19l6t1224r148b1310],

1	Zhang	NNP	PERSON	Zhang	nn	2	SENT_727	[p19l263t1228r556b1335],
2	JT	NNP	PERSON	JT	_	0	SENT_727	[p19l583t1228r725b1324],
3	,	,	O	,	_	0	SENT_727	[p19l583t1228r725b1324],
4	Ling	NNP	O	Ling	nn	5	SENT_727	[p19l762t1228r982b1335],
5	V.	NNP	O	V.	appos	2	SENT_727	[p19l1012t1227r1119b1310],
6	1991	CD	DATE	1991	dep	5	SENT_727	[p19l1167t1227r1407b1314],
7	.	.	O	.	_	0	SENT_727	[p19l1167t1227r1407b1314],

1	Study	NN	O	study	nn	11	SENT_728	[p19l1448t1228r1713b1335],
2	of	IN	O	of	dep	11	SENT_728	[p19l1747t1228r1851b1310],
3	membrane	NN	O	membrane	nn	4	SENT_728	[p19l1873t1252r2139b1314, p19l259t1343r518b1429],
4	orientation	NN	O	orientation	pobj	2	SENT_728	[p19l569t1343r1077b1432],
5	and	CC	O	and	_	0	SENT_728	[p19l1131t1347r1295b1432],
6	glycosylated	VBN	O	glycosylate	conj_and	2	SENT_728	[p19l1349t1343r1946b1457],
7	extracellular	JJ	O	extracellular	amod	8	SENT_728	[p19l1993t1371r2139b1432, p19l263t1461r736b1547],
8	loops	NNS	O	loop	dobj	6	SENT_728	[p19l822t1461r1073b1571],
9	of	IN	O	of	_	0	SENT_728	[p19l1159t1461r1267b1547],
10	mouse	NN	O	mouse	prep_of	8	SENT_728	[p19l1346t1489r1650b1550],
11	Pglycoprotein	NN	O	pglycoprotein	_	0	SENT_728	[p19l1740t1464r2139b1575, p19l263t1578r588b1689],
12	by	IN	O	by	prep	11	SENT_728	[p19l639t1582r753b1689],
13	in	FW	O	in	nn	14	SENT_728	[p19l804t1582r894b1664],
14	vitro	FW	O	vitro	dep	15	SENT_728	[p19l949t1582r1168b1668],
15	translation	NN	O	translation	dep	12	SENT_728	[p19l1216t1582r1731b1668],
16	.	.	O	.	_	0	SENT_728	[p19l1216t1582r1731b1668],

1	J.	NNP	O	J.	nn	2	SENT_729	[p19l1785t1582r1858b1664],
2	Biol	NNP	O	Biol	_	0	SENT_729	[p19l1919t1582r2132b1664],
3	.	.	O	.	_	0	SENT_729	[p19l1919t1582r2132b1664],

1	Chem	NNP	O	Chem	_	0	SENT_730	[p19l266t1693r549b1779],
2	.	.	O	.	_	0	SENT_730	[p19l266t1693r549b1779],

1	266	CD	NUMBER	266	_	0	SENT_731	[p19l607t1696r803b1783],
2	:	:	O	:	_	0	SENT_731	[p19l607t1696r803b1783],
3	18224-32	CD	NUMBER	18224-32	dep	1	SENT_731	[p19l825t1696r1277b1786],

1	47	CD	NUMBER	47	_	0	SENT_732	[p19l6t1815r148b1901],
2	.	.	O	.	_	0	SENT_732	[p19l6t1815r148b1901],

1	Zhang	NNP	PERSON	Zhang	nn	2	SENT_733	[p19l259t1815r556b1926],
2	JT	NNP	PERSON	JT	_	0	SENT_733	[p19l621t1818r764b1915],
3	,	,	O	,	_	0	SENT_733	[p19l621t1818r764b1915],
4	Duthie	NNP	PERSON	Duthie	nn	8	SENT_733	[p19l832t1815r1151b1904],
5	M	NNP	O	M	nn	8	SENT_733	[p19l1219t1818r1344b1918],
6	,	,	O	,	_	0	SENT_733	[p19l1219t1818r1344b1918],
7	Ling	NNP	O	Ling	appos	8	SENT_733	[p19l1416t1815r1636b1929],
8	V.	NNP	O	V.	appos	2	SENT_733	[p19l1701t1818r1808b1904],
9	1993	CD	DATE	1993	num	8	SENT_733	[p19l1895t1818r2135b1908],
10	.	.	O	.	_	0	SENT_733	[p19l1895t1818r2135b1908],

1	Membrane	NN	O	membrane	nn	2	SENT_734	[p19l263t1932r767b2018],
2	topology	NN	O	topology	_	0	SENT_734	[p19l818t1932r1232b2043],
3	of	IN	O	of	_	0	SENT_734	[p19l1286t1932r1386b2018],
4	the	DT	O	the	det	6	SENT_734	[p19l1434t1932r1576b2018],
5	N-terminal	JJ	MISC	n-terminal	amod	6	SENT_734	[p19l1627t1932r2139b2022],
6	half	NN	O	half	prep_of	2	SENT_734	[p19l263t2051r447b2137],
7	of	IN	O	of	_	0	SENT_734	[p19l463t2051r570b2137],
8	the	DT	O	the	det	11	SENT_734	[p19l586t2051r725b2137],
9	hamster	NN	O	hamster	nn	11	SENT_734	[p19l755t2054r1126b2140],
10	P-glycoprotein	NN	MISC	p-glycoprotein	nn	11	SENT_734	[p19l1149t2051r1844b2165],
11	molecule	NN	O	molecule	prep_of	2	SENT_734	[p19l1870t2054r2139b2140, p19l263t2169r476b2255],
12	.	.	O	.	_	0	SENT_734	[p19l1870t2054r2139b2140, p19l263t2169r476b2255],

1	J.	NNP	O	J.	nn	2	SENT_735	[p19l523t2172r599b2255],
2	Biol	NNP	O	Biol	_	0	SENT_735	[p19l650t2169r866b2255],
3	.	.	O	.	_	0	SENT_735	[p19l650t2169r866b2255],

1	Chem	NNP	O	Chem	_	0	SENT_736	[p19l924t2172r1214b2255],
2	.	.	O	.	_	0	SENT_736	[p19l924t2172r1214b2255],

1	268	CD	NUMBER	268	_	0	SENT_737	[p19l1269t2169r1467b2255],
2	:	:	O	:	_	0	SENT_737	[p19l1269t2169r1467b2255],
3	15101-10	CD	NUMBER	15101-10	dep	1	SENT_737	[p19l1490t2172r1949b2255],

1	48	CD	NUMBER	48	_	0	SENT_738	[p19l6t2287r148b2373],
2	.	.	O	.	_	0	SENT_738	[p19l6t2287r148b2373],

1	Skach	NNP	O	Skach	nn	2	SENT_739	[p19l263t2287r542b2376],
2	WR	NNP	O	WR	_	0	SENT_739	[p19l572t2290r789b2391],
3	,	,	O	,	_	0	SENT_739	[p19l572t2290r789b2391],
4	Calayag	NNP	O	Calayag	nn	5	SENT_739	[p19l825t2290r1203b2401],
5	MC	NNP	O	MC	appos	2	SENT_739	[p19l1233t2290r1443b2387],
6	,	,	O	,	_	0	SENT_739	[p19l1233t2290r1443b2387],
7	Lingappa	NNP	O	Lingappa	nn	8	SENT_739	[p19l1479t2287r1921b2401],
8	VR	NN	O	vr	appos	5	SENT_739	[p19l1951t2290r2135b2376],
9	.	.	O	.	_	0	SENT_739	[p19l1951t2290r2135b2376],

1	1993	CD	DATE	1993	_	0	SENT_740	[p19l273t2408r514b2494],
2	.	.	O	.	_	0	SENT_740	[p19l273t2408r514b2494],

1	Evidence	NN	O	evidence	_	0	SENT_741	[p19l569t2408r1003b2494],
2	for	IN	O	for	_	0	SENT_741	[p19l1054t2408r1193b2494],
3	an	DT	O	a	det	5	SENT_741	[p19l1240t2433r1348b2494],
4	alternate	JJ	O	alternate	amod	5	SENT_741	[p19l1399t2408r1801b2494],
5	model	NN	O	model	prep_for	1	SENT_741	[p19l1849t2408r2139b2494],
6	of	IN	O	of	_	0	SENT_741	[p19l263t2523r363b2612],
7	human	JJ	O	human	amod	9	SENT_741	[p19l407t2526r725b2612],
8	P-glycoprotein	NN	MISC	p-glycoprotein	nn	9	SENT_741	[p19l773t2526r1467b2637],
9	structure	NN	O	structure	prep_of	1	SENT_741	[p19l1518t2541r1924b2612],
10	and	CC	O	and	_	0	SENT_741	[p19l1975t2527r2146b2612],
11	biogenesis	NN	O	biogenesis	prep_of	1	SENT_741	[p19l263t2641r774b2755],
12	.	.	O	.	_	0	SENT_741	[p19l263t2641r774b2755],

1	J.	NNP	O	J.	nn	2	SENT_742	[p19l822t2644r894b2730],
2	Biol	NNP	O	Biol	_	0	SENT_742	[p19l948t2641r1161b2727],
3	.	.	O	.	_	0	SENT_742	[p19l948t2641r1161b2727],

1	Chem	NNP	O	Chem	_	0	SENT_743	[p19l1226t2641r1509b2730],
2	.	.	O	.	_	0	SENT_743	[p19l1226t2641r1509b2730],

1	26	CD	NUMBER	26	num	3	SENT_744	[p19l1567t2644r1682b2730],
2	8:6903	CD	NUMBER	8:6903	num	3	SENT_744	[p19l1691t2644r2125b2734],
3	—	NN	O	—	_	0	SENT_744	[p19l1691t2644r2125b2734],
4	8	CD	NUMBER	8	number	5	SENT_744	[p19l1691t2644r2125b2734],
5	49	CD	NUMBER	49	num	3	SENT_744	[p19l6t2762r148b2848],
6	.	.	O	.	_	0	SENT_744	[p19l6t2762r148b2848],

1	Gottesman	NNP	PERSON	Gottesman	nn	2	SENT_745	[p19l263t2762r764b2848],
2	MM	NN	O	mm	_	0	SENT_745	[p19l825t2765r1059b2862],
3	,	,	O	,	_	0	SENT_745	[p19l825t2765r1059b2862],
4	Pastan	NNP	PERSON	Pastan	nn	5	SENT_745	[p19l1124t2765r1429b2848],
5	I.	NNP	O	I.	appos	2	SENT_745	[p19l1490t2765r1545b2848],
6	1993	CD	DATE	1993	dep	5	SENT_745	[p19l1627t2762r1872b2848],
7	.	.	O	.	_	0	SENT_745	[p19l1627t2762r1872b2848],

1	Biochemistry	NNP	O	Biochemistry	nsubj	5	SENT_746	[p19l1937t2762r2139b2848, p19l259t2877r722b2991],
2	of	IN	O	of	_	0	SENT_746	[p19l776t2881r876b2966],
3	multidrug	JJ	O	multidrug	amod	4	SENT_746	[p19l927t2880r1390b2988],
4	resistance	NN	O	resistance	prep_of	1	SENT_746	[p19l1444t2880r1907b2966],
5	mediated	VBN	O	mediate	_	0	SENT_746	[p19l1965t2909r2139b2966, p19l263t2995r542b3084],
6	by	IN	O	by	_	0	SENT_746	[p19l628t2999r743b3109],
7	the	DT	O	the	det	9	SENT_746	[p19l832t2998r975b3084],
8	multidrug	JJ	O	multidrug	amod	9	SENT_746	[p19l1061t2998r1516b3109],
9	transporter	NN	O	transporter	prep_by	5	SENT_746	[p19l1606t3013r2135b3109],
10	.	.	O	.	_	0	SENT_746	[p19l1606t3013r2135b3109],

1	Annu	NNP	PERSON	Annu	_	0	SENT_747	[p19l256t3116r521b3199],
2	.	.	O	.	_	0	SENT_747	[p19l256t3116r521b3199],

1	Rev.	NNP	O	Rev.	nn	2	SENT_748	[p19l576t3116r771b3202],
2	Biochem	NNP	PERSON	Biochem	_	0	SENT_748	[p19l829t3116r1256b3202],
3	.	.	O	.	_	0	SENT_748	[p19l829t3116r1256b3202],

1	62:385	CD	NUMBER	62:385	_	0	SENT_749	[p19l1314t3116r1808b3202],
2	—	CD	NUMBER	—	num	3	SENT_749	[p19l1314t3116r1808b3202],
3	42	CD	NUMBER	42	dep	1	SENT_749	[p19l1314t3116r1808b3202],

1	50	CD	NUMBER	50	_	0	SENT_750	[p19l9t3230r148b3316],
2	.	.	O	.	_	0	SENT_750	[p19l9t3230r148b3316],

1	Higgins	NNP	PERSON	Higgins	nn	2	SENT_751	[p19l263t3230r627b3341],
2	CF	NN	O	cf	_	0	SENT_751	[p19l681t3230r845b3330],
3	,	,	O	,	_	0	SENT_751	[p19l681t3230r845b3330],
4	Gottesman	NNP	PERSON	Gottesman	nn	5	SENT_751	[p19l899t3234r1404b3316],
5	MM	NN	O	mm	appos	2	SENT_751	[p19l1458t3234r1689b3316],
6	.	.	O	.	_	0	SENT_751	[p19l1458t3234r1689b3316],

1	1992	CD	DATE	1992	_	0	SENT_752	[p19l1757t3233r2002b3320],
2	.	.	O	.	_	0	SENT_752	[p19l1757t3233r2002b3320],

1	Is	VBZ	O	be	cop	6	SENT_753	[p19l2060t3234r2139b3316],
2	the	DT	O	the	det	4	SENT_753	[p19l263t3349r405b3438],
3	multidrug	JJ	O	multidrug	amod	4	SENT_753	[p19l477t3349r933b3463],
4	transporter	NN	O	transporter	nsubj	6	SENT_753	[p19l1012t3367r1520b3463],
5	a	DT	O	a	det	6	SENT_753	[p19l1596t3377r1647b3438],
6	ﬂippase	NN	O	ﬂippase	_	0	SENT_753	[p19l1722t3349r2139b3463],
7	?	.	O	?	_	0	SENT_753	[p19l1722t3349r2139b3463],

1	Trends	NNS	O	trend	_	0	SENT_754	[p19l266t3467r581b3553],
2	Blochem	NNP	O	Blochem	dep	1	SENT_754	[p19l628t3467r1052b3553],
3	.	.	O	.	_	0	SENT_754	[p19l628t3467r1052b3553],

1	Sci	NNP	O	Sci	_	0	SENT_755	[p19l1110t3470r1270b3553],
2	.	.	O	.	_	0	SENT_755	[p19l1110t3470r1270b3553],

1	17:18	CD	TIME	17:18	num	2	SENT_756	[p19l1339t3467r1756b3553],
2	-21	CD	NUMBER	-21	_	0	SENT_756	[p19l1339t3467r1756b3553],

1	S1	NN	O	s1	_	0	SENT_757	[p20l9t24r145b110],
2	.	.	O	.	_	0	SENT_757	[p20l9t24r145b110],

1	S3	NN	O	s3	_	0	SENT_758	[p20l9t1200r148b1286],
2	.	.	O	.	_	0	SENT_758	[p20l9t1200r148b1286],

1	S6	NN	O	s6	_	0	SENT_759	[p20l13t3206r148b3292],
2	.	.	O	.	_	0	SENT_759	[p20l13t3206r148b3292],

1	Zamora	NNP	PERSON	Zamora	nn	2	SENT_760	[p20l263t24r623b110],
2	JM	NN	O	jm	_	0	SENT_760	[p20l699t27r873b124],
3	,	,	O	,	_	0	SENT_760	[p20l699t27r873b124],
4	Pearce	NNP	PERSON	Pearce	nn	5	SENT_760	[p20l959t27r1267b110],
5	H1	NN	O	h1	appos	2	SENT_760	[p20l1349t27r1527b124],
6	...	:	O	...	_	0	SENT_760	[p20l1349t27r1527b124],
7	Beck	NNP	O	Beck	nn	8	SENT_760	[p20l1613t27r1854b110],
8	WT	NNP	O	WT	dep	2	SENT_760	[p20l1933t27r2135b110],
9	.	.	O	.	_	0	SENT_760	[p20l1933t27r2135b110],

1	1988	CD	DATE	1988	_	0	SENT_761	[p20l273t138r514b224],
2	.	.	O	.	_	0	SENT_761	[p20l273t138r514b224],

1	Physical-chemical	JJ	O	physical-chemical	amod	2	SENT_762	[p20l671t138r1524b249],
2	properties	NNS	O	property	nsubj	3	SENT_762	[p20l1673t142r2139b249],
3	shared	VBN	O	share	_	0	SENT_762	[p20l266t260r567b346],
4	by	IN	O	by	_	0	SENT_762	[p20l643t260r757b371],
5	compounds	NNS	O	compound	prep_by	3	SENT_762	[p20l836t260r1372b371],
6	that	WDT	O	that	nsubj	7	SENT_762	[p20l1451t260r1629b346],
7	modulate	VBP	O	modulate	rcmod	5	SENT_762	[p20l1708t260r2142b346],
8	multidru	JJ	O	multidru	amod	10	SENT_762	[p20l266t374r658b460],
9	g	NN	O	g	nn	10	SENT_762	[p20l664t402r722b485],
10	resistance	NN	O	resistance	dobj	7	SENT_762	[p20l752t374r1214b460],
11	in	IN	O	in	_	0	SENT_762	[p20l1244t378r1330b460],
12	human	JJ	O	human	amod	14	SENT_762	[p20l1367t378r1682b460],
13	leukemic	JJ	O	leukemic	amod	14	SENT_762	[p20l1715t374r2139b460],
14	cells	NNS	O	cell	prep_in	10	SENT_762	[p20l263t496r497b579],
15	.	.	O	.	_	0	SENT_762	[p20l263t496r497b579],

1	Mol	NNP	O	Mol	_	0	SENT_763	[p20l544t496r753b579],
2	.	.	O	.	_	0	SENT_763	[p20l544t496r753b579],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_764	[p20l811t496r1348b582],
2	.	.	O	.	_	0	SENT_764	[p20l811t496r1348b582],

1	33:454	CD	NUMBER	33:454	_	0	SENT_765	[p20l1406t496r1903b582],
2	—	CD	NUMBER	—	num	3	SENT_765	[p20l1406t496r1903b582],
3	62	CD	NUMBER	62	dep	1	SENT_765	[p20l1406t496r1903b582],

1	Bruggemann	NNP	PERSON	Bruggemann	nn	2	SENT_766	[p20l263t614r859b721],
2	EP	NNP	O	EP	_	0	SENT_766	[p20l896t614r1056b714],
3	,	,	O	,	_	0	SENT_766	[p20l896t614r1056b714],
4	Currier	NNP	ORGANIZATION	Currier	nn	5	SENT_766	[p20l1096t614r1432b700],
5	SJ	NNP	ORGANIZATION	SJ	appos	2	SENT_766	[p20l1465t614r1597b714],
6	,	,	O	,	_	0	SENT_766	[p20l1465t614r1597b714],
7	Gottesman	NNP	PERSON	Gottesman	nn	8	SENT_766	[p20l1638t614r2146b700],
8	MM	NN	O	mm	appos	2	SENT_766	[p20l263t732r493b829],
9	,	,	O	,	_	0	SENT_766	[p20l263t732r493b829],
10	Pastan	NNP	PERSON	Pastan	nn	11	SENT_766	[p20l558t732r862b815],
11	I.	NNP	O	I.	appos	2	SENT_766	[p20l924t732r982b815],
12	1992	CD	DATE	1992	dep	11	SENT_766	[p20l1057t732r1302b818],
13	.	.	O	.	_	0	SENT_766	[p20l1057t732r1302b818],

1	Characterization	NN	O	characterization	_	0	SENT_767	[p20l1367t732r2146b815],
2	of	IN	O	of	_	0	SENT_767	[p20l263t847r366b933],
3	the	DT	O	the	det	4	SENT_767	[p20l389t850r532b933],
4	azidopine	NN	O	azidopine	prep_of	1	SENT_767	[p20l562t847r1014b958],
5	and	CC	O	and	_	0	SENT_767	[p20l1047t850r1214b933],
6	vinblastine	NN	O	vinblastine	nn	8	SENT_767	[p20l1247t847r1756b933],
7	binding	NN	O	binding	nn	8	SENT_767	[p20l1785t850r2146b961],
8	site	NN	O	site	prep_of	1	SENT_767	[p20l266t965r423b1051],
9	of	IN	O	of	_	0	SENT_767	[p20l481t965r585b1051],
10	P-glycoprotein	NN	O	p-glycoprotein	prep_of	1	SENT_767	[p20l639t968r1355b1079],
11	.	.	O	.	_	0	SENT_767	[p20l639t968r1355b1079],

1	J.	NNP	O	J.	nn	2	SENT_768	[p20l1416t969r1488b1054],
2	Biol	NNP	O	Biol	_	0	SENT_768	[p20l1557t968r1770b1054],
3	.	.	O	.	_	0	SENT_768	[p20l1557t968r1770b1054],

1	Chem	NNP	O	Chem	_	0	SENT_769	[p20l1849t968r2132b1054],
2	.	.	O	.	_	0	SENT_769	[p20l1849t968r2132b1054],

1	267:21020	CD	NUMBER	267:21020	_	0	SENT_770	[p20l263t1083r933b1169],
2	—	CD	NUMBER	—	num	3	SENT_770	[p20l263t1083r933b1169],
3	26	CD	NUMBER	26	dep	1	SENT_770	[p20l263t1083r933b1169],

1	Zhang	NNP	PERSON	Zhang	nn	2	SENT_771	[p20l263t1200r560b1311],
2	X	NNP	PERSON	X	_	0	SENT_771	[p20l590t1200r697b1300],
3	,	,	O	,	_	0	SENT_771	[p20l590t1200r697b1300],
4	Collins	NNP	ORGANIZATION	Collins	nn	5	SENT_771	[p20l734t1200r1070b1286],
5	KL	NNP	ORGANIZATION	KL	appos	2	SENT_771	[p20l1110t1203r1284b1300],
6	,	,	O	,	_	0	SENT_771	[p20l1110t1203r1284b1300],
7	Greenberger	NNP	PERSON	Greenberger	nn	8	SENT_771	[p20l1321t1200r1907b1311],
8	LM	NNP	O	LM	appos	5	SENT_771	[p20l1940t1203r2139b1290],
9	.	.	O	.	_	0	SENT_771	[p20l1940t1203r2139b1290],

1	1995	CD	DATE	1995	_	0	SENT_772	[p20l277t1318r514b1408],
2	.	.	O	.	_	0	SENT_772	[p20l277t1318r514b1408],

1	Functional	JJ	O	functional	amod	2	SENT_773	[p20l590t1318r1084b1405],
2	evidence	NN	O	evidence	_	0	SENT_773	[p20l1156t1318r1569b1405],
3	that	IN	O	that	_	0	SENT_773	[p20l1638t1321r1812b1405],
4	transmembrane	NN	O	transmembrane	prep_that	2	SENT_773	[p20l1880t1336r2139b1408, p20l266t1437r753b1523],

1	12	CD	NUMBER	12	nsubj	18	SENT_774	[p20l839t1440r943b1523],
2	and	CC	O	and	_	0	SENT_774	[p20l1019t1441r1186b1526],
3	the	DT	O	the	det	4	SENT_774	[p20l1258t1440r1400b1523],
4	loop	NN	O	loop	conj_and	1	SENT_774	[p20l1476t1440r1682b1551],
5	between	IN	O	between	_	0	SENT_774	[p20l1754t1440r2146b1526],
6	transmembrane	JJ	O	transmembrane	amod	11	SENT_774	[p20l263t1554r982b1640],
7	11	CD	NUMBER	11	tmod	6	SENT_774	[p20l1036t1554r1126b1640],
8	and	CC	O	and	_	0	SENT_774	[p20l1188t1554r1351b1640],
9	12	CD	NUMBER	12	tmod	6	SENT_774	[p20l1409t1554r1509b1640],
10	form	NN	O	form	nn	11	SENT_774	[p20l1553t1554r1780b1640],
11	part	NN	O	part	prep_between	4	SENT_774	[p20l1824t1568r2005b1665],
12	of	IN	O	of	_	0	SENT_774	[p20l2049t1554r2153b1640],
13	the	DT	O	the	det	15	SENT_774	[p20l263t1676r409b1762],
14	drug-binding	JJ	O	drug-binding	amod	15	SENT_774	[p20l439t1676r1045b1787],
15	domain	NN	O	domain	prep_of	11	SENT_774	[p20l1079t1676r1429b1762],
16	in	IN	O	in	_	0	SENT_774	[p20l1462t1676r1552b1762],
17	Pglycoprotein	NN	LOCATION	pglycoprotein	prep_in	15	SENT_774	[p20l1585t1680r2142b1787, p20l263t1790r437b1876],
18	encoded	VBN	O	encode	_	0	SENT_774	[p20l477t1794r869b1876],
19	by	IN	O	by	_	0	SENT_774	[p20l906t1794r1021b1901],
20	MDRI	NN	ORGANIZATION	mdrus	prep_by	18	SENT_774	[p20l1061t1793r1407b1876],
21	.	.	O	.	_	0	SENT_774	[p20l1061t1793r1407b1876],

1	J.	NNP	O	J.	nn	2	SENT_775	[p20l1451t1793r1524b1876],
2	Biol	NNP	O	Biol	_	0	SENT_775	[p20l1574t1793r1787b1876],
3	.	.	O	.	_	0	SENT_775	[p20l1574t1793r1787b1876],

1	Chem	NNP	O	Chem	_	0	SENT_776	[p20l1849t1794r2132b1876],
2	.	.	O	.	_	0	SENT_776	[p20l1849t1794r2132b1876],

1	270	CD	NUMBER	270	_	0	SENT_777	[p20l266t1908r458b1995],
2	:	:	O	:	_	0	SENT_777	[p20l266t1908r458b1995],
3	5441-48	CD	NUMBER	5441-48	dep	1	SENT_777	[p20l474t1908r876b1998],

1	Loo	NNP	O	Loo	nn	2	SENT_778	[p20l266t2030r451b2116],
2	TW	NNP	O	TW	_	0	SENT_778	[p20l488t2030r694b2130],
3	,	,	O	,	_	0	SENT_778	[p20l488t2030r694b2130],
4	Clarke	NNP	PERSON	Clarke	nn	5	SENT_778	[p20l737t2030r1045b2116],
5	DM	NN	O	dm	appos	2	SENT_778	[p20l1082t2033r1295b2116],
6	.	.	O	.	_	0	SENT_778	[p20l1082t2033r1295b2116],

1	1995	CD	DATE	1995	_	0	SENT_779	[p20l1349t2030r1594b2116],
2	.	.	O	.	_	0	SENT_779	[p20l1349t2030r1594b2116],

1	Membrane	NN	O	membrane	nn	2	SENT_780	[p20l1638t2030r2142b2116],
2	topology	NN	O	topology	_	0	SENT_780	[p20l266t2144r676b2255],
3	of	IN	O	of	_	0	SENT_780	[p20l734t2144r841b2230],
4	a	DT	O	a	det	6	SENT_780	[p20l896t2172r947b2230],
5	cysteine-less	JJ	O	cysteine-less	amod	6	SENT_780	[p20l1005t2144r1597b2255],
6	mutant	NN	O	mutant	prep_of	2	SENT_780	[p20l1662t2158r1988b2230],
7	of	IN	O	of	_	0	SENT_780	[p20l2049t2144r2153b2230],
8	human	JJ	O	human	amod	9	SENT_780	[p20l263t2262r578b2348],
9	p-glycoprotein	NN	O	p-glycoprotein	prep_of	2	SENT_780	[p20l643t2266r1351b2373],
10	.	.	O	.	_	0	SENT_780	[p20l643t2266r1351b2373],

1	J.	NNP	O	J.	nn	2	SENT_781	[p20l1413t2262r1485b2348],
2	Biol	NNP	O	Biol	_	0	SENT_781	[p20l1553t2262r1773b2348],
3	.	.	O	.	_	0	SENT_781	[p20l1553t2262r1773b2348],

1	Chem	NNP	O	Chem	_	0	SENT_782	[p20l1849t2262r2132b2348],
2	.	.	O	.	_	0	SENT_782	[p20l1849t2262r2132b2348],

1	270	CD	NUMBER	270	_	0	SENT_783	[p20l266t2384r458b2470],
2	:	:	O	:	_	0	SENT_783	[p20l266t2384r458b2470],
3	843-43	CD	NUMBER	843-43	dep	1	SENT_783	[p20l474t2384r813b2470],

1	Azzaria	NNP	O	Azzaria	nn	2	SENT_784	[p20l266t2495r627b2585],
2	M	NNP	O	M	_	0	SENT_784	[p20l688t2498r820b2599],
3	,	,	O	,	_	0	SENT_784	[p20l688t2498r820b2599],
4	Schurr	NNP	PERSON	Schurr	nn	8	SENT_784	[p20l889t2498r1204b2585],
5	E	NNP	PERSON	E	nn	8	SENT_784	[p20l1265t2498r1362b2599],
6	,	,	O	,	_	0	SENT_784	[p20l1265t2498r1362b2599],
7	Gros	NNP	O	Gros	appos	8	SENT_784	[p20l1434t2499r1657b2585],
8	P.	NNP	O	P.	appos	2	SENT_784	[p20l1726t2502r1812b2585],
9	1989	CD	DATE	1989	num	8	SENT_784	[p20l1894t2498r2139b2588],
10	.	.	O	.	_	0	SENT_784	[p20l1894t2498r2139b2588],

1	Discrete	JJ	O	discrete	amod	2	SENT_785	[p20l266t2620r651b2706],
2	mutations	NNS	O	mutation	nsubj	15	SENT_785	[p20l727t2620r1186b2706],
3	introduced	VBN	O	introduce	partmod	2	SENT_785	[p20l1265t2620r1766b2706],
4	in	IN	O	in	_	0	SENT_785	[p20l1838t2620r1924b2706],
5	the	DT	O	the	prep_in	3	SENT_785	[p20l2003t2623r2142b2706],
6	predicted	VBN	O	predict	partmod	5	SENT_785	[p20l266t2734r701b2845],
7	nucleotide-bindi	NN	O	nucleotide-bindus	nn	10	SENT_785	[p20l730t2734r1488b2820],
8	n	NN	O	n	nn	10	SENT_785	[p20l1497t2762r1548b2820],
9	g	NN	O	g	nn	10	SENT_785	[p20l1553t2762r1611b2845],
10	sites	NNS	O	site	dobj	6	SENT_785	[p20l1641t2734r1844b2820],
11	of	IN	O	of	_	0	SENT_785	[p20l1877t2738r1981b2820],
12	the	DT	O	the	det	14	SENT_785	[p20l2003t2738r2142b2824],
13	mdrl	NN	O	mdrl	nn	14	SENT_785	[p20l266t2853r497b2939],
14	gene	NN	O	gene	prep_of	10	SENT_785	[p20l555t2881r778b2964],
15	abolish	VB	O	abolish	_	0	SENT_785	[p20l822t2853r1158b2939],
16	its	PRP$	O	its	poss	17	SENT_785	[p20l1209t2853r1313b2939],
17	ability	NN	O	ability	dobj	15	SENT_785	[p20l1363t2853r1657b2967],
18	to	TO	O	to	aux	19	SENT_785	[p20l1708t2871r1801b2942],
19	confer	VB	O	confer	infmod	17	SENT_785	[p20l1845t2856r2146b2942],
20	multidrug	JJ	O	multidrug	amod	21	SENT_785	[p20l266t2967r725b3081],
21	resistance	NN	O	resistance	dobj	19	SENT_785	[p20l790t2970r1274b3056],
22	.	.	O	.	_	0	SENT_785	[p20l790t2970r1274b3056],

1	Mol	NNP	O	Mol	_	0	SENT_786	[p20l1342t2970r1552b3056],
2	.	.	O	.	_	0	SENT_786	[p20l1342t2970r1552b3056],

1	Cell	NN	O	cell	_	0	SENT_787	[p20l1634t2970r1844b3060],
2	.	.	O	.	_	0	SENT_787	[p20l1634t2970r1844b3060],

1	Biol	NNP	O	Biol	_	0	SENT_788	[p20l1919t2970r2132b3060],
2	.	.	O	.	_	0	SENT_788	[p20l1919t2970r2132b3060],

1	9:5289	CD	NUMBER	9:5289	_	0	SENT_789	[p20l266t3092r760b3178],
2	—	CD	NUMBER	—	num	3	SENT_789	[p20l266t3092r760b3178],
3	97	CD	NUMBER	97	dep	1	SENT_789	[p20l266t3092r760b3178],

1	Currier	NNP	PERSON	Currier	nn	2	SENT_790	[p20l266t3206r602b3292],
2	SJ	NNP	O	SJ	_	0	SENT_790	[p20l657t3206r789b3306],
3	,	,	O	,	_	0	SENT_790	[p20l657t3206r789b3306],
4	Ueda	NNP	PERSON	Ueda	nn	5	SENT_790	[p20l850t3210r1098b3292],
5	K	NNP	PERSON	K	appos	2	SENT_790	[p20l1156t3210r1260b3306],
6	,	,	O	,	_	0	SENT_790	[p20l1156t3210r1260b3306],
7	Willingham	NNP	PERSON	Willingham	nn	8	SENT_790	[p20l1321t3206r1879b3317],
8	MC	NNP	O	MC	appos	2	SENT_790	[p20l1933t3210r2142b3310],
9	,	,	O	,	_	0	SENT_790	[p20l1933t3210r2142b3310],
10	Pastan	NNP	PERSON	Pastan	appos	2	SENT_790	[p20l266t3328r567b3414],
11	I	PRP	O	I	dep	10	SENT_790	[p20l618t3328r679b3425],
12	,	,	O	,	_	0	SENT_790	[p20l618t3328r679b3425],
13	Gottesman	NNP	PERSON	Gottesman	nn	14	SENT_790	[p20l734t3328r1239b3414],
14	MM	NN	O	mm	appos	2	SENT_790	[p20l1290t3328r1520b3414],
15	.	.	O	.	_	0	SENT_790	[p20l1290t3328r1520b3414],

1	1989	CD	DATE	1989	_	0	SENT_791	[p20l1585t3328r1829b3414],
2	.	.	O	.	_	0	SENT_791	[p20l1585t3328r1829b3414],

1	Deletion	NN	O	deletion	nn	4	SENT_792	[p20l1887t3328r2142b3414, p20l266t3446r444b3532],
2	and	CC	O	and	_	0	SENT_792	[p20l495t3446r658b3532],
3	insertion	NN	O	insertion	nn	4	SENT_792	[p20l713t3446r1119b3532],
4	mutants	NNS	O	mutant	_	0	SENT_792	[p20l1170t3460r1534b3532],
5	of	IN	O	of	_	0	SENT_792	[p20l1589t3446r1692b3532],
6	the	DT	O	the	det	7	SENT_792	[p20l1736t3446r1875b3532],
7	multidrug	JJ	O	multidrug	prep_of	4	SENT_792	[p20l1930t3449r2142b3532, p20l266t3562r539b3673],

1	transporter	NN	O	transporter	_	0	SENT_793	[p20l593t3576r1119b3673],
2	.	.	O	.	_	0	SENT_793	[p20l593t3576r1119b3673],

1	J.	NNP	O	J.	nn	2	SENT_794	[p20l1174t3566r1249b3648],
2	Biol	NNP	O	Biol	_	0	SENT_794	[p20l1307t3566r1520b3648],
3	.	.	O	.	_	0	SENT_794	[p20l1307t3566r1520b3648],

1	Chem	NNP	O	Chem	_	0	SENT_795	[p20l1589t3566r1875b3652],
2	.	.	O	.	_	0	SENT_795	[p20l1589t3566r1875b3652],

1	264	CD	NUMBER	264	_	0	SENT_796	[p20l1937t3565r2139b3652],
2	:	:	O	:	_	0	SENT_796	[p20l1937t3565r2139b3652],
3	14376-81	CD	NUMBER	14376-81	dep	1	SENT_796	[p20l277t3678r715b3768],

1	57	CD	NUMBER	57	_	0	SENT_797	[p21l13t29r148b112],
2	.	.	O	.	_	0	SENT_797	[p21l13t29r148b112],

1	Higgins	NNP	PERSON	Higgins	nn	2	SENT_798	[p21l266t26r630b137],
2	CF.	NNP	O	CF.	_	0	SENT_798	[p21l699t29r862b115],
3	1992	CD	DATE	1992	dep	2	SENT_798	[p21l945t29r1186b115],
4	.	.	O	.	_	0	SENT_798	[p21l945t29r1186b115],

1	ABC	NNP	ORGANIZATION	ABC	nn	2	SENT_799	[p21l1258t29r1495b112],
2	transporters	NNS	O	transporter	_	0	SENT_799	[p21l1560t44r2135b140],
3	:	:	O	:	_	0	SENT_799	[p21l1560t44r2135b140],
4	from	IN	O	from	_	0	SENT_799	[p21l266t145r486b227],
5	microorganisms	NNS	O	microorganism	prep_from	2	SENT_799	[p21l569t145r1316b252],
6	to	TO	O	to	_	0	SENT_799	[p21l1395t159r1485b227],
7	man	NN	O	man	prep_to	5	SENT_799	[p21l1564t170r1784b231],
8	.	.	O	.	_	0	SENT_799	[p21l1564t170r1784b231],

1	Annu	NNP	PERSON	Annu	_	0	SENT_800	[p21l1863t148r2135b231],
2	.	.	O	.	_	0	SENT_800	[p21l1863t148r2135b231],

1	Rev.	NNP	O	Rev.	nn	3	SENT_801	[p21l266t263r458b346],
2	Cell	NNP	PERSON	Cell	nn	3	SENT_801	[p21l516t263r708b346],
3	Biol	NNP	PERSON	Biol	_	0	SENT_801	[p21l748t263r961b346],
4	.	.	O	.	_	0	SENT_801	[p21l748t263r961b346],

1	8:67	CD	NUMBER	8:67	_	0	SENT_802	[p21l1022t263r1453b346],
2	--	:	O	--	_	0	SENT_802	[p21l1022t263r1453b346],
3	113	CD	NUMBER	113	dep	1	SENT_802	[p21l1022t263r1453b346],

1	58	CD	NUMBER	58	_	0	SENT_803	[p21l13t377r152b463],
2	.	.	O	.	_	0	SENT_803	[p21l13t377r152b463],

1	Childs	NNP	O	Childs	nn	2	SENT_804	[p21l266t377r563b463],
2	S	NNP	O	S	_	0	SENT_804	[p21l614t377r697b477],
3	,	,	O	,	_	0	SENT_804	[p21l614t377r697b477],
4	Yeh	NNP	ORGANIZATION	Yeh	nn	5	SENT_804	[p21l744t377r943b463],
5	RL	NNP	ORGANIZATION	RL	appos	2	SENT_804	[p21l984t377r1154b477],
6	,	,	O	,	_	0	SENT_804	[p21l984t377r1154b477],
7	Georges	NNP	PERSON	Georges	nn	8	SENT_804	[p21l1202t377r1587b485],
8	E	NNP	PERSON	E	appos	2	SENT_804	[p21l1631t380r1727b477],
9	,	,	O	,	_	0	SENT_804	[p21l1631t380r1727b477],
10	Ling	NNP	O	Ling	nn	11	SENT_804	[p21l1771t377r1991b488],
11	V.	NNP	O	V.	appos	2	SENT_804	[p21l2039t381r2139b463],
12	1995	CD	DATE	1995	dep	11	SENT_804	[p21l277t499r518b585],
13	.	.	O	.	_	0	SENT_804	[p21l277t499r518b585],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_805	[p21l572t499r1200b585],
2	of	IN	O	of	_	0	SENT_805	[p21l1251t499r1355b582],
3	a	DT	O	a	det	5	SENT_805	[p21l1395t527r1446b585],
4	sister	NN	O	sister	nn	5	SENT_805	[p21l1497t499r1742b585],
5	gene	NN	O	gene	prep_of	1	SENT_805	[p21l1789t527r2012b610],
6	to	TO	O	to	_	0	SENT_805	[p21l2056t517r2146b585],
7	P-glycoprotein	NN	O	p-glycoprotein	prep_to	1	SENT_805	[p21l266t617r982b728],
8	.	.	O	.	_	0	SENT_805	[p21l266t617r982b728],

1	Cancer	NN	O	cancer	_	0	SENT_806	[p21l1050t614r1393b700],
2	Res	NNP	O	Res	dep	1	SENT_806	[p21l1448t618r1636b700],
3	.	.	O	.	_	0	SENT_806	[p21l1448t618r1636b700],

1	55:2029	CD	NUMBER	55:2029	_	0	SENT_807	[p21l1705t617r2153b703],
2	-	:	O	-	_	0	SENT_807	[p21l1705t617r2153b703],
3	34	CD	DATE	34	dep	1	SENT_807	[p21l270t738r381b821],

1	59	CD	NUMBER	59	_	0	SENT_808	[p21l13t849r152b939],
2	.	.	O	.	_	0	SENT_808	[p21l13t849r152b939],

1	Cordon-Cardo	NNP	PERSON	Cordon-Cardo	nn	2	SENT_809	[p21l266t853r936b939],
2	C	NNP	O	C	_	0	SENT_809	[p21l963t853r1066b953],
3	,	,	O	,	_	0	SENT_809	[p21l963t853r1066b953],
4	O‘Brien	NNP	O	O‘Brien	nn	5	SENT_809	[p21l1103t849r1481b939],
5	JP	NNP	O	JP	appos	2	SENT_809	[p21l1508t853r1643b939],
6	.	.	O	.	_	0	SENT_809	[p21l1508t853r1643b939],

1	1991	CD	DATE	1991	_	0	SENT_810	[p21l1690t852r1931b942],
2	.	.	O	.	_	0	SENT_810	[p21l1690t852r1931b942],

1	The	DT	O	the	det	4	SENT_811	[p21l1965t852r2142b939],
2	multidrug	JJ	O	multidrug	amod	4	SENT_811	[p21l266t968r725b1078],
3	resistance	NN	O	resistance	nn	4	SENT_811	[p21l780t968r1242b1054],
4	phenotype	NN	O	phenotype	_	0	SENT_811	[p21l1300t968r1784b1082],
5	in	IN	O	in	_	0	SENT_811	[p21l1849t968r1935b1054],
6	human	JJ	O	human	amod	7	SENT_811	[p21l1993t972r2142b1054, p21l270t1114r461b1171],
7	cancer	NN	O	cancer	prep_in	4	SENT_811	[p21l516t1114r841b1171],
8	.	.	O	.	_	0	SENT_811	[p21l516t1114r841b1171],

1	In	IN	O	in	_	0	SENT_812	[p21l899t1089r992b1171],
2	Important	JJ	O	important	amod	3	SENT_812	[p21l1040t1089r1513b1196],
3	Advances	NNS	O	advance	prep_in	7	SENT_812	[p21l1550t1089r2009b1171],
4	in	IN	O	in	_	0	SENT_812	[p21l2060t1089r2146b1171],
5	Oncology	NNP	O	Oncology	prep_in	7	SENT_812	[p21l270t1203r736b1314],
6	,	,	O	,	_	0	SENT_812	[p21l270t1203r736b1314],
7	ed	VBD	O	ed	_	0	SENT_812	[p21l794t1203r926b1289],
8	.	.	O	.	_	0	SENT_812	[p21l794t1203r926b1289],

1	VT	NNP	O	VT	_	0	SENT_813	[p21l984t1203r1140b1286],
2	DeVita	NNP	PERSON	DeVita	dep	1	SENT_813	[p21l1184t1200r1548b1304],
3	,	,	O	,	_	0	SENT_813	[p21l1184t1200r1548b1304],
4	S	NNP	O	S	nn	5	SENT_813	[p21l1603t1203r1661b1289],
5	Hellman	NNP	PERSON	Hellman	appos	2	SENT_813	[p21l1719t1203r2142b1303],
6	,	,	O	,	_	0	SENT_813	[p21l1719t1203r2142b1303],
7	'	''	O	'	_	0	SENT_813	[p21l65t1524r132b1655],

1	A	DT	O	a	det	3	SENT_814	[p21l65t1524r132b1655],
2	Annual	JJ	SET	annual	amod	3	SENT_814	[p21l254t1535r588b1615],
3	Reviews	NNS	O	review	nsubj	4	SENT_814	[p21l620t1535r1009b1638],
4	_	VBP	O	_	_	0	SENT_814	[p21l1649t1626r1661b1638],
5	'	''	O	'	_	0	SENT_814	[p21l133t1615r177b1674],

1	wwW.annua1reV1ews.org/aronhne	NN	O	www.annua1rev1ews.org/aronhne	_	0	SENT_815	[p21l255t1626r1778b1730],

1	180	CD	NUMBER	180	num	2	SENT_816	[p21l395t1907r542b1983],
2	BELLAMY	NN	O	bellamy	_	0	SENT_816	[p21l730t1907r1229b1983],

1	SA	NNP	PERSON	SA	nn	2	SENT_817	[p21l642t2143r754b2213],
2	Rosenberg	NNP	PERSON	Rosenberg	_	0	SENT_817	[p21l791t2143r1196b2230],
3	,	,	O	,	_	0	SENT_817	[p21l791t2143r1196b2230],
4	pp	NN	O	pp	appos	2	SENT_817	[p21l1231t2143r1589b2230],
5	.	.	O	.	_	0	SENT_817	[p21l1231t2143r1589b2230],

1	l9	NN	O	l9	_	0	SENT_818	[p21l1231t2143r1589b2230],
2	—	CD	NUMBER	—	number	3	SENT_818	[p21l1231t2143r1589b2230],
3	38	CD	NUMBER	38	num	1	SENT_818	[p21l1231t2143r1589b2230],
4	.	.	O	.	_	0	SENT_818	[p21l1231t2143r1589b2230],

1	Philadelphia	NNP	LOCATION	Philadelphia	_	0	SENT_819	[p21l1626t2143r2098b2230],
2	:	:	O	:	_	0	SENT_819	[p21l1626t2143r2098b2230],
3	Lippincott	NNP	PERSON	Lippincott	dep	1	SENT_819	[p21l639t2234r1023b2323],

1	60	CD	NUMBER	60	_	0	SENT_820	[p21l441t2330r550b2403],
2	.	.	O	.	_	0	SENT_820	[p21l441t2330r550b2403],

1	Cordon	NNP	O	Cordon	nn	2	SENT_821	[p21l639t2333r913b2403],
2	CC	NN	O	cc	_	0	SENT_821	[p21l978t2330r1116b2411],
3	,	,	O	,	_	0	SENT_821	[p21l978t2330r1116b2411],
4	o‘Brien	NN	O	o‘brien	nn	5	SENT_821	[p21l1184t2330r1482b2400],
5	JP	NNP	O	JP	appos	2	SENT_821	[p21l1547t2333r1653b2411],
6	,	,	O	,	_	0	SENT_821	[p21l1547t2333r1653b2411],
7	Casals	NNP	PERSON	Casals	nn	8	SENT_821	[p21l1717t2330r1952b2400],
8	D	NNP	PERSON	D	appos	2	SENT_821	[p21l2017t2333r2103b2411],
9	,	,	O	,	_	0	SENT_821	[p21l2017t2333r2103b2411],
10	Rittman	NNP	PERSON	Rittman	nn	11	SENT_821	[p21l639t2423r932b2493],
11	GL	NNP	O	GL	appos	2	SENT_821	[p21l983t2423r1122b2504],
12	,	,	O	,	_	0	SENT_821	[p21l983t2423r1122b2504],
13	Biedler	NNP	PERSON	Biedler	nn	14	SENT_821	[p21l1176t2423r1446b2490],
14	IL	NN	PERSON	il	appos	2	SENT_821	[p21l1492t2423r1603b2501],
15	,	,	O	,	_	0	SENT_821	[p21l1492t2423r1603b2501],
16	et	FW	O	et	nn	17	SENT_821	[p21l1654t2434r1719b2493],
17	al.	FW	O	al.	appos	2	SENT_821	[p21l1764t2423r1848b2490],
18	1989	CD	DATE	1989	dep	17	SENT_821	[p21l1912t2423r2101b2493],
19	.	.	O	.	_	0	SENT_821	[p21l1912t2423r2101b2493],

1	Multidrug-resistance	JJ	O	multidrug-resistance	amod	3	SENT_822	[p21l639t2526r1400b2613],
2	gene	NN	O	gene	nn	3	SENT_822	[p21l1434t2545r1606b2613],
3	(	NN	O	(	nsubjpass	7	SENT_822	[p21l1643t2526r2104b2613, p21l639t2619r808b2703],
4	Pglycoprotein	NN	O	pglycoprotein	nn	5	SENT_822	[p21l1643t2526r2104b2613, p21l639t2619r808b2703],
5	)	NN	O	)	dep	3	SENT_822	[p21l1643t2526r2104b2613, p21l639t2619r808b2703],
6	is	VBZ	O	be	auxpass	7	SENT_822	[p21l851t2619r913b2687],
7	expressed	VBN	O	express	_	0	SENT_822	[p21l956t2619r1317b2706],
8	by	IN	O	by	_	0	SENT_822	[p21l1357t2619r1449b2706],
9	endothelial	JJ	O	endothelial	amod	10	SENT_822	[p21l1492t2619r1895b2689],
10	cells	NNS	O	cell	agent	7	SENT_822	[p21l1937t2619r2104b2687],
11	at	IN	O	at	_	0	SENT_822	[p21l642t2732r707b2791],
12	blood-brain	JJ	O	blood-brain	amod	14	SENT_822	[p21l738t2721r1169b2788],
13	barrier	NN	O	barrier	nn	14	SENT_822	[p21l1200t2721r1446b2788],
14	sites	NNS	O	site	prep_at	7	SENT_822	[p21l1478t2721r1655b2788],
15	.	.	O	.	_	0	SENT_822	[p21l1478t2721r1655b2788],

1	Proc	NNP	O	Proc	_	0	SENT_823	[p21l1692t2721r1884b2788],
2	.	.	O	.	_	0	SENT_823	[p21l1692t2721r1884b2788],

1	Natl.	NNP	O	Natl.	nn	2	SENT_824	[p21l1926t2721r2098b2788],
2	Acad	NNP	O	Acad	_	0	SENT_824	[p21l634t2823r841b2893],
3	.	.	O	.	_	0	SENT_824	[p21l634t2823r841b2893],

1	Sci	NNP	O	Sci	_	0	SENT_825	[p21l887t2826r1012b2893],
2	.	.	O	.	_	0	SENT_825	[p21l887t2826r1012b2893],

1	USA	NNP	LOCATION	USA	_	0	SENT_826	[p21l1060t2826r1218b2893],
2	86:695	CD	NUMBER	86:695	num	3	SENT_826	[p21l1258t2823r1647b2893],
3	-98	CD	NUMBER	-98	dep	1	SENT_826	[p21l1258t2823r1647b2893],

1	61	CD	NUMBER	61	_	0	SENT_827	[p21l441t2918r550b2985],
2	.	.	O	.	_	0	SENT_827	[p21l441t2918r550b2985],

1	Thiebaut	NNP	PERSON	Thiebaut	nn	2	SENT_828	[p21l639t2915r968b2985],
2	F	NN	O	f	_	0	SENT_828	[p21l994t2918r1067b2996],
3	,	,	O	,	_	0	SENT_828	[p21l994t2918r1067b2996],
4	Tsuruo	NNP	PERSON	Tsuruo	nn	5	SENT_828	[p21l1096t2918r1353b2985],
5	T	NN	PERSON	t	appos	2	SENT_828	[p21l1382t2918r1463b2996],
6	,	,	O	,	_	0	SENT_828	[p21l1382t2918r1463b2996],
7	Harnada	NN	O	harnada	nn	8	SENT_828	[p21l1492t2915r1796b2985],
8	I-I	NN	O	i-i	appos	2	SENT_828	[p21l1824t2918r1908b2996],
9	,	,	O	,	_	0	SENT_828	[p21l1824t2918r1908b2996],
10	Gottesman	NNP	PERSON	Gottesman	nn	11	SENT_828	[p21l1940t2915r2106b2985, p21l642t3031r899b3087],
11	MM	NN	O	mm	appos	2	SENT_828	[p21l925t3020r1108b3098],
12	,	,	O	,	_	0	SENT_828	[p21l925t3020r1108b3098],
13	Pastan	NNP	PERSON	Pastan	nn	17	SENT_828	[p21l1137t3020r1378b3087],
14	I	PRP	O	I	dep	17	SENT_828	[p21l1404t3020r1455b3098],
15	,	,	O	,	_	0	SENT_828	[p21l1404t3020r1455b3098],
16	Willingham	NNP	PERSON	Willingham	dep	17	SENT_828	[p21l1483t3020r1917b3109],
17	MC	NNP	O	MC	appos	2	SENT_828	[p21l1943t3020r2104b3109],
18	.	.	O	.	_	0	SENT_828	[p21l1943t3020r2104b3109],

1	1989	CD	DATE	1989	_	0	SENT_829	[p21l650t3121r841b3191],
2	.	.	O	.	_	0	SENT_829	[p21l650t3121r841b3191],

1	Immunohistochemical	JJ	O	immunohistochemical	amod	2	SENT_830	[p21l912t3120r1724b3188],
2	localizaAnnu	NN	O	localizaannu	_	0	SENT_830	[p21l1794t3120r2106b3188, p22l7t3279r91b3499],
3	.	.	O	.	_	0	SENT_830	[p21l1794t3120r2106b3188, p22l7t3279r91b3499],

1	Rev.	NNP	O	Rev.	nn	2	SENT_831	[p22l8t3085r71b3249],
2	Pharmaeol	NNP	PERSON	Pharmaeol	_	0	SENT_831	[p22l7t2648r71b3056],
3	.	.	O	.	_	0	SENT_831	[p22l7t2648r71b3056],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_832	[p22l7t2317r71b2618],
2	.	.	O	.	_	0	SENT_832	[p22l7t2317r71b2618],

1	1996.36	CD	NUMBER	1996.36	_	0	SENT_833	[p22l7t1972r72b2278],
2	:	:	O	:	_	0	SENT_833	[p22l7t1972r72b2278],
3	161-183	CD	NUMBER	161-183	dep	1	SENT_833	[p22l7t1643r72b1955],
4	.	.	O	.	_	0	SENT_833	[p22l7t1643r72b1955],

1	Downloaded	VBN	O	download	_	0	SENT_834	[p22l7t1145r71b1613],
2	from	IN	O	from	_	0	SENT_834	[p22l7t945r71b1121],
3	www.annualreViews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_834	[p22l7t27r90b920],
4	by	IN	O	by	_	0	SENT_834	[p22l99t3038r182b3128],
5	University	NNP	ORGANIZATION	University	prep_by	3	SENT_834	[p22l99t2629r182b3013],
6	of	IN	ORGANIZATION	of	_	0	SENT_834	[p22l99t2523r163b2602],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	9	SENT_834	[p22l99t2119r163b2505],
8	—	NNP	O	—	nn	9	SENT_834	[p22l137t2068r144b2092],
9	Madison	NNP	O	Madison	prep_of	5	SENT_834	[p22l99t1722r163b2041],
10	on	IN	O	on	_	0	SENT_834	[p22l118t1607r163b1696],
11	O1/O5	NNP	O	O1/O5	prep_on	9	SENT_834	[p22l98t1348r163b1581],
12	/	:	O	/	punct	18	SENT_834	[p22l98t1348r163b1581],
13	14	CD	NUMBER	14	dep	18	SENT_834	[p22l99t1259r161b1339],
14	For	IN	O	for	_	0	SENT_834	[p22l100t1084r163b1211],
15	personal	JJ	O	personal	amod	16	SENT_834	[p22l99t752r182b1061],
16	use	NN	O	use	prep_for	13	SENT_834	[p22l118t608r163b728],
17	only	RB	O	only	advmod	18	SENT_834	[p22l99t422r182b581],
18	an	DT	O	a	parataxis	1	SENT_834	[p22l444t571r490b641],

1	N	NN	O	n	nn	2	SENT_835	[p22l494t571r553b641],
2	ch	NN	O	ch	_	0	SENT_835	[p22l447t1124r490b1191],
3	5	CD	NUMBER	5	number	4	SENT_835	[p22l496t1124r556b1191],
4	*	CD	NUMBER	*	num	5	SENT_835	[p22l496t1124r556b1191],
5	’	NN	O	’	dep	2	SENT_835	[p22l496t1124r556b1191],
6	as	IN	O	as	_	0	SENT_835	[p22l447t1580r492b1647],
7	:3	CD	NUMBER	:3	number	8	SENT_835	[p22l494t1580r556b1647, p22l642t18r784b88],
8	‘	CD	NUMBER	‘	num	9	SENT_835	[p22l494t1580r556b1647, p22l642t18r784b88],
9	tion	NN	O	tion	prep_as	5	SENT_835	[p22l494t1580r556b1647, p22l642t18r784b88],

1	in	IN	O	in	dep	14	SENT_836	[p22l824t18r891b85],
2	normal	JJ	O	normal	amod	3	SENT_836	[p22l931t18r1185b88],
3	tissues	NNS	O	tissue	pobj	1	SENT_836	[p22l1225t18r1468b85],
4	of	IN	O	of	_	0	SENT_836	[p22l1505t18r1587b85],
5	different	JJ	O	different	amod	6	SENT_836	[p22l1615t18r1930b85],
6	epitopes	NNS	O	epitope	prep_of	3	SENT_836	[p22l1967t18r2106b108, p22l642t123r833b198],
7	in	IN	O	in	_	0	SENT_836	[p22l868t112r938b176],
8	the	DT	O	the	det	12	SENT_836	[p22l967t112r1075b176],
9	multidrug	JJ	O	multidrug	amod	12	SENT_836	[p22l1110t109r1468b196],
10	transport	NN	O	transport	nn	12	SENT_836	[p22l1500t120r1820b196],
11	protein	NN	O	protein	nn	12	SENT_836	[p22l1849t109r2109b196],
12	P170	NN	O	p170	prep_in	6	SENT_836	[p22l642t200r847b270],
13	:	:	O	:	_	0	SENT_836	[p22l642t200r847b270],
14	evidence	NN	O	evidence	_	0	SENT_836	[p22l881t200r1207b270],
15	for	IN	O	for	_	0	SENT_836	[p22l1236t200r1345b267],
16	localization	NN	O	localization	prep_for	14	SENT_836	[p22l1371t200r1796b267],
17	in	IN	O	in	_	0	SENT_836	[p22l1822t200r1895b267],
18	brain	NN	O	brain	nn	19	SENT_836	[p22l1921t200r2106b267],
19	capillaries	NNS	O	capillary	prep_in	16	SENT_836	[p22l642t293r1017b383],
20	and	CC	O	and	_	0	SENT_836	[p22l1074t293r1204b361],
21	crossreactivity	NN	O	crossreactivity	conj_and	14	SENT_836	[p22l1261t293r1787b380],
22	of	IN	O	of	_	0	SENT_836	[p22l1846t291r1928b361],
23	one	CD	NUMBER	one	num	24	SENT_836	[p22l1976t313r2106b361],
24	antibody	NN	O	antibody	prep_of	21	SENT_836	[p22l645t384r960b473],
25	with	IN	O	with	_	0	SENT_836	[p22l994t384r1155b451],
26	a	DT	O	a	det	28	SENT_836	[p22l1187t403r1229b451],
27	muscle	NN	O	muscle	nn	28	SENT_836	[p22l1261t384r1515b451],
28	protein	NN	O	protein	prep_with	24	SENT_836	[p22l1549t384r1823b473],
29	.	.	O	.	_	0	SENT_836	[p22l1549t384r1823b473],

1	J.	NNP	PERSON	J.	nn	2	SENT_837	[p22l1855t387r1914b451],
2	Histochem	NNP	PERSON	Histochem	_	0	SENT_837	[p22l1951t387r2106b451, p22l645t477r921b548],
3	.	.	O	.	_	0	SENT_837	[p22l1951t387r2106b451, p22l645t477r921b548],

1	Cytochem	NNP	O	Cytochem	_	0	SENT_838	[p22l967t477r1345b564],
2	.	.	O	.	_	0	SENT_838	[p22l967t477r1345b564],

1	37	CD	NUMBER	37	_	0	SENT_839	[p22l1390t477r1499b545],
2	:	:	O	:	_	0	SENT_839	[p22l1390t477r1499b545],
3	159-64	CD	NUMBER	159-64	num	5	SENT_839	[p22l1514t475r1774b548],
4	Wilisch	NN	O	wilisch	nn	5	SENT_839	[p22l645t571r927b641],
5	A	NN	O	a	dep	1	SENT_839	[p22l964t574r1045b652],
6	,	,	O	,	_	0	SENT_839	[p22l964t574r1045b652],
7	Noller	NNP	PERSON	Noller	nn	8	SENT_839	[p22l1082t571r1317b638],
8	A	NNP	O	A	appos	5	SENT_839	[p22l1349t574r1433b649],
9	,	,	O	,	_	0	SENT_839	[p22l1349t574r1433b649],
10	Handgretinger	NNP	PERSON	Handgretinger	nn	11	SENT_839	[p22l1470t571r1994b658],
11	R	NNP	PERSON	R	appos	5	SENT_839	[p22l2028t571r2106b649],
12	,	,	O	,	_	0	SENT_839	[p22l2028t571r2106b649],
13	Weger	NNP	PERSON	Weger	nn	14	SENT_839	[p22l645t664r888b748],
14	S	NNP	O	S	appos	5	SENT_839	[p22l961t662r1028b740],
15	,	,	O	,	_	0	SENT_839	[p22l961t662r1028b740],
16	Nussler	NNP	O	Nussler	nn	17	SENT_839	[p22l1101t662r1383b729],
17	V	NNP	O	V	appos	5	SENT_839	[p22l1453t664r1537b740],
18	,	,	O	,	_	0	SENT_839	[p22l1453t664r1537b740],
19	et	FW	O	et	nn	20	SENT_839	[p22l1613t673r1677b729],
20	al.	FW	O	al.	appos	5	SENT_839	[p22l1747t662r1829b729],
21	1993	CD	DATE	1993	dep	20	SENT_839	[p22l1915t662r2104b732],
22	.	.	O	.	_	0	SENT_839	[p22l1915t662r2104b732],

1	MdrllP-glycoprotein	NN	O	mdrllp-glycoprotein	nn	2	SENT_840	[p22l645t752r1416b839],
2	expression	NN	O	expression	nsubj	10	SENT_840	[p22l1533t752r1919b839],
3	in	IN	O	in	_	0	SENT_840	[p22l2039t752r2109b820],
4	natural	JJ	O	natural	amod	5	SENT_840	[p22l645t849r896b916],
5	killer	NN	O	killer	prep_in	2	SENT_840	[p22l931t849r1125b913],
6	(	CD	NUMBER	(	num	9	SENT_840	[p22l1159t849r1347b930],
7	NK	NN	O	nk	nn	9	SENT_840	[p22l1159t849r1347b930],
8	)	NN	O	)	nn	9	SENT_840	[p22l1159t849r1347b930],
9	cells	NNS	O	cell	dep	5	SENT_840	[p22l1387t849r1554b913],
10	enriched	VBN	O	enrich	_	0	SENT_840	[p22l1588t846r1897b913],
11	from	IN	O	from	_	0	SENT_840	[p22l1934t846r2109b913],
12	peripheral	JJ	O	peripheral	prep_from	10	SENT_840	[p22l645t939r1012b1026],
13	or	CC	O	or	_	0	SENT_840	[p22l1038t959r1114b1007],
14	umbilical	JJ	O	umbilical	amod	16	SENT_840	[p22l1134t937r1474b1007],
15	cord	NN	O	cord	nn	16	SENT_840	[p22l1497t937r1661b1004],
16	blood	NN	O	blood	conj_or	12	SENT_840	[p22l1679t937r1903b1007],
17	.	.	O	.	_	0	SENT_840	[p22l1679t937r1903b1007],

1	Cancer	NNP	O	Cancer	nn	2	SENT_841	[p22l1932t937r2106b1004, p22l645t1049r764b1095],
2	Lett	NNP	PERSON	Lett	_	0	SENT_841	[p22l796t1027r951b1095],
3	.	.	O	.	_	0	SENT_841	[p22l796t1027r951b1095],

1	69	CD	NUMBER	69	_	0	SENT_842	[p22l997t1027r1383b1097],
2	:	:	O	:	_	0	SENT_842	[p22l997t1027r1383b1097],
3	l39	CD	NUMBER	l39	dep	1	SENT_842	[p22l997t1027r1383b1097],
4	—	CD	NUMBER	—	number	5	SENT_842	[p22l997t1027r1383b1097],
5	48	CD	NUMBER	48	dep	3	SENT_842	[p22l997t1027r1383b1097],

1	Chaudhary	NNP	O	Chaudhary	nn	2	SENT_843	[p22l645t1124r1042b1210],
2	PM	NNP	O	PM	_	0	SENT_843	[p22l1107t1124r1259b1202],
3	,	,	O	,	_	0	SENT_843	[p22l1107t1124r1259b1202],
4	Roninson	NNP	O	Roninson	nn	5	SENT_843	[p22l1324t1121r1672b1191],
5	IB	NNP	O	IB	appos	2	SENT_843	[p22l1731t1124r1840b1191],
6	.	.	O	.	_	0	SENT_843	[p22l1731t1124r1840b1191],

1	1991	CD	DATE	1991	_	0	SENT_844	[p22l1915t1121r2106b1191],
2	.	.	O	.	_	0	SENT_844	[p22l1915t1121r2106b1191],

1	Expression	NN	O	expression	_	0	SENT_845	[p22l645t1214r1048b1301],
2	and	CC	O	and	_	0	SENT_845	[p22l1088t1214r1218b1282],
3	activity	NN	O	activity	conj_and	1	SENT_845	[p22l1255t1214r1529b1301],
4	of	IN	O	of	_	0	SENT_845	[p22l1566t1212r1647b1282],
5	Pglycoprotein	NN	LOCATION	pglycoprotein	prep_of	1	SENT_845	[p22l1679t1214r2109b1301, p22l645t1305r803b1383],
6	,	,	O	,	_	0	SENT_845	[p22l1679t1214r2109b1301, p22l645t1305r803b1383],
7	a	DT	O	a	det	10	SENT_845	[p22l829t1327r869b1372],
8	multidrug	JJ	O	multidrug	amod	10	SENT_845	[p22l895t1305r1254b1392],
9	efflux	NN	O	efflux	nn	10	SENT_845	[p22l1277t1305r1493b1372],
10	pump	NN	O	pump	appos	5	SENT_845	[p22l1519t1324r1743b1392],
11	,	,	O	,	_	0	SENT_845	[p22l1519t1324r1743b1392],
12	in	IN	O	in	_	0	SENT_845	[p22l1772t1305r1842b1372],
13	human	JJ	O	human	amod	16	SENT_845	[p22l1866t1305r2112b1372],
14	hematopoietic	JJ	O	hematopoietic	amod	16	SENT_845	[p22l645t1398r1160b1485],
15	stem	NN	O	stem	nn	16	SENT_845	[p22l1211t1409r1380b1466],
16	cells	NNS	O	cell	prep_in	1	SENT_845	[p22l1426t1399r1611b1466],
17	.	.	O	.	_	0	SENT_845	[p22l1426t1399r1611b1466],

1	Cell	NN	O	cell	_	0	SENT_846	[p22l1668t1398r1815b1466],
2	66:8594	CD	NUMBER	66:8594	num	1	SENT_846	[p22l1860t1396r2115b1466, p22l645t1489r737b1557],

1	Brightman	NNP	PERSON	Brightman	nn	2	SENT_847	[p22l648t1577r1037b1667],
2	MW	NNP	O	MW	_	0	SENT_847	[p22l1088t1580r1273b1645],
3	.	.	O	.	_	0	SENT_847	[p22l1088t1580r1273b1645],

1	1989	CD	DATE	1989	_	0	SENT_848	[p22l1341t1577r1529b1647],
2	.	.	O	.	_	0	SENT_848	[p22l1341t1577r1529b1647],

1	The	DT	O	the	det	3	SENT_849	[p22l1585t1577r1724b1645],
2	anatomic	JJ	O	anatomic	amod	3	SENT_849	[p22l1778t1577r2109b1645],
3	basis	NN	O	basis	_	0	SENT_849	[p22l645t1671r828b1741],
4	of	IN	O	of	_	0	SENT_849	[p22l862t1671r946b1741],
5	the	DT	O	the	det	7	SENT_849	[p22l972t1673r1084b1741],
6	blood-brain	JJ	O	blood-brain	amod	7	SENT_849	[p22l1118t1671r1545b1741],
7	barrier	NN	O	barrier	prep_of	3	SENT_849	[p22l1577t1671r1837b1741],
8	.	.	O	.	_	0	SENT_849	[p22l1577t1671r1837b1741],

1	In	IN	O	in	_	0	SENT_850	[p22l1877t1673r1950b1741],
2	Implications	NNS	MISC	implication	pobj	1	SENT_850	[p22l1984t1671r2109b1738, p22l639t1761r1009b1851],

1	of	IN	O	of	dep	9	SENT_851	[p22l1055t1761r1141b1848],
2	the	DT	O	the	det	4	SENT_851	[p22l1176t1761r1290b1832],
3	Blood-Brain	NNP	O	Blood-Brain	nn	4	SENT_851	[p22l1335t1761r1793b1829],
4	Barrier	NNP	O	Barrier	pobj	1	SENT_851	[p22l1838t1761r2115b1829],
5	and	CC	O	and	_	0	SENT_851	[p22l645t1858r789b1928],
6	Its	PRP$	O	its	poss	7	SENT_851	[p22l815t1860r907b1928],
7	Manipulation	NN	O	manipulation	conj_and	4	SENT_851	[p22l934t1858r1452b1944],
8	,	,	O	,	_	0	SENT_851	[p22l934t1858r1452b1944],
9	ed	VBD	O	ed	_	0	SENT_851	[p22l1489t1858r1592b1925],
10	EA	NN	ORGANIZATION	ea	nn	11	SENT_851	[p22l1629t1858r1746b1925],
11	Neuwalt	NN	ORGANIZATION	neuwalt	nsubj	9	SENT_851	[p22l1778t1858r2109b1936],
12	,	,	O	,	_	0	SENT_851	[p22l1778t1858r2109b1936],
13	pp	NN	O	pp	appos	11	SENT_851	[p22l648t1970r756b2038],
14	.	.	O	.	_	0	SENT_851	[p22l648t1970r756b2038],

1	53-83	NN	O	53-83	_	0	SENT_852	[p22l796t1948r1039b2019],
2	.	.	O	.	_	0	SENT_852	[p22l796t1948r1039b2019],

1	New	NNP	LOCATION	New	nn	2	SENT_853	[p22l1079t1951r1251b2018],
2	York	NNP	LOCATION	York	_	0	SENT_853	[p22l1288t1948r1493b2019],
3	:	:	O	:	_	0	SENT_853	[p22l1288t1948r1493b2019],
4	Plenum	NNP	ORGANIZATION	Plenum	nn	6	SENT_853	[p22l1536t1948r1812b2016],
5	Hegmann	NNP	ORGANIZATION	Hegmann	nn	6	SENT_853	[p22l648t2042r1001b2128],
6	EJ	NNP	ORGANIZATION	EJ	dep	2	SENT_853	[p22l1052t2042r1163b2120],
7	,	,	O	,	_	0	SENT_853	[p22l1052t2042r1163b2120],
8	Bauer	NNP	PERSON	Bauer	nn	9	SENT_853	[p22l1217t2042r1435b2109],
9	HC	NNP	O	HC	appos	2	SENT_853	[p22l1483t2039r1628b2120],
10	,	,	O	,	_	0	SENT_853	[p22l1483t2039r1628b2120],
11	Kerbel	NNP	PERSON	Kerbel	nn	12	SENT_853	[p22l1681t2039r1928b2109],
12	RS	NN	O	r	appos	2	SENT_853	[p22l1978t2039r2109b2109],
13	.	.	O	.	_	0	SENT_853	[p22l1978t2039r2109b2109],

1	1992	CD	DATE	1992	_	0	SENT_854	[p22l656t2135r847b2203],
2	.	.	O	.	_	0	SENT_854	[p22l656t2135r847b2203],

1	Expression	NN	O	expression	nn	4	SENT_855	[p22l876t2135r1279b2219],
2	and	CC	O	and	_	0	SENT_855	[p22l1302t2135r1430b2200],
3	functional	JJ	O	functional	nn	4	SENT_855	[p22l1450t2133r1818b2200],
4	activity	NN	O	activity	nsubj	8	SENT_855	[p22l1841t2133r2112b2219],
5	of	IN	O	of	_	0	SENT_855	[p22l648t2223r729b2291],
6	P-glycoprotein	NN	O	p-glycoprotein	prep_of	4	SENT_855	[p22l771t2223r1312b2310],
7	in	IN	O	in	advmod	8	SENT_855	[p22l1360t2223r1430b2291],
8	cultured	VBN	O	culture	_	0	SENT_855	[p22l1475t2223r1774b2291],
9	cerebral	JJ	O	cerebral	amod	12	SENT_855	[p22l1819t2223r2112b2291],
10	capillary	JJ	O	capillary	amod	12	SENT_855	[p22l648t2314r965b2401],
11	endothelial	JJ	O	endothelial	amod	12	SENT_855	[p22l1002t2314r1405b2381],
12	cells	NNS	O	cell	dobj	8	SENT_855	[p22l1440t2314r1622b2381],
13	.	.	O	.	_	0	SENT_855	[p22l1440t2314r1622b2381],

1	Cancer	NN	O	cancer	_	0	SENT_856	[p22l1665t2314r1933b2381],
2	Res	NNP	O	Res	dep	1	SENT_856	[p22l1956t2314r2104b2381],
3	.	.	O	.	_	0	SENT_856	[p22l1956t2314r2104b2381],

1	S2	NN	O	s2	_	0	SENT_857	[p22l648t2410r1078b2478],
2	:6969	CD	NUMBER	:6969	num	3	SENT_857	[p22l648t2410r1078b2478],
3	-75	CD	NUMBER	-75	dep	1	SENT_857	[p22l648t2410r1078b2478],

1	Tsuji	NNP	PERSON	Tsuji	nn	2	SENT_858	[p22l645t2501r833b2588],
2	A	NNP	O	A	_	0	SENT_858	[p22l895t2504r979b2579],
3	,	,	O	,	_	0	SENT_858	[p22l895t2504r979b2579],
4	Terasaki	NNP	PERSON	Terasaki	nn	5	SENT_858	[p22l1038t2498r1353b2568],
5	T	NN	O	t	appos	2	SENT_858	[p22l1412t2501r1488b2579],
6	,	,	O	,	_	0	SENT_858	[p22l1412t2501r1488b2579],
7	Takabatake	NNP	O	Takabatake	nn	8	SENT_858	[p22l1547t2501r1966b2568],
8	Y	NN	O	y	appos	2	SENT_858	[p22l2028t2501r2109b2579],
9	,	,	O	,	_	0	SENT_858	[p22l2028t2501r2109b2579],
10	Tenda	NNP	ORGANIZATION	Tenda	nn	11	SENT_858	[p22l648t2592r877b2659],
11	Y	NN	ORGANIZATION	y	appos	2	SENT_858	[p22l939t2594r1023b2670],
12	,	,	O	,	_	0	SENT_858	[p22l939t2594r1023b2670],
13	Tamai	NNP	PERSON	Tamai	appos	2	SENT_858	[p22l1085t2592r1317b2659],
14	I	PRP	O	I	dep	13	SENT_858	[p22l1384t2594r1433b2670],
15	,	,	O	,	_	0	SENT_858	[p22l1384t2594r1433b2670],
16	et	FW	O	et	nn	17	SENT_858	[p22l1494t2605r1562b2659],
17	al.	FW	O	al.	appos	2	SENT_858	[p22l1624t2592r1705b2659],
18	1992	CD	DATE	1992	dep	17	SENT_858	[p22l1778t2592r1969b2659],
19	.	.	O	.	_	0	SENT_858	[p22l1778t2592r1969b2659],

1	P_glycoprote1n	NN	O	p_glycoprote1n	nsubj	10	SENT_859	[p22l2036t2594r2112b2659, p22l648t2682r1108b2791],
2	as	IN	O	as	_	0	SENT_859	[p22l1156t2704r1229b2753],
3	the	DT	O	the	det	7	SENT_859	[p22l1277t2682r1386b2753],
4	drug	NN	O	drug	nn	7	SENT_859	[p22l1434t2685r1603b2788],
5	efﬂux	NN	O	efﬂux	nn	7	SENT_859	[p22l1646t2682r1862b2788],
6	_	CD	NUMBER	_	num	7	SENT_859	[p22l1646t2682r1862b2788],
7	pump	NN	O	pump	prep_as	1	SENT_859	[p22l1907t2704r2117b2772],
8	in	IN	O	in	_	0	SENT_859	[p22l650t2798r718b2843],
9	primary	JJ	O	primary	prep_in	7	SENT_859	[p22l760t2795r1050b2865],
10	cultured	VBN	O	culture	_	0	SENT_859	[p22l1096t2776r1397b2843],
11	bovine	NN	O	bovine	nn	12	SENT_859	[p22l1437t2776r1683b2843],
12	brain	NN	O	brain	nsubj	15	SENT_859	[p22l1728t2776r1914b2843],
13	capillary	JJ	O	capillary	amod	15	SENT_859	[p22l1956t2795r2112b2863, p22l650t2869r839b2956],
14	endothelial	JJ	O	endothelial	amod	15	SENT_859	[p22l901t2867r1303b2937],
15	cells	NNS	O	cell	xcomp	10	SENT_859	[p22l1363t2869r1548b2937],
16	.	.	O	.	_	0	SENT_859	[p22l1363t2869r1548b2937],

1	Life	NNP	O	Life	nn	2	SENT_860	[p22l1607t2869r1749b2953],
2	Sci	NNP	O	Sci	_	0	SENT_860	[p22l1808t2869r1933b2937],
3	.	.	O	.	_	0	SENT_860	[p22l1808t2869r1933b2937],

1	51	CD	NUMBER	51	_	0	SENT_861	[p22l2000t2869r2109b2937],
2	:	:	O	:	_	0	SENT_861	[p22l2000t2869r2109b2937],
3	1427-37	CD	NUMBER	1427-37	dep	1	SENT_861	[p22l659t2963r965b3033],

1	Chan	NNP	O	Chan	nn	2	SENT_862	[p22l648t3054r839b3124],
2	HS	NN	O	h	_	0	SENT_862	[p22l870t3054r1009b3135],
3	,	,	O	,	_	0	SENT_862	[p22l870t3054r1009b3135],
4	Thorner	NNP	PERSON	Thorner	nn	5	SENT_862	[p22l1035t3054r1334b3124],
5	PS	NNP	O	PS	appos	2	SENT_862	[p22l1363t3054r1482b3132],
6	,	,	O	,	_	0	SENT_862	[p22l1363t3054r1482b3132],
7	Haddad	NNP	PERSON	Haddad	nn	8	SENT_862	[p22l1517t3054r1796b3124],
8	G	NNP	PERSON	G	appos	2	SENT_862	[p22l1827t3054r1911b3135],
9	,	,	O	,	_	0	SENT_862	[p22l1827t3054r1911b3135],
10	Ling	NNP	O	Ling	nn	11	SENT_862	[p22l1945t3054r2117b3140],
11	V.	NNP	O	V.	appos	2	SENT_862	[p22l650t3147r732b3214],
12	1990	CD	DATE	1990	dep	11	SENT_862	[p22l791t3147r982b3217],
13	.	.	O	.	_	0	SENT_862	[p22l791t3147r982b3217],

1	Immunohistochemieal	JJ	O	immunohistochemieal	_	0	SENT_863	[p22l1035t3144r1845b3214],
2	detec	NN	O	detec	dep	1	SENT_863	[p22l1890t3144r2153b3242],
3	-	:	O	-	_	0	SENT_863	[p22l1890t3144r2153b3242],
4	.	.	O	.	_	0	SENT_863	[p22l1890t3144r2153b3242],

1	tion	NN	O	tion	_	0	SENT_864	[p22l650t3243r792b3311],
2	of	IN	O	of	_	0	SENT_864	[p22l829t3243r910b3311],
3	P-glycoprotein	NN	O	p-glycoprotein	prep_of	1	SENT_864	[p22l942t3243r1504b3330],
4	:	:	O	:	_	0	SENT_864	[p22l942t3243r1504b3330],
5	prognostic	JJ	O	prognostic	amod	6	SENT_864	[p22l1549t3241r1930b3330],
6	cmrelation	NN	O	cmrelation	dep	1	SENT_864	[p22l1967t3263r2112b3311, p22l650t3334r929b3404],
7	in	IN	O	in	_	0	SENT_864	[p22l1011t3334r1078b3401],
8	soft	JJ	O	soft	amod	10	SENT_864	[p22l1159t3334r1292b3404],
9	tissue	NN	O	tissue	nn	10	SENT_864	[p22l1374t3334r1581b3404],
10	sarcoma	NN	O	sarcoma	prep_in	6	SENT_864	[p22l1662t3353r1961b3404],
11	of	IN	O	of	_	0	SENT_864	[p22l2042t3334r2120b3401],
12	childhood	NN	O	childhood	prep_of	10	SENT_864	[p22l648t3427r1031b3495],
13	.	.	O	.	_	0	SENT_864	[p22l648t3427r1031b3495],

1	J.	NNP	PERSON	J.	nn	2	SENT_865	[p22l1068t3425r1125b3492],
2	Clin	NNP	PERSON	Clin	_	0	SENT_865	[p22l1173t3425r1339b3495],
3	.	.	O	.	_	0	SENT_865	[p22l1173t3425r1339b3495],

1	Oncol	NN	O	oncol	_	0	SENT_866	[p22l1387t3425r1622b3495],
2	.	.	O	.	_	0	SENT_866	[p22l1387t3425r1622b3495],

1	8:689	CD	NUMBER	8:689	num	2	SENT_867	[p22l1668t3425r2054b3495],
2	-704	CD	NUMBER	-704	_	0	SENT_867	[p22l1668t3425r2054b3495],

1	Salmon	VB	O	salmon	_	0	SENT_868	[p22l650t3521r929b3588],
2	SE	NN	O	se	dep	1	SENT_868	[p22l994t3521r1119b3597],
3	,	,	O	,	_	0	SENT_868	[p22l994t3521r1119b3597],
4	Grogan	NNP	PERSON	Grogan	nn	5	SENT_868	[p22l1187t3521r1457b3605],
5	TM	NNP	O	TM	appos	2	SENT_868	[p22l1522t3521r1677b3599],
6	,	,	O	,	_	0	SENT_868	[p22l1522t3521r1677b3599],
7	Miller	NNP	PERSON	Miller	appos	2	SENT_868	[p22l1747t3518r1974b3588],
8	1	CD	NUMBER	1	number	9	SENT_868	[p22l2036t3521r2112b3600],
9	‘	CD	NUMBER	‘	dep	7	SENT_868	[p22l2036t3521r2112b3600],
10	,	,	O	,	_	0	SENT_868	[p22l2036t3521r2112b3600],

1	Scheper	NNP	PERSON	Scheper	nn	2	SENT_869	[p22l650t3623r946b3709],
2	R	NNP	PERSON	R	_	0	SENT_869	[p22l967t3623r1045b3698],
3	,	,	O	,	_	0	SENT_869	[p22l967t3623r1045b3698],
4	Dalton	NNP	PERSON	Dalton	nn	5	SENT_869	[p22l1071t3623r1314b3690],
5	WS	NNP	O	WS	appos	2	SENT_869	[p22l1338t3620r1493b3690],
6	.	.	O	.	_	0	SENT_869	[p22l1338t3620r1493b3690],

1	1989	CD	DATE	1989	_	0	SENT_870	[p22l1525t3620r1716b3690],
2	.	.	O	.	_	0	SENT_870	[p22l1525t3620r1716b3690],

1	Prediction	NN	O	prediction	nsubj	7	SENT_871	[p22l1742t3620r2117b3690],
2	of	IN	O	of	_	0	SENT_871	[p22l650t3725r729b3792],
3	doxorubicin	NN	O	doxorubicin	nn	4	SENT_871	[p22l782t3722r1224b3792],
4	resistance	NN	O	resistance	prep_of	1	SENT_871	[p22l1280t3725r1636b3792],
5	in	FW	O	in	nn	6	SENT_871	[p22l1692t3725r1760b3792],
6	vitro	FW	O	vitro	dep	7	SENT_871	[p22l1819t3722r1991b3792],
7	in	IN	O	in	_	0	SENT_871	[p22l2044t3722r2117b3792],
8	myeloma	NN	O	myeloma	nn	10	SENT_871	[p23l650t18r1009b105],
9	,	,	O	,	_	0	SENT_871	[p23l650t18r1009b105],
10	lymphoma	NN	O	lymphoma	pobj	7	SENT_871	[p23l1038t21r1449b105],
11	,	,	O	,	_	0	SENT_871	[p23l1038t21r1449b105],
12	and	CC	O	and	_	0	SENT_871	[p23l1478t21r1609b86],
13	breast	NN	O	breast	nn	14	SENT_871	[p23l1635t21r1853b86],
14	cancer	NN	O	cancer	pobj	7	SENT_871	[p23l1879t37r2117b86],
15	by	IN	O	by	_	0	SENT_871	[p23l648t123r737b210],
16	P-glycoprotein	NN	O	p-glycoprotein	nn	17	SENT_871	[p23l763t123r1301b210],
17	staining	NN	O	staining	prep_by	7	SENT_871	[p23l1327t123r1628b210],
18	.	.	O	.	_	0	SENT_871	[p23l1327t123r1628b210],

1	J.	NNP	O	J.	nn	4	SENT_872	[p23l1654t126r1705b191],
2	Natl.	NNP	O	Natl.	nn	4	SENT_872	[p23l1734t123r1908b191],
3	Cancer	NNP	O	Cancer	nn	4	SENT_872	[p23l1937t123r2115b191, p23l650t248r770b293],
4	Inst	NNP	O	Inst	_	0	SENT_872	[p23l802t226r951b293],
5	.	.	O	.	_	0	SENT_872	[p23l802t226r951b293],

1	8l	NN	O	8l	_	0	SENT_873	[p23l1000t226r1422b293],
2	:696	CD	NUMBER	:696	number	3	SENT_873	[p23l1000t226r1422b293],
3	—	CD	NUMBER	—	dep	1	SENT_873	[p23l1000t226r1422b293],
4	70l	NN	O	70l	dep	3	SENT_873	[p23l1000t226r1422b293],

1	69	CD	NUMBER	69	_	0	SENT_874	[p23l452t321r561b389],
2	.	.	O	.	_	0	SENT_874	[p23l452t321r561b389],

1	Grogan	NNP	PERSON	Grogan	nn	2	SENT_875	[p23l650t321r924b408],
2	TM	NNP	O	TM	_	0	SENT_875	[p23l978t321r1133b400],
3	,	,	O	,	_	0	SENT_875	[p23l978t321r1133b400],
4	Spier	NNP	PERSON	Spier	nn	5	SENT_875	[p23l1195t321r1386b408],
5	CM	NN	O	cm	appos	2	SENT_875	[p23l1440t321r1600b400],
6	,	,	O	,	_	0	SENT_875	[p23l1440t321r1600b400],
7	Salmon	NNP	O	Salmon	nn	8	SENT_875	[p23l1659t321r1933b389],
8	SE	NN	O	se	appos	2	SENT_875	[p23l1989t321r2114b400],
9	,	,	O	,	_	0	SENT_875	[p23l1989t321r2114b400],
10	Matzner	NNP	PERSON	Matzner	nn	11	SENT_875	[p23l650t427r954b492],
11	M	NNP	O	M	appos	2	SENT_875	[p23l1000t427r1100b503],
12	,	,	O	,	_	0	SENT_875	[p23l1000t427r1100b503],
13	Rybski	NNP	PERSON	Rybski	nn	14	SENT_875	[p23l1148t424r1402b511],
14	J	NNP	PERSON	J	appos	2	SENT_875	[p23l1448t424r1504b503],
15	,	,	O	,	_	0	SENT_875	[p23l1448t424r1504b503],
16	et	FW	O	et	nn	17	SENT_875	[p23l1549t435r1614b492],
17	al.	FW	O	al.	appos	2	SENT_875	[p23l1659t424r1741b492],
18	1993	CD	DATE	1993	dep	17	SENT_875	[p23l1797t424r1985b492],
19	.	.	O	.	_	0	SENT_875	[p23l1797t424r1985b492],

1	Pglycoprotein	NN	O	pglycoprotein	nn	2	SENT_876	[p23l2039t424r2115b489, p23l650t527r1111b614],
2	expression	NN	O	expression	_	0	SENT_876	[p23l1211t527r1603b611],
3	in	IN	O	in	_	0	SENT_876	[p23l1698t527r1771b595],
4	human	JJ	O	human	amod	7	SENT_876	[p23l1868t527r2117b595],
5	plasma	NN	O	plasma	nn	7	SENT_876	[p23l650t620r910b706],
6	cell	NN	O	cell	nn	7	SENT_876	[p23l947t620r1075b687],
7	myeloma	NN	O	myeloma	prep_in	2	SENT_876	[p23l1121t620r1477b706],
8	:	:	O	:	_	0	SENT_876	[p23l1121t620r1477b706],
9	correlation	NN	O	correlation	dep	2	SENT_876	[p23l1525t620r1917b687],
10	with	IN	O	with	_	0	SENT_876	[p23l1956t617r2117b684],
11	prior	JJ	O	prior	amod	12	SENT_876	[p23l650t709r830b798],
12	chemotherapy	NN	O	chemotherapy	prep_with	9	SENT_876	[p23l862t709r1397b795],
13	.	.	O	.	_	0	SENT_876	[p23l862t709r1397b795],

1	Blood	NN	O	blood	_	0	SENT_877	[p23l1437t709r1658b776],
2	81:490	CD	NUMBER	81:490	number	3	SENT_877	[p23l1690t709r2073b779],
3	—	CD	NUMBER	—	dep	1	SENT_877	[p23l1690t709r2073b779],
4	9S	NN	O	9	dep	3	SENT_877	[p23l1690t709r2073b779],
5	70	CD	NUMBER	70	num	4	SENT_877	[p23l452t814r561b881],
6	.	.	O	.	_	0	SENT_877	[p23l452t814r561b881],

1	Weinstein	NNP	PERSON	Weinstein	nn	2	SENT_878	[p23l650t811r1023b881],
2	RS	NN	O	r	_	0	SENT_878	[p23l1060t814r1191b892],
3	,	,	O	,	_	0	SENT_878	[p23l1060t814r1191b892],
4	Jakate	NN	O	jakate	nn	5	SENT_878	[p23l1233t814r1460b881],
5	SM	NN	O	sm	appos	2	SENT_878	[p23l1503t814r1653b892],
6	,	,	O	,	_	0	SENT_878	[p23l1503t814r1653b892],
7	Dominguez	NNP	PERSON	Dominguez	nn	8	SENT_878	[p23l1695t811r2117b900],
8	JM	NN	O	jm	appos	2	SENT_878	[p23l650t906r787b984],
9	,	,	O	,	_	0	SENT_878	[p23l650t906r787b984],
10	Lebovitz	NNP	PERSON	Lebovitz	nn	11	SENT_878	[p23l837t906r1160b973],
11	MD	NNP	O	MD	appos	2	SENT_878	[p23l1209t906r1378b984],
12	,	,	O	,	_	0	SENT_878	[p23l1209t906r1378b984],
13	Koukoulis	NNP	PERSON	Koukoulis	nn	14	SENT_878	[p23l1431t906r1804b973],
14	GK	NNP	PERSON	GK	appos	2	SENT_878	[p23l1852t906r2002b984],
15	,	,	O	,	_	0	SENT_878	[p23l1852t906r2002b984],
16	et	FW	O	et	nn	17	SENT_878	[p23l2053t917r2117b973],
17	al.	FW	O	al.	appos	2	SENT_878	[p23l653t1011r734b1078],
18	1991	CD	DATE	1991	dep	17	SENT_878	[p23l777t1011r968b1078],
19	.	.	O	.	_	0	SENT_878	[p23l777t1011r968b1078],

1	Relationship	NN	O	relationship	_	0	SENT_879	[p23l1000t1011r1463b1097],
2	of	IN	O	of	_	0	SENT_879	[p23l1489t1011r1570b1078],
3	the	DT	O	the	det	4	SENT_879	[p23l1593t1011r1699b1078],
4	expression	NN	O	expression	prep_of	1	SENT_879	[p23l1728t1008r2120b1097],
5	of	IN	O	of	_	0	SENT_879	[p23l256t1360r359b1446],
6	the	DT	O	the	det	13	SENT_879	[p23l379t1360r521b1446],
7	multidrug	JJ	O	multidrug	amod	13	SENT_879	[p23l555t1360r1014b1471],
8	resistance	NN	O	resistance	nn	13	SENT_879	[p23l1040t1360r1499b1450],
9	gene	NN	O	gene	nn	13	SENT_879	[p23l1532t1388r1752b1474],
10	product	NN	O	product	nn	13	SENT_879	[p23l1778t1364r2135b1474],
11	(	CD	NUMBER	(	num	13	SENT_879	[p23l256t1476r1024b1591],
12	P-glycoprotein	NN	O	p-glycoprotein	nn	13	SENT_879	[p23l256t1476r1024b1591],
13	)	NN	O	)	prep_of	4	SENT_879	[p23l256t1476r1024b1591],
14	in	IN	O	in	_	0	SENT_879	[p23l1072t1476r1161b1566],
15	human	JJ	O	human	amod	17	SENT_879	[p23l1205t1480r1520b1566],
16	colon	NN	O	colon	nn	17	SENT_879	[p23l1567t1480r1822b1566],
17	carcinoma	NN	O	carcinoma	prep_in	13	SENT_879	[p23l1866t1480r2132b1566, p23l256t1637r518b1698],
18	to	TO	O	to	_	0	SENT_879	[p23l548t1627r641b1698],
19	local	JJ	O	local	amod	21	SENT_879	[p23l671t1609r894b1698],
20	tumor	NN	O	tumor	nn	21	SENT_879	[p23l927t1627r1210b1698],
21	aggressiveness	NN	O	aggressiveness	prep_to	1	SENT_879	[p23l1240t1612r1935b1723],
22	and	CC	O	and	_	0	SENT_879	[p23l1965t1612r2139b1702],
23	lymph	NN	O	lymph	nn	25	SENT_879	[p23l256t1728r556b1842],
24	node	NN	O	node	nn	25	SENT_879	[p23l632t1728r855b1818],
25	metastasis	NN	O	metastasis	prep_to	1	SENT_879	[p23l934t1728r1436b1818],
26	.	.	O	.	_	0	SENT_879	[p23l934t1728r1436b1818],

1	Cancer	NN	O	cancer	_	0	SENT_880	[p23l1522t1728r1865b1814],
2	Res	NNP	O	Res	dep	1	SENT_880	[p23l1937t1728r2125b1814],
3	.	.	O	.	_	0	SENT_880	[p23l1937t1728r2125b1814],

1	S1	NN	O	s1	_	0	SENT_881	[p23l256t1844r813b1934],
2	:2720	CD	NUMBER	:2720	num	3	SENT_881	[p23l256t1844r813b1934],
3	-26	CD	NUMBER	-26	dep	1	SENT_881	[p23l256t1844r813b1934],

1	Bonadonna	NNP	PERSON	Bonadonna	nn	2	SENT_882	[p23l256t1973r789b2059],
2	G	NNP	PERSON	G	_	0	SENT_882	[p23l825t1973r933b2073],
3	,	,	O	,	_	0	SENT_882	[p23l825t1973r933b2073],
4	Valagussa	NNP	PERSON	Valagussa	nn	5	SENT_882	[p23l973t1973r1457b2084],
5	P	NN	PERSON	p	appos	2	SENT_882	[p23l1494t1977r1583b2077],
6	,	,	O	,	_	0	SENT_882	[p23l1494t1977r1583b2077],
7	Santoro	NNP	PERSON	Santoro	nn	8	SENT_882	[p23l1627t1976r1984b2063],
8	A.	NNP	O	A.	appos	2	SENT_882	[p23l2025t1977r2132b2063],
9	1986	CD	DATE	1986	dep	8	SENT_882	[p23l270t2089r511b2178],
10	.	.	O	.	_	0	SENT_882	[p23l270t2089r511b2178],

1	Altemating	VBG	O	altemate	_	0	SENT_883	[p23l621t2089r1151b2203],
2	non	JJ	O	non	amod	8	SENT_883	[p23l1258t2089r2139b2178],
3	-	:	O	-	_	0	SENT_883	[p23l1258t2089r2139b2178],
4	’	SYM	O	’	dep	7	SENT_883	[p23l1258t2089r2139b2178],
5	-	:	O	-	_	0	SENT_883	[p23l1258t2089r2139b2178],
6	cross-resistant	JJ	O	cross-resistant	amod	7	SENT_883	[p23l1258t2089r2139b2178],
7	combination	NN	O	combination	dep	8	SENT_883	[p23l256t2221r841b2310],
8	chemotherapy	NN	O	chemotherapy	dobj	1	SENT_883	[p23l871t2221r1531b2335],
9	or	CC	O	or	_	0	SENT_883	[p23l1567t2249r1668b2310],
10	MOPP	NN	O	mopp	poss	16	SENT_883	[p23l1694t2224r2012b2310],
11	in	IN	O	in	_	0	SENT_883	[p23l2046t2224r2135b2310],
12	stage	NN	O	stage	nn	14	SENT_883	[p23l259t2363r497b2463],
13	IV	CD	NUMBER	iv	num	14	SENT_883	[p23l555t2352r676b2438],
14	Hodgkin	NN	PERSON	hodgkin	prep_in	10	SENT_883	[p23l734t2349r1228b2463],
15	's	POS	O	's	_	0	SENT_883	[p23l734t2349r1228b2463],
16	disease	NN	O	disease	dobj	1	SENT_883	[p23l1283t2349r1643b2442],
17	.	.	O	.	_	0	SENT_883	[p23l1283t2349r1643b2442],

1	Ann	NNP	PERSON	Ann	_	0	SENT_884	[p23l1698t2352r1910b2442],
2	.	.	O	.	_	0	SENT_884	[p23l1698t2352r1910b2442],

1	Int	NN	O	int	_	0	SENT_885	[p23l1975t2352r2128b2442],
2	.	.	O	.	_	0	SENT_885	[p23l1975t2352r2128b2442],

1	Med	NNP	O	Med	_	0	SENT_886	[p23l256t2484r483b2571],
2	.	.	O	.	_	0	SENT_886	[p23l256t2484r483b2571],

1	104:739	CD	NUMBER	104:739	_	0	SENT_887	[p23l551t2484r1098b2574],
2	—	CD	NUMBER	—	num	3	SENT_887	[p23l551t2484r1098b2574],
3	46	CD	NUMBER	46	dep	1	SENT_887	[p23l551t2484r1098b2574],

1	72	CD	NUMBER	72	_	0	SENT_888	[p23l6t2616r145b2702],
2	.	.	O	.	_	0	SENT_888	[p23l6t2616r145b2702],

1	Devita	NNP	PERSON	Devita	nn	2	SENT_889	[p23l259t2616r574b2702],
2	V	NNP	PERSON	V	_	0	SENT_889	[p23l607t2616r715b2716],
3	,	,	O	,	_	0	SENT_889	[p23l607t2616r715b2716],
4	Serpick	NNP	O	Serpick	nn	8	SENT_889	[p23l766t2616r1123b2727],
5	A	NNP	O	A	nn	8	SENT_889	[p23l1159t2620r1267b2716],
6	,	,	O	,	_	0	SENT_889	[p23l1159t2620r1267b2716],
7	Carbone	NNP	PERSON	Carbone	appos	8	SENT_889	[p23l1311t2616r1703b2706],
8	P.	NNP	O	P.	appos	2	SENT_889	[p23l1743t2616r1833b2702],
9	1970	CD	DATE	1970	num	8	SENT_889	[p23l1887t2616r2132b2706],
10	.	.	O	.	_	0	SENT_889	[p23l1887t2616r2132b2706],

1	Combination	NN	O	combination	nn	2	SENT_890	[p23l259t2748r866b2866],
2	chemotherapy	NN	O	chemotherapy	_	0	SENT_890	[p23l899t2748r1562b2863],
3	in	IN	O	in	_	0	SENT_890	[p23l1596t2752r1682b2834],
4	the	DT	O	the	det	5	SENT_890	[p23l1715t2752r1861b2866],
5	treatment	NN	O	treatment	prep_in	2	SENT_890	[p23l1891t2762r2135b2838, p23l259t2894r490b2966],
6	of	IN	O	of	_	0	SENT_890	[p23l555t2882r658b2966],
7	advanced	JJ	O	advanced	amod	8	SENT_890	[p23l713t2884r1154b2966],
8	Hodgkin	NN	PERSON	hodgkin	poss	10	SENT_890	[p23l1216t2884r1706b2991],
9	’s	POS	O	’s	_	0	SENT_890	[p23l1216t2884r1706b2991],
10	disease	NN	O	disease	prep_of	2	SENT_890	[p23l1768t2882r2132b2970],
11	.	.	O	.	_	0	SENT_890	[p23l1768t2882r2132b2970],

1	Ann	NNP	PERSON	Ann	_	0	SENT_891	[p23l252t3017r465b3103],
2	.	.	O	.	_	0	SENT_891	[p23l252t3017r465b3103],

1	Int	NN	O	int	_	0	SENT_892	[p23l519t3017r669b3103],
2	.	.	O	.	_	0	SENT_892	[p23l519t3017r669b3103],

1	Med	NNP	O	Med	_	0	SENT_893	[p23l720t3013r947b3103],
2	.	.	O	.	_	0	SENT_893	[p23l720t3013r947b3103],

1	’	NN	O	’	_	0	SENT_894	[p23l1001t3016r1506b3106],
2	73:88	CD	NUMBER	73:88	num	3	SENT_894	[p23l1001t3016r1506b3106],
3	l	NN	O	l	dep	1	SENT_894	[p23l1001t3016r1506b3106],
4	—	CD	NUMBER	—	number	5	SENT_894	[p23l1001t3016r1506b3106],
5	89	CD	NUMBER	89	dep	3	SENT_894	[p23l1001t3016r1506b3106],

1	73	CD	NUMBER	73	_	0	SENT_895	[p23l9t3144r145b3230],
2	.	.	O	.	_	0	SENT_895	[p23l9t3144r145b3230],

1	McLachlin	NN	PERSON	mclachlin	nn	2	SENT_896	[p23l259t3144r771b3230],
2	I	NN	O	i	_	0	SENT_896	[p23l815t3144r883b3244],
3	,	,	O	,	_	0	SENT_896	[p23l815t3144r883b3244],
4	Eglitis	NN	O	eglitis	nn	5	SENT_896	[p23l931t3144r1239b3255],
5	M	NN	O	m	appos	2	SENT_896	[p23l1283t3147r1411b3244],
6	,	,	O	,	_	0	SENT_896	[p23l1283t3147r1411b3244],
7	Ueda	NNP	PERSON	Ueda	nn	8	SENT_896	[p23l1462t3144r1706b3234],
8	K	NNP	PERSON	K	appos	2	SENT_896	[p23l1754t3144r1858b3244],
9	,	,	O	,	_	0	SENT_896	[p23l1754t3144r1858b3244],
10	Kantoff	NNP	PERSON	Kantoff	nn	11	SENT_896	[p23l1909t3144r2135b3234, p23l259t3276r433b3394],
11	P	NN	PERSON	p	appos	2	SENT_896	[p23l463t3276r556b3380],
12	,	,	O	,	_	0	SENT_896	[p23l463t3276r556b3380],
13	Pastan	NNP	O	Pastan	appos	2	SENT_896	[p23l600t3276r905b3362],
14	I	PRP	O	I	dep	13	SENT_896	[p23l941t3280r1003b3380],
15	,	,	O	,	_	0	SENT_896	[p23l941t3280r1003b3380],
16	et	FW	O	et	nn	17	SENT_896	[p23l1047t3290r1130b3362],
17	al.	FW	O	al.	appos	2	SENT_896	[p23l1170t3276r1277b3362],
18	1990	CD	DATE	1990	dep	17	SENT_896	[p23l1332t3276r1576b3366],
19	.	.	O	.	_	0	SENT_896	[p23l1332t3276r1576b3366],

1	Expression	NN	O	expression	_	0	SENT_897	[p23l1620t3276r2142b3390],
2	of	IN	O	of	_	0	SENT_897	[p23l259t3407r363b3495],
3	a	DT	O	a	det	6	SENT_897	[p23l414t3433r468b3495],
4	human	JJ	O	human	amod	6	SENT_897	[p23l526t3409r841b3495],
5	complementary	JJ	O	complementary	amod	6	SENT_897	[p23l899t3409r1629b3523],
6	DNA	NN	MISC	dna	prep_of	1	SENT_897	[p23l1691t3409r1942b3495],
7	for	IN	O	for	_	0	SENT_897	[p23l2007t3409r2142b3495],
8	the	DT	O	the	det	11	SENT_897	[p23l259t3540r405b3626],
9	multidrug	JJ	O	multidrug	amod	11	SENT_897	[p23l439t3540r894b3651],
10	resistance	NN	O	resistance	nn	11	SENT_897	[p23l931t3540r1393b3630],
11	gene	NN	O	gene	prep_for	6	SENT_897	[p23l1430t3568r1647b3651],
12	in	IN	O	in	_	0	SENT_897	[p23l1683t3540r1770b3626],
13	murine	JJ	O	murine	amod	16	SENT_897	[p23l1807t3540r2135b3630],
14	hematopoietic	JJ	O	hematopoietic	amod	16	SENT_897	[p24l259t18r919b132],
15	precursor	NN	O	precursor	nn	16	SENT_897	[p24l973t43r1414b129],
16	cells	NNS	O	cell	prep_in	11	SENT_897	[p24l1458t18r1675b107],
17	with	IN	O	with	_	0	SENT_897	[p24l1726t18r1935b104],
18	use	NN	O	use	prep_with	16	SENT_897	[p24l1986t46r2139b107],
19	of	IN	O	of	_	0	SENT_897	[p24l259t149r363b235],
20	retroviral	JJ	O	retroviral	amod	22	SENT_897	[p24l389t149r824b239],
21	gene	NN	O	gene	nn	22	SENT_897	[p24l857t174r1077b260],
22	transfer	NN	O	transfer	prep_of	1	SENT_897	[p24l1110t149r1488b239],
23	.	.	O	.	_	0	SENT_897	[p24l1110t149r1488b239],

1	J.	NNP	O	J.	nn	4	SENT_898	[p24l1525t152r1597b239],
2	Natl.	NNP	O	Natl.	nn	4	SENT_898	[p24l1641t153r1865b235],
3	Cancer	NNP	O	Cancer	nn	4	SENT_898	[p24l1912t152r2135b239, p24l259t309r412b367],
4	Inst	NNP	O	Inst	_	0	SENT_898	[p24l453t281r644b367],
5	.	.	O	.	_	0	SENT_898	[p24l453t281r644b367],

1	82	CD	NUMBER	82	_	0	SENT_899	[p24l706t284r1253b371],
2	:	:	O	:	_	0	SENT_899	[p24l706t284r1253b371],
3	l260	CD	NUMBER	l260	dep	1	SENT_899	[p24l706t284r1253b371],
4	—	CD	NUMBER	—	number	5	SENT_899	[p24l706t284r1253b371],
5	63	CD	NUMBER	63	dep	3	SENT_899	[p24l706t284r1253b371],

1	Tsuruo	NNP	PERSON	Tsuruo	nn	2	SENT_900	[p24l259t417r592b531],
2	T.	NNP	O	T.	_	0	SENT_900	[p24l621t416r722b503],
3	1989	CD	DATE	1989	dep	2	SENT_900	[p24l773t413r1017b531],
4	.	.	O	.	_	0	SENT_900	[p24l773t413r1017b531],

1	Circumvention	NN	O	circumvention	_	0	SENT_901	[p24l1058t413r1759b503],
2	of	IN	O	of	_	0	SENT_901	[p24l1793t413r1900b503],
3	drug	NN	O	drug	nn	4	SENT_901	[p24l1926t416r2142b527],
4	resistance	NN	O	resistance	prep_of	1	SENT_901	[p24l263t547r722b635],
5	with	IN	O	with	_	0	SENT_901	[p24l769t547r975b635],
6	calcium	NN	O	calcium	nn	8	SENT_901	[p24l1019t549r1390b635],
7	channel	NN	O	channel	nn	8	SENT_901	[p24l1434t549r1794b635],
8	blockers	NNS	O	blocker	prep_with	1	SENT_901	[p24l1842t549r2139b635, p24l263t705r398b767],

1	and	CC	O	and	_	0	SENT_902	[p24l442t681r613b767],
2	monoclonal	JJ	O	monoclonal	amod	3	SENT_902	[p24l653t677r1200b767],
3	antibodies	NNS	O	antibody	dep	1	SENT_902	[p24l1247t677r1749b767],
4	.	.	O	.	_	0	SENT_902	[p24l1247t677r1749b767],

1	Cancer	NN	O	cancer	_	0	SENT_903	[p24l1803t681r2146b767],
2	Treat	NN	O	treat	dep	1	SENT_903	[p24l266t809r535b896],
3	.	.	O	.	_	0	SENT_903	[p24l266t809r535b896],

1	Res	NNP	O	Res	_	0	SENT_904	[p24l586t809r774b896],
2	.	.	O	.	_	0	SENT_904	[p24l586t809r774b896],

1	48:73	CD	NUMBER	48:73	num	2	SENT_905	[p24l829t806r1267b899],
2	-95	CD	NUMBER	-95	_	0	SENT_905	[p24l829t806r1267b899],

1	F1tzGerald	NN	O	f1tzgerald	_	0	SENT_906	[p24l263t941r760b1027],
2	DJ	NNP	O	DJ	dep	1	SENT_906	[p24l825t941r950b1027],
3	,	,	O	,	_	0	SENT_906	[p24l956t1008r978b1041],
4	Willi	NNP	PERSON	Willi	nn	6	SENT_906	[p24l1043t941r1281b1027],
5	ngharn	NNP	O	ngharn	nn	6	SENT_906	[p24l1290t941r1604b1052],
6	MC	NNP	O	MC	appos	2	SENT_906	[p24l1666t941r1868b1041],
7	,	,	O	,	_	0	SENT_906	[p24l1666t941r1868b1041],
8	Cardarelli	NNP	ORGANIZATION	Cardarelli	nn	9	SENT_906	[p24l1933t941r2139b1027, p24l263t1073r556b1163],
9	Co	NNP	ORGANIZATION	Co	appos	2	SENT_906	[p24l600t1073r785b1173],
10	,	,	O	,	_	0	SENT_906	[p24l600t1073r785b1173],
11	Hamada	NNP	PERSON	Hamada	nn	12	SENT_906	[p24l829t1076r1221b1163],
12	I-I	NNP	O	I-I	appos	2	SENT_906	[p24l1258t1076r1365b1177],
13	,	,	O	,	_	0	SENT_906	[p24l1258t1076r1365b1177],
14	Tsuruo	NNP	PERSON	Tsuruo	nn	15	SENT_906	[p24l1402t1077r1735b1163],
15	T	NN	PERSON	t	appos	2	SENT_906	[p24l1768t1076r1865b1173],
16	,	,	O	,	_	0	SENT_906	[p24l1768t1076r1865b1173],
17	et	FW	O	et	nn	18	SENT_906	[p24l1909t1091r1991b1163],
18	al.	FW	O	al.	appos	2	SENT_906	[p24l2032t1076r2135b1163],
19	1987	CD	DATE	1987	dep	18	SENT_906	[p24l273t1205r518b1291],
20	.	.	O	.	_	0	SENT_906	[p24l273t1205r518b1291],

1	A	DT	O	a	det	5	SENT_907	[p24l579t1209r662b1291],
2	monoclonal	JJ	O	monoclonal	amod	5	SENT_907	[p24l716t1205r1263b1291],
3	antibodyPseudomonas	NN	O	antibodypseudomona	nn	5	SENT_907	[p24l1321t1205r2139b1316, p24l263t1362r563b1423],
4	toxin	NN	O	toxin	nn	5	SENT_907	[p24l607t1337r845b1423],
5	conjugate	NN	O	conjugate	_	0	SENT_907	[p24l889t1337r1344b1448],
6	that	WDT	O	that	nsubj	8	SENT_907	[p24l1388t1337r1562b1423],
7	speciﬁcally	RB	O	speciﬁcally	advmod	8	SENT_907	[p24l1606t1337r2142b1448],
8	kills	VBZ	O	kill	rcmod	5	SENT_907	[p24l263t1470r461b1559],
9	rnultidrug-resistant	JJ	O	rnultidrug-resistant	amod	10	SENT_907	[p24l562t1470r1450b1584],
10	cells	NNS	O	cell	dobj	8	SENT_907	[p24l1546t1470r1784b1559],
11	.	.	O	.	_	0	SENT_907	[p24l1546t1470r1784b1559],

1	Prac	NNP	O	Prac	_	0	SENT_908	[p24l1887t1470r2132b1556],
2	.	.	O	.	_	0	SENT_908	[p24l1887t1470r2132b1556],

1	.	.	O	.	_	0	SENT_909	[p24l171t1679r184b1691],

1	Natl.	NNP	O	Natl.	nn	2	SENT_910	[p24l259t1601r483b1687],
2	Acad	NNP	O	Acad	_	0	SENT_910	[p24l534t1601r796b1688],
3	.	.	O	.	_	0	SENT_910	[p24l534t1601r796b1688],

1	Sci	NNP	O	Sci	_	0	SENT_911	[p24l850t1601r1010b1687],
2	.	.	O	.	_	0	SENT_911	[p24l850t1601r1010b1687],

1	USA	NNP	LOCATION	USA	_	0	SENT_912	[p24l1079t1601r1277b1687],
2	84:4288	CD	NUMBER	84:4288	number	3	SENT_912	[p24l1328t1601r1882b1691],
3	—	CD	NUMBER	—	dep	1	SENT_912	[p24l1328t1601r1882b1691],
4	92	CD	NUMBER	92	dep	3	SENT_912	[p24l1328t1601r1882b1691],

1	Fogler	NNP	PERSON	Fogler	nn	2	SENT_913	[p24l266t1733r570b1844],
2	WE	NNP	O	WE	_	0	SENT_913	[p24l643t1733r848b1833],
3	,	,	O	,	_	0	SENT_913	[p24l643t1733r848b1833],
4	Pearson	NNP	ORGANIZATION	Pearson	nn	5	SENT_913	[p24l927t1733r1295b1819],
5	JW	NNP	ORGANIZATION	JW	appos	2	SENT_913	[p24l1370t1733r1552b1833],
6	,	,	O	,	_	0	SENT_913	[p24l1370t1733r1552b1833],
7	Volker	NNP	PERSON	Volker	nn	8	SENT_913	[p24l1634t1733r1956b1819],
8	K	NNP	PERSON	K	appos	2	SENT_913	[p24l2035t1733r2139b1837],
9	,	,	O	,	_	0	SENT_913	[p24l2035t1733r2139b1837],
10	Ariyoshi	NNP	PERSON	Ariyoshi	nn	11	SENT_913	[p24l266t1865r669b1976],
11	K	NNP	PERSON	K	appos	2	SENT_913	[p24l748t1865r855b1969],
12	,	,	O	,	_	0	SENT_913	[p24l748t1865r855b1969],
13	Watabe	NNP	PERSON	Watabe	nn	14	SENT_913	[p24l927t1865r1288b1951],
14	H	NNP	PERSON	H	appos	2	SENT_913	[p24l1356t1868r1467b1969],
15	,	,	O	,	_	0	SENT_913	[p24l1356t1868r1467b1969],
16	et	FW	O	et	nn	17	SENT_913	[p24l1543t1879r1625b1955],
17	al.	FW	O	al.	appos	2	SENT_913	[p24l1698t1865r1805b1955],
18	1995	CD	DATE	1995	dep	17	SENT_913	[p24l1895t1865r2139b1955],
19	.	.	O	.	_	0	SENT_913	[p24l1895t1865r2139b1955],

1	Enhancement	NN	O	enhancement	_	0	SENT_914	[p24l266t2001r898b2087],
2	by	IN	O	by	dep	1	SENT_914	[p24l973t1998r1091b2112],
3	recombinant	JJ	O	recombinant	amod	6	SENT_914	[p24l1170t1998r1752b2087],
4	human	JJ	O	human	amod	6	SENT_914	[p24l1824t2001r2146b2087],
5	interferon	NN	O	interferon	nn	6	SENT_914	[p24l266t2130r725b2216],
6	alfa	NN	O	alfa	pobj	2	SENT_914	[p24l776t2130r954b2216],
7	of	IN	O	of	_	0	SENT_914	[p24l1005t2130r1112b2216],
8	the	DT	O	the	det	9	SENT_914	[p24l1159t2134r1298b2216],
9	reversal	NN	O	reversal	prep_of	6	SENT_914	[p24l1353t2130r1717b2216],
10	of	IN	O	of	_	0	SENT_914	[p24l1771t2130r1879b2216],
11	multidrug	JJ	O	multidrug	prep_of	9	SENT_914	[p24l1926t2130r2142b2216, p24l266t2265r542b2373],

1	resistance	NN	O	resistance	_	0	SENT_915	[p24l618t2265r1080b2351],
2	by	IN	O	by	_	0	SENT_915	[p24l1149t2265r1270b2376],
3	MRK-16	JJ	MISC	mrk-16	amod	4	SENT_915	[p24l1342t2262r1763b2351],
4	monoclonal	JJ	O	monoclonal	amod	5	SENT_915	[p24l1842t2290r2142b2351, p24l266t2394r546b2483],
5	antibody	NN	O	antibody	prep_by	1	SENT_915	[p24l614t2394r1042b2508],
6	.	.	O	.	_	0	SENT_915	[p24l614t2394r1042b2508],

1	J.	NNP	O	J.	nn	4	SENT_916	[p24l1100t2397r1175b2483],
2	Natl.	NNP	O	Natl.	nn	4	SENT_916	[p24l1244t2397r1467b2483],
3	Cancer	NNP	O	Cancer	nn	4	SENT_916	[p24l1543t2398r1886b2483],
4	Inst	NNP	O	Inst	_	0	SENT_916	[p24l1937t2398r2135b2483],
5	.	.	O	.	_	0	SENT_916	[p24l1937t2398r2135b2483],

1	87:94	CD	NUMBER	87:94	num	4	SENT_917	[p24l270t2529r767b2619],
2	-104	CD	NUMBER	-104	num	4	SENT_917	[p24l270t2529r767b2619],
3	Pearson	NNP	ORGANIZATION	Pearson	nn	4	SENT_917	[p24l266t2657r634b2743],
4	JW	NNP	ORGANIZATION	JW	_	0	SENT_917	[p24l709t2657r890b2757],
5	,	,	O	,	_	0	SENT_917	[p24l709t2657r890b2757],
6	Fogler	NNP	PERSON	Fogler	nn	7	SENT_917	[p24l966t2657r1274b2768],
7	WE	NNP	O	WE	appos	4	SENT_917	[p24l1346t2657r1555b2757],
8	,	,	O	,	_	0	SENT_917	[p24l1346t2657r1555b2757],
9	Volker	NNP	PERSON	Volker	nn	10	SENT_917	[p24l1634t2657r1960b2743],
10	K	NNP	PERSON	K	appos	4	SENT_917	[p24l2035t2657r2142b2757],
11	,	,	O	,	_	0	SENT_917	[p24l2035t2657r2142b2757],
12	Usui	NNP	PERSON	Usui	nn	13	SENT_917	[p24l266t2793r483b2879],
13	N	NNP	O	N	appos	4	SENT_917	[p24l544t2793r655b2893],
14	,	,	O	,	_	0	SENT_917	[p24l544t2793r655b2893],
15	Goldenberg	NNP	ORGANIZATION	Goldenberg	nn	16	SENT_917	[p24l720t2793r1270b2900],
16	SK	NNP	ORGANIZATION	SK	appos	4	SENT_917	[p24l1332t2793r1506b2893],
17	,	,	O	,	_	0	SENT_917	[p24l1332t2793r1506b2893],
18	et	FW	O	et	nn	19	SENT_917	[p24l1567t2807r1654b2879],
19	al.	FW	O	al.	appos	4	SENT_917	[p24l1712t2793r1815b2879],
20	1991	CD	DATE	1991	dep	19	SENT_917	[p24l1895t2793r2139b2879],
21	.	.	O	.	_	0	SENT_917	[p24l1895t2793r2139b2879],

1	Reversal	NN	O	reversal	_	0	SENT_918	[p24l266t2921r669b3011],
2	of	IN	O	of	_	0	SENT_918	[p24l713t2921r817b3007],
3	drug	NN	O	drug	nn	4	SENT_918	[p24l854t2921r1066b3032],
4	resistance	NN	O	resistance	prep_of	1	SENT_918	[p24l1103t2921r1562b3011],
5	in	IN	O	in	dep	1	SENT_918	[p24l1606t2921r1692b3011],
6	a	DT	O	a	det	10	SENT_918	[p24l1736t2946r1787b3011],
7	human	JJ	O	human	amod	10	SENT_918	[p24l1828t2921r2149b3011],
8	colon	NN	O	colon	nn	10	SENT_918	[p24l266t3054r525b3139],
9	cancer	NN	O	cancer	nn	10	SENT_918	[p24l646t3078r954b3139],
10	xenograft	NN	O	xenograft	nsubj	11	SENT_918	[p24l1075t3054r1524b3164],
11	expressing	VBG	O	express	pcomp	5	SENT_918	[p24l1648t3050r2149b3164],
12	MDR1	NN	O	mdr1	nn	14	SENT_918	[p24l266t3189r577b3272],
13	complementary	JJ	O	complementary	amod	14	SENT_918	[p24l681t3189r1407b3300],
14	DNA	NN	O	dna	nsubj	21	SENT_918	[p24l1504t3189r1756b3272],
15	by	IN	O	by	prep	14	SENT_918	[p24l1849t3186r1960b3300],
16	in	FW	O	in	dep	18	SENT_918	[p24l2056t3186r2146b3272],
17	vivo	FW	O	vivo	pobj	16	SENT_918	[p24l270t3314r472b3404],
18	administration	NN	O	administration	dep	15	SENT_918	[p24l519t3314r1193b3404],
19	of	IN	O	of	_	0	SENT_918	[p24l1233t3314r1341b3404],
20	MRK-16	JJ	O	mrk-16	prep_of	18	SENT_918	[p24l1378t3314r1798b3404],
21	monoclonal	JJ	O	monoclonal	xcomp	11	SENT_918	[p24l1845t3342r2146b3404, p24l266t3449r549b3535],

1	antibody	NN	O	antibody	_	0	SENT_919	[p24l614t3446r1042b3560],
2	.	.	O	.	_	0	SENT_919	[p24l614t3446r1042b3560],

1	J.	NNP	O	J.	nn	4	SENT_920	[p24l1103t3449r1175b3535],
2	Natl.	NNP	O	Natl.	nn	4	SENT_920	[p24l1247t3449r1467b3535],
3	Cancer	NNP	O	Cancer	nn	4	SENT_920	[p24l1543t3449r1889b3535],
4	Inst	NNP	O	Inst	_	0	SENT_920	[p24l1940t3450r2139b3535],
5	.	.	O	.	_	0	SENT_920	[p24l1940t3450r2139b3535],

1	83	CD	NUMBER	83	_	0	SENT_921	[p24l270t3581r409b3671],
2	:	:	O	:	_	0	SENT_921	[p24l270t3581r409b3671],
3	1386-91	CD	NUMBER	1386-91	dep	1	SENT_921	[p24l428t3581r813b3671],

1	Kobayashi	NNP	PERSON	Kobayashi	nn	2	SENT_922	[p25l270t26r764b140],
2	I-1	NNP	O	I-1	_	0	SENT_922	[p25l801t29r908b129],
3	,	,	O	,	_	0	SENT_922	[p25l801t29r908b129],
4	Dorai	NNP	PERSON	Dorai	nn	5	SENT_922	[p25l948t26r1211b115],
5	T	NN	PERSON	t	appos	2	SENT_922	[p25l1247t30r1344b129],
6	,	,	O	,	_	0	SENT_922	[p25l1247t30r1344b129],
7	Holland	NNP	ORGANIZATION	Holland	appos	2	SENT_922	[p25l1385t26r1763b115],
8	IF	IN	ORGANIZATION	if	amod	7	SENT_922	[p25l1793t29r1928b129],
9	,	,	O	,	_	0	SENT_922	[p25l1793t29r1928b129],
10	Ohnuma	NNP	PERSON	Ohnuma	nn	11	SENT_922	[p25l1968t26r2146b115, p25l270t186r532b247],
11	T.	NNP	O	T.	appos	2	SENT_922	[p25l572t165r665b251],
12	1994	CD	DATE	1994	dep	11	SENT_922	[p25l727t161r971b251],
13	.	.	O	.	_	0	SENT_922	[p25l727t161r971b251],

1	Reversal	NN	O	reversal	_	0	SENT_923	[p25l1022t161r1429b251],
2	of	IN	O	of	_	0	SENT_923	[p25l1476t161r1583b247],
3	drug	NN	O	drug	nn	4	SENT_923	[p25l1617t165r1829b272],
4	sensitivity	NN	O	sensitivity	prep_of	1	SENT_923	[p25l1877t161r2146b247, p25l270t294r511b408],
5	in	IN	O	in	_	0	SENT_923	[p25l555t294r644b383],
6	multidrug-resistant	JJ	O	multidrug-resistant	amod	8	SENT_923	[p25l685t294r1576b408],
7	tumor	NN	O	tumor	nn	8	SENT_923	[p25l1613t312r1896b383],
8	cells	NNS	O	cell	prep_in	1	SENT_923	[p25l1933t294r2146b383],
9	by	IN	O	by	_	0	SENT_923	[p25l270t429r381b536],
10	an	DT	O	a	det	11	SENT_923	[p25l417t454r525b511],
11	MDRI	NN	O	mdrus	prep_by	1	SENT_923	[p25l555t429r866b511],
12	(	CD	NUMBER	(	num	15	SENT_923	[p25l910t429r1277b529],
13	PGY1	NN	O	pgy1	nn	15	SENT_923	[p25l910t429r1277b529],
14	)	NN	O	)	nn	15	SENT_923	[p25l910t429r1277b529],
15	ribozyme	NN	O	ribozyme	dep	11	SENT_923	[p25l1307t429r1770b536],
16	.	.	O	.	_	0	SENT_923	[p25l1307t429r1770b536],

1	Cancer	NN	O	cancer	_	0	SENT_924	[p25l1810t429r2153b515],
2	Res	NNP	O	Res	dep	1	SENT_924	[p25l266t561r454b647],
3	.	.	O	.	_	0	SENT_924	[p25l266t561r454b647],

1	54	CD	NUMBER	54	num	3	SENT_925	[p25l509t557r651b647],
2	:	:	O	:	_	0	SENT_925	[p25l509t557r651b647],
3	1271	CD	DATE	1271	_	0	SENT_925	[p25l671t557r1066b647],
4	--	:	O	--	_	0	SENT_925	[p25l671t557r1066b647],
5	75	CD	NUMBER	75	num	7	SENT_925	[p25l671t557r1066b647],
6	Holm	NNP	ORGANIZATION	Holm	nn	7	SENT_925	[p25l270t690r535b779],
7	PS	NNP	ORGANIZATION	PS	dep	3	SENT_925	[p25l576t690r732b790],
8	,	,	O	,	_	0	SENT_925	[p25l576t690r732b790],
9	Scanlon	NNP	PERSON	Scanlon	nn	13	SENT_925	[p25l776t690r1147b779],
10	KJ	NNP	PERSON	KJ	nn	13	SENT_925	[p25l1195t694r1344b790],
11	,	,	O	,	_	0	SENT_925	[p25l1195t694r1344b790],
12	Dietel	NNP	PERSON	Dietel	appos	13	SENT_925	[p25l1388t690r1671b776],
13	M.	NNP	O	M.	appos	7	SENT_925	[p25l1715t693r1844b780],
14	1994	CD	DATE	1994	num	13	SENT_925	[p25l1902t690r2142b780],
15	.	.	O	.	_	0	SENT_925	[p25l1902t690r2142b780],

1	Reversion	NN	O	reversion	_	0	SENT_926	[p25l270t825r739b911],
2	of	IN	O	of	_	0	SENT_926	[p25l773t825r876b911],
3	multidru	FW	O	multidru	prep_of	1	SENT_926	[p25l903t825r1302b911],
4	g	NN	O	g	nn	5	SENT_926	[p25l1304t853r1362b936],
5	resistance	NN	O	resistance	dep	1	SENT_926	[p25l1392t825r1854b911],
6	in	IN	O	in	_	0	SENT_926	[p25l1884t825r1977b908],
7	the	DT	O	the	det	13	SENT_926	[p25l2007t825r2146b911],
8	P-glycoprotein-positive	JJ	O	p-glycoprotein-positive	amod	13	SENT_926	[p25l270t957r1372b1068],
9	human	JJ	O	human	amod	13	SENT_926	[p25l1427t957r1742b1043],
10	pancreatic	JJ	O	pancreatic	amod	13	SENT_926	[p25l1800t982r2146b1068, p25l270t1085r437b1175],
11	cell	NN	O	cell	nn	13	SENT_926	[p25l491t1085r658b1171],
12	line	NN	O	line	nn	13	SENT_926	[p25l716t1085r890b1171],
13	(	NN	O	(	prep_in	5	SENT_926	[p25l945t1085r1794b1193],
14	EPP85-18lRDB	NN	O	epp85-18lrdb	dep	13	SENT_926	[p25l945t1085r1794b1193],
15	)	CD	NUMBER	)	num	14	SENT_926	[p25l945t1085r1794b1193],
16	by	IN	O	by	_	0	SENT_926	[p25l1849t1085r1967b1196],
17	introduction	NN	O	introduction	prep_by	14	SENT_926	[p25l2021t1085r2146b1171, p25l270t1217r746b1303],
18	of	IN	O	of	_	0	SENT_926	[p25l794t1217r898b1303],
19	a	DT	O	a	det	21	SENT_926	[p25l934t1245r985b1303],
20	hammerhead	NN	O	hammerhead	nn	21	SENT_926	[p25l1033t1217r1636b1303],
21	ribozyme	NN	O	ribozyme	prep_of	17	SENT_926	[p25l1680t1217r2146b1328],
22	.	.	O	.	_	0	SENT_926	[p25l1680t1217r2146b1328],

1	Br	NN	O	br	_	0	SENT_927	[p25l270t1353r402b1436],
2	.	.	O	.	_	0	SENT_927	[p25l270t1353r402b1436],

1	J.	NNP	O	J.	nn	2	SENT_928	[p25l456t1353r528b1439],
2	Cancer	NNP	O	Cancer	_	0	SENT_928	[p25l590t1353r933b1439],
3	70:239	CD	NUMBER	70:239	num	7	SENT_928	[p25l970t1353r1471b1443],
4	-43	CD	NUMBER	-43	num	7	SENT_928	[p25l970t1353r1471b1443],
5	Scanlon	NNP	PERSON	Scanlon	nn	7	SENT_928	[p25l273t1482r644b1568],
6	K	NNP	O	K	nn	7	SENT_928	[p25l713t1485r866b1582],
7	]	NNP	O	]	dep	2	SENT_928	[p25l713t1485r866b1582],
8	,	,	O	,	_	0	SENT_928	[p25l713t1485r866b1582],
9	Ishida	NNP	PERSON	Ishida	nn	10	SENT_928	[p25l938t1482r1225b1568],
10	H	NNP	PERSON	H	appos	7	SENT_928	[p25l1290t1485r1397b1582],
11	,	,	O	,	_	0	SENT_928	[p25l1290t1485r1397b1582],
12	Kashani-S	NNP	O	Kashani-S	nn	14	SENT_928	[p25l1472t1482r1946b1568],
13	abet	NNP	O	abet	nn	14	SENT_928	[p25l1958t1486r2153b1568],
14	M.	NNP	O	M.	appos	7	SENT_928	[p25l270t1616r395b1703],
15	1994	CD	DATE	1994	num	14	SENT_928	[p25l470t1613r715b1703],
16	.	.	O	.	_	0	SENT_928	[p25l470t1613r715b1703],

1	Ribozyme-mediated	JJ	O	ribozyme-mediated	amod	2	SENT_929	[p25l776t1613r1724b1724],
2	reversal	NN	O	reversal	_	0	SENT_929	[p25l1778t1613r2149b1699],
3	of	IN	O	of	_	0	SENT_929	[p25l270t1746r374b1835],
4	the	DT	O	the	det	6	SENT_929	[p25l449t1746r585b1835],
5	multidrug-resistant	JJ	O	multidrug-resistant	amod	6	SENT_929	[p25l667t1746r1555b1860],
6	phenotype	NN	O	phenotype	prep_of	2	SENT_929	[p25l1634t1746r2146b1860],
7	.	.	O	.	_	0	SENT_929	[p25l1634t1746r2146b1860],

1	Proc	NNP	O	Proc	_	0	SENT_930	[p25l270t1881r514b1964],
2	.	.	O	.	_	0	SENT_930	[p25l270t1881r514b1964],

1	Natl.	NNP	O	Natl.	nn	2	SENT_931	[p25l548t1877r767b1963],
2	Acad	NNP	O	Acad	_	0	SENT_931	[p25l801t1877r1063b1963],
3	.	.	O	.	_	0	SENT_931	[p25l801t1877r1063b1963],

1	Sci	NNP	O	Sci	_	0	SENT_932	[p25l1100t1881r1260b1967],
2	.	.	O	.	_	0	SENT_932	[p25l1100t1881r1260b1967],

1	USA	NNP	LOCATION	USA	_	0	SENT_933	[p25l1304t1881r1506b1967],
2	91:1	CD	NUMBER	91:1	number	3	SENT_933	[p25l1536t1877r1731b1967],
3	1123	CD	DATE	1123	dep	1	SENT_933	[p25l1757t1877r2149b1964],
4	--	:	O	--	_	0	SENT_933	[p25l1757t1877r2149b1964],
5	27	CD	NUMBER	27	num	7	SENT_933	[p25l1757t1877r2149b1964],
6	Tsuruo	NNP	PERSON	Tsuruo	nn	7	SENT_933	[p25l270t2012r602b2095],
7	T	NN	PERSON	t	dep	1	SENT_933	[p25l625t2013r722b2109],
8	,	,	O	,	_	0	SENT_933	[p25l625t2013r722b2109],
9	Iida	NN	PERSON	iida	nn	10	SENT_933	[p25l755t2009r936b2095],
10	H	NN	O	h	appos	7	SENT_933	[p25l966t2013r1077b2109],
11	,	,	O	,	_	0	SENT_933	[p25l966t2013r1077b2109],
12	Tsukagoshi	NNP	LOCATION	Tsukagoshi	nn	13	SENT_933	[p25l1107t2009r1643b2120],
13	S	NNP	LOCATION	S	appos	7	SENT_933	[p25l1676t2012r1763b2109],
14	,	,	O	,	_	0	SENT_933	[p25l1676t2012r1763b2109],
15	Sakurai	NNP	PERSON	Sakurai	nn	16	SENT_933	[p25l1800t2009r2149b2095],
16	Y.	NNP	O	Y.	appos	7	SENT_933	[p25l273t2144r377b2227],
17	1981	CD	DATE	1981	dep	16	SENT_933	[p25l435t2141r679b2231],
18	.	.	O	.	_	0	SENT_933	[p25l435t2141r679b2231],

1	Overcoming	VBG	O	overcome	_	0	SENT_934	[p25l727t2141r1312b2252],
2	of	IN	O	of	_	0	SENT_934	[p25l1353t2141r1457b2227],
3	vincristine	NN	O	vincristine	nn	4	SENT_934	[p25l1487t2141r1981b2227],
4	reAnnual	NN	O	reannual	prep_of	1	SENT_934	[p25l2021t2169r2149b2227, p25l447t2330r569b2359],

1	Reviews	NNS	O	review	nsubj	2	SENT_935	[p25l580t2330r722b2368],
2	_	VBP	O	_	_	0	SENT_935	[p25l955t2364r959b2368],
3	WWW.annualreviews.org/aronhne	NN	O	www.annualreviews.org/aronhne	dobj	2	SENT_935	[p25l448t2364r1002b2401],

1	P-GLYCOPROTEINS	NNPS	O	P-GLYCOPROTEINS	_	0	SENT_936	[p25l875t2459r1215b2486],
2	AND	CC	O	and	_	0	SENT_936	[p25l1226t2459r1306b2486],
3	DRUG	NN	O	drug	nn	4	SENT_936	[p25l1316t2458r1423b2486],
4	RESISTANCE	NN	O	resistance	conj_and	1	SENT_936	[p25l1432t2458r1660b2485],
5	181	CD	NUMBER	181	dep	1	SENT_936	[p25l1733t2458r1782b2485],

1	sistance	NN	O	sistance	nsubj	11	SENT_937	[p25l622t2657r916b2725],
2	in	IN	O	in	_	0	SENT_937	[p25l959t2657r1031b2725],
3	P388	NN	O	p388	nn	4	SENT_937	[p25l1070t2657r1264b2725],
4	leukemia	NN	O	leukemia	prep_in	1	SENT_937	[p25l1304t2657r1650b2725],
5	in	FW	O	in	dep	4	SENT_937	[p25l1689t2654r1761b2722],
6	vivo	FW	O	vivo	pobj	5	SENT_937	[p25l1800t2654r1969b2722],
7	and	CC	O	and	_	0	SENT_937	[p25l2006t2654r2145b2722],
8	in	FW	O	in	nn	9	SENT_937	[p25l622t2750r691b2821],
9	vitro	FW	O	vitro	dep	4	SENT_937	[p25l736t2750r914b2821],
10	through	IN	O	through	advmod	11	SENT_937	[p25l956t2750r1247b2838],
11	enhanced	VBN	O	enhance	_	0	SENT_937	[p25l1290t2750r1650b2818],
12	cytotoxicity	NN	O	cytotoxicity	dobj	11	SENT_937	[p25l1689t2747r2142b2838],
13	of	IN	O	of	_	0	SENT_937	[p25l622t2848r702b2919],
14	vincristine	NN	O	vincristine	prep_of	12	SENT_937	[p25l742t2848r1139b2919],
15	and	CC	O	and	_	0	SENT_937	[p25l1184t2848r1319b2916],
16	vinblastine	NN	O	vinblastine	prep_of	12	SENT_937	[p25l1358t2845r1772b2916],
17	by	IN	O	by	_	0	SENT_937	[p25l1812t2845r1909b2933],
18	verapamil	NN	O	verapamil	prep_by	11	SENT_937	[p25l1949t2865r2139b2916, p25l622t2941r854b3035],
19	.	.	O	.	_	0	SENT_937	[p25l1949t2865r2139b2916, p25l622t2941r854b3035],

1	Cancer	NN	O	cancer	_	0	SENT_938	[p25l899t2941r1179b3013],
2	Res	NNP	O	Res	dep	1	SENT_938	[p25l1210t2941r1362b3010],
3	.	.	O	.	_	0	SENT_938	[p25l1210t2941r1362b3010],

1	41:1	CD	NUMBER	41:1	_	0	SENT_939	[p25l1404t2938r1858b3013],
2	!	.	O	!	_	0	SENT_939	[p25l1404t2938r1858b3013],

1	-967	CD	NUMBER	-967	num	2	SENT_940	[p25l1404t2938r1858b3013],
2	-72	CD	NUMBER	-72	_	0	SENT_940	[p25l1404t2938r1858b3013],

1	82	CD	NUMBER	82	_	0	SENT_941	[p25l417t3041r528b3112],
2	.	.	O	.	_	0	SENT_941	[p25l417t3041r528b3112],

1	Tsuruo	NNP	PERSON	Tsuruo	nn	2	SENT_942	[p25l619t3041r888b3109],
2	T	NN	PERSON	t	_	0	SENT_942	[p25l907t3041r988b3121],
3	,	,	O	,	_	0	SENT_942	[p25l907t3041r988b3121],
4	Iida	NN	PERSON	iida	nn	5	SENT_942	[p25l1013t3038r1162b3109],
5	H	NN	PERSON	h	appos	2	SENT_942	[p25l1187t3038r1273b3121],
6	,	,	O	,	_	0	SENT_942	[p25l1187t3038r1273b3121],
7	Tsukagoshi	NNP	LOCATION	Tsukagoshi	nn	8	SENT_942	[p25l1298t3035r1730b3129],
8	S	NNP	LOCATION	S	appos	2	SENT_942	[p25l1758t3038r1829b3121],
9	,	,	O	,	_	0	SENT_942	[p25l1758t3038r1829b3121],
10	Sakurai	NNP	PERSON	Sakurai	nn	11	SENT_942	[p25l1857t3035r2142b3107],
11	Y.	NNP	O	Y.	appos	2	SENT_942	[p25l622t3139r708b3208],
12	1982	CD	DATE	1982	dep	11	SENT_942	[p25l745t3137r942b3208],
13	.	.	O	.	_	0	SENT_942	[p25l745t3137r942b3208],

1	Increased	VBN	O	increase	amod	2	SENT_943	[p25l973t3137r1336b3205],
2	accumulation	NN	O	accumulation	_	0	SENT_943	[p25l1358t3134r1867b3205],
3	of	IN	O	of	_	0	SENT_943	[p25l1892t3134r1975b3203],
4	vincristine	NN	O	vincristine	prep_of	2	SENT_943	[p25l1992t3134r2139b3203, p25l622t3230r899b3301],
5	and	CC	O	and	_	0	SENT_943	[p25l924t3232r1059b3301],
6	adriamycin	NN	O	adriamycin	prep_of	2	SENT_943	[p25l1084t3230r1504b3318],
7	in	IN	O	in	_	0	SENT_943	[p25l1529t3230r1601b3298],
8	drug-resistant	JJ	O	drug-resistant	amod	11	SENT_943	[p25l1623t3227r2142b3318],
9	P383	NN	O	p383	nn	11	SENT_943	[p25l622t3336r811b3407],
10	tumor	NN	O	tumor	nn	11	SENT_943	[p25l856t3347r1082b3407],
11	cells	NNS	O	cell	prep_in	2	SENT_943	[p25l1121t3336r1296b3404],
12	following	VBG	O	follow	_	0	SENT_943	[p25l1335t3333r1704b3424],
13	incubation	NN	O	incubation	prep_following	11	SENT_943	[p25l1743t3333r2145b3402],
14	with	IN	O	with	_	0	SENT_943	[p25l622t3431r788b3500],
15	calcium	NN	O	calcium	nn	16	SENT_943	[p25l876t3431r1179b3500],
16	antagonists	NNS	O	antagonist	prep_with	13	SENT_943	[p25l1267t3429r1690b3517],
17	and	CC	O	and	_	0	SENT_943	[p25l1778t3429r1912b3497],
18	calmodulin	NN	O	calmodulin	nn	19	SENT_943	[p25l1997t3426r2142b3495, p25l622t3535r936b3603],
19	inhibitors	NNS	O	inhibitor	conj_and	16	SENT_943	[p25l1004t3535r1384b3603],
20	.	.	O	.	_	0	SENT_943	[p25l1004t3535r1384b3603],

1	Cancer	NN	O	cancer	_	0	SENT_944	[p25l1458t3535r1738b3603],
2	Res	NNP	O	Res	dep	1	SENT_944	[p25l1795t3535r1949b3600],
3	.	.	O	.	_	0	SENT_944	[p25l1795t3535r1949b3600],

1	42	CD	NUMBER	42	_	0	SENT_945	[p25l2020t3532r2136b3600],
2	:	:	O	:	_	0	SENT_945	[p25l2020t3532r2136b3600],
3	4730-33	CD	NUMBER	4730-33	dep	1	SENT_945	[p25l619t3628r951b3696],

1	Annu	NNP	PERSON	Annu	_	0	SENT_946	[p26l6t3429r72b3658],
2	.	.	O	.	_	0	SENT_946	[p26l6t3429r72b3658],

1	Rev.	NNP	O	Rev.	nn	2	SENT_947	[p26l7t3229r72b3398],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_947	[p26l6t2775r72b3197],
3	.	.	O	.	_	0	SENT_947	[p26l6t2775r72b3197],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_948	[p26l6t2431r72b2743],
2	.	.	O	.	_	0	SENT_948	[p26l6t2431r72b2743],

1	1996.36	CD	NUMBER	1996.36	_	0	SENT_949	[p26l6t2073r73b2391],
2	:	:	O	:	_	0	SENT_949	[p26l6t2073r73b2391],
3	16	CD	NUMBER	16	num	4	SENT_949	[p26l6t1973r73b2055],
4	l	NN	O	l	dep	1	SENT_949	[p26l6t1933r72b1960],
5	-	:	O	-	_	0	SENT_949	[p26l46t1896r53b1920],
6	183	CD	NUMBER	183	dep	4	SENT_949	[p26l6t1731r73b1881],
7	.	.	O	.	_	0	SENT_949	[p26l6t1731r73b1881],

1	Downloaded	VBN	O	download	_	0	SENT_950	[p26l6t1215r73b1699],
2	from	IN	O	from	_	0	SENT_950	[p26l6t1007r72b1190],
3	www.annualreViews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_950	[p26l6t55r92b981],
4	by	IN	O	by	_	0	SENT_950	[p26l101t3180r187b3273],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_950	[p26l101t2755r187b3153],
6	of	IN	ORGANIZATION	of	_	0	SENT_950	[p26l101t2645r167b2726],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_950	[p26l101t2225r167b2626],
8	-	:	O	-	_	0	SENT_950	[p26l141t2173r148b2197],
9	Madison	NNP	O	Madison	prep_by	1	SENT_950	[p26l101t1813r167b2144],
10	on	IN	O	on	_	0	SENT_950	[p26l122t1695r167b1786],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_950	[p26l100t1314r168b1668],
12	.	.	O	.	_	0	SENT_950	[p26l100t1314r168b1668],

1	For	IN	O	for	_	0	SENT_951	[p26l103t1151r167b1283],
2	personal	JJ	O	personal	amod	3	SENT_951	[p26l101t807r187b1128],
3	use	NN	O	use	pobj	1	SENT_951	[p26l122t657r167b782],
4	only	RB	O	only	advmod	3	SENT_951	[p26l101t445r187b629],
5	.	.	O	.	_	0	SENT_951	[p26l101t445r187b629],

1	Beck	NNP	PERSON	Beck	nn	2	SENT_952	[p26l622t25r817b92],
2	WT	NNP	O	WT	_	0	SENT_952	[p26l853t25r1019b92],
3	.	.	O	.	_	0	SENT_952	[p26l853t25r1019b92],

1	1991	CD	DATE	1991	_	0	SENT_953	[p26l1076t23r1273b94],
2	.	.	O	.	_	0	SENT_953	[p26l1076t23r1273b94],

1	Modulators	NNS	O	modulator	_	0	SENT_954	[p26l1315t23r1750b92],
2	of	IN	O	of	_	0	SENT_954	[p26l1789t20r1875b89],
3	Pglycoprotein-associated	JJ	MISC	pglycoprotein-associated	amod	5	SENT_954	[p26l1909t23r2142b109, p26l622t117r1399b206],
4	multidrug	JJ	O	multidrug	amod	5	SENT_954	[p26l1487t114r1855b203],
5	resistance	NN	O	resistance	prep_of	1	SENT_954	[p26l1940t114r2142b183, p26l622t223r839b280],
6	.	.	O	.	_	0	SENT_954	[p26l1940t114r2142b183, p26l622t223r839b280],

1	In	IN	O	in	_	0	SENT_955	[p26l942t214r1016b280],
2	Molecular	JJ	O	molecular	pobj	1	SENT_955	[p26l1113t208r1513b277],
3	and	CC	O	and	_	0	SENT_955	[p26l1604t208r1749b277],
4	Clinical	JJ	O	clinical	conj_and	2	SENT_955	[p26l1843t205r2145b277],

1	Advances	NNS	O	advance	nsubj	7	SENT_956	[p26l616t308r985b377],
2	in	IN	O	in	_	0	SENT_956	[p26l1050t311r1119b377],
3	Anticancer	NNP	O	Anticancer	nn	5	SENT_956	[p26l1173t308r1598b377],
4	Drug	NNP	O	Drug	nn	5	SENT_956	[p26l1655t308r1855b394],
5	Resistance	NNP	O	Resistance	prep_in	1	SENT_956	[p26l1912t308r2142b374, p26l625t419r848b485],
6	,	,	O	,	_	0	SENT_956	[p26l1912t308r2142b374, p26l625t419r848b485],
7	ed	VBD	O	ed	_	0	SENT_956	[p26l887t405r993b474],
8	.	.	O	.	_	0	SENT_956	[p26l887t405r993b474],

1	RF	NNP	O	RF	nn	2	SENT_957	[p26l1039t405r1156b471],
2	Ozols	NNP	O	Ozols	_	0	SENT_957	[p26l1190t402r1430b482],
3	,	,	O	,	_	0	SENT_957	[p26l1190t402r1430b482],
4	pp	NN	O	pp	appos	2	SENT_957	[p26l1469t425r1581b494],
5	.	.	O	.	_	0	SENT_957	[p26l1469t425r1581b494],

1	151-70	CD	NUMBER	151-70	_	0	SENT_958	[p26l1635t402r1926b471],
2	.	.	O	.	_	0	SENT_958	[p26l1635t402r1926b471],

1	Boston	NNP	LOCATION	Boston	_	0	SENT_959	[p26l1969t402r2142b471, p26l622t510r762b568],
2	:	:	O	:	_	0	SENT_959	[p26l1969t402r2142b471, p26l622t510r762b568],
3	Kluwer	NNP	PERSON	Kluwer	dep	1	SENT_959	[p26l807t499r1090b568],

1	Ford	NNP	ORGANIZATION	Ford	nn	2	SENT_960	[p26l622t596r802b668],
2	JM	NN	ORGANIZATION	jm	_	0	SENT_960	[p26l865t596r1008b679],
3	,	,	O	,	_	0	SENT_960	[p26l865t596r1008b679],
4	Hait	NNP	PERSON	Hait	nn	5	SENT_960	[p26l1076t596r1239b665],
5	WN	NNP	O	WN	appos	2	SENT_960	[p26l1307t596r1478b665],
6	.	.	O	.	_	0	SENT_960	[p26l1307t596r1478b665],

1	1990	CD	DATE	1990	_	0	SENT_961	[p26l1558t593r1755b665],
2	.	.	O	.	_	0	SENT_961	[p26l1558t593r1755b665],

1	Pharmacology	NN	O	pharmacology	_	0	SENT_962	[p26l1826t593r2142b665, p26l622t693r876b782],
2	of	IN	O	of	_	0	SENT_962	[p26l939t693r1022b762],
3	drugs	NNS	O	drug	prep_of	1	SENT_962	[p26l1076t693r1284b782],
4	that	WDT	O	that	nsubj	5	SENT_962	[p26l1344t693r1487b759],
5	alter	VBP	O	alter	rcmod	3	SENT_962	[p26l1546t690r1715b759],
6	multidmg	JJ	O	multidmg	amod	7	SENT_962	[p26l1775t690r2148b779],
7	resistance	NN	O	resistance	dobj	5	SENT_962	[p26l625t787r996b859],
8	in	IN	O	in	_	0	SENT_962	[p26l1044t787r1119b856],
9	cancer	NN	O	cancer	prep_in	7	SENT_962	[p26l1170t807r1433b856],
10	.	.	O	.	_	0	SENT_962	[p26l1170t807r1433b856],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_963	[p26l1489t784r1924b856],
2	.	.	O	.	_	0	SENT_963	[p26l1489t784r1924b856],

1	Rev.	NNP	O	Rev.	_	0	SENT_964	[p26l1977t787r2136b856],

1	Horton	NNP	PERSON	Horton	nn	2	SENT_965	[p26l625t984r891b1053],
2	J	NNP	PERSON	J	_	0	SENT_965	[p26l939t984r993b1064],
3	,	,	O	,	_	0	SENT_965	[p26l939t984r993b1064],
4	Thimmaiah	NNP	O	Thimmaiah	nn	5	SENT_965	[p26l1044t981r1481b1050],
5	K	NNP	O	K	appos	2	SENT_965	[p26l1529t981r1613b1062],
6	,	,	O	,	_	0	SENT_965	[p26l1529t981r1613b1062],
7	Houghton	NNP	PERSON	Houghton	nn	8	SENT_965	[p26l1663t981r2041b1070],
8	J	NNP	PERSON	J	appos	2	SENT_965	[p26l2086t981r2145b1059],
9	,	,	O	,	_	0	SENT_965	[p26l2086t981r2145b1059],
10	Horowitz	NNP	PERSON	Horowitz	nn	11	SENT_965	[p26l625t1075r982b1144],
11	M	NNP	O	M	appos	2	SENT_965	[p26l1007t1078r1113b1159],
12	,	,	O	,	_	0	SENT_965	[p26l1007t1078r1113b1159],
13	Houghton	NNP	O	Houghton	nn	14	SENT_965	[p26l1144t1075r1521b1164],
14	P.	NNP	O	P.	appos	2	SENT_965	[p26l1549t1078r1618b1144],
15	1989	CD	DATE	1989	dep	14	SENT_965	[p26l1661t1075r1858b1144],
16	.	.	O	.	_	0	SENT_965	[p26l1661t1075r1858b1144],

1	Modulation	NN	O	modulation	_	0	SENT_966	[p26l1892t1075r2145b1141, p26l625t1172r839b1241],
2	by	IN	O	by	_	0	SENT_966	[p26l870t1172r965b1261],
3	verapamil	NN	O	verapamil	prep_by	1	SENT_966	[p26l999t1172r1376b1261],
4	of	IN	O	of	_	0	SENT_966	[p26l1410t1172r1493b1238],
5	vincristine	NN	O	vincristine	nn	6	SENT_966	[p26l1518t1169r1918b1238],
6	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	3	SENT_966	[p26l1949t1169r2145b1258, p26l625t1264r1125b1335],
7	and	CC	O	and	_	0	SENT_966	[p26l1210t1264r1350b1335],
8	toxicity	NN	O	toxicity	conj_and	3	SENT_966	[p26l1432t1261r1718b1353],
9	in	IN	O	in	_	0	SENT_966	[p26l1806t1264r1878b1333],
10	mice	NNS	O	mouse	prep_in	8	SENT_966	[p26l1966t1261r2145b1333],
11	bearing	VBG	O	bear	partmod	1	SENT_966	[p26l625t1361r908b1447],
12	human	JJ	O	human	amod	14	SENT_966	[p26l942t1361r1199b1427],
13	tumor	NN	O	tumor	nn	14	SENT_966	[p26l1235t1369r1461b1427],
14	xenographs	NNS	O	xenograph	dobj	11	SENT_966	[p26l1492t1358r1946b1447],
15	.	.	O	.	_	0	SENT_966	[p26l1492t1358r1946b1447],

1	Biachem	NNP	O	Biachem	_	0	SENT_967	[p26l1983t1358r2145b1424, p26l625t1458r839b1524],
2	.	.	O	.	_	0	SENT_967	[p26l1983t1358r2145b1424, p26l625t1458r839b1524],

1	Pharm	NNP	O	Pharm	_	0	SENT_968	[p26l885t1455r1156b1524],
2	.	.	O	.	_	0	SENT_968	[p26l885t1455r1156b1524],

1	38	CD	NUMBER	38	_	0	SENT_969	[p26l1204t1455r1655b1524],
2	:	:	O	:	_	0	SENT_969	[p26l1204t1455r1655b1524],
3	l727	CD	NUMBER	l727	num	5	SENT_969	[p26l1204t1455r1655b1524],
4	--	:	O	--	_	0	SENT_969	[p26l1204t1455r1655b1524],
5	36	CD	NUMBER	36	dep	1	SENT_969	[p26l1204t1455r1655b1524],

1	Mickisch	NNP	O	Mickisch	nn	2	SENT_970	[p26l625t1549r979b1618],
2	GH	NN	O	gh	_	0	SENT_970	[p26l1021t1546r1176b1626],
3	,	,	O	,	_	0	SENT_970	[p26l1021t1546r1176b1626],
4	Merlino	NNP	PERSON	Merlino	nn	5	SENT_970	[p26l1224t1546r1533b1615],
5	GT	NN	O	gt	appos	2	SENT_970	[p26l1572t1546r1718b1626],
6	,	,	O	,	_	0	SENT_970	[p26l1572t1546r1718b1626],
7	Galslci	NN	PERSON	galslcus	nn	8	SENT_970	[p26l1769t1543r2009b1615],
8	H	NN	PERSON	h	appos	2	SENT_970	[p26l2057t1546r2145b1624],
9	,	,	O	,	_	0	SENT_970	[p26l2057t1546r2145b1624],
10	Gottesman	NNP	PERSON	Gottesman	nn	11	SENT_970	[p26l628t1643r1036b1714],
11	MM	NN	O	mm	appos	2	SENT_970	[p26l1070t1643r1259b1725],
12	,	,	O	,	_	0	SENT_970	[p26l1070t1643r1259b1725],
13	Pastan	NNP	PERSON	Pastan	nn	14	SENT_970	[p26l1295t1643r1538b1711],
14	I.	NNP	O	I.	appos	2	SENT_970	[p26l1572t1643r1618b1711],
15	1991	CD	DATE	1991	dep	14	SENT_970	[p26l1669t1640r1864b1713],
16	.	.	O	.	_	0	SENT_970	[p26l1669t1640r1864b1713],

1	Transgenic	JJ	O	transgenic	amod	2	SENT_971	[p26l1900t1640r2145b1711, p26l628t1744r828b1833],
2	mice	NNS	O	mouse	nsubj	12	SENT_971	[p26l859t1742r1042b1813],
3	that	WDT	O	that	nsubj	4	SENT_971	[p26l1067t1744r1210b1813],
4	express	VBP	O	express	rcmod	2	SENT_971	[p26l1235t1761r1516b1833],
5	the	DT	O	the	det	8	SENT_971	[p26l1544t1742r1661b1811],
6	human	JJ	O	human	amod	8	SENT_971	[p26l1689t1742r1944b1811],
7	multidmg-resistance	JJ	O	multidmg-resistance	amod	8	SENT_971	[p26l1972t1739r2148b1811, p26l628t1839r1259b1927],
8	gene	NN	O	gene	dobj	4	SENT_971	[p26l1301t1858r1473b1927],
9	in	IN	O	in	_	0	SENT_971	[p26l1518t1836r1587b1905],
10	bone	NN	O	bone	nn	11	SENT_971	[p26l1629t1839r1812b1905],
11	marrow	NN	O	marrow	prep_in	8	SENT_971	[p26l1855t1856r2148b1905],
12	enable	VBP	O	enable	_	0	SENT_971	[p26l628t1936r874b2005],
13	a	DT	O	a	det	15	SENT_971	[p26l916t1956r956b2005],
14	rapid	JJ	O	rapid	amod	15	SENT_971	[p26l1002t1933r1196b2022],
15	identiﬁcation	NN	O	identiﬁcation	dobj	12	SENT_971	[p26l1241t1933r1744b2002],
16	of	IN	O	of	_	0	SENT_971	[p26l1786t1933r1872b2002],
17	agents	NNS	O	agent	prep_of	15	SENT_971	[p26l1912t1944r2148b2019],
18	that	WDT	O	that	nsubj	19	SENT_971	[p26l628t2030r768b2099],
19	reverse	VBP	O	reverse	rcmod	17	SENT_971	[p26l799t2050r1068b2099],
20	drug	NN	O	drug	nn	21	SENT_971	[p26l1099t2030r1270b2119],
21	resistance	NN	O	resistance	dobj	19	SENT_971	[p26l1304t2027r1692b2099],
22	.	.	O	.	_	0	SENT_971	[p26l1304t2027r1692b2099],

1	Proc	NNP	O	Proc	_	0	SENT_972	[p26l1726t2030r1924b2096],
2	.	.	O	.	_	0	SENT_972	[p26l1726t2030r1924b2096],

1	Natl.	NNP	O	Natl.	nn	2	SENT_973	[p26l1960t2027r2139b2096],
2	Acad	NNP	O	Acad	_	0	SENT_973	[p26l622t2127r834b2196],
3	.	.	O	.	_	0	SENT_973	[p26l622t2127r834b2196],

1	Sci	NNP	O	Sci	_	0	SENT_974	[p26l882t2127r1011b2196],
2	.	.	O	.	_	0	SENT_974	[p26l882t2127r1011b2196],

1	USA	NNP	LOCATION	USA	_	0	SENT_975	[p26l1064t2127r1225b2196],
2	88	CD	NUMBER	88	num	1	SENT_975	[p26l1270t2124r1661b2193],
3	:	:	O	:	_	0	SENT_975	[p26l1270t2124r1661b2193],
4	S47	CD	NUMBER	s47	number	5	SENT_975	[p26l1270t2124r1661b2193],
5	—	CD	NUMBER	—	num	6	SENT_975	[p26l1270t2124r1661b2193],
6	5l	NN	O	5l	dep	1	SENT_975	[p26l1270t2124r1661b2193],

1	Bellamy	NNP	PERSON	Bellamy	nn	2	SENT_976	[p26l628t2224r948b2313],
2	WT	NNP	O	WT	_	0	SENT_976	[p26l1007t2224r1176b2301],
3	,	,	O	,	_	0	SENT_976	[p26l1007t2224r1176b2301],
4	Odeleye	NNP	MISC	Odeleye	nn	5	SENT_976	[p26l1241t2221r1556b2310],
5	A	NNP	MISC	A	appos	2	SENT_976	[p26l1618t2224r1704b2301],
6	,	,	O	,	_	0	SENT_976	[p26l1618t2224r1704b2301],
7	Finley	NNP	PERSON	Finley	nn	8	SENT_976	[p26l1772t2221r2012b2310],
8	P	NN	O	p	appos	2	SENT_976	[p26l2074t2221r2148b2298],
9	,	,	O	,	_	0	SENT_976	[p26l2074t2221r2148b2298],
10	Huizenga	NN	PERSON	huizenga	nn	11	SENT_976	[p26l628t2318r991b2407],
11	B	NN	O	b	appos	2	SENT_976	[p26l1036t2318r1119b2398],
12	,	,	O	,	_	0	SENT_976	[p26l1036t2318r1119b2398],
13	Dalton	NNP	PERSON	Dalton	nn	14	SENT_976	[p26l1170t2315r1424b2387],
14	WS	NNP	O	WS	appos	2	SENT_976	[p26l1475t2315r1633b2395],
15	,	,	O	,	_	0	SENT_976	[p26l1475t2315r1633b2395],
16	et	FW	O	et	nn	17	SENT_976	[p26l1686t2326r1752b2384],
17	al.	FW	O	al.	appos	2	SENT_976	[p26l1803t2315r1886b2384],
18	1993	CD	DATE	1993	dep	17	SENT_976	[p26l1949t2315r2145b2387],
19	.	.	O	.	_	0	SENT_976	[p26l1949t2315r2145b2387],

1	An	DT	O	a	_	0	SENT_977	[p26l628t2415r742b2481],
2	in	FW	O	in	nn	3	SENT_977	[p26l773t2412r848b2481],
3	vivo	FW	O	vivo	advmod	4	SENT_977	[p26l879t2412r1045b2481],
4	model	NN	O	model	dep	1	SENT_977	[p26l1081t2412r1313b2481],
5	of	IN	O	of	_	0	SENT_977	[p26l1347t2409r1433b2478],
6	human	JJ	O	human	amod	9	SENT_977	[p26l1458t2412r1712b2478],
7	multidrugresistant	JJ	O	multidrugresistant	amod	9	SENT_977	[p26l1749t2409r2148b2498, p26l628t2512r942b2581],
8	multiple	JJ	O	multiple	amod	9	SENT_977	[p26l1007t2509r1319b2601],
9	myeloma	NN	O	myeloma	prep_of	4	SENT_977	[p26l1384t2509r1738b2598],
10	in	IN	O	in	_	0	SENT_977	[p26l1800t2509r1869b2578],
11	SCID	NN	O	scid	nn	12	SENT_977	[p26l1937t2509r2148b2578],
12	mice	NNS	O	mouse	prep_in	9	SENT_977	[p26l628t2606r828b2678],
13	.	.	O	.	_	0	SENT_977	[p26l628t2606r828b2678],

1	Am	NNP	O	Am	_	0	SENT_978	[p26l865t2606r1011b2675],
2	.	.	O	.	_	0	SENT_978	[p26l865t2606r1011b2675],

1	J.	NNP	PERSON	J.	nn	2	SENT_979	[p26l1053t2606r1113b2675],
2	Pathol	NNP	PERSON	Pathol	_	0	SENT_979	[p26l1158t2603r1424b2675],
3	.	.	O	.	_	0	SENT_979	[p26l1158t2603r1424b2675],

1	14	CD	NUMBER	14	_	0	SENT_980	[p26l1481t2603r1921b2678],
2	‘	CD	NUMBER	‘	num	4	SENT_980	[p26l1481t2603r1921b2678],
3	2:69	CD	NUMBER	2:69	num	4	SENT_980	[p26l1481t2603r1921b2678],
4	l	NN	O	l	dep	1	SENT_980	[p26l1481t2603r1921b2678],
5	—	CD	NUMBER	—	number	6	SENT_980	[p26l1481t2603r1921b2678],
6	98	CD	NUMBER	98	dep	4	SENT_980	[p26l1481t2603r1921b2678],

1	Mickiseh	NNP	O	Mickiseh	nn	2	SENT_981	[p26l628t2700r982b2772],
2	GH	NN	O	gh	_	0	SENT_981	[p26l1024t2700r1179b2784],
3	,	,	O	,	_	0	SENT_981	[p26l1024t2700r1179b2784],
4	Pai	NNP	ORGANIZATION	Pai	nn	5	SENT_981	[p26l1227t2700r1342b2769],
5	LH	NNP	ORGANIZATION	LH	appos	2	SENT_981	[p26l1390t2700r1533b2781],
6	,	,	O	,	_	0	SENT_981	[p26l1390t2700r1533b2781],
7	Siegsmund	NNP	O	Siegsmund	nn	8	SENT_981	[p26l1581t2697r1998b2789],
8	M	NNP	O	M	appos	2	SENT_981	[p26l2043t2700r2148b2778],
9	,	,	O	,	_	0	SENT_981	[p26l2043t2700r2148b2778],
10	Campain	NNP	O	Campain	nn	11	SENT_981	[p26l628t2797r968b2886],
11	J	NNP	O	J	appos	2	SENT_981	[p26l1013t2797r1068b2878],
12	,	,	O	,	_	0	SENT_981	[p26l1013t2797r1068b2878],
13	Gottesman	NNP	PERSON	Gottesman	nn	14	SENT_981	[p26l1118t2797r1527b2863],
14	MM	NN	O	mm	appos	2	SENT_981	[p26l1569t2797r1758b2875],
15	,	,	O	,	_	0	SENT_981	[p26l1569t2797r1758b2875],
16	Pastan	NNP	PERSON	Pastan	nn	17	SENT_981	[p26l1806t2797r2049b2863],
17	I.	NNP	O	I.	appos	2	SENT_981	[p26l2097t2794r2145b2861],
18	1993	CD	DATE	1993	dep	17	SENT_981	[p26l636t2891r834b2960],
19	.	.	O	.	_	0	SENT_981	[p26l636t2891r834b2960],

1	Pseudomonas	FW	PERSON	pseudomonas	nn	2	SENT_982	[p26l916t2891r1433b2960],
2	exotoxin	FW	O	exotoxin	nsubj	9	SENT_982	[p26l1507t2889r1838b2958],
3	conjugated	VBN	O	conjugate	partmod	2	SENT_982	[p26l1912t2886r2148b2978, p26l628t2986r831b3075],
4	to	TO	O	to	_	0	SENT_982	[p26l873t2997r948b3055],
5	monoclonal	JJ	O	monoclonal	amod	7	SENT_982	[p26l987t2983r1430b3055],
6	antibody	NN	O	antibody	nn	7	SENT_982	[p26l1469t2983r1801b3072],
7	MRK16	NN	O	mrk16	prep_to	3	SENT_982	[p26l1843t2983r2153b3052],
8	speciﬁcally	RB	O	speciﬁcally	advmod	9	SENT_982	[p26l631t3083r1062b3172],
9	kills	VBZ	O	kill	_	0	SENT_982	[p26l1144t3080r1304b3152],
10	multidrug	JJ	O	multidrug	amod	11	SENT_982	[p26l1384t3080r1755b3169],
11	resistant	JJ	O	resistant	amod	12	SENT_982	[p26l1837t3080r2153b3152],
12	cells	NNS	O	cell	dobj	9	SENT_982	[p26l628t3177r799b3246],
13	in	IN	O	in	_	0	SENT_982	[p26l845t3177r914b3246],
14	cultured	VBN	O	culture	dep	20	SENT_982	[p26l959t3177r1267b3246],
15	renal	JJ	O	renal	amod	16	SENT_982	[p26l1310t3177r1496b3246],
16	carcinomas	NNS	O	carcinoma	dobj	14	SENT_982	[p26l1541t3174r1972b3246],
17	and	CC	O	and	_	0	SENT_982	[p26l2014t3174r2153b3243],
18	in	IN	O	in	conj_and	14	SENT_982	[p26l631t3271r700b3340],
19	MDR-transgenic	JJ	O	mdr-transgenic	pobj	18	SENT_982	[p26l733t3271r1370b3360],
20	mice	NNS	O	mouse	prep_in	12	SENT_982	[p26l1409t3271r1607b3340],
21	.	.	O	.	_	0	SENT_982	[p26l1409t3271r1607b3340],

1	J.	NNP	O	J.	nn	2	SENT_983	[p26l1646t3271r1704b3340],
2	Urol	NNP	O	Urol	_	0	SENT_983	[p26l1755t3271r1938b3340],
3	.	.	O	.	_	0	SENT_983	[p26l1755t3271r1938b3340],

1	149	CD	NUMBER	149	_	0	SENT_984	[p26l1992t3271r2145b3340],
2	:	:	O	:	_	0	SENT_984	[p26l1992t3271r2145b3340],
3	174-78	CD	NUMBER	174-78	dep	1	SENT_984	[p26l639t3371r908b3443],

1	Bellamy	NNP	PERSON	Bellamy	nn	2	SENT_985	[p26l631t3468r951b3557],
2	WT	NNP	O	WT	_	0	SENT_985	[p26l1010t3468r1179b3548],
3	,	,	O	,	_	0	SENT_985	[p26l1010t3468r1179b3548],
4	Odeleye	NNP	MISC	Odeleye	nn	5	SENT_985	[p26l1244t3468r1556b3557],
5	A	NNP	MISC	A	appos	2	SENT_985	[p26l1621t3468r1707b3548],
6	,	,	O	,	_	0	SENT_985	[p26l1621t3468r1707b3548],
7	Finley	NNP	PERSON	Finley	nn	8	SENT_985	[p26l1775t3465r2015b3557],
8	P	NN	O	p	appos	5	SENT_985	[p26l2077t3465r2150b3548],
9	,	,	O	,	_	0	SENT_985	[p26l2077t3465r2150b3548],
10	Huizenga	NNP	PERSON	Huizenga	nn	11	SENT_985	[p26l631t3565r991b3651],
11	E	NNP	O	E	appos	5	SENT_985	[p26l1061t3565r1139b3642],
12	,	,	O	,	_	0	SENT_985	[p26l1061t3565r1139b3642],
13	Weinstein	NNP	PERSON	Weinstein	nn	14	SENT_985	[p26l1213t3562r1593b3631],
14	RS	NN	O	r	appos	5	SENT_985	[p26l1663t3562r1795b3642],
15	,	,	O	,	_	0	SENT_985	[p26l1663t3562r1795b3642],
16	Grogan	NNP	PERSON	Grogan	nn	17	SENT_985	[p26l1872t3562r2153b3651],
17	TM	NNP	O	TM	appos	5	SENT_985	[p26l628t3662r791b3728],
18	.	.	O	.	_	0	SENT_985	[p26l628t3662r791b3728],

1	1993	CD	DATE	1993	_	0	SENT_986	[p26l847t3659r1045b3731],
2	.	.	O	.	_	0	SENT_986	[p26l847t3659r1045b3731],

1	An	DT	O	a	_	0	SENT_987	[p26l1096t3662r1210b3728],
2	in	FW	O	in	nn	3	SENT_987	[p26l1258t3659r1327b3728],
3	vivo	FW	O	vivo	advmod	4	SENT_987	[p26l1375t3659r1544b3728],
4	model	NN	O	model	dep	1	SENT_987	[p26l1586t3659r1821b3728],
5	of	IN	O	of	_	0	SENT_987	[p26l1866t3656r1952b3726],
6	chemosensitization	NN	O	chemosensitization	prep_of	1	SENT_987	[p26l1989t3659r2150b3726, p27l631t18r1222b89],

1	of	IN	O	of	_	0	SENT_988	[p27l1278t18r1361b89],
2	multidrug	JJ	O	multidrug	amod	3	SENT_988	[p27l1412t18r1784b106],
3	resistant	JJ	O	resistant	amod	7	SENT_988	[p27l1837t18r2153b86],
4	human	JJ	O	human	amod	7	SENT_988	[p27l631t114r882b182],
5	myeloma	NN	O	myeloma	nn	7	SENT_988	[p27l956t114r1307b202],
6	cell	NN	O	cell	nn	7	SENT_988	[p27l1375t111r1510b182],
7	line	NN	O	line	pobj	1	SENT_988	[p27l1584t111r1724b182],
8	in	IN	O	in	_	0	SENT_988	[p27l1795t111r1866b182],
9	SCID	NN	O	scid	nn	10	SENT_988	[p27l1940t111r2150b182],
10	mice	NNS	O	mouse	prep_in	7	SENT_988	[p27l631t210r831b278],
11	.	.	O	.	_	0	SENT_988	[p27l631t210r831b278],

1	Proc	NNP	O	Proc	_	0	SENT_989	[p27l893t213r1088b278],
2	.	.	O	.	_	0	SENT_989	[p27l893t213r1088b278],

1	Am	NNP	O	Am	_	0	SENT_990	[p27l1150t213r1296b278],
2	.	.	O	.	_	0	SENT_990	[p27l1150t213r1296b278],

1	Assoc	NNP	O	Assoc	_	0	SENT_991	[p27l1352t213r1593b278],
2	.	.	O	.	_	0	SENT_991	[p27l1352t213r1593b278],

1	Cancer	NN	O	cancer	_	0	SENT_992	[p27l1663t210r1941b278],
2	Res	NNP	O	Res	dep	1	SENT_992	[p27l1989t210r2142b275],
3	.	.	O	.	_	0	SENT_992	[p27l1989t210r2142b275],

1	34:319	CD	NUMBER	34:319	number	2	SENT_993	[p27l631t303r888b372],
2	(	CD	NUMBER	(	_	0	SENT_993	[p27l947t303r1242b386],
3	Abstr	NNP	O	Abstr	dep	2	SENT_993	[p27l947t303r1242b386],
4	.	.	O	.	_	0	SENT_993	[p27l947t303r1242b386],
5	)	NN	O	)	dep	2	SENT_993	[p27l947t303r1242b386],

1	90	CD	NUMBER	90	_	0	SENT_994	[p27l422t396r537b464],
2	.	.	O	.	_	0	SENT_994	[p27l422t396r537b464],

1	Bellamy	NNP	PERSON	Bellamy	nn	2	SENT_995	[p27l631t396r951b481],
2	W	NNP	O	W	_	0	SENT_995	[p27l1030t396r1139b473],
3	,	,	O	,	_	0	SENT_995	[p27l1030t396r1139b473],
4	Peng	NNP	PERSON	Peng	nn	5	SENT_995	[p27l1227t396r1410b481],
5	Y	NN	PERSON	y	appos	2	SENT_995	[p27l1495t396r1581b473],
6	,	,	O	,	_	0	SENT_995	[p27l1495t396r1581b473],
7	Ocleleye	NNP	O	Ocleleye	nn	8	SENT_995	[p27l1666t393r1978b481],
8	A	NNP	O	A	appos	2	SENT_995	[p27l2063t396r2148b473],
9	,	,	O	,	_	0	SENT_995	[p27l2063t396r2148b473],
10	Huizenga	NNP	PERSON	Huizenga	nn	11	SENT_995	[p27l631t492r993b580],
11	E	NNP	O	E	appos	2	SENT_995	[p27l1041t492r1119b572],
12	,	,	O	,	_	0	SENT_995	[p27l1041t492r1119b572],
13	Xu	NNP	O	Xu	nn	14	SENT_995	[p27l1173t492r1287b560],
14	M	NNP	O	M	appos	2	SENT_995	[p27l1335t492r1441b569],
15	,	,	O	,	_	0	SENT_995	[p27l1335t492r1441b569],
16	et	FW	O	et	nn	17	SENT_995	[p27l1492t503r1558b558],
17	al.	FW	O	al.	appos	2	SENT_995	[p27l1606t492r1692b557],
18	1994	CD	DATE	1994	dep	17	SENT_995	[p27l1755t489r1952b560],
19	.	.	O	.	_	0	SENT_995	[p27l1755t489r1952b560],

1	The	DT	O	the	det	2	SENT_996	[p27l2006t489r2150b557],
2	addition	NN	O	addition	nsubj	6	SENT_996	[p27l631t585r942b653],
3	of	IN	O	of	_	0	SENT_996	[p27l1004t585r1085b653],
4	cyclosporin	NN	O	cyclosporin	nn	5	SENT_996	[p27l1141t582r1578b670],
5	A	NN	O	a	prep_of	2	SENT_996	[p27l1646t585r1710b650],
6	results	VBZ	O	result	_	0	SENT_996	[p27l1772t582r2018b650],
7	in	IN	O	in	_	0	SENT_996	[p27l2080t582r2153b650],
8	markedly	RB	O	markedly	advmod	9	SENT_996	[p27l633t678r985b766],
9	elevated	JJ	O	elevated	amod	11	SENT_996	[p27l1021t678r1336b746],
10	tissue	NN	O	tissue	nn	11	SENT_996	[p27l1370t675r1581b746],
11	levels	NNS	O	level	prep_in	6	SENT_996	[p27l1618t678r1835b746],
12	of	IN	O	of	_	0	SENT_996	[p27l1872t675r1952b743],
13	do	VBP	O	do	prepc_of	11	SENT_996	[p27l1983t675r2150b744, p27l631t773r945b844],
14	)	CD	NUMBER	)	dobj	13	SENT_996	[p27l1983t675r2150b744, p27l631t773r945b844],
15	:	:	O	:	_	0	SENT_996	[p27l1983t675r2150b744, p27l631t773r945b844],
16	orubicin	NN	O	orubicin	dep	11	SENT_996	[p27l1983t675r2150b744, p27l631t773r945b844],
17	in	IN	O	in	_	0	SENT_996	[p27l976t773r1048b841],
18	the	DT	O	the	det	20	SENT_996	[p27l1079t773r1193b841],
19	SCID	NN	O	scid	nn	20	SENT_996	[p27l1227t773r1436b841],
20	mouse	NN	O	mouse	prep_in	16	SENT_996	[p27l1469t793r1732b841],
21	.	.	O	.	_	0	SENT_996	[p27l1469t793r1732b841],

1	Proc	NNP	O	Proc	_	0	SENT_997	[p27l1766t773r1964b841],
2	.	.	O	.	_	0	SENT_997	[p27l1766t773r1964b841],

1	Am	NNP	O	Am	_	0	SENT_998	[p27l1997t773r2145b841],
2	.	.	O	.	_	0	SENT_998	[p27l1997t773r2145b841],

1	Assoc	NNP	O	Assoc	_	0	SENT_999	[p27l625t872r865b939],
2	.	.	O	.	_	0	SENT_999	[p27l625t872r865b939],

1	Cancer	NN	O	cancer	_	0	SENT_1000	[p27l916t870r1190b939],
2	Res	NNP	O	Res	dep	1	SENT_1000	[p27l1224t870r1373b939],
3	.	.	O	.	_	0	SENT_1000	[p27l1224t870r1373b939],

1	351354	CD	NUMBER	351354	number	2	SENT_1001	[p27l1424t867r1681b939],
2	(	CD	NUMBER	(	_	0	SENT_1001	[p27l1721t867r2012b953],
3	Abstr	NNP	O	Abstr	dep	2	SENT_1001	[p27l1721t867r2012b953],
4	.	.	O	.	_	0	SENT_1001	[p27l1721t867r2012b953],
5	)	NN	O	)	dep	2	SENT_1001	[p27l1721t867r2012b953],

1	91	CD	NUMBER	91	_	0	SENT_1002	[p27l425t963r537b1034],
2	.	.	O	.	_	0	SENT_1002	[p27l425t963r537b1034],

1	Dalton	NNP	PERSON	Dalton	nn	2	SENT_1003	[p27l633t966r888b1034],
2	WS	NNP	O	WS	_	0	SENT_1003	[p27l936t963r1099b1043],
3	,	,	O	,	_	0	SENT_1003	[p27l936t963r1099b1043],
4	Grogan	NNP	PERSON	Grogan	nn	5	SENT_1003	[p27l1147t963r1427b1051],
5	TM	NNP	O	TM	appos	2	SENT_1003	[p27l1475t963r1635b1043],
6	,	,	O	,	_	0	SENT_1003	[p27l1475t963r1635b1043],
7	Meltzer	NNP	PERSON	Meltzer	nn	8	SENT_1003	[p27l1686t963r1981b1031],
8	PS	NNP	O	PS	appos	2	SENT_1003	[p27l2026t963r2150b1043],
9	,	,	O	,	_	0	SENT_1003	[p27l2026t963r2150b1043],
10	Scheper	NNP	PERSON	Scheper	nn	11	SENT_1003	[p27l633t1062r936b1150],
11	RJ	NN	PERSON	rj	appos	2	SENT_1003	[p27l996t1062r1113b1142],
12	,	,	O	,	_	0	SENT_1003	[p27l996t1062r1113b1142],
13	Durie	NNP	ORGANIZATION	Durie	nn	14	SENT_1003	[p27l1178t1059r1390b1130],
14	BG	NNP	ORGANIZATION	BG	appos	2	SENT_1003	[p27l1452t1059r1604b1142],
15	,	,	O	,	_	0	SENT_1003	[p27l1452t1059r1604b1142],
16	et	FW	O	et	nn	17	SENT_1003	[p27l1666t1073r1732b1130],
17	al.	FW	O	al.	appos	2	SENT_1003	[p27l1792t1059r1875b1130],
18	1989	CD	DATE	1989	dep	17	SENT_1003	[p27l1952t1059r2150b1130],
19	.	.	O	.	_	0	SENT_1003	[p27l1952t1059r2150b1130],

1	Drug-resistance	NN	O	drug-resistance	_	0	SENT_1004	[p27l633t1168r1230b1256],
2	in	IN	O	in	_	0	SENT_1004	[p27l1295t1168r1364b1236],
3	multiple	JJ	O	multiple	amod	4	SENT_1004	[p27l1427t1168r1741b1256],
4	myeloma	NN	O	myeloma	prep_in	1	SENT_1004	[p27l1803t1168r2153b1256],
5	and	CC	O	and	_	0	SENT_1004	[p27l286t1518r445b1602],
6	non-Hodgkin	JJ	PERSON	non-hodgkin	poss	8	SENT_1004	[p27l511t1515r1206b1626],
7	's	POS	O	's	_	0	SENT_1004	[p27l511t1515r1206b1626],
8	lymphoma	NN	O	lymphoma	conj_and	4	SENT_1004	[p27l1268t1515r1783b1623],
9	:	:	O	:	_	0	SENT_1004	[p27l1268t1515r1783b1623],
10	detection	NN	O	detection	dep	1	SENT_1004	[p27l1852t1515r2133b1598, p27l286t1634r463b1718],
11	of	IN	O	of	_	0	SENT_1004	[p27l542t1631r642b1718],
12	P-glycoprotein	NN	O	p-glycoprotein	nn	15	SENT_1004	[p27l718t1631r1403b1742],
13	and	CC	O	and	_	0	SENT_1004	[p27l1485t1631r1652b1718],
14	potential	JJ	O	potential	nn	15	SENT_1004	[p27l1731t1631r2133b1742],
15	circumvention	NN	O	circumvention	prep_of	10	SENT_1004	[p27l286t1750r947b1834],
16	by	IN	O	by	_	0	SENT_1004	[p27l1036t1750r1154b1858],
17	addition	NN	O	addition	prep_by	15	SENT_1004	[p27l1243t1747r1621b1834],
18	of	IN	O	of	_	0	SENT_1004	[p27l1714t1747r1814b1831],
19	verapamil	NN	O	verapamil	prep_of	17	SENT_1004	[p27l1900t1771r2133b1831, p27l286t1865r539b1976],
20	to	TO	O	to	_	0	SENT_1004	[p27l587t1879r674b1952],
21	chemotherapy	NN	O	chemotherapy	prep_to	19	SENT_1004	[p27l715t1865r1389b1972],
22	.	.	O	.	_	0	SENT_1004	[p27l715t1865r1389b1972],

1	J.	NNP	PERSON	J.	nn	2	SENT_1005	[p27l1430t1861r1503b1948],
2	Clin	NNP	PERSON	Clin	_	0	SENT_1005	[p27l1562t1858r1773b1948],
3	.	.	O	.	_	0	SENT_1005	[p27l1562t1858r1773b1948],

1	Oncot	NN	O	oncot	_	0	SENT_1006	[p27l1828t1858r2122b1945],
2	.	.	O	.	_	0	SENT_1006	[p27l1828t1858r2122b1945],

1	7	CD	NUMBER	7	_	0	SENT_1007	[p27l286t1982r715b2069],
2	:	:	O	:	_	0	SENT_1007	[p27l286t1982r715b2069],
3	-415	CD	NUMBER	-415	num	4	SENT_1007	[p27l286t1982r715b2069],
4	-24	CD	NUMBER	-24	dep	1	SENT_1007	[p27l286t1982r715b2069],

1	Miller	NNP	PERSON	Miller	nn	2	SENT_1008	[p27l286t2100r573b2187],
2	TP	NNP	O	TP	_	0	SENT_1008	[p27l635t2103r798b2200],
3	,	,	O	,	_	0	SENT_1008	[p27l635t2103r798b2200],
4	Grogan	NNP	PERSON	Grogan	nn	5	SENT_1008	[p27l870t2100r1216b2207],
5	TM	NNP	O	TM	appos	2	SENT_1008	[p27l1282t2100r1479b2197],
6	,	,	O	,	_	0	SENT_1008	[p27l1282t2100r1479b2197],
7	Dalton	NNP	PERSON	Dalton	nn	8	SENT_1008	[p27l1555t2100r1863b2183],
8	WS	NNP	O	WS	appos	5	SENT_1008	[p27l1935t2100r2132b2197],
9	,	,	O	,	_	0	SENT_1008	[p27l1935t2100r2132b2197],
10	Spier	NNP	ORGANIZATION	Spier	nn	11	SENT_1008	[p27l289t2217r528b2325],
11	CM	NN	ORGANIZATION	cm	appos	5	SENT_1008	[p27l600t2217r801b2315],
12	,	,	O	,	_	0	SENT_1008	[p27l600t2217r801b2315],
13	Scheper	NNP	PERSON	Scheper	nn	14	SENT_1008	[p27l884t2217r1251b2325],
14	RJ	NN	PERSON	rj	appos	5	SENT_1008	[p27l1326t2217r1469b2311],
15	,	,	O	,	_	0	SENT_1008	[p27l1326t2217r1469b2311],
16	Salmon	NNP	O	Salmon	nn	17	SENT_1008	[p27l1548t2214r1901b2298],
17	SE	NN	O	se	appos	5	SENT_1008	[p27l1976t2214r2129b2298],
18	.	.	O	.	_	0	SENT_1008	[p27l1976t2214r2129b2298],

1	1991	CD	DATE	1991	_	0	SENT_1009	[p27l296t2331r535b2418],
2	.	.	O	.	_	0	SENT_1009	[p27l296t2331r535b2418],

1	P-glycoprotein	NN	O	p-glycoprotein	nn	2	SENT_1010	[p27l580t2331r1261b2438],
2	expression	NN	O	expression	_	0	SENT_1010	[p27l1299t2331r1790b2438],
3	in	IN	O	in	_	0	SENT_1010	[p27l1831t2331r1922b2414],
4	malignant	JJ	O	malignant	amod	5	SENT_1010	[p27l1959t2355r2132b2414, p27l286t2449r604b2557],
5	lymphoma	NN	O	lymphoma	prep_in	2	SENT_1010	[p27l638t2449r1130b2557],
6	and	CC	O	and	_	0	SENT_1010	[p27l1167t2449r1330b2530],
7	reversal	NN	O	reversal	prep_in	2	SENT_1010	[p27l1361t2446r1725b2530],
8	of	IN	O	of	_	0	SENT_1010	[p27l1766t2446r1866b2530],
9	clinical	JJ	O	clinical	amod	11	SENT_1010	[p27l1893t2446r2133b2530, p27l286t2566r414b2650],
10	drug	NN	O	drug	nn	11	SENT_1010	[p27l469t2563r680b2670],
11	resistance	NN	O	resistance	prep_of	2	SENT_1010	[p27l725t2563r1178b2646],
12	with	IN	O	with	_	0	SENT_1010	[p27l1233t2563r1434b2646],
13	chemotherapy	NN	O	chemotherapy	prep_with	11	SENT_1010	[p27l1485t2563r2139b2670],
14	plus	CC	O	plus	prep	2	SENT_1010	[p27l286t2682r473b2793],
15	high-dose	JJ	O	high-dose	amod	16	SENT_1010	[p27l521t2682r974b2790],
16	verapamil	NN	O	verapamil	dep	14	SENT_1010	[p27l1026t2682r1503b2790],
17	.	.	O	.	_	0	SENT_1010	[p27l1026t2682r1503b2790],

1	J.	NNP	PERSON	J.	nn	2	SENT_1011	[p27l1555t2682r1628b2766],
2	Clin	NNP	PERSON	Clin	_	0	SENT_1011	[p27l1689t2679r1901b2762],
3	.	.	O	.	_	0	SENT_1011	[p27l1689t2679r1901b2762],

1	Oncol	NN	O	oncol	_	0	SENT_1012	[p27l1963t2682r2133b2766, p27l286t2794r442b2877],
2	.	.	O	.	_	0	SENT_1012	[p27l1963t2682r2133b2766, p27l286t2794r442b2877],

1	9:17	CD	TIME	9:17	num	2	SENT_1013	[p27l497t2797r874b2880],
2	-24	CD	NUMBER	-24	_	0	SENT_1013	[p27l497t2797r874b2880],

1	Sonneveld	JJ	MISC	sonneveld	amod	2	SENT_1014	[p27l289t2913r770b2997],
2	P	NN	O	p	_	0	SENT_1014	[p27l808t2913r891b3007],
3	,	,	O	,	_	0	SENT_1014	[p27l808t2913r891b3007],
4	Schoster	NN	O	schoster	nn	5	SENT_1014	[p27l939t2913r1334b2993],
5	M	NN	O	m	appos	2	SENT_1014	[p27l1368t2913r1493b3007],
6	,	,	O	,	_	0	SENT_1014	[p27l1368t2913r1493b3007],
7	de	IN	PERSON	de	amod	9	SENT_1014	[p27l1530t2910r1638b2993],
8	Leeuw	NNP	PERSON	Leeuw	nn	9	SENT_1014	[p27l1679t2913r1987b2993],
9	K.	NNP	PERSON	K.	appos	2	SENT_1014	[p27l2028t2910r2133b2993],

1	1994	CD	DATE	1994	_	0	SENT_1015	[p27l300t3029r535b3113],
2	.	.	O	.	_	0	SENT_1015	[p27l300t3029r535b3113],

1	Clinical	JJ	O	clinical	amod	2	SENT_1016	[p27l580t3026r943b3113],
2	modulation	NN	O	modulation	_	0	SENT_1016	[p27l988t3026r1510b3109],
3	of	IN	O	of	_	0	SENT_1016	[p27l1548t3026r1652b3109],
4	multidrug	JJ	O	multidrug	amod	5	SENT_1016	[p27l1686t3026r2139b3133],
5	resistance	NN	O	resistance	prep_of	2	SENT_1016	[p27l289t3141r739b3228],
6	in	IN	O	in	_	0	SENT_1016	[p27l791t3141r877b3225],
7	multiple	JJ	O	multiple	amod	8	SENT_1016	[p27l932t3141r1313b3252],
8	myeloma	NN	O	myeloma	prep_in	5	SENT_1016	[p27l1364t3141r1814b3252],
9	:	:	O	:	_	0	SENT_1016	[p27l1364t3141r1814b3252],
10	effect	NN	O	effect	dep	2	SENT_1016	[p27l1876t3138r2139b3225],
11	of	IN	O	of	_	0	SENT_1016	[p27l289t3257r390b3344],
12	eyelosporine	NN	O	eyelosporine	prep_of	10	SENT_1016	[p27l410t3257r1002b3368],
13	on	IN	O	on	_	0	SENT_1016	[p27l1029t3285r1147b3341],
14	resistant	JJ	O	resistant	amod	16	SENT_1016	[p27l1178t3257r1559b3341],
15	tumor	NN	O	tumor	nn	16	SENT_1016	[p27l1589t3271r1870b3341],
16	cells	NNS	O	cell	prep_on	12	SENT_1016	[p27l1897t3254r2133b3341],
17	.	.	O	.	_	0	SENT_1016	[p27l1897t3254r2133b3341],

1	J.	NNP	PERSON	J.	nn	2	SENT_1017	[p27l286t3376r359b3459],
2	Clin	NNP	PERSON	Clin	_	0	SENT_1017	[p27l414t3376r625b3459],
3	.	.	O	.	_	0	SENT_1017	[p27l414t3376r625b3459],

1	Oncol	NN	O	oncol	_	0	SENT_1018	[p27l683t3376r978b3459],
2	.	.	O	.	_	0	SENT_1018	[p27l683t3376r978b3459],

1	l2	NN	O	l2	_	0	SENT_1019	[p27l1046t3373r1569b3459],
2	:	:	O	:	_	0	SENT_1019	[p27l1046t3373r1569b3459],
3	l584-91	NN	O	l584-91	dep	1	SENT_1019	[p27l1046t3373r1569b3459],

1	94	CD	NUMBER	94	_	0	SENT_1020	[p28l40t25r176b112],
2	.	.	O	.	_	0	SENT_1020	[p28l40t25r176b112],

1	Yahanda	NNP	ORGANIZATION	Yahanda	nn	2	SENT_1021	[p28l289t25r698b108],
2	AM	NNP	ORGANIZATION	AM	_	0	SENT_1021	[p28l749t25r960b122],
3	,	,	O	,	_	0	SENT_1021	[p28l749t25r960b122],
4	Alder	NNP	ORGANIZATION	Alder	nn	5	SENT_1021	[p28l1019t25r1282b108],
5	KM	NNP	ORGANIZATION	KM	appos	2	SENT_1021	[p28l1337t22r1541b122],
6	,	,	O	,	_	0	SENT_1021	[p28l1337t22r1541b122],
7	Fisher	NNP	PERSON	Fisher	nn	8	SENT_1021	[p28l1603t22r1890b105],
8	GA	NNP	O	GA	appos	2	SENT_1021	[p28l1945t22r2136b119],
9	,	,	O	,	_	0	SENT_1021	[p28l1945t22r2136b119],
10	Brophy	NNP	ORGANIZATION	Brophy	nn	11	SENT_1021	[p28l289t140r625b248],
11	NA	NNP	ORGANIZATION	NA	appos	2	SENT_1021	[p28l659t140r850b238],
12	,	,	O	,	_	0	SENT_1021	[p28l659t140r850b238],
13	Halsey	NNP	PERSON	Halsey	nn	14	SENT_1021	[p28l884t140r1202b248],
14	J	NNP	PERSON	J	appos	2	SENT_1021	[p28l1230t140r1299b238],
15	,	,	O	,	_	0	SENT_1021	[p28l1230t140r1299b238],
16	et	FW	O	et	nn	17	SENT_1021	[p28l1333t151r1413b221],
17	al.	FW	O	al.	appos	2	SENT_1021	[p28l1444t137r1548b221],
18	1992	CD	DATE	1992	dep	17	SENT_1021	[p28l1600t137r1835b224],
19	.	.	O	.	_	0	SENT_1021	[p28l1600t137r1835b224],

1	Phase	NN	O	phase	nn	3	SENT_1022	[p28l1876t137r2136b221],
2	I	CD	NUMBER	i	num	3	SENT_1022	[p28l289t257r328b340],
3	trial	NN	O	trial	_	0	SENT_1022	[p28l362t253r542b340],
4	of	IN	O	of	_	0	SENT_1022	[p28l580t253r680b337],
5	etoposide	NN	O	etoposide	prep_of	3	SENT_1022	[p28l708t253r1147b361],
6	with	IN	O	with	_	0	SENT_1022	[p28l1188t250r1389b337],
7	cyclosporine	NN	O	cyclosporine	prep_with	3	SENT_1022	[p28l1423t250r2008b361],
8	as	IN	O	as	_	0	SENT_1022	[p28l2046t278r2136b337],
9	a	DT	O	a	det	10	SENT_1022	[p28l293t400r342b459],
10	modulator	NN	O	modulator	prep_as	3	SENT_1022	[p28l386t372r857b456],
11	of	IN	O	of	_	0	SENT_1022	[p28l901t372r1002b456],
12	multidrug	JJ	O	multidrug	amod	13	SENT_1022	[p28l1040t369r1486b480],
13	resistance	NN	O	resistance	prep_of	10	SENT_1022	[p28l1534t369r2012b456],
14	.	.	O	.	_	0	SENT_1022	[p28l1534t369r2012b456],

1	J.	NNP	PERSON	J.	nn	2	SENT_1023	[p28l2056t369r2129b453],
2	Clin	NNP	PERSON	Clin	_	0	SENT_1023	[p28l296t489r501b572],
3	.	.	O	.	_	0	SENT_1023	[p28l296t489r501b572],

1	Oncol	NN	O	oncol	_	0	SENT_1024	[p28l562t489r857b572],
2	.	.	O	.	_	0	SENT_1024	[p28l562t489r857b572],

1	l0	NN	O	l0	_	0	SENT_1025	[p28l922t489r1465b572],
2	:1624	CD	NUMBER	:1624	num	3	SENT_1025	[p28l922t489r1465b572],
3	-34	CD	NUMBER	-34	dep	1	SENT_1025	[p28l922t489r1465b572],

1	95	CD	NUMBER	95	_	0	SENT_1026	[p28l40t608r176b688],
2	.	.	O	.	_	0	SENT_1026	[p28l40t608r176b688],

1	List	NN	O	list	nn	2	SENT_1027	[p28l293t604r466b688],
2	AF	NN	O	af	_	0	SENT_1027	[p28l535t608r701b702],
3	,	,	O	,	_	0	SENT_1027	[p28l535t608r701b702],
4	Spier	NN	PERSON	spier	nn	5	SENT_1027	[p28l773t604r1016b712],
5	C	NN	O	c	appos	2	SENT_1027	[p28l1081t604r1178b702],
6	,	,	O	,	_	0	SENT_1027	[p28l1081t604r1178b702],
7	Greer	NNP	PERSON	Greer	nn	8	SENT_1027	[p28l1247t604r1510b685],
8	J	NNP	PERSON	J	appos	2	SENT_1027	[p28l1572t604r1642b698],
9	,	,	O	,	_	0	SENT_1027	[p28l1572t604r1642b698],
10	Wolff	NNP	PERSON	Wolff	nn	11	SENT_1027	[p28l1710t601r1991b685],
11	S	NNP	O	S	appos	2	SENT_1027	[p28l2049t601r2139b698],
12	,	,	O	,	_	0	SENT_1027	[p28l2049t601r2139b698],
13	I	PRP	O	I	appos	2	SENT_1027	[p28l293t724r584b808],
14	-	:	O	-	_	0	SENT_1027	[p28l293t724r584b808],
15	[	NN	O	[	nn	17	SENT_1027	[p28l293t724r584b808],
16	utter	JJ	O	utter	amod	17	SENT_1027	[p28l293t724r584b808],
17	J	NN	O	j	dep	2	SENT_1027	[p28l625t724r691b818],
18	,	,	O	,	_	0	SENT_1027	[p28l625t724r691b818],
19	et	FW	O	et	nn	20	SENT_1027	[p28l742t738r822b804],
20	al.	FW	O	al.	appos	17	SENT_1027	[p28l867t724r971b804],
21	1993	CD	DATE	1993	dep	20	SENT_1027	[p28l1033t721r1268b808],
22	.	.	O	.	_	0	SENT_1027	[p28l1033t721r1268b808],

1	Phase	NN	O	phase	nn	3	SENT_1028	[p28l1320t721r1590b804],
2	I/II	NN	O	i/ii	nn	3	SENT_1028	[p28l1631t721r1776b804],
3	trial	NN	O	trial	_	0	SENT_1028	[p28l1817t721r2005b801],
4	of	IN	O	of	_	0	SENT_1028	[p28l2046t721r2146b801],
5	cyclosporine	NN	O	cyclosporine	prep_of	3	SENT_1028	[p28l293t836r874b944],
6	as	IN	O	as	_	0	SENT_1028	[p28l939t861r1030b920],
7	a	DT	O	a	det	9	SENT_1028	[p28l1091t860r1140b920],
8	chemotherapyresistance	NN	O	chemotherapyresistance	nn	9	SENT_1028	[p28l1202t833r2139b941, p28l293t966r528b1035],
9	modiﬁer	NN	O	modiﬁer	prep_as	3	SENT_1028	[p28l604t952r999b1035],
10	in	IN	O	in	_	0	SENT_1028	[p28l1071t952r1154b1035],
11	acute	JJ	O	acute	amod	12	SENT_1028	[p28l1230t966r1469b1035],
12	leukemia	NN	O	leukemia	prep_in	3	SENT_1028	[p28l1544t949r1987b1032],
13	.	.	O	.	_	0	SENT_1028	[p28l1544t949r1987b1032],

1	J.	NNP	O	J.	_	0	SENT_1029	[p28l2059t952r2129b1032],

1	Clin	NNP	O	Clin	_	0	SENT_1030	[p28l296t1067r504b1150],
2	.	.	O	.	_	0	SENT_1030	[p28l296t1067r504b1150],

1	Oncol	NN	O	oncol	_	0	SENT_1031	[p28l566t1067r860b1147],
2	.	.	O	.	_	0	SENT_1031	[p28l566t1067r860b1147],

1	ll	NN	O	ll	_	0	SENT_1032	[p28l925t1064r1465b1147],
2	:16	CD	NUMBER	:16	num	3	SENT_1032	[p28l925t1064r1465b1147],
3	S2	NN	O	s2	dep	1	SENT_1032	[p28l925t1064r1465b1147],
4	—	CD	NUMBER	—	number	5	SENT_1032	[p28l925t1064r1465b1147],
5	60	CD	NUMBER	60	dep	3	SENT_1032	[p28l925t1064r1465b1147],

1	96	CD	NUMBER	96	_	0	SENT_1033	[p28l44t1180r179b1267],
2	.	.	O	.	_	0	SENT_1033	[p28l44t1180r179b1267],

1	Erlichman	NN	PERSON	erlichman	nn	2	SENT_1034	[p28l293t1180r767b1263],
2	C	NN	O	c	_	0	SENT_1034	[p28l829t1180r929b1277],
3	,	,	O	,	_	0	SENT_1034	[p28l829t1180r929b1277],
4	Moore	NNP	PERSON	Moore	nn	5	SENT_1034	[p28l998t1184r1303b1263],
5	M	NNP	O	M	appos	2	SENT_1034	[p28l1364t1180r1489b1277],
6	,	,	O	,	_	0	SENT_1034	[p28l1364t1180r1489b1277],
7	Thiessen	NNP	PERSON	Thiessen	nn	8	SENT_1034	[p28l1555t1177r1967b1263],
8	JJ	NN	PERSON	jj	appos	2	SENT_1034	[p28l2025t1180r2139b1274],
9	,	,	O	,	_	0	SENT_1034	[p28l2025t1180r2139b1274],
10	Kerr	NNP	PERSON	Kerr	nn	11	SENT_1034	[p28l296t1297r504b1382],
11	IG	NNP	O	IG	appos	2	SENT_1034	[p28l549t1294r691b1396],
12	,	,	O	,	_	0	SENT_1034	[p28l549t1294r691b1396],
13	Walker	NNP	PERSON	Walker	nn	14	SENT_1034	[p28l746t1294r1088b1382],
14	S	NNP	O	S	appos	2	SENT_1034	[p28l1140t1294r1220b1396],
15	,	,	O	,	_	0	SENT_1034	[p28l1140t1294r1220b1396],
16	et	FW	O	et	nn	17	SENT_1034	[p28l1275t1308r1358b1379],
17	al.	FW	O	al.	appos	2	SENT_1034	[p28l1409t1294r1510b1379],
18	1993	CD	DATE	1993	dep	17	SENT_1034	[p28l1579t1294r1818b1382],
19	.	.	O	.	_	0	SENT_1034	[p28l1579t1294r1818b1382],

1	Phase	NN	O	phase	npadvmod	3	SENT_1035	[p28l1876t1294r2139b1379],
2	I	CD	NUMBER	i	num	1	SENT_1035	[p28l293t1414r328b1498],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_1035	[p28l372t1411r1133b1522],
4	study	NN	O	study	nsubj	8	SENT_1035	[p28l1181t1411r1424b1519],
5	of	IN	O	of	_	0	SENT_1035	[p28l1472t1411r1569b1495],
6	cyclosporin	NN	O	cyclosporin	nn	7	SENT_1035	[p28l1606t1411r2143b1519],
7	A	NN	O	a	prep_of	4	SENT_1035	[p28l293t1534r373b1613],
8	combined	VBN	O	combine	_	0	SENT_1035	[p28l417t1530r871b1613],
9	with	IN	O	with	_	0	SENT_1035	[p28l922t1530r1126b1613],
10	doxorubicin	NN	O	doxorubicin	prep_with	8	SENT_1035	[p28l1174t1527r1752b1613],
11	.	.	O	.	_	0	SENT_1035	[p28l1174t1527r1752b1613],

1	Cancer	NN	O	cancer	_	0	SENT_1036	[p28l1810t1527r2146b1610],

1	Res	NNP	O	Res	_	0	SENT_1037	[p28l289t1645r473b1728],
2	.	.	O	.	_	0	SENT_1037	[p28l289t1645r473b1728],

1	53:4837	CD	NUMBER	53:4837	num	2	SENT_1038	[p28l528t1642r1078b1728],
2	-42	CD	NUMBER	-42	_	0	SENT_1038	[p28l528t1642r1078b1728],

1	97	CD	NUMBER	97	_	0	SENT_1039	[p28l44t1761r179b1844],
2	.	.	O	.	_	0	SENT_1039	[p28l44t1761r179b1844],

1	Lum	NNP	PERSON	Lum	nn	2	SENT_1040	[p28l293t1761r508b1844],
2	BL	NN	O	bl	_	0	SENT_1040	[p28l569t1761r739b1858],
3	,	,	O	,	_	0	SENT_1040	[p28l569t1761r739b1858],
4	Kauhisch	NNP	PERSON	Kauhisch	nn	5	SENT_1040	[p28l808t1758r1240b1844],
5	S	NNP	PERSON	S	appos	2	SENT_1040	[p28l1306t1758r1389b1858],
6	,	,	O	,	_	0	SENT_1040	[p28l1306t1758r1389b1858],
7	Yahanda	NNP	ORGANIZATION	Yahanda	nn	8	SENT_1040	[p28l1458t1758r1866b1844],
8	AM	NNP	ORGANIZATION	AM	appos	2	SENT_1040	[p28l1932t1758r2139b1858],
9	,	,	O	,	_	0	SENT_1040	[p28l1932t1758r2139b1858],
10	Adler	NNP	PERSON	Adler	nn	11	SENT_1040	[p28l296t1874r552b1957],
11	KM	NNP	O	KM	appos	2	SENT_1040	[p28l628t1877r833b1971],
12	,	,	O	,	_	0	SENT_1040	[p28l628t1877r833b1971],
13	Jew	NNP	O	Jew	nn	14	SENT_1040	[p28l905t1877r1085b1957],
14	L	NNP	O	L	appos	2	SENT_1040	[p28l1161t1877r1251b1971],
15	,	,	O	,	_	0	SENT_1040	[p28l1161t1877r1251b1971],
16	et	FW	O	et	nn	17	SENT_1040	[p28l1323t1888r1410b1957],
17	al.	FW	O	al.	appos	2	SENT_1040	[p28l1479t1874r1583b1957],
18	1992	CD	DATE	1992	dep	17	SENT_1040	[p28l1676t1874r1915b1957],
19	.	.	O	.	_	0	SENT_1040	[p28l1676t1874r1915b1957],

1	Alteration	NN	O	alteration	nsubj	17	SENT_1041	[p28l1994t1874r2139b1957, p28l293t1990r642b2077],
2	of	IN	O	of	_	0	SENT_1041	[p28l721t1990r826b2073],
3	etoposide	NN	O	etoposide	nn	4	SENT_1041	[p28l901t1990r1341b2097],
4	pharmacokinet	NN	O	pharmacokinet	prep_of	1	SENT_1041	[p28l1420t1990r2139b2097],
5	—	CD	NUMBER	—	num	6	SENT_1041	[p28l1420t1990r2139b2097],
6	ics	NNS	O	ic	dep	4	SENT_1041	[p28l296t2108r418b2192],
7	and	CC	O	and	_	0	SENT_1041	[p28l483t2108r653b2192],
8	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	4	SENT_1041	[p28l718t2105r1607b2216],
9	by	IN	O	by	_	0	SENT_1041	[p28l1676t2105r1787b2213],
10	cyclo	NN	O	cyclo	nn	12	SENT_1041	[p28l1855t2105r2143b2213],
11	~	NN	O	~	nn	12	SENT_1041	[p28l1855t2105r2143b2213],
12	sporine	NN	O	sporine	prep_by	8	SENT_1041	[p28l296t2224r625b2332],
13	in	IN	O	in	_	0	SENT_1041	[p28l683t2224r770b2305],
14	a	DT	O	a	det	15	SENT_1041	[p28l825t2249r874b2308],
15	phase	NN	O	phase	prep_in	12	SENT_1041	[p28l929t2224r1189b2332],
16	I	PRP	O	I	dep	15	SENT_1041	[p28l1247t2224r1282b2304],
17	trial	NN	O	trial	_	0	SENT_1041	[p28l1337t2224r1517b2305],
18	to	TO	O	to	aux	19	SENT_1041	[p28l1572t2238r1659b2304],
19	modulate	VB	O	modulate	xcomp	17	SENT_1041	[p28l1717t2221r2143b2305],
20	multidrug	JJ	O	multidrug	amod	21	SENT_1041	[p28l296t2341r746b2448],
21	resistance	NN	O	resistance	dobj	19	SENT_1041	[p28l822t2341r1292b2424],
22	.	.	O	.	_	0	SENT_1041	[p28l822t2341r1292b2424],

1	J.	NNP	PERSON	J.	nn	2	SENT_1042	[p28l1375t2337r1444b2421],
2	Clin	NNP	PERSON	Clin	_	0	SENT_1042	[p28l1534t2334r1749b2421],
3	.	.	O	.	_	0	SENT_1042	[p28l1534t2334r1749b2421],

1	Oncot	NN	O	oncot	_	0	SENT_1043	[p28l1838t2334r2133b2421],
2	.	.	O	.	_	0	SENT_1043	[p28l1838t2334r2133b2421],

1	10:1635	CD	NUMBER	10:1635	num	2	SENT_1044	[p28l307t2453r836b2539],
2	-42	CD	NUMBER	-42	_	0	SENT_1044	[p28l307t2453r836b2539],

1	98	CD	NUMBER	98	_	0	SENT_1045	[p28l47t2572r183b2659],
2	.	.	O	.	_	0	SENT_1045	[p28l47t2572r183b2659],

1	Yuen	NNP	PERSON	Yuen	nn	2	SENT_1046	[p28l296t2575r539b2655],
2	AR	NNS	O	ar	_	0	SENT_1046	[p28l604t2575r784b2669],
3	,	,	O	,	_	0	SENT_1046	[p28l604t2575r784b2669],
4	Sikic	JJ	O	sikic	amod	5	SENT_1046	[p28l856t2572r1088b2655],
5	BI	NN	O	bus	appos	2	SENT_1046	[p28l1154t2572r1289b2655],
6	.	.	O	.	_	0	SENT_1046	[p28l1154t2572r1289b2655],

1	1994	CD	DATE	1994	_	0	SENT_1047	[p28l1368t2572r1610b2655],
2	.	.	O	.	_	0	SENT_1047	[p28l1368t2572r1610b2655],

1	Multidrug	JJ	O	multidrug	amod	2	SENT_1048	[p28l1679t2572r2146b2676],
2	resistance	NN	O	resistance	_	0	SENT_1048	[p28l296t2688r746b2768],
3	in	IN	O	in	_	0	SENT_1048	[p28l777t2685r860b2768],
4	lymphomas	NNS	O	lymphoma	prep_in	2	SENT_1048	[p28l891t2688r1444b2792],
5	.	.	O	.	_	0	SENT_1048	[p28l891t2688r1444b2792],

1	J’	NN	O	j’	_	0	SENT_1049	[p28l1472t2688r1545b2768],
2	.	.	O	.	_	0	SENT_1049	[p28l1472t2688r1545b2768],

1	Clin	NNP	O	Clin	_	0	SENT_1050	[p28l1586t2685r1797b2768],
2	.	.	O	.	_	0	SENT_1050	[p28l1586t2685r1797b2768],

1	Oncol	NN	O	oncol	_	0	SENT_1051	[p28l1842t2685r2132b2768],
2	.	.	O	.	_	0	SENT_1051	[p28l1842t2685r2132b2768],

1	l2	NN	O	l2	_	0	SENT_1052	[p28l307t2800r839b2886],
2	:2453	CD	NUMBER	:2453	number	3	SENT_1052	[p28l307t2800r839b2886],
3	—	CD	NUMBER	—	dep	1	SENT_1052	[p28l307t2800r839b2886],
4	59	CD	NUMBER	59	dep	3	SENT_1052	[p28l307t2800r839b2886],

1	99	CD	NUMBER	99	_	0	SENT_1053	[p28l47t2919r183b3006],
2	.	.	O	.	_	0	SENT_1053	[p28l47t2919r183b3006],

1	Beck	NNP	PERSON	Beck	nn	2	SENT_1054	[p28l296t2919r528b3002],
2	WT	NNP	O	WT	_	0	SENT_1054	[p28l562t2919r763b3016],
3	,	,	O	,	_	0	SENT_1054	[p28l562t2919r763b3016],
4	Cirtain	NNP	O	Cirtain	nn	5	SENT_1054	[p28l801t2916r1116b3002],
5	MC	NNP	O	MC	appos	2	SENT_1054	[p28l1150t2916r1355b3016],
6	,	,	O	,	_	0	SENT_1054	[p28l1150t2916r1355b3016],
7	Danks	NNP	PERSON	Danks	nn	8	SENT_1054	[p28l1392t2916r1683b3002],
8	MK	NNP	O	MK	appos	2	SENT_1054	[p28l1714t2916r1925b3016],
9	,	,	O	,	_	0	SENT_1054	[p28l1714t2916r1925b3016],
10	Felsted	NNP	ORGANIZATION	Felsted	nn	11	SENT_1054	[p28l1963t2916r2143b3002, p28l300t3032r480b3115],
11	RL	NNP	ORGANIZATION	RL	appos	2	SENT_1054	[p28l517t3032r687b3129],
12	,	,	O	,	_	0	SENT_1054	[p28l517t3032r687b3129],
13	Safa	NNP	O	Safa	nn	14	SENT_1054	[p28l732t3032r933b3115],
14	AR	NNS	O	ar	appos	2	SENT_1054	[p28l970t3032r1151b3129],
15	,	,	O	,	_	0	SENT_1054	[p28l970t3032r1151b3129],
16	et	FW	O	et	nn	17	SENT_1054	[p28l1195t3046r1275b3115],
17	al.	FW	O	al.	appos	2	SENT_1054	[p28l1316t3032r1417b3115],
18	1987	CD	DATE	1987	dep	17	SENT_1054	[p28l1472t3029r1714b3115],
19	.	.	O	.	_	0	SENT_1054	[p28l1472t3029r1714b3115],

1	Pharmacological	JJ	O	pharmacological	_	0	SENT_1055	[p28l1759t3029r2143b3115, p28l296t3151r739b3258],
2	,	,	O	,	_	0	SENT_1055	[p28l1759t3029r2143b3115, p28l296t3151r739b3258],
3	molecular	JJ	O	molecular	conj_and	1	SENT_1055	[p28l818t3151r1299b3248],
4	,	,	O	,	_	0	SENT_1055	[p28l818t3151r1299b3248],
5	and	CC	O	and	_	0	SENT_1055	[p28l1378t3151r1545b3234],
6	cytogenetic	JJ	O	cytogenetic	amod	7	SENT_1055	[p28l1613t3151r2143b3258],
7	analysis	NN	O	analysis	conj_and	1	SENT_1055	[p28l296t3264r663b3371],
8	of	IN	O	of	_	0	SENT_1055	[p28l721t3264r826b3347],
9	“	NN	O	“	prep_of	7	SENT_1055	[p28l880t3264r1344b3371],
10	atypical	JJ	O	atypical	amod	11	SENT_1055	[p28l880t3264r1344b3371],
11	”	NN	O	”	dep	1	SENT_1055	[p28l880t3264r1344b3371],
12	multidrugresistant	JJ	O	multidrugresistant	amod	15	SENT_1055	[p28l1406t3264r2143b3371, p28l300t3393r466b3466],
13	human	JJ	O	human	amod	15	SENT_1055	[p28l500t3379r812b3466],
14	leukemic	JJ	O	leukemic	amod	15	SENT_1055	[p28l849t3379r1268b3463],
15	cells	NNS	O	cell	dep	11	SENT_1055	[p28l1302t3379r1534b3466],
16	.	.	O	.	_	0	SENT_1055	[p28l1302t3379r1534b3466],

1	Cancer	NN	O	cancer	nsubj	2	SENT_1056	[p28l1582t3376r1925b3463],
2	Res	NNP	O	Res	_	0	SENT_1056	[p28l1952t3376r2136b3463],
3	.	.	O	.	_	0	SENT_1056	[p28l1952t3376r2136b3463],
4	'	''	O	'	_	0	SENT_1056	[p29l65t1969r217b2209],

1	1	CD	NUMBER	1	_	0	SENT_1057	[p29l65t1969r217b2209],
2	ii	LS	O	ii	dep	1	SENT_1057	[p29l65t2062r192b2209],

1	Danks	NNP	PERSON	Danks	nn	2	SENT_1058	[p29l300t25r587b108],
2	MK	NNP	O	MK	_	0	SENT_1058	[p29l652t25r857b122],
3	,	,	O	,	_	0	SENT_1058	[p29l652t25r857b122],
4	Yalowich	NNP	ORGANIZATION	Yalowich	nn	5	SENT_1058	[p29l925t22r1368b108],
5	JC	NNP	ORGANIZATION	JC	appos	2	SENT_1058	[p29l1430t22r1576b119],
6	,	,	O	,	_	0	SENT_1058	[p29l1430t22r1576b119],
7	Beck	NNP	PERSON	Beck	nn	8	SENT_1058	[p29l1645t22r1884b105],
8	WT	NNP	O	WT	appos	5	SENT_1058	[p29l1942t25r2139b105],
9	.	.	O	.	_	0	SENT_1058	[p29l1942t25r2139b105],

1	1987	CD	DATE	1987	_	0	SENT_1059	[p29l310t138r546b225],
2	.	.	O	.	_	0	SENT_1059	[p29l310t138r546b225],

1	Atypical	JJ	O	atypical	amod	4	SENT_1060	[p29l590t138r985b245],
2	multiple	JJ	O	multiple	amod	4	SENT_1060	[p29l1029t138r1406b245],
3	drug	NN	O	drug	nn	4	SENT_1060	[p29l1447t138r1659b245],
4	resistance	NN	O	resistance	nsubj	11	SENT_1060	[p29l1696t138r2143b221],
5	in	IN	O	in	_	0	SENT_1060	[p29l300t256r383b339],
6	a	DT	O	a	det	10	SENT_1060	[p29l431t280r480b339],
7	human	JJ	O	human	amod	10	SENT_1060	[p29l524t256r833b339],
8	leukemic	JJ	O	leukemic	amod	10	SENT_1060	[p29l884t253r1299b339],
9	cell	NN	O	cell	nn	10	SENT_1060	[p29l1351t253r1510b339],
10	line	NN	O	line	prep_in	4	SENT_1060	[p29l1562t253r1731b339],
11	selected	VBN	O	select	_	0	SENT_1060	[p29l1779t253r2150b339],
12	for	IN	O	for	_	0	SENT_1060	[p29l300t368r428b455],
13	resistance	NN	O	resistance	prep_for	11	SENT_1060	[p29l493t368r947b452],
14	to	TO	O	to	_	0	SENT_1060	[p29l1015t382r1099b452],
15	teniposide	NN	O	teniposide	nn	18	SENT_1060	[p29l1167t365r1638b476],
16	(	CD	NUMBER	(	num	18	SENT_1060	[p29l1707t368r2143b469],
17	VM-26	NN	O	vm-26	nn	18	SENT_1060	[p29l1707t368r2143b469],
18	)	NN	O	)	prep_to	11	SENT_1060	[p29l1707t368r2143b469],
19	.	.	O	.	_	0	SENT_1060	[p29l1707t368r2143b469],

1	Cancer	NN	O	cancer	_	0	SENT_1061	[p29l303t487r635b570],
2	Res	NNP	O	Res	dep	1	SENT_1061	[p29l676t487r860b567],
3	.	.	O	.	_	0	SENT_1061	[p29l676t487r860b567],

1	47	CD	NUMBER	47	_	0	SENT_1062	[p29l912t487r1054b567],
2	:	:	O	:	_	0	SENT_1062	[p29l912t487r1054b567],
3	1297-301	CD	NUMBER	1297-301	num	4	SENT_1062	[p29l1078t484r1514b570],
4	Danks	NNPS	ORGANIZATION	Danks	dep	1	SENT_1062	[p29l300t603r587b686],
5	MK	NNP	ORGANIZATION	MK	dep	1	SENT_1062	[p29l704t606r912b700],
6	,	,	O	,	_	0	SENT_1062	[p29l704t606r912b700],
7	Schmidt	NNP	PERSON	Schmidt	nn	8	SENT_1062	[p29l1033t603r1413b686],
8	CA	NNP	O	CA	appos	1	SENT_1062	[p29l1530t603r1711b700],
9	,	,	O	,	_	0	SENT_1062	[p29l1530t603r1711b700],
10	Cirtain	NNP	O	Cirtain	nn	11	SENT_1062	[p29l1831t603r2150b686],
11	MC	NNP	O	MC	appos	1	SENT_1062	[p29l300t719r497b813],
12	,	,	O	,	_	0	SENT_1062	[p29l300t719r497b813],
13	Suttle	NNP	PERSON	Suttle	nn	14	SENT_1062	[p29l604t719r871b802],
14	DP	NN	O	dp	appos	1	SENT_1062	[p29l974t719r1147b816],
15	,	,	O	,	_	0	SENT_1062	[p29l974t719r1147b816],
16	Beck	NNP	PERSON	Beck	nn	17	SENT_1062	[p29l1247t719r1486b799],
17	WT	NNP	O	WT	appos	1	SENT_1062	[p29l1586t719r1783b799],
18	.	.	O	.	_	0	SENT_1062	[p29l1586t719r1783b799],

1	1988	CD	DATE	1988	_	0	SENT_1063	[p29l1907t716r2143b802],
2	.	.	O	.	_	0	SENT_1063	[p29l1907t716r2143b802],

1	Altered	JJ	O	altered	amod	3	SENT_1064	[p29l300t835r642b918],
2	catalytic	JJ	O	catalytic	amod	3	SENT_1064	[p29l694t835r1081b942],
3	activity	NN	O	activity	nsubj	16	SENT_1064	[p29l1136t835r1479b939],
4	of	IN	O	of	prep	3	SENT_1064	[p29l1537t835r1638b918],
5	and	CC	O	and	_	0	SENT_1064	[p29l1686t835r1849b918],
6	DNA	NN	O	dna	nn	7	SENT_1064	[p29l1900t835r2150b915],
7	cleavage	NN	O	cleavage	nsubj	16	SENT_1064	[p29l300t947r698b1055],
8	by	IN	O	by	_	0	SENT_1064	[p29l787t947r898b1055],
9	DNA	NN	MISC	dna	nn	10	SENT_1064	[p29l988t947r1234b1031],
10	topoisomerase	NN	O	topoisomerase	prep_by	7	SENT_1064	[p29l1326t944r1987b1055],
11	II	CD	NUMBER	ii	num	10	SENT_1064	[p29l2077t947r2150b1031],
12	from	IN	O	from	_	0	SENT_1064	[p29l300t1064r518b1147],
13	human	JJ	O	human	amod	15	SENT_1064	[p29l597t1064r912b1147],
14	leukemic	JJ	O	leukemic	amod	15	SENT_1064	[p29l991t1064r1406b1147],
15	cells	NNS	O	cell	prep_from	7	SENT_1064	[p29l1489t1064r1697b1147],
16	selected	VBN	O	select	_	0	SENT_1064	[p29l1783t1064r2153b1147],
17	for	IN	O	for	_	0	SENT_1064	[p29l300t1179r432b1262],
18	resistance	NN	O	resistance	prep_for	16	SENT_1064	[p29l504t1179r954b1265],
19	to	TO	O	to	_	0	SENT_1064	[p29l1029t1196r1119b1262],
20	VM-26	NNP	O	VM-26	prep_to	16	SENT_1064	[p29l1195t1179r1552b1262],
21	.	.	O	.	_	0	SENT_1064	[p29l1195t1179r1552b1262],

1	Biochemistry	NNP	O	Biochemistry	nn	6	SENT_1065	[p29l1631t1179r2146b1262, p29l303t1312r425b1402],
2	27:8861	CD	NUMBER	27:8861	num	6	SENT_1065	[p29l504t1295r1054b1378],
3	—	CD	NUMBER	—	num	6	SENT_1065	[p29l504t1295r1054b1378],
4	69	CD	NUMBER	69	num	6	SENT_1065	[p29l504t1295r1054b1378],
5	Fernandes	NNP	ORGANIZATION	Fernandes	nn	6	SENT_1065	[p29l300t1414r767b1497],
6	DJ	NNP	ORGANIZATION	DJ	_	0	SENT_1065	[p29l825t1414r974b1511],
7	,	,	O	,	_	0	SENT_1065	[p29l825t1414r974b1511],
8	Danks	NNP	PERSON	Danks	nn	9	SENT_1065	[p29l1039t1414r1330b1497],
9	MK	NNP	O	MK	appos	6	SENT_1065	[p29l1385t1414r1593b1511],
10	,	,	O	,	_	0	SENT_1065	[p29l1385t1414r1593b1511],
11	Beck	NNP	PERSON	Beck	nn	12	SENT_1065	[p29l1655t1414r1894b1494],
12	WT	NNP	O	WT	appos	9	SENT_1065	[p29l1945t1414r2146b1494],
13	.	.	O	.	_	0	SENT_1065	[p29l1945t1414r2146b1494],

1	1990	CD	DATE	1990	_	0	SENT_1066	[p29l313t1526r549b1613],
2	.	.	O	.	_	0	SENT_1066	[p29l313t1526r549b1613],

1	Decreased	VBN	O	decrease	_	0	SENT_1067	[p29l614t1526r1095b1613],
2	nuclear	JJ	O	nuclear	amod	5	SENT_1067	[p29l1150t1526r1489b1610],
3	matrix	NN	O	matrix	nn	5	SENT_1067	[p29l1548t1523r1846b1610],
4	DNA	NN	MISC	dna	nn	5	SENT_1067	[p29l1904t1526r2150b1610],
5	topoisomerase	NN	O	topoisomerase	dobj	1	SENT_1067	[p29l300t1645r960b1753],
6	II	CD	NUMBER	ii	num	5	SENT_1067	[p29l1033t1645r1109b1725],
7	in	IN	O	in	_	0	SENT_1067	[p29l1185t1645r1268b1726],
8	human	JJ	O	human	amod	9	SENT_1067	[p29l1344t1645r1659b1726],
9	leukemia	NN	O	leukemia	prep_in	1	SENT_1067	[p29l1731t1642r2153b1726],

1	Annual	JJ	SET	annual	amod	2	SENT_1068	[p29l260t1983r602b2065],
2	Reviews	NNS	O	review	nsubj	3	SENT_1068	[p29l635t1983r1034b2089],
3	_	VBP	O	_	_	0	SENT_1068	[p29l1689t2077r1702b2089],
4	WWW	NNP	O	WWW	dobj	3	SENT_1068	[p29l261t2077r1822b2184],
5	.	.	O	.	_	0	SENT_1068	[p29l261t2077r1822b2184],

1	annualreV1ews	NNS	O	annualrev1ew	_	0	SENT_1069	[p29l261t2077r1822b2184],
2	.0	CD	NUMBER	.0	num	3	SENT_1069	[p29l261t2077r1822b2184],
3	rg/aronhne	NN	O	rg/aronhne	dep	1	SENT_1069	[p29l261t2077r1822b2184],

1	1	CD	NUMBER	1	number	2	SENT_1070	[p29l385t2334r416b2407],
2	82	CD	NUMBER	82	num	3	SENT_1070	[p29l433t2334r532b2410],
3	BELLAMY	NN	O	bellamy	_	0	SENT_1070	[p29l729t2334r1240b2407],

1	cells	NNS	O	cell	dep	2	SENT_1071	[p29l636t2576r806b2644],
2	resistant	JJ	O	resistant	_	0	SENT_1071	[p29l836t2576r1147b2644],
3	to	TO	O	to	_	0	SENT_1071	[p29l1177t2587r1248b2644],
4	VM-26	NN	O	vm-26	prep_to	2	SENT_1071	[p29l1276t2576r1550b2644],
5	and	CC	O	and	_	0	SENT_1071	[p29l1583t2576r1716b2644],
6	In-AMSA	NN	O	in-amsa	prep_to	2	SENT_1071	[p29l1744t2576r2134b2644],
7	.	.	O	.	_	0	SENT_1071	[p29l1744t2576r2134b2644],

1	Biochemistry	NNP	O	Biochemistry	_	0	SENT_1072	[p29l633t2670r1133b2757],
2	29:4235	CD	NUMBER	29:4235	number	3	SENT_1072	[p29l1166t2667r1601b2738],
3	—	CD	NUMBER	—	dep	1	SENT_1072	[p29l1166t2667r1601b2738],
4	4l	NN	O	4l	dep	3	SENT_1072	[p29l1166t2667r1601b2738],

1	103	CD	NUMBER	103	_	0	SENT_1073	[p29l396t2763r543b2833],
2	.	.	O	.	_	0	SENT_1073	[p29l396t2763r543b2833],

1	Cole	NNP	O	Cole	nn	2	SENT_1074	[p29l636t2763r811b2831],
2	SP	NN	O	sp	dep	18	SENT_1074	[p29l878t2763r1000b2845],
3	,	,	O	,	_	0	SENT_1074	[p29l878t2763r1000b2845],
4	Bhardwaj	NNP	PERSON	Bhardwaj	nn	5	SENT_1074	[p29l1070t2763r1429b2850],
5	G	NNP	PERSON	G	appos	2	SENT_1074	[p29l1501t2763r1587b2842],
6	,	,	O	,	_	0	SENT_1074	[p29l1501t2763r1587b2842],
7	Gerlach	NNP	PERSON	Gerlach	nn	8	SENT_1074	[p29l1657t2763r1947b2831],
8	JH	NNP	O	JH	appos	2	SENT_1074	[p29l2012t2763r2136b2845],
9	,	,	O	,	_	0	SENT_1074	[p29l2012t2763r2136b2845],
10	Mackie	NNP	PERSON	Mackie	nn	11	SENT_1074	[p29l636t2860r918b2928],
11	JE	NNP	O	JE	appos	2	SENT_1074	[p29l940t2860r1056b2939],
12	,	,	O	,	_	0	SENT_1074	[p29l940t2860r1056b2939],
13	Grant	NNP	PERSON	Grant	nn	14	SENT_1074	[p29l1084t2860r1293b2928],
14	CE	NNP	O	CE	appos	2	SENT_1074	[p29l1318t2860r1457b2936],
15	,	,	O	,	_	0	SENT_1074	[p29l1318t2860r1457b2936],
16	et	FW	O	et	appos	2	SENT_1074	[p29l1485t2871r1550b2925],
17	al.	FW	O	al.	nn	18	SENT_1074	[p29l1578t2860r1674b2939],
18	_	FW	O	_	_	0	SENT_1074	[p29l1578t2860r1674b2939],
19	1992	CD	DATE	1992	dep	18	SENT_1074	[p29l1702t2860r1891b2928],
20	.	.	O	.	_	0	SENT_1074	[p29l1702t2860r1891b2928],

1	Overexpression	NN	O	overexpression	_	0	SENT_1075	[p29l1924t2860r2136b2928, p29l636t2953r1037b3037],
2	of	IN	O	of	_	0	SENT_1075	[p29l1084t2950r1166b3020],
3	a	DT	O	a	det	5	SENT_1075	[p29l1214t2972r1254b3018],
4	transporter	NN	O	transporter	nn	5	SENT_1075	[p29l1304t2964r1708b3037],
5	gene	NN	O	gene	prep_of	1	SENT_1075	[p29l1755t2972r1928b3037],
6	in	IN	O	in	_	0	SENT_1075	[p29l1981t2953r2052b3018],
7	a	DT	O	a	det	13	SENT_1075	[p29l2099t2975r2139b3020],
8	multidrug-resistant	JJ	O	multidrug-resistant	amod	13	SENT_1075	[p29l636t3043r1347b3130],
9	human	JJ	O	human	amod	13	SENT_1075	[p29l1392t3043r1643b3111],
10	lung	NN	O	lung	nn	13	SENT_1075	[p29l1690t3043r1852b3130],
11	cancer	NN	O	cancer	nn	13	SENT_1075	[p29l1899t3062r2142b3111],
12	cell	NN	O	cell	nn	13	SENT_1075	[p29l636t3136r769b3204],
13	line	NN	O	line	prep_in	1	SENT_1075	[p29l808t3136r966b3204],
14	.	.	O	.	_	0	SENT_1075	[p29l808t3136r966b3204],

1	Science	NNP	O	Science	_	0	SENT_1076	[p29l1008t3139r1290b3204],
2	258	CD	NUMBER	258	num	1	SENT_1076	[p29l1332t3136r1818b3204],
3	:	:	O	:	_	0	SENT_1076	[p29l1332t3136r1818b3204],
4	l650	CD	NUMBER	l650	dep	1	SENT_1076	[p29l1332t3136r1818b3204],
5	—	CD	NUMBER	—	number	6	SENT_1076	[p29l1332t3136r1818b3204],
6	54	CD	NUMBER	54	dep	4	SENT_1076	[p29l1332t3136r1818b3204],

1	104	CD	NUMBER	104	_	0	SENT_1077	[p29l396t3230r543b3298],
2	.	.	O	.	_	0	SENT_1077	[p29l396t3230r543b3298],

1	Krishnamachary	JJ	O	krishnamachary	amod	2	SENT_1078	[p29l639t3230r1254b3317],
2	N	NN	O	n	_	0	SENT_1078	[p29l1301t3233r1386b3309],
3	,	,	O	,	_	0	SENT_1078	[p29l1301t3233r1386b3309],
4	Center	NNP	O	Center	nn	5	SENT_1078	[p29l1437t3230r1688b3298],
5	MS.	NNP	O	MS.	appos	2	SENT_1078	[p29l1730t3233r1883b3298],
6	1993	CD	DATE	1993	dep	5	SENT_1078	[p29l1941t3230r2136b3300],
7	.	.	O	.	_	0	SENT_1078	[p29l1941t3230r2136b3300],

1	The	DT	O	the	det	3	SENT_1079	[p29l636t3323r783b3391],
2	MRP	NN	ORGANIZATION	mrp	nn	3	SENT_1079	[p29l819t3326r1017b3391],
3	gene	NN	O	gene	nsubj	10	SENT_1079	[p29l1053t3345r1228b3410],
4	associated	VBN	O	associate	partmod	3	SENT_1079	[p29l1270t3323r1651b3393],
5	with	IN	O	with	_	0	SENT_1079	[p29l1693t3323r1854b3391],
6	a	DT	O	a	det	9	SENT_1079	[p29l1893t3345r1933b3393],
7	nonP-glycoprotein	JJ	O	nonp-glycoprotein	amod	9	SENT_1079	[p29l1975t3345r2139b3391, p29l636t3416r1192b3503],
8	multidrug	JJ	O	multidrug	amod	9	SENT_1079	[p29l1225t3416r1592b3503],
9	resistance	NN	O	resistance	prep_with	4	SENT_1079	[p29l1628t3416r1990b3484],
10	encodes	VBZ	O	encode	_	0	SENT_1079	[p29l2023t3438r2139b3484, p29l636t3512r848b3580],
11	a	DT	O	a	det	13	SENT_1079	[p29l926t3532r966b3580],
12	190-kDa	JJ	O	190-kda	amod	13	SENT_1079	[p29l1050t3512r1367b3580],
13	membrane	NN	O	membrane	nsubj	14	SENT_1079	[p29l1442t3512r1835b3580],
14	bound	VBD	O	bind	ccomp	10	SENT_1079	[p29l1910t3512r2145b3580],

1	Annu	NNP	PERSON	Annu	_	0	SENT_1080	[p30l6t3389r71b3614],
2	.	.	O	.	_	0	SENT_1080	[p30l6t3389r71b3614],

1	Rev.	NNP	O	Rev.	nn	2	SENT_1081	[p30l7t3190r71b3358],
2	Pharmaeol	NNP	PERSON	Pharmaeol	_	0	SENT_1081	[p30l6t2742r71b3160],
3	.	.	O	.	_	0	SENT_1081	[p30l6t2742r71b3160],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_1082	[p30l6t2402r71b2711],
2	.	.	O	.	_	0	SENT_1082	[p30l6t2402r71b2711],

1	1996.36	CD	NUMBER	1996.36	_	0	SENT_1083	[p30l6t2049r72b2363],
2	:	:	O	:	_	0	SENT_1083	[p30l6t2049r72b2363],
3	161	CD	NUMBER	161	num	5	SENT_1083	[p30l6t1873r72b2031],
4	-	:	O	-	_	0	SENT_1083	[p30l6t1873r72b2031],
5	183	CD	NUMBER	183	dep	1	SENT_1083	[p30l6t1711r72b1858],
6	.	.	O	.	_	0	SENT_1083	[p30l6t1711r72b1858],

1	Downloaded	VBN	O	download	_	0	SENT_1084	[p30l6t1201r72b1679],
2	from	IN	O	from	_	0	SENT_1084	[p30l6t995r71b1176],
3	www	NN	O	www	prep_from	1	SENT_1084	[p30l6t204r72b969],
4	.	.	O	.	_	0	SENT_1084	[p30l6t204r72b969],

1	annualreViews	NNS	O	annualreview	_	0	SENT_1085	[p30l6t204r72b969],
2	.	.	O	.	_	0	SENT_1085	[p30l27t54r91b194],

1	org	NN	O	org	_	0	SENT_1086	[p30l27t54r91b194],
2	by	IN	O	by	_	0	SENT_1086	[p30l100t3142r185b3234],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_1086	[p30l99t2722r185b3116],
4	of	IN	ORGANIZATION	of	_	0	SENT_1086	[p30l99t2613r165b2694],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	7	SENT_1086	[p30l99t2199r166b2595],
6	—	NNP	O	—	nn	7	SENT_1086	[p30l140t2147r146b2171],
7	Madison	NNP	O	Madison	prep_of	1	SENT_1086	[p30l100t1792r165b2119],
8	on	IN	O	on	_	0	SENT_1086	[p30l120t1674r165b1765],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_1086	[p30l99t1298r166b1648],
10	.	.	O	.	_	0	SENT_1086	[p30l99t1298r166b1648],

1	For	IN	O	for	_	0	SENT_1087	[p30l102t1137r165b1268],
2	personal	JJ	O	personal	amod	3	SENT_1087	[p30l100t797r185b1115],
3	use	NN	O	use	pobj	1	SENT_1087	[p30l120t649r165b772],
4	only	RB	O	only	advmod	3	SENT_1087	[p30l100t439r185b621],
5	.	.	O	.	_	0	SENT_1087	[p30l100t439r185b621],

1	Ill.	NNP	LOCATION	Ill.	_	0	SENT_1088	[p30l405t3422r552b3488],
2	.	.	O	.	_	0	SENT_1088	[p30l405t3422r552b3488],

1	glycoprotein	NN	O	glycoprotein	_	0	SENT_1089	[p30l639t21r1130b108],
2	.	.	O	.	_	0	SENT_1089	[p30l639t21r1130b108],

1	Cancer	NN	O	cancer	_	0	SENT_1090	[p30l1183t18r1457b86],
2	Res	NNP	O	Res	dep	1	SENT_1090	[p30l1496t21r1646b86],
3	.	.	O	.	_	0	SENT_1090	[p30l1496t21r1646b86],

1	533658-61	CD	NUMBER	533658-61	_	0	SENT_1091	[p30l1699t21r2136b89],
2	Grant	NNP	O	Grant	nn	3	SENT_1091	[p30l639t114r851b182],
3	CE	NNP	O	CE	dep	1	SENT_1091	[p30l881t114r1023b193],
4	,	,	O	,	_	0	SENT_1091	[p30l881t114r1023b193],
5	Valdimarsson	NNP	PERSON	Valdimarsson	nn	6	SENT_1091	[p30l1059t114r1572b182],
6	G	NNP	PERSON	G	appos	3	SENT_1091	[p30l1611t114r1697b193],
7	,	,	O	,	_	0	SENT_1091	[p30l1611t114r1697b193],
8	Hipfner	NNP	O	Hipfner	nn	9	SENT_1091	[p30l1733t114r2021b201],
9	D	NNP	O	D	appos	3	SENT_1091	[p30l2051t116r2139b193],
10	,	,	O	,	_	0	SENT_1091	[p30l2051t116r2139b193],
11	Almquist	NNP	PERSON	Almquist	nn	12	SENT_1091	[p30l639t207r986b292],
12	KC	NNP	O	KC	appos	3	SENT_1091	[p30l1036t207r1181b286],
13	,	,	O	,	_	0	SENT_1091	[p30l1036t207r1181b286],
14	Cole	NNP	ORGANIZATION	Cole	nn	15	SENT_1091	[p30l1228t207r1403b275],
15	SPC	NNP	ORGANIZATION	SPC	appos	3	SENT_1091	[p30l1451t207r1634b286],
16	,	,	O	,	_	0	SENT_1091	[p30l1451t207r1634b286],
17	Deeley	NNP	PERSON	Deeley	nn	18	SENT_1091	[p30l1685t207r1945b292],
18	RG	NNP	O	RG	appos	3	SENT_1091	[p30l1992t207r2136b275],
19	.	.	O	.	_	0	SENT_1091	[p30l1992t207r2136b275],

1	1994	CD	DATE	1994	_	0	SENT_1092	[p30l647t302r842b371],
2	.	.	O	.	_	0	SENT_1092	[p30l647t302r842b371],

1	Overexpression	NN	O	overexpression	nsubj	6	SENT_1093	[p30l890t300r1474b388],
2	of	IN	O	of	_	0	SENT_1093	[p30l1516t300r1598b368],
3	multidrng	JJ	O	multidrng	amod	5	SENT_1093	[p30l1634t302r1998b388],
4	resistance	NN	O	resistance	nn	5	SENT_1093	[p30l2037t322r2139b368, p30l639t396r1350b464],
5	—	NN	O	—	prep_of	1	SENT_1093	[p30l2037t322r2139b368, p30l639t396r1350b464],
6	associated	VBN	O	associate	_	0	SENT_1093	[p30l2037t322r2139b368, p30l639t396r1350b464],
7	protein	NN	O	protein	nn	10	SENT_1093	[p30l1406t396r1668b483],
8	(	CD	NUMBER	(	num	10	SENT_1093	[p30l1727t395r1981b481],
9	MRP	NN	O	mrp	nn	10	SENT_1093	[p30l1727t395r1981b481],
10	)	NN	O	)	dobj	6	SENT_1093	[p30l1727t395r1981b481],
11	increases	VBZ	O	increase	rcmod	10	SENT_1093	[p30l2040t396r2139b464, p30l639t511r907b560],
12	resistance	NN	O	resistance	dobj	11	SENT_1093	[p30l971t491r1338b560],
13	to	TO	O	to	_	0	SENT_1093	[p30l1403t503r1477b560],
14	natural	JJ	O	natural	amod	16	SENT_1093	[p30l1538t491r1792b560],
15	product	NN	O	product	nn	16	SENT_1093	[p30l1860t491r2145b579],
16	drugs	NNS	O	drug	prep_to	11	SENT_1093	[p30l639t587r862b675],
17	.	.	O	.	_	0	SENT_1093	[p30l639t587r862b675],

1	Cancer	NN	O	cancer	_	0	SENT_1094	[p30l909t590r1183b655],
2	Res	NNP	O	Res	dep	1	SENT_1094	[p30l1217t590r1364b655],
3	.	.	O	.	_	0	SENT_1094	[p30l1217t590r1364b655],

1	54:357	CD	NUMBER	54:357	number	2	SENT_1095	[p30l1411t587r1801b655],
2	—	CD	NUMBER	—	num	3	SENT_1095	[p30l1411t587r1801b655],
3	6l	NN	O	6l	_	0	SENT_1095	[p30l1411t587r1801b655],
4	Kruh	NNP	PERSON	Kruh	nn	5	SENT_1095	[p30l642t683r828b749],
5	GD	NN	MISC	gd	dep	3	SENT_1095	[p30l867t683r1020b760],
6	,	,	O	,	_	0	SENT_1095	[p30l867t683r1020b760],
7	Chan	NNP	O	Chan	nn	8	SENT_1095	[p30l1059t680r1254b749],
8	A	NNP	O	A	appos	5	SENT_1095	[p30l1290t683r1375b760],
9	,	,	O	,	_	0	SENT_1095	[p30l1290t683r1375b760],
10	Myers	NNP	ORGANIZATION	Myers	nn	11	SENT_1095	[p30l1414t683r1651b768],
11	K	NNP	ORGANIZATION	K	appos	5	SENT_1095	[p30l1688t683r1770b760],
12	,	,	O	,	_	0	SENT_1095	[p30l1688t683r1770b760],
13	Gaughan	NNP	PERSON	Gaughan	nn	14	SENT_1095	[p30l1809t680r2145b768],
14	K	NNP	PERSON	K	appos	5	SENT_1095	[p30l642t773r727b853],
15	,	,	O	,	_	0	SENT_1095	[p30l642t773r727b853],
16	Mild	JJ	ORGANIZATION	mild	amod	17	SENT_1095	[p30l757t773r932b842],
17	T	NN	ORGANIZATION	t	appos	5	SENT_1095	[p30l960t776r1040b853],
18	,	,	O	,	_	0	SENT_1095	[p30l960t776r1040b853],
19	Aaronson	NNP	ORGANIZATION	Aaronson	nn	20	SENT_1095	[p30l1070t776r1431b842],
20	SA	NNP	ORGANIZATION	SA	appos	5	SENT_1095	[p30l1456t773r1589b842],
21	.	.	O	.	_	0	SENT_1095	[p30l1456t773r1589b842],

1	1994	CD	DATE	1994	_	0	SENT_1096	[p30l1631t773r1823b842],
2	.	.	O	.	_	0	SENT_1096	[p30l1631t773r1823b842],

1	Expression	NN	O	expression	nsubj	6	SENT_1097	[p30l1851t776r2139b861, p30l642t869r791b940],
2	complementary	JJ	O	complementary	amod	5	SENT_1097	[p30l822t872r1400b960],
3	DNA	NN	O	dna	nn	5	SENT_1097	[p30l1431t872r1632b937],
4	library	NN	O	library	nn	5	SENT_1097	[p30l1659t869r1908b957],
5	transfer	NN	O	transfer	dep	1	SENT_1097	[p30l1933t883r2142b940, p30l639t965r744b1031],
6	establishes	VBZ	O	establish	_	0	SENT_1097	[p30l816t965r1217b1031],
7	mrp	NN	O	mrp	dobj	6	SENT_1097	[p30l1293t985r1440b1050],
8	as	IN	O	as	_	0	SENT_1097	[p30l1516t985r1592b1031],
9	a	DT	O	a	det	12	SENT_1097	[p30l1668t985r1708b1031],
10	multidrug	JJ	O	multidrug	amod	12	SENT_1097	[p30l1778t965r2145b1050],
11	resistance	NN	O	resistance	nn	12	SENT_1097	[p30l639t1058r1009b1126],
12	gene	NN	O	gene	prep_as	6	SENT_1097	[p30l1050t1078r1240b1143],
13	.	.	O	.	_	0	SENT_1097	[p30l1050t1078r1240b1143],

1	Cancer	NN	O	cancer	_	0	SENT_1098	[p30l1290t1058r1564b1124],
2	Res	NNP	O	Res	dep	1	SENT_1098	[p30l1597t1058r1747b1124],
3	.	.	O	.	_	0	SENT_1098	[p30l1597t1058r1747b1124],

1	54:164952	CD	NUMBER	54:164952	_	0	SENT_1099	[p30l1795t1058r2148b1126, p30l642t1154r729b1219],

1	Zaman	NNP	PERSON	Zaman	nn	2	SENT_1100	[p30l639t1247r899b1313],
2	G	NNP	PERSON	G	_	0	SENT_1100	[p30l932t1247r1017b1324],
3	,	,	O	,	_	0	SENT_1100	[p30l932t1247r1017b1324],
4	Flens	NNP	O	Flens	nn	5	SENT_1100	[p30l1053t1247r1251b1313],
5	MJ	NNP	O	MJ	appos	2	SENT_1100	[p30l1284t1247r1420b1324],
6	,	,	O	,	_	0	SENT_1100	[p30l1284t1247r1420b1324],
7	Van	NNP	ORGANIZATION	Van	nn	8	SENT_1100	[p30l1456t1247r1609b1313],
8	LM	NNP	ORGANIZATION	LM	appos	2	SENT_1100	[p30l1640t1247r1801b1324],
9	,	,	O	,	_	0	SENT_1100	[p30l1640t1247r1801b1324],
10	De	NNP	O	De	nn	11	SENT_1100	[p30l1834t1247r1939b1313],
11	HM	NNS	O	hm	appos	2	SENT_1100	[p30l1972t1247r2142b1324],
12	,	,	O	,	_	0	SENT_1100	[p30l1972t1247r2142b1324],
13	Miilder	NNP	O	Miilder	nn	14	SENT_1100	[p30l642t1340r915b1406],
14	HS	NN	O	h	appos	2	SENT_1100	[p30l966t1340r1104b1417],
15	,	,	O	,	_	0	SENT_1100	[p30l966t1340r1104b1417],
16	Lankelma	NN	PERSON	lankelma	nn	17	SENT_1100	[p30l1157t1337r1530b1406],
17	J	NN	PERSON	j	appos	2	SENT_1100	[p30l1578t1340r1634b1417],
18	,	,	O	,	_	0	SENT_1100	[p30l1578t1340r1634b1417],
19	et	FW	O	et	nn	20	SENT_1100	[p30l1685t1349r1750b1406],
20	al.	FW	O	al.	appos	2	SENT_1100	[p30l1800t1340r1883b1406],
21	1994	CD	DATE	1994	dep	20	SENT_1100	[p30l1947t1337r2139b1406],
22	.	.	O	.	_	0	SENT_1100	[p30l1947t1337r2139b1406],

1	The	DT	O	the	det	6	SENT_1101	[p30l639t1433r786b1501],
2	human	JJ	O	human	amod	6	SENT_1101	[p30l811t1433r1068b1501],
3	multidrug	JJ	O	multidrug	amod	6	SENT_1101	[p30l1093t1433r1460b1521],
4	resistanceassociated	JJ	O	resistanceassociated	amod	6	SENT_1101	[p30l1487t1433r2142b1501, p30l642t1529r800b1595],
5	protein	NN	O	protein	nn	6	SENT_1101	[p30l816t1526r1082b1614],
6	MRP	NN	ORGANIZATION	mrp	nsubj	12	SENT_1101	[p30l1104t1529r1302b1595],
7	is	VBZ	O	be	cop	12	SENT_1101	[p30l1324t1526r1384b1595],
8	a	DT	O	a	det	12	SENT_1101	[p30l1406t1546r1448b1595],
9	plasma	NN	O	plasma	nn	12	SENT_1101	[p30l1468t1526r1733b1614],
10	membrane	NN	O	membrane	nn	12	SENT_1101	[p30l1752t1526r2142b1595],
11	drug-efflux	NN	O	drug-efflux	nn	12	SENT_1101	[p30l642t1619r1068b1709],
12	pump	NN	O	pump	_	0	SENT_1101	[p30l1087t1643r1316b1709],
13	.	.	O	.	_	0	SENT_1101	[p30l1087t1643r1316b1709],

1	Prcc	NNP	O	Prcc	_	0	SENT_1102	[p30l1344t1622r1539b1689],
2	.	.	O	.	_	0	SENT_1102	[p30l1344t1622r1539b1689],

1	Natl.	NNP	O	Natl.	nn	3	SENT_1103	[p30l1569t1619r1744b1689],
2	Acad	NNP	O	Acad	nn	3	SENT_1103	[p30l1769t1619r1978b1689],
3	Sci	NNP	O	Sci	_	0	SENT_1103	[p30l2006t1622r2136b1689],
4	.	.	O	.	_	0	SENT_1103	[p30l2006t1622r2136b1689],

1	USA	NNP	O	USA	_	0	SENT_1104	[p30l647t1719r808b1788],
2	9	CD	NUMBER	9	num	3	SENT_1104	[p30l850t1719r1293b1788],
3	]	NN	O	]	dep	1	SENT_1104	[p30l850t1719r1293b1788],
4	:8822	CD	NUMBER	:8822	num	5	SENT_1104	[p30l850t1719r1293b1788],
5	-26	CD	NUMBER	-26	dep	1	SENT_1104	[p30l850t1719r1293b1788],

1	Cole	NNP	O	Cole	dep	4	SENT_1105	[p30l642t1815r817b1884],
2	8	CD	NUMBER	8	dep	1	SENT_1105	[p30l850t1815r918b1895],
3	,	,	O	,	_	0	SENT_1105	[p30l850t1815r918b1895],
4	Sparks	VBZ	PERSON	spark	_	0	SENT_1105	[p30l954t1815r1206b1903],
5	KE	NNP	PERSON	KE	nsubj	4	SENT_1105	[p30l1239t1815r1381b1895],
6	,	,	O	,	_	0	SENT_1105	[p30l1239t1815r1381b1895],
7	Fraser	NNP	PERSON	Fraser	nn	8	SENT_1105	[p30l1411t1815r1649b1881],
8	K	NNP	PERSON	K	appos	5	SENT_1105	[p30l1679t1815r1761b1895],
9	,	,	O	,	_	0	SENT_1105	[p30l1679t1815r1761b1895],
10	Loe	NNP	PERSON	Loe	nn	11	SENT_1105	[p30l1795t1815r1936b1884],
11	DW	NNP	O	DW	appos	5	SENT_1105	[p30l1969t1815r2142b1895],
12	,	,	O	,	_	0	SENT_1105	[p30l1969t1815r2142b1895],
13	Grant	NNP	PERSON	Grant	nn	14	SENT_1105	[p30l642t1911r854b1979],
14	CE	NNP	O	CE	appos	5	SENT_1105	[p30l887t1911r1023b1991],
15	,	,	O	,	_	0	SENT_1105	[p30l887t1911r1023b1991],
16	et	FW	O	et	nn	17	SENT_1105	[p30l1059t1923r1124b1979],
17	al.	FW	O	al.	appos	5	SENT_1105	[p30l1158t1911r1243b1977],
18	1994	CD	DATE	1994	dep	17	SENT_1105	[p30l1287t1908r1482b1979],
19	.	.	O	.	_	0	SENT_1105	[p30l1287t1908r1482b1979],

1	Pharmacological	JJ	O	pharmacological	amod	2	SENT_1106	[p30l1518t1911r2145b1999],
2	characterization	NN	O	characterization	_	0	SENT_1106	[p30l642t2004r1237b2073],
3	of	IN	O	of	_	0	SENT_1106	[p30l1290t2004r1375b2073],
4	multidrug	JJ	O	multidrug	amod	5	SENT_1106	[p30l1420t2004r1784b2092],
5	resistant	JJ	O	resistant	amod	9	SENT_1106	[p30l1837t2004r2148b2073],
6	MRP-transfected	JJ	MISC	mrp-transfected	amod	9	SENT_1106	[p30l642t2097r1285b2166],
7	human	JJ	O	human	amod	9	SENT_1106	[p30l1346t2097r1598b2166],
8	tumor	NN	O	tumor	nn	9	SENT_1106	[p30l1668t2109r1888b2166],
9	cells	NNS	O	cell	prep_of	2	SENT_1106	[p30l1953t2097r2142b2166],
10	.	.	O	.	_	0	SENT_1106	[p30l1953t2097r2142b2166],

1	Cancer	NN	O	cancer	_	0	SENT_1107	[p30l644t2196r918b2264],
2	Res	NNP	O	Res	dep	1	SENT_1107	[p30l955t2196r1102b2262],
3	.	.	O	.	_	0	SENT_1107	[p30l955t2196r1102b2262],

1	54:59	NN	O	54:59	_	0	SENT_1108	[p30l1149t2193r1592b2264],
2	'	POS	O	'	_	0	SENT_1108	[p30l1149t2193r1592b2264],
3	0	CD	NUMBER	0	dep	1	SENT_1108	[p30l1149t2193r1592b2264],
4	’	CD	NUMBER	’	num	5	SENT_1108	[p30l1149t2193r1592b2264],
5	2-I0	NN	O	2-i0	dep	1	SENT_1108	[p30l1149t2193r1592b2264],

1	Flens	NNP	O	Flens	nn	2	SENT_1109	[p30l642t2289r842b2355],
2	MJ	NNP	O	MJ	_	0	SENT_1109	[p30l878t2289r1017b2366],
3	,	,	O	,	_	0	SENT_1109	[p30l878t2289r1017b2366],
4	Izquierdo	NNP	PERSON	Izquierdo	nn	5	SENT_1109	[p30l1056t2286r1409b2374],
5	MA	NNP	PERSON	MA	appos	2	SENT_1109	[p30l1445t2289r1615b2366],
6	,	,	O	,	_	0	SENT_1109	[p30l1445t2289r1615b2366],
7	Scheffer	NNP	ORGANIZATION	Scheffer	nn	8	SENT_1109	[p30l1654t2286r1967b2355],
8	GL	NNP	ORGANIZATION	GL	appos	2	SENT_1109	[p30l2000t2289r2142b2366],
9	,	,	O	,	_	0	SENT_1109	[p30l2000t2289r2142b2366],
10	Fritz	NNP	PERSON	Fritz	nn	11	SENT_1109	[p30l642t2379r820b2448],
11	JM	NN	PERSON	jm	appos	2	SENT_1109	[p30l870t2382r1011b2459],
12	,	,	O	,	_	0	SENT_1109	[p30l870t2382r1011b2459],
13	Meijer	NNP	PERSON	Meijer	nn	14	SENT_1109	[p30l1067t2379r1316b2464],
14	CJLM	NNP	O	CJLM	appos	2	SENT_1109	[p30l1369t2379r1623b2459],
15	,	,	O	,	_	0	SENT_1109	[p30l1369t2379r1623b2459],
16	et	FW	O	et	nn	17	SENT_1109	[p30l1679t2391r1747b2445],
17	al.	FW	O	al.	appos	2	SENT_1109	[p30l1798t2379r1883b2448],
18	1994	CD	DATE	1994	dep	17	SENT_1109	[p30l1950t2379r2142b2448],
19	.	.	O	.	_	0	SENT_1109	[p30l1950t2379r2142b2448],

1	Immunochemical	JJ	O	immunochemical	amod	2	SENT_1110	[p30l644t2475r1293b2543],
2	detection	NN	O	detection	_	0	SENT_1110	[p30l1335t2475r1677b2543],
3	of	IN	O	of	_	0	SENT_1110	[p30l1713t2475r1792b2543],
4	the	DT	O	the	det	5	SENT_1110	[p30l1823t2478r1936b2543],
5	multidrug	JJ	O	multidrug	prep_of	2	SENT_1110	[p30l1975t2475r2145b2543, p30l642t2568r862b2656],

1	resistance	NN	O	resistance	nsubj	2	SENT_1111	[p30l954t2568r1324b2636],
2	associated	VBN	O	associate	_	0	SENT_1111	[p30l1411t2568r1795b2636],
3	protein	NN	O	protein	nn	4	SENT_1111	[p30l1882t2568r2148b2656],
4	MRP	NN	ORGANIZATION	mrp	dobj	2	SENT_1111	[p30l642t2664r839b2729],
5	in	IN	O	in	_	0	SENT_1111	[p30l881t2661r955b2729],
6	human	JJ	O	human	amod	9	SENT_1111	[p30l1000t2664r1248b2729],
7	multidrug-resistant	JJ	O	multidrug-resistant	amod	9	SENT_1111	[p30l1293t2661r2004b2749],
8	tumor	NN	O	tumor	nn	9	SENT_1111	[p30l2043t2675r2145b2729, p30l644t2780r794b2825],
9	cells	NNS	O	cell	prep_in	2	SENT_1111	[p30l853t2760r1023b2825],
10	by	IN	O	by	_	0	SENT_1111	[p30l1084t2760r1178b2845],
11	monoclonal	JJ	O	monoclonal	amod	12	SENT_1111	[p30l1242t2757r1680b2825],
12	antibodies	NNS	O	antibody	prep_by	2	SENT_1111	[p30l1744t2757r2142b2825],
13	.	.	O	.	_	0	SENT_1111	[p30l1744t2757r2142b2825],

1	Cancer	NN	O	cancer	_	0	SENT_1112	[p30l647t2853r921b2921],
2	Res	NNP	O	Res	dep	1	SENT_1112	[p30l954t2853r1102b2918],
3	.	.	O	.	_	0	SENT_1112	[p30l954t2853r1102b2918],

1	5414557-63	NN	O	5414557-63	_	0	SENT_1113	[p30l1149t2850r1589b2921],

1	Hipfner	NNP	O	Hipfner	nn	2	SENT_1114	[p30l644t2946r935b3034],
2	DR	NN	O	dr	_	0	SENT_1114	[p30l977t2946r1124b3025],
3	,	,	O	,	_	0	SENT_1114	[p30l977t2946r1124b3025],
4	Gauldie	NNP	O	Gauldie	nn	5	SENT_1114	[p30l1172t2943r1465b3014],
5	SD	NN	O	sd	appos	2	SENT_1114	[p30l1510t2946r1646b3025],
6	,	,	O	,	_	0	SENT_1114	[p30l1510t2946r1646b3025],
7	Deeley	NNP	PERSON	Deeley	nn	8	SENT_1114	[p30l1693t2946r1950b3034],
8	RG	NNP	O	RG	appos	2	SENT_1114	[p30l1998t2946r2145b3025],
9	,	,	O	,	_	0	SENT_1114	[p30l1998t2946r2145b3025],
10	Cole	NNP	O	Cole	nn	11	SENT_1114	[p30l644t3042r820b3110],
11	S.	NNP	O	S.	appos	2	SENT_1114	[p30l884t3042r952b3110],
12	1994	CD	DATE	1994	dep	11	SENT_1114	[p30l1031t3042r1226b3110],
13	.	.	O	.	_	0	SENT_1114	[p30l1031t3042r1226b3110],

1	Detection	NN	O	detection	_	0	SENT_1115	[p30l1296t3042r1657b3107],
2	of	IN	O	of	_	0	SENT_1115	[p30l1721t3042r1801b3107],
3	the	DT	O	the	det	4	SENT_1115	[p30l1860t3042r1970b3107],
4	Mr	NN	O	mr	prep_of	1	SENT_1115	[p30l2034t3042r2148b3107],

1	190,000	CD	NUMBER	190,000	num	4	SENT_1116	[p30l653t3135r949b3214],
2	multidrug	JJ	O	multidrug	amod	4	SENT_1116	[p30l1008t3135r1375b3223],
3	resistance	NN	O	resistance	nn	4	SENT_1116	[p30l1434t3135r1801b3203],
4	protein	NN	O	protein	_	0	SENT_1116	[p30l1862t3135r2145b3223],
5	,	,	O	,	_	0	SENT_1116	[p30l1862t3135r2145b3223],
6	MRP	NN	ORGANIZATION	mrp	appos	4	SENT_1116	[p30l644t3231r862b3307],
7	,	,	O	,	_	0	SENT_1116	[p30l644t3231r862b3307],
8	with	IN	O	with	_	0	SENT_1116	[p30l887t3228r1054b3296],
9	monoclonal	JJ	O	monoclonal	amod	10	SENT_1116	[p30l1079t3228r1513b3296],
10	antibodies	NNS	O	antibody	prep_with	4	SENT_1116	[p30l1538t3228r1936b3296],
11	.	.	O	.	_	0	SENT_1116	[p30l1538t3228r1936b3296],

1	Cancer	NN	O	cancer	_	0	SENT_1117	[p30l1967t3228r2145b3296, p30l644t3346r766b3395],

1	Res	NNP	O	Res	_	0	SENT_1118	[p30l799t3326r947b3392],
2	.	.	O	.	_	0	SENT_1118	[p30l799t3326r947b3392],

1	545788-92	CD	NUMBER	545788-92	_	0	SENT_1119	[p30l994t3326r1437b3397],

1	Almquist	NNP	PERSON	Almquist	nn	2	SENT_1120	[p30l644t3422r994b3510],
2	KC	NNP	O	KC	_	0	SENT_1120	[p30l1045t3422r1189b3502],
3	,	,	O	,	_	0	SENT_1120	[p30l1045t3422r1189b3502],
4	Loe	NNP	PERSON	Loe	nn	5	SENT_1120	[p30l1239t3422r1384b3488],
5	DW	NNP	O	DW	appos	2	SENT_1120	[p30l1434t3422r1612b3499],
6	,	,	O	,	_	0	SENT_1120	[p30l1434t3422r1612b3499],
7	Hipfner	NNP	O	Hipfner	nn	8	SENT_1120	[p30l1662t3419r1950b3507],
8	DR	NN	O	dr	appos	5	SENT_1120	[p30l1998t3422r2145b3502],
9	,	,	O	,	_	0	SENT_1120	[p30l1998t3422r2145b3502],
10	Mackie	NNP	PERSON	Mackie	nn	11	SENT_1120	[p30l644t3515r927b3583],
11	JE	NNP	O	JE	appos	5	SENT_1120	[p30l966t3515r1079b3595],
12	,	,	O	,	_	0	SENT_1120	[p30l966t3515r1079b3595],
13	Cole	NNP	O	Cole	nn	14	SENT_1120	[p30l1118t3515r1293b3583],
14	S	NNP	O	S	appos	5	SENT_1120	[p30l1335t3515r1406b3595],
15	,	,	O	,	_	0	SENT_1120	[p30l1335t3515r1406b3595],
16	Deeley	NNP	PERSON	Deeley	nn	17	SENT_1120	[p30l1448t3515r1713b3600],
17	RG	NNP	O	RG	appos	5	SENT_1120	[p30l1750t3515r1897b3583],
18	.	.	O	.	_	0	SENT_1120	[p30l1750t3515r1897b3583],

1	1995	CD	DATE	1995	_	0	SENT_1121	[p30l1950t3515r2145b3583],
2	.	.	O	.	_	0	SENT_1121	[p30l1950t3515r2145b3583],

1	Characterization	NN	O	characterization	_	0	SENT_1122	[p30l644t3611r1262b3679],
2	of	IN	O	of	_	0	SENT_1122	[p30l1287t3611r1367b3679],
3	the	DT	O	the	det	8	SENT_1122	[p30l1383t3611r1496b3679],
4	Mr	NNP	O	Mr	nn	8	SENT_1122	[p30l1518t3611r1632b3679],
5	190,000	CD	NUMBER	190,000	num	8	SENT_1122	[p30l1662t3611r1953b3690],
6	multidrug	JJ	O	multidrug	amod	8	SENT_1122	[p30l1975t3611r2148b3679, p30l644t3707r865b3791],
7	resistance	NN	O	resistance	nn	8	SENT_1122	[p30l892t3707r1262b3772],
8	protein	NN	O	protein	prep_of	1	SENT_1122	[p30l1284t3704r1547b3791],
9	(	CD	NUMBER	(	num	11	SENT_1122	[p30l1575t3707r1829b3786],
10	MRP	NN	O	mrp	nn	11	SENT_1122	[p30l1575t3707r1829b3786],
11	)	NN	O	)	dep	1	SENT_1122	[p30l1575t3707r1829b3786],
12	in	IN	O	in	_	0	SENT_1122	[p30l1857t3707r1925b3772],
13	drugselected	JJ	O	drugselected	prep_in	11	SENT_1122	[p30l1953t3707r2148b3791, p31l647t13r947b78],

1	and	CC	O	and	cc	2	SENT_1123	[p31l997t13r1127b78],
2	transfected	VBN	O	transfect	_	0	SENT_1123	[p31l1172t10r1584b78],
3	human	JJ	O	human	amod	5	SENT_1123	[p31l1628t13r1883b78],
4	tumor	NN	O	tumor	nn	5	SENT_1123	[p31l1927t21r2150b78],
5	cells	NNS	O	cell	dobj	2	SENT_1123	[p31l644t104r837b171],
6	.	.	O	.	_	0	SENT_1123	[p31l644t104r837b171],

1	Cancer	NN	O	cancer	_	0	SENT_1124	[p31l878t107r1155b174],
2	Res	NNP	O	Res	dep	1	SENT_1124	[p31l1186t107r1336b171],
3	.	.	O	.	_	0	SENT_1124	[p31l1186t107r1336b171],

1	55:102	CD	NUMBER	55:102	number	2	SENT_1125	[p31l1383t104r1778b171],
2	—	CD	NUMBER	—	num	3	SENT_1125	[p31l1383t104r1778b171],
3	1O	NN	O	1o	_	0	SENT_1125	[p31l1383t104r1778b171],

1	112	CD	NUMBER	112	_	0	SENT_1126	[p31l407t200r552b265],
2	.	.	O	.	_	0	SENT_1126	[p31l407t200r552b265],

1	Ma	NNP	O	Ma	nn	2	SENT_1127	[p31l644t200r769b265],
2	L	NNP	O	L	_	0	SENT_1127	[p31l808t200r882b276],
3	,	,	O	,	_	0	SENT_1127	[p31l808t200r882b276],
4	Krishnarnachary	NNP	ORGANIZATION	Krishnarnachary	nn	8	SENT_1127	[p31l926t197r1541b284],
5	N	NNP	ORGANIZATION	N	nn	8	SENT_1127	[p31l1580t200r1668b276],
6	,	,	O	,	_	0	SENT_1127	[p31l1580t200r1668b276],
7	Center	NNP	O	Center	appos	8	SENT_1127	[p31l1707t197r1956b265],
8	MS.	NNP	O	MS.	appos	2	SENT_1127	[p31l1992t200r2145b265],
9	1995	CD	DATE	1995	num	8	SENT_1127	[p31l656t290r851b360],
10	.	.	O	.	_	0	SENT_1127	[p31l656t290r851b360],

1	Phosphorylation	NN	O	phosphorylation	nsubj	6	SENT_1128	[p31l890t290r1496b377],
2	of	IN	O	of	_	0	SENT_1128	[p31l1530t290r1615b358],
3	the	DT	O	the	det	5	SENT_1128	[p31l1640t290r1750b358],
4	multidrug	JJ	O	multidrug	amod	5	SENT_1128	[p31l1783t290r2150b377],
5	resistance	NN	O	resistance	prep_of	1	SENT_1128	[p31l647t383r1017b451],
6	associated	VBN	O	associate	_	0	SENT_1128	[p31l1064t383r1448b451],
7	protein	NN	O	protein	nn	8	SENT_1128	[p31l1496t383r1759b470],
8	gene	NN	O	gene	dobj	6	SENT_1128	[p31l1809t405r1981b470],
9	encoded	VBN	O	encode	partmod	8	SENT_1128	[p31l2034t405r2148b451, p31l647t479r868b547],
10	protein	NN	O	protein	nn	11	SENT_1128	[p31l921t479r1181b567],
11	P190	NN	O	p190	dobj	9	SENT_1128	[p31l1231t479r1437b547],
12	.	.	O	.	_	0	SENT_1128	[p31l1231t479r1437b547],

1	Biochemistry	NNP	O	Biochemistry	_	0	SENT_1129	[p31l1493t476r1987b561],
2	34	CD	NUMBER	34	num	1	SENT_1129	[p31l2034t479r2145b544],
3	:	:	O	:	_	0	SENT_1129	[p31l2034t479r2145b544],
4	3338-43	CD	NUMBER	3338-43	dep	1	SENT_1129	[p31l650t572r969b640],

1	113	CD	NUMBER	113	_	0	SENT_1130	[p31l408t670r552b740],
2	.	.	O	.	_	0	SENT_1130	[p31l408t670r552b740],

1	Zhu	NNP	PERSON	Zhu	nn	2	SENT_1131	[p31l647t673r797b738],
2	Q	NNP	O	Q	_	0	SENT_1131	[p31l836t670r921b754],
3	,	,	O	,	_	0	SENT_1131	[p31l836t670r921b754],
4	Center	NNP	O	Center	nn	5	SENT_1131	[p31l960t670r1209b740],
5	MS.	NNP	O	MS.	appos	2	SENT_1131	[p31l1248t670r1398b738],
6	1994	CD	DATE	1994	dep	5	SENT_1131	[p31l1448t670r1640b740],
7	.	.	O	.	_	0	SENT_1131	[p31l1448t670r1640b740],

1	Cloning	NN	O	cloning	nn	4	SENT_1132	[p31l1685t670r1981b757],
2	and	CC	O	and	_	0	SENT_1132	[p31l2017t670r2153b738],
3	sequence	NN	O	sequence	conj_and	1	SENT_1132	[p31l650t788r986b853],
4	analysis	NN	O	analysis	nsubj	16	SENT_1132	[p31l1036t766r1336b853],
5	of	IN	O	of	_	0	SENT_1132	[p31l1380t763r1462b834],
6	the	DT	O	the	det	8	SENT_1132	[p31l1501t766r1615b834],
7	promoter	NN	O	promoter	nn	8	SENT_1132	[p31l1665t777r2004b853],
8	region	NN	O	region	prep_of	4	SENT_1132	[p31l2048t788r2148b834, p31l647t856r811b943],
9	of	IN	O	of	_	0	SENT_1132	[p31l856t856r941b924],
10	the	DT	O	the	det	12	SENT_1132	[p31l980t856r1093b924],
11	MRP	NN	ORGANIZATION	mrp	nn	12	SENT_1132	[p31l1138t859r1336b924],
12	gene	NN	O	gene	prep_of	8	SENT_1132	[p31l1377t875r1553b943],
13	of	IN	O	of	_	0	SENT_1132	[p31l1600t856r1682b924],
14	HL60	NN	O	hl60	nn	15	SENT_1132	[p31l1721t856r1939b924],
15	cells	NNS	O	cell	prep_of	12	SENT_1132	[p31l1981t856r2150b924],
16	isolated	VBN	O	isolate	_	0	SENT_1132	[p31l647t952r935b1020],
17	for	IN	O	for	_	0	SENT_1132	[p31l994t952r1102b1020],
18	resistance	NN	O	resistance	prep_for	16	SENT_1132	[p31l1157t952r1525b1020],
19	to	TO	O	to	_	0	SENT_1132	[p31l1583t963r1654b1020],
20	adriamycin	NN	O	adriamycin	prep_to	16	SENT_1132	[p31l1710t952r2148b1039],
21	.	.	O	.	_	0	SENT_1132	[p31l1710t952r2148b1039],

1	Cancer	NN	O	cancer	_	0	SENT_1133	[p31l650t1048r924b1110],
2	Res	NNP	O	Res	dep	1	SENT_1133	[p31l960t1048r1107b1110],
3	.	.	O	.	_	0	SENT_1133	[p31l960t1048r1107b1110],

1	S4	NN	O	s4	_	0	SENT_1134	[p31l1152t1045r1595b1113],
2	:	:	O	:	_	0	SENT_1134	[p31l1152t1045r1595b1113],
3	-4438	CD	NUMBER	-4438	num	4	SENT_1134	[p31l1152t1045r1595b1113],
4	-92	CD	NUMBER	-92	dep	1	SENT_1134	[p31l1152t1045r1595b1113],

1	114	CD	NUMBER	114	_	0	SENT_1135	[p31l6t1144r182b1227],
2	.	.	O	.	_	0	SENT_1135	[p31l6t1144r182b1227],

1	Leier	JJR	O	leier	_	0	SENT_1136	[p31l294t1144r539b1227],
2	I	PRP	O	I	dep	1	SENT_1136	[p31l563t1147r621b1241],
3	,	,	O	,	_	0	SENT_1136	[p31l563t1147r621b1241],
4	Jedlitschky	NNP	O	Jedlitschky	nn	5	SENT_1136	[p31l648t1144r1164b1251],
5	G	NNP	O	G	appos	2	SENT_1136	[p31l1188t1144r1292b1244],
6	,	,	O	,	_	0	SENT_1136	[p31l1188t1144r1292b1244],
7	Buchholz	NNP	PERSON	Buchholz	nn	8	SENT_1136	[p31l1322t1147r1759b1227],
8	U	NNP	O	U	appos	2	SENT_1136	[p31l1786t1147r1890b1244],
9	,	,	O	,	_	0	SENT_1136	[p31l1786t1147r1890b1244],
10	Cole	NNP	O	Cole	appos	2	SENT_1136	[p31l1920t1147r2134b1231],

1	S	NN	O	s	_	0	SENT_1137	[p31l298t1261r381b1361],
2	,	,	O	,	_	0	SENT_1137	[p31l298t1261r381b1361],
3	Deeley	NNP	PERSON	Deeley	nn	7	SENT_1137	[p31l442t1261r766b1368],
4	RG	NNP	O	RG	nn	7	SENT_1137	[p31l820t1261r1003b1357],
5	,	,	O	,	_	0	SENT_1137	[p31l820t1261r1003b1357],
6	Keppler	NNP	PERSON	Keppler	appos	7	SENT_1137	[p31l1061t1261r1429b1371],
7	D.	NNP	O	D.	appos	1	SENT_1137	[p31l1487t1264r1587b1347],
8	1994	CD	DATE	1994	num	7	SENT_1137	[p31l1659t1261r1897b1347],
9	.	.	O	.	_	0	SENT_1137	[p31l1659t1261r1897b1347],

1	The	DT	O	the	det	3	SENT_1138	[p31l1958t1261r2134b1347],
2	MRP	NN	O	mrp	nn	3	SENT_1138	[p31l298t1385r535b1468],
3	gene	NN	O	gene	nsubj	4	SENT_1138	[p31l583t1405r797b1492],
4	encodes	VBZ	O	encode	_	0	SENT_1138	[p31l844t1385r1209b1468],
5	an	DT	O	a	det	8	SENT_1138	[p31l1260t1409r1364b1468],
6	ATP-dependent	JJ	O	atp-dependent	amod	8	SENT_1138	[p31l1411t1385r2137b1492],
7	export	NN	O	export	nn	8	SENT_1138	[p31l298t1513r587b1606],
8	pump	NN	O	pump	dobj	4	SENT_1138	[p31l655t1523r917b1606],
9	for	IN	O	for	_	0	SENT_1138	[p31l985t1499r1120b1582],
10	leukotriene	NN	O	leukotriene	nn	11	SENT_1138	[p31l1188t1499r1704b1582],
11	C4	NN	O	c4	prep_for	4	SENT_1138	[p31l1769t1499r1903b1582],
12	and	CC	O	and	_	0	SENT_1138	[p31l1972t1502r2140b1582],
13	structurally	RB	O	structurally	advmod	14	SENT_1138	[p31l301t1626r814b1733],
14	related	JJ	O	related	amod	15	SENT_1138	[p31l865t1626r1178b1709],
15	conjugates	NNS	O	conjugate	conj_and	11	SENT_1138	[p31l1222t1626r1735b1733],
16	.	.	O	.	_	0	SENT_1138	[p31l1222t1626r1735b1733],

1	J.	NNP	O	J.	nn	2	SENT_1139	[p31l1786t1626r1859b1706],
2	Biol	NNP	O	Biol	_	0	SENT_1139	[p31l1917t1626r2127b1709],
3	.	.	O	.	_	0	SENT_1139	[p31l1917t1626r2127b1709],

1	Chem	NNP	O	Chem	_	0	SENT_1140	[p31l301t1743r580b1826],
2	.	.	O	.	_	0	SENT_1140	[p31l301t1743r580b1826],

1	2159:2780	CD	NUMBER	2159:2780	_	0	SENT_1141	[p31l638t1740r1295b1826],
2	?	.	O	?	_	0	SENT_1141	[p31l638t1740r1295b1826],

1	-10	CD	NUMBER	-10	_	0	SENT_1142	[p31l638t1740r1295b1826],

1	Gekeler	NNP	MISC	Gekeler	nn	2	SENT_1143	[p31l298t1857r659b1936],
2	V	NNP	O	V	_	0	SENT_1143	[p31l703t1857r807b1953],
3	,	,	O	,	_	0	SENT_1143	[p31l703t1857r807b1953],
4	Ise	NNP	O	Ise	nn	5	SENT_1143	[p31l855t1857r986b1936],
5	W	NNP	O	W	appos	2	SENT_1143	[p31l1030t1857r1161b1953],
6	,	,	O	,	_	0	SENT_1143	[p31l1030t1857r1161b1953],
7	Sanders	NNP	ORGANIZATION	Sanders	nn	8	SENT_1143	[p31l1209t1857r1567b1940],
8	KH	NNP	ORGANIZATION	KH	appos	2	SENT_1143	[p31l1611t1860r1797b1953],
9	,	,	O	,	_	0	SENT_1143	[p31l1611t1860r1797b1953],
10	Ulrich	NNP	ORGANIZATION	Ulrich	nn	11	SENT_1143	[p31l1844t1857r2140b1940],
11	WR	NNP	ORGANIZATION	WR	appos	2	SENT_1143	[p31l298t1970r505b2066],
12	,	,	O	,	_	0	SENT_1143	[p31l298t1970r505b2066],
13	Beck	NNP	PERSON	Beck	nn	14	SENT_1143	[p31l587t1970r821b2053],
14	J.	NNP	O	J.	appos	2	SENT_1143	[p31l892t1970r958b2053],
15	1995	CD	DATE	1995	dep	14	SENT_1143	[p31l1051t1970r1288b2053],
16	.	.	O	.	_	0	SENT_1143	[p31l1051t1970r1288b2053],

1	The	DT	O	the	det	2	SENT_1144	[p31l1367t1970r1546b2053],
2	leukotriene	NN	O	leukotriene	_	0	SENT_1144	[p31l1624t1970r2134b2053],

1	LTD4	NN	O	ltd4	nn	4	SENT_1145	[p31l298t2087r577b2170],
2	receptor	NN	O	receptor	nn	4	SENT_1145	[p31l621t2101r993b2194],
3	antagonist	NN	O	antagonist	nn	4	SENT_1145	[p31l1037t2087r1508b2191],
4	MK57l	NN	O	mk57l	nsubj	6	SENT_1145	[p31l1552t2087r1897b2170],
5	speciﬁcally	RB	O	speciﬁcally	advmod	4	SENT_1145	[p31l1951t2114r2134b2194, p31l298t2211r670b2318],
6	modulates	VBZ	O	modulate	_	0	SENT_1145	[p31l769t2214r1233b2298],
7	MRP	NN	ORGANIZATION	mrp	dobj	6	SENT_1145	[p31l1332t2214r1573b2298],
8	associated	VBN	O	associate	partmod	7	SENT_1145	[p31l1669t2214r2140b2298],
9	multidrug	JJ	O	multidrug	amod	10	SENT_1145	[p31l301t2328r749b2432],
10	resistance	NN	O	resistance	dobj	8	SENT_1145	[p31l776t2328r1247b2408],
11	.	.	O	.	_	0	SENT_1145	[p31l776t2328r1247b2408],

1	Biochem	NNP	ORGANIZATION	Biochem	_	0	SENT_1146	[p31l1284t2328r1701b2411],
2	.	.	O	.	_	0	SENT_1146	[p31l1284t2328r1701b2411],

1	Biophys	NNS	O	biophy	_	0	SENT_1147	[p31l1738t2328r2127b2435],
2	.	.	O	.	_	0	SENT_1147	[p31l1738t2328r2127b2435],

1	Res	NNP	O	Res	_	0	SENT_1148	[p31l298t2446r477b2525],
2	.	.	O	.	_	0	SENT_1148	[p31l298t2446r477b2525],

1	Commun	NNP	O	Commun	_	0	SENT_1149	[p31l538t2446r965b2529],
2	.	.	O	.	_	0	SENT_1149	[p31l538t2446r965b2529],

1	208:345	CD	NUMBER	208:345	num	2	SENT_1150	[p31l1020t2446r1563b2532],
2	-52	CD	NUMBER	-52	_	0	SENT_1150	[p31l1020t2446r1563b2532],

1	Hart	NNP	ORGANIZATION	Hart	nn	2	SENT_1151	[p31l301t2562r501b2642],
2	SM	NNP	ORGANIZATION	SM	_	0	SENT_1151	[p31l569t2559r755b2656],
3	,	,	O	,	_	0	SENT_1151	[p31l569t2559r755b2656],
4	Ganeshaguru	NNP	PERSON	Ganeshaguru	nn	5	SENT_1151	[p31l824t2559r1426b2666],
5	K	NNP	PERSON	K	appos	2	SENT_1151	[p31l1490t2562r1594b2656],
6	,	,	O	,	_	0	SENT_1151	[p31l1490t2562r1594b2656],
7	I-Ioffbrand	NNP	O	I-Ioffbrand	nn	8	SENT_1151	[p31l1662t2559r2144b2646],
8	AV	NNP	O	AV	appos	2	SENT_1151	[p31l301t2675r487b2768],
9	,	,	O	,	_	0	SENT_1151	[p31l301t2675r487b2768],
10	Prentice	NNP	ORGANIZATION	Prentice	nn	11	SENT_1151	[p31l563t2672r938b2755],
11	HG	NNP	ORGANIZATION	HG	appos	2	SENT_1151	[p31l1006t2672r1192b2768],
12	,	,	O	,	_	0	SENT_1151	[p31l1006t2672r1192b2768],
13	Mehta	NNP	ORGANIZATION	Mehta	nn	14	SENT_1151	[p31l1267t2675r1560b2755],
14	AB	NNP	ORGANIZATION	AB	appos	2	SENT_1151	[p31l1628t2675r1807b2755],
15	.	.	O	.	_	0	SENT_1151	[p31l1628t2675r1807b2755],

1	1994	CD	DATE	1994	_	0	SENT_1152	[p31l1896t2672r2134b2758],
2	.	.	O	.	_	0	SENT_1152	[p31l1896t2672r2134b2758],

1	Expression	NN	O	expression	_	0	SENT_1153	[p31l301t2789r804b2896],
2	of	IN	O	of	_	0	SENT_1153	[p31l844t2789r948b2872],
3	the	DT	O	the	det	9	SENT_1153	[p31l982t2789r1116b2869],
4	multidrug	JJ	O	multidrug	amod	9	SENT_1153	[p31l1161t2789r1611b2896],
5	resistanceassociated	JJ	O	resistanceassociated	amod	9	SENT_1153	[p31l1652t2789r2137b2872, p31l301t2903r766b2989],
6	protein	NN	O	protein	nn	9	SENT_1153	[p31l813t2903r1137b3013],
7	(	CD	NUMBER	(	num	9	SENT_1153	[p31l1185t2906r1494b3006],
8	MRP	NN	O	mrp	nn	9	SENT_1153	[p31l1185t2906r1494b3006],
9	)	NN	O	)	prep_of	1	SENT_1153	[p31l1185t2906r1494b3006],
10	in	IN	O	in	_	0	SENT_1153	[p31l1545t2903r1632b2989],
11	acute	JJ	O	acute	amod	12	SENT_1153	[p31l1679t2920r1914b2989],
12	leukaemia	NN	O	leukaemia	prep_in	9	SENT_1153	[p31l1965t2906r2137b2989, p31l301t3020r652b3103],
13	.	.	O	.	_	0	SENT_1153	[p31l1965t2906r2137b2989, p31l301t3020r652b3103],

1	Leukemia	NN	O	leukemia	_	0	SENT_1154	[p31l700t3020r1147b3103],
2	8:2163	CD	NUMBER	8:2163	number	3	SENT_1154	[p31l1195t3020r1680b3106],
3	—	CD	NUMBER	—	dep	1	SENT_1154	[p31l1195t3020r1680b3106],
4	68	CD	NUMBER	68	dep	3	SENT_1154	[p31l1195t3020r1680b3106],

1	Schneider	NNP	PERSON	Schneider	nn	2	SENT_1155	[p31l305t3137r755b3220],
2	E	NNP	O	E	_	0	SENT_1155	[p31l834t3140r927b3237],
3	,	,	O	,	_	0	SENT_1155	[p31l834t3140r927b3237],
4	Cowan	NNP	PERSON	Cowan	nn	5	SENT_1155	[p31l1009t3140r1329b3223],
5	KI-I	NNP	O	KI-I	appos	2	SENT_1155	[p31l1411t3140r1597b3237],
6	,	,	O	,	_	0	SENT_1155	[p31l1411t3140r1597b3237],
7	Bader	NNP	PERSON	Bader	nn	8	SENT_1155	[p31l1683t3140r1955b3223],
8	H	NNP	PERSON	H	appos	2	SENT_1155	[p31l2030t3140r2137b3237],
9	,	,	O	,	_	0	SENT_1155	[p31l2030t3140r2137b3237],
10	Toomey	NNP	PERSON	Toomey	nn	11	SENT_1155	[p31l298t3254r680b3357],
11	S	NNP	O	S	appos	2	SENT_1155	[p31l731t3254r817b3347],
12	,	,	O	,	_	0	SENT_1155	[p31l731t3254r817b3347],
13	Schwartz	NNP	ORGANIZATION	Schwartz	nn	14	SENT_1155	[p31l875t3254r1298b3333],
14	GN	NNP	ORGANIZATION	GN	appos	2	SENT_1155	[p31l1350t3254r1536b3347],
15	,	,	O	,	_	0	SENT_1155	[p31l1350t3254r1536b3347],
16	et	FW	O	et	appos	2	SENT_1155	[p31l1594t3268r1673b3333],
17	a	FW	O	a	nn	18	SENT_1155	[p31l1728t3254r1828b3333],
18	]	FW	O	]	dep	16	SENT_1155	[p31l1728t3254r1828b3333],
19	.	.	O	.	_	0	SENT_1155	[p31l1728t3254r1828b3333],

1	1995	CD	DATE	1995	_	0	SENT_1156	[p31l1896t3254r2134b3337],
2	.	.	O	.	_	0	SENT_1156	[p31l1896t3254r2134b3337],

1	Increased	VBN	O	increase	amod	2	SENT_1157	[p31l301t3363r738b3446],
2	expression	NN	O	expression	_	0	SENT_1157	[p31l796t3363r1281b3470],
3	of	IN	O	of	_	0	SENT_1157	[p31l1343t3363r1443b3446],
4	the	DT	O	the	det	8	SENT_1157	[p31l1494t3366r1635b3446],
5	multidrug	JJ	O	multidrug	amod	8	SENT_1157	[p31l1693t3366r2144b3473],
6	resistance-associated	JJ	O	resistance-associated	amod	8	SENT_1157	[p31l301t3480r1261b3566],
7	protein	NN	O	protein	nn	8	SENT_1157	[p31l1346t3483r1670b3590],
8	gene	NN	O	gene	prep_of	2	SENT_1157	[p31l1755t3511r1965b3590],
9	in	IN	O	in	_	0	SENT_1157	[p31l2054t3483r2141b3566],
10	relapsed	JJ	O	relapsed	amod	12	SENT_1157	[p31l301t3596r683b3703],
11	acute	JJ	O	acute	amod	12	SENT_1157	[p31l769t3610r1010b3679],
12	leukemia	NN	O	leukemia	prep_in	8	SENT_1157	[p31l1102t3596r1539b3679],
13	.	.	O	.	_	0	SENT_1157	[p31l1102t3596r1539b3679],

1	Blood	NN	O	blood	_	0	SENT_1158	[p31l1638t3593r1910b3676],
2	85	CD	NUMBER	85	num	1	SENT_1158	[p31l1999t3596r2134b3679],
3	:	:	O	:	_	0	SENT_1158	[p31l1999t3596r2134b3679],
4	186-93	CD	NUMBER	186-93	dep	1	SENT_1158	[p31l315t3709r635b3792],

1	Burger	NNP	O	Burger	nn	2	SENT_1159	[p32l305t25r618b128],
2	H	NNP	O	H	_	0	SENT_1159	[p32l655t25r759b121],
3	,	,	O	,	_	0	SENT_1159	[p32l655t25r759b121],
4	Nooter	NNP	PERSON	Nooter	nn	5	SENT_1159	[p32l803t25r1120b108],
5	K	NNP	PERSON	K	appos	2	SENT_1159	[p32l1157t25r1261b121],
6	,	,	O	,	_	0	SENT_1159	[p32l1157t25r1261b121],
7	Sonneveld	NNP	ORGANIZATION	Sonneveld	nn	8	SENT_1159	[p32l1308t25r1787b108],
8	P	NN	ORGANIZATION	p	appos	2	SENT_1159	[p32l1824t28r1910b121],
9	,	,	O	,	_	0	SENT_1159	[p32l1824t28r1910b121],
10	Van	NNP	LOCATION	Van	nn	11	SENT_1159	[p32l1954t28r2144b108],
11	WK	NNP	LOCATION	WK	appos	2	SENT_1159	[p32l301t138r515b231],
12	,	,	O	,	_	0	SENT_1159	[p32l301t138r515b231],
13	Zaman	NNP	PERSON	Zaman	nn	14	SENT_1159	[p32l576t138r890b218],
14	G	NNP	PERSON	G	appos	2	SENT_1159	[p32l947t138r1051b231],
15	,	,	O	,	_	0	SENT_1159	[p32l947t138r1051b231],
16	Stoter	NNP	O	Stoter	nn	17	SENT_1159	[p32l1112t138r1384b221],
17	G.	NNP	O	G.	appos	2	SENT_1159	[p32l1442t138r1543b221],
18	1994	CD	DATE	1994	dep	17	SENT_1159	[p32l1614t138r1852b221],
19	.	.	O	.	_	0	SENT_1159	[p32l1614t138r1852b221],

1	High	JJ	O	high	amod	2	SENT_1160	[p32l1917t138r2147b245],
2	expression	NN	O	expression	_	0	SENT_1160	[p32l301t248r790b355],
3	of	IN	O	of	_	0	SENT_1160	[p32l834t251r934b334],
4	the	DT	O	the	det	10	SENT_1160	[p32l971t248r1109b331],
5	multidrug	JJ	O	multidrug	amod	10	SENT_1160	[p32l1157t251r1604b358],
6	resistanceassociated	JJ	O	resistanceassociated	amod	10	SENT_1160	[p32l1655t251r2141b334, p32l305t365r769b448],
7	protein	NN	O	protein	nn	10	SENT_1160	[p32l803t365r1120b472],
8	(	CD	NUMBER	(	num	10	SENT_1160	[p32l1150t368r1463b469],
9	MRP	NN	O	mrp	nn	10	SENT_1160	[p32l1150t368r1463b469],
10	)	NN	O	)	prep_of	2	SENT_1160	[p32l1150t368r1463b469],
11	in	IN	O	in	_	0	SENT_1160	[p32l1494t368r1580b448],
12	chronic	JJ	O	chronic	amod	15	SENT_1160	[p32l1611t368r1948b448],
13	and	CC	O	and	_	0	SENT_1160	[p32l1978t368r2147b452],
14	prolymphocytic	JJ	O	prolymphocytic	conj_and	12	SENT_1160	[p32l301t479r1024b586],
15	leukaemia	NN	O	leukaemia	prep_in	10	SENT_1160	[p32l1068t482r1560b562],
16	.	.	O	.	_	0	SENT_1160	[p32l1068t482r1560b562],

1	Br	NN	O	br	_	0	SENT_1161	[p32l1611t482r1742b562],
2	.	.	O	.	_	0	SENT_1161	[p32l1611t482r1742b562],

1	J.	NNP	PERSON	J.	nn	2	SENT_1162	[p32l1789t482r1859b562],
2	Haematol	NNP	PERSON	Haematol	_	0	SENT_1162	[p32l1913t486r2140b562, p32l301t596r577b678],
3	.	.	O	.	_	0	SENT_1162	[p32l1913t486r2140b562, p32l301t596r577b678],

1	33:34	CD	NUMBER	33:34	num	2	SENT_1163	[p32l638t593r1123b681],
2	~	NN	O	~	_	0	SENT_1163	[p32l638t593r1123b681],
3	3	CD	NUMBER	3	dep	2	SENT_1163	[p32l638t593r1123b681],
4	.	.	O	.	_	0	SENT_1163	[p32l638t593r1123b681],

1	—	NN	O	—	_	0	SENT_1164	[p32l638t593r1123b681],
2	.	.	O	.	_	0	SENT_1164	[p32l638t593r1123b681],

1	.	.	O	.	_	0	SENT_1165	[p32l638t593r1123b681],

1	—	NN	O	—	_	0	SENT_1166	[p32l638t593r1123b681],
2	.	.	O	.	_	0	SENT_1166	[p32l638t593r1123b681],

1	56	CD	NUMBER	56	_	0	SENT_1167	[p32l638t593r1123b681],

1	Scheper	NNP	PERSON	Scheper	nn	2	SENT_1168	[p32l305t716r673b823],
2	RJ	NN	PERSON	rj	_	0	SENT_1168	[p32l731t719r872b816],
3	,	,	O	,	_	0	SENT_1168	[p32l731t719r872b816],
4	Broxterman	NNP	PERSON	Broxterman	nn	5	SENT_1168	[p32l937t719r1484b799],
5	HJ	NNP	O	HJ	appos	2	SENT_1168	[p32l1542t719r1694b816],
6	,	,	O	,	_	0	SENT_1168	[p32l1542t719r1694b816],
7	Scheffer	NNP	ORGANIZATION	Scheffer	nn	8	SENT_1168	[p32l1759t719r2144b803],
8	GL	NNP	ORGANIZATION	GL	appos	2	SENT_1168	[p32l305t833r477b930],
9	,	,	O	,	_	0	SENT_1168	[p32l305t833r477b930],
10	Kaaijk	NNP	ORGANIZATION	Kaaijk	nn	11	SENT_1168	[p32l532t833r835b940],
11	P	NN	ORGANIZATION	p	appos	2	SENT_1168	[p32l875t836r962b930],
12	,	,	O	,	_	0	SENT_1168	[p32l875t836r962b930],
13	Dalton	NNP	PERSON	Dalton	nn	14	SENT_1168	[p32l1009t833r1319b916],
14	WS	NNP	O	WS	appos	2	SENT_1168	[p32l1363t833r1563b933],
15	,	,	O	,	_	0	SENT_1168	[p32l1363t833r1563b933],
16	et	FW	O	et	nn	17	SENT_1168	[p32l1607t847r1690b916],
17	al.	FW	O	al.	appos	2	SENT_1168	[p32l1734t833r1835b916],
18	1993	CD	DATE	1993	dep	17	SENT_1168	[p32l1899t833r2137b920],
19	.	.	O	.	_	0	SENT_1168	[p32l1899t833r2137b920],

1	Overexpression	NN	O	overexpression	_	0	SENT_1169	[p32l305t950r1017b1057],
2	of	IN	O	of	_	0	SENT_1169	[p32l1071t950r1168b1033],
3	a	DT	O	a	det	10	SENT_1169	[p32l1215t977r1264b1033],
4	M	NN	O	m	nn	10	SENT_1169	[p32l1315t953r1529b1054],
5	(	NN	O	(	nn	10	SENT_1169	[p32l1315t953r1529b1054],
6	r	NN	O	r	nn	10	SENT_1169	[p32l1315t953r1529b1054],
7	)	CD	NUMBER	)	num	10	SENT_1169	[p32l1315t953r1529b1054],
8	110,000	CD	NUMBER	110,000	num	10	SENT_1169	[p32l1594t950r1948b1050],
9	vesicular	JJ	O	vesicular	amod	10	SENT_1169	[p32l1999t977r2140b1033, p32l308t1063r608b1146],
10	protein	NN	O	protein	prep_of	1	SENT_1169	[p32l676t1063r993b1170],
11	in	IN	O	in	_	0	SENT_1169	[p32l1061t1063r1147b1146],
12	nonPglycoproteinmediated	JJ	O	nonpglycoproteinmediated	amod	14	SENT_1169	[p32l1219t1066r2140b1173, p32l308t1177r725b1260],
13	multidrug	JJ	O	multidrug	amod	14	SENT_1169	[p32l776t1177r1223b1284],
14	resistance	NN	O	resistance	prep_in	10	SENT_1169	[p32l1277t1180r1749b1264],
15	.	.	O	.	_	0	SENT_1169	[p32l1277t1180r1749b1264],

1	Cancer	NN	O	cancer	_	0	SENT_1170	[p32l1814t1180r2147b1264],
2	Res	NNP	O	Res	dep	1	SENT_1170	[p32l305t1297r487b1377],
3	.	.	O	.	_	0	SENT_1170	[p32l305t1297r487b1377],

1	53:14	NN	O	53:14	_	0	SENT_1171	[p32l542t1294r1085b1380],
2	'	''	DATE	'	_	0	SENT_1171	[p32l542t1294r1085b1380],
3	75	CD	DATE	75	number	4	SENT_1171	[p32l542t1294r1085b1380],
4	—	CD	NUMBER	—	dep	1	SENT_1171	[p32l542t1294r1085b1380],
5	79	CD	NUMBER	79	dep	4	SENT_1171	[p32l542t1294r1085b1380],

1	Scheffer	NNP	ORGANIZATION	Scheffer	nn	2	SENT_1172	[p32l308t1408r690b1491],
2	GL	NNP	ORGANIZATION	GL	_	0	SENT_1172	[p32l724t1411r903b1505],
3	,	,	O	,	_	0	SENT_1172	[p32l724t1411r903b1505],
4	Wijngaard	NNP	O	Wijngaard	nn	6	SENT_1172	[p32l937t1411r1419b1515],
5	PL	NNP	O	PL	nn	6	SENT_1172	[p32l1456t1411r1656b1508],
6	]	NNP	O	]	appos	2	SENT_1172	[p32l1456t1411r1656b1508],
7	,	,	O	,	_	0	SENT_1172	[p32l1456t1411r1656b1508],
8	Flens	NNP	ORGANIZATION	Flens	nn	9	SENT_1172	[p32l1693t1411r1934b1491],
9	MJ	NNP	ORGANIZATION	MJ	appos	2	SENT_1172	[p32l1972t1415r2140b1508],
10	,	,	O	,	_	0	SENT_1172	[p32l1972t1415r2140b1508],
11	Izquierdo	NNP	PERSON	Izquierdo	nn	12	SENT_1172	[p32l308t1535r742b1642],
12	MA	NNP	PERSON	MA	appos	2	SENT_1172	[p32l779t1538r986b1632],
13	,	,	O	,	_	0	SENT_1172	[p32l779t1538r986b1632],
14	Slovak	NNP	MISC	Slovak	nn	15	SENT_1172	[p32l1033t1538r1347b1618],
15	ML	NNP	O	ML	appos	2	SENT_1172	[p32l1384t1538r1580b1632],
16	,	,	O	,	_	0	SENT_1172	[p32l1384t1538r1580b1632],
17	et	FW	O	et	nn	18	SENT_1172	[p32l1625t1552r1704b1618],
18	al.	FW	O	al.	appos	2	SENT_1172	[p32l1741t1538r1842b1618],
19	1995	CD	DATE	1995	dep	18	SENT_1172	[p32l1899t1538r2140b1622],
20	.	.	O	.	_	0	SENT_1172	[p32l1899t1538r2140b1622],

1	The	DT	O	the	det	3	SENT_1173	[p32l305t1656r481b1736],
2	drug	NN	O	drug	nn	3	SENT_1173	[p32l514t1656r718b1760],
3	resistance	NN	O	resistance	nsubj	11	SENT_1173	[p32l755t1653r1206b1736],
4	related	JJ	O	related	amod	6	SENT_1173	[p32l1236t1656r1546b1736],
5	protein	NN	O	protein	nn	6	SENT_1173	[p32l1583t1656r1903b1760],
6	LRP	NN	ORGANIZATION	lrp	dep	3	SENT_1173	[p32l1934t1656r2147b1740],
7	is	VBZ	O	be	cop	11	SENT_1173	[p32l308t1767r377b1850],
8	a	DT	O	a	det	11	SENT_1173	[p32l456t1794r505b1850],
9	major	JJ	O	major	amod	11	SENT_1173	[p32l580t1767r845b1874],
10	vault	NN	O	vault	nn	11	SENT_1173	[p32l920t1767r1144b1850],
11	protein	NN	O	protein	_	0	SENT_1173	[p32l1219t1767r1560b1874],
12	.	.	O	.	_	0	SENT_1173	[p32l1219t1767r1560b1874],

1	Prcc	NNP	O	Prcc	_	0	SENT_1174	[p32l1642t1770r1879b1850],
2	.	.	O	.	_	0	SENT_1174	[p32l1642t1770r1879b1850],

1	Am	NNP	O	Am	_	0	SENT_1175	[p32l1961t1770r2134b1850],
2	.	.	O	.	_	0	SENT_1175	[p32l1961t1770r2134b1850],

1	Assoc	NNP	O	Assoc	_	0	SENT_1176	[p32l301t1884r587b1961],
2	.	.	O	.	_	0	SENT_1176	[p32l301t1884r587b1961],

1	Cancer	NN	O	cancer	_	0	SENT_1177	[p32l648t1881r982b1964],
2	Res	NNP	O	Res	dep	1	SENT_1177	[p32l1020t1884r1202b1964],
3	.	.	O	.	_	0	SENT_1177	[p32l1020t1884r1202b1964],

1	363323	CD	NUMBER	363323	_	0	SENT_1178	[p32l1264t1884r1570b1968],
2	(	CD	NUMBER	(	num	3	SENT_1178	[p32l1625t1884r1976b1988],
3	Abst1	NN	O	abst1	dep	1	SENT_1178	[p32l1625t1884r1976b1988],
4	'	''	O	'	_	0	SENT_1178	[p32l1625t1884r1976b1988],
5	.	.	O	.	_	0	SENT_1178	[p32l1625t1884r1976b1988],
6	)	SYM	O	)	prep	3	SENT_1178	[p32l1625t1884r1976b1988],

1	Kedersha	NNP	ORGANIZATION	Kedersha	nn	2	SENT_1179	[p32l312t2001r738b2080],
2	NL	NNP	ORGANIZATION	NL	_	0	SENT_1179	[p32l762t2001r938b2094],
3	,	,	O	,	_	0	SENT_1179	[p32l762t2001r938b2094],
4	Rome	NNP	LOCATION	Rome	nn	5	SENT_1179	[p32l968t2001r1237b2080],
5	LH	NNP	O	LH	appos	2	SENT_1179	[p32l1264t2001r1436b2080],
6	.	.	O	.	_	0	SENT_1179	[p32l1264t2001r1436b2080],

1	1986	CD	DATE	1986	_	0	SENT_1180	[p32l1480t2001r1718b2084],
2	.	.	O	.	_	0	SENT_1180	[p32l1480t2001r1718b2084],

1	Isolation	NN	O	isolation	_	0	SENT_1181	[p32l1748t2001r2147b2080],
2	and	CC	O	and	_	0	SENT_1181	[p32l308t2115r467b2194],
3	characterization	NN	O	characterization	conj_and	1	SENT_1181	[p32l514t2115r1243b2197],
4	of	IN	O	of	_	0	SENT_1181	[p32l1284t2115r1384b2197],
5	a	DT	O	a	det	7	SENT_1181	[p32l1425t2142r1474b2197],
6	novel	JJ	O	novel	amod	7	SENT_1181	[p32l1518t2115r1766b2197],
7	ribonucleoprotein	NN	O	ribonucleoprotein	prep_of	1	SENT_1181	[p32l1810t2115r2144b2197, p32l308t2228r817b2335],

1	particle	NN	O	particle	_	0	SENT_1182	[p32l916t2228r1278b2335],
2	:	:	O	:	_	0	SENT_1182	[p32l916t2228r1278b2335],
3	large	JJ	O	large	amod	4	SENT_1182	[p32l1384t2228r1608b2335],
4	structures	NNS	O	structure	nsubj	5	SENT_1182	[p32l1707t2242r2144b2315],
5	contain	VBP	O	contain	dep	1	SENT_1182	[p32l308t2345r642b2428],
6	a	DT	O	a	det	8	SENT_1182	[p32l686t2372r735b2428],
7	single	JJ	O	single	amod	8	SENT_1182	[p32l776t2345r1044b2452],
8	species	NNS	O	species	dobj	5	SENT_1182	[p32l1088t2348r1412b2452],
9	of	IN	O	of	_	0	SENT_1182	[p32l1456t2345r1556b2428],
10	small	JJ	O	small	amod	11	SENT_1182	[p32l1594t2348r1831b2428],
11	RNA	NN	O	rna	prep_of	8	SENT_1182	[p32l1879t2348r2141b2428],
12	.	.	O	.	_	0	SENT_1182	[p32l1879t2348r2141b2428],

1	J.	NNP	O	J.	nn	3	SENT_1183	[p32l305t2462r374b2542],
2	Cell	NNP	O	Cell	nn	3	SENT_1183	[p32l432t2459r618b2542],
3	Biol	NNP	O	Biol	_	0	SENT_1183	[p32l662t2462r869b2542],
4	.	.	O	.	_	0	SENT_1183	[p32l662t2462r869b2542],

1	103:699	CD	NUMBER	103:699	num	2	SENT_1184	[p32l937t2459r1529b2545],
2	—	NN	O	—	_	0	SENT_1184	[p32l937t2459r1529b2545],
3	709	CD	NUMBER	709	dep	2	SENT_1184	[p32l937t2459r1529b2545],

1	Vasu	NNP	PERSON	Vasu	nn	2	SENT_1185	[p32l308t2573r536b2656],
2	SK	NNP	PERSON	SK	_	0	SENT_1185	[p32l618t2573r783b2673],
3	,	,	O	,	_	0	SENT_1185	[p32l618t2573r783b2673],
4	Kedersha	NNP	ORGANIZATION	Kedersha	nn	5	SENT_1185	[p32l868t2573r1295b2659],
5	NL	NNP	ORGANIZATION	NL	appos	2	SENT_1185	[p32l1370t2576r1542b2673],
6	,	,	O	,	_	0	SENT_1185	[p32l1370t2576r1542b2673],
7	Rome	NNP	LOCATION	Rome	nn	8	SENT_1185	[p32l1625t2576r1890b2659],
8	LH	NNP	O	LH	appos	5	SENT_1185	[p32l1968t2576r2140b2659],
9	.	.	O	.	_	0	SENT_1185	[p32l1968t2576r2140b2659],

1	1993	CD	DATE	1993	_	0	SENT_1186	[p32l319t2693r556b2779],
2	.	.	O	.	_	0	SENT_1186	[p32l319t2693r556b2779],

1	cDNA	NN	O	cdna	nn	2	SENT_1187	[p32l607t2696r903b2776],
2	cloning	NN	O	cloning	_	0	SENT_1187	[p32l951t2693r1292b2800],
3	and	CC	O	and	_	0	SENT_1187	[p32l1339t2696r1501b2779],
4	disruption	NN	O	disruption	conj_and	2	SENT_1187	[p32l1545t2693r2010b2803],
5	of	IN	O	of	_	0	SENT_1187	[p32l2054t2696r2154b2779],
6	the	DT	O	the	det	9	SENT_1187	[p32l308t2810r450b2890],
7	major	JJ	O	major	amod	9	SENT_1187	[p32l494t2810r755b2917],
8	vault	NN	O	vault	nn	9	SENT_1187	[p32l800t2810r1024b2893],
9	protein	NN	O	protein	prep_of	2	SENT_1187	[p32l1068t2810r1391b2917],
10	a	DT	O	a	det	14	SENT_1187	[p32l1439t2834r1488b2893],
11	gene	NN	O	gene	nn	14	SENT_1187	[p32l1528t2834r1745b2917],
12	(	NN	O	(	nn	14	SENT_1187	[p32l1786t2810r2147b2917],
13	mvpA	NN	O	mvpa	nn	14	SENT_1187	[p32l1786t2810r2147b2917],
14	)	NN	O	)	dep	2	SENT_1187	[p32l1786t2810r2147b2917],
15	in	IN	O	in	_	0	SENT_1187	[p32l312t2924r395b3007],
16	Dictyosrelium	NNP	O	Dictyosrelium	nn	17	SENT_1187	[p32l463t2924r1096b3027],
17	discoidewn	NN	O	discoidewn	prep_in	14	SENT_1187	[p32l1164t2924r1711b3007],
18	.	.	O	.	_	0	SENT_1187	[p32l1164t2924r1711b3007],

1	J.	NNP	O	J.	nn	2	SENT_1188	[p32l1783t2924r1848b3007],
2	Biol	NNP	O	Biol	_	0	SENT_1188	[p32l1930t2924r2137b3007],
3	.	.	O	.	_	0	SENT_1188	[p32l1930t2924r2137b3007],

1	Chem	NNP	O	Chem	_	0	SENT_1189	[p32l315t3040r590b3123],
2	.	.	O	.	_	0	SENT_1189	[p32l315t3040r590b3123],

1	268	CD	NUMBER	268	_	0	SENT_1190	[p32l648t3040r1305b3126],
2	:	:	O	:	_	0	SENT_1190	[p32l648t3040r1305b3126],
3	l5356	CD	NUMBER	l5356	num	5	SENT_1190	[p32l648t3040r1305b3126],
4	—	CD	NUMBER	—	num	5	SENT_1190	[p32l648t3040r1305b3126],
5	6O	NN	O	6o	dep	1	SENT_1190	[p32l648t3040r1305b3126],

1	Chugani	NNP	PERSON	Chugani	nn	2	SENT_1191	[p32l312t3157r690b3260],
2	DC	NNP	O	DC	_	0	SENT_1191	[p32l738t3157r917b3253],
3	,	,	O	,	_	0	SENT_1191	[p32l738t3157r917b3253],
4	Rome	NNP	LOCATION	Rome	nn	5	SENT_1191	[p32l965t3157r1233b3236],
5	LH	NNP	O	LH	appos	2	SENT_1191	[p32l1277t3157r1453b3250],
6	,	,	O	,	_	0	SENT_1191	[p32l1277t3157r1453b3250],
7	Kedersha	NNP	ORGANIZATION	Kedersha	nn	8	SENT_1191	[p32l1501t3157r1931b3240],
8	NL	NNP	ORGANIZATION	NL	appos	5	SENT_1191	[p32l1972t3160r2144b3240],
9	.	.	O	.	_	0	SENT_1191	[p32l1972t3160r2144b3240],

1	1993	CD	DATE	1993	_	0	SENT_1192	[p32l322t3267r556b3353],
2	.	.	O	.	_	0	SENT_1192	[p32l322t3267r556b3353],

1	Evidence	NN	O	evidence	_	0	SENT_1193	[p32l624t3267r1044b3350],
2	that	WDT	O	that	nsubj	3	SENT_1193	[p32l1109t3270r1274b3350],
3	vault	VBP	O	vault	dep	1	SENT_1193	[p32l1339t3270r1563b3350],
4	ribonucleoprotein	NN	O	ribonucleoprotein	dobj	3	SENT_1193	[p32l1625t3270r2147b3350, p32l312t3384r628b3491],

1	particles	NNS	O	particle	nsubj	2	SENT_1194	[p32l710t3384r1096b3491],
2	localize	VBP	O	localize	_	0	SENT_1194	[p32l1181t3387r1536b3471],
3	to	TO	O	to	_	0	SENT_1194	[p32l1614t3401r1701b3471],
4	the	DT	O	the	det	6	SENT_1194	[p32l1779t3387r1917b3467],
5	nucleopore	NN	O	nucleopore	nn	6	SENT_1194	[p32l1999t3411r2147b3471, p32l312t3501r700b3604],
6	complex	NN	O	complex	prep_to	2	SENT_1194	[p32l779t3501r1195b3604],
7	.	.	O	.	_	0	SENT_1194	[p32l779t3501r1195b3604],

1	J.	NNP	O	J.	nn	3	SENT_1195	[p32l1274t3501r1343b3584],
2	Cell	NNP	O	Cell	nn	3	SENT_1195	[p32l1439t3501r1625b3584],
3	Sci	NNP	O	Sci	_	0	SENT_1195	[p32l1704t3504r1859b3584],
4	.	.	O	.	_	0	SENT_1195	[p32l1704t3504r1859b3584],

1	106	CD	NUMBER	106	_	0	SENT_1196	[p32l1958t3501r2144b3584],
2	:	:	O	:	_	0	SENT_1196	[p32l1958t3501r2144b3584],
3	23-29	CD	DATE	23-29	dep	1	SENT_1196	[p32l312t3611r594b3697],

1	Kedersha	NNP	ORGANIZATION	Kedersha	nn	2	SENT_1197	[p33l315t28r742b108],
2	NL	NNP	ORGANIZATION	NL	_	0	SENT_1197	[p33l779t28r955b125],
3	,	,	O	,	_	0	SENT_1197	[p33l779t28r955b125],
4	Heuser	NNP	PERSON	Heuser	nn	5	SENT_1197	[p33l999t28r1323b108],
5	JE	NNP	O	JE	appos	2	SENT_1197	[p33l1356t28r1494b125],
6	,	,	O	,	_	0	SENT_1197	[p33l1356t28r1494b125],
7	Chugani	NNP	ORGANIZATION	Chugani	nn	8	SENT_1197	[p33l1539t25r1924b132],
8	DC	NNP	ORGANIZATION	DC	appos	2	SENT_1197	[p33l1965t28r2147b125],
9	,	,	O	,	_	0	SENT_1197	[p33l1965t28r2147b125],
10	Rome	NNP	LOCATION	Rome	nn	11	SENT_1197	[p33l312t142r580b224],
11	LH	NNP	O	LH	appos	2	SENT_1197	[p33l631t142r804b224],
12	.	.	O	.	_	0	SENT_1197	[p33l631t142r804b224],

1	1991	CD	DATE	1991	_	0	SENT_1198	[p33l875t142r1113b224],
2	.	.	O	.	_	0	SENT_1198	[p33l875t142r1113b224],

1	Vaults	NNS	O	vault	_	0	SENT_1199	[p33l1171t142r1487b224],
2	.	.	O	.	_	0	SENT_1199	[p33l1171t142r1487b224],

1	III	NNP	O	III	_	0	SENT_1200	[p33l1549t142r1680b224],
2	.	.	O	.	_	0	SENT_1200	[p33l1549t142r1680b224],

1	Vault	NNP	O	Vault	nn	3	SENT_1201	[p33l1741t142r1993b224],
2	ribonucleopretein	NN	O	ribonucleopretein	nn	3	SENT_1201	[p33l2047t142r2147b224, p33l312t255r1048b362],
3	particles	NNS	O	particle	nsubj	4	SENT_1201	[p33l1160t255r1543b362],
4	open	JJ	O	open	_	0	SENT_1201	[p33l1652t279r1866b362],
5	into	IN	O	into	_	0	SENT_1201	[p33l1978t255r2151b338],
6	flower-like	JJ	O	flower-like	amod	7	SENT_1201	[p33l312t373r814b456],
7	structures	NNS	O	structure	prep_into	4	SENT_1201	[p33l903t390r1340b456],
8	with	IN	O	with	_	0	SENT_1201	[p33l1425t373r1625b456],
9	octagonal	JJ	O	octagonal	amod	10	SENT_1201	[p33l1707t376r2147b480],
10	symmetry	NN	O	symmetry	prep_with	4	SENT_1201	[p33l315t504r790b597],
11	.	.	O	.	_	0	SENT_1201	[p33l315t504r790b597],

1	J.	NNP	O	J.	nn	3	SENT_1202	[p33l837t490r907b573],
2	Cell	NNP	O	Cell	nn	3	SENT_1202	[p33l965t490r1151b573],
3	Biol	NNP	O	Biol	_	0	SENT_1202	[p33l1195t490r1402b573],
4	.	.	O	.	_	0	SENT_1202	[p33l1195t490r1402b573],

1	ll2	NN	O	ll2	nn	5	SENT_1203	[p33l1470t490r2000b573],
2	:225	CD	NUMBER	:225	num	5	SENT_1203	[p33l1470t490r2000b573],
3	-35	CD	NUMBER	-35	num	5	SENT_1203	[p33l1470t490r2000b573],
4	Slovak	NNP	MISC	Slovak	nn	5	SENT_1203	[p33l315t604r628b687],
5	ML	NNP	O	ML	_	0	SENT_1203	[p33l693t607r886b704],
6	,	,	O	,	_	0	SENT_1203	[p33l693t607r886b704],
7	Ho	NNP	PERSON	Ho	nn	8	SENT_1203	[p33l958t607r1096b687],
8	J	NNP	PERSON	J	appos	5	SENT_1203	[p33l1161t607r1226b701],
9	,	,	O	,	_	0	SENT_1203	[p33l1161t607r1226b701],
10	Deeley	NNP	PERSON	Deeley	nn	11	SENT_1203	[p33l1298t604r1618b711],
11	RG	NNP	O	RG	appos	5	SENT_1203	[p33l1686t604r1866b701],
12	,	,	O	,	_	0	SENT_1203	[p33l1686t604r1866b701],
13	Cole	NNP	ORGANIZATION	Cole	nn	14	SENT_1203	[p33l1937t604r2151b691],
14	SPC	NNP	ORGANIZATION	SPC	appos	5	SENT_1203	[p33l315t721r539b817],
15	,	,	O	,	_	0	SENT_1203	[p33l315t721r539b817],
16	de	FW	O	de	appos	5	SENT_1203	[p33l600t721r700b804],
17	Vries	NNP	ORGANIZATION	Vries	nn	18	SENT_1203	[p33l758t721r1003b804],
18	EGE	NNP	ORGANIZATION	EGE	dep	16	SENT_1203	[p33l1057t721r1305b817],
19	,	,	O	,	_	0	SENT_1203	[p33l1057t721r1305b817],
20	et	FW	O	et	nn	21	SENT_1203	[p33l1363t738r1446b804],
21	al.	FW	O	al.	appos	5	SENT_1203	[p33l1504t721r1604b804],
22	1995	CD	DATE	1995	dep	21	SENT_1203	[p33l1676t721r1914b807],
23	.	.	O	.	_	0	SENT_1203	[p33l1676t721r1914b807],

1	The	DT	O	the	det	3	SENT_1204	[p33l1975t724r2151b804],
2	drug	NN	O	drug	nn	3	SENT_1204	[p33l312t848r518b952],
3	resistance	NN	O	resistance	_	0	SENT_1204	[p33l607t848r1051b931],
4	related	JJ	O	related	amod	6	SENT_1204	[p33l1140t848r1450b931],
5	protein	NN	O	protein	nn	6	SENT_1204	[p33l1539t848r1859b955],
6	LRP	NN	O	lrp	dep	3	SENT_1204	[p33l1941t851r2154b931],

1	Annual	JJ	SET	annual	amod	2	SENT_1205	[p33l461t1036r582b1065],
2	Reviews	NNS	O	review	nsubj	3	SENT_1205	[p33l594t1036r736b1074],
3	_	VBP	O	_	_	0	SENT_1205	[p33l968t1070r973b1074],
4	www.annua1rev1ews.org	NN	O	www.annua1rev1ews.org	dobj	3	SENT_1205	[p33l461t1070r880b1108],
5	/	:	O	/	punct	6	SENT_1205	[p33l461t1070r880b1108],
6	aronhne	NN	O	aronhne	dep	4	SENT_1205	[p33l881t1070r1015b1099],

1	P-GLYCOPROTEINS	NNPS	O	P-GLYCOPROTEINS	_	0	SENT_1206	[p33l877t1185r1217b1213],
2	AND	CC	O	and	_	0	SENT_1206	[p33l1227t1186r1308b1212],
3	DRUG	NN	O	drug	nn	4	SENT_1206	[p33l1318t1185r1424b1212],
4	RESISTANCE	NN	O	resistance	conj_and	1	SENT_1206	[p33l1433t1185r1661b1212],
5	183	CD	NUMBER	183	dep	1	SENT_1206	[p33l1734t1185r1785b1212],

1	maps	NNS	O	map	_	0	SENT_1207	[p33l575t1280r644b1303],
2	proximal	JJ	O	proximal	amod	15	SENT_1207	[p33l653t1272r772b1303],
3	to	TO	O	to	_	0	SENT_1207	[p33l780t1276r807b1296],
4	MRP	NN	ORGANIZATION	mrp	prep_to	2	SENT_1207	[p33l814t1273r886b1296],
5	on	IN	O	on	_	0	SENT_1207	[p33l893t1279r926b1296],
6	the	DT	O	the	det	8	SENT_1207	[p33l934t1272r975b1296],
7	short	JJ	O	short	amod	8	SENT_1207	[p33l983t1272r1049b1295],
8	arm	NN	O	arm	prep_on	4	SENT_1207	[p33l1057t1279r1108b1295],
9	with	IN	O	with	_	0	SENT_1207	[p33l1251t1272r1308b1295],
10	non-P-glycoprotein	JJ	O	non-p-glycoprotein	amod	13	SENT_1207	[p33l1325t1271r1584b1302],
11	mu	NN	O	mu	nn	13	SENT_1207	[p33l1601t1278r1642b1295],
12	‘	NN	O	‘	nn	13	SENT_1207	[p33l1663t1271r1732b1301],
13	drug	NN	O	drug	prep_with	8	SENT_1207	[p33l1663t1271r1732b1301],
14	rcof	NN	O	rcof	nn	15	SENT_1207	[p33l1748t1278r1784b1294, p33l575t1305r604b1329],
15	chromosome	NN	O	chromosome	dep	1	SENT_1207	[p33l618t1305r791b1329],
16	16	CD	NUMBER	16	dep	15	SENT_1207	[p33l809t1305r846b1329],
17	.	.	O	.	_	0	SENT_1207	[p33l809t1305r846b1329],

1	Proc	NNP	O	Proc	_	0	SENT_1208	[p33l864t1305r934b1329],
2	.	.	O	.	_	0	SENT_1208	[p33l864t1305r934b1329],

1	Am	NNP	O	Am	_	0	SENT_1209	[p33l951t1305r1003b1329],
2	.	.	O	.	_	0	SENT_1209	[p33l951t1305r1003b1329],

1	Assoc	NNP	O	Assoc	_	0	SENT_1210	[p33l1020t1305r1105b1329],
2	.	.	O	.	_	0	SENT_1210	[p33l1020t1305r1105b1329],

1	sistance	NN	O	sistance	_	0	SENT_1211	[p33l1251t1304r1361b1329],
2	.	.	O	.	_	0	SENT_1211	[p33l1251t1304r1361b1329],

1	Proc	NNP	O	Proc	_	0	SENT_1212	[p33l1374t1304r1443b1328],
2	.	.	O	.	_	0	SENT_1212	[p33l1374t1304r1443b1328],

1	Am	NNP	O	Am	_	0	SENT_1213	[p33l1457t1305r1508b1328],
2	.	.	O	.	_	0	SENT_1213	[p33l1457t1305r1508b1328],

1	Assoc	NNP	O	Assoc	_	0	SENT_1214	[p33l1520t1304r1605b1328],
2	.	.	O	.	_	0	SENT_1214	[p33l1520t1304r1605b1328],

1	ancer	NN	O	ancer	_	0	SENT_1215	[p33l1642t1311r1719b1328],
2	Res	NNP	O	Res	dep	1	SENT_1215	[p33l1728t1304r1782b1328],
3	.	.	O	.	_	0	SENT_1215	[p33l1728t1304r1782b1328],

1	Cancer	NN	O	cancer	nn	2	SENT_1216	[p33l576t1339r674b1364],
2	es	NNS	O	e	_	0	SENT_1216	[p33l706t1347r738b1363],
3	.	.	O	.	_	0	SENT_1216	[p33l706t1347r738b1363],

1	36:19	CD	NUMBER	36:19	_	0	SENT_1217	[p33l754t1339r830b1364],
2	(	CD	NUMBER	(	dep	1	SENT_1217	[p33l842t1339r946b1369],
3	Abstn	NNP	O	Abstn	rcmod	2	SENT_1217	[p33l842t1339r946b1369],
4	)	CD	NUMBER	)	rcmod	3	SENT_1217	[p33l842t1339r946b1369],
5	351344	CD	NUMBER	351344	dep	7	SENT_1217	[p33l1251t1339r1341b1364],
6	(	NN	O	(	amod	5	SENT_1217	[p33l1355t1339r1458b1369],
7	Abstr	NN	PERSON	abstr	dep	4	SENT_1217	[p33l1355t1339r1458b1369],
8	.	.	O	.	_	0	SENT_1217	[p33l1355t1339r1458b1369],
9	)	SYM	O	)	dep	3	SENT_1217	[p33l1355t1339r1458b1369],

1	R	NN	O	r	nn	2	SENT_1218	[p33l1251t1376r1273b1400],
2	n	NN	O	n	_	0	SENT_1218	[p33l1289t1383r1304b1400],

1	126	CD	NUMBER	126	_	0	SENT_1219	[p33l490t1376r543b1401],
2	.	.	O	.	_	0	SENT_1219	[p33l490t1376r543b1401],

1	Scheper	NNP	PERSON	Scheper	_	0	SENT_1220	[p33l576t1376r683b1412],
2	,	,	O	,	_	0	SENT_1220	[p33l739t1396r746b1405],
3	Scheffer	NNP	ORGANIZATION	Scheffer	nn	4	SENT_1220	[p33l769t1376r882b1401],
4	GL	NNP	ORGANIZATION	GL	appos	1	SENT_1220	[p33l903t1376r955b1405],
5	,	,	O	,	_	0	SENT_1220	[p33l903t1376r955b1405],
6	Flens	NNP	O	Flens	nn	7	SENT_1220	[p33l977t1376r1049b1400],
7	M	NNP	O	M	appos	1	SENT_1220	[p33l1070t1376r1108b1404],
8	,	,	O	,	_	0	SENT_1220	[p33l1070t1376r1108b1404],
9	127	CD	NUMBER	127	appos	1	SENT_1220	[p33l1165t1376r1218b1400],
10	.	.	O	.	_	0	SENT_1220	[p33l1165t1376r1218b1400],

1	o	NN	O	o	nn	2	SENT_1221	[p33l1273t1383r1290b1400],
2	inson	NN	O	inson	_	0	SENT_1221	[p33l1306t1375r1377b1400],
3	,	,	O	,	_	0	SENT_1221	[p33l1424t1395r1430b1404],
4	ed	VBN	O	ed	partmod	2	SENT_1221	[p33l1444t1376r1482b1400],
5	.	.	O	.	_	0	SENT_1221	[p33l1444t1376r1482b1400],

1	1991	CD	DATE	1991	_	0	SENT_1222	[p33l1500t1375r1569b1400],
2	.	.	O	.	_	0	SENT_1222	[p33l1500t1375r1569b1400],

1	Molecular	JJ	O	molecular	_	0	SENT_1223	[p33l1583t1374r1724b1399],
2	and	CC	O	and	_	0	SENT_1223	[p33l1736t1374r1788b1398],
3	f	SYM	O	f	conj_and	1	SENT_1223	[p33l1515t1412r1535b1443],
4	Multidru	FW	O	multidru	nn	6	SENT_1223	[p33l1549t1411r1668b1436],
5	exisIzquierdo	FW	O	exisizquierdo	nn	6	SENT_1223	[p33l1725t1412r1784b1436, p33l575t1414r702b1445],
6	MA	NN	O	ma	dep	1	SENT_1223	[p33l717t1414r778b1442],
7	,	,	O	,	_	0	SENT_1223	[p33l717t1414r778b1442],
8	van	NN	PERSON	van	appos	6	SENT_1223	[p33l795t1421r842b1438],
9	der	FW	PERSON	der	nn	11	SENT_1223	[p33l857t1414r901b1438],
10	Valk	FW	PERSON	valk	nn	11	SENT_1223	[p33l915t1413r981b1438],
11	P	NN	O	p	dep	8	SENT_1223	[p33l995t1414r1022b1442],
12	,	,	O	,	_	0	SENT_1223	[p33l995t1414r1022b1442],
13	et	FW	O	et	nn	14	SENT_1223	[p33l1037t1417r1062b1438],
14	al.	FW	O	al.	appos	6	SENT_1223	[p33l1076t1413r1107b1437],
15	.	.	O	.	_	0	SENT_1223	[p33l1076t1413r1107b1437],

1	Cellular	JJ	O	cellular	nn	4	SENT_1224	[p33l1252t1412r1362b1437],
2	'	''	O	'	_	0	SENT_1224	[p33l1406t1413r1427b1436],
3	o	NN	O	o	nn	4	SENT_1224	[p33l1406t1413r1427b1436],
4	ogy	NN	O	ogy	nsubj	5	SENT_1224	[p33l1437t1420r1484b1443],
5	o	NN	O	o	_	0	SENT_1224	[p33l1504t1420r1520b1436],
6	1994	CD	DATE	1994	dobj	5	SENT_1224	[p33l578t1451r648b1475],
7	.	.	O	.	_	0	SENT_1224	[p33l578t1451r648b1475],

1	Molec	NNP	O	Molec	_	0	SENT_1225	[p33l669t1451r755b1475],
2	at	IN	O	at	advmod	1	SENT_1225	[p33l780t1458r807b1475],
3	and	CC	O	and	_	0	SENT_1225	[p33l826t1451r874b1475],
4	clinical	JJ	O	clinical	amod	5	SENT_1225	[p33l893t1450r991b1474],
5	charac	NN	O	charac	conj_and	1	SENT_1225	[p33l1011t1451r1108b1474],
6	-	:	O	-	_	0	SENT_1225	[p33l1011t1451r1108b1474],
7	tance	NN	O	tance	dep	1	SENT_1225	[p33l1252t1455r1322b1474],
8	in	IN	O	in	_	0	SENT_1225	[p33l1336t1451r1361b1474],
9	Tumor	NN	O	tumor	nn	10	SENT_1225	[p33l1375t1450r1465b1474],
10	Cells	NNS	O	cell	prep_in	7	SENT_1225	[p33l1477t1450r1548b1474],
11	.	.	O	.	_	0	SENT_1225	[p33l1477t1450r1548b1474],

1	New	NNP	O	New	nn	2	SENT_1226	[p33l1565t1450r1627b1473],
2	Yor	NNP	O	Yor	_	0	SENT_1226	[p33l1642t1450r1693b1473],
3	:	:	O	:	_	0	SENT_1226	[p33l1712t1457r1717b1473],
4	Pleterization	NN	O	pleterization	nn	7	SENT_1226	[p33l1733t1449r1785b1473, p33l575t1487r702b1512],
5	o	NN	O	o	nn	7	SENT_1226	[p33l710t1495r727b1512],
6	LRP	NN	O	lrp	nn	7	SENT_1226	[p33l798t1488r860b1511],
7	protein	NN	O	protein	dep	2	SENT_1226	[p33l869t1487r963b1518],
8	associated	VBN	O	associate	partmod	7	SENT_1226	[p33l973t1486r1110b1511],
9	num	NN	O	num	dobj	8	SENT_1226	[p33l1252t1493r1309b1511],

1	An	DT	O	a	det	2	SENT_1227	[p33l371t2946r394b2985],
2	nu	NN	O	nu	_	0	SENT_1227	[p33l378t2897r394b2937],
3	.	.	O	.	_	0	SENT_1227	[p33l378t2897r394b2937],

1	Rev.	NNP	O	Rev.	nn	2	SENT_1228	[p33l371t2826r394b2886],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_1228	[p33l371t2667r394b2816],
3	.	.	O	.	_	0	SENT_1228	[p33l371t2667r394b2816],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_1229	[p33l371t2546r394b2656],
2	.	.	O	.	_	0	SENT_1229	[p33l371t2546r394b2656],

1	1996.36	CD	NUMBER	1996.36	_	0	SENT_1230	[p33l371t2418r395b2530],
2	:	:	O	:	_	0	SENT_1230	[p33l371t2418r395b2530],
3	161-183	CD	NUMBER	161-183	dep	1	SENT_1230	[p33l371t2297r394b2411],
4	.	.	O	.	_	0	SENT_1230	[p33l371t2297r394b2411],

1	Do	VB	O	do	aux	2	SENT_1231	[p33l371t2247r394b2286],
2	wnloaded	VBN	O	wnload	_	0	SENT_1231	[p33l371t2073r394b2202],
3	from	IN	O	from	_	0	SENT_1231	[p33l371t1999r394b2064],
4	www	NN	O	www	prep_from	2	SENT_1231	[p33l378t1870r394b1991],
5	.	.	O	.	_	0	SENT_1231	[p33l378t1870r394b1991],

1	a.	IN	O	a.	_	0	SENT_1232	[p33l378t1870r394b1991],
2	n1	NN	O	n1	nn	4	SENT_1232	[p33l378t1870r394b1991],
3	iualrevi	NN	O	iualrevus	nn	4	SENT_1232	[p33l371t1720r394b1821],
4	ews	NNS	O	ew	pobj	1	SENT_1232	[p33l378t1643r394b1701],
5	.	.	O	.	_	0	SENT_1232	[p33l378t1643r394b1701],

1	org	NN	O	org	_	0	SENT_1233	[p33l378t1593r401b1636],
2	by	IN	O	by	_	0	SENT_1233	[p33l404t2810r435b2842],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_1233	[p33l404t2660r435b2800],
4	of	IN	ORGANIZATION	of	_	0	SENT_1233	[p33l404t2621r428b2650],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	3	SENT_1233	[p33l404t2471r428b2615],
6	-	:	O	-	_	0	SENT_1233	[p33l418t2453r421b2462],
7	Madison	NNP	PERSON	Madison	dep	1	SENT_1233	[p33l404t2325r428b2443],
8	on	IN	O	on	_	0	SENT_1233	[p33l412t2284r428b2316],
9	01	CD	NUMBER	01	prep_on	7	SENT_1233	[p33l404t2246r428b2275],
10	/	:	O	/	punct	1	SENT_1233	[p33l404t2147r428b2199],
11	O5	CD	NUMBER	o5	dep	1	SENT_1233	[p33l404t2147r428b2199],
12	/	:	O	/	punct	11	SENT_1233	[p33l404t2147r428b2199],
13	14	CD	NUMBER	14	dep	11	SENT_1233	[p33l404t2107r428b2143],
14	.	.	O	.	_	0	SENT_1233	[p33l404t2107r428b2143],

1	For	IN	O	for	_	0	SENT_1234	[p33l405t2050r428b2096],
2	personal	JJ	O	personal	amod	3	SENT_1234	[p33l404t1930r435b2042],
3	use	NN	O	use	pobj	1	SENT_1234	[p33l412t1876r428b1920],
4	only	RB	O	only	advmod	3	SENT_1234	[p33l404t1752r435b1818],
5	.	.	O	.	_	0	SENT_1234	[p33l404t1752r435b1818],

